Citrus Sinensis ID: 004174
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 770 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.427 | 0.464 | 0.430 | 5e-72 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.376 | 0.389 | 0.452 | 5e-72 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.392 | 0.396 | 0.449 | 7e-72 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.394 | 0.466 | 0.445 | 4e-71 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.371 | 0.397 | 0.448 | 4e-70 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.364 | 0.391 | 0.442 | 3e-69 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.397 | 0.426 | 0.439 | 4e-69 | |
| Q8RXC8 | 460 | Receptor-like cytosolic s | no | no | 0.397 | 0.665 | 0.44 | 4e-69 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.372 | 0.404 | 0.440 | 7e-69 | |
| Q5XF57 | 579 | Probable receptor-like se | no | no | 0.375 | 0.499 | 0.441 | 8e-69 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 273 bits (697), Expect = 5e-72, Method: Compositional matrix adjust.
Identities = 149/346 (43%), Positives = 211/346 (60%), Gaps = 17/346 (4%)
Query: 411 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKEFVLEIE 469
LF+Y++L+ AT+ F ENL+G+GG VYKG LPDG+ +AVK LK +EF E+E
Sbjct: 364 LFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVE 423
Query: 470 IITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 529
++ +HH++++S++G C + LL+YD++S L +LHG K + W+ R K+A G
Sbjct: 424 TLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGEK---SVLDWATRVKIAAG 480
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
A L YLH R+IHRD+KSSNILL D+F+ ++SDFGLA+ A ++HIT T V GT
Sbjct: 481 AARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHIT-TRVIGT 539
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 649
FGY+APEY GK+ +K DV++FGVVLLEL+TGRKP+ P G ESLV WA+P++S
Sbjct: 540 FGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAI 599
Query: 650 VTQ----LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA--DVTK 703
T+ L DP LG NY +M RM+ A+ C+R RP+M +++ A D+T
Sbjct: 600 ETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESLAAEDLTN 659
Query: 704 WARLQVNASEESEMLDD-ESCPRSNLQSHLNLALLDVEDDSFSMSS 748
RL ESE+ + + L + + D FS SS
Sbjct: 660 GMRLG-----ESEVFNSAQQSAEIRLFRRMAFGSQNYSTDFFSHSS 700
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 273 bits (697), Expect = 5e-72, Method: Compositional matrix adjust.
Identities = 138/305 (45%), Positives = 201/305 (65%), Gaps = 15/305 (4%)
Query: 407 ATCRL----FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKIL-KPSEDVI 461
ATC L F +L AT F A+ ++G+GG +VY+G + DG E+AVK+L + +++
Sbjct: 328 ATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRD 387
Query: 462 KEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWS 521
+EF+ E+E+++ LHH+N++ L+G C E L+Y+ + GS+E +LH D W
Sbjct: 388 REFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHEGTLD-----WD 442
Query: 522 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581
R K+A+G A L YLH S RVIHRD K+SN+LL DDF P++SDFGLA+ A+ S HI
Sbjct: 443 ARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 502
Query: 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 641
+ T V GTFGY+APEY M G + K DVY++GVVLLELLTGR+P+ P G+E+LV WA
Sbjct: 503 S-TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWA 561
Query: 642 KPILSSGK-VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLV---LKLLRG 697
+P+L++ + + QL+DPAL Y++D M ++ + +C+ ++ RP M V LKL+
Sbjct: 562 RPLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLIYN 621
Query: 698 DADVT 702
DAD T
Sbjct: 622 DADET 626
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 272 bits (696), Expect = 7e-72, Method: Compositional matrix adjust.
Identities = 142/316 (44%), Positives = 203/316 (64%), Gaps = 14/316 (4%)
Query: 411 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKEFVLEIE 469
LF+Y++L+ AT+ F ENL+G+GG +VYKG LPD + +AVK LK +EF E++
Sbjct: 417 LFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDREFKAEVD 476
Query: 470 IITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 529
I+ +HH+N++S++G+C +N LL+YD++ +L +LH W+ R K+A G
Sbjct: 477 TISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGT--PGLDWATRVKIAAG 534
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
A L YLH R+IHRD+KSSNILL ++F +SDFGLAK A ++HIT T V GT
Sbjct: 535 AARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTHIT-TRVMGT 593
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG- 648
FGY+APEY GK+ +K DV++FGVVLLEL+TGRKP+ P G ESLV WA+P+LS+
Sbjct: 594 FGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSNAT 653
Query: 649 ---KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR--GDADVTK 703
+ T L DP LG NY +M RM+ A+ CIR RP+MS +++ + D+T
Sbjct: 654 ETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDSLAEEDLTN 713
Query: 704 WARLQ----VNASEES 715
RL +N++++S
Sbjct: 714 GMRLGESEIINSAQQS 729
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 270 bits (689), Expect = 4e-71, Method: Compositional matrix adjust.
Identities = 140/314 (44%), Positives = 204/314 (64%), Gaps = 10/314 (3%)
Query: 394 LPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKI 453
LP GL +S + F Y++L AT+ F NL+G+GG V+KG LP GKE+AVK
Sbjct: 252 LPPPSPGLVLGFSKST--FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQ 309
Query: 454 LKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK 512
LK S +EF E+EII+ +HH++++SL+G+C LLVY+F+ +LE +LHG
Sbjct: 310 LKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG-- 367
Query: 513 KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
K WS R K+A+G A+ L YLH ++IHRD+K+SNIL+ FE +++DFGLAK
Sbjct: 368 KGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK 427
Query: 573 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632
AS +++H++ T V GTFGYLAPEY GK+ +K DV++FGVVLLEL+TGR+P+ ++
Sbjct: 428 IASDTNTHVS-TRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVY 486
Query: 633 GQESLVMWAKPILS----SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQM 688
+SLV WA+P+L+ G L D +GN YD ++M RMV + C+R R RP+M
Sbjct: 487 VDDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRM 546
Query: 689 SLVLKLLRGDADVT 702
S +++ L G+ ++
Sbjct: 547 SQIVRALEGNVSLS 560
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 266 bits (681), Expect = 4e-70, Method: Compositional matrix adjust.
Identities = 132/294 (44%), Positives = 197/294 (67%), Gaps = 8/294 (2%)
Query: 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP-SEDVIKEFVLEIEI 470
F+Y++L T F +N++G+GG VYKG L DGK +AVK LK S +EF E+EI
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEI 418
Query: 471 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 530
I+ +HH++++SL+G+C D + LL+Y+++S +LE +LHG K WS+R ++A+G
Sbjct: 419 ISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHG--KGLPVLEWSKRVRIAIGS 476
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
A+ L YLH ++IHRD+KS+NILL D++E Q++DFGLA+ T+ +H++ T V GTF
Sbjct: 477 AKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVS-TRVMGTF 535
Query: 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL----S 646
GYLAPEY GK+ D+ DV++FGVVLLEL+TGRKP+ P G+ESLV WA+P+L
Sbjct: 536 GYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIE 595
Query: 647 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 700
+G +++L+D L Y ++ RM+ + C+R RP+M V++ L D D
Sbjct: 596 TGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCDGD 649
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 264 bits (674), Expect = 3e-69, Method: Compositional matrix adjust.
Identities = 128/289 (44%), Positives = 192/289 (66%), Gaps = 8/289 (2%)
Query: 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP-SEDVIKEFVLEIEI 470
F Y++L T F ++G+GG VYKG L +GK +A+K LK S + +EF E+EI
Sbjct: 358 FTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEI 417
Query: 471 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 530
I+ +HH++++SL+G+C + + L+Y+F+ +L+ +LHG K+ WS R ++A+G
Sbjct: 418 ISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHG--KNLPVLEWSRRVRIAIGA 475
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
A+ L YLH ++IHRD+KSSNILL D+FE Q++DFGLA+ T+ SHI+ T V GTF
Sbjct: 476 AKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHIS-TRVMGTF 534
Query: 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL----S 646
GYLAPEY GK+ D+ DV++FGVVLLEL+TGRKP+ P G+ESLV WA+P L
Sbjct: 535 GYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLIEAIE 594
Query: 647 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695
G +++++DP L N+Y ++ +M+ + C+R RP+M V++ L
Sbjct: 595 KGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRAL 643
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 263 bits (672), Expect = 4e-69, Method: Compositional matrix adjust.
Identities = 138/314 (43%), Positives = 199/314 (63%), Gaps = 8/314 (2%)
Query: 390 DSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKEL 449
D + LP GL FNY++L AT+ F NL+G+GG V+KG L +GKE+
Sbjct: 320 DQSVLPPPSPGLALGLGIYQGTFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEV 379
Query: 450 AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL 508
AVK LK S +EF E+ II+ +HH+++++L+G+C D LLVY+F+ +LE +L
Sbjct: 380 AVKQLKEGSSQGEREFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHL 439
Query: 509 HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568
HG K WS R K+A+G A+ L YLH ++IHRD+K+SNIL+ FE +++DF
Sbjct: 440 HG--KGRPTMEWSSRLKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADF 497
Query: 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628
GLAK AS +++H++ T V GTFGYLAPEY GK+ +K DV++FGVVLLEL+TGR+PI
Sbjct: 498 GLAKIASDTNTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDV 556
Query: 629 DHPKGQESLVMWAKPILSS----GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA 684
++ SLV WA+P+L+ G ++D L N YD ++M RMV + C+R
Sbjct: 557 NNVHADNSLVDWARPLLNQVSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPR 616
Query: 685 RPQMSLVLKLLRGD 698
RP+M V ++L G+
Sbjct: 617 RPRMDQVARVLEGN 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RXC8|RBK2_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK2 OS=Arabidopsis thaliana GN=RBK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 263 bits (672), Expect = 4e-69, Method: Compositional matrix adjust.
Identities = 143/325 (44%), Positives = 197/325 (60%), Gaps = 19/325 (5%)
Query: 401 LHEKYSATCRLFNYQ--DLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK--- 455
LH+ Y L N+ D+ AT NF EN+IG+GG + VY+G LP+GK +AVK L
Sbjct: 118 LHDIYDFQSSLQNFSISDIEIATDNFSPENIIGRGGYADVYQGILPEGKLIAVKRLTKGT 177
Query: 456 PSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP 515
P E EF+ E+ II + H N +G C E + LV+ GSL LHG K
Sbjct: 178 PDEQT-AEFLSELGIIAHVDHPNTAKFIGCCIE-GGMHLVFRLSPLGSLGSLLHGPSK-- 233
Query: 516 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575
WS RY VA+G A+ L YLH G +R+IHRD+K+ NILL++DF+PQ+ DFGLAKW
Sbjct: 234 YKLTWSRRYNVALGTADGLVYLHEGCQRRIIHRDIKADNILLTEDFQPQICDFGLAKWLP 293
Query: 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635
+H + GTFGY APEYFM+G V++K DV+AFGV+LLEL+TG + + Q+
Sbjct: 294 KQLTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVFAFGVLLLELITGHPALD----ESQQ 349
Query: 636 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695
SLV+WAKP+L + +L+DP+LG+ Y+ +++ R+ + LCI + RP+MS V++LL
Sbjct: 350 SLVLWAKPLLERKAIKELVDPSLGDEYNREELIRLTSTASLCIDQSSLLRPRMSQVVELL 409
Query: 696 RGDADVTKWAR------LQVNASEE 714
G DV R +Q SEE
Sbjct: 410 LGHEDVVMTPREAKIKMMQRTYSEE 434
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 262 bits (670), Expect = 7e-69, Method: Compositional matrix adjust.
Identities = 130/295 (44%), Positives = 195/295 (66%), Gaps = 8/295 (2%)
Query: 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKEFVLEIEI 470
F Y++L T F N++G+GG VYKG L DGK +AVK LK S +EF E+EI
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400
Query: 471 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 530
I+ +HH++++SL+G+C D+ LL+Y+++ +LE +LHG K W+ R ++A+G
Sbjct: 401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHG--KGRPVLEWARRVRIAIGS 458
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
A+ L YLH ++IHRD+KS+NILL D+FE Q++DFGLAK ++ +H++ T V GTF
Sbjct: 459 AKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVS-TRVMGTF 517
Query: 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL----S 646
GYLAPEY GK+ D+ DV++FGVVLLEL+TGRKP+ P G+ESLV WA+P+L
Sbjct: 518 GYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIE 577
Query: 647 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADV 701
+G ++L+D L +Y +++ RM+ + C+R RP+M V++ L + D+
Sbjct: 578 TGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDM 632
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5XF57|Y5576_ARATH Probable receptor-like serine/threonine-protein kinase At5g57670 OS=Arabidopsis thaliana GN=At5g57670 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 262 bits (669), Expect = 8e-69, Method: Compositional matrix adjust.
Identities = 133/301 (44%), Positives = 194/301 (64%), Gaps = 12/301 (3%)
Query: 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKIL-KPSEDVIKE--FVLEI 468
F Y ++ AT++F N++G GG S+VY+G L DG+ +AVK L K S D+ KE F+ E+
Sbjct: 255 FTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESGDMNKEKEFLTEL 314
Query: 469 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 528
II+ + H N LLG C E L LV+ F G+L LH N+ + W RYK+A+
Sbjct: 315 GIISHVSHPNTALLLGCCVE-KGLYLVFRFSENGTLYSALHENEN--GSLDWPVRYKIAV 371
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
GVA L YLH R+IHRD+KSSN+LL D+EPQ++DFGLAKW +H V G
Sbjct: 372 GVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIPVEG 431
Query: 589 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 648
TFGYLAPE M G +++K D+YAFG++LLE++TGR+P++ Q+ +++WAKP + +G
Sbjct: 432 TFGYLAPESLMQGTIDEKTDIYAFGILLLEIITGRRPVN----PTQKHILLWAKPAMETG 487
Query: 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR--GDADVTKWAR 706
++L+DP L + YD QM ++VL + C+++ P RP M+ VL+LL +A++ K R
Sbjct: 488 NTSELVDPKLQDKYDDQQMNKLVLTASHCVQQSPILRPTMTQVLELLTNGNEAEIAKSWR 547
Query: 707 L 707
+
Sbjct: 548 M 548
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 770 | ||||||
| 255558560 | 758 | ATP binding protein, putative [Ricinus c | 0.981 | 0.997 | 0.742 | 0.0 | |
| 224066793 | 738 | predicted protein [Populus trichocarpa] | 0.940 | 0.981 | 0.722 | 0.0 | |
| 356547275 | 736 | PREDICTED: uncharacterized protein LOC10 | 0.951 | 0.995 | 0.672 | 0.0 | |
| 449523137 | 756 | PREDICTED: uncharacterized LOC101203034 | 0.954 | 0.972 | 0.687 | 0.0 | |
| 449463428 | 756 | PREDICTED: uncharacterized protein LOC10 | 0.954 | 0.972 | 0.687 | 0.0 | |
| 224082346 | 697 | predicted protein [Populus trichocarpa] | 0.894 | 0.988 | 0.704 | 0.0 | |
| 356515943 | 743 | PREDICTED: probable receptor-like serine | 0.945 | 0.979 | 0.658 | 0.0 | |
| 302141759 | 732 | unnamed protein product [Vitis vinifera] | 0.919 | 0.967 | 0.690 | 0.0 | |
| 356507630 | 750 | PREDICTED: probable receptor-like serine | 0.946 | 0.972 | 0.658 | 0.0 | |
| 42563282 | 794 | adenine nucleotide alpha hydrolases-doma | 0.961 | 0.931 | 0.625 | 0.0 |
| >gi|255558560|ref|XP_002520305.1| ATP binding protein, putative [Ricinus communis] gi|223540524|gb|EEF42091.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1139 bits (2946), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 573/772 (74%), Positives = 648/772 (83%), Gaps = 16/772 (2%)
Query: 1 MKMVQQEGDVISSGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVD 60
MKM+Q SG RTV+VGVKLD+ SRELLTWA+VKVAQPGDTVIALHVL NN IVD
Sbjct: 1 MKMIQHAEKKGGSGC-RTVMVGVKLDSESRELLTWAMVKVAQPGDTVIALHVLGNNEIVD 59
Query: 61 RDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIV 120
R+GKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRG+SIRKILVREA+SYSAT IV
Sbjct: 60 REGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGSSIRKILVREAKSYSATNIIV 119
Query: 121 GTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRN 180
G A+ HHTIRS TS+AKYCAKKLSKDC VLAV+NGKVVFQKEG + G+S G+ED +R
Sbjct: 120 GAARTHHTIRSPTSVAKYCAKKLSKDCLVLAVHNGKVVFQKEGSTAKTGDSHGSEDDQRK 179
Query: 181 SLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLG-GSVMNLEQALVKARSDCSG 239
+++ HRSIS+SK NSKV+++ G I P +G G+ QALVKAR + G
Sbjct: 180 GFVNIFHRSISLSK-----NSKVISESG--INEAPKYVVGEGNEQTFHQALVKARPNSLG 232
Query: 240 SAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQ 299
S K+NC++CG V N D SC+QS E+S D G ++SLA+VPV VE S+S L+ Q
Sbjct: 233 SIMKQNCTVCGAVGNSLDESCNQSAEKSSGDNGGDNKSLALVPVSKVEGRSSSFRSLIAQ 292
Query: 300 LPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTRQ-PSYLANSDVKQITYDP 358
+PE +PGWPLLRRAI P +A DRSSLR+ISVVQWA+RLP+RQ S ++N D KQ
Sbjct: 293 VPELKPGWPLLRRAILPGGQASDRSSLRQISVVQWAMRLPSRQLSSSISNLDHKQ----N 348
Query: 359 GDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLL 418
G+ + +L+G+SGAIV VG + ++ P S DH++ +LP ELEG HEKYSATCRLF YQ+LL
Sbjct: 349 GEGQP-SLDGESGAIVAVGTDALTIPPSPDHNA-KLPIELEGFHEKYSATCRLFQYQELL 406
Query: 419 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN 478
SATSNFLAE L+GKGGSSQVYKGCLPDGKELAVKILKPSEDV+KEFVLEIEIITTL+HKN
Sbjct: 407 SATSNFLAEYLVGKGGSSQVYKGCLPDGKELAVKILKPSEDVLKEFVLEIEIITTLNHKN 466
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
IISLLGFCFE N LLLVYDFLSRGSLEENLHGN+KDP AF W ERYKVA+GVAEAL YLH
Sbjct: 467 IISLLGFCFEYNKLLLVYDFLSRGSLEENLHGNRKDPLAFNWYERYKVAVGVAEALNYLH 526
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
+G+AQ VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI CTDVAGTFGYLAPEYF
Sbjct: 527 TGTAQPVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIICTDVAGTFGYLAPEYF 586
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658
MYGKVN+KIDVYAFGVVLLELL+GRKPISND PKGQESLVMWAKPIL GK QLLDP+L
Sbjct: 587 MYGKVNEKIDVYAFGVVLLELLSGRKPISNDLPKGQESLVMWAKPILDDGKFCQLLDPSL 646
Query: 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEML 718
G++YD DQMERMVLA+ LC++R PRARPQMSLVLKLL GDA+VTKWARLQVN EES+ML
Sbjct: 647 GDDYDQDQMERMVLAATLCVKRSPRARPQMSLVLKLLHGDAEVTKWARLQVNKVEESDML 706
Query: 719 DDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 770
DDE+CPRSN+QSHLNLA LDVEDDS S+SSIEQ+VSLEDYL GR SRSSSFD
Sbjct: 707 DDETCPRSNIQSHLNLAFLDVEDDSLSISSIEQTVSLEDYLQGRCSRSSSFD 758
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224066793|ref|XP_002302218.1| predicted protein [Populus trichocarpa] gi|222843944|gb|EEE81491.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1035 bits (2675), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 538/745 (72%), Positives = 619/745 (83%), Gaps = 21/745 (2%)
Query: 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSV 77
TV+VGVKLD+ SRELLTWALVKVAQPGDTVIALHVL +N IVDR+GKSSLLSLVKAFDSV
Sbjct: 8 TVIVGVKLDSMSRELLTWALVKVAQPGDTVIALHVLGSNEIVDREGKSSLLSLVKAFDSV 67
Query: 78 LAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAK 137
LAVYEGFCNLKQVDLKLKICRG+S RKILVRE +SY+ATK IVG AKNH +I S+TS+AK
Sbjct: 68 LAVYEGFCNLKQVDLKLKICRGSSTRKILVREVKSYAATKVIVGAAKNHPSIWSSTSVAK 127
Query: 138 YCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVIHRSISMSKITG 197
YCAKKL KDCSVLAVNNGKVVFQ+E P+T+G T+DH + SLL V+HR+IS K +
Sbjct: 128 YCAKKLPKDCSVLAVNNGKVVFQRERSPNTSG----TKDHSK-SLLSVVHRTISSEKKSR 182
Query: 198 QKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPD 257
+ N + +G S + D + LE+AL+KARS+ S K NCS+CG D
Sbjct: 183 ELNES--SANGGSKDDQDSDQI------LEKALMKARSNSLESIMKENCSVCGSATIFAD 234
Query: 258 GSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPD 317
S ++S E S SD G D+SLA+VPV +E ++S++ L+RQ+PE +PGWPLL RA+ PD
Sbjct: 235 DSSNESAEASSSDNGGDDKSLALVPVPRLEEPTSSVSTLIRQVPELKPGWPLLCRAVLPD 294
Query: 318 RRAPDRSSLRKISVVQW-ALRLPTRQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPV 376
++ + S +R++ VVQW L L T NSD KQ D G+++ NL+G+SGAIV V
Sbjct: 295 KKESNISLVRQVCVVQWEQLSLST------VNSDHKQDGSDKGEDK-FNLDGESGAIVAV 347
Query: 377 GNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSS 436
G E ++P + H+S PKELEGLHEKYSATCRLF YQ+LLSATSNFLAENLIGKGGSS
Sbjct: 348 GMETATAPHTPHHNSRSPPKELEGLHEKYSATCRLFQYQELLSATSNFLAENLIGKGGSS 407
Query: 437 QVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496
QVYKGCL DGKELAVKILKPSEDV+KEFVLEIEIITTLHHKNIISLLGFCFED NLLLVY
Sbjct: 408 QVYKGCLSDGKELAVKILKPSEDVLKEFVLEIEIITTLHHKNIISLLGFCFEDKNLLLVY 467
Query: 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556
DFL RGSLE+NL+GNKKDP FGW+ERYKVA+GVAEAL+YLHS SAQ VIHRDVKSSNIL
Sbjct: 468 DFLPRGSLEDNLYGNKKDPLTFGWNERYKVALGVAEALDYLHSCSAQPVIHRDVKSSNIL 527
Query: 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 616
LSDDFEPQLSDFGLAKWA TSSSHI CTDVAGTFGYLAPEYFMYGKVN KIDVYAFGVVL
Sbjct: 528 LSDDFEPQLSDFGLAKWAPTSSSHIICTDVAGTFGYLAPEYFMYGKVNKKIDVYAFGVVL 587
Query: 617 LELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL 676
LELL+G+KPISND PKGQESLVMWAKPIL+ GKV+QLLD +LG++YD DQMERMVLA+ L
Sbjct: 588 LELLSGKKPISNDLPKGQESLVMWAKPILNGGKVSQLLDSSLGDSYDLDQMERMVLAANL 647
Query: 677 CIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNLQSHLNLAL 736
C++R PRARPQMSLV+KLL+GDA+ TKWARLQVNA+EES++LDDE+CPRSNL SHLNLAL
Sbjct: 648 CVKRAPRARPQMSLVVKLLQGDAEATKWARLQVNAAEESDVLDDEACPRSNLLSHLNLAL 707
Query: 737 LDVEDDSFSMSSIEQSVSLEDYLLG 761
LDVEDD S+SSIE S+SLEDYL G
Sbjct: 708 LDVEDDLLSLSSIEHSISLEDYLAG 732
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547275|ref|XP_003542041.1| PREDICTED: uncharacterized protein LOC100797280 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1023 bits (2644), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 520/773 (67%), Positives = 602/773 (77%), Gaps = 40/773 (5%)
Query: 1 MKMVQ--QEGDVISSGAG-RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNA 57
MKM+ G SGAG RTVVVG+K+D+HS ELLTWAL KVAQPGD V+ALHVL N+
Sbjct: 1 MKMLPPPTAGGASHSGAGDRTVVVGMKMDSHSTELLTWALFKVAQPGDVVLALHVLGNDE 60
Query: 58 IVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATK 117
IV+R+GKSSL SLVKAFDS+LAVYEGFCNLKQVDLK KICRG+S+R+ILVREA +YSAT
Sbjct: 61 IVNREGKSSLFSLVKAFDSILAVYEGFCNLKQVDLKFKICRGSSVRRILVREANAYSATH 120
Query: 118 FIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDH 177
IVG+++ H IR S+A+YCAKKL KDC VLAV+NGK+VF++EG P+T E KG +
Sbjct: 121 IIVGSSQGLHIIRPCISVARYCAKKLPKDCWVLAVDNGKIVFKREGSPATRAELKGLDQD 180
Query: 178 RRNSLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDC 237
+ LL IHR+IS K SKV+ DDG+ I K G+ + +L KA D
Sbjct: 181 HKTRLLGSIHRTIS-------KGSKVLDDDGTGIHEKGC----GNGEYSDHSLAKAFLDS 229
Query: 238 SGSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLV 297
K+ CSIC SEEES D + LAIVPVQ +AAS
Sbjct: 230 KEFVEKKRCSICA------------SEEESCGDASDENNPLAIVPVQTNDAAS------- 270
Query: 298 RQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYD 357
+PGWPLLR+ I D++ ++S LR+ISVVQWA++LP+R SY A+ D K D
Sbjct: 271 ------KPGWPLLRKTIASDKKCSEKSLLRQISVVQWAMQLPSRDLSYAAHQDHKANNCD 324
Query: 358 PGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDL 417
++ + L+ SGA+VPV EI ++ S + +S +PKELEGLHEKYS+TCRLF YQ+L
Sbjct: 325 QNKDQFLALDSKSGALVPVDAEIGTAS-SPERNSRSIPKELEGLHEKYSSTCRLFEYQEL 383
Query: 418 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK 477
+ ATSNFL ENLIGKGGSSQVY+GCLPDGKELAVKILKPS+DV+KEFVLEIEIITTL+HK
Sbjct: 384 VLATSNFLPENLIGKGGSSQVYRGCLPDGKELAVKILKPSDDVLKEFVLEIEIITTLNHK 443
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
NIISLLGFCFED NLLLVYDFLSRGSLEENLHGNKK+P FGW+ERYKVAMGVAEALEYL
Sbjct: 444 NIISLLGFCFEDGNLLLVYDFLSRGSLEENLHGNKKNPLVFGWTERYKVAMGVAEALEYL 503
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
H+ Q VIHRDVKSSN+LLS+DFEPQLSDFGLAKWASTSSSHI CTDVAGTFGY+APEY
Sbjct: 504 HNNEGQSVIHRDVKSSNVLLSEDFEPQLSDFGLAKWASTSSSHIICTDVAGTFGYMAPEY 563
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657
FMYGKVNDKIDVYAFGVVLLELL+GRKPIS D+PKGQESLVMWA PIL+SGKV Q+LDP+
Sbjct: 564 FMYGKVNDKIDVYAFGVVLLELLSGRKPISGDYPKGQESLVMWASPILNSGKVLQMLDPS 623
Query: 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEM 717
LG NYD+++MERMVLA+ LCIRR PRARP MSL+ KLL GD DV KWARL+ NA E EM
Sbjct: 624 LGENYDHEEMERMVLAATLCIRRAPRARPLMSLISKLLGGDPDVIKWARLEANALEAPEM 683
Query: 718 LDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 770
LD E+CP SNLQSHLNLALLDVEDDS SM S+EQ+VSLEDYL GRWSRSSSFD
Sbjct: 684 LDGEACPPSNLQSHLNLALLDVEDDSLSMCSVEQNVSLEDYLRGRWSRSSSFD 736
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449523137|ref|XP_004168581.1| PREDICTED: uncharacterized LOC101203034 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1022 bits (2642), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 523/761 (68%), Positives = 616/761 (80%), Gaps = 26/761 (3%)
Query: 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF 74
+ RTV+VG+KLD+HSRELLTWALVKVAQPGD VIALHVL N+ IV++DGKSSLLSLVKAF
Sbjct: 17 SARTVLVGMKLDSHSRELLTWALVKVAQPGDLVIALHVLGNHEIVNQDGKSSLLSLVKAF 76
Query: 75 DSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTS 134
D+VLAVYEGFCNLKQVDLKLKICRG S RKILVREA+SY AT IVGTA+ HH IRS+TS
Sbjct: 77 DTVLAVYEGFCNLKQVDLKLKICRGESARKILVREAKSYRATNLIVGTARKHHKIRSSTS 136
Query: 135 LAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVIHRSISMSK 194
+AKYCAKKL KD VLAV+NGKV+F++EGCP G+ G E+ R ++LL ++ S S
Sbjct: 137 VAKYCAKKLPKDFWVLAVHNGKVIFEREGCPVATGDCHGNEEQRHSNLLAAVYGSAGSSP 196
Query: 195 ITGQKNSKVVTDDG-SSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVR 253
KV + + S+ ++ D+LG N +Q KA S K+NCSICG
Sbjct: 197 -------KVQSGESFGSLLARDRDNLGIG-KNSDQEFEKA---LSVGTDKQNCSICGSES 245
Query: 254 NLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLR-- 311
+ + QS E S SDG DESLA+VPVQ VE AS+SIT L++QLPE +PGWPLLR
Sbjct: 246 SFVE----QSAEISSSDGEKHDESLALVPVQIVEVASSSITKLIKQLPEVKPGWPLLRHV 301
Query: 312 -RAIFPDRRAP-DRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGD 369
++ R+A DRS ++ISVVQWA++LP+R P Y A D K T D +S+ L+G+
Sbjct: 302 DQSCESGRQASSDRSLAKQISVVQWAMKLPSRSPLYPAALDYKSNTSD----QSLGLDGE 357
Query: 370 SGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENL 429
+GA+V VG+E V SPLS+D D+ LPKELEG HEKYS+TCRLFNY +LL+ATSNFL ENL
Sbjct: 358 NGAMVLVGSEPVPSPLSSDSDTETLPKELEGFHEKYSSTCRLFNYHELLTATSNFLPENL 417
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
IGKGGSSQV++GCLPDGKE+AVKILK SEDV+KEFV+E+EIIT+L HKNIISLLGFCFE+
Sbjct: 418 IGKGGSSQVFRGCLPDGKEVAVKILKTSEDVLKEFVMEVEIITSLSHKNIISLLGFCFEN 477
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ LLVYDFLSRG LEE LHGN+K+P FGWSERYKVA+GVAEAL+YLH AQ VIHRD
Sbjct: 478 SKFLLVYDFLSRGCLEEILHGNRKNPNTFGWSERYKVAVGVAEALDYLHL-DAQHVIHRD 536
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 609
VKSSNILLSDDFEPQLSDFGLAK S++SSH+TCTDVAGTFGYLAPEYFMYGKVNDKIDV
Sbjct: 537 VKSSNILLSDDFEPQLSDFGLAK-RSSNSSHVTCTDVAGTFGYLAPEYFMYGKVNDKIDV 595
Query: 610 YAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMER 669
YA+GVVLLEL++GRKPIS ++PKGQESLVMWA+PIL GKV++LLDP LG NY+ D+MER
Sbjct: 596 YAYGVVLLELISGRKPISTEYPKGQESLVMWARPILIDGKVSRLLDPTLGGNYNQDEMER 655
Query: 670 MVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNLQ 729
+VLA+ LCIRR PRARP MSLVLKLL+GDADVTKWAR Q+NA +S LDDE CPRS++Q
Sbjct: 656 VVLAASLCIRRAPRARPPMSLVLKLLQGDADVTKWARQQINALGDSNTLDDEVCPRSDIQ 715
Query: 730 SHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 770
SHLNLALLDV+DDS S+SSIE S+SLEDYL GRWSRSSSFD
Sbjct: 716 SHLNLALLDVDDDSLSLSSIEHSISLEDYLQGRWSRSSSFD 756
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463428|ref|XP_004149436.1| PREDICTED: uncharacterized protein LOC101203034 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1021 bits (2640), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 523/761 (68%), Positives = 615/761 (80%), Gaps = 26/761 (3%)
Query: 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF 74
+ RTV+VG+KLD+HSRELLTWALVKVAQPGD VIALHVL N+ IV++DGKSSLLSLVKAF
Sbjct: 17 SARTVLVGMKLDSHSRELLTWALVKVAQPGDLVIALHVLGNHEIVNQDGKSSLLSLVKAF 76
Query: 75 DSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTS 134
D+VLAVYEGFCNLKQVDLKLKICRG S RKILVREA+SY AT IVGTA+ HH IRS+TS
Sbjct: 77 DTVLAVYEGFCNLKQVDLKLKICRGESARKILVREAKSYRATNLIVGTARKHHKIRSSTS 136
Query: 135 LAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVIHRSISMSK 194
+AKYCAKKL KD VLAV+NGKV+F++EGCP G+ G E+ R ++LL ++ S S
Sbjct: 137 VAKYCAKKLPKDFWVLAVHNGKVIFEREGCPVATGDCHGNEEQRHSNLLAAVYGSAGSSP 196
Query: 195 ITGQKNSKVVTDDG-SSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVR 253
KV + + S+ ++ D+LG N +Q KA S K+NCSICG
Sbjct: 197 -------KVQSGESFGSLLARDRDNLGIG-KNSDQEFEKA---LSVGTDKQNCSICGSES 245
Query: 254 NLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLR-- 311
+ + QS E S SDG DESLA+VPVQ VE AS+SIT L++QLPE +PGWPLLR
Sbjct: 246 SFVE----QSAEISSSDGEKHDESLALVPVQIVEVASSSITKLIKQLPEVKPGWPLLRHV 301
Query: 312 -RAIFPDRRAP-DRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGD 369
++ R+A DRS ++ISVVQWA++LP+R P Y A D K T D +S+ L+G+
Sbjct: 302 DQSCESGRQASSDRSLAKQISVVQWAMKLPSRSPLYPAALDYKSNTSD----QSLGLDGE 357
Query: 370 SGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENL 429
+GA+V VG+E V SPLS+D D+ LPKELEG HEKYS+TCRLFNY +LL+ATSNFL ENL
Sbjct: 358 NGAMVLVGSEPVPSPLSSDSDTETLPKELEGFHEKYSSTCRLFNYHELLTATSNFLPENL 417
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
IGKGGSSQV++GCLPDGKE+AVKILK SEDV+KEFV+E+EIIT+L HKNIISLLGFCFE+
Sbjct: 418 IGKGGSSQVFRGCLPDGKEVAVKILKTSEDVLKEFVMEVEIITSLSHKNIISLLGFCFEN 477
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ LLVYDFLSRG LEE LHGN+K+P FGWSERYKVA+GVAEAL+YLH AQ VIHRD
Sbjct: 478 SKFLLVYDFLSRGCLEEILHGNRKNPNTFGWSERYKVAVGVAEALDYLHL-DAQHVIHRD 536
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 609
VKSSNILLSDDFEPQLSDFGLAK S++SSH+TCTDVAGTFGYLAPEYFMYGKVNDKIDV
Sbjct: 537 VKSSNILLSDDFEPQLSDFGLAK-RSSNSSHVTCTDVAGTFGYLAPEYFMYGKVNDKIDV 595
Query: 610 YAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMER 669
YA+GVVLLEL++GRKPIS +PKGQESLVMWA+PIL GKV++LLDP LG NY+ D+MER
Sbjct: 596 YAYGVVLLELISGRKPISTKYPKGQESLVMWARPILIDGKVSRLLDPTLGGNYNQDEMER 655
Query: 670 MVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNLQ 729
+VLA+ LCIRR PRARP MSLVLKLL+GDADVTKWAR Q+NA +S LDDE CPRS++Q
Sbjct: 656 VVLAASLCIRRAPRARPPMSLVLKLLQGDADVTKWARQQINALGDSNTLDDEVCPRSDIQ 715
Query: 730 SHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 770
SHLNLALLDV+DDS S+SSIE S+SLEDYL GRWSRSSSFD
Sbjct: 716 SHLNLALLDVDDDSLSLSSIEHSISLEDYLQGRWSRSSSFD 756
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224082346|ref|XP_002306655.1| predicted protein [Populus trichocarpa] gi|222856104|gb|EEE93651.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1021 bits (2640), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 531/754 (70%), Positives = 603/754 (79%), Gaps = 65/754 (8%)
Query: 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSV 77
TV+VGVKLD SRELLTWALVKVAQPGDTVIALH+L NN IVDR+GKSSLLSLVKAFD+V
Sbjct: 8 TVIVGVKLDPASRELLTWALVKVAQPGDTVIALHILDNNEIVDREGKSSLLSLVKAFDNV 67
Query: 78 LAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAK 137
LAVYEGFCNLKQVDLKLKICRG+SIR+ILVREA+SY+ATK IVG +NH +I +TS+AK
Sbjct: 68 LAVYEGFCNLKQVDLKLKICRGSSIRRILVREAKSYTATKVIVGATRNHLSIWPSTSVAK 127
Query: 138 YCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVIHRSISMSKITG 197
YCAKKL KDCSVLA NNGKVVFQ+E P+ G + S S++ I
Sbjct: 128 YCAKKLPKDCSVLAFNNGKVVFQRERTPNNTG-----------------NFSCSLASIM- 169
Query: 198 QKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPD 257
++N V GS + KP DD
Sbjct: 170 KENCSVC---GSVM--KPADD--------------------------------------- 185
Query: 258 GSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPD 317
SC+QS E S D D+SLA+VPV VE ++S++ L+ Q+PE +PGWPLLR ++ P+
Sbjct: 186 -SCNQSAEASCGDRDGDDKSLALVPVPRVEEPTSSVSTLIGQVPELKPGWPLLRSSVLPN 244
Query: 318 RRAPDRSSLRKISVVQWALRLPTRQPSY-LANSDVKQITYDPGDNESINLNGDSGAIVPV 376
R+ +RS +R+ISVVQWA+RLP+RQ S NSD KQ D G+ E +NL+G+SGAIV V
Sbjct: 245 RKTSNRSLVRQISVVQWAMRLPSRQLSLSTVNSDHKQDVSDKGE-EQLNLDGESGAIVAV 303
Query: 377 GNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSS 436
G E ++PLS DH+S LPKELEGLHEKYSATCRLF Q+LLSATSNFLAENLIGKGGSS
Sbjct: 304 GMETATAPLSPDHNSRSLPKELEGLHEKYSATCRLFQCQELLSATSNFLAENLIGKGGSS 363
Query: 437 QVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496
QVYKGCLPDGKELAVKILKPSEDV+KEFV EIEIITTL HKNIISLLGFCFE NLLLVY
Sbjct: 364 QVYKGCLPDGKELAVKILKPSEDVLKEFVQEIEIITTLSHKNIISLLGFCFEGKNLLLVY 423
Query: 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556
DFLSRGSLEENLHGNKKDP AFGW+ERYKVA+G+AEAL+YLHS SAQ VIHRDVKSSNIL
Sbjct: 424 DFLSRGSLEENLHGNKKDPRAFGWNERYKVALGIAEALDYLHSCSAQPVIHRDVKSSNIL 483
Query: 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 616
LSDDFEPQLSDFGLAKWA TSSSHI C DVAGTFGYLAPEYFMYGKVN+KIDVYAFGVVL
Sbjct: 484 LSDDFEPQLSDFGLAKWAPTSSSHIICNDVAGTFGYLAPEYFMYGKVNNKIDVYAFGVVL 543
Query: 617 LELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL 676
LELL+G+KPISND PKGQESLVMWAKPIL+ GKV+QLLDP LG++ D DQMERMVLA+ L
Sbjct: 544 LELLSGKKPISNDLPKGQESLVMWAKPILNGGKVSQLLDPILGDSCDRDQMERMVLAATL 603
Query: 677 CIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNLQSHLNLAL 736
C+RR PRARPQMSLV+KLL+GDA+VT+WARLQVNA EES++LDDE+CPRSNLQSHLNLAL
Sbjct: 604 CVRRAPRARPQMSLVVKLLQGDAEVTRWARLQVNAVEESDVLDDEACPRSNLQSHLNLAL 663
Query: 737 LDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 770
LDVE+DS S SS+EQS+SL+DYL GRWSRSSS D
Sbjct: 664 LDVENDSLSSSSLEQSISLQDYLQGRWSRSSSLD 697
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356515943|ref|XP_003526656.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 989 bits (2556), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 502/762 (65%), Positives = 591/762 (77%), Gaps = 34/762 (4%)
Query: 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF 74
GRTV+VGVK+D+ S+ELLTWALVKVA PGDTV+ALHVL NN V+ DGKSSLLSLVKAF
Sbjct: 10 GGRTVLVGVKMDSPSKELLTWALVKVAHPGDTVVALHVLGNNETVNGDGKSSLLSLVKAF 69
Query: 75 DSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTS 134
DSVLA Y+GFCNLKQVDLKLKICRG+S++K LVREA YSAT +VGT H IRS+T
Sbjct: 70 DSVLAAYKGFCNLKQVDLKLKICRGSSVKKTLVREANGYSATHVVVGTTHGLHKIRSSTV 129
Query: 135 LAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVIHRSISMSK 194
+AK+CAKKLSKDC VLAVNNGKVVF+++ P + E +G + H RN LL IH ++
Sbjct: 130 VAKHCAKKLSKDCCVLAVNNGKVVFKRDSSPPSVAELQGVDRHNRNGLLGSIHWTLG--- 186
Query: 195 ITGQKNSKVVTDDGSSI-----TSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSIC 249
KN KV++DD S + + P+ D +L K + + +CSIC
Sbjct: 187 ----KNRKVLSDDSSGMDADEKKTGPISD---------HSLAKFFLESKETVRNPSCSIC 233
Query: 250 GPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPL 309
G LPD S QS E D G + SLA+VPVQ AA T E +PGWPL
Sbjct: 234 GTTLALPDPSFYQSAEGVSGDEGR-ENSLAMVPVQPTVAAKT----------ELKPGWPL 282
Query: 310 LRRAIFPDRRAPDRSSLR-KISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNG 368
L I DR++ RS +ISVVQWA+RLP+R SY + D K D G ++ L+
Sbjct: 283 LDGRILSDRQSAGRSLFHLQISVVQWAMRLPSRNLSYAVDRDEKSKICDQGQDQPAALDS 342
Query: 369 DSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAEN 428
+SGA+V V E+ ++ S +++S +PKELEGLHEKYS+TCRLF YQ+L+SATSNFL EN
Sbjct: 343 ESGALVLVDAELGTAS-SPENNSGNIPKELEGLHEKYSSTCRLFEYQELVSATSNFLHEN 401
Query: 429 LIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 488
LIGKGGSSQVY+GCLPDGKELAVKIL PS+DV+ EF+LEIEIITTLHHKNIISLLGFCFE
Sbjct: 402 LIGKGGSSQVYRGCLPDGKELAVKILNPSDDVLSEFLLEIEIITTLHHKNIISLLGFCFE 461
Query: 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 548
+ LLLVYDFLSRGSLEENLHGNKK+ FGWSERYKVA+GVAEAL+YLHS Q VIHR
Sbjct: 462 NGKLLLVYDFLSRGSLEENLHGNKKNSLVFGWSERYKVAVGVAEALDYLHSKDDQPVIHR 521
Query: 549 DVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKID 608
DVKSSN+LLS++FEPQLSDFGLAKWAST SSHITCTDVAGTFGYLAPEYFMYGKVNDKID
Sbjct: 522 DVKSSNVLLSENFEPQLSDFGLAKWASTLSSHITCTDVAGTFGYLAPEYFMYGKVNDKID 581
Query: 609 VYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQME 668
VYAFGVVLLELL+GRKPIS D+PKGQESLVMWA PIL+SGKV QLLDP+LG+NYD+++ME
Sbjct: 582 VYAFGVVLLELLSGRKPISRDYPKGQESLVMWASPILNSGKVLQLLDPSLGDNYDHEEME 641
Query: 669 RMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNL 728
++VLA+ LCI+R PRARPQM+L+ KLL+GDA+ KWARLQVNA + EMLDDE+CP SNL
Sbjct: 642 KIVLAATLCIKRAPRARPQMNLISKLLQGDAEAIKWARLQVNALDPPEMLDDEACPPSNL 701
Query: 729 QSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 770
QSH+NLALLDVEDD SM S+EQ ++LEDYL GRWSR+SSFD
Sbjct: 702 QSHINLALLDVEDDLLSMCSVEQGLTLEDYLRGRWSRASSFD 743
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302141759|emb|CBI18962.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 987 bits (2552), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 516/747 (69%), Positives = 593/747 (79%), Gaps = 39/747 (5%)
Query: 24 KLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEG 83
KLD+ SRELLTWALVKVAQPGD VIALHVL +N + S +V +F AVYEG
Sbjct: 25 KLDSQSRELLTWALVKVAQPGDRVIALHVLGHNEMGVCRNCGSRWEIVASF----AVYEG 80
Query: 84 FCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKL 143
FCNLKQVDLKLKICRG+SI KILVRE +SY A+K IVGTA+NHH IRS+ ++AKYCAKKL
Sbjct: 81 FCNLKQVDLKLKICRGSSIGKILVREVKSYVASKVIVGTARNHHAIRSSAAVAKYCAKKL 140
Query: 144 SKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVIHRSISMSKITGQKNSKV 203
KDCSVLAVNNGKVVFQ+E T +S+ E+HRRN LL I +S+ SK + N
Sbjct: 141 PKDCSVLAVNNGKVVFQREASMRTTVDSQEKEEHRRNGLLGGIQQSV--SKKSKALNHGK 198
Query: 204 VTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSCSQS 263
V ++ S+I C SA + L SCSQS
Sbjct: 199 VNEEPSTI-------------------------CDPSACQS--------LELGLNSCSQS 225
Query: 264 EEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDR 323
E S D D+SLAIVPVQ +EA+S+SI++L+R+LPE RPGWPLLRRAI PDR+ +
Sbjct: 226 IEGSSGDSHHEDDSLAIVPVQKLEASSSSISLLIRELPELRPGWPLLRRAILPDRQTSTK 285
Query: 324 SSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSS 383
SS+R+ISVVQWA+RLP+R A+ D + + D ++ S NL+G+SGAIVPVG S+
Sbjct: 286 SSVRQISVVQWAMRLPSRNFPSAASLDNIESSCDGDEDLSTNLDGESGAIVPVGTVNASA 345
Query: 384 PLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL 443
P S ST+L KELEGLHEKYSATCRLF +Q+L SATSNF+ ENLIGKGGSS+VY+GCL
Sbjct: 346 PPSPSRSSTKLAKELEGLHEKYSATCRLFKFQELFSATSNFMPENLIGKGGSSRVYRGCL 405
Query: 444 PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 503
DGKELAVKILK S+D++KEF+LEIEII+TLHHKNIISLLGFCFE+NNLLLVYDFLSRGS
Sbjct: 406 SDGKELAVKILKQSDDILKEFLLEIEIISTLHHKNIISLLGFCFENNNLLLVYDFLSRGS 465
Query: 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563
LEENL+GNKKD AFGWSERYKVA+GVAEAL+YLH GSAQ VIH DVKSSNILL+DDFEP
Sbjct: 466 LEENLYGNKKDLFAFGWSERYKVAVGVAEALDYLHCGSAQAVIHGDVKSSNILLADDFEP 525
Query: 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 623
QLSDFGLAKWASTSSSHITC+DVAGTFGY+APEYFMYGKVN+KIDVYAFGVVLLELL+GR
Sbjct: 526 QLSDFGLAKWASTSSSHITCSDVAGTFGYMAPEYFMYGKVNEKIDVYAFGVVLLELLSGR 585
Query: 624 KPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPR 683
KPIS+D+PKGQESLVMWAKPIL GKV++LLDP+LG+NYD QMERMV A+ILCIRR PR
Sbjct: 586 KPISSDYPKGQESLVMWAKPILYGGKVSELLDPSLGSNYDSSQMERMVWAAILCIRRAPR 645
Query: 684 ARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDS 743
ARPQMSLVLKLL+GDA+ TKWARLQVNA E S+ DDE+ P SNLQSHLNLALLDVE+DS
Sbjct: 646 ARPQMSLVLKLLQGDAEATKWARLQVNACEGSDTPDDEAFPHSNLQSHLNLALLDVEEDS 705
Query: 744 FSMSSIEQSVSLEDYLLGRWSRSSSFD 770
SMSSIEQSVSLEDYL GRWSRSSSFD
Sbjct: 706 LSMSSIEQSVSLEDYLQGRWSRSSSFD 732
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507630|ref|XP_003522567.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 979 bits (2532), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 501/761 (65%), Positives = 592/761 (77%), Gaps = 32/761 (4%)
Query: 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF 74
GRTVVVGVK+D+ +ELLTWALVKVA P DTV+ALHVL ++ V+ GKSSLLSLVKAF
Sbjct: 17 GGRTVVVGVKMDSPCKELLTWALVKVAHPRDTVVALHVLGSHETVNGVGKSSLLSLVKAF 76
Query: 75 DSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTS 134
DSVLAVY+GFCNLKQVDLKLKICRG+S++K LVREA YSAT +VGT H IRS+T
Sbjct: 77 DSVLAVYKGFCNLKQVDLKLKICRGSSVKKSLVREANGYSATHIVVGTTHGLHKIRSSTV 136
Query: 135 LAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVIHRSISMSK 194
+AKYCAKKLSKDC VLAVNNGKVVF+++ P + E +G + H RN L+ I ++
Sbjct: 137 VAKYCAKKLSKDCCVLAVNNGKVVFKRDSSPPSVTELQGIDRHNRNGLIGSIQWTLG--- 193
Query: 195 ITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRN 254
K++KV++DD S + + + G V + +L K + + +CSICG
Sbjct: 194 ----KSTKVLSDDNSGMEAD--EKKTGQVS--DHSLAKLFLESKETVRNPSCSICGTTLA 245
Query: 255 LPDGSCSQSEEESPSDGGAGDE----SLAIVPVQNVEAASTSITMLVRQLPESRPGWPLL 310
LPD SC QS +DG +GD+ SLAIVPVQ AA T E +PGWPLL
Sbjct: 246 LPDSSCYQS-----ADGVSGDDGRENSLAIVPVQPSVAAIT----------EMKPGWPLL 290
Query: 311 RRAIFPDRRAPDRSSLR-KISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGD 369
R I DR++ DR + +ISVVQWA+RLP+R SY + + K D G ++ L+ +
Sbjct: 291 HRGILLDRQSADRLLMHPQISVVQWAMRLPSRNLSYAVDCNEKPNICDQGQDQHAALDSE 350
Query: 370 SGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENL 429
SGA+VPV E+ ++ L +H+S +PKELEGLHEKYS+TCRLF YQ+L+ ATSNFL NL
Sbjct: 351 SGALVPVDAELGTASLP-EHNSGNIPKELEGLHEKYSSTCRLFEYQELVLATSNFLPGNL 409
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
IGKGGSSQVY+GCLPDGKELAVKILKPS++V+ EF+LEIEIITTLHHKNIISLLGFCFE+
Sbjct: 410 IGKGGSSQVYRGCLPDGKELAVKILKPSDNVLSEFLLEIEIITTLHHKNIISLLGFCFEN 469
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
LLLVYDFLSRGSLEENLHGNKK FGWSERYKVA+G+AEAL+YLHS Q VIHRD
Sbjct: 470 GKLLLVYDFLSRGSLEENLHGNKKISLVFGWSERYKVAVGIAEALDYLHSKDDQPVIHRD 529
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 609
VKSSN+LLS+DFEPQL DFGLAKWAST SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV
Sbjct: 530 VKSSNVLLSEDFEPQLCDFGLAKWASTLSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 589
Query: 610 YAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMER 669
YAFGVVLLELL+GRKPIS D+PKGQESLVMWA PIL+SGKV QLLDP+LG NYD+ +ME+
Sbjct: 590 YAFGVVLLELLSGRKPISPDYPKGQESLVMWATPILNSGKVLQLLDPSLGENYDHGEMEK 649
Query: 670 MVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDESCPRSNLQ 729
MVLA+ LCI+R PRARPQMSL+ KLL+GDA+ K ARLQVNA + EMLDDE+CP SNLQ
Sbjct: 650 MVLAATLCIKRAPRARPQMSLISKLLQGDAEAIKRARLQVNALDAPEMLDDEACPPSNLQ 709
Query: 730 SHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 770
SH+NLALLDVEDDS SM S+EQ ++LEDYL GRWSR+SSFD
Sbjct: 710 SHINLALLDVEDDSLSMCSVEQGLTLEDYLRGRWSRASSFD 750
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42563282|ref|NP_177852.2| adenine nucleotide alpha hydrolases-domain containing protein kinase [Arabidopsis thaliana] gi|332197836|gb|AEE35957.1| adenine nucleotide alpha hydrolases-domain containing protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 934 bits (2415), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 497/795 (62%), Positives = 596/795 (74%), Gaps = 55/795 (6%)
Query: 2 KMVQQEGDVISS----GAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNA 57
+M++ GD SS GRT++VGVKLD SRELLTWALVKVA+PGDTVIALH+L N
Sbjct: 29 EMIETGGDKQSSVEEGCGGRTILVGVKLDAPSRELLTWALVKVAEPGDTVIALHILGNE- 87
Query: 58 IVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATK 117
IVDR G SSLLSLV+ FDSVL VYEGFCNLKQVDLKLK+CRG+S RKILVREA+S+SATK
Sbjct: 88 IVDRAGNSSLLSLVRTFDSVLDVYEGFCNLKQVDLKLKLCRGSSARKILVREAKSFSATK 147
Query: 118 FIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPS-TAGESK---- 172
+VG +K+HH IRS+ S+AKY AKKLSKDC V+AVNNGK++FQKEG PS T +S+
Sbjct: 148 VLVGISKSHHAIRSSASVAKYIAKKLSKDCWVIAVNNGKILFQKEGSPSSTINQSQVVEE 207
Query: 173 --------GTEDHRRNSLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVM 224
G ED RR +LL+V+ RS++++K T KVV+ SK ++
Sbjct: 208 TVIGFGYIGKEDVRRITLLNVLQRSVTLNKTT-----KVVSHSEEDSNSKEEEEDQACGQ 262
Query: 225 NLEQALVKARSDCSGSAAKRNCSICG-----PVRNLPDGSCS-QSEEESPSDGGAGDESL 278
NL Q L AR + NCS+CG P G S S+ + D ++++
Sbjct: 263 NLRQVLAAARLE--------NCSVCGFDSLSPNDTTTPGKLSGASDFDRSEDDDECNKAM 314
Query: 279 AIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRL 338
IVPV E + S+TMLVR+LPE RPGWPLLRRA+ + KI VVQWAL+L
Sbjct: 315 EIVPVNGSEDSGGSVTMLVRKLPEPRPGWPLLRRAV---STLGQSVTPHKIPVVQWALKL 371
Query: 339 PTRQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKEL 398
P R D KQ+ YD ++ LN A+VP G +++ D+ +LP+EL
Sbjct: 372 PPR--------DTKQLGYDSSEDNLSTLN----ALVPFGINSITNKSIPDNSPRKLPEEL 419
Query: 399 EGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE 458
EGL+E++S+TCR F Y++L+S TSNF A+N IGKGGSS+V++GCL +G+ +AVKILK +E
Sbjct: 420 EGLYERFSSTCRFFKYKELVSVTSNFSADNFIGKGGSSRVFRGCLSNGRVVAVKILKQTE 479
Query: 459 DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAF 518
DV+ +FV EIEIITTLHHKNIISLLGFCFED+NLLLVY++LSRGSLEENLHGNKKDP AF
Sbjct: 480 DVLNDFVAEIEIITTLHHKNIISLLGFCFEDHNLLLVYNYLSRGSLEENLHGNKKDPLAF 539
Query: 519 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578
WSERYKVA+GVAEAL+YLH+ ++Q VIHRDVKSSNILLSDDFEPQLSDFGLA+WAS S+
Sbjct: 540 CWSERYKVAVGVAEALDYLHNTASQPVIHRDVKSSNILLSDDFEPQLSDFGLARWASIST 599
Query: 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638
+HI C+DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL+GRKPIS+ PKGQESLV
Sbjct: 600 THIICSDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLSGRKPISSGCPKGQESLV 659
Query: 639 MWAKPILSSGKVTQLLDPAL--GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
MWAKPIL GK +QLLDP+L NN + DQM+RM LA+ LCIRR P+ARP+MS+VLKLL+
Sbjct: 660 MWAKPILDDGKYSQLLDPSLRDNNNNNDDQMQRMALAATLCIRRSPQARPKMSIVLKLLK 719
Query: 697 GDADVTKWARLQVN-ASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSL 755
GD D +WA QVN +SEESEML DE C RSNLQSHLNLALLDVEDDS SM SIEQ VS+
Sbjct: 720 GDEDTLEWAMQQVNSSSEESEMLKDEQCQRSNLQSHLNLALLDVEDDSISMGSIEQGVSV 779
Query: 756 EDYLLGRWSRSSSFD 770
EDYL GR SRSSSFD
Sbjct: 780 EDYLKGRTSRSSSFD 794
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 770 | ||||||
| TAIR|locus:2195975 | 794 | AT1G77280 [Arabidopsis thalian | 0.971 | 0.942 | 0.618 | 1.5e-239 | |
| TAIR|locus:2026957 | 756 | AT1G21590 [Arabidopsis thalian | 0.966 | 0.984 | 0.576 | 2.6e-221 | |
| TAIR|locus:2160801 | 705 | AT5G63940 [Arabidopsis thalian | 0.688 | 0.751 | 0.556 | 7.8e-194 | |
| TAIR|locus:2059919 | 617 | AT2G16750 [Arabidopsis thalian | 0.436 | 0.544 | 0.556 | 1.4e-118 | |
| TAIR|locus:2172555 | 579 | AT5G57670 [Arabidopsis thalian | 0.394 | 0.525 | 0.432 | 4.6e-80 | |
| TAIR|locus:2156050 | 552 | AT5G37790 [Arabidopsis thalian | 0.561 | 0.782 | 0.399 | 1.9e-74 | |
| TAIR|locus:2165041 | 669 | AT5G56790 [Arabidopsis thalian | 0.379 | 0.436 | 0.447 | 2.1e-74 | |
| TAIR|locus:2091511 | 753 | AT3G13690 [Arabidopsis thalian | 0.371 | 0.379 | 0.446 | 2.9e-72 | |
| TAIR|locus:2044420 | 392 | AT2G18890 [Arabidopsis thalian | 0.436 | 0.857 | 0.433 | 2.3e-71 | |
| TAIR|locus:2019938 | 718 | PERK11 "proline-rich extensin- | 0.490 | 0.526 | 0.387 | 4.7e-70 |
| TAIR|locus:2195975 AT1G77280 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2309 (817.9 bits), Expect = 1.5e-239, P = 1.5e-239
Identities = 487/787 (61%), Positives = 588/787 (74%)
Query: 2 KMVQQEGDVISS---GAG-RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNA 57
+M++ GD SS G G RT++VGVKLD SRELLTWALVKVA+PGDTVIALH+L N
Sbjct: 29 EMIETGGDKQSSVEEGCGGRTILVGVKLDAPSRELLTWALVKVAEPGDTVIALHILGNE- 87
Query: 58 IVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATK 117
IVDR G SSLLSLV+ FDSVL VYEGFCNLKQVDLKLK+CRG+S RKILVREA+S+SATK
Sbjct: 88 IVDRAGNSSLLSLVRTFDSVLDVYEGFCNLKQVDLKLKLCRGSSARKILVREAKSFSATK 147
Query: 118 FIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPS-TAGESKGTED 176
+VG +K+HH IRS+ S+AKY AKKLSKDC V+AVNNGK++FQKEG PS T +S+ E+
Sbjct: 148 VLVGISKSHHAIRSSASVAKYIAKKLSKDCWVIAVNNGKILFQKEGSPSSTINQSQVVEE 207
Query: 177 HRRN----SLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVK 232
DV R I++ + Q++ V + + + S +D +QA +
Sbjct: 208 TVIGFGYIGKEDV--RRITLLNVL-QRS--VTLNKTTKVVSHSEEDSNSKEEEEDQACGQ 262
Query: 233 ARSDCSGSAAKRNCSICG-----PVRNLPDGSCS-QSEEESPSDGGAGDESLAIVPVQNV 286
+A NCS+CG P G S S+ + D ++++ IVPV
Sbjct: 263 NLRQVLAAARLENCSVCGFDSLSPNDTTTPGKLSGASDFDRSEDDDECNKAMEIVPVNGS 322
Query: 287 EAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTRQPSYL 346
E + S+TMLVR+LPE RPGWPLLRRA+ + KI VVQWAL+LP R
Sbjct: 323 EDSGGSVTMLVRKLPEPRPGWPLLRRAV---STLGQSVTPHKIPVVQWALKLPPR----- 374
Query: 347 ANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYS 406
D KQ+ YD ++ LN A+VP G +++ D+ +LP+ELEGL+E++S
Sbjct: 375 ---DTKQLGYDSSEDNLSTLN----ALVPFGINSITNKSIPDNSPRKLPEELEGLYERFS 427
Query: 407 ATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVL 466
+TCR F Y++L+S TSNF A+N IGKGGSS+V++GCL +G+ +AVKILK +EDV+ +FV
Sbjct: 428 STCRFFKYKELVSVTSNFSADNFIGKGGSSRVFRGCLSNGRVVAVKILKQTEDVLNDFVA 487
Query: 467 EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 526
EIEIITTLHHKNIISLLGFCFED+NLLLVY++LSRGSLEENLHGNKKDP AF WSERYKV
Sbjct: 488 EIEIITTLHHKNIISLLGFCFEDHNLLLVYNYLSRGSLEENLHGNKKDPLAFCWSERYKV 547
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586
A+GVAEAL+YLH+ ++Q VIHRDVKSSNILLSDDFEPQLSDFGLA+WAS S++HI C+DV
Sbjct: 548 AVGVAEALDYLHNTASQPVIHRDVKSSNILLSDDFEPQLSDFGLARWASISTTHIICSDV 607
Query: 587 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 646
AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL+GRKPIS+ PKGQESLVMWAKPIL
Sbjct: 608 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLSGRKPISSGCPKGQESLVMWAKPILD 667
Query: 647 SGKVTQLLDPAL--GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKW 704
GK +QLLDP+L NN + DQM+RM LA+ LCIRR P+ARP+MS+VLKLL+GD D +W
Sbjct: 668 DGKYSQLLDPSLRDNNNNNDDQMQRMALAATLCIRRSPQARPKMSIVLKLLKGDEDTLEW 727
Query: 705 ARLQVNAS-EESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRW 763
A QVN+S EESEML DE C RSNLQSHLNLALLDVEDDS SM SIEQ VS+EDYL GR
Sbjct: 728 AMQQVNSSSEESEMLKDEQCQRSNLQSHLNLALLDVEDDSISMGSIEQGVSVEDYLKGRT 787
Query: 764 SRSSSFD 770
SRSSSFD
Sbjct: 788 SRSSSFD 794
|
|
| TAIR|locus:2026957 AT1G21590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2137 (757.3 bits), Expect = 2.6e-221, P = 2.6e-221
Identities = 446/774 (57%), Positives = 570/774 (73%)
Query: 7 EGDVISSGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSS 66
E V++ G G TV+VGVK D S ELL WALVKVA+PGDTVIALHVL N IVDR SS
Sbjct: 3 ENGVVTGG-GHTVMVGVKFDESSNELLDWALVKVAEPGDTVIALHVLGNE-IVDRADNSS 60
Query: 67 LLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNH 126
L+S+VK FDSVL VYEGFC LKQ++LKLK+ RG+S RKILV+EA+ SA+K +VG ++
Sbjct: 61 LVSIVKNFDSVLEVYEGFCKLKQLELKLKLSRGSSTRKILVKEAKMCSASKVVVGISRRF 120
Query: 127 HTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVI 186
HTI S+ S+AKY A+K++KDC VLAV+NGKV+FQK+G S SKG D RRN+L
Sbjct: 121 HTIHSSVSVAKYLARKVAKDCWVLAVDNGKVMFQKDGSSSIIHHSKGKSDARRNTL---- 176
Query: 187 HRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNC 246
S +T +KN+KVV S + + ++ + +L ++LV A C G NC
Sbjct: 177 -SSFFQMPVTLRKNTKVVNH--SEVEEEEAEEDHSNGQSLRRSLVYA---CLG-----NC 225
Query: 247 SICGPVRNLPD-GSCSQSEE-ESPSDGGAG-DESLAIVPVQNVEAASTSITMLVRQLPES 303
S+ + +LP G+ S+S D A +++A+VP + E + ITMLV++LPE
Sbjct: 226 SV-RDMNSLPTPGNLSRSSSCNGDQDDNADLHKAMALVPAKFPEDLTPFITMLVKELPEF 284
Query: 304 RPGWPLLRRAIFPD--RRAPDRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDN 361
RPGWPLL R D AP SS RKI VVQW L+LP R S + +SD KQI +D ++
Sbjct: 285 RPGWPLLCRVASSDVLASAPRSSSFRKIPVVQWVLKLPARTNSVVGSSDTKQIGFDSSES 344
Query: 362 ES----INLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDL 417
E + N + AIVP + IV L DH S P+ +EGL + S +C+ F Y++L
Sbjct: 345 EENDKLSSSNVERQAIVPDESMIVKCSL--DHSSGRFPENVEGLQARISTSCQFFTYKEL 402
Query: 418 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK 477
+S TSNF A+N IGKGGSS+V++G LP+G+E+AVKILK +E V+K+FV EI+IITTLHHK
Sbjct: 403 VSVTSNFCADNFIGKGGSSRVFRGYLPNGREVAVKILKRTECVLKDFVAEIDIITTLHHK 462
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
N+ISLLG+CFE+NNLLLVY++LSRGSLEENLHGNKKD AF W+ERYKVA+G+AEAL+YL
Sbjct: 463 NVISLLGYCFENNNLLLVYNYLSRGSLEENLHGNKKDLVAFRWNERYKVAVGIAEALDYL 522
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
H+ + Q VIHRDVKSSNILLSDDFEPQLSDFGLAKWAS S++ I C+DVAGTFGYLAPEY
Sbjct: 523 HNDAPQPVIHRDVKSSNILLSDDFEPQLSDFGLAKWASESTTQIICSDVAGTFGYLAPEY 582
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657
FMYGK+N+KIDVYA+GVVLLELL+GRKP++++ PK Q+SLVMWAKPIL + +QLLD +
Sbjct: 583 FMYGKMNNKIDVYAYGVVLLELLSGRKPVNSESPKAQDSLVMWAKPILDDKEYSQLLDSS 642
Query: 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQV-NASEESE 716
L ++ + DQME+M LA+ LCIR +P+ RP M +VL+LL+GD ++ KWA+LQV N E+S
Sbjct: 643 LQDDNNSDQMEKMALAATLCIRHNPQTRPTMGMVLELLKGDVEMLKWAKLQVSNPLEDSM 702
Query: 717 MLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 770
+L DE RSNLQSHLNLA LD+EDDS SM S+EQ +S+E+YL GR SRSSSF+
Sbjct: 703 LLKDEKLRRSNLQSHLNLAFLDMEDDSLSMGSMEQGISVEEYLKGRTSRSSSFN 756
|
|
| TAIR|locus:2160801 AT5G63940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1460 (519.0 bits), Expect = 7.8e-194, Sum P(2) = 7.8e-194
Identities = 309/555 (55%), Positives = 397/555 (71%)
Query: 221 GSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGS-CSQSEE-ESPSDGGAGDESL 278
G MN+ +LV D + AAK S P R + S+S +SP G D L
Sbjct: 169 GPQMNIP-SLVCGSPDIAIEAAKIGNSF-SPARTSSRWTRTSRSSSLQSPDSLGV-DNLL 225
Query: 279 AIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRL 338
A+VPVQ E S S+ ES PGW LR +R++ + S +K +V+QW RL
Sbjct: 226 ALVPVQTNETDSGSL--------ESGPGWHFLRGLYGNNRKSWTKVSAKK-AVLQWVSRL 276
Query: 339 PTRQPSYLANSDVKQITYDPGDNE--SINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPK 396
R + D K+ D G +E S +++G+ +I G+E++ SPLS S +P+
Sbjct: 277 RGRHSETVIYLDRKRS--DSGCDEDCSSSIDGEDVSISRFGSELMQSPLSPFIGSNNIPE 334
Query: 397 ELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP 456
ELEGLHEKYS+TCRLF Y+++LS TSNF +ENL+G+GG+S VY+G LPDG+ELAVKILKP
Sbjct: 335 ELEGLHEKYSSTCRLFTYEEVLSITSNFASENLVGEGGNSYVYRGDLPDGRELAVKILKP 394
Query: 457 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 516
DV+KEF+LEIE+IT++HHKNI+SL GFCFE+NNL+LVYD+L RGSLEENLHGN+KD
Sbjct: 395 CLDVLKEFILEIEVITSVHHKNIVSLFGFCFENNNLMLVYDYLPRGSLEENLHGNRKDAK 454
Query: 517 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576
FGW ERYKVA+GVAEAL+YLH+ VIHRDVKSSN+LL+DDFEPQLSDFG A AS+
Sbjct: 455 KFGWMERYKVAVGVAEALDYLHNTHDPEVIHRDVKSSNVLLADDFEPQLSDFGFASLASS 514
Query: 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636
+S H+ D+AGTFGYLAPEYFM+GKV DKIDVYAFGVVLLEL++GRKPI D KGQES
Sbjct: 515 TSQHVAGGDIAGTFGYLAPEYFMHGKVTDKIDVYAFGVVLLELISGRKPICVDQSKGQES 574
Query: 637 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
LV+WA PIL SGK QLLDP+L N+ D +E+++LA+ LCI+R P RPQ+ LVLK+L+
Sbjct: 575 LVLWANPILDSGKFAQLLDPSLENDNSNDLIEKLLLAATLCIKRTPHDRPQIGLVLKILQ 634
Query: 697 GDADVTKWARLQVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIE-QSVSL 755
G+ + T+W + QV ASE D S +N++SH+NLALLD+EDD+ S SS E S+S+
Sbjct: 635 GEEEATEWGKQQVRASE------DVSAYLTNIESHINLALLDLEDDAASDSSPEASSISV 688
Query: 756 EDYLLGRWSRSSSFD 770
E+YL GRWSR++SF+
Sbjct: 689 EEYLKGRWSRTASFN 703
|
|
| TAIR|locus:2059919 AT2G16750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 973 (347.6 bits), Expect = 1.4e-118, Sum P(2) = 1.4e-118
Identities = 192/345 (55%), Positives = 250/345 (72%)
Query: 410 RLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS-EDVIKEFVLEI 468
R F+Y L +ATS+F ENLIGKGG ++VYKG L DGK +AVKILKPS ++ +KEFV E+
Sbjct: 263 RWFSYDVLKTATSDFSLENLIGKGGCNEVYKGFLEDGKGVAVKILKPSVKEAVKEFVHEV 322
Query: 469 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 528
I+++L H NI L+G C N+L+ VY+ S+GSLEE L G W ER K+A+
Sbjct: 323 SIVSSLSHSNISPLIGVCVHYNDLISVYNLSSKGSLEETLQGKH----VLRWEERLKIAI 378
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
G+ EAL+YLH+ + VIHRDVKSSN+LLSD+FEPQLSDFGL+ W S S + DV G
Sbjct: 379 GLGEALDYLHNQCSNPVIHRDVKSSNVLLSDEFEPQLSDFGLSMWGSKSCRYTIQRDVVG 438
Query: 589 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 648
TFGYLAPEYFMYGKV+DK+DVYAFGVVLLEL++GR IS+D P+GQESLVMWAKP++ G
Sbjct: 439 TFGYLAPEYFMYGKVSDKVDVYAFGVVLLELISGRTSISSDSPRGQESLVMWAKPMIEKG 498
Query: 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQ 708
+LLDP + +D DQ +MVLA+ C+ R RP + +LKLLRG+ DV+KW +++
Sbjct: 499 NAKELLDPNIAGTFDEDQFHKMVLAATHCLTRAATYRPNIKEILKLLRGEDDVSKWVKIE 558
Query: 709 VNASEESEMLDDESCPRSNLQSHLNLALLDVED-DSFSMSSIEQS 752
++ + DDE P SN + HL+LA++DVED DS S SS+E+S
Sbjct: 559 ---EDDEDGFDDEVYPNSNTELHLSLAMVDVEDNDSVSNSSLERS 600
|
|
| TAIR|locus:2172555 AT5G57670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 663 (238.4 bits), Expect = 4.6e-80, Sum P(2) = 4.6e-80
Identities = 138/319 (43%), Positives = 202/319 (63%)
Query: 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKIL-KPSEDVIKE--FVLEI 468
F Y ++ AT++F N++G GG S+VY+G L DG+ +AVK L K S D+ KE F+ E+
Sbjct: 255 FTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESGDMNKEKEFLTEL 314
Query: 469 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 528
II+ + H N LLG C E L LV+ F G+L LH N+ + W RYK+A+
Sbjct: 315 GIISHVSHPNTALLLGCCVE-KGLYLVFRFSENGTLYSALHENEN--GSLDWPVRYKIAV 371
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
GVA L YLH R+IHRD+KSSN+LL D+EPQ++DFGLAKW +H V G
Sbjct: 372 GVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIPVEG 431
Query: 589 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 648
TFGYLAPE M G +++K D+YAFG++LLE++TGR+P++ P Q+ +++WAKP + +G
Sbjct: 432 TFGYLAPESLMQGTIDEKTDIYAFGILLLEIITGRRPVN---PT-QKHILLWAKPAMETG 487
Query: 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG--DADVTKWAR 706
++L+DP L + YD QM ++VL + C+++ P RP M+ VL+LL +A++ K R
Sbjct: 488 NTSELVDPKLQDKYDDQQMNKLVLTASHCVQQSPILRPTMTQVLELLTNGNEAEIAKSWR 547
Query: 707 L---QVNASEESEMLDDES 722
+ N +++ DD S
Sbjct: 548 MPKDMTNDDDDNNEWDDYS 566
|
|
| TAIR|locus:2156050 AT5G37790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 751 (269.4 bits), Expect = 1.9e-74, P = 1.9e-74
Identities = 185/463 (39%), Positives = 260/463 (56%)
Query: 302 ESRPGWPLLRRAIFPDRRAPD----RSSLRKISVVQWAL-RLPTRQPSYLANSDVKQITY 356
E+ W L A P+ PD SS R Q L ++ +PS A+S + ++
Sbjct: 93 ENNKAWLLAETA--PENMNPDPHSVHSSFRFSLCSQIELEKMKGEEPSLSASSSCRNLSV 150
Query: 357 DPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQD 416
G + +N ++G GN +TD + LE + T F+Y +
Sbjct: 151 SGGSTTVLMVNLENGVKETTGN-------ATDDLRWTRARSLEKSISPVANTLVRFSYGE 203
Query: 417 LLSATSNFLAENLIGKGGSSQVYKGCLPDGKE-LAVKIL-KPSEDVIKEFVLEIEIITTL 474
+++AT NF ++G+G S V++G + + LA+K L K ++ K F E+ I ++L
Sbjct: 204 IVAATRNFSKGRVLGRGACSYVFRGKIGMWRTALAIKRLDKEDKESPKSFCRELMIASSL 263
Query: 475 HHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDP---AAFG--WSERYKVAM 528
H NI+ LLGFC + + L LVY ++S GSLE LH KK AAFG WS RYKVA+
Sbjct: 264 HSSNIVPLLGFCIDPEEGLFLVYKYVSGGSLEHYLHDKKKKKGVKAAFGLPWSARYKVAL 323
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
G+A+A+ YLH+G+ Q V+HRD+K SNILLS P+L DFGLA W + S C V G
Sbjct: 324 GIADAIAYLHNGTEQCVVHRDIKPSNILLSSKKIPKLCDFGLATWTAAPSVPFLCKTVKG 383
Query: 589 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 648
TFGYLAPEYF +GK++DK DVYAFGVVLLEL+TGRKPI GQE+LV+WAKP+L G
Sbjct: 384 TFGYLAPEYFQHGKISDKTDVYAFGVVLLELITGRKPIEARRASGQENLVVWAKPLLDRG 443
Query: 649 --KVTQLLDPALG-NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADV---T 702
+ +LLDP L + QMERM+ A+ C+ + RP M ++ +L+G+ V T
Sbjct: 444 IEAIVELLDPRLKCTRKNSVQMERMIRAAAACVINEESRRPGMEEIVSILKGEEGVEPET 503
Query: 703 KWARLQVNASEESEMLDDESCPRSNLQSHLNLALLDV---EDD 742
+R N S + +S ++ HL+LA+L V EDD
Sbjct: 504 HSSRKTTNISGMIDSYTQLQQTKSEMKCHLDLAMLGVTEFEDD 546
|
|
| TAIR|locus:2165041 AT5G56790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 679 (244.1 bits), Expect = 2.1e-74, Sum P(3) = 2.1e-74
Identities = 133/297 (44%), Positives = 188/297 (63%)
Query: 404 KYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIK 462
K+ R F Y +L +AT F + + +GG V+ G LPDG+ +AVK K S +
Sbjct: 370 KFGNPPRWFTYSELETATKGFSKGSFLAEGGFGSVHLGTLPDGQIIAVKQYKIASTQGDR 429
Query: 463 EFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE 522
EF E+E+++ H+N++ L+G C ED LLVY+++ GSL +L+G ++P GWS
Sbjct: 430 EFCSEVEVLSCAQHRNVVMLIGLCVEDGKRLLVYEYICNGSLHSHLYGMGREP--LGWSA 487
Query: 523 RYKVAMGVAEALEYLHSGSAQR-VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581
R K+A+G A L YLH ++HRD++ +NILL+ DFEP + DFGLA+W +
Sbjct: 488 RQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPEGDKGV 547
Query: 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 641
T V GTFGYLAPEY G++ +K DVY+FGVVL+EL+TGRK + PKGQ+ L WA
Sbjct: 548 E-TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELITGRKAMDIKRPKGQQCLTEWA 606
Query: 642 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698
+P+L + +LLDP L N Y ++ M L + LCIRRDP +RP+MS VL++L GD
Sbjct: 607 RPLLQKQAINELLDPRLMNCYCEQEVYCMALCAYLCIRRDPNSRPRMSQVLRMLEGD 663
|
|
| TAIR|locus:2091511 AT3G13690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 666 (239.5 bits), Expect = 2.9e-72, Sum P(2) = 2.9e-72
Identities = 130/291 (44%), Positives = 187/291 (64%)
Query: 410 RLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKEFVLEI 468
RLF Y +L AT F N + +GG V++G LP+G+ +AVK K S EF E+
Sbjct: 397 RLFTYAELELATGGFSQANFLAEGGYGSVHRGVLPEGQVVAVKQHKLASSQGDVEFCSEV 456
Query: 469 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 528
E+++ H+N++ L+GFC ED+ LLVY+++ GSL+ +L+G +K+ W R K+A+
Sbjct: 457 EVLSCAQHRNVVMLIGFCIEDSRRLLVYEYICNGSLDSHLYGRQKE--TLEWPARQKIAV 514
Query: 529 GVAEALEYLHSGSAQR-VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
G A L YLH ++HRD++ +NIL++ D EP + DFGLA+W + T V
Sbjct: 515 GAARGLRYLHEECRVGCIVHRDMRPNNILITHDNEPLVGDFGLARWQPDGEMGVD-TRVI 573
Query: 588 GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 647
GTFGYLAPEY G++ +K DVY+FGVVL+EL+TGRK I PKGQ+ L WA+P+L
Sbjct: 574 GTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAIDITRPKGQQCLTEWARPLLEE 633
Query: 648 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698
+ +L+DP LGN + ++ M+ A+ LCIRRDP RP+MS VL++L GD
Sbjct: 634 YAIDELIDPRLGNRFVESEVICMLHAASLCIRRDPHLRPRMSQVLRILEGD 684
|
|
| TAIR|locus:2044420 AT2G18890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 722 (259.2 bits), Expect = 2.3e-71, P = 2.3e-71
Identities = 154/355 (43%), Positives = 222/355 (62%)
Query: 382 SSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG 441
SSPL+ ST+ + + + + F++Q++ AT+ F +ENL+G+GG ++VYKG
Sbjct: 28 SSPLAAS--STKCVEGFQETDQFQRPKWKCFSFQEIYDATNGFSSENLVGRGGFAEVYKG 85
Query: 442 CL-PDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496
L +G+E+AVK + + E KEF++EI I + H N++SLLG C DN L LV+
Sbjct: 86 ILGKNGEEIAVKRITRGGRDDERREKEFLMEIGTIGHVSHPNVLSLLGCCI-DNGLYLVF 144
Query: 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556
F SRGSL LH + P W RYK+A+G A+ L YLH G +R+IHRD+KSSN+L
Sbjct: 145 IFSSRGSLASLLHDLNQAPLE--WETRYKIAIGTAKGLHYLHKGCQRRIIHRDIKSSNVL 202
Query: 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 616
L+ DFEPQ+SDFGLAKW + SH + + GTFG+LAPEY+ +G V++K DV+AFGV L
Sbjct: 203 LNQDFEPQISDFGLAKWLPSQWSHHSIAPIEGTFGHLAPEYYTHGIVDEKTDVFAFGVFL 262
Query: 617 LELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL 676
LEL++G+KP+ H +SL WAK I+ G++ +L+DP +G +D Q+ R+ A+ L
Sbjct: 263 LELISGKKPVDASH----QSLHSWAKLIIKDGEIEKLVDPRIGEEFDLQQLHRIAFAASL 318
Query: 677 CIRRDPRARPQMSLVLKLLRG-DADVTKWARLQVNASEES----EMLDDESCPRS 726
CIR RP M VL++L+G D + KW + +E E L+D C S
Sbjct: 319 CIRSSSLCRPSMIEVLEVLQGEDIEKEKWKMEEEEEVKEEFWGYEDLEDCECDSS 373
|
|
| TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 686 (246.5 bits), Expect = 4.7e-70, Sum P(2) = 4.7e-70
Identities = 152/392 (38%), Positives = 233/392 (59%)
Query: 341 RQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLST-DHDSTELPKELE 399
R+ +S + Y P N S+N G GN S+ S+ D +S PK
Sbjct: 284 RRKQKKGSSSPRSNQYLPPANVSVNTEGFIHYRQKPGNGNSSAQNSSPDTNSLGNPKHGR 343
Query: 400 GLHEK-YSATCRL-FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP- 456
G + T ++ F Y++L T F ++G+GG VYKG L +GK +A+K LK
Sbjct: 344 GTPDSAVIGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSV 403
Query: 457 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 516
S + +EF E+EII+ +HH++++SL+G+C + + L+Y+F+ +L+ +LHG K+
Sbjct: 404 SAEGYREFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHG--KNLP 461
Query: 517 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576
WS R ++A+G A+ L YLH ++IHRD+KSSNILL D+FE Q++DFGLA+ T
Sbjct: 462 VLEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDT 521
Query: 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636
+ SHI+ T V GTFGYLAPEY GK+ D+ DV++FGVVLLEL+TGRKP+ P G+ES
Sbjct: 522 AQSHIS-TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEES 580
Query: 637 LVMWAKPIL----SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 692
LV WA+P L G +++++DP L N+Y ++ +M+ + C+R RP+M V+
Sbjct: 581 LVEWARPRLIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVV 640
Query: 693 KLL--RGD-ADVTKWARLQVNASEESEMLDDE 721
+ L R D +D+T ++ + +S +E
Sbjct: 641 RALDTRDDLSDLTNGVKVGQSRVYDSGQYSNE 672
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 770 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-39 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-32 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-27 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-24 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-23 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-16 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-14 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-10 | |
| cd01989 | 146 | cd01989, STK_N, The N-terminal domain of Eukaryoti | 7e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-07 | |
| cd00293 | 130 | cd00293, USP_Like, Usp: Universal stress protein f | 8e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-05 | |
| pfam00582 | 139 | pfam00582, Usp, Universal stress protein family | 3e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-04 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 6e-51
Identities = 87/268 (32%), Positives = 127/268 (47%), Gaps = 36/268 (13%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL---EIEIITTLHHKNIISLLGF 485
+G G VYK GK +AVKILK + K+ EI I+ L H NI+ L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
+ ++L LV ++ G L + L E K+A+ + LEYLHS +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGP----LSEDEAKKIALQILRGLEYLHS---NGI 119
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE----YFMYG 601
IHRD+K NILL ++ +++DFGLAK SSS T GT Y+APE YG
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS--LTTFVGTPWYMAPEVLLGGNGYG 177
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL---VMWAKPILSSGKVTQLLDPAL 658
K+DV++ GV+L ELLTG+ P S ++ Q L ++ K + + A
Sbjct: 178 P---KVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAK 234
Query: 659 GNNYDYDQMERMVLASILCIRRDPRARP 686
D +++ C+ +DP RP
Sbjct: 235 ------DLIKK-------CLNKDPSKRP 249
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 6e-48
Identities = 72/195 (36%), Positives = 114/195 (58%), Gaps = 13/195 (6%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G+GG VY GK++A+KI+K S +++E + EIEI+ L+H NI+ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
++N+L LV ++ GSL++ L N+ E ++ + + E LEYLHS +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHS---NGII 114
Query: 547 HRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVN 604
HRD+K NILL SD+ + +L+DFGL+K +S + GT Y+APE + G +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSK--LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 605 DKIDVYAFGVVLLEL 619
+K D+++ GV+L EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 6e-47
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDV--IKEFVLEIEIITTLHHKNIISLLG 484
+G+G +VY GK +A+K++K + + + EI+I+ L H NI+ L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEALEYLHSGS 541
+++ L LV ++ G L + L + A F + + ALEYLHS
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQ-------ILSALEYLHS-- 115
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
+ ++HRD+K NILL +D +L+DFGLA+ T GT Y+APE +
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGK 171
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPISNDH 630
+D+++ GV+L ELLTG+ P D
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFPGDD 200
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 3e-44
Identities = 88/277 (31%), Positives = 131/277 (47%), Gaps = 36/277 (12%)
Query: 430 IGKGGSSQVYKGCL---PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 482
+G+G +VYKG L DGKE+ AVK LK SE I+EF+ E I+ L H NI+ L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
LG C E+ L++V +++ G L + L K P S+ A+ +A +EYL S
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLES--- 121
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
+ IHRD+ + N L+ ++ ++SDFGL++ + ++APE GK
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 603 VNDKIDVYAFGVVLLELLT-GRKP---ISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658
K DV++FGV+L E+ T G +P +SN L G L P
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE----------VLEYLKKGYR--LPKPPN 228
Query: 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695
Y M + C DP RP S ++++L
Sbjct: 229 CPPELYKLMLQ-------CWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 71/206 (34%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 487
IGKGG +VYK GKE+A+K++K KE ++ EI+I+ H NI+ G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 545
+ + L +V +F S GSL++ L + +E V + + LEYLHS +
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQ-----TLTESQIAYVCKELLKGLEYLHS---NGI 119
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 605
IHRD+K++NILL+ D E +L DFGL+ S + + T + GT ++APE +
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAPEVINGKPYDY 176
Query: 606 KIDVYAFGVVLLELLTGRKPISNDHP 631
K D+++ G+ +EL G+ P S P
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPP 202
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 8e-43
Identities = 84/278 (30%), Positives = 128/278 (46%), Gaps = 39/278 (14%)
Query: 430 IGKGGSSQVYKGCL----PDGKEL-AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 482
+G+G +VYKG L K AVK LK SE I+EF+ E I+ L H N++ L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
LG C E+ L +V +++ G L L N+ S+ A+ +A +EYL S
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLES--- 120
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYG 601
+ IHRD+ + N L+ ++ ++SDFGL++ + ++APE G
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEG 178
Query: 602 KVNDKIDVYAFGVVLLELLT-GRKP---ISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657
K K DV++FGV+L E+ T G +P +SN+ L +G L P
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE----------VLEYLKNGYR--LPQPP 226
Query: 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695
YD M + C DP RP S ++++L
Sbjct: 227 NCPPELYDLMLQ-------CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 5e-40
Identities = 79/272 (29%), Positives = 124/272 (45%), Gaps = 41/272 (15%)
Query: 428 NLIGKGGSSQVYKGCLPD-GKELAVK---ILKPSEDVIKEFVLEIEIITTLHHKNIISLL 483
L+G+G VY D G+ +AVK + SE+ ++ EI I+++L H NI+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 484 GFCF--EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE----RYKVAMGVAEALEYL 537
G E N L + +++S GSL L K P E +Y + E L YL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP------EPVIRKY-TRQ-ILEGLAYL 117
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
HS ++HRD+K +NIL+ D +L+DFG AK + V GT ++APE
Sbjct: 118 HS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL---L 654
+ D+++ G ++E+ TG+ P S G ++ I SSG+ ++ L
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPPWSE---LGNPMAALYK--IGSSGEPPEIPEHL 229
Query: 655 DPALGNNYDYDQMERMVLASILCIRRDPRARP 686
D + + C+RRDP+ RP
Sbjct: 230 SEEA-----KDFLRK-------CLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 7e-40
Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 37/284 (13%)
Query: 428 NLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 481
+G+G +VYKG L DGK AVK LK SE+ K+F+ E ++ L H N++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 482 LLGFCFEDNNLLLVYDFLSRGSL-----EENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
LLG C E+ L LV +++ G L + + + + A+ +A+ +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
L S ++ +HRD+ + N L+ +D ++SDFGL++ + T ++APE
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISNDHPKGQESLVMWAKPILSSGKVTQ 652
G K DV++FGV+L E+ T G P +SN+ V+ L G +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VL---EYLRKGY--R 225
Query: 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
L P + Y+ M C + DP RP S +++ L
Sbjct: 226 LPKPEYCPDELYELMLS-------CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 7e-39
Identities = 67/216 (31%), Positives = 110/216 (50%), Gaps = 38/216 (17%)
Query: 430 IGKGGSSQVYKGCL---PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 482
+G+G +VYKG L +G E AVK LK SE+ +EF+ E I+ L H NI+ L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
LG C + L +V +++ G L + L + + + ++A+ +A+ +EYL S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLES--- 120
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY---------- 592
+ +HRD+ + N L++++ ++SDFGL++ D+ Y
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSR------------DIYEDDYYRKRGGGKLPI 168
Query: 593 --LAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+APE GK K DV++FGV+L E+ T G +P
Sbjct: 169 KWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 3e-33
Identities = 80/286 (27%), Positives = 127/286 (44%), Gaps = 27/286 (9%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHK 477
++ +G+G +VY D K +A+K+L ++ F+ EI+I+ +L H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
NI+ L F ++ +L LV +++ GSLE+ L SE + + ALEYL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYL 117
Query: 538 HSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSH----ITCTDVAGTFGY 592
HS + +IHRD+K NILL D +L DFGLAK S + GT GY
Sbjct: 118 HS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 593 LAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 649
+APE + + D+++ G+ L ELLTG P + S + I+
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL---KIILELP 231
Query: 650 VTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLK 693
L P + ++ + +L + +DP+ R S L
Sbjct: 232 TPSLASP---LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 67/200 (33%), Positives = 108/200 (54%), Gaps = 16/200 (8%)
Query: 429 LIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 488
IGKG V G G+++AVK LK + F+ E ++TTL H N++ LLG +
Sbjct: 13 TIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 548
N L +V +++++GSL + L + A +++ A+ V E +EYL + +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEE---KNFVHR 126
Query: 549 DVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEYFMYGKVNDK 606
D+ + N+L+S+D ++SDFGLAK AS +G + APE K + K
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQD-------SGKLPVKWTAPEALREKKFSTK 179
Query: 607 IDVYAFGVVLLELLT-GRKP 625
DV++FG++L E+ + GR P
Sbjct: 180 SDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 73/276 (26%), Positives = 129/276 (46%), Gaps = 25/276 (9%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN 478
+ IGKG +VY DGK +K + SE ++ + E++I+ L+H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
II E L +V ++ G L + + KK+ F + + + AL+YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
S ++++HRD+K NI L+ + +L DFG++K S++ V GT YL+PE
Sbjct: 121 S---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL--AKTVVGTPYYLSPELC 175
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658
N K D+++ G VL EL T + P ++ L + K+ + P +
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELAL---------KILKGQYPPI 223
Query: 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694
+ Y + + +V + +++DP RP ++ +L+
Sbjct: 224 PSQYSSE-LRNLVSS---LLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 488
IG+G S +VYK GKE+A+K ++ + + + EI I+ H NI+ +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD-SYL 85
Query: 489 DNNLL-LVYDFLSRGSLEENLHGNKKD----PAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+ L +V +++ GSL + + N A+ V V + LEYLHS Q
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-------VCREVLQGLEYLHS---Q 135
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
VIHRD+KS NILLS D +L+DFG A A + V GT ++APE
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFA--AQLTKEKSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 604 NDKIDVYAFGVVLLELLTGRKPISNDHP 631
K+D+++ G++ +E+ G P + P
Sbjct: 194 GPKVDIWSLGIMCIEMAEGEPPYLREPP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 423 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKN 478
N+ +LIG+G VYKG L G +A+K + E+ +K + EI+++ L H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
I+ +G ++L ++ ++ GSL + + F S V + L YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP----FPESLVAVYVYQVLQGLAYLH 116
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
Q VIHRD+K++NIL + D +L+DFG+A + V GT ++APE
Sbjct: 117 E---QGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVI 171
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKP-------------ISNDHP 631
+ D+++ G ++ELLTG P + +DHP
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP 217
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 83/292 (28%), Positives = 128/292 (43%), Gaps = 42/292 (14%)
Query: 428 NLIGKGGSSQVYKGCLP-----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNII 480
+G+G +V G+++AVK L S E +F EIEI+ TL H+NI+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 481 SLLGFCFED--NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
G C + +L L+ ++L GSL + L ++ + + + ++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLG 126
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT--FGYLAPE 596
S QR IHRD+ + NIL+ + ++SDFGLAK + + + F Y APE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655
K + DV++FGV L EL T G + P E L M VT+LL+
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDP---SQSPP-AEFLRMIG-IAQGQMIVTRLLE 237
Query: 656 ----------PALGNNYDYDQMERMVLASILCIRRDPRARPQMS-LVLKLLR 696
P + YD M+ C +P+ RP + L+L + R
Sbjct: 238 LLKEGERLPRPPSCPDEVYDLMKL-------CWEAEPQDRPSFADLILIVDR 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 77/278 (27%), Positives = 129/278 (46%), Gaps = 37/278 (13%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
IG G ++ VY CLP+ +++A+K + K V E E++ ++ +H N++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAMSQCNHPNVVKYYTS 67
Query: 486 CFEDNNLLLVYDFLSRGSLEENL-HGNKKDPAAFGWSERYKVAM--GVAEALEYLHSGSA 542
+ L LV +LS GSL + + + G E + V + LEYLHS
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRG----GLDEAIIATVLKEVLKGLEYLHS--- 120
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS--SSHITCTDVAGTFGYLAPEYFMY 600
IHRD+K+ NILL +D +++DFG++ + + GT ++APE
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 601 GK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659
+ K D+++FG+ +EL TG P S P + L++ L + P+L
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAPYSKYPP--MKVLML----TLQNDP------PSLE 228
Query: 660 NNYDYDQ----MERMVLASILCIRRDPRARPQMSLVLK 693
DY + +M+ LC+++DP RP +LK
Sbjct: 229 TGADYKKYSKSFRKMI---SLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 67/222 (30%), Positives = 109/222 (49%), Gaps = 36/222 (16%)
Query: 430 IGKGGSSQVYKG-----CLPDGKEL-AVKILK--PSEDVIKEFVLEIEIITTLHHKNIIS 481
+G+G +V+ G + KEL AVK LK S D K+F E E++T H+NI+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENL--HG--------NKKDPAAFGWSERYKVAMGVA 531
G C E + ++V++++ G L + L HG S+ ++A+ +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD---VAG 588
+ YL ++Q +HRD+ + N L+ D ++ DFG+ S + TD V G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGM-------SRDVYTTDYYRVGG 182
Query: 589 T----FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
++ PE MY K + DV++FGVVL E+ T G++P
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 77/276 (27%), Positives = 127/276 (46%), Gaps = 31/276 (11%)
Query: 428 NLIGKGGSSQVYKGC-LPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLL 483
N IG G +VY L G+ +AVK ++ IKE E++++ L H N++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
G + + ++ S G+LEE L + Y + + E L YLHS
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV--IRVYTLQL--LEGLAYLHS---H 118
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKW--ASTSSSHITCTDVAGTFGYLAPEYFMYG 601
++HRD+K +NI L + +L DFG A +T++ +AGT Y+APE G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 602 KVNDK---IDVYAFGVVLLELLTGRKPISN-DHPKGQESLVMWAKPILSSGKVTQLLDPA 657
K D+++ G V+LE+ TG++P S D+ E +M+ + +G + D
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----EFQIMFH---VGAGHKPPIPDSL 231
Query: 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
+ D ++R C+ DP+ RP S +L+
Sbjct: 232 QLSPEGKDFLDR-------CLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 15/212 (7%)
Query: 424 FLAENLIGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNII 480
F IGKG +VYK + +A+K+ L+ +ED I++ EI+ ++ I
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
G + + L ++ ++ GS + L K D + R V LEYLH
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILRE-----VLLGLEYLHE- 116
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEYFM 599
+ IHRD+K++NILLS++ + +L+DFG++ + ST S T GT ++APE
Sbjct: 117 --EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT---FVGTPFWMAPEVIK 171
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
++K D+++ G+ +EL G P+S+ HP
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLSDLHP 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 71/211 (33%), Positives = 104/211 (49%), Gaps = 34/211 (16%)
Query: 430 IGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIKEFVL----EIEIITTLHHKNIIS 481
+GKG +V K GK A+K+LK + + ++ V E I++ ++H I+
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 482 LLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEYL 537
L + F+ L LV ++ G L +L + + Y AE ALEYL
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE--ERARFY-----AAEIVLALEYL 109
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
HS +I+RD+K NILL D +L+DFGLAK S+ S GT YLAPE
Sbjct: 110 HS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEV 164
Query: 598 FM---YGKVNDKIDVYAFGVVLLELLTGRKP 625
+ YGK +D ++ GV+L E+LTG+ P
Sbjct: 165 LLGKGYGKA---VDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 71/232 (30%), Positives = 107/232 (46%), Gaps = 39/232 (16%)
Query: 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKE----FVL-EIEIITTL- 474
+F +IG+G S V KE A+KIL + +IKE +V E E++T L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ-LIKEKKVKYVKIEKEVLTRLN 59
Query: 475 HHKNIISLLGFCFEDN-NLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVA 531
H II L + F+D NL V ++ G L + +G+ + R+ A +
Sbjct: 60 GHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT-----RFYAAE-IL 112
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA---- 587
ALEYLHS + +IHRD+K NILL D +++DFG AK +SS + A
Sbjct: 113 LALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 588 --------------GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
GT Y++PE D++A G ++ ++LTG+ P
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 61/210 (29%), Positives = 109/210 (51%), Gaps = 12/210 (5%)
Query: 424 FLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISL 482
F +G+G VYK G+ +A+K++ P E+ ++E + EI I+ I+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
G F++ +L +V ++ GS+ + + K E + + LEYLHS
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLHS--- 117
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
+ IHRD+K+ NILL+++ + +L+DFG++ + T + T V GT ++APE
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT---VIGTPFWMAPEVIQEI 174
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
N+K D+++ G+ +E+ G+ P S+ HP
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHP 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 83/283 (29%), Positives = 136/283 (48%), Gaps = 35/283 (12%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL--------KPSEDVIKEFVLEIEII 471
NF E IGKG S VYK CL DG+ +A+K + K +D +KE I+++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKE----IDLL 56
Query: 472 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA 531
L H N+I L E+N L +V + G L + KK +K + +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS--TSSSHITCTDVAGT 589
ALE++HS +R++HRD+K +N+ ++ +L D GL ++ S T+++H + GT
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGT 169
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 649
Y++PE N K D+++ G +L E+ + P D + +L K K
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYSLCK------K 219
Query: 650 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 692
+ + P L ++ Y + R +++ CI DP RP +S VL
Sbjct: 220 IEKCDYPPLPADH-YSEELRDLVS--RCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNI 479
F E +G G +V++G + +A+KILK S+D++K +F E++ + L HK++
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILK-SDDLLKQQDFQKEVQALKRLRHKHL 64
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
ISL C + ++ + + +GSL L + + +A VAE + YL
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK-----WASTSSSHITCTDVAGTFGYLA 594
Q IHRD+ + NIL+ +D +++DFGLA+ +S I + + A
Sbjct: 123 ---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-------PYKWTA 172
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLT 621
PE +G + K DV++FG++L E+ T
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 80/284 (28%), Positives = 139/284 (48%), Gaps = 35/284 (12%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL--------KPSEDVIKEFVLEIEIIT 472
+NF E IG+G S+VY+ CL D K +A+K + K +D +KE I+++
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKE----IDLLK 57
Query: 473 TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
L+H N+I L EDN L +V + G L + + KK +K + +
Sbjct: 58 QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS--TSSSHITCTDVAGTF 590
A+E++HS +RV+HRD+K +N+ ++ +L D GL ++ S T+++H + GT
Sbjct: 118 AVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGTP 170
Query: 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650
Y++PE N K D+++ G +L E+ + P D + +L + K+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLFSLCQ------KI 220
Query: 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694
Q P L + Y + R +++ +CI DP RP + V ++
Sbjct: 221 EQCDYPPLPTEH-YSEKLRELVS--MCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-25
Identities = 82/296 (27%), Positives = 137/296 (46%), Gaps = 30/296 (10%)
Query: 406 SATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEF 464
S + D+LS+ EN+I +G YKG + +G + VK + +
Sbjct: 677 SKVSKSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSE 733
Query: 465 VLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 524
+ ++ L H NI+ L+G C + L+++++ +L E L W R
Sbjct: 734 IADMG---KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRR 783
Query: 525 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584
K+A+G+A+AL +LH + V+ ++ I++ EP L S + CT
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---------LSLPGLLCT 834
Query: 585 DVAGTF--GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 642
D Y+APE + +K D+Y FG++L+ELLTG+ P ++ S+V WA+
Sbjct: 835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP-ADAEFGVHGSIVEWAR 893
Query: 643 PILSSGKVTQLLDPALGNNYDYDQ---MERMVLASILCIRRDPRARPQMSLVLKLL 695
S + +DP++ + +Q +E M LA + C DP ARP + VLK L
Sbjct: 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLA-LHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 62/274 (22%), Positives = 118/274 (43%), Gaps = 51/274 (18%)
Query: 430 IGKGGSSQVYKGCL-PDGKELAVKILK--PSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G+G S VYK P GK A+K + E+ K+ + E++ + + ++ G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 544
+++ + +V +++ GSL + L KK E +A + + L+YLH+
Sbjct: 69 YKEGEISIVLEYMDGGSLADLL---KKVG---KIPEPVLAYIARQILKGLDYLHTKR--H 120
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV-----AGTFGYLAPEYF- 598
+IHRD+K SN+L++ E +++DFG+ S + T GT Y++PE
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGI-------SKVLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 599 --MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ----ESLVMWAKPILSSGKVTQ 652
Y D+++ G+ LLE G+ P +++ P L + + +
Sbjct: 174 GESYSY---AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSP 230
Query: 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARP 686
+ + C+++DP+ RP
Sbjct: 231 -------------EFRDFI---SACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 78/272 (28%), Positives = 126/272 (46%), Gaps = 46/272 (16%)
Query: 430 IGKGGSSQVYKGCL--PDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+G G S V K L P GK +AVK L+ +E + K+ + E++I+ + I+ G
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGW-SERY--KVAMGVAEALEYLHSGSA 542
+ + ++ + +++ GSL++ L G ER K+A+ V + L YLH
Sbjct: 68 FYNNGDISICMEYMDGGSLDKIL------KEVQGRIPERILGKIAVAVLKGLTYLHE--K 119
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
++IHRDVK SNIL++ + +L DFG++ S + T V GT Y+APE
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFV-GTSSYMAPERIQGND 175
Query: 603 VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD------- 655
+ K D+++ G+ L+EL TGR P + + +LL
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFP--------------YPPENDPPDGIFELLQYIVNEPP 221
Query: 656 PALGN-NYDYDQMERMVLASILCIRRDPRARP 686
P L + + D LC+ +DPR RP
Sbjct: 222 PRLPSGKFSPD----FQDFVNLCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 85/278 (30%), Positives = 128/278 (46%), Gaps = 34/278 (12%)
Query: 430 IGKGGSSQVYKGC--LPDGKEL--AVKILKPSEDVI--KEFVLEIEIITTLHHKNIISLL 483
+G G V KG + GKE+ AVK LK KEF+ E ++ L H I+ L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
G C + L+LV + G L + L ++ P S+ ++A VA + YL S +
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPV----SDLKELAHQVAMGMAYLES---K 114
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEYFMYG 601
+HRD+ + N+LL + + ++SDFG+++ S + T AG + + APE YG
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT-AGRWPLKWYAPECINYG 173
Query: 602 KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660
K + K DV+++GV L E + G KP KG E + M L SG+ +L P
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGE--MKGAEVIAM-----LESGE--RLPRPEECP 224
Query: 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698
Y M C + P RP S + R D
Sbjct: 225 QEIYSIMLS-------CWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 81/286 (28%), Positives = 139/286 (48%), Gaps = 35/286 (12%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL--------KPSEDVIKEFVLEIEIIT 472
+NF E IG+G S+VY+ CL DG +A+K + K D IKE I+++
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKE----IDLLK 57
Query: 473 TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
L+H N+I EDN L +V + G L + KK +K + +
Sbjct: 58 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS--TSSSHITCTDVAGTF 590
ALE++HS +RV+HRD+K +N+ ++ +L D GL ++ S T+++H + GT
Sbjct: 118 ALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGTP 170
Query: 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650
Y++PE N K D+++ G +L E+ + P D + +L K K+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYSLCK------KI 220
Query: 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
Q P L +++ +++ ++V +CI DP RP ++ V + +
Sbjct: 221 EQCDYPPLPSDHYSEELRQLV---NMCINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 82/276 (29%), Positives = 132/276 (47%), Gaps = 39/276 (14%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVKILK-PSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 487
+G G +VYK + A KI++ SE+ +++F++EI+I++ H NI+ L F
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 488 EDNNLLLVYDFLSRGSL----EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+N L ++ +F G+L E G + + V + EAL +LHS
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-------VCRQMLEALNFLHS---H 122
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
+VIHRD+K+ NILL+ D + +L+DFG+ AK ST T GT ++APE
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVACET 179
Query: 603 VND-----KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657
D K D+++ G+ L+EL P +P V+ IL S T L P+
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNP----MRVLLK--ILKSEPPT-LDQPS 232
Query: 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
++ D ++ C+ +DP RP + +LK
Sbjct: 233 KWSSSFNDFLKS-------CLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 71/270 (26%), Positives = 131/270 (48%), Gaps = 30/270 (11%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
IG G V+ G + +++A+K ++ ++F+ E +++ L H ++ L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ + LV++F+ G L + L + F + + V E + YL S + VIHRD
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWA---STSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 606
+ + N L+ ++ ++SDFG+ ++ +SS T V + +PE F + K + K
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK----WSSPEVFSFSKYSSK 181
Query: 607 IDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 665
DV++FGV++ E+ + G+ P N + +V +++G +L P L + Y+
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYEN---RSNSEVV----ETINAG--FRLYKPRLASQSVYE 232
Query: 666 QMERMVLASILCIRRDPRARPQMSLVLKLL 695
M+ C + P RP SL+L L
Sbjct: 233 LMQH-------CWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 7e-23
Identities = 67/223 (30%), Positives = 117/223 (52%), Gaps = 26/223 (11%)
Query: 424 FLAENLIGKGGSSQVYKGCL--PDGKE----LAVKILKPSE--DVIKEFVLEIEIITTLH 475
FL E +G+G +VYKG L P+ + +A+K LK + V +EF E E+++ L
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYK-------- 525
H NI+ LLG C ++ +++++L+ G L E L + D A E K
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 526 --VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
+A+ +A +EYL S+ +HRD+ + N L+ + ++SDFGL++ ++ +
Sbjct: 127 LHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 584 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ ++ PE +YGK + D+++FGVVL E+ + G +P
Sbjct: 184 SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 7e-23
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSE----DVIKEFVLEIEIITTLHHK 477
+F +IGKG +V D K++ A+K + + ++ + E I+ L+H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 478 NIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEA 533
+++L + F+D N+ LV D L G L +L K + F E + A
Sbjct: 61 FLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICE-------IVLA 112
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
LEYLHS + +IHRD+K NILL + ++DF +A + + T +GT GY+
Sbjct: 113 LEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYM 166
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
APE + +D ++ GV E L G++P
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 8e-23
Identities = 68/182 (37%), Positives = 101/182 (55%), Gaps = 13/182 (7%)
Query: 446 GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVYDFLSR 501
G+++AVK LKP + I + EIEI+ L+H+NI+ G C ED N + L+ +FL
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561
GSL+E L NK ++ K A+ + + ++YL GS Q V HRD+ + N+L+ +
Sbjct: 93 GSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYL--GSRQYV-HRDLAARNVLVESEH 146
Query: 562 EPQLSDFGLAKWASTSSSHITCTD--VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 619
+ ++ DFGL K T + T D + F Y APE + K DV++FGV L EL
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYEL 205
Query: 620 LT 621
LT
Sbjct: 206 LT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 9e-23
Identities = 70/205 (34%), Positives = 115/205 (56%), Gaps = 20/205 (9%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKE-FVLEIEIITTLHHKNIISLLGFCFE 488
IG+G V +G G+++AVK +K DV + F+ E ++T LHHKN++ LLG
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 548
N L +V + +S+G+L L + A + + ++ VAE +EYL S ++++HR
Sbjct: 71 -NGLYIVMELMSKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLES---KKLVHR 124
Query: 549 DVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKID 608
D+ + NIL+S+D ++SDFGLA+ + + V T APE + K + K D
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVKWT----APEALKHKKFSSKSD 179
Query: 609 VYAFGVVLLELLT-GRKPISNDHPK 632
V+++GV+L E+ + GR P +PK
Sbjct: 180 VWSYGVLLWEVFSYGRAP----YPK 200
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 50/290 (17%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHH---KNIIS 481
LIG+G VY+G +P G+ +A+KI+ P +DV + E+ +++ L NI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV-SDIQREVALLSQLRQSQPPNITK 66
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK--VAMGVAEALEYLHS 539
G + L ++ ++ GS+ + E+Y + V AL+Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIA-------EKYISVIIREVLVALKYIHK 119
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYF 598
VIHRD+K++NIL+++ +L DFG+ A SS T GT ++APE
Sbjct: 120 VG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST---FVGTPYWMAPEVI 173
Query: 599 MYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657
GK D K D+++ G+ + E+ TG P S+ L+ +KP P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP------------PR 221
Query: 658 L-GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWAR 706
L N Y E + C+ +P+ R +LK +KW +
Sbjct: 222 LEDNGYSKLLREFVA----ACLDEEPKERLSAEELLK--------SKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 63/212 (29%), Positives = 104/212 (49%), Gaps = 32/212 (15%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKE-----FVLEIEIITTLHHKNIISLL 483
IG+G QVYK G+ +A+K ++ + KE + EI+++ L H NI+ L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENE--KEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 484 GFCFED--NNLLLVYDFLS---RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
++ +V++++ G L+ K F S+ + E L+YLH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLD---SPEVK----FTESQIKCYMKQLLEGLQYLH 117
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
S ++HRD+K SNIL+++D +L+DFGLA+ T + T+ T Y PE
Sbjct: 118 S---NGILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSADYTNRVITLWYRPPELL 173
Query: 599 M----YGKVNDKIDVYAFGVVLLELLTGRKPI 626
+ YG ++D+++ G +L EL G KPI
Sbjct: 174 LGATRYGP---EVDMWSVGCILAELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 37/275 (13%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL------KPSEDVIKEFVLEIEIITTLHHKNIIS 481
L+G G VY+G L DG AVK + + ++ +K+ EI +++ L H NI+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
LG E++NL + + + GSL + L +G+ +P ++ + + LEYLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ------ILLGLEYLHD 120
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+ +HRD+K +NIL+ + +L+DFG+AK S G+ ++APE
Sbjct: 121 ---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIA 174
Query: 600 -YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658
G D+++ G +LE+ TG+ P S ++ I S ++ P +
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA----AVFK--IGRSKEL-----PPI 223
Query: 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
++ D+ + +L C++RDP RP + +L+
Sbjct: 224 PDHLS-DEAKDFIL---KCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 56/180 (31%), Positives = 88/180 (48%), Gaps = 10/180 (5%)
Query: 450 AVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEEN 507
AVK LK D++ +F+ E I+ +L H+N+I L G + L++V + GSL +
Sbjct: 27 AVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-THPLMMVTELAPLGSLLDR 85
Query: 508 LHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 567
L + Y A+ +A + YL S +R IHRD+ + NILL+ D + ++ D
Sbjct: 86 LRKDALGHFLISTLCDY--AVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGD 140
Query: 568 FGLAKWASTSSSHITCT-DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
FGL + + H + F + APE + DV+ FGV L E+ T G +P
Sbjct: 141 FGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 4e-22
Identities = 63/213 (29%), Positives = 108/213 (50%), Gaps = 15/213 (7%)
Query: 425 LAENLIGKGGSSQVYKGCLPDGKEL-AVKILK-PSEDVIKEFVLEIEIITTLHHKNIISL 482
L E GK ++ Y C K L AVK LK S++ K+F E E++T L H++I+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD---------PAAFGWSERYKVAMGVAEA 533
G C E + L++V++++ G L + L + D PA S+ +A +A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
+ YL S Q +HRD+ + N L+ ++ ++ DFG+++ ++ + ++
Sbjct: 133 MVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
PE MY K + DV++ GVVL E+ T G++P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 32/223 (14%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFC 486
+IG+G +VYK G+ +A+KI+ ED +E E I+ +H NI + G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG-A 71
Query: 487 F-------EDNNLLLVYDFLSRGS---LEENLH--GNKKDPAAFGWSERYKVAMGVAEAL 534
F D+ L LV + GS L + L G + + R L
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR-----ETLRGL 126
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYL 593
YLH +VIHRD+K NILL+ + E +L DFG+ A+ ST T GT ++
Sbjct: 127 AYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---GTPYWM 180
Query: 594 APEYFMYGKVND-----KIDVYAFGVVLLELLTGRKPISNDHP 631
APE + D + DV++ G+ +EL G+ P+ + HP
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP 223
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 62/199 (31%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
+G G +V++G + +AVK LKP K+F+ E +I+ L H +I L C +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ +V + + GSL E L G A + +A VA + YL AQ IHRD
Sbjct: 74 EPIYIVTELMKYGSLLEYLQGGAG--RALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEYFMYGKVNDKI 607
+ + N+L+ ++ +++DFGLA+ I F + APE +Y + + K
Sbjct: 129 LAARNVLVGENNICKVADFGLAR---VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 608 DVYAFGVVLLELLT-GRKP 625
DV++FG++L E++T GR P
Sbjct: 186 DVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 5e-22
Identities = 78/267 (29%), Positives = 125/267 (46%), Gaps = 29/267 (10%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IGKG +VYKG KE+ A+KI L+ +ED I++ EI +++ I G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
+ L ++ ++L GS + L P + + + + L+YLHS +R I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHS---ERKI 123
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 606
HRD+K++N+LLS+ + +L+DFG+A + + I GT ++APE + K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 607 IDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQ 666
D+++ G+ +EL G P S+ HP L+ P P L Y
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP------------PTLEGQYS-KP 228
Query: 667 MERMVLASILCIRRDPRARPQMSLVLK 693
+ V A C+ +DPR RP +LK
Sbjct: 229 FKEFVEA---CLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 72/280 (25%), Positives = 124/280 (44%), Gaps = 35/280 (12%)
Query: 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVK---ILKPSEDVIKEFVLEIEIITTLHHKN 478
+F N IGKG V+K D + A+K + K + +E + E ++ L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER--YKVAMGVAEALEY 536
II + L +V ++ G L + L + P E ++ + + L +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPL----PEDQVWRFFIQILLGLAH 116
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
LHS ++++HRD+KS N+ L ++ D G+AK S ++ + GT YL+PE
Sbjct: 117 LHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPE 171
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656
N+K DV+A GVVL E TG+ P ++ Q +L++ K+ + + P
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALIL---------KIIRGVFP 219
Query: 657 ALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKL 694
+ Y LA ++ C+ +D R RP +L+
Sbjct: 220 PVSQMYSQQ------LAQLIDQCLTKDYRQRPDTFQLLRN 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 5e-22
Identities = 65/199 (32%), Positives = 109/199 (54%), Gaps = 16/199 (8%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
IGKG V G G ++AVK +K ++ + F+ E ++T L H N++ LLG E+
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 490 N-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 548
L +V +++++GSL + L + + G K ++ V EA+EYL + + +HR
Sbjct: 72 KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 549 DVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG-TFGYLAPEYFMYGKVNDKI 607
D+ + N+L+S+D ++SDFGL K AS++ D + APE K + K
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTAPEALREKKFSTKS 180
Query: 608 DVYAFGVVLLELLT-GRKP 625
DV++FG++L E+ + GR P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLL 483
++G+G V K C G+ +A+K K SED +K+ L E++++ L H+NI++L
Sbjct: 8 VVGEGAYGVVLK-CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
L LV++++ R LE + P + +A+ Y HS
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLEL----LEASPGGLPPDAVRSYIWQLLQAIAYCHS---H 119
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE----YFM 599
+IHRD+K NIL+S+ +L DFG A+ A + TD T Y APE
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFAR-ALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 600 YGKVNDKIDVYAFGVVLLELLTGR 623
YGK +DV+A G ++ ELL G
Sbjct: 179 YGK---PVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 9e-22
Identities = 75/267 (28%), Positives = 127/267 (47%), Gaps = 29/267 (10%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IGKG +V+KG K +A+KI L+ +ED I++ EI +++ + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
+D L ++ ++L GS + L +P ++ + + + L+YLHS ++ I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS---EKKI 123
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 606
HRD+K++N+LLS+ E +L+DFG+A + + I GT ++APE + K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 607 IDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQ 666
D+++ G+ +EL G P S HP L+ P P L NY
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP------------PTLEGNYS-KP 228
Query: 667 MERMVLASILCIRRDPRARPQMSLVLK 693
++ V A C+ ++P RP +LK
Sbjct: 229 LKEFVEA---CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCF 487
IG G VYK + G+ +A+K++K D + EI ++ H NI++ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL---EYLHSGSAQR 544
+ L +V ++ GSL++ + G ++A E L YLH
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTR------GPLSELQIAYVCRETLKGLAYLHE---TG 121
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYF---MY 600
IHRD+K +NILL++D + +L+DFG+ A+ +T + + GT ++APE
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS---FIGTPYWMAPEVAAVERK 178
Query: 601 GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
G + K D++A G+ +EL + P+ + HP
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPPMFDLHP 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 9e-22
Identities = 76/286 (26%), Positives = 129/286 (45%), Gaps = 43/286 (15%)
Query: 428 NLIGKGGSSQVYKGCLPDGKELAVK--ILKPS-----EDVIKEFVLEIEIITTLHHKNII 480
++GKG VY G G+ +AVK L S E ++ E++++ +L H NI+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 538
LG C +DN + + +F+ GS+ L N+ P +Y ++ GVA YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVA----YLH 119
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK---WASTSSSHIT-CTDVAGTFGYLA 594
+ V+HRD+K +N++L + +L DFG A+ W +H + GT ++A
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK--VTQ 652
PE K D+++ G + E+ TG+ P+++ + A + + + + +
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-------LAAMFYIGAHRGLMPR 229
Query: 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698
L D D+ C+ RD RP L+LLR D
Sbjct: 230 LPDSFSAAAIDFVTS---------CLTRDQHERPS---ALQLLRHD 263
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII 480
++ ++ +G G +VY+G +AVK LK ++EF+ E ++ + H N++
Sbjct: 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 65
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYL 537
LLG C + ++ +F++ G+L + L + + +A ++ A+EYL
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL 120
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT---FGYLA 594
+ IHRD+ + N L+ ++ +++DFGL++ + T T AG + A
Sbjct: 121 EKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTA 173
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLT 621
PE Y K + K DV+AFGV+L E+ T
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 74/278 (26%), Positives = 126/278 (45%), Gaps = 35/278 (12%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKIL--KPSEDVIKEFVLEIEIITTLHHKNI 479
+ + +G+G V K L + + A+K + P+ D+ K+ + E+EI + I
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 480 ISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+ G + +++ + ++ GSL+ KK G K+A V + L YL
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG----YL 593
HS +++IHRD+K SNILL+ + +L DFG++ S +AGTF Y+
Sbjct: 122 HS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS--------LAGTFTGTSFYM 170
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI-----LSSG 648
APE + DV++ G+ LLE+ R P P+G+ L PI + +
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLG----PIELLSYIVNM 223
Query: 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP 686
+L D GN + + + + C+ +DP RP
Sbjct: 224 PNPELKD-EPGNGIKWSEEFKDFIKQ--CLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 429 LIGKGGSSQVYKGC---LPD--GKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISL 482
+GKG V L D G+ +AVK L+ S + +++F EIEI+ +L H NI+
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 483 LGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
G C+ NL LV ++L GSL + L ++ + A + + +EYL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYL--- 124
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT--FGYLAPEYF 598
++R +HRD+ + NIL+ + ++ DFGL K + + + F Y APE
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESL 183
Query: 599 MYGKVNDKIDVYAFGVVLLELLT 621
K + DV++FGVVL EL T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 73/277 (26%), Positives = 119/277 (42%), Gaps = 39/277 (14%)
Query: 430 IGKG--GSSQVYK----GCLPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIIS 481
+GKG G + +Y+ L KE+ + L E D + E I I++ L H NII+
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNE----IVILSLLQHPNIIA 63
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM--GVAEALEYLHS 539
+DN LL+ ++ + G+L + + ++ F E + + A+ Y+H
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKI--VRQKGQLF--EEEMVLWYLFQIVSAVSYIHK 119
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
++HRD+K+ NI L+ +L DFG++K + S V GT Y++PE
Sbjct: 120 AG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM--AETVVGTPYYMSPELCQ 174
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659
K N K D++A G VL ELLT ++ +P L V P +
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----------LNLVVKIVQGNYTPVVS 223
Query: 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
Y ++ S +++DP RP VL
Sbjct: 224 V---YSSELISLVHS--LLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 77/290 (26%), Positives = 123/290 (42%), Gaps = 60/290 (20%)
Query: 424 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNII 480
FL E +G G V+ G ++A+K+++ SED +F+ E +++ L H N++
Sbjct: 8 FLKE--LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLV 62
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L G C + + +V ++++ G L L K G + V EA+EYL S
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN 119
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA----STSSSHITCTDVAGT---FGYL 593
IHRD+ + N L+ +D ++SDFGLA++ TSS GT +
Sbjct: 120 G---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ--------GTKFPVKWA 168
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT- 651
PE F Y + + K DV++FGV++ E+ + G+ P S+ +V
Sbjct: 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER----------------FSNSEVVE 212
Query: 652 ------QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695
+L P L Y M C P RP +L L
Sbjct: 213 SVSAGYRLYRPKLAPTEVYTIMY-------SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 74/286 (25%), Positives = 132/286 (46%), Gaps = 34/286 (11%)
Query: 425 LAENLIGKGGSSQVYKGCLPDGKEL-AVKILK-PSEDVIKEFVLEIEIITTLHHKNIISL 482
L E GK ++ Y K L AVK LK P+ K+F E E++T L H++I+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP------------AAFGWSERYKVAMGV 530
G C + + L++V++++ G L + L + D G S+ +A +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
A + YL S Q +HRD+ + N L+ + ++ DFG+++ ++ +
Sbjct: 133 ASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGK 649
++ PE MY K + DV++FGV+L E+ T G++P + V+ ++ G+
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN----TEVI---ECITQGR 242
Query: 650 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695
V L P + YD M + C +R+P+ R + + K+L
Sbjct: 243 V--LERPRVCPKEVYDIM-------LGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSE--DVIKEFVL-EIEIITTLHHKNIISLLGF 485
IG+G VYK G+ +A+K +K + I + L EI+++ L+H NII LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVAEALEYLHSGSA 542
+L LV++F+ + +L+ KD G E + + + + L + HS
Sbjct: 67 FRHKGDLYLVFEFM-----DTDLYKLIKD-RQRGLPESLIKSYLYQ-LLQGLAFCHS--- 116
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF---- 598
++HRD+K N+L++ + +L+DFGLA+ S S T T Y APE
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLAR--SFGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGR 623
Y +D+++ G + ELL+ R
Sbjct: 175 GYST---PVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 487
IG+G S VY + G+E+A+K + + KE ++ EI ++ H NI++ L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547
+ L +V ++L+ GSL + + D V +ALE+LHS +VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHS---NQVIH 138
Query: 548 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 607
RD+KS NILL D +L+DFG A + + + GT ++APE K+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 608 DVYAFGVVLLELLTGRKPISNDHP 631
D+++ G++ +E++ G P N++P
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 430 IGKGGSSQVYKGC-LPDGK----ELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISL 482
+G G VYKG +P+G+ +A+K+L+ KE + E ++ ++ H +++ L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA---FGWSERYKVAMGVAEALEYLHS 539
LG C + L+ + G L + + +K + + W + +A+ + YL
Sbjct: 75 LGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYL-- 125
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+R++HRD+ + N+L+ +++DFGLAK ++A E +
Sbjct: 126 -EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 600 YGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ K DV+++GV + EL+T G KP
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
+G G +V+ G ++AVK LKP + F+ E +I+ L H ++ L C E+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ +V +++S+GSL + L + + +A +AE + YL S + IHRD
Sbjct: 74 EPIYIVTEYMSKGSLLDFLK--SGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRD 128
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEYFMYGKVNDKI 607
+ + NIL+ ++ +++DFGLA+ F + APE YG+ K
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDD---EYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 608 DVYAFGVVLLELLT-GRKP 625
DV++FG++L E++T GR P
Sbjct: 186 DVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 26/216 (12%)
Query: 423 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE-----DVIKEFVL-EIEIITTLH 475
+ +G+G + VYK G+ +A+K +K E D I L EI+++ L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA-EAL 534
H NII LL +N+ LV++F+ LE+ + KD + K M + L
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVI----KDKSIVLTPADIKSYMLMTLRGL 115
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
EYLHS ++HRD+K +N+L++ D +L+DFGLA+ + + +T V T Y A
Sbjct: 116 EYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRA 170
Query: 595 PEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 626
PE YG +D+++ G + ELL R P
Sbjct: 171 PELLFGARHYGV---GVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 78/291 (26%), Positives = 132/291 (45%), Gaps = 42/291 (14%)
Query: 429 LIGKGGSSQVYKGCL--PDGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLL 483
L+G+G V K C G+ +A+K SED V K + EI ++ L H+N+++L+
Sbjct: 8 LVGEGSYGMVMK-CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
L LV++F+ L++ +K P S K + +E+ HS
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDL----EKYPNGLDESRVRKYLFQILRGIEFCHS---H 119
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---- 599
+IHRD+K NIL+S +L DFG A+ + ++ TD T Y APE +
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 600 YGKVNDKIDVYAFGVVLLELLTGR----------------KPISNDHPKGQESLVMWAKP 643
YG+ +D++A G ++ E+LTG K + N P+ QE + P
Sbjct: 178 YGR---AVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE--IFQKNP 232
Query: 644 ILSSGKVTQLLDPALGNNYDYDQMERMVLASI-LCIRRDPRARPQMSLVLK 693
+ + ++ ++ + + ++ +VL C+R DP RP S +L
Sbjct: 233 LFAGMRLPEVKEIE-PLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 429 LIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
IGKG VYKG L E+AVK + P + K F+ E EI+ H NI+ L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGV 60
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
C + + +V + + GSL L K + ++++ A +EYL S +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLES---KNC 114
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAK----WASTSSSHITCTDVAGTFGYLAPEYFMYG 601
IHRD+ + N L+ ++ ++SDFG+++ T S + + T APE YG
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT----APEALNYG 170
Query: 602 KVNDKIDVYAFGVVLLELLT-GRKPISN 628
+ + DV+++G++L E + G P
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPG 198
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 5e-20
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVK-------ILKPSEDVIKEFV----LEIEIITTLHH 476
LIGKG +VY + G+ +AVK I + K+ V EIE + L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
NI+ LGF + L + +++ GS+ L + F V E L Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
LHS + ++HRD+K+ N+L+ D ++SDFG++K + + + G+ ++APE
Sbjct: 124 LHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 597 YF-MYGK-VNDKIDVYAFGVVLLELLTGRKPISND 629
Y + + K+D+++ G V+LE+ GR+P S++
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 7e-20
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 16/216 (7%)
Query: 446 GKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYDFLSR 501
G+ +AVK LK + + EI I+ TL+H+NI+ G C E L L+ +++
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92
Query: 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561
GSL + L +K ++ A + E + YLHS Q IHRD+ + N+LL +D
Sbjct: 93 GSLRDYLPKHK-----LNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDR 144
Query: 562 EPQLSDFGLAKWASTSSSHITCTDVAGT--FGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 619
++ DFGLAK + + + F Y A E K + DV++FGV L EL
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKENKFSYASDVWSFGVTLYEL 203
Query: 620 LTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655
LT PK E ++ + ++ ++ +LL+
Sbjct: 204 LTHCDS-KQSPPKKFEEMIGPKQGQMTVVRLIELLE 238
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 57/188 (30%), Positives = 99/188 (52%), Gaps = 26/188 (13%)
Query: 448 ELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504
++A+K++K SED EF+ E +++ L H+ ++ L G C + + +V +++S G L
Sbjct: 30 DVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86
Query: 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564
L + K S+ ++ V E + YL S ++ IHRD+ + N L+ D +
Sbjct: 87 LNYLREHGKRFQP---SQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVK 140
Query: 565 LSDFGLAKWA----STSSSHITCTDVAGTF--GYLAPEYFMYGKVNDKIDVYAFGVVLLE 618
+SDFGL+++ TSS V F + PE +Y K + K DV+AFGV++ E
Sbjct: 141 VSDFGLSRYVLDDEYTSS-------VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWE 193
Query: 619 LLT-GRKP 625
+ + G+ P
Sbjct: 194 VYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 25/216 (11%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKIL------KPSEDVIKEFVLEIEIITTLHHKNII 480
L+G+G +VY C + G+ELAVK + ++ + EI+++ L H+ I+
Sbjct: 9 LLGQGAFGRVYL-CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 481 SLLGFCFEDNNLLLVY-DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
G C D+ L ++ +++ GS+++ L K A + K + E +EYLHS
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT-CTDVAGTFGYLAPEYF 598
++HRD+K +NIL +L DFG +K T S T V GT +++PE
Sbjct: 123 ---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 599 M---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
YG+ K DV++ G ++E+LT + P +
Sbjct: 180 SGEGYGR---KADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 1e-19
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 28/206 (13%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILK--PSEDVIKEFVL-EIEIITTLHHKNIISLLGF 485
+G+G VYK G+ +A+K ++ E+ I L EI ++ L H NI+ LL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHG--NKKDPAAFGWSERY-KVAMG-VAEALEYLHSGS 541
+ L LV+++ + +L +K+ S K M + L Y HS
Sbjct: 67 IHTERKLYLVFEYC-----DMDLKKYLDKRPGPL---SPNLIKSIMYQLLRGLAYCHS-- 116
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 599
R++HRD+K NIL++ D +L+DFGLA+ A T T T Y APE +
Sbjct: 117 -HRILHRDLKPQNILINRDGVLKLADFGLAR-AFGIPLR-TYTHEVVTLWYRAPEILLGS 173
Query: 600 --YGKVNDKIDVYAFGVVLLELLTGR 623
Y +D+++ G + E++TG+
Sbjct: 174 KHYST---AVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 25/212 (11%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
E +IG G +V +G L P KE+ A+K LK S+ +F+ E I+ H NII
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L G + ++++ +++ GSL++ L N F + + G+A ++YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYL--- 122
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG------YLA 594
S +HRD+ + NIL++ + ++SDFGL++ S + T T G + A
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT------TKGGKIPIRWTA 176
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
PE Y K DV++FG+V+ E+++ G +P
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 73/265 (27%), Positives = 110/265 (41%), Gaps = 26/265 (9%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKNIISLLGF 485
IGKG V K DGK L K + KE V E+ I+ L H NI+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 486 CFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA- 542
+ +N L +V ++ G L + + KK+ +++ + AL H+ S
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 543 -QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
V+HRD+K +NI L + +L DFGLAK SS GT Y++PE +
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHM 185
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661
++K D+++ G ++ EL P + Q L K GK ++ P
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPPF---TARNQLQLASKIK----EGKFRRI--P----- 231
Query: 662 YDYDQMERMVLASILCIRRDPRARP 686
Y Y V+ S + DP RP
Sbjct: 232 YRYSSELNEVIKS--MLNVDPDKRP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 61/204 (29%), Positives = 106/204 (51%), Gaps = 12/204 (5%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 487
IG+G S V+ + G+E+A+K + + KE ++ EI ++ L + NI++ L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547
+ L +V ++L+ GSL + + D A V +ALE+LH A +VIH
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIA-----AVCRECLQALEFLH---ANQVIH 138
Query: 548 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 607
RD+KS N+LL D +L+DFG A + + + GT ++APE K+
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 608 DVYAFGVVLLELLTGRKPISNDHP 631
D+++ G++ +E++ G P N++P
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 72/253 (28%), Positives = 126/253 (49%), Gaps = 28/253 (11%)
Query: 445 DGKELAVK---ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501
DGK+ +K I K S +E E+ +++ + H NI+ E+ NL +V D+
Sbjct: 24 DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83
Query: 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561
G L + + N + F + + + AL+++H ++++HRD+KS NI L+ D
Sbjct: 84 GDLYKKI--NAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDG 138
Query: 562 EPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 620
+L DFG+A+ ST TC GT YL+PE N+K D++A G VL E+
Sbjct: 139 TIKLGDFGIARVLNSTVELARTCI---GTPYYLSPEICENRPYNNKSDIWALGCVLYEMC 195
Query: 621 TGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRR 680
T + + K +LV+ K+ + P + ++Y YD R +++ + +R
Sbjct: 196 TLKHAFEAGNMK---NLVL---------KIIRGSYPPVSSHYSYDL--RNLVSQLF--KR 239
Query: 681 DPRARPQMSLVLK 693
+PR RP ++ +L+
Sbjct: 240 NPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-19
Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 36/222 (16%)
Query: 430 IGKGGSSQVY----KGCLPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISL 482
+G+G +V+ LP+ ++ AVK LK SE ++F E E++T L H++I+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD-----------PAAFGWSERYKVAMGVA 531
G C E LL+V++++ G L L + D P + +A +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 591
+ YL S +HRD+ + N L+ ++ DFG+ S I TD G
Sbjct: 133 SGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGM-------SRDIYSTDYYRVGG 182
Query: 592 -------YLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
++ PE +Y K + D+++FGVVL E+ T G++P
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 6e-19
Identities = 62/210 (29%), Positives = 111/210 (52%), Gaps = 20/210 (9%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKE--LAVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
+ +IG G +V++G L P KE +A+K LKP +E ++F+ E I+ H NII
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM--GVAEALEYLH 538
L G + +++ +++ G+L++ L + + +++ V M G+A ++YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-----VGMLRGIAAGMKYL- 123
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG--YLAPE 596
S +HRD+ + NIL++ + E ++SDFGL++ T T G + APE
Sbjct: 124 --SDMNYVHRDLAARNILVNSNLECKVSDFGLSR-VLEDDPEGTYTTSGGKIPIRWTAPE 180
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
Y K DV++FG+V+ E+++ G +P
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 8e-19
Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 487
IG+G S VY + G+E+A++ + + KE ++ EI ++ + NI++ L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547
+ L +V ++L+ GSL + + D V +ALE+LHS +VIH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHS---NQVIH 139
Query: 548 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 607
RD+KS NILL D +L+DFG A + + + GT ++APE K+
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 608 DVYAFGVVLLELLTGRKPISNDHP 631
D+++ G++ +E++ G P N++P
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
+G+G +V+ G +A+K LKP + F+ E +++ L H+ ++ L E+
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73
Query: 490 NNLLLVYDFLSRGSLEENLHGNK----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
+ +V +++S+GSL + L G + P + + M E + Y
Sbjct: 74 P-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY--------- 123
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 605
+HRD++++NIL+ ++ +++DFGLA+ + + + APE +YG+
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 606 KIDVYAFGVVLLELLT-GRKP 625
K DV++FG++L EL T GR P
Sbjct: 183 KSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 40/222 (18%)
Query: 429 LIGKGGSSQVYKG------CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNI 479
+G+G QV K + +AVK+LK E + + V E+E++ + HKNI
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK--------------------KDPAAFG 519
I+LLG C ++ L +V ++ + G+L + L + KD +F
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 520 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579
+ VA +E+L S ++ IHRD+ + N+L+++D +++DFGLA+
Sbjct: 139 YQ--------VARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY 187
Query: 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
+ T+ ++APE + DV++FGV+L E+ T
Sbjct: 188 YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 429 LIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
L+GKG +V+KG L D +AVK K P E IK F+ E I+ H NI+ L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGV 60
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
C + + +V + + G L K + + K A+ A + YL S +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLES---KNC 114
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWAST---SSSHITCTDVAGTFGYLAPEYFMYGK 602
IHRD+ + N L+ ++ ++SDFG+++ SSS + + T APE YG+
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT----APEALNYGR 170
Query: 603 VNDKIDVYAFGVVLLELLT 621
+ + DV+++G++L E +
Sbjct: 171 YSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 22/236 (9%)
Query: 402 HEKYSATCRLF-NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKP 456
HE++ A +L + D +F+ IG+G + V C+ GK++AVK +
Sbjct: 4 HEQFRAALQLVVSPGDPREYLDSFIK---IGEGSTGIV---CIATEKHTGKQVAVKKMDL 57
Query: 457 SEDVIKEFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP 515
+ +E + E+ I+ HH+N++ + + L +V +FL G+L + + + +
Sbjct: 58 RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE 117
Query: 516 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575
V + V AL YLH+ Q VIHRD+KS +ILL+ D +LSDFG A
Sbjct: 118 EQIA-----TVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFC--AQ 167
Query: 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
S + GT ++APE ++D+++ G++++E++ G P N+ P
Sbjct: 168 VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-18
Identities = 71/270 (26%), Positives = 128/270 (47%), Gaps = 35/270 (12%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IGKG +V+KG +++ A+KI L+ +ED I++ EI +++ + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEYLHSGSAQ 543
+ L ++ ++L GS + L D +++A + E L+YLHS +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFD--------EFQIATMLKEILKGLDYLHS---E 120
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
+ IHRD+K++N+LLS+ + +L+DFG+A + + I GT ++APE
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 604 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 663
+ K D+++ G+ +EL G P S+ HP L+ P +G+ ++
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSK----------- 227
Query: 664 YDQMERMVLASILCIRRDPRARPQMSLVLK 693
+ + A C+ +DP RP +LK
Sbjct: 228 --PFKEFIDA---CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 72/248 (29%), Positives = 117/248 (47%), Gaps = 27/248 (10%)
Query: 401 LHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYK-GCLPDGKELAVKILKPSED 459
L+ + + + L T + IGKG +VYK DG AVKIL P D
Sbjct: 1 LYGLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD 60
Query: 460 VIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN-----LLLVYDFLSRGSLEENLHG--- 510
V +E E I+ +L +H N++ G ++ + L LV + + GS+ E + G
Sbjct: 61 VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI 120
Query: 511 --NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568
+ D A + + G L++LH+ R+IHRDVK +NILL+ + +L DF
Sbjct: 121 CGQRLDEAMISY-----ILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDF 172
Query: 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND-----KIDVYAFGVVLLELLTGR 623
G++ A +S+ + GT ++APE + D + DV++ G+ +EL G
Sbjct: 173 GVS--AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD 230
Query: 624 KPISNDHP 631
P+ + HP
Sbjct: 231 PPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 33/212 (15%)
Query: 428 NLIGKGGSSQVYKGCL--PDGKEL--AVKILKPSEDV--IKEFVLEIEIITTLHHKNIIS 481
+IGKG VY G L DG+++ AVK L D+ +++F+ E I+ H N++S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 482 LLGFCFEDNNL-LLVYDFLSRGSLEENLHGNKKDPA-----AFGWSERYKVAMGVAEALE 535
LLG C L+V ++ G L + +P FG + VA+ +E
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG--------LQVAKGME 112
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK------WASTSSSHITCTDVAGT 589
YL S ++ +HRD+ + N +L + F +++DFGLA+ + S + V
Sbjct: 113 YLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK-- 167
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
++A E K K DV++FGV+L EL+T
Sbjct: 168 --WMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 56/197 (28%), Positives = 104/197 (52%), Gaps = 8/197 (4%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
+G+G +V+ G ++A+K LKP + + F+ E +I+ L H ++ L E+
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ +V +F+ +GSL + L + D + +A +A+ + Y+ IHRD
Sbjct: 74 P-IYIVTEFMGKGSLLDFL--KEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRD 127
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 609
++++NIL+ D+ +++DFGLA+ + + + APE +YG+ K DV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 610 YAFGVVLLELLT-GRKP 625
++FG++L EL+T GR P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 487
IG+G S VY + G+E+A+K + + KE ++ EI ++ + NI++ L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547
+ L +V ++L+ GSL + + D V +AL++LHS +VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALDFLHS---NQVIH 138
Query: 548 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 607
RD+KS NILL D +L+DFG A + + + GT ++APE K+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 608 DVYAFGVVLLELLTGRKPISNDHP 631
D+++ G++ +E++ G P N++P
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-18
Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 29/204 (14%)
Query: 430 IGKGGSSQVYK------GCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 483
+G G +VYK G L K + K SE+ ++++++EIEI+ T +H I+ LL
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 484 GFCFEDNNLLLVYDFLSRGSLEE---NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
G + D L ++ +F G+++ L +P + + + EAL+YLHS
Sbjct: 76 GAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP------QIQVICRQMLEALQYLHS- 128
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
++IHRD+K+ N+LL+ D + +L+DFG++ A + GT ++APE M
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMC 184
Query: 601 GKVND-----KIDVYAFGVVLLEL 619
+ D K D+++ G+ L+E+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKE--LAVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
E +IG G +V +G L P +E +A+K LK +E ++F+ E I+ H NII
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L G + ++++ +F+ G+L+ L N F + + G+A ++YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYL--- 122
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG---TFGYLAPEY 597
S +HRD+ + NIL++ + ++SDFGL+++ +S T T G + APE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 598 FMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
Y K DV+++G+V+ E+++ G +P
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 8/197 (4%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
+G G +V+ G ++AVK LKP + F+ E +I+ L H ++ L E+
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ +V +++S+GSL + L + A +A VA + Y+ IHRD
Sbjct: 74 P-IYIVTEYMSKGSLLDFL--KDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRD 127
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 609
++S+NIL+ D +++DFGLA+ + + + APE +YG+ K DV
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 610 YAFGVVLLELLT-GRKP 625
++FG++L EL+T GR P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-18
Identities = 70/274 (25%), Positives = 124/274 (45%), Gaps = 27/274 (9%)
Query: 423 NFLAENLIGKGGSSQVYK-GCLPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKN 478
+F +GKG VYK L D + A+K + KE V EI I+ +++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
IIS + N L +V ++ G L + + KK E +++ + + L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
Q+++HRD+KS+NILL + ++ D G++K ++ T + GT Y+APE +
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQI-GTPHYMAPEVW 173
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658
+ K D+++ G +L E+ T P + + L KV + P +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEA---RSMQDL---------RYKVQRGKYPPI 221
Query: 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 692
Y D ++ + + ++ P+ RP +L
Sbjct: 222 PPIYSQD-LQNFIRS---MLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 19/217 (8%)
Query: 425 LAENLIGKGGSSQVYKGCLPDGKELAVKILK--PSEDVIKEFVLEIEIITTLHHKNIISL 482
L E GK +Y + + +A+K LK + EF E ++ LHH NI+ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENL-----H---GNKKD-----PAAFGWSERYKVAMG 529
LG ++ + +++++L++G L E L H G D ++ + +A+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
+A +EYL S+ +H+D+ + NIL+ + ++SD GL++ ++ +
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
++ PE MYGK + D+++FGVVL E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 6e-18
Identities = 70/268 (26%), Positives = 124/268 (46%), Gaps = 35/268 (13%)
Query: 449 LAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 506
+AVKIL+P +++ +F+ E++I++ L NII LLG C +++ L ++ +++ G L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 507 NL----------HGNKKDPAA-----FGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 551
L +GN P A +S VA+ +A ++YL S+ +HRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 552 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYA 611
+ N L+ ++ +++DFG+++ + ++A E + GK DV+A
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 612 FGVVLLELLTGRKPISNDHPKGQ---ESLVMWAKPIL-SSGKVTQLLDPALGNNYDYDQM 667
FGV L E+L + + P G+ E ++ A G+ L P Y+ M
Sbjct: 226 FGVTLWEILM----LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELM 281
Query: 668 ERMVLASILCIRRDPRARPQMSLVLKLL 695
+ C RD R RP S + L
Sbjct: 282 LQ-------CWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 8e-18
Identities = 83/297 (27%), Positives = 129/297 (43%), Gaps = 50/297 (16%)
Query: 431 GKGGSSQVYKGCLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 488
G GGS K +P G +A K+ + V K+ + E++I+ I+S G
Sbjct: 16 GNGGSVSKVKH-IPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74
Query: 489 DNNLLLVYDFLSRGSLEENLH-GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547
+NN+ + +F+ GSL+ G G K+A+ V E L YL++ R++H
Sbjct: 75 ENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYN--VHRIMH 127
Query: 548 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 607
RD+K SNIL++ + +L DFG++ S I T V GT Y++PE GK K
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFV-GTSTYMSPERIQGGKYTVKS 183
Query: 608 DVYAFGVVLLELLTGRKPI--SNDHPKGQES----------LVMWAKPILSSGKVTQLLD 655
DV++ G+ ++EL G+ P SN GQ+ +V P L S +
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPED-- 241
Query: 656 PALGNNYDYDQMERMVLASILCIRRDP--RARPQ-----MSLVLKLLRGDADVTKWA 705
+ V A C+ +DP R PQ + L + D+ WA
Sbjct: 242 -----------LRDFVDA---CLLKDPTERPTPQQLCAMPPFIQALRASNVDLQAWA 284
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 8e-18
Identities = 67/194 (34%), Positives = 103/194 (53%), Gaps = 24/194 (12%)
Query: 446 GKELAVKILKPSEDVIK----EFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500
GK A+KIL ++K E VL E I+ ++ H +++L G +D+NL LV +++
Sbjct: 26 GKYYALKILS-KAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVP 84
Query: 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560
G L +L + + P + Y A V ALEYLHS +++RD+K N+LL D
Sbjct: 85 GGELFSHLRKSGRFPE--PVARFY--AAQVVLALEYLHS---LDIVYRDLKPENLLLDSD 137
Query: 561 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLL 617
+++DFG AK T T + GT YLAPE + YGK +D +A G+++
Sbjct: 138 GYIKITDFGFAKRVKGR----TYT-LCGTPEYLAPEIILSKGYGK---AVDWWALGILIY 189
Query: 618 ELLTGRKPISNDHP 631
E+L G P +D+P
Sbjct: 190 EMLAGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 36/222 (16%)
Query: 430 IGKGGSSQVY---KGCLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISL 482
I KG +V+ K G A+K++K + ++ + + + E +I++ ++ L
Sbjct: 1 ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 483 LGFCFE-DNNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+ F+ NL LV ++L G SL EN+ +D A +E + ALEYLH
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAE-------IVLALEYLH 110
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT------CTDVAGTFGY 592
S +IHRD+K NIL+ + +L+DFGL+K + GT Y
Sbjct: 111 S---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 593 LAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
+APE + + K +D ++ G +L E L G P + P
Sbjct: 168 IAPEVILGQGHSK---TVDWWSLGCILYEFLVGIPPFHGETP 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 71/288 (24%), Positives = 126/288 (43%), Gaps = 42/288 (14%)
Query: 423 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILK-------PSEDVIKEFVLEIEIITTL 474
+L +G G S Y+ + G +AVK + E+V++ EI ++ L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 475 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 534
+H +II +LG ED++ L ++++ GS+ L AF + + L
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGL 116
Query: 535 EYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTD-----VAG 588
YLH ++IHRDVK +N+L+ S +++DFG A+ ++ T + G
Sbjct: 117 SYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGA---AARLAAKGTGAGEFQGQLLG 170
Query: 589 TFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 645
T ++APE YG+ DV++ G V++E+ T + P + + +L+
Sbjct: 171 TIAFMAPEVLRGEQYGR---SCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227
Query: 646 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
++ + + L P L R V + C+ P RP +LK
Sbjct: 228 TAPSIPEHLSPGL----------RDVT--LRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 58/218 (26%), Positives = 113/218 (51%), Gaps = 21/218 (9%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
+G G +V+ G + ++AVK LKP ++ F+ E ++ TL H ++ L ++
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKD----PAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
+ ++ +++++GSL + L ++ P +S + +AE + Y+ +
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIER---KNY 124
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG-TFGYLAPEYFMYGKVN 604
IHRD++++N+L+S+ +++DFGLA+ + T + A + APE +G
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 605 DKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWA 641
K DV++FG++L E++T G+ P +P S VM A
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIP----YPGMSNSDVMSA 216
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 66/273 (24%), Positives = 119/273 (43%), Gaps = 26/273 (9%)
Query: 424 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 483
F+ E +G G V+ G ++A+K + ++F+ E +++ L H ++ L
Sbjct: 8 FMKE--LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLY 65
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
G C + L +V +F+ G L L+ ++ + V E +EYL S
Sbjct: 66 GVCTQQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS-- 120
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
IHRD+ + N L+S ++SDFG+ ++ + + + + PE F + K
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 604 NDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 662
+ K DV++FGV++ E+ T G+ P E + M +S G +L P L +
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPFEKK--SNYEVVEM-----ISRGF--RLYRPKLASMT 229
Query: 663 DYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695
Y+ M C P RP + +L+ +
Sbjct: 230 VYEVMYS-------CWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 69/222 (31%), Positives = 112/222 (50%), Gaps = 32/222 (14%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFC 486
++G G QVYKG + G+ A+K++ +ED +E LEI ++ HH+NI + G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 487 FE------DNNLLLVYDFLSRGS---LEENLHGN--KKDPAAFGWSERYKVAMGVAEALE 535
+ D+ L LV +F GS L +N GN K+D A+ + + L
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-------ICREILRGLA 135
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLA 594
+LH A +VIHRD+K N+LL+++ E +L DFG+ A+ T T GT ++A
Sbjct: 136 HLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYWMA 189
Query: 595 PEYFMYGKVND-----KIDVYAFGVVLLELLTGRKPISNDHP 631
PE + D + D+++ G+ +E+ G P+ + HP
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK--PSEDVIKEFVL-EIEIITTLHHK 477
+ F N IG+G VY+ G+ +A+K ++ D I L EI ++ L H
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 478 NIISLLGFCFED--NNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
NI+ L +++ LV ++ + SL +N+ P F S+ + + +
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM------PTPFSESQVKCLMLQLLRG 120
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
L+YLH +IHRD+K SN+LL+D +++DFGLA+ + +T V T Y
Sbjct: 121 LQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYR 175
Query: 594 APEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPI 626
APE + ID++A G +L ELL KP+
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAH-KPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 76/295 (25%), Positives = 134/295 (45%), Gaps = 30/295 (10%)
Query: 402 HEKYSATCRLF-NYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSED 459
HE++ A ++ + D + NF+ IG+G + V + GK +AVK + +
Sbjct: 2 HEQFRAALQMVVDPGDPRTYLDNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ 58
Query: 460 VIKEFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAF 518
+E + E+ I+ H+N++ + + L +V +FL G+L + + + +
Sbjct: 59 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI 118
Query: 519 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578
V + V +AL LH AQ VIHRD+KS +ILL+ D +LSDFG A S
Sbjct: 119 A-----AVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK 168
Query: 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638
+ GT ++APE ++D+++ G++++E++ G P N+
Sbjct: 169 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--------- 219
Query: 639 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
P+ + + L P L N + + L +L RDP R + +LK
Sbjct: 220 ---PPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV--RDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 4e-17
Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 30/223 (13%)
Query: 430 IGKGGSSQVYK----GCLPDGKEL--AVKILK--PSEDVIKEFVLEIEIITTLHHKNIIS 481
IG+G +V++ G LP AVK+LK S D+ +F E ++ H NI+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNK------------------KDPAAFGWSER 523
LLG C + L++++++ G L E L +P +E+
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 524 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
+A VA + YL S ++ +HRD+ + N L+ ++ +++DFGL++ ++ +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 584 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ A ++ PE Y + + DV+A+GVVL E+ + G +P
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 428 NLIGKGGSSQVYKGC----LPDGKE---LAVKILK--PSEDVIKEFVLEIEIITTLHHKN 478
N +G G +VY+G L G +AVK L+ ++ KEF+ E +++ +H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD---PAAFGWSERYKVAMGVAEALE 535
I+ LLG C + ++ + + G L L + + P E + + VA+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 536 YLHSGSAQRVIHRDVKSSNILLSD-----DFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
YL IHRD+ + N L+S+ D ++ DFGLA+ S + +
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
++APE + GK + DV++FGV++ E+LT G++P
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 55/189 (29%), Positives = 101/189 (53%), Gaps = 18/189 (9%)
Query: 448 ELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504
++AVK+LK +E + + + E+E++ + HKNII+LLG C +D L ++ ++ S+G+L
Sbjct: 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 505 EENLHGNKKDPAAFGWS------------ERYKVAMGVAEALEYLHSGSAQRVIHRDVKS 552
E L + + ++ + A VA +EYL S ++ IHRD+ +
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAA 168
Query: 553 SNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAF 612
N+L+++D +++DFGLA+ + T+ ++APE + DV++F
Sbjct: 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228
Query: 613 GVVLLELLT 621
GV+L E+ T
Sbjct: 229 GVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 64/218 (29%), Positives = 112/218 (51%), Gaps = 34/218 (15%)
Query: 427 ENLIGKGGSSQVYKGCLP-DGKEL--AVKILK--PSEDVIKEFVLEIEIITTL-HHKNII 480
E++IG+G QV + + DG ++ A+K+LK SE+ ++F E+E++ L HH NII
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPA---------AFGWSERYKVAM 528
+LLG C L + ++ G+L + L ++ DPA + + A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
VA ++YL S ++ IHRD+ + N+L+ ++ +++DFGL++ V
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY--------VKK 175
Query: 589 TFG-----YLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
T G ++A E Y K DV++FGV+L E+++
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 430 IGKGGSSQVYKGCLP----DGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLG 484
IG+G + V C+ G+++AVK + + +E + E+ I+ H NI+ +
Sbjct: 27 IGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 485 FCFEDNNLLLVYDFLSRGSLEENL-HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+ L +V +FL G+L + + H + V + V +AL +LH+ Q
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI------ATVCLAVLKALSFLHA---Q 134
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
VIHRD+KS +ILL+ D +LSDFG A S + GT ++APE
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISRLPY 192
Query: 604 NDKIDVYAFGVVLLELLTGRKPISNDHP 631
++D+++ G++++E++ G P N+ P
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPYFNEPP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 8e-17
Identities = 58/190 (30%), Positives = 100/190 (52%), Gaps = 22/190 (11%)
Query: 449 LAVKILK--PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505
+AVK+LK ++ + + V E+E++ + HKNII+LLG C +D L ++ ++ S+G+L
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 506 ENLHGNKKDPAAFGWS--------------ERYKVAMGVAEALEYLHSGSAQRVIHRDVK 551
E L + P +S + A VA +EYL S Q+ IHRD+
Sbjct: 107 EYLRARR--PPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLA 161
Query: 552 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYA 611
+ N+L+++D +++DFGLA+ + T+ ++APE + DV++
Sbjct: 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 221
Query: 612 FGVVLLELLT 621
FGV+L E+ T
Sbjct: 222 FGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 65/205 (31%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 430 IGKGGSSQVYKGC--LPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLLG 484
IG+G V+K C G+ +A+K SED VIK+ L EI ++ L H N+++L+
Sbjct: 9 IGEGSYGVVFK-CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 485 FCFEDNNLLLVYDFLSR---GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L LV+++ LE+N G + K+ +A+ + H
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-------KIIWQTLQAVNFCH--- 117
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 599
IHRDVK NIL++ + +L DFG A+ + TD T Y APE +
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPELLVGD 175
Query: 600 --YGKVNDKIDVYAFGVVLLELLTG 622
YG +DV+A G V ELLTG
Sbjct: 176 TQYGP---PVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 57/197 (28%), Positives = 103/197 (52%), Gaps = 15/197 (7%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVK--ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 487
+G G +VYK + LA I SE+ ++++++EI+I+ + H NI+ LL +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547
+NNL ++ +F + G+++ + ++ + V EAL YLH ++IH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHE---NKIIH 126
Query: 548 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND-- 605
RD+K+ NIL + D + +L+DFG++ A + + GT ++APE M D
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 606 ---KIDVYAFGVVLLEL 619
K DV++ G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 22/228 (9%)
Query: 428 NLIGKGGSSQVYKGCL----PDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNI 479
+G G +VY+G D EL V + SE +F++E I++ +H+NI
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEY 536
+ L+G FE ++ + ++ G L+ L N+ + P++ + A VA+ +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGY 592
L IHRD+ + N LL+ P ++DFG+A+ +S + +
Sbjct: 132 LEE---NHFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 593 LAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639
+ PE F+ G K DV++FGV+L E+ + G P QE +
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT--NQEVMEF 233
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 51/188 (27%), Positives = 98/188 (52%), Gaps = 18/188 (9%)
Query: 449 LAVKILK--PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505
+AVK+LK ++ + + + E+E++ + HKNII+LLG C ++ L ++ ++ ++G+L
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 506 ENLH------------GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 553
E L K + + A VA +EYL S +R IHRD+ +
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAAR 163
Query: 554 NILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFG 613
N+L+++D +++DFGLA+ + ++ ++APE + DV++FG
Sbjct: 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 614 VVLLELLT 621
+++ E+ T
Sbjct: 224 ILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 50/272 (18%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G G VYK L + LAVK+ L + ++ K+ + E+EI+ II G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
F +N + + +F+ GSL+ ++ + G ++A+ V + L YL S +++
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPEHV-LG-----RIAVAVVKGLTYLWS---LKIL 117
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 606
HRDVK SN+L++ + +L DFG+ ST + GT Y+APE +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGV----STQLVNSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 607 IDVYAFGVVLLELLTGRKPISNDHPKGQ------------ESLVMWAKPILSSGKVTQLL 654
DV++ G+ +EL GR P +P+ Q + +V P+L G+ +
Sbjct: 174 SDVWSLGISFMELALGRFP----YPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFS--- 226
Query: 655 DPALGNNYDYDQMERMVLASILCIRRDPRARP 686
E+ V C+R+ P+ RP
Sbjct: 227 -------------EKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 26/270 (9%)
Query: 430 IGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IG+G +V+ G L D +AVK + + D+ +F+ E I+ H NI+ L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
+ + +V + + G L + + E ++ A +EYL S + I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL---RTEGPRLKVKELIQMVENAAAGMEYLES---KHCI 116
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 606
HRD+ + N L+++ ++SDFG+++ T + APE YG+ + +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 607 IDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 665
DV++FG++L E + G P +N + + + +L P L + Y
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE---------QGVRLPCPELCPDAVYR 227
Query: 666 QMERMVLASILCIRRDPRARPQMSLVLKLL 695
MER C DP RP S V + L
Sbjct: 228 LMER-------CWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 24/208 (11%)
Query: 430 IGKGGSSQVYKGCLPDGK---ELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLG 484
+G G V KG K ++A+K+LK + V E + E EI+ L + I+ ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE-RYKVAMGVAEALEYLHSGSAQ 543
C E L+LV + S G L + L G K + E ++V+MG ++YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMG----MKYLEG---K 114
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG-----YLAPEYF 598
+HRD+ + N+LL + ++SDFGL+K S+ A + G + APE
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK----ARSAGKWPLKWYAPECI 170
Query: 599 MYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ K + + DV+++G+ + E + G+KP
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 2e-16
Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFC 486
L+G G QVYKG + G+ A+K++ + D +E EI ++ HH+NI + G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 487 FE------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
+ D+ L LV +F GS+ + + K + W + + L +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQ- 129
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+VIHRD+K N+LL+++ E +L DFG+ A+ T T GT ++APE
Sbjct: 130 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYWMAPEVIA 184
Query: 600 YGKVND-----KIDVYAFGVVLLELLTGRKPISNDHP 631
+ D K D+++ G+ +E+ G P+ + HP
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 57/192 (29%), Positives = 102/192 (53%), Gaps = 26/192 (13%)
Query: 449 LAVKILK--PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505
+AVK+LK +E + + V E+E++ + HKNII+LLG C +D L ++ ++ S+G+L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 506 ENLHGNKKDPAAFGW----------------SERYKVAMGVAEALEYLHSGSAQRVIHRD 549
E L + + + S Y+VA G +EYL S Q+ IHRD
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARG----MEYLAS---QKCIHRD 162
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 609
+ + N+L++++ +++DFGLA+ + + T+ ++APE + DV
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222
Query: 610 YAFGVVLLELLT 621
++FGV++ E+ T
Sbjct: 223 WSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 430 IGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKE----FVLEIEIITTLHHKNIISLL 483
+GKGG +V C GK A K L ++ + E +I+ + + I+SL
Sbjct: 1 LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL- 58
Query: 484 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
+ FE ++L LV ++ G L+ H F + A + LE+LH
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLK--YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ--- 113
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
+R+++RD+K N+LL D ++SD GLA AGT GY+APE
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEV 170
Query: 603 VNDKIDVYAFGVVLLELLTGRKP 625
+ +D +A G L E++ GR P
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-16
Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 19/229 (8%)
Query: 449 LAVKILKPSEDVIKEFVL------------EIEIITTLHHKNIISLLGFCFEDNNLLLVY 496
+A + P E V+ +FV+ E+ + H I+ D+ LLL+
Sbjct: 85 VATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144
Query: 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556
++ S G L + + K+ F E + + AL+ +HS ++++HRD+KS+NI
Sbjct: 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIF 201
Query: 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 616
L +L DFG +K S S S + GT YLAPE + + + K D+++ GV+L
Sbjct: 202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVIL 261
Query: 617 LELLTGRKPISNDHPKGQESLVMWAK----PILSSGKVTQLLDPALGNN 661
ELLT +P + V++ K P S + LLDP L N
Sbjct: 262 YELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKN 310
|
Length = 478 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 64/293 (21%), Positives = 121/293 (41%), Gaps = 58/293 (19%)
Query: 430 IGKGGSSQVYKGCLPD------GKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 481
+G+G VY+G +A+K + S EF+ E ++ + +++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 482 LLGFCFEDNNLLLVYDFLSRGSL--------EENLHGNKKDPAAFGWSERYKVAMGVAEA 533
LLG L+V + +++G L E + P + ++A +A+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP--TLQKFIQMAAEIADG 131
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG-- 591
+ YL A++ +HRD+ + N ++++D ++ DFG+ + I TD G
Sbjct: 132 MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-------DIYETDYYRKGGKG 181
Query: 592 -----YLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISNDHPKGQESLVMWAK 642
++APE G K DV++FGVVL E+ T +P +SN+ V+ K
Sbjct: 182 LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VL--K 232
Query: 643 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695
++ G + P + + M C + +P+ RP ++ L
Sbjct: 233 FVIDGGHLDL---PENCPDKLLELMRM-------CWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 5e-16
Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 34/217 (15%)
Query: 428 NLIGKGGSSQVYKGCLP-DGKEL--AVKILK--PSEDVIKEFVLEIEIITTL-HHKNIIS 481
++IG+G QV K + DG + A+K +K S+D ++F E+E++ L HH NII+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPA-------AFGWSER--YKVAMG 529
LLG C L L ++ G+L + L ++ DPA A S + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
VA ++YL S ++ IHRD+ + NIL+ +++ +++DFGL++ V T
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--------VKKT 169
Query: 590 FG-----YLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
G ++A E Y DV+++GV+L E+++
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 78/279 (27%), Positives = 129/279 (46%), Gaps = 37/279 (13%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCF 487
IGKG +V+K +G + AVKIL P D+ +E E I+ L H N++ G +
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 488 EDN-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK---VAMGVAEALEYLHS 539
+ + L LV + + GS+ + + G K ER + +A + EAL L
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR------GERMEEPIIAYILHEALMGLQH 139
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF- 598
+ IHRDVK +NILL+ + +L DFG++ A +S+ + GT ++APE
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPFWMAPEVIA 197
Query: 599 ----MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654
+ + + DV++ G+ +EL G P+++ HP M A + L
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-------MRALFKIPRNPPPTLH 250
Query: 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
P L +N D + + C+ +D RP +S +L+
Sbjct: 251 QPELWSNEFNDFIRK-------CLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-16
Identities = 80/290 (27%), Positives = 134/290 (46%), Gaps = 51/290 (17%)
Query: 427 ENLIGKGGSSQVYKGCL-PDGKEL--AVKILK--PSEDVIKEFVLEIEIITTL-HHKNII 480
+++IG+G QV K + DG + A+K +K S+D ++F E+E++ L HH NII
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPA---------AFGWSERYKVAM 528
+LLG C L L ++ G+L + L ++ DPA + A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
VA ++YL S ++ IHRD+ + NIL+ +++ +++DFGL++ V
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--------VKK 180
Query: 589 TFG-----YLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 642
T G ++A E Y DV+++GV+L E+++ G P G ++ K
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-----GMTCAELYEK 235
Query: 643 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 692
L G +L P ++ YD M + C R P RP + +L
Sbjct: 236 --LPQG--YRLEKPLNCDDEVYDLMRQ-------CWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 66/236 (27%), Positives = 104/236 (44%), Gaps = 21/236 (8%)
Query: 452 KILKPSEDVIKEFVLEIEIIT-TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHG 510
K + + I + V E+ II L H NI+ E++ L +V D + L E+ +
Sbjct: 43 KDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNS 102
Query: 511 NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570
K+ F + + + + AL YLH +R++HRD+ +NI+L +D + ++DFGL
Sbjct: 103 LKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGL 160
Query: 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630
AK S T V GT Y PE +K DV+AFG +L ++ T + P +
Sbjct: 161 AKQKQPESK---LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF---Y 214
Query: 631 PKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP 686
SL V + +P Y + V+ S C+ D ARP
Sbjct: 215 STNMLSLATKI--------VEAVYEPL--PEGMYSEDVTDVITS--CLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 9e-16
Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 22/236 (9%)
Query: 402 HEKYSATCRLFNYQ-DLLSATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKP 456
HE++ A R+ Q D S N++ IG+G + V C+ G+++AVK++
Sbjct: 3 HEQFKAALRMVVDQGDPRSLLENYIK---IGEGSTGIV---CIAREKHSGRQVAVKMMDL 56
Query: 457 SEDVIKEFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP 515
+ +E + E+ I+ H+N++ + L ++ +FL G+L + + + +
Sbjct: 57 RKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNE 116
Query: 516 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575
V V +AL YLHS Q VIHRD+KS +ILL+ D +LSDFG A
Sbjct: 117 EQIA-----TVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFC--AQ 166
Query: 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
S + GT ++APE ++D+++ G++++E++ G P +D P
Sbjct: 167 ISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 429 LIGKGGSSQVYKGCLPDGK----ELAVKILK--PSEDVIKEFVLEIEIITTLHHKNIISL 482
IG+G VY+G + +AVK K S V ++F+ E I+ H +I+ L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
+G +N + +V + G L L NK + + + ++ AL YL S
Sbjct: 73 IGVI-TENPVWIVMELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLES--- 125
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
+R +HRD+ + N+L+S +L DFGL+++ S+ + ++APE + +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFRR 184
Query: 603 VNDKIDVYAFGVVLLELLT-GRKP 625
DV+ FGV + E+L G KP
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 78/283 (27%), Positives = 130/283 (45%), Gaps = 39/283 (13%)
Query: 424 FLAENLIGKGGSSQVYKGCLPDGKEL-AVKIL----KPSEDVIKEFVLEIEIITTLHHKN 478
F+ + IG G VY E+ AVK + K + + ++ + E++ + L H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
I G +++ LV ++ GS + L +KK E + G + L YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEY-CLGSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLH 138
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
S +IHRD+K+ NILL++ + +L+DFG A +S ++S + GT ++APE
Sbjct: 139 S---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVI 189
Query: 599 MY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655
+ G+ + K+DV++ G+ +EL + P+ N M A L + Q
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFN----------MNAMSALY--HIAQNDS 237
Query: 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698
P L +N D V C+++ P+ RP +LLR D
Sbjct: 238 PTLQSNEWTDSFRGFV---DYCLQKIPQERPAS---AELLRHD 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 78/279 (27%), Positives = 123/279 (44%), Gaps = 40/279 (14%)
Query: 430 IGKGGSSQVYKG---CLPDGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLL 483
+G G V KG K +AVKILK + + E + E ++ L + I+ ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
G C E + +LV + G L + L NK ++V+MG ++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG----MKYLEETN-- 115
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG-----YLAPEYF 598
+HRD+ + N+LL ++SDFGL+K ++ A T G + APE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK----AKTHGKWPVKWYAPECM 170
Query: 599 MYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657
Y K + K DV++FGV++ E + G+KP KG E M + SG+ ++ P
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG--MKGNEVTQM-----IESGE--RMECPQ 221
Query: 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
YD M+ LC RP ++V LR
Sbjct: 222 RCPPEMYDLMK-------LCWTYGVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 74/283 (26%), Positives = 126/283 (44%), Gaps = 50/283 (17%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHH-KNIISLLG 484
IG G QVYK G +AVK ++ + ++ K +++++++ H I+ G
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 485 FCFEDNNLLLVYDFLS----------RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 534
+ D+++ + + +S +G + E++ G K+ + + +AL
Sbjct: 82 YFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG--------------KMTVAIVKAL 127
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
YL VIHRDVK SNILL +L DFG++ S + T AG Y+A
Sbjct: 128 HYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMA 182
Query: 595 PEYFMYGKVNDKI----DVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650
PE N K DV++ G+ L+EL TG+ P N + + +L+ K+
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE---------VLT--KI 231
Query: 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
Q P+L N + + LC+ +D R RP+ +L+
Sbjct: 232 LQEEPPSLPPNEGFSPDFCSFV--DLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 65/262 (24%), Positives = 119/262 (45%), Gaps = 28/262 (10%)
Query: 449 LAVKILKPSEDVIK----EFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504
+AVK+L+ DV K +F+ EI+I++ L + NII LLG C D+ L ++ +++ G L
Sbjct: 47 VAVKMLRA--DVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 505 EENL----------HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 554
+ L H N + + + +A+ +A ++YL S +HRD+ + N
Sbjct: 105 NQFLSQREIESTFTHAN--NIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN 159
Query: 555 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGV 614
L+ + + +++DFG+++ + + ++A E + GK DV+AFGV
Sbjct: 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 615 VLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLAS 674
L E+ T K ++ + + + G+ L L + + M R
Sbjct: 220 TLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMR----- 274
Query: 675 ILCIRRDPRARPQMSLVLKLLR 696
C RD + RP + + LR
Sbjct: 275 --CWSRDIKDRPTFNKIHHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 37/214 (17%)
Query: 428 NLIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLG 484
N IG G VYK P G+ A+K++ + V ++ EIEI+ ++H N++
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSA 542
+ + ++ +F+ GSLE E++ VA + + YLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLE----------GTHIADEQFLADVARQILSGIAYLHR--- 186
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYG 601
+ ++HRD+K SN+L++ +++DFG+++ A T C GT Y++PE
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPE----- 238
Query: 602 KVNDKI----------DVYAFGVVLLELLTGRKP 625
++N + D+++ GV +LE GR P
Sbjct: 239 RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 68/217 (31%), Positives = 111/217 (51%), Gaps = 33/217 (15%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
NFL ++GKG +V EL A+KILK +DVI + + ++ T+ K +++
Sbjct: 3 NFLM--VLGKGSFGKVMLAERKGTDELYAIKILK--KDVI---IQDDDVECTMVEKRVLA 55
Query: 482 LLG---F------CFED-NNLLLVYDFLSRGSLEENLH--GNKKDP-AAFGWSERYKVAM 528
L G F CF+ + L V ++++ G L ++ G K+P A F +E
Sbjct: 56 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAE------ 109
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
+A L +LHS + +I+RD+K N++L + +++DFG+ K + T T G
Sbjct: 110 -IAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRT-FCG 163
Query: 589 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
T Y+APE Y +D +AFGV+L E+L G+ P
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLG 484
IG G VY + + +A+K + K S + ++ + E+ + L H N I G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
++ LV ++ GS + L +KK E + G + L YLHS
Sbjct: 83 CYLREHTAWLVMEY-CLGSASDILEVHKK---PLQEVEIAAICHGALQGLAYLHS---HE 135
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY---G 601
IHRD+K+ NILL++ +L+DFG A S ++S + GT ++APE + G
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDEG 189
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPISN 628
+ + K+DV++ G+ +EL + P+ N
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 66/254 (25%), Positives = 120/254 (47%), Gaps = 28/254 (11%)
Query: 448 ELAVKILKPSEDVIKEFVL--EIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504
++AVK+LKP+ + L E++I++ L +H+NI++LLG C +L++ ++ G L
Sbjct: 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 505 EENLHGNKKDPAAFG--WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 562
L ++ S Y+VA G + +L S + IHRD+ + N+LL+
Sbjct: 127 LNFLRRKRESFLTLEDLLSFSYQVAKG----MAFLASKNC---IHRDLAARNVLLTHGKI 179
Query: 563 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT- 621
++ DFGLA+ S+++ + ++APE + DV+++G++L E+ +
Sbjct: 180 VKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 239
Query: 622 GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRD 681
G P +P G + K I ++ Q P YD M+ C D
Sbjct: 240 GSNP----YP-GMPVDSKFYKLIKEGYRMAQ---PEHAPAEIYDIMKT-------CWDAD 284
Query: 682 PRARPQMSLVLKLL 695
P RP +++L+
Sbjct: 285 PLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 29/221 (13%)
Query: 422 SNFLAENLIGKGGSSQV----YKGCLPDGKELAVKILKPSEDV----IKEFVLEIEIITT 473
S+F +G G +V +KG G+ A+K LK E + ++ E I+
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILME 74
Query: 474 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGV 530
L H I++++ ++N + + +F+ G L +L + P A F +E +
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE-------L 127
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
A EYLHS + +I+RD+K N+LL + +++DFG AK + C GT
Sbjct: 128 VLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFTLC----GTP 179
Query: 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
YLAPE +D + GV+L E + G P +D P
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220
|
Length = 329 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 74/272 (27%), Positives = 128/272 (47%), Gaps = 32/272 (11%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILK--PSED--VIKEFVLEIEIITTLHHKNIISLLG 484
IG G VYK + G+ A+K++K P ED V+++ EI ++ H NI++ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHSNIVAYFG 73
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
+ L + +F GSL++ H S+ V+ + L YLHS
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSKGK-- 127
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY---G 601
+HRD+K +NILL+D+ +L+DFG++ A +++ GT ++APE G
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661
N D++A G+ +EL + P+ + HP +L + K S+ + +L D +N
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHP--MRALFLMTK---SNFQPPKLKDKMKWSN 239
Query: 662 YDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
+ +M L ++P+ RP +L+
Sbjct: 240 -SFHHFVKMALT------KNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 22/203 (10%)
Query: 446 GKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLS 500
GK A+KILK ++D + + E ++ H + SL + F+ + L V ++++
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVN 78
Query: 501 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557
G L +L + +D F +E + AL+YLHSG ++++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFSEDRTRFYGAE-------IVSALDYLHSG---KIVYRDLKLENLML 128
Query: 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 617
D +++DFGL K T ++ T GT YLAPE +D + GVV+
Sbjct: 129 DKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 186
Query: 618 ELLTGRKPISN-DHPKGQESLVM 639
E++ GR P N DH K E ++M
Sbjct: 187 EMMCGRLPFYNQDHEKLFELILM 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 429 LIGKGGSSQVYKGC-LPDGKEL----AVKILK----PSEDVIKEFVLEIEIITTLHHKNI 479
++G G VYKG +P+G+ + A+KIL P +V EF+ E I+ ++ H ++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHPHL 71
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
+ LLG C + LV + G L + +H +K + G + +A+ + YL
Sbjct: 72 VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDN---IGSQLLLNWCVQIAKGMMYLEE 127
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+R++HRD+ + N+L+ +++DFGLA+ ++A E
Sbjct: 128 ---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 600 YGKVNDKIDVYAFGVVLLELLT-GRKP 625
Y K + DV+++GV + EL+T G KP
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 54/204 (26%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
E +G G +V+ ++AVK +KP ++ F+ E ++ TL H ++ L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 487 FEDNNLLLVYDFLSRGSLEENL---HGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSA 542
++ + ++ +F+++GSL + L G+K+ P +S + +AE + ++
Sbjct: 71 TKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQ--- 120
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
+ IHRD++++NIL+S +++DFGLA+ + + + APE +G
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGS 179
Query: 603 VNDKIDVYAFGVVLLELLT-GRKP 625
K DV++FG++L+E++T GR P
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 64/249 (25%), Positives = 114/249 (45%), Gaps = 23/249 (9%)
Query: 449 LAVKILKPSEDVIK----EFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504
+AVK+L+ ED K +F+ EI+I++ L NII LL C + L ++ +++ G L
Sbjct: 49 VAVKMLR--EDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 505 EENL-------HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557
+ L K D +S +A +A ++YL S+ +HRD+ + N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLV 163
Query: 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 617
++ +++DFG+++ + + +++ E + GK DV+AFGV L
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223
Query: 618 ELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILC 677
E+LT K ++ + + G+ L PAL + Y M + C
Sbjct: 224 EILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLM-------LSC 276
Query: 678 IRRDPRARP 686
RR+ + RP
Sbjct: 277 WRRNAKERP 285
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLG 484
+G+GG QV+ D E+ A+K +K S + ++ + E +I+TT + ++ LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 485 FCFED-NNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS- 539
+ F+D L L +++ G +L NL +D A F Y M EA++ LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-----YMAEM--FEAVDALHEL 120
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
G IHRD+K N L+ +L+DFGL+K + ++ V G+ Y+APE
Sbjct: 121 G----YIHRDLKPENFLIDASGHIKLTDFGLSK-GIVTYAN----SVVGSPDYMAPEVLR 171
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
+ +D ++ G +L E L G P S P
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 429 LIGKGGSSQVY----KGCLPDGKEL--AVKIL--KPSEDVIKEFVLEIEIITTLHHKNII 480
+G+G +V+ KG +G E VK L E++ EF E+++ L HKN++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-----DPAAFGWSERYKVAMGVAEALE 535
LLG C E ++ ++ G L++ L K P ++ + +A ++
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
+L S R +HRD+ + N L+S E ++S L+K S + + +LAP
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAP 187
Query: 596 EYFMYGKVNDKIDVYAFGVVLLELLT 621
E + K DV++FGV++ E+ T
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 54/214 (25%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 429 LIGKGGSSQVYKGC-LPDGKEL----AVKIL--KPSEDVIKEFVLEIEIITTLHHKNIIS 481
L+G G V+KG +P+G + A+K + + +E + + +L H I+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK--DPAAF-GWSERYKVAMGVAEALEYLH 538
LLG C +L LV GSL +++ ++ DP W + +A+ + YL
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLE 126
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
R++HR++ + NILL D Q++DFG+A ++ ++A E
Sbjct: 127 E---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 599 MYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 631
++G+ + DV+++GV + E+++ G +P + P
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 31/215 (14%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIISL----- 482
++GKG +V L EL AVK+LK +DVI + + ++ T+ K +++L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLK--KDVI---LQDDDVECTMTEKRVLALAGKHP 56
Query: 483 ----LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEAL 534
L CF+ + L V ++++ G L ++ + + A F Y A + L
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-----Y--AAEIVLGL 109
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
++LH + +I+RD+K N+LL + +++DFG+ K +T + GT Y+A
Sbjct: 110 QFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGTPDYIA 164
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
PE Y +D +A GV+L E+L G+ P D
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 72/271 (26%), Positives = 125/271 (46%), Gaps = 33/271 (12%)
Query: 429 LIGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL----EIEIITTLHHKNIISL 482
++G+G V+ C D K + +K + P E + K+ L E +++ L H NII
Sbjct: 7 VVGRGAFGIVHL-CRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
ED L++V ++ G+L E + K+ + + + AL ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVH---T 119
Query: 543 QRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
+ ++HRD+K+ NILL ++ DFG++K S+ S T V GT Y++PE
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELCEGK 176
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661
N K D++A G VL EL + ++ + +LV+ K+ + +
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAAN---LPALVL---------KIMSGTFAPISDR 224
Query: 662 YDYDQMERMVLASILCIRRDPRARPQMSLVL 692
Y D R ++ S+L DP RPQ+S ++
Sbjct: 225 YSPDL--RQLILSML--NLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 429 LIGKGGSSQVYKGCLPDGKE-LAVKILKPSEDVIK----EFVL-EIEIITTLHHKNIISL 482
+G G +V+ + A+K++ +VI+ + V E ++ + H II L
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIP-EVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
+ L ++ +++ G L L + + F S A + ALEYLHS
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR----FSNSTGLFYASEIVCALEYLHS--- 119
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
+ +++RD+K NILL + +L+DFG AK T T + GT YLAPE
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWT-LCGTPEYLAPEVIQSKG 174
Query: 603 VNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633
N +D +A G+++ E+L G P +D+P G
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-15
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 446 GKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLS 500
G+ A+KIL+ ++D + V E ++ H ++ L + F+ ++ L V ++ +
Sbjct: 20 GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP-FLTALKYAFQTHDRLCFVMEYAN 78
Query: 501 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557
G L +L + ++ A F +E + ALEYLHS + V++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFTEERARFYGAE-------IVSALEYLHS---RDVVYRDIKLENLML 128
Query: 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 617
D +++DFGL K + + T GT YLAPE +D + GVV+
Sbjct: 129 DKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 186
Query: 618 ELLTGRKPISN-DHPKGQESLVM 639
E++ GR P N DH + E ++M
Sbjct: 187 EMMCGRLPFYNQDHERLFELILM 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-15
Identities = 70/240 (29%), Positives = 115/240 (47%), Gaps = 37/240 (15%)
Query: 429 LIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLG--- 484
++GKG +V+ L + A+K LK +DV+ +++ ++ T+ K ++SL
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALK--KDVV---LMDDDVECTMVEKRVLSLAWEHP 56
Query: 485 -----FC-FE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+C F+ NL V ++L+ G L ++ K F A + L++L
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK----FDLPRATFYAAEIICGLQFL 112
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
HS + +++RD+K NILL D +++DFG+ K + TCT GT Y+APE
Sbjct: 113 HS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCT-FCGTPDYIAPEI 167
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKP------------ISNDHPKGQESLVMWAKPIL 645
+ K N +D ++FGV+L E+L G+ P I D+P L AK IL
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDIL 227
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 9e-15
Identities = 72/222 (32%), Positives = 105/222 (47%), Gaps = 40/222 (18%)
Query: 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKE-----FVLEIEIITTLHHKNIISL 482
IG+G QVYK D EL V + K D KE + EI+I+ L+H+NI++L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGEL-VALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 483 ----------LGFCFEDNNLLLVYDFLSR---GSLEENL-HGNKKDPAAFGWSERYKVAM 528
L F + LV++++ G LE L H ++ +F K +
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF-----MKQLL 126
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
E L Y H + +HRD+K SNILL++ + +L+DFGLA+ ++ S V
Sbjct: 127 ---EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI- 179
Query: 589 TFGYLAPEYF----MYGKVNDKIDVYAFGVVLLELLTGRKPI 626
T Y PE YG IDV++ G +L EL T +KPI
Sbjct: 180 TLWYRPPELLLGEERYGPA---IDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 37/216 (17%)
Query: 430 IGKGGSSQVYKGCL-PDGKELAVKILKPSEDV---IKEFV-LEIEIITTLHHKNIISLLG 484
+G GG +V + + A+K +K V +E + E EI+ +H I+ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 485 FCFEDNN---LLL-------VYDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
F+D +L+ ++ L RG +E ++ R+ +A V A
Sbjct: 61 -TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE-------------YTARFYIAC-VVLA 105
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
EYLH+ + +I+RD+K N+LL + +L DFG AK S T T GT Y+
Sbjct: 106 FEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAK--KLKSGQKTWTFC-GTPEYV 159
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
APE + + +D ++ G++L ELLTGR P D
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
+G G +V+ G ++A+K LK + F+ E ++ L H ++ L ++
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG--VAEALEYLHSGSAQRVIH 547
+ ++ +++ GSL + L K P + + M +AE + ++ + IH
Sbjct: 74 P-IYIITEYMENGSLVDFL----KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIH 125
Query: 548 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG-TFGYLAPEYFMYGKVNDK 606
RD++++NIL+S+ +++DFGLA+ + T + A + APE YG K
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 607 IDVYAFGVVLLELLT-GRKP 625
DV++FG++L E++T GR P
Sbjct: 184 SDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVK---ILKPSED-------VIKEFVLEIEIITTLHHK 477
LIG G VY G G+ +AVK + S ++ EI ++ L H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALE 535
NI+ LG + ++L + +++ GS+ N +G ++ + + + + L
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ------ILKGLN 120
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT----DVAGTFG 591
YLH+ + +IHRD+K +NIL+ + ++SDFG++K +S + G+
Sbjct: 121 YLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 592 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628
++APE K D+++ G +++E+LTG+ P +
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKN 478
NF IG+G VYK G+ +A+K ++ +E V + EI ++ L+H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD--PAAFGWSERYKVAMGVAEALEY 536
I+ LL +N L LV++FL + L++ + + P S +++ G+A +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----F 115
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
HS RV+HRD+K N+L++ + +L+DFGLA+ T T T Y APE
Sbjct: 116 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPE 170
Query: 597 YFMYGKV-NDKIDVYAFGVVLLELLTGR 623
+ K + +D+++ G + E++T R
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 62/232 (26%), Positives = 110/232 (47%), Gaps = 36/232 (15%)
Query: 420 ATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSEDVI--KEFVLEIEII 471
+T F+ E +G+ +VYKG L + +A+K LK + +EF E +
Sbjct: 5 STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 472 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL-----H---GNKKD--------- 514
+ L H NI+ LLG ++ L +++ + S L E L H G+ D
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 515 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574
PA F + +A +E+L S+ V+H+D+ + N+L+ D ++SD GL +
Sbjct: 123 PADF-----VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ + + +++PE MYGK + D++++GVVL E+ + G +P
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 26/217 (11%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL----AVKILKPSEDVIKE-----FVLEIEIITTLHHKNI 479
++GKGG +V++ G + A+K+LK + V + E I+ + H I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 480 ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALE 535
+ L+ + F+ L L+ ++LS G L +L +D A F SE ++ ALE
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE-------ISLALE 114
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
+LH Q +I+RD+K NILL +L+DFGL K S +T T GT Y+AP
Sbjct: 115 HLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHT-FCGTIEYMAP 169
Query: 596 EYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632
E M +D ++ G ++ ++LTG P + ++ K
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK 206
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 69/274 (25%), Positives = 126/274 (45%), Gaps = 38/274 (13%)
Query: 430 IGKGGSSQVY--------KGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
IG+G ++Y + C+ +L +K E KE +L + + H NI++
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVIL----LAKMKHPNIVT 63
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
E+ L +V ++ G L + + N++ F + + ++ L+++H
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDLMKRI--NRQRGVLFSEDQILSWFVQISLGLKHIHD-- 119
Query: 542 AQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWASTSSSHI-TCTDVAGTFGYLAPEYFM 599
++++HRD+KS NI LS + +L DFG+A+ + S TC GT YL+PE
Sbjct: 120 -RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC---VGTPYYLSPEICQ 175
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659
N+K D+++ G VL EL T + P ++ LV+ K+ Q +
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNN---LHQLVL---------KICQGYFAPIS 223
Query: 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
N+ D R +++ + + PR RP ++ +LK
Sbjct: 224 PNFSRDL--RSLISQLF--KVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 71/269 (26%), Positives = 110/269 (40%), Gaps = 65/269 (24%)
Query: 430 IGKGGSSQVYKGCL---PDGKELAVKILKPSEDVIKEF----VLEIEIITTLHHKNIISL 482
IG+G +VYK DGKE A+K K ++ EI ++ L H+N++SL
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 483 LGFCFEDNN--LLLVYDFLSRGSLEENL---------HGNKKDPAAFGWSERYKVAMGVA 531
+ E + + L++D+ E +L P + S +++ GV
Sbjct: 68 VEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLA-KWASTSSSHITCTDV 586
YLHS V+HRD+K +NIL+ + + + D GLA + + V
Sbjct: 123 ----YLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 587 AGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 642
T Y APE + Y K ID++A G + ELLT PI KG+E+
Sbjct: 176 VVTIWYRAPELLLGARHYTKA---IDIWAIGCIFAELLTLE-PIF----KGREA------ 221
Query: 643 PILSSGKVTQLLDPALGNNYDYDQMERMV 671
N + DQ+ER+
Sbjct: 222 ------------KIKKSNPFQRDQLERIF 238
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 18/209 (8%)
Query: 444 PDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499
P G +A K++ KP+ + + + E++++ + I+ G + D + + + +
Sbjct: 28 PSGLIMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85
Query: 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 559
GSL++ L K+ P KV++ V L YL +++HRDVK SNIL++
Sbjct: 86 DGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNS 139
Query: 560 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 619
E +L DFG++ S ++ GT Y++PE + + D+++ G+ L+EL
Sbjct: 140 RGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
Query: 620 LTGRKPISNDHPKGQESLVMWAKPILSSG 648
GR PI P +E ++ +P++
Sbjct: 196 AIGRYPIPP--PDAKELEAIFGRPVVDGE 222
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 50/193 (25%), Positives = 84/193 (43%), Gaps = 20/193 (10%)
Query: 446 GKELAVKILKPSEDV----IKEFVLEIEIITTLHHKNIISLLGFCFED-NNLLLVYDFLS 500
G A+K+LK S+ + + E I+ ++ L + F+ + L LV ++L+
Sbjct: 21 GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80
Query: 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-VIHRDVKSSNILLSD 559
G + W+++Y V +E LH QR +IHRD+K N+L+
Sbjct: 81 GGDCASLI--KTLGGLPEDWAKQY--IAEVVLGVEDLH----QRGIIHRDIKPENLLIDQ 132
Query: 560 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 619
+L+DFGL++ + GT YLAPE + + D ++ G V+ E
Sbjct: 133 TGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEF 186
Query: 620 LTGRKPISNDHPK 632
L G P + P
Sbjct: 187 LFGYPPFHAETPD 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 68/239 (28%), Positives = 110/239 (46%), Gaps = 35/239 (14%)
Query: 458 EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA 517
+D+IKE + + L H N I G ++ LV ++ GS + L +KK
Sbjct: 60 QDIIKE----VRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQE 114
Query: 518 FGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577
E V G + L YLHS +IHRDVK+ NILLS+ +L DFG A + +
Sbjct: 115 V---EIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168
Query: 578 SSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634
+ + GT ++APE + G+ + K+DV++ G+ +EL + P+ N
Sbjct: 169 NXFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN------ 216
Query: 635 ESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
M A L + Q PAL + + + V + C+++ P+ RP ++LK
Sbjct: 217 ----MNAMSALY--HIAQNESPALQSGHWSEYFRNFVDS---CLQKIPQDRPTSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 57/193 (29%), Positives = 90/193 (46%), Gaps = 29/193 (15%)
Query: 525 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584
K+A+ + +ALEYLHS VIHRDVK SN+L++ + + +L DFG++ + S + T
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---VAKT 161
Query: 585 DVAGTFGYLAPEYF---MYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMW 640
AG Y+APE + K D K DV++ G+ ++EL TGR P + W
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS-----------W 210
Query: 641 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP------QMSLVLKL 694
P +V + P L + + V C++++ + RP Q
Sbjct: 211 KTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNK---CLKKNYKERPNYPELLQHPFFELH 267
Query: 695 LRGDADVTKWARL 707
L + DV + L
Sbjct: 268 LSKNTDVASFVSL 280
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 71/249 (28%), Positives = 111/249 (44%), Gaps = 46/249 (18%)
Query: 423 NFLAENLIGKGGSSQVY----KGCLPDGKELAVKILKP--------------SEDVIKEF 464
NF ++G G +V+ G GK A+K+LK +E + E
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 465 VLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 523
V + TLH + F+ D L L+ D+++ G L +L+ + F SE
Sbjct: 61 VRRCPFLVTLH---------YAFQTDTKLHLILDYVNGGELFTHLYQREH----FTESE- 106
Query: 524 YKVAMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580
V + +AE AL++LH +I+RD+K NILL + L+DFGL+K
Sbjct: 107 --VRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
Query: 581 ITCTDVAGTFGYLAPEYFMYGKV--NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638
GT Y+APE G + +D ++ GV+ ELLTG P + D + +S +
Sbjct: 162 RA-YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI 220
Query: 639 MWAKPILSS 647
++ IL S
Sbjct: 221 --SRRILKS 227
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILK--PSED--VIKEFVLEIEIITTLHHKNIISLLG 484
+G G VYK L G+ AVKI+K P +D +I++ EI ++ H NI++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKHCNIVAYFG 73
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE---YLHSGS 541
L + ++ GSL++ H G ++A E L+ YLHS
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYH-------VTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY- 600
+HRD+K +NILL+D+ + +L+DFG+A A +++ GT ++APE
Sbjct: 127 K---MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 601 --GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
G N D++A G+ +EL + P+ + HP
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 14/212 (6%)
Query: 422 SNFLAENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLH 475
S E +IG G +V G L P +E+ A+K LK +E ++F+ E I+
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
H NII L G + +++V +++ GSL+ L +K F + + G+A ++
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL---RKHDGQFTVIQLVGMLRGIASGMK 120
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLA 594
YL S +HRD+ + NIL++ + ++SDFGL++ + T + A
Sbjct: 121 YL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 177
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
PE Y K DV+++G+V+ E+++ G +P
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 67/227 (29%), Positives = 116/227 (51%), Gaps = 28/227 (12%)
Query: 429 LIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFV---LEIEIITTLHHKNIIS 481
++G+G +V+ K PD +L A+K+LK + +++ V +E +I+ ++H I+
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 482 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGN---KKDPAAFGWSERYKVAMGVAEALEYL 537
L + F+ + L L+ DFL G L L ++ F +E +A AL++L
Sbjct: 63 L-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-------LALALDHL 114
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA--STSSSHITCTDVAGTFGYLAP 595
HS +I+RD+K NILL ++ +L+DFGL+K + ++ C GT Y+AP
Sbjct: 115 HSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC----GTVEYMAP 167
Query: 596 EYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 642
E D ++FGV++ E+LTG P K ++++ AK
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 5e-14
Identities = 67/242 (27%), Positives = 114/242 (47%), Gaps = 31/242 (12%)
Query: 455 KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD 514
K S + ++ + E++ + + H N I G ++ LV ++ GS + L +KK
Sbjct: 63 KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY-CLGSASDLLEVHKKP 121
Query: 515 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574
E + G + L YLHS +IHRD+K+ NILL++ + +L+DFG A A
Sbjct: 122 LQEV---EIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIA 175
Query: 575 STSSSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
S ++S + GT ++APE + G+ + K+DV++ G+ +EL + P+ N
Sbjct: 176 SPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--- 226
Query: 632 KGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLV 691
M A L + Q P L +N D V + C+++ P+ RP +
Sbjct: 227 -------MNAMSALY--HIAQNESPTLQSNEWSDYFRNFVDS---CLQKIPQDRPTSEEL 274
Query: 692 LK 693
LK
Sbjct: 275 LK 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 429 LIGKGGSSQVYKGCL--PDGKEL--AVKILKP---SEDVIKEFVLEIEIITTLHHKNIIS 481
++G+G V +G L DG +L AVK +K + I+EF+ E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 482 LLGFCFEDNNL------LLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEA 533
L+G CFE ++L +++ F+ G L L ++ P K + +A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS----SHITCTDVAGT 589
+EYL S + IHRD+ + N +L +D ++DFGL+K + I V
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 180
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
++A E K DV+AFGV + E+ T G+ P
Sbjct: 181 --WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-14
Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 31/220 (14%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
NFL ++GKG +V EL A+KILK +DV+ + + ++ T+ K +++
Sbjct: 3 NFLM--VLGKGSFGKVMLAERKGTDELYAIKILK--KDVV---IQDDDVECTMVEKRVLA 55
Query: 482 LLG---------FCFED-NNLLLVYDFLSRGSLEENLH--GNKKDPAAFGWSERYKVAMG 529
L G CF+ + L V ++++ G L + G K+P A + A
Sbjct: 56 LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY------AAE 109
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
+A L +LHS + +I+RD+K N++L + +++DFG+ K +T GT
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGT 164
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
Y+APE Y +D +AFGV+L E+L G+ P +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSED--VIKEFVLEIEIITTLHHKNIISLLGF 485
IG+G VYKG G+ +A+K I SE+ V + EI ++ L H NI+ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 486 CFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
+++ L L+++FLS L+ ++L + A S Y++ G+ + HS
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGIL----FCHS--- 119
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG- 601
+RV+HRD+K N+L+ + +L+DFGLA+ T V T Y APE +
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLLGSP 177
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPI 626
+ + +D+++ G + E+ T +KP+
Sbjct: 178 RYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 6e-14
Identities = 70/235 (29%), Positives = 92/235 (39%), Gaps = 52/235 (22%)
Query: 418 LSATSNFLAE-------NLI-GKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIE 469
LS FL LI GK G V K P K KI+K K F IE
Sbjct: 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKH-KPTQKLFVQKIIKA-----KNFN-AIE 58
Query: 470 I-ITTL--HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 526
+ L + N I L +L+ D++ G L + L K +E K+
Sbjct: 59 PMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK----LSEAEVKKI 114
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCT 584
+ EAL LH +IH D+K N+L D + + L D+GL K T S +
Sbjct: 115 IRQLVEALNDLHK---HNIIHNDIKLENVLY-DRAKDRIYLCDYGLCKIIGTPSCY---- 166
Query: 585 DVAGTFGYLAPEYFMYGKVNDKI---------DVYAFGVVLLELLTGRKPISNDH 630
D GT Y +PE KI D +A GV+ ELLTG+ P D
Sbjct: 167 D--GTLDYFSPE---------KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 7e-14
Identities = 69/213 (32%), Positives = 103/213 (48%), Gaps = 34/213 (15%)
Query: 430 IGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI--------- 479
IGKG QVY+ D + A+K+L KE V + E+ T+ +NI
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK-----KEIVAKKEVAHTIGERNILVRTLLDES 55
Query: 480 --ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
I L F F+ D++L LV D++S G L +L + ++ +A V ALE+
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED---RAKFYIAELVL-ALEH 111
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
LH +++RD+K NILL L DFGL+K A+ + + T T GT YLAPE
Sbjct: 112 LHK---YDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNT-FCGTTEYLAPE 166
Query: 597 YFM----YGKVNDKIDVYAFGVVLLELLTGRKP 625
+ Y K +D ++ GV++ E+ G P
Sbjct: 167 VLLDEKGYTK---HVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 54/229 (23%), Positives = 108/229 (47%), Gaps = 35/229 (15%)
Query: 423 NFLAENLIGKGGSSQVYKGC------LPDGKELAVKILK----PSEDVIKEFVLEIEIIT 472
N + +G+G +V K +AVK+LK SE +++ + E ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE--LRDLLSEFNLLK 58
Query: 473 TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-DPAAFGWSERYK------ 525
++H ++I L G C +D LLL+ ++ GSL L ++K P+ G
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 526 -----VAMG--------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ MG ++ ++YL + +++HRD+ + N+L+++ + ++SDFGL++
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 573 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
S++ + ++A E + DV++FGV+L E++T
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 76/298 (25%), Positives = 122/298 (40%), Gaps = 60/298 (20%)
Query: 424 FLAENL-----IGKGGSSQVYKGCLPD-GKELAVKILKPSED--VIKEFVLEIEIITTLH 475
F AE+L IG+G V K G +AVK ++ + D K +++++++
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 476 H-KNIISLLG---------FCFE------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFG 519
I+ G C E D VY+ L + + E + G
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL-KSVIPEEILG--------- 110
Query: 520 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579
K+A+ +AL YL ++IHRDVK SNILL + +L DFG++ S
Sbjct: 111 -----KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS-- 161
Query: 580 HITCTDVAGTFGYLAPEY---FMYGKVNDKIDVYAFGVVLLELLTGRKPISN-DHPKGQE 635
I T AG Y+APE + + DV++ G+ L E+ TG+ P + Q
Sbjct: 162 -IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
Query: 636 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
+ V+ P P L N+ + + V LC+ +D RP+ +L+
Sbjct: 221 TQVVKGDP------------PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIE-----IITTLHHKNIISLL 483
IGKG +V DGK AVK+L+ + K+ I ++ + H ++ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 484 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEALEYLHS 539
+ F+ + L V D+++ G L +L + P A F +E +A AL YLHS
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAE-------IASALGYLHS 114
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+I+RD+K NILL L+DFGL K S T + GT YLAPE
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLR 169
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKPI-SNDH 630
+ +D + G VL E+L G P S D
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT 201
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 21/206 (10%)
Query: 429 LIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLL 483
++GKG +V L G+ AVK+LK +D ++ + E I++ + ++ L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 484 GFCFED-NNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHS 539
CF+ + L V +F++ G L ++ +++ A F +E + AL +LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE-------ITSALMFLHD 114
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+ +I+RD+K N+LL + +L+DFG+ K + T + GT Y+APE
Sbjct: 115 ---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQ 169
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKP 625
+D +A GV+L E+L G P
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 421 TSNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKP----SEDVIKEFVLEIEIITTLH 475
NFL ++GKG +V EL A+KILK +D ++ ++E ++
Sbjct: 1 DFNFLM--VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 476 HKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLH--GNKKDPAAFGWSERYKVAMGVAE 532
++ L CF+ + L V ++++ G L ++ G K+P A + A ++
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY------AAEISV 112
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
L +LH + +I+RD+K N++L + +++DFG+ K +T GT Y
Sbjct: 113 GLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDY 167
Query: 593 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
+APE Y +D +A+GV+L E+L G+ P +
Sbjct: 168 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 66/239 (27%), Positives = 116/239 (48%), Gaps = 35/239 (14%)
Query: 458 EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK----K 513
ED KE VL + + H NI++ D +L +V ++ G L + + +
Sbjct: 43 EDSRKEAVL----LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFP 98
Query: 514 DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
+ W ++ +GV +++H +RV+HRD+KS NI L+ + + +L DFG A+
Sbjct: 99 EDTILQWF--VQMCLGV----QHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL 149
Query: 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633
++ ++ CT V GT Y+ PE + N+K D+++ G +L EL T + P +
Sbjct: 150 LTSPGAY-ACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS--- 204
Query: 634 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 692
W IL KV Q L ++Y Y+ R ++ + +R+PR+RP + +L
Sbjct: 205 ------WKNLIL---KVCQGSYKPLPSHYSYEL--RSLIKQMF--KRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 2e-13
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 49/206 (23%)
Query: 446 GKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLLGF-------CFEDNNLLLV 495
G+++A+K I +D+I K + EI+++ L H+NII LL F D + +V
Sbjct: 25 GRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND--VYIV 82
Query: 496 YDFL---------SRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLHSGSAQRV 545
+ + S L + + + + + L+YLHS + V
Sbjct: 83 TELMETDLHKVIKSPQPLTD---------------DHIQYFLYQILRGLKYLHSAN---V 124
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC-TDVAGTFGYLAPEYFM----Y 600
IHRD+K SNIL++ + + ++ DFGLA+ T+ T Y APE + Y
Sbjct: 125 IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRY 184
Query: 601 GKVNDKIDVYAFGVVLLELLTGRKPI 626
K ID+++ G + ELLT RKP+
Sbjct: 185 TK---AIDIWSVGCIFAELLT-RKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 26/213 (12%)
Query: 428 NLIGKGGSSQVYKGC-LPDGKELAVK-ILKP-SEDVIKEFVL-EIEI---ITTLHHKNII 480
IG+G VYK L G+ +A+K + P SE+ I L EI + + + H NI+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 481 SLLGFC-----FEDNNLLLVYDFLSRGSLEENLHGN-KKDPAAFGWSERYKVAMG-VAEA 533
LL C + L LV++ + +++L K P E K M +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
+++LHS R++HRD+K NIL++ D + +++DFGLA+ S + T V T Y
Sbjct: 120 VDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVVTLWYR 173
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
APE + +D+++ G + EL R+P+
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAELFR-RRPL 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 47/133 (35%), Positives = 75/133 (56%), Gaps = 5/133 (3%)
Query: 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 553
LV D+ + G L + + K F E + + V A+ ++HS + +IHRD+KS+
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSA 172
Query: 554 NILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAF 612
NILL + +L DFG +K +A+T S + T GT Y+APE + + K D+++
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTPYYVAPEIWRRKPYSKKADMFSL 231
Query: 613 GVVLLELLTGRKP 625
GV+L ELLT ++P
Sbjct: 232 GVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEII-TTLHHKNIISLLG-- 484
++GKG +V L E A+K LK K+ VLE + + T+ + +++L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALK------KDVVLEDDDVECTMVERRVLALAWEH 55
Query: 485 ------FC-FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
FC F+ +L V ++L+ G L ++ + + F + A + L++
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR----FDEARARFYAAEIICGLQF 111
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
LH + +I+RD+K N+LL D +++DFG+ K + GT Y+APE
Sbjct: 112 LHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTPDYIAPE 166
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
K N+ +D ++FGV+L E+L G+ P +
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 430 IGKGGSSQVY------KGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 483
+GKGG +V G L K+L K LK + V E I+ +H + I+SL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV-EKRILAKVHSRFIVSL- 58
Query: 484 GFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
+ F+ +L LV ++ G L +++ ++ F + LE+LH
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--- 115
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
+R+I+RD+K N+LL +D ++SD GLA AGT G++APE +
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 603 VNDKIDVYAFGVVLLELLTGRKP 625
+ +D +A GV L E++ R P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 2e-13
Identities = 53/165 (32%), Positives = 86/165 (52%), Gaps = 35/165 (21%)
Query: 475 HHKNIISLLGFCFEDNN--LLLVYDFLS-------RGSLEENLHGNKKDPAAFGWSERYK 525
H NI+ LL +N+ + LV++++ R ++ E++H +RY
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH------------KRY- 111
Query: 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST---SSSHIT 582
+ + +AL+Y+HSG VIHRD+K SNILL+ D +L+DFGLA+ S + +
Sbjct: 112 IMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 583 CTDVAGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGR 623
TD T Y APE + Y K +D+++ G +L E+L G+
Sbjct: 169 LTDYVATRWYRAPEILLGSTRYTK---GVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 3e-13
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 38/211 (18%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVKILK---PS-EDVIKEFVLEIEIITTL-HHKNIISLL 483
+G G VY + EL A+K +K S E+ + + E++ + L H NI+ L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN--LREVKSLRKLNEHPNIVKLK 64
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYL 537
E++ L V++++ E NL+ KD +SE Y++ G L ++
Sbjct: 65 EVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQG----LAHI 115
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC----TDVAGTFGYL 593
H HRD+K N+L+S +++DFGLA+ I TD T Y
Sbjct: 116 HK---HGFFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRWYR 165
Query: 594 APEYFMY-GKVNDKIDVYAFGVVLLELLTGR 623
APE + + +D++A G ++ EL T R
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 429 LIGKGGSSQVYKGCLPD-GKELAVKILK---PSEDVIKE---FVLEIEIITTLHHKNIIS 481
L+G+G +VY D G+ELA K ++ S + KE EI+++ L H+ I+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 482 LLGFCFEDN---NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
G C D L + +++ GS+++ L K A S K + E + YLH
Sbjct: 69 YYG-CLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILEGMSYLH 123
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST-SSSHITCTDVAGTFGYLAPEY 597
S ++HRD+K +NIL +L DFG +K T S V GT +++PE
Sbjct: 124 S---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKP 625
K DV++ G ++E+LT + P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 430 IGKGGSSQVYK-GCLPDGKELAVK--ILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGF 485
IG+G V+K G+ +A+K L+ E I L EI+ + H ++ LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
+ +LV +++ L E L +++ P + Y + + + Y+H A +
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLR-DEERPLPEAQVKSY--MRMLLKGVAYMH---ANGI 120
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG--KV 603
+HRD+K +N+L+S D +++DFGLA+ S + VA T Y APE +YG K
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPE-LLYGARKY 178
Query: 604 NDKIDVYAFGVVLLELLTGR 623
+ +D++A G + ELL G
Sbjct: 179 DPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 65/250 (26%), Positives = 102/250 (40%), Gaps = 55/250 (22%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKE-----FVLEIEIITTLH 475
+F +IG+G +V+ D ++ A+K+L+ S D+IK E +I+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKS-DMIKRNQIAHVRAERDILADAD 59
Query: 476 HKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE-- 532
I+ L + F+D +L LV +++ G L L +KD + Y +AE
Sbjct: 60 SPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEETARFY-----IAELV 111
Query: 533 -ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK------------------- 572
AL+ +H IHRD+K NIL+ D +L+DFGL K
Sbjct: 112 LALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 573 --------WASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLT 621
+ GT Y+APE YG + D ++ GV+L E+L
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGL---ECDWWSLGVILYEMLY 225
Query: 622 GRKPISNDHP 631
G P +D
Sbjct: 226 GFPPFYSDTL 235
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 28/206 (13%)
Query: 446 GKELAVKILKPSEDVIKEFV----LEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLS 500
GK A+KILK + K+ V E ++ H + +L + F+ ++ L V ++ +
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYAN 78
Query: 501 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557
G L +L + +D A F +E + AL YLHS V++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFSEDRARFYGAE-------IVSALGYLHS---CDVVYRDLKLENLML 128
Query: 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGV 614
D +++DFGL K + + T GT YLAPE YG+ +D + GV
Sbjct: 129 DKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRA---VDWWGLGV 183
Query: 615 VLLELLTGRKPISN-DHPKGQESLVM 639
V+ E++ GR P N DH K E ++M
Sbjct: 184 VMYEMMCGRLPFYNQDHEKLFELILM 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 446 GKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLS 500
G+ A+KILK ++D + + E ++ H ++ L + F+ ++ L V ++ +
Sbjct: 20 GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP-FLTALKYSFQTHDRLCFVMEYAN 78
Query: 501 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557
G L +L + +D A F +E + AL+YLHS + V++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFSEDRARFYGAE-------IVSALDYLHS--EKNVVYRDLKLENLML 129
Query: 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 617
D +++DFGL K + T GT YLAPE +D + GVV+
Sbjct: 130 DKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 187
Query: 618 ELLTGRKPISN-DHPKGQESLVM 639
E++ GR P N DH K E ++M
Sbjct: 188 EMMCGRLPFYNQDHEKLFELILM 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 17/214 (7%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILK---PSEDVIKE---FVLEIEIITTL 474
+N+ L+G+G +VY D G+ELAVK ++ S + KE EI+++ L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 475 HHKNIISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
H+ I+ G + + L + + + GS+++ L K A + K + E
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILE 117
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS-SHITCTDVAGTFG 591
+ YLHS ++HRD+K +NIL +L DFG +K T S V GT
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174
Query: 592 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
+++PE K D+++ G ++E+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIISL----- 482
++GKG +V L E+ A+K+LK +DVI + + ++ T+ K I++L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLK--KDVI---LQDDDVDCTMTEKRILALAAKHP 56
Query: 483 ----LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
L CF+ + L V ++++ G L + ++K F A V AL +L
Sbjct: 57 FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK----FDEPRSRFYAAEVTLALMFL 112
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
H VI+RD+K NILL + +L+DFG+ K + +T T GT Y+APE
Sbjct: 113 HRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEI 167
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630
+ +D +A GV++ E++ G+ P D+
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 36/213 (16%)
Query: 446 GKELAVKILKPSEDVI---KEFVLEIEIITTLHHKNIISLL------GFCFEDNNLLLVY 496
GK++A+K + + DV K + E++I+ H NII++ G F+D + +V
Sbjct: 30 GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD--VYVVM 87
Query: 497 DFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHSGSAQRVIHRDV 550
D L L +H ++ +E Y++ G L+Y+HS + VIHRD+
Sbjct: 88 D-LMESDLHHIIHSDQP------LTEEHIRYFLYQLLRG----LKYIHSAN---VIHRDL 133
Query: 551 KSSNILLSDDFEPQLSDFGLAKWASTSSSHIT--CTDVAGTFGYLAPE-YFMYGKVNDKI 607
K SN+L+++D E ++ DFG+A+ S+S + T+ T Y APE + I
Sbjct: 134 KPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAI 193
Query: 608 DVYAFGVVLLELLTGRKPI-SNDHPKGQESLVM 639
D+++ G + E+L GR+ + + Q L++
Sbjct: 194 DMWSVGCIFAEML-GRRQLFPGKNYVHQLKLIL 225
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVK-ILKPSED--VIKEFVLEIEIITTLHHKNIISLLGF 485
IG+G VYK G+ +A+K I +ED V + EI ++ L+H NI+ LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
+N L LV++FL L+ + + + + + Y HS RV
Sbjct: 67 VHSENKLYLVFEFLD---LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRV 120
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK-VN 604
+HRD+K N+L+ + +L+DFGLA+ T V T Y APE + + +
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGSRQYS 178
Query: 605 DKIDVYAFGVVLLELLTGRKPI 626
+D+++ G + E++ R+P+
Sbjct: 179 TPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 39/106 (36%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
+ E L YLH AQR+IHRDVK+ NI ++D + + D G A++ + + + +AGT
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL---GLAGT 219
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635
APE K N K D+++ G+VL E+L I D P E
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPE 265
|
Length = 357 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 446 GKELAVKILKPSEDVIKEFV-----LEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFL 499
GK A+K+LK + V K E +++ + + L + F+ D L L+ D++
Sbjct: 28 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYI 87
Query: 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 559
+ G L +L ++ F E + + ALE+LH +I+RD+K NILL
Sbjct: 88 NGGELFTHLSQRER----FKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDS 140
Query: 560 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDK-IDVYAFGVVLL 617
+ L+DFGL+K GT Y+AP+ G +DK +D ++ GV++
Sbjct: 141 NGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMY 199
Query: 618 ELLTGRKPISNDHPKGQES 636
ELLTG P + D K ++
Sbjct: 200 ELLTGASPFTVDGEKNSQA 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 26/203 (12%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFV--LEIEIITTL-HHKNIISLLGF 485
IG+G S+V K GK A+K +K +++ EI+ + L H NI+ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 486 CFE--DNNLLLVYDFLSRGSLEENLH---GNKKDPAAFGWSERYKVAM-GVAEALEYLHS 539
F+ L LV++ + + NL+ +K P +R K M + ++L+++H
Sbjct: 67 LFDRKTGRLALVFELM-----DMNLYELIKGRKRPLP---EKRVKSYMYQLLKSLDHMH- 117
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+ HRD+K NIL+ DD +L+DFG + S T+ T Y APE +
Sbjct: 118 --RNGIFHRDIKPENILIKDD-ILKLADFGSCR---GIYSKPPYTEYISTRWYRAPECLL 171
Query: 600 Y-GKVNDKIDVYAFGVVLLELLT 621
G K+D++A G V E+L+
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILK---PSEDVIKE---FVLEIEIITTLH 475
N+ L+G+G +VY D G+ELAVK + S++ KE EI+++ L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 476 HKNIISLLGFCFED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
H I+ G C D L + +++ GS+++ L K A + + + +
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQ 117
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST-SSSHITCTDVAGTFG 591
+ YLHS ++HRD+K +NIL +L DFG +K T S V GT
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 592 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
+++PE K DV++ ++E+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKN---II 480
+IG+GG +VY GC GK A+K L +K+ L I+ +L I
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 481 SLLGFCFED-NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+ + F + L + D ++ G L +L HG F E A + LE++
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHM 113
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
H+ + V++RD+K +NILL + ++SD GLA S H + GT GY+APE
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 598 FMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637
G D D ++ G +L +LL G P K + +
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 50/230 (21%)
Query: 423 NFLAENLIGKGGSSQV----YKGCLPDGKELAVKILKPSEDVIKEFVLE----------- 467
LA ++G+G +V YK G+ A+K LK K ++
Sbjct: 2 RCLA--VLGRGHFGKVLLAEYK---KTGELYAIKALK------KGDIIARDEVESLMCEK 50
Query: 468 --IEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 524
E + H +++L CF+ ++++ V ++ + G L ++H + +SE
Sbjct: 51 RIFETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDV-------FSEPR 102
Query: 525 KV--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK---WASTSSS 579
V A V L+YLH ++++RD+K N+LL + +++DFGL K +S
Sbjct: 103 AVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159
Query: 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
C GT +LAPE +D + GV++ E+L G P D
Sbjct: 160 TF-C----GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 67/237 (28%), Positives = 99/237 (41%), Gaps = 53/237 (22%)
Query: 429 LIGKGGSSQVY----KGCLPDGKELAVKILKPSEDV----IKEFVLEIEIITTLHHKNII 480
L+GKG +V+ KG GK A+K+L E + +K + E EI+ TL H +
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLH---GN--KKDPAAFGWSERYKVAMGVAEALE 535
+L + L LV D+ G L L G ++ A F +E V ALE
Sbjct: 65 TLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAE-------VLLALE 117
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA---------------STSSSH 580
YLH +++RD+K NILL + LSDF L+K + SS +
Sbjct: 118 YLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 581 ITCTDVA------------GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
++ GT Y+APE +D + G++L E+L G P
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 57/220 (25%), Positives = 107/220 (48%), Gaps = 19/220 (8%)
Query: 430 IGKGGSSQVYK-GCLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLG 484
+G G V+K P G +A K++ KP+ + + + E++++ + I+ G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYG 70
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
+ D + + + + GSL++ L + P KV++ V + L YL +
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE--KHK 124
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 604
++HRDVK SNIL++ E +L DFG++ S ++ GT Y++PE +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYS 180
Query: 605 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 644
+ D+++ G+ L+E+ GR PI P +E +M+ P+
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMFGCPV 218
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 37/219 (16%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKE-FVL----EIEIITTLHHKNIISL 482
IG+G +V+K + +A+K +L +E KE F + EI+I+ L H+N+++L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKILQLLKHENVVNL 76
Query: 483 LGFCFED----NN----LLLVYDFLSRGSLEENLHGNKKDPAA-FGWSERYKVAMGVAEA 533
+ C N LV++F E +L G + F SE KV +
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFC-----EHDLAGLLSNKNVKFTLSEIKKVMKMLLNG 131
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS-SSHITC-TDVAGTFG 591
L Y+H +++HRD+K++NIL++ D +L+DFGLA+ S S +S T+ T
Sbjct: 132 LYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 592 YLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 626
Y PE + YG ID++ G ++ E+ T R PI
Sbjct: 189 YRPPELLLGERDYGP---PIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 67/246 (27%), Positives = 106/246 (43%), Gaps = 29/246 (11%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKN---II 480
+IG+GG +VY GC GK A+K L +K+ L I+ +L I
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 481 SLLGFCFED-NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+ + F + L + D ++ G L +L HG F +E A + LE++
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG------VFSEAEMRFYAAEIILGLEHM 113
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
H+ + V++RD+K +NILL + ++SD GLA S H + GT GY+APE
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 598 FMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQ---ESLVMWAKPILSSGKVTQL 653
G D D ++ G +L +LL G P K + + + + L +L
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 226
Query: 654 LDPALG 659
G
Sbjct: 227 RSLLEG 232
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
++GKG VY L +A+K + + S V + EI + + L H+NI+ LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV-QPLHEEIALHSYLKHRNIVQYLGS 73
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
E+ + + + GSL L +K P + E L+YLH ++
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQI 129
Query: 546 IHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDV-AGTFGYLAPEYF----- 598
+HRD+K N+L++ ++SDFG +K + + CT+ GT Y+APE
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP---CTETFTGTLQYMAPEVIDKGPR 186
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKP 625
YG D+++ G ++E+ TG+ P
Sbjct: 187 GYGA---PADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 6e-12
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 9/92 (9%)
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
L+Y+HS +IHRD+K SNI +++D E ++ DFGLA+ T T Y
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 181
Query: 593 LAPE-YFMYGKVNDKIDVYAFGVVLLELLTGR 623
APE + N +D+++ G ++ ELLTG+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 25/212 (11%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKI--LKPSEDVIKEFVLEIEIITTLHHKNI 479
NF +G+G + VYKG E+ A+K L E + EI ++ L H+NI
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEE--NLHGNKKD-PAAFGWSERYKVAMGVAEALEY 536
+ L +N L+LV++++ L++ + HG + S Y++ G+A +
Sbjct: 61 VRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA----F 115
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW----ASTSSSHITCTDVAGTFGY 592
H RV+HRD+K N+L++ E +L+DFGLA+ +T S+ + T Y
Sbjct: 116 CHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV------TLWY 166
Query: 593 LAPEYFMYGKV-NDKIDVYAFGVVLLELLTGR 623
AP+ + + + ID+++ G ++ E++TGR
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 9e-12
Identities = 64/227 (28%), Positives = 107/227 (47%), Gaps = 44/227 (19%)
Query: 422 SNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL----EIEIITTLHH 476
+ + IG+G V P G ++A+K + P E F EI+I+ H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT--FCQRTLREIKILRRFKH 62
Query: 477 KNIISLLGF----CFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER-------- 523
+NII +L FE N++ +V + + E +L+ K ++
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELM-----ETDLYKLIK-------TQHLSNDHIQY 110
Query: 524 --YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH- 580
Y++ G L+Y+HS + V+HRD+K SN+LL+ + + ++ DFGLA+ A H
Sbjct: 111 FLYQILRG----LKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163
Query: 581 ITCTDVAGTFGYLAPEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPI 626
T+ T Y APE + K K ID+++ G +L E+L+ R P+
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 65/206 (31%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 429 LIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVI------KEFVLEIEII-TTLHHKNII 480
+IGKG +V DGK AVK+L+ + ++ K + E ++ + H ++
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQ--KKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 481 SLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
L + F+ L V DF++ G L +L + P R+ A +A AL YLHS
Sbjct: 60 GL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP---RARFYAAE-IASALGYLHS 114
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+++RD+K NILL L+DFGL K S T T GT YLAPE
Sbjct: 115 ---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIR 169
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKP 625
++ +D + G VL E+L G P
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 72/280 (25%), Positives = 126/280 (45%), Gaps = 44/280 (15%)
Query: 423 NFLAENLIGKGGSSQVY---KGCLPD-GKELAVKILKPSEDVIKEFVLE-----IEIITT 473
NF ++G G +V+ K D GK A+K+L+ + V K +E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 474 LHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGN---KKDPAAFGWSERYKVAMG 529
+ + L + F+ + L L+ D++S G + +L+ +D F E
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGE------- 113
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
+ ALE+LH +++RD+K NILL + L+DFGL+K + T + GT
Sbjct: 114 IILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGT 169
Query: 590 FGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 645
Y+APE +GK +D ++ G+++ ELLTG P + + + +S V ++ IL
Sbjct: 170 IEYMAPEIIRGKGGHGKA---VDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRIL 224
Query: 646 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRAR 685
K +G + +L +L +DP+ R
Sbjct: 225 ---KCDPPFPSFIG------PEAQDLLHKLLR--KDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 58/192 (30%), Positives = 92/192 (47%), Gaps = 22/192 (11%)
Query: 446 GKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL--GFCFEDNNLLLVYDFL 499
G E+A+K+L+ E F E + L+H NI++LL G L V++++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS- 558
+L E L + PA E ++ + V +AL H Q ++HRD+K NI++S
Sbjct: 62 PGRTLREVLAADGALPAG----ETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQ 114
Query: 559 DDFEP--QLSDFGLAKWAS----TSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYA 611
P ++ DFG+ + +T T+V GT Y APE V D+YA
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 612 FGVVLLELLTGR 623
+G++ LE LTG+
Sbjct: 175 WGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 51/191 (26%), Positives = 93/191 (48%), Gaps = 26/191 (13%)
Query: 454 LKPSEDVIKEFVLEIEIITTLHHKN---IISLLGFCFEDNNLLLVYDFLSRGSLEENLHG 510
+KP+ + + + E+++ LH N I+ G + D + + + + GSL++ L
Sbjct: 38 IKPA--IRNQIIRELKV---LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 92
Query: 511 NKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568
+ P E K+++ V L YL +++HRDVK SNIL++ E +L DF
Sbjct: 93 AGRIP------ENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDF 144
Query: 569 GLAKWA--STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
G++ S ++S + GT Y++PE + D+++ G+ L+E+ GR PI
Sbjct: 145 GVSGQLIDSMANSFV------GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
Query: 627 SNDHPKGQESL 637
K E++
Sbjct: 199 PPPDAKELEAM 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 55/212 (25%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 424 FLAENLIGKGGSSQVYKGCLPDGK-----ELAVKILK--PSEDVIKEFVLEIEIITTLHH 476
+L+ +G +++ G L D K E+ VK +K SE + + E ++ L H
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67
Query: 477 KNIISLLGFCFEDNNLLLV-YDFLSRGSLEENL----HGNKKDPAAFGWSERYKVAMG-- 529
+NI+ +L C ED V Y +++ G+L+ L G +P A S + V M
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL--STQQLVHMAIQ 125
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
+A + YLH + VIH+D+ + N ++ ++ + +++D L++ H +
Sbjct: 126 IACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
++A E + + + DV++FGV+L EL+T
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 31/213 (14%)
Query: 430 IGKGGSSQVY----KGCLPDGKE--LAVKILKPSEDVIK--EFVLEIEIITTLHHKNIIS 481
+G+G VY KG + D E +A+K + + + + EF+ E ++ + +++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP------AAFGWSERYKVAMGVAEALE 535
LLG + L++ + ++RG L+ L + + A + ++A +A+ +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG---- 591
YL +A + +HRD+ + N ++++DF ++ DFG+ + I TD G
Sbjct: 134 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-------DIYETDYYRKGGKGLL 183
Query: 592 ---YLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
+++PE G DV++FGVVL E+ T
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 61/215 (28%), Positives = 106/215 (49%), Gaps = 31/215 (14%)
Query: 429 LIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISL----- 482
++GKG +V L G+ AVK LK +DV+ +++ ++ T+ K +++L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALK--KDVV---LIDDDVECTMVEKRVLALAWENP 56
Query: 483 ----LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---AL 534
L F+ +L V +FL+ G L ++ +D F + Y+ AE L
Sbjct: 57 FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHI----QDKGRF---DLYRATFYAAEIVCGL 109
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
++LHS + +I+RD+K N++L D +++DFG+ K + + GT Y+A
Sbjct: 110 QFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIA 164
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
PE K +D ++FGV+L E+L G+ P D
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEF--VLEIEIITTLHHKNIISLLGFC 486
+G+G + VYKG +GK +A+K+++ E+ F + E ++ L H NI+ L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
L LV++++ + K P + L Y+H + ++
Sbjct: 73 HTKETLTLVFEYVHTDLCQYM----DKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYIL 125
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVND 605
HRD+K N+L+SD E +L+DFGLA+ A + SH +V T Y P+ + + +
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 606 KIDVYAFGVVLLELLTG 622
+D++ G + +E++ G
Sbjct: 184 CLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 70/296 (23%), Positives = 128/296 (43%), Gaps = 45/296 (15%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNIISLLGFC 486
+GKG VYK P G +A+K ++ D K + ++E++I+ I+ G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
F + + + +++ GSL++ L+ ++ V + L++L +I
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNII 125
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAK--WASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 604
HRDVK +N+L++ + + +L DFG++ AS + ++I C Y+APE G N
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS------YMAPERIKSGGPN 179
Query: 605 DKI------DVYAFGVVLLELLTGRKPI---SNDHPKGQESLVMWAKPILSSGKVTQLLD 655
DV++ G+ +LE+ GR P + + Q S ++ P
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------------ 227
Query: 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL------KLLRGDADVTKWA 705
P L + Y D + + C+ + P RP + +L K D D+ +W
Sbjct: 228 PTLPSGYSDDAQDFVA----KCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWV 279
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 49/206 (23%), Positives = 101/206 (49%), Gaps = 14/206 (6%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
E ++G G ++ +GCL P +EL A+ L+ S+ + F+ E + H NI+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L G N +++V +++S G+L+ L +K + + G+A ++YL
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYL--- 123
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
S +H+ + + +L++ D ++S F + + + + T + + + APE Y
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL-WAAPEAIQY 182
Query: 601 GKVNDKIDVYAFGVVLLELLT-GRKP 625
+ DV++FG+V+ E+++ G +P
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSE--DVIKEFVL-EIEIITTLHHKNIISLLG 484
++G+G V K + KE+ A+K K SE + +KE L E++++ TL +NI+ L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 485 FCFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L LV++++ + LE E +G + KV + + ++ +H
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE----------KVRSYIYQLIKAIHWCH 117
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
++HRD+K N+L+S + +L DFG A+ S S+ T+ T Y +PE +
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGA 176
Query: 602 KVNDKIDVYAFGVVLLELLTGR 623
+D+++ G +L EL G+
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 52/212 (24%), Positives = 102/212 (48%), Gaps = 15/212 (7%)
Query: 422 SNFLAENLIGKGGSSQVYKGC-LPDGKEL----AVKILK--PSEDVIKEFVLEIEIITTL 474
+ F ++G G VYKG +P+G+++ A+K L+ S KE + E ++ ++
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 475 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 534
+ ++ LLG C + + L+ + G L + + +K + G + +A+ +
Sbjct: 67 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGM 122
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
YL +R++HRD+ + N+L+ +++DFGLAK ++A
Sbjct: 123 NYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
E ++ + DV+++GV + EL+T G KP
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 37/222 (16%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLE---IEIITTLHH-----KNI 479
+IG+G ++V L + + A+K++K KE V + I+ + T H N
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIK------KELVNDDEDIDWVQTEKHVFETASNH 55
Query: 480 ISLLGF--CFE-DNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEA 533
L+G CF+ ++ L V +F+S G L ++ +K P A F +E ++ A
Sbjct: 56 PFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAE-------ISLA 108
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
L +LH +I+RD+K N+LL + +L+D+G+ K T + GT Y+
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYI 163
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI----SNDHP 631
APE +D +A GV++ E++ GR P +D+P
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 429 LIGKGGSSQVYKGC-LPDGKEL----AVKILK--PSEDVIKEFVLEIEIITTLHHKNIIS 481
++G G VYKG +PDG+ + A+K+L+ S KE + E ++ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
LLG C + + LV + G L + + NK G + + +A+ + YL
Sbjct: 74 LLGICLT-STVQLVTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEE-- 127
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
R++HRD+ + N+L+ +++DFGLA+ + ++A E ++
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 602 KVNDKIDVYAFGVVLLELLT-GRKP 625
+ + DV+++GV + EL+T G KP
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 54/187 (28%), Positives = 91/187 (48%), Gaps = 24/187 (12%)
Query: 450 AVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEEN 507
AVK+L+P ++F+ E++I++ L NI LLG C D L ++ +++ G L +
Sbjct: 50 AVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQF 109
Query: 508 LHGNKKDPAAFGWSERYK-------VAMGV--AEALEYLHSGSAQRVIHRDVKSSNILLS 558
L K G + K + M A + YL S +HRD+ + N L+
Sbjct: 110 LQ--KHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVG 164
Query: 559 DDFEPQLSDFGLAKWASTSSSHITCTDVAGT----FGYLAPEYFMYGKVNDKIDVYAFGV 614
++ +++DFG+++ +S + V G ++A E + GK K DV+AFGV
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYY----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220
Query: 615 VLLELLT 621
L E+LT
Sbjct: 221 TLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 16/166 (9%)
Query: 486 CFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
CF+ + L LV ++++ G L ++ +K P R+ A + AL +LH +
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHA---RFYAAE-ICIALNFLHE---RG 116
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 604
+I+RD+K N+LL D +L+D+G+ K T + GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYG 174
Query: 605 DKIDVYAFGVVLLELLTGRKP--ISNDHP--KGQESL--VMWAKPI 644
+D +A GV++ E++ GR P I D+P ++ L V+ KPI
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 59/192 (30%), Positives = 99/192 (51%), Gaps = 22/192 (11%)
Query: 446 GKELAVK-ILKP-SEDVI-KEFVLEIEIITTLHHKNIISLLG-FCFEDNNLLLVYDFLSR 501
G+ +A+K I+KP S V+ K E++++ L H+NIISL F ++ V + L
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT 94
Query: 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561
L L + F Y++ G L+Y+HS V+HRD+K SNIL++++
Sbjct: 95 -DLHRLLTSRPLEKQ-FIQYFLYQILRG----LKYVHSAG---VVHRDLKPSNILINENC 145
Query: 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELL 620
+ ++ DFGLA+ + T T Y APE + + K + ++D+++ G + E+L
Sbjct: 146 DLKICDFGLAR---IQDPQM--TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
Query: 621 TGRKPI--SNDH 630
G KP+ DH
Sbjct: 201 EG-KPLFPGKDH 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 76/307 (24%), Positives = 121/307 (39%), Gaps = 61/307 (19%)
Query: 429 LIGK----GGSSQVYKGCLPDGKELAVKILKPSEDVIKEFV-LEIEIITT--LHHKNIIS 481
LIGK + K P +AVK + ++ L+ EIIT+ L H NI+
Sbjct: 5 LIGKCFEDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 482 LLGFCF-EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVAEALEYL 537
+ F D+ L +V ++ GS E+ L + + G E + + V AL+Y+
Sbjct: 64 YV-TSFIVDSELYVVSPLMAYGSCEDLLKTHFPE----GLPELAIAF-ILKDVLNALDYI 117
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG-----Y 592
HS + IHR VK+S+ILLS D + LS + +
Sbjct: 118 HS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174
Query: 593 LAPEYF---MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 649
L+PE + G N+K D+Y+ G+ EL G P + M + + G
Sbjct: 175 LSPEVLQQNLQG-YNEKSDIYSVGITACELANGHVPFKDMPA-----TQMLLEKV--RGT 226
Query: 650 VTQLLD---------------PALGNNYDYDQMERMVLASI---------LCIRRDPRAR 685
V LLD + + + D ++ + LC++RDP +R
Sbjct: 227 VPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESR 286
Query: 686 PQMSLVL 692
P S +L
Sbjct: 287 PSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 42/201 (20%)
Query: 446 GKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLLGFC-------FEDNNLLLV 495
+++A+K I ++ I K + EI+++ L H+N+I++ F D + +V
Sbjct: 30 NEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND--VYIV 87
Query: 496 YDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHSGSAQRVIHRD 549
Y+ + + +LH + S+ Y++ G L+Y+HS + V+HRD
Sbjct: 88 YELM-----DTDLHQIIRSSQTL--SDDHCQYFLYQLLRG----LKYIHSAN---VLHRD 133
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM----YGKVND 605
+K SN+LL+ + + ++ DFGLA+ +TS T+ T Y APE + Y
Sbjct: 134 LKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTA-- 189
Query: 606 KIDVYAFGVVLLELLTGRKPI 626
IDV++ G + ELL GRKP+
Sbjct: 190 -IDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 14/151 (9%)
Query: 486 CFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
CF+ ++ L V ++++ G L ++ +K P R+ A ++ AL YLH +
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA---RFYSAE-ISLALNYLHE---RG 116
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 604
+I+RD+K N+LL + +L+D+G+ K T + GT Y+APE
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYG 174
Query: 605 DKIDVYAFGVVLLELLTGRKPI----SNDHP 631
+D +A GV++ E++ GR P S+D+P
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 54/200 (27%), Positives = 101/200 (50%), Gaps = 17/200 (8%)
Query: 430 IGKGGSSQVYKG--CLPDGKELAVKI-LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G+G + VYKG L D +I L+ E + E+ ++ L H NI++L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 487 FEDNNLLLVYDFLSRGSLEENLH--GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
+ +L LV+++L + L++ L GN + + V + + + L L+ ++
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLDDCGNSIN--------MHNVKLFLFQLLRGLNYCHRRK 124
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKV 603
V+HRD+K N+L+++ E +L+DFGLA+ S + T ++ T Y P+ +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDY 182
Query: 604 NDKIDVYAFGVVLLELLTGR 623
+ +ID++ G + E+ TGR
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 66/272 (24%), Positives = 119/272 (43%), Gaps = 44/272 (16%)
Query: 430 IGKGGSSQVYKGCL---PD------GKELAV--KILKPSEDVIKEFVLEIEIITTLHHKN 478
+G+G + +YKG L D G+E++V K+L F +++ L HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
++ L G C D N ++V +++ G L+ LH K + + W + VA +A AL YL
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSL-HW--KLDVAKQLASALHYLE 118
Query: 539 SGSAQRVIHRDVKSSNILL---SDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFG 591
++++H +V NIL+ + LSD G+ + +
Sbjct: 119 D---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE------RIP 169
Query: 592 YLAPEYFMYGKVNDKI--DVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK----PI 644
++APE G+ + I D ++FG LLE+ + G +P+S E + P+
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--SEKERFYQDQHRLPM 227
Query: 645 LSSGKVTQLLDPALGNNYDYDQMERMVLASIL 676
++ L++ + YD +R +IL
Sbjct: 228 PDCAELANLIN----QCWTYDPTKRPSFRAIL 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 526
E +I+ ++H ++L G +++ L LV +F+ G L NK+ P G ++
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586
+ EYL S +++RD+K N+LL D +++DFG AK T ++ C
Sbjct: 141 VL----IFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTYTLC--- 189
Query: 587 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
GT Y+APE + D + G+ + E+L G P + P
Sbjct: 190 -GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 54/189 (28%), Positives = 89/189 (47%), Gaps = 26/189 (13%)
Query: 446 GKELAVKIL-KPSEDVI--KEFVLEIEIITTLHHKNIISLLGF-----CFEDNNLLLVYD 497
G +AVK L +P + +I K E+ ++ + H+N+I LL E+ N + +
Sbjct: 42 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101
Query: 498 FLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 555
L L + K D F + + L+Y+HS +IHRD+K SN+
Sbjct: 102 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSAD---IIHRDLKPSNL 151
Query: 556 LLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGV 614
+++D E ++ DFGLA+ T T Y APE + + N +D+++ G
Sbjct: 152 AVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 206
Query: 615 VLLELLTGR 623
++ ELLTGR
Sbjct: 207 IMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 64/252 (25%), Positives = 103/252 (40%), Gaps = 50/252 (19%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVL----EIEIITTLHH 476
+F + +IG+G +V D G A+K L+ SE + KE V E +I+ +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 477 KNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
++ L + F+D N L L+ ++L G + L KKD + Y +AE +
Sbjct: 61 PWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFY-----IAETIL 112
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL----------------AKWASTSSS 579
+ S IHRD+K N+LL +LSDFGL + ++
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 580 HITCT--------------------DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 619
GT Y+APE F+ N + D ++ GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 620 LTGRKPISNDHP 631
L G P +D+P
Sbjct: 233 LVGYPPFCSDNP 244
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 430 IGKGGSSQV------YKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 483
+GKGG +V G + K+L K LK K +LE EI+ ++ I++L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGE-KMALLEKEILEKVNSPFIVNL- 58
Query: 484 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
+ FE +L LV ++ G L+ H + + + +LHS
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHLHS--- 113
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
+++RD+K N+LL D +LSD GLA T T AGT GY+APE
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEP 170
Query: 603 VNDKIDVYAFGVVLLELLTGRKPISNDHPK 632
+ +D +A G + E++ GR P + K
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFKDHKEK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 35/94 (37%), Positives = 55/94 (58%), Gaps = 6/94 (6%)
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA-STSSSHITCTDVAGTFG 591
AL+Y+H+ + V HRD+K NIL + D + ++ DFGLA+ A + + + I TD T
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 592 YLAPEY--FMYGKVNDKIDVYAFGVVLLELLTGR 623
Y APE + K ID+++ G + E+LTG+
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 28/223 (12%)
Query: 423 NFLAENLIGKG--GSSQVYKGCLPDGKELAVKILKPSEDVIKEFVL----EIEIITTLHH 476
+F ++L+G+G G QV + G A+K++K S + +E V E +I++ +
Sbjct: 2 DFDVKSLVGRGHFGEVQVVRE-KATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 477 KNIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
I L + F+D NL LV ++ G L +L +D ++ Y +AE +
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLL-SLLNRYEDQFDEDMAQFY-----LAELVL 113
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
+HS +HRD+K N+L+ +L+DFG A T++ + GT Y+AP
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIAP 172
Query: 596 EYF---------MYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
E YG + D ++ GV+ E++ GR P
Sbjct: 173 EVLTTMNGDGKGTYGV---ECDWWSLGVIAYEMIYGRSPFHEG 212
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 53/169 (31%), Positives = 75/169 (44%), Gaps = 22/169 (13%)
Query: 480 ISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
I L + F+D+ L +V +++ G L NL N P W+ Y V AL+ +H
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLV-NLMSNYDIPEK--WARFY--TAEVVLALDAIH 159
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEY 597
S IHRDVK N+LL +L+DFG K + C GT Y++PE
Sbjct: 160 S---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR--CDTAVGTPDYISPEV 214
Query: 598 FM-------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639
YG+ + D ++ GV L E+L G P D G S +M
Sbjct: 215 LKSQGGDGYYGR---ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVK--ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G+G + V+KG + L A+K L+ E + E+ ++ L H NI++L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLHSGSAQRV 545
D +L LV+++L +++L D K+ + + L Y H ++V
Sbjct: 74 HTDKSLTLVFEYL-----DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKV 125
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVN 604
+HRD+K N+L+++ E +L+DFGLA+ S + T ++ T Y P+ + + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYS 183
Query: 605 DKIDVYAFGVVLLELLTGR 623
+ID++ G + E+ +GR
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 44/124 (35%), Positives = 62/124 (50%), Gaps = 25/124 (20%)
Query: 528 MGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----- 579
M AE ALEYLH+ ++HRD+K N+L++ +L+DFGL+K S +
Sbjct: 105 MYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE 161
Query: 580 -HITC-------TDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISN 628
HI V GT Y+APE + YGK +D +A G++L E L G P
Sbjct: 162 GHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGK---PVDWWAMGIILYEFLVGCVPFFG 218
Query: 629 DHPK 632
D P+
Sbjct: 219 DTPE 222
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 37/99 (37%), Positives = 58/99 (58%), Gaps = 11/99 (11%)
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS----SSHITCTDVAG 588
L+Y+HS + V+HRD+K N+L++ D E ++ DFGLA+ S + + + T+
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM--TEYVA 171
Query: 589 TFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPI 626
T Y APE + + IDV++ G +L ELL GRKP+
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 430 IGKGGSSQVYKGCLPD-GKELA---VKILKPSEDVIKEFVLEIEIITTLH---HKNIISL 482
IG G VYK P G +A V++ + + V E+ ++ L H NI+ L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 483 LGFCF-----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEY 536
+ C + + LV++ + + L L K P +E K M L++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYL---DKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
LH A ++HRD+K NIL++ + +L+DFGLA+ S + T V T Y APE
Sbjct: 124 LH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVVVTLWYRAPE 177
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
+ +D+++ G + E+ RKP+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 10/167 (5%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 525
E +I+ ++ + ++SL + +E + L LV ++ G L+ H A F
Sbjct: 50 EKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLK--FHIYHMGEAGFEEGRAVF 106
Query: 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 585
A + LE LH +R+++RD+K NILL D ++SD GLA T
Sbjct: 107 YAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKG 160
Query: 586 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632
GT GY+APE + D +A G +L E++ G+ P K
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISL--LGF 485
+G+G VYK DGK+ LK E + EI ++ L H N+I+L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 486 CFEDNNLLLVYDFLSRG-----SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
D + L++D+ NKK P S + + + + YLH
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKK-PMQLPRSMVKSLLYQILDGIHYLH-- 125
Query: 541 SAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAP 595
A V+HRD+K +NIL+ + +++D G A+ ++ + D V TF Y AP
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 596 EYFMYGKVNDK-IDVYAFGVVLLELLTGRKPI 626
E + + K ID++A G + ELLT +PI
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 430 IGKGGSSQVYKGCLPDGKELA----VKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
IG+G V+K + E+ V++ E V + EI ++ L HKNI+ L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 486 CFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
D L LV+++ + L+ ++ +G DP S +++ G+A + HS
Sbjct: 68 LHSDKKLTLVFEYCDQ-DLKKYFDSCNG-DIDPEIVK-SFMFQLLKGLA----FCHS--- 117
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
V+HRD+K N+L++ + E +L+DFGLA+ + V T Y P+ K
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAK 175
Query: 603 VND-KIDVYAFGVVLLELLTGRKPI 626
+ ID+++ G + EL +P+
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 5e-10
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 36/207 (17%)
Query: 447 KELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN--LLLVYDFLSRGSL 504
K ++ + LK E + V+E+ ++ L HKNI+ + N L ++ +F G L
Sbjct: 44 KAISYRGLKEREK--SQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDL 101
Query: 505 EENLHGNKKDPAAFGWSERY---KVAMGVAEALEYLHS----GSAQRVIHRDVKSSNILL 557
N+ K FG E + + + AL Y H+ + +RV+HRD+K NI L
Sbjct: 102 SRNIQKCYK---MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158
Query: 558 SDDFE-----------------PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
S ++ DFGL+K S +C GT Y +PE ++
Sbjct: 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCV---GTPYYWSPELLLH 215
Query: 601 --GKVNDKIDVYAFGVVLLELLTGRKP 625
+DK D++A G ++ EL +G+ P
Sbjct: 216 ETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|238947 cd01989, STK_N, The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 7e-10
Identities = 37/146 (25%), Positives = 62/146 (42%), Gaps = 8/146 (5%)
Query: 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHV-LANNAIVDRDGKSSLLSLVKA--- 73
+V V V D S+ L WAL +A G T++ +HV +I GK + S K
Sbjct: 1 SVAVAVDKDKKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGKLEVASAYKQEED 60
Query: 74 --FDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS 131
+L Y FC+ K V + + + K +V + TK ++G + ++H
Sbjct: 61 KEAKELLLPYRCFCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMK 120
Query: 132 T--TSLAKYCAKKLSKDCSVLAVNNG 155
+ +A K+ C+V V+ G
Sbjct: 121 FKKSDVASSVLKEAPDFCTVYVVSKG 146
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. Length = 146 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 17/213 (7%)
Query: 430 IGKGGSSQVYKGCLPDGKELA---VKILKPSEDVIKE--FVLEIEIITTLHHKNIISLLG 484
IG G +V G G A VK L+ S ++ F+ E++ L+H N++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE-RYKVAMGVAEALEYLHSGSAQ 543
C E LLV +F G L+ L N+ A + ++A VA L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY------ 597
IH D+ N L+ D ++ D+GLA +IT A +LAPE
Sbjct: 121 -FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 598 -FMYGKVNDKIDVYAFGVVLLELLT-GRKPISN 628
+ K ++++ GV + EL T +P +
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 42/230 (18%)
Query: 428 NLIGKGGSSQVYKGC-LPDGKELAVKILKPSE---DVIKE----------FVL--EIEII 471
+G+G +V K GK +A+K +K E DV K+ F E++I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 472 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK--VAMG 529
+ H+NI+ L+ E + + LV D ++ L++ + + +E + +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR------LTESQVKCILLQ 127
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG- 588
+ L LH +HRD+ +NI ++ +++DFGLA+ T +
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 589 -----------TFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPI 626
T Y APE M K + +D+++ G + ELLTG KP+
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL 233
|
Length = 335 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 430 IGKGGSSQVYKG--CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+G+G + VYKG L G+ +A+K L+ E + E ++ L H NI++L
Sbjct: 13 LGEGSYATVYKGRSKL-TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 486 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPA---AFGWSERYKVAMGVAEALEYLHSG 540
L LV+++L L++ + G F +++ G L Y H
Sbjct: 72 IHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLF----LFQLLRG----LAYCHQ- 121
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
+RV+HRD+K N+L+S+ E +L+DFGLA+ A + S +V T Y P+ +
Sbjct: 122 --RRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVV-TLWYRPPDVLL- 176
Query: 601 GKVN--DKIDVYAFGVVLLELLTGR 623
G +D++ G + E+ TGR
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 430 IGKGGSSQVYKGC-LPDGKELA----VKILKPSEDVIKEFVLEIEII---TTLHHKNIIS 481
IG+G +V+K L +G V++ E + + E+ ++ T H N++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 482 LLGFCF-----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALE 535
L C + L LV++ + + L L K P +E K M + L+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL---DKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
+LHS RV+HRD+K NIL++ + +L+DFGLA+ S + T V T Y AP
Sbjct: 125 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAP 178
Query: 596 EYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
E + +D+++ G + E+ RKP+
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 65/253 (25%), Positives = 113/253 (44%), Gaps = 27/253 (10%)
Query: 445 DGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLL-GFCFEDNNLLLVYDFLS 500
DGK+ +K L S K E ++++ L H NI++ + ED L +V F
Sbjct: 24 DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83
Query: 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560
G L L K ++ + + +A AL+YLH + ++HRD+K+ N+ L+
Sbjct: 84 GGDLYHKLKEQKGK--LLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRT 138
Query: 561 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 620
++ D G+A+ + + + GT Y++PE F N K DV+A G + E+
Sbjct: 139 NIIKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMA 196
Query: 621 TGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRR 680
T + + K SLV + GK+ + P DY ++A++L +
Sbjct: 197 TLKHAFN---AKDMNSLVYR----IIEGKLPPM--PK-----DYSPELGELIATMLS--K 240
Query: 681 DPRARPQMSLVLK 693
P RP + +L+
Sbjct: 241 RPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 429 LIGKGGSSQVY---KGCLPDGKELAVKILKPSEDVIKEFVLEIE-----IITTLHHKNII 480
+IGKG +V + DG AVK+L+ + K+ I ++ L H ++
Sbjct: 2 VIGKGSFGKVLLAKRKS--DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 481 SLLGFCFED-NNLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYL 537
L + F+ L V D+++ G L +L + +P A R+ A VA A+ YL
Sbjct: 60 GL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRA-----RFYAAE-VASAIGYL 112
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
HS +I+RD+K NILL L+DFGL K T + GT YLAPE
Sbjct: 113 HS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEV 167
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKP 625
+ +D + G VL E+L G P
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 20/212 (9%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISL--LGF 485
+G+G VYK DGK+ LK E + EI ++ L H N+ISL +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 486 CFEDNNLLLVYDFLSRG-----SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
D + L++D+ NKK P + + + + YLH
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKK-PVQLPRGMVKSLLYQILDGIHYLH-- 125
Query: 541 SAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAP 595
A V+HRD+K +NIL+ + +++D G A+ ++ + D V TF Y AP
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 596 EYFMYGKVNDK-IDVYAFGVVLLELLTGRKPI 626
E + + K ID++A G + ELLT +PI
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 42/161 (26%), Positives = 80/161 (49%), Gaps = 12/161 (7%)
Query: 465 VLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 524
+ E+ ++ L H NI++L + L LV+++L + +L +
Sbjct: 51 IREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-----DSDLKQYLDNCGNLMSMHNV 105
Query: 525 KVAM-GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
K+ M + L Y H ++++HRD+K N+L+++ E +L+DFGLA+ S + T
Sbjct: 106 KIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TY 160
Query: 584 TDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGR 623
++ T Y P+ + + + ID++ G +L E+ TGR
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 64/291 (21%), Positives = 125/291 (42%), Gaps = 48/291 (16%)
Query: 430 IGKGGSSQVYKGCLPD------GKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNIIS 481
+G+G VY+G D +AVK + S + + EF+ E ++ +++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA------AFGWSERYKVAMGVAEALE 535
LLG + L+V + ++ G L+ L + + E ++A +A+ +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG---- 591
YL +A++ +HRD+ + N +++ DF ++ DFG+ + I TD G
Sbjct: 134 YL---NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-------DIYETDYYRKGGKGLL 183
Query: 592 ---YLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSS 647
++APE G D+++FGVVL E+ + +P LS+
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG----------------LSN 227
Query: 648 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698
+V + + + + ER+ +C + +P+ RP ++ LL+ D
Sbjct: 228 EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 71/264 (26%), Positives = 111/264 (42%), Gaps = 28/264 (10%)
Query: 396 KELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKG--GSSQVYKGCLPDGKELAVKI 453
K ++ +Y T + +DL ++ +IG+G G Q+ + K A+K+
Sbjct: 19 KNIDNFLNRYKDT--INKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR-KVYAMKL 75
Query: 454 LKPSEDVIKE---FVLEIEIITTLHHKNIISLLGFCFEDNNLL-LVYDFLSRGSLEENLH 509
L E + + F E I + + L + F+D+ L +V +++ G L NL
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLM 134
Query: 510 GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569
N P W+ Y V AL+ +HS IHRDVK N+LL +L+DFG
Sbjct: 135 SNYDVPEK--WARFYTAE--VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG 187
Query: 570 LAKWASTSSSHITCTDVAGTFGYLAPEYF-------MYGKVNDKIDVYAFGVVLLELLTG 622
+ C GT Y++PE YG+ + D ++ GV L E+L G
Sbjct: 188 TCM-KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR---ECDWWSVGVFLYEMLVG 243
Query: 623 RKPISNDHPKGQESLVMWAKPILS 646
P D G S +M K L+
Sbjct: 244 DTPFYADSLVGTYSKIMNHKNSLT 267
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 40/173 (23%), Positives = 82/173 (47%), Gaps = 8/173 (4%)
Query: 447 KELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 506
KE+ V L P+E V + E ++++ L H I+ E + ++ ++ L+
Sbjct: 34 KEIPVGELNPNETV--QANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDC 91
Query: 507 NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566
L K ++ + + + + Y+H +R++HRD+K+ NI L ++ ++
Sbjct: 92 KLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIG 147
Query: 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 619
DFG+++ S T GT Y++PE + + K D+++ G +L E+
Sbjct: 148 DFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKI--LKPSEDVIKEFVLEIEIITTLHH 476
A +++L +G+G + VYKG +G+ +A+K+ +K E V + E ++ L H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
NI+ L L V++++ L + + + P + L Y
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYM-HTDLAQYM---IQHPGGLHPYNVRLFMFQLLRGLAY 118
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
+H Q ++HRD+K N+L+S E +L+DFGLA+ S S + V T Y P+
Sbjct: 119 IHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD 173
Query: 597 YFMYG-KVNDKIDVYAFGVVLLELLTGR 623
+ + +D++ G + +E+L G+
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-09
Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 45/232 (19%)
Query: 429 LIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVI------KEFVLEIEIITTLHHKNIIS 481
LIGKGG +VY P + +A+K K ED+ K F+ E +I L H I+
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALK--KIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENL------------HGNKKDPAAFGWSERYKVAMG 529
+ C + + + ++ +L+ L K AF S +K+
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF-LSIFHKICAT 125
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW---------------- 573
+ EY+HS + V+HRD+K NILL E + D+G A +
Sbjct: 126 I----EYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
SS + GT Y+APE + ++ D+YA GV+L ++LT P
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 19/166 (11%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDN--NLLLVYDFLSRGSLEENLHG---NKKDPAAFGWS 521
EI I+ L H NI+++ N + +V +++ E +L K P F S
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV-----EHDLKSLMETMKQP--FLQS 106
Query: 522 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581
E + + + + +LH ++HRD+K+SN+LL++ ++ DFGLA+ +
Sbjct: 107 EVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163
Query: 582 TCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPI 626
T V T Y APE + K + ID+++ G + ELLT +KP+
Sbjct: 164 TQLVV--TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 429 LIGKGGSSQVYKGCLP----DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNII 480
++GKG V + L +++AVK+LK S D I+EF+ E + H N+I
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVI 64
Query: 481 SLLGFCFEDNNL------LLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAE 532
L+G +++ F+ G L L ++ ++P + + +A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
+EYL S++ IHRD+ + N +L+++ ++DFGL+K + + +
Sbjct: 125 GMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 593 LAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
LA E DV+AFGV + E++T G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 63/211 (29%), Positives = 91/211 (43%), Gaps = 34/211 (16%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNI--------I 480
IGKG +V + D + + A+K ++ + V + E+ TL + + I
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRS-----EVTHTLAERTVLAQVNCPFI 55
Query: 481 SLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEY 536
L F F+ L LV F++ G L +L G + + AE ALE
Sbjct: 56 VPLKFSFQSPEKLYLVLAFINGGELFHHLQRE-------GRFDLSRARFYTAELLCALEN 108
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK--WASTSSSHITCTDVAGTFGYLA 594
LH + VI+RD+K NILL L DFGL K ++ C GT YLA
Sbjct: 109 LHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC----GTPEYLA 161
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
PE + +D + GV+L E+LTG P
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 49/146 (33%), Positives = 70/146 (47%), Gaps = 14/146 (9%)
Query: 483 LGFCFED-NNLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHS 539
L F F+ + L V D+++ G L +L + +P A R+ A +A AL YLHS
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-----RFYAAE-IASALGYLHS 114
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+++RD+K NILL L+DFGL K + T + GT YLAPE
Sbjct: 115 ---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLH 169
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKP 625
+ +D + G VL E+L G P
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 54/242 (22%)
Query: 419 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKE-FVL----EIEII 471
S ++ +G+G +VYK + G+ +A+K IL +E K+ F + EI+I+
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE---KDGFPITALREIKIL 61
Query: 472 TTLHHKNIISLLGFCFE-----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 526
L H N++ L+ E VY ++ +L G ++P K+
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP--YMDHDLSGLLENP-------SVKL 112
Query: 527 AMG--------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA------- 571
+ E + YLH ++HRD+K++NIL+ + +++DFGLA
Sbjct: 113 TESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169
Query: 572 ---KWASTSSSHITCTDVAGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRK 624
K + T++ T Y PE + Y +D++ G V E+ T R+
Sbjct: 170 PNPKGGGGGGTR-KYTNLVVTRWYRPPELLLGERRYTT---AVDIWGIGCVFAEMFT-RR 224
Query: 625 PI 626
PI
Sbjct: 225 PI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 49/174 (28%), Positives = 83/174 (47%), Gaps = 35/174 (20%)
Query: 462 KEFVLEIEIITTLHHKNIISLLGFCF-------EDNNLLLVYDFLSRGSLEENLHGNKKD 514
+E VL + ++HKNII LL F E ++ LV + + +L + + +
Sbjct: 64 RELVL----MKLVNHKNIIGLLN-VFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLD- 116
Query: 515 PAAFGWSER-----YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569
ER Y++ G+ ++LHS +IHRD+K SNI++ D ++ DFG
Sbjct: 117 ------HERMSYLLYQMLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163
Query: 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 623
LA+ A TS T T Y APE + + +D+++ G ++ E++ G
Sbjct: 164 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 69/256 (26%), Positives = 109/256 (42%), Gaps = 47/256 (18%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFV----LEIEIITTLHHK 477
+F + +IG+G +V D G A+KIL+ ++ + KE V E +I+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 478 NIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
++ + + F+D NL L+ +FL G + L KKD ++ Y +AE +
Sbjct: 62 WVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFY-----IAETVLA 113
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA---KWASTSS-----SHITCTD--- 585
+ S IHRD+K N+LL +LSDFGL K A + +H +D
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 586 ----------------------VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 623
GT Y+APE FM N D ++ GV++ E+L G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 624 KPISNDHPKGQESLVM 639
P ++ P+ VM
Sbjct: 234 PPFCSETPQETYKKVM 249
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 68/256 (26%), Positives = 111/256 (43%), Gaps = 47/256 (18%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEI----EIITTLHHK 477
+F + +IG+G +V D G A+KIL+ ++ + KE V I +I+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 478 NIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
++ + + F+D NL L+ +FL G + L KKD + ++ Y +AE +
Sbjct: 62 WVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFY-----IAETVLA 113
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA---KWASTSS-----SHITCTDVA- 587
+ + IHRD+K N+LL +LSDFGL K A + +H +D +
Sbjct: 114 IDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 588 ------------------------GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 623
GT Y+APE FM N D ++ GV++ E+L G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 624 KPISNDHPKGQESLVM 639
P ++ P+ VM
Sbjct: 234 PPFCSETPQETYRKVM 249
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 35/222 (15%)
Query: 430 IGKGGSSQVYKGCLPD-----------GKELAV--KILKPSE-DVIKEFVLEIEIITTLH 475
+G+G +Q+Y G L KE+ V K+L PS D+ F ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
HK+I+ L G C D ++V +F+ G L+ +H K D W ++KVA +A AL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSDVLTTPW--KFKVAKQLASALS 119
Query: 536 YLHSGSAQRVIHRDVKSSNILLS-----DDFEP--QLSDFGLAKWASTSSSHITCTDVAG 588
YL + ++H +V + NILL+ + P +LSD G+ T S C +
Sbjct: 120 YLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI---PITVLSRQECVE--- 170
Query: 589 TFGYLAPEYFMYGKV-NDKIDVYAFGVVLLEL-LTGRKPISN 628
++APE K + D ++FG L E+ G P+ +
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 54/165 (32%), Positives = 76/165 (46%), Gaps = 23/165 (13%)
Query: 485 FC-FEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
FC F+D+ L +V +++ G L NL N P W++ Y V AL+ +HS
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEK--WAKFYTAE--VVLALDAIHS--- 160
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEYF--- 598
+IHRDVK N+LL +L+DFG K T C GT Y++PE
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR--CDTAVGTPDYISPEVLKSQ 218
Query: 599 ----MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639
YG+ + D ++ GV L E+L G P D G S +M
Sbjct: 219 GGDGYYGR---ECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 58/239 (24%), Positives = 104/239 (43%), Gaps = 70/239 (29%)
Query: 447 KELAVKILK----PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN-LLLVYDFLS 500
+ +AVK+LK SE K + E++I+ + HH N+++LLG C + L+++ ++
Sbjct: 38 RTVAVKMLKEGATASEY--KALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCK 95
Query: 501 RGSLEENLHGNK--------------------------------KDPAAFGW-------- 520
G+L L + + A+ G+
Sbjct: 96 FGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD 155
Query: 521 -------SERYKV----------AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563
E YK + VA +E+L S ++ IHRD+ + NILLS++
Sbjct: 156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVV 212
Query: 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLT 621
++ DFGLA+ ++ D ++APE ++ KV + DV++FGV+L E+ +
Sbjct: 213 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPES-IFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 79/352 (22%), Positives = 144/352 (40%), Gaps = 46/352 (13%)
Query: 430 IGKGGSSQVYKGCLPD-GKELAVKILKPSEDV-IKEFVLEIEIITTLHHKNII------- 480
+G G + V+ D K +AVK + ++ +K + EI+II L H NI+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 481 -------SLLGFCFEDNNLLLVYDFLS---RGSLEENLHGNKKDPAAFGWSERYKVAMGV 530
+G E N++ +V +++ LE+ + Y++ G
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFM-----YQLLRG- 126
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSH---ITCTDV 586
L+Y+HS + V+HRD+K +N+ ++ +D ++ DFGLA+ SH ++ V
Sbjct: 127 ---LKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 587 AGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 645
T Y +P + ID++A G + E+LTG+ + H Q L++ + P++
Sbjct: 181 --TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238
Query: 646 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWA 705
+LL+ + R L +L +P A + + ++L +
Sbjct: 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLP-GVNPEA---LDFLEQILTFN----PMD 290
Query: 706 RLQVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLED 757
RL + + SCP S + D DD M+ I + D
Sbjct: 291 RLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDELDDILLMTEIHSIIYNWD 342
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 29/167 (17%)
Query: 467 EIEIITTLHHKNIISLLGF------CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGW 520
E+ ++ ++HKNIISLL E ++ LV + + +L + +H
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELD------- 121
Query: 521 SER-----YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575
ER Y++ G+ ++LHS +IHRD+K SNI++ D ++ DFGLA+
Sbjct: 122 HERMSYLLYQMLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--- 171
Query: 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG 622
T+ ++ T T Y APE + + +D+++ G ++ EL+ G
Sbjct: 172 TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 69/265 (26%), Positives = 117/265 (44%), Gaps = 27/265 (10%)
Query: 446 GKELAVKIL-KP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502
G ++A+K L +P SE K E+ ++ + H+N+I LL D +L +DF
Sbjct: 40 GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99
Query: 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 562
G + + + L+Y+H+ +IHRD+K N+ +++D E
Sbjct: 100 PFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCE 156
Query: 563 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLT 621
++ DFGLA+ + T T Y APE + + +D+++ G ++ E+LT
Sbjct: 157 LKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211
Query: 622 GRKPI--SNDH-PKGQESLVMWAKPILSSGKVTQLLDPALGNNY--DYDQMERMVLASIL 676
G KP+ +DH + E + + P S + Q L NY + + S+L
Sbjct: 212 G-KPLFKGHDHLDQLMEIMKVTGTP---SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLL 267
Query: 677 CIRRDPRARPQMSLVL-KLLRGDAD 700
P A P VL K+L DA+
Sbjct: 268 -----PNANPLAVNVLEKMLVLDAE 287
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 22/166 (13%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 525
E +I+ ++ + ++SL + +E + L LV ++ G L+ +++ N +P G+ E
Sbjct: 50 EKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY-NMGNP---GFDEERA 104
Query: 526 V--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI-- 581
V A + LE LH +R+++RD+K NILL D ++SD GLA I
Sbjct: 105 VFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLA-------VEIPE 154
Query: 582 --TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
T GT GY+APE + D + G ++ E++ G+ P
Sbjct: 155 GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 26/192 (13%)
Query: 445 DGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLLGF-------CFEDNNLLL 494
DGK +A+K + K E++++ H N++S L FE+ + +
Sbjct: 24 DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE--IYV 81
Query: 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLHSGSAQRVIHRDVKSS 553
V + + + +LH P S+ KV + + L+YLHS ++HRD+K
Sbjct: 82 VTELM-----QSDLHKIIVSPQPLS-SDHVKVFLYQILRGLKYLHSA---GILHRDIKPG 132
Query: 554 NILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYA 611
N+L++ + ++ DFGLA S H+T V T Y APE M + +D+++
Sbjct: 133 NLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV--TQYYRAPEILMGSRHYTSAVDIWS 190
Query: 612 FGVVLLELLTGR 623
G + ELL R
Sbjct: 191 VGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 9/91 (9%)
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
L+Y+HS +IHRD+K SN+ +++D E ++ DFGLA+ A T T Y
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYR 182
Query: 594 APEYFM-YGKVNDKIDVYAFGVVLLELLTGR 623
APE + + N +D+++ G ++ ELL G+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 44/162 (27%), Positives = 79/162 (48%), Gaps = 14/162 (8%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 525
E +I+ ++ + +++L + +E + L LV ++ G L+ +++ N +P G+ E
Sbjct: 50 EKQILEKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIY-NMGNP---GFEEERA 104
Query: 526 V--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
+ A + LE LH + ++RD+K NILL D ++SD GLA S
Sbjct: 105 LFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---I 158
Query: 584 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
GT GY+APE + D + G ++ E++ G+ P
Sbjct: 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 27/209 (12%)
Query: 430 IGKGGSSQVYKGCLPDGKE-LAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
IG+G VYK E +A+K ++ E V + EI ++ + H NI+ L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHS 539
+ L LV+++ L+ +L + F + R Y++ G+A Y HS
Sbjct: 70 VHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA----YCHS 120
Query: 540 GSAQRVIHRDVKSSNILLSDDFEP-QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
RV+HRD+K N+L+ +L+DFGLA+ T V T Y APE
Sbjct: 121 ---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEIL 175
Query: 599 MYGK-VNDKIDVYAFGVVLLELLTGRKPI 626
+ + + +D+++ G + E++ +KP+
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203
|
Length = 294 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 525
E I+ ++ + ++SL + +E + L LV ++ G L+ +++ N +P G+ E+
Sbjct: 50 EKRILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIY-NMGNP---GFDEQRA 104
Query: 526 V--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
+ A + LE L +R+++RD+K NILL D ++SD GLA T
Sbjct: 105 IFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TV 158
Query: 584 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
GT GY+APE K D + G ++ E++ G+ P
Sbjct: 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 9e-08
Identities = 66/272 (24%), Positives = 108/272 (39%), Gaps = 62/272 (22%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFV----LEIEIITTLHH 476
S F+ IG G +V D L A+K L+ ++ +++ E +I+ +
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN 60
Query: 477 KNIISLLGFCFED-NNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
+ ++ L + F+D +NL V D++ G SL L ++D A F +E +
Sbjct: 61 EWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAE-------LTC 112
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA--------------------- 571
A+E +H IHRD+K NIL+ D +L+DFGL
Sbjct: 113 AIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQD 169
Query: 572 ------KWASTSSS------------HITCT--DVAGTFGYLAPEYFMYGKVNDKIDVYA 611
+W+ H C + GT Y+APE + D ++
Sbjct: 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229
Query: 612 FGVVLLELLTGRKPISNDHPKG-QESLVMWAK 642
GV+L E+L G+ P D P Q ++ W
Sbjct: 230 VGVILYEMLVGQPPFLADTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 22/161 (13%)
Query: 471 ITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 529
ITTLH + F+D N L LV D+ G L L +D + Y
Sbjct: 63 ITTLH---------YAFQDENYLYLVMDYYVGGDLL-TLLSKFEDRLPEDMARFY----- 107
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
+AE + +HS +HRD+K N+LL + +L+DFG + + + GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGT 166
Query: 590 FGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKP 625
Y++PE GK + D ++ GV + E+L G P
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 430 IGKGGSSQVYKGCLPDGK---ELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 483
+G+G V +G L ++AVK +K + +++F+ E + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 484 GFCFEDN------NLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALE 535
G C + + +++ F+ G L L ++ P K +A +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
YL S++ IHRD+ + N +L+++ ++DFGL+K + ++A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 596 EYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
E K DV++FGV + E+ T G+ P
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 430 IGKGGSSQVYKGCLPDG---KELAVKILKPSEDVIKE--FVLEIEIITTLHHKNIISLLG 484
IG G +V G + G ++ VK L+ S V ++ F+ E + +L H N++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKK------DPAAFGWSERYKVAMGVAEALEYLH 538
C E LLV +F G L+ L +K DP ++A +A L +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTL-----QRMACEIALGLLHLH 117
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
+ IH D+ N LL+ D ++ D+GL+ ++T + ++APE
Sbjct: 118 KNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174
Query: 599 --MYGK--VNDKI---DVYAFGVVLLELLT-GRKP 625
++G V D+ +V++ GV + EL G +P
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 55/186 (29%), Positives = 92/186 (49%), Gaps = 21/186 (11%)
Query: 446 GKELAVKIL-KP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF-LSR 501
G+++A+K L +P SE K E+ ++ + H+N+I LL + DF L
Sbjct: 40 GEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99
Query: 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLS 558
++ +L P SE KV V + L+Y+HS +IHRD+K N+ ++
Sbjct: 100 PYMQTDLQKIMGHP----LSED-KVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVN 151
Query: 559 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLL 617
+D E ++ DFGLA+ A T T Y APE + + N +D+++ G ++
Sbjct: 152 EDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMA 206
Query: 618 ELLTGR 623
E+LTG+
Sbjct: 207 EMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 42/165 (25%), Positives = 70/165 (42%), Gaps = 18/165 (10%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDNNLLLV-----YDFLSRGSLEENLHGNKKDPAAFGWS 521
EI+I+ T+ H+ II+L+ + + +V D + + ++ P
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFT--------YVDRSGPLPL--E 185
Query: 522 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581
+ + + EAL YLH + +IHRDVK+ NI L + L DFG A
Sbjct: 186 QAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242
Query: 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
C +GT +PE K D+++ G+VL E+ +
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
VA+ +E+L S ++ IHRD+ + NILLS++ ++ DFGLA+ ++ D
Sbjct: 188 VAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
++APE + DV++FGV+L E+ + G P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 19/167 (11%)
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
VA +E+L S ++ IHRD+ + NILLS++ ++ DFGLA+ ++
Sbjct: 183 VARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSG 648
++APE + DV++FGV+L E+ + G P +P Q + + L G
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP----YPGVQINEEFCQR--LKDG 293
Query: 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695
T++ P ++ R++LA C + DP+ RP S ++++L
Sbjct: 294 --TRMRAP----ENATPEIYRIMLA---CWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 17/163 (10%)
Query: 465 VLEIEIITTLHHKNIISLLG-FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 523
E I+ ++H +II L G F + L++ + + L L + +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYLAAKRNIAIC----DI 184
Query: 524 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
+ V A++YLH R+IHRD+K+ NI ++ + L DFG A+ I
Sbjct: 185 LAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFG----AACFPVDINA 237
Query: 584 TDV---AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 623
AGT APE +D+++ G+VL E+ T
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 15/158 (9%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDNNLLLVYD-FLSRGSLEENLHG---NKKDPAAFGWSE 522
E+ ++ ++HKNIISLL +L D +L ++ NL + D +
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL- 124
Query: 523 RYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582
Y++ G+ ++LHS +IHRD+K SNI++ D ++ DFGLA+ A TS
Sbjct: 125 LYQMLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FM 174
Query: 583 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 620
T T Y APE + + +D+++ G ++ E++
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 8e-07
Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 22/153 (14%)
Query: 430 IGKGGSSQVY---KGCLPDGKELAVKILKPSEDVIKEFV----LEIEIITTLHHKNIISL 482
I +G +VY K + K AVK++K ++ + K V E + + I+ L
Sbjct: 12 ISRGAFGKVYLGRKKN--NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL 69
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLH--GNKKDPAAFGW-SERYKVAMGVAEALEYLHS 539
NN+ LV ++L G ++ LH G + A + SE VA AL+YLH
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISE-------VALALDYLHR 122
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+IHRD+K N+L+S++ +L+DFGL+K
Sbjct: 123 HG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|238182 cd00293, USP_Like, Usp: Universal stress protein family | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 8e-07
Identities = 27/137 (19%), Positives = 47/137 (34%), Gaps = 9/137 (6%)
Query: 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSV 77
++V V S L WA + G ++ LHV+ + L +A +
Sbjct: 1 RILVAVDGSEESERALRWAARLARRLGAELVLLHVVDPPPSSAAELAELLEEEARA---L 57
Query: 78 LAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRST--TSL 135
L V ++ + G IL A+ A ++G+ +R S+
Sbjct: 58 LEALREALAEAGVKVETVVLEGDPAEAIL-EAAEELGADLIVMGSRG-RSGLRRLLLGSV 115
Query: 136 AKYCAKKLSKDCSVLAV 152
A+ + C VL V
Sbjct: 116 AERVLRHAP--CPVLVV 130
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. Length = 130 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 28/97 (28%), Positives = 56/97 (57%), Gaps = 4/97 (4%)
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
VA+ +++L +++ IHRDV + N+LL+D ++ DFGLA+ S+++ +
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
++APE + DV+++G++L E+ + G+ P
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
+++LHS +IHRD+K SNI++ D ++ DFGLA+ A TS T T Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYY 191
Query: 593 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 623
APE + + +D+++ G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 31/216 (14%)
Query: 431 GKGGSSQVYKGCLPDGKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNIISLLGFCFE 488
GK S++Y + VK LK + + EF+ + + L H NI+ LG C E
Sbjct: 9 GKVLLSEIYTD--TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE 66
Query: 489 DNNLLLVYDFLSRGSL------EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
LLV+++ G L E+ N + ++A +A + ++H
Sbjct: 67 AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQL------LLLQRMACEIAAGVTHMHK--- 117
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
+H D+ N L+ D ++ D+G+ T D +LAPE + G+
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE--LVGE 175
Query: 603 VNDKI---------DVYAFGVVLLELL-TGRKPISN 628
+ + +V+A GV L EL +P S+
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 44/156 (28%), Positives = 70/156 (44%), Gaps = 13/156 (8%)
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
N++ L + ++++ LV G L ++ P +R+ M VA L+ L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPE--ECVKRWAAEMVVA--LDAL 101
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
H + ++ RD+ +NILL D QL+ F +W+ S C A Y APE
Sbjct: 102 HR---EGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDS---CDGEAVENMYCAPEV 153
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633
+ + D ++ G +L ELLTG K + HP G
Sbjct: 154 GGISEETEACDWWSLGAILFELLTG-KTLVECHPSG 188
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 49/169 (28%), Positives = 73/169 (43%), Gaps = 38/169 (22%)
Query: 471 ITTLHHKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 529
IT LH + F+D NNL LV D+ G L L + F +R M
Sbjct: 63 ITNLH---------YAFQDENNLYLVMDYYVGGDLLTLL-------SKFE--DRLPEDMA 104
Query: 530 ---VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG----LAKWASTSSSHIT 582
+AE + + S +HRD+K N+LL + +L+DFG L + S+
Sbjct: 105 RFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN--- 161
Query: 583 CTDVA-GTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKP 625
VA GT Y++PE G+ + D ++ GV + E+L G P
Sbjct: 162 ---VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 31/220 (14%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDG-KELAVKILKPSEDVIKE----FVLEIEIITTLHHK 477
+F +IG+G +V L + K A+KIL E + + F E +++ ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSL-------EENLHGNKKDPAAFGWSERYKVAMGV 530
I +L ++NNL LV D+ G L E+ L +D A F +E +A+
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL---PEDMARFYLAEMV-IAIDS 117
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
L Y +HRD+K NIL+ + +L+DFG + + + GT
Sbjct: 118 VHQLHY---------VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTP 167
Query: 591 GYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKP 625
Y++PE GK + D ++ GV + E+L G P
Sbjct: 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 46/210 (21%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 429 LIGKGGSSQVYKGCLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLG 484
LI + + +YKG + KE+ ++ K + +I EI+ + + NI+ + G
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85
Query: 485 FCFEDNNLL----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
F + + L L+ ++ +RG L E L K + + +A+ + L L+
Sbjct: 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKY 141
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF-- 598
+ + ++++ S + L++++++ ++ GL K S+ +V Y + +
Sbjct: 142 TNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK----NV-NFMVYFSYKMLND 194
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKPISN 628
++ + K D+Y+ GVVL E+ TG+ P N
Sbjct: 195 IFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224
|
Length = 283 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 3/93 (3%)
Query: 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 585
VA + A++Y+H + +IHRD+K+ N+L++ + L DFG A +A S S
Sbjct: 265 VARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 586 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLE 618
+AGT APE +D+++ G+V+ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-06
Identities = 66/271 (24%), Positives = 108/271 (39%), Gaps = 60/271 (22%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSE----DVIKEFVLEIEIITTLHH 476
S F+ +G G +V C D L A+K L+ + + + E +I+ +
Sbjct: 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN 60
Query: 477 KNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
+ ++ L + F+D +NL V D++ G + L + P R+ +A + A+E
Sbjct: 61 EWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA---RFYIAE-LTLAIE 115
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA---KWASTSS-----SHI------ 581
+H IHRD+K NIL+ D +L+DFGL +W S SHI
Sbjct: 116 SVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172
Query: 582 -----------TCTD--------------------VAGTFGYLAPEYFMYGKVNDKIDVY 610
C D + GT Y+APE + D +
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232
Query: 611 AFGVVLLELLTGRKPISNDHP-KGQESLVMW 640
+ GV+L E+L G+ P P + Q ++ W
Sbjct: 233 SVGVILFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 52/208 (25%), Positives = 81/208 (38%), Gaps = 60/208 (28%)
Query: 483 LGFCFED-NNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
L + F+D +NL V D++ G SL + +D A F +E + A+E +H
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAE-------LTCAVESVH 118
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA---KWASTS------------------ 577
IHRD+K NIL+ D +L+DFGL +W S
Sbjct: 119 K---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 578 ----SSHITCTD--------------------VAGTFGYLAPEYFMYGKVNDKIDVYAFG 613
++ C D + GT Y+APE + D ++ G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235
Query: 614 VVLLELLTGRKPISNDHP-KGQESLVMW 640
V+L E+L G+ P P + Q ++ W
Sbjct: 236 VILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
VA+ + +L S + IHRD+ + NILL+ ++ DFGLA+ S+++ +
Sbjct: 223 VAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
++APE + DV+++G++L E+ + G P
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 27/92 (29%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
VA +E+L S + +HRD+ + N+L+ + ++ DFGLA+ S++I+
Sbjct: 248 VANGMEFLAS---KNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
++APE DV++FG++L E+ T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|216006 pfam00582, Usp, Universal stress protein family | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 23/138 (16%), Positives = 48/138 (34%), Gaps = 4/138 (2%)
Query: 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDS 76
+ ++V V S L WAL + G +I LHV+ + +
Sbjct: 3 KRILVAVDGSEESERALEWALELAKRRGAELILLHVIDPEPSGAASEALEEEEEEELEEE 62
Query: 77 VLAVYEGFCNLKQVDLKLK-ICRGTSIRKILVREAQSYSATKFIVGT-AKNHHTIRSTTS 134
+ + ++ + RG + ++ A+ A ++G+ ++ S
Sbjct: 63 EAEAEALAAAAEAGGVVVEVVVRGGDPAEAILEVAEEEDADLIVMGSRGRSGLRRLLLGS 122
Query: 135 LAKYCAKKLSKDCSVLAV 152
+A+ + C VL V
Sbjct: 123 VAEKVLRHAP--CPVLVV 138
|
The universal stress protein UspA is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, though UspA lacks ATP-binding activity. Length = 139 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 38/140 (27%), Positives = 70/140 (50%), Gaps = 16/140 (11%)
Query: 427 ENLIGKGGSSQVYKGC---LPDGKEL-----AVKILKPSEDVIKEFVLE-IEIITTLHHK 477
E+L G+G ++++KG + D EL +K+L S E E +++ L HK
Sbjct: 1 ESL-GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHK 59
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+++ G C + ++V +++ GSL+ L KK+ S + +VA +A AL +L
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYL---KKNKNLINISWKLEVAKQLAWALHFL 116
Query: 538 HSGSAQRVIHRDVKSSNILL 557
+ + H +V + N+LL
Sbjct: 117 ED---KGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 50/189 (26%), Positives = 81/189 (42%), Gaps = 21/189 (11%)
Query: 457 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 516
+ +++ E+ + +H NI+ DN L +V F++ GS ++ + + D
Sbjct: 39 TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD-- 96
Query: 517 AFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574
G SE + GV +AL+Y+H +HR VK+S+IL+S D + LS GL
Sbjct: 97 --GMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLS--GLRSNL 149
Query: 575 STSSS-------HITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKP 625
S + H +L+PE + K D+Y+ G+ EL G P
Sbjct: 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209
Query: 626 ISNDHPKGQ 634
D P Q
Sbjct: 210 F-KDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 9e-05
Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVK--ILKPSEDVIKEFVL-EIEIITTLHHKN-IISLLG 484
IG+G +VYK GK +A+K L+ E+ I L EI ++ L I+ LL
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 485 FCFEDNN-----LLLVYDFLSRGSLEENLHGNKKD-----PAAFGWSERYKVAMGVAEAL 534
+ L LV+++L L++ + N + PA S Y++ GVA
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA--- 124
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEP-QLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
+ H V+HRD+K N+L+ +++D GL + S T V T Y
Sbjct: 125 -HCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLWYR 178
Query: 594 APEYFMYGK-VNDKIDVYAFGVVLLELLTG 622
APE + + +D+++ G + E+
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 33/148 (22%), Positives = 57/148 (38%), Gaps = 15/148 (10%)
Query: 429 LIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS--LLGFC 486
L+ G +++VY D +KI E E+ I+ L K + +L
Sbjct: 5 LLKGGLTNRVYLLGTKDED-YVLKINPSREKGAD-REREVAILQLLARKGLPVPKVLASG 62
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
D L+ +++ +L+E K+D +A +AE L LH +
Sbjct: 63 ESDGWSYLLMEWIEGETLDEVSEEEKED-----------IAEQLAELLAKLHQLPLLVLC 111
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWA 574
H D+ NIL+ D + D+ A +
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 67/265 (25%), Positives = 101/265 (38%), Gaps = 69/265 (26%)
Query: 423 NFLAENLIGKGGSSQV---YKGCLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLH 475
+F +IGKG +V K GK A+K L SE D + E +++
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQK--KDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD 59
Query: 476 HKNIISLLGFCFEDNNLL-LVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVA 531
++SL + F+D L L+ +FL G L L K D +SE R+ +A V
Sbjct: 60 SPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTML--IKYDT----FSEDVTRFYMAECVL 112
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK------------------- 572
A+E +H IHRD+K NIL+ +LSDFGL+
Sbjct: 113 -AIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168
Query: 573 ----------------WASTSSSHITCT----------DVAGTFGYLAPEYFMYGKVNDK 606
+ SS T GT Y+APE F+ +
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228
Query: 607 IDVYAFGVVLLELLTGRKPISNDHP 631
D ++ G ++ E L G P +++
Sbjct: 229 CDWWSLGAIMFECLIGWPPFCSENS 253
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 55/204 (26%), Positives = 82/204 (40%), Gaps = 22/204 (10%)
Query: 444 PDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500
P G + V+I +E+ +K E+ + H NI++ + L ++ F++
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 501 RGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558
GS L K G SE + G L YLH IHR++K+S+IL+S
Sbjct: 83 YGSANSLL----KTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILIS 135
Query: 559 DDFEPQLSDFG-LAKWASTSSSHITCTDV----AGTFGYLAPEYF---MYGKVNDKIDVY 610
D LS L D +L+PE +YG N K D+Y
Sbjct: 136 GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIY 194
Query: 611 AFGVVLLELLTGRKPISNDHPKGQ 634
+ G+ EL TGR P D + Q
Sbjct: 195 SVGITACELATGRVPFQ-DMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 25/92 (27%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
VA +E+L S + +HRD+ + N+LL+ ++ DFGLA+ S++++
Sbjct: 246 VARGMEFLAS---KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
++APE DV+++G++L E+ +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 49/189 (25%), Positives = 82/189 (43%), Gaps = 26/189 (13%)
Query: 444 PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC-FEDNNLLLV--YDFLS 500
P + L K +K + EI + L+H+NI+ + E N ++ YDF
Sbjct: 190 PKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-- 247
Query: 501 RGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 554
+L+ D AF W +R + + A+EY+H +++IHRD+K N
Sbjct: 248 ------DLYSFMYD-EAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLEN 297
Query: 555 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA--GTFGYLAPEYFMYGKVNDKIDVYAF 612
I L+ D + L DFG A D GT +PE + D+++
Sbjct: 298 IFLNCDGKIVLGDFGT---AMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSC 354
Query: 613 GVVLLELLT 621
G++LL++L+
Sbjct: 355 GLILLDMLS 363
|
Length = 501 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 770 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 99.62 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 99.61 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 99.56 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 99.53 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| PRK09982 | 142 | universal stress protein UspD; Provisional | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.4 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 99.28 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.26 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.23 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| COG0589 | 154 | UspA Universal stress protein UspA and related nuc | 99.12 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.96 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.93 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.85 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.8 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.69 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.66 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.62 | |
| PRK12652 | 357 | putative monovalent cation/H+ antiporter subunit E | 98.58 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.55 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.41 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.38 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.37 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.37 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.24 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.23 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.2 | |
| PRK10490 | 895 | sensor protein KdpD; Provisional | 98.18 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.13 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.07 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.06 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.93 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.87 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.87 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.85 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.81 | |
| COG2205 | 890 | KdpD Osmosensitive K+ channel histidine kinase [Si | 97.8 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.78 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.72 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.61 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.59 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.45 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.41 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.37 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.23 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.17 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.17 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.16 | |
| cd01984 | 86 | AANH_like Adenine nucleotide alpha hydrolases supe | 97.13 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.07 | |
| PLN02236 | 344 | choline kinase | 96.9 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.88 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.65 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.43 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-56 Score=488.90 Aligned_cols=287 Identities=49% Similarity=0.883 Sum_probs=259.8
Q ss_pred cccccCHHHHHHhhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhH-HHHHHHHHHHHHhcCCCceeEEeeEE
Q 004174 408 TCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV-IKEFVLEIEIITTLHHKNIISLLGFC 486 (770)
Q Consensus 408 ~~~~f~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~~~~ 486 (770)
..+.|++.++..+|++|...+.||+||||.||+|.+++|..||||++...... .++|.+|+++|.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999998875543 66799999999999999999999999
Q ss_pred eecC-ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEE
Q 004174 487 FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565 (770)
Q Consensus 487 ~~~~-~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL 565 (770)
.+.+ +.+||||||++|+|.++|+..... .++|..|++|+.++|+||+|||..+..+||||||||+|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9998 499999999999999999976543 7899999999999999999999988779999999999999999999999
Q ss_pred ccccccccccC-CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhccc
Q 004174 566 SDFGLAKWAST-SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 644 (770)
Q Consensus 566 ~DFGla~~~~~-~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~ 644 (770)
+|||+|+.... ....... ..||.+|+||||+..+..+.|+|||||||+|+||+||++|++...+.....++.|+++.
T Consensus 219 sDFGLa~~~~~~~~~~~~~--~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTT--VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred cCccCcccCCccccceeee--cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 99999977665 3222211 17999999999999999999999999999999999999999877666777799999999
Q ss_pred ccCCccccccCcccC-CCCCh-HHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 645 LSSGKVTQLLDPALG-NNYDY-DQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 645 ~~~g~l~~lld~~l~-~~~~~-~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
+..+.+.+++|+.+. ..+.. +++.+++.+|+.|++.+|.+||+|.+|+++|...
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 999999999999997 55554 7899999999999999999999999999999543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=379.17 Aligned_cols=248 Identities=26% Similarity=0.421 Sum_probs=205.1
Q ss_pred ccceeecccCceEEEEEEeC-CCCEEEEEEeC--CChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc-eEEEEeecC
Q 004174 425 LAENLIGKGGSSQVYKGCLP-DGKELAVKILK--PSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLS 500 (770)
Q Consensus 425 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~--~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~-~~LV~E~~~ 500 (770)
...+.||+|..|+||++.++ +++.+|+|++. ......+++.+|+++++..+|||||.++|.|..++. ..|+||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 44678999999999999874 78899999994 355778899999999999999999999999999985 999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+|+|++++...+ .+++...-+|+.+|++||.|||+ .++||||||||+|||++..|++||||||.++.+.+.
T Consensus 162 gGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 162 GGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 999999997653 58899999999999999999995 288999999999999999999999999999987665
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCc--cchhhHHHhhcccccCCccccccCccc
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP--KGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~--~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
.+.+++||..|||||.+++..|+.++||||||++++|+.+|+.||....+ .....+..+.- .-.-|.+
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv---------~~ppP~l 302 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV---------DEPPPRL 302 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh---------cCCCCCC
Confidence 34558999999999999999999999999999999999999999976421 12222222211 0011333
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
... .....+..++..||++||.+||++.+++++
T Consensus 303 P~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 303 PEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred Ccc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 332 122334445567999999999999999874
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=385.99 Aligned_cols=252 Identities=28% Similarity=0.407 Sum_probs=201.3
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh--------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~--------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 491 (770)
.+.|.+.+.||+|+||.|-+|.. ++|+.||||++++.. .......+|++||++|+|||||+++++|...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 34577899999999999999985 589999999997532 122335699999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC---CceEEccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDF 568 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~---~~vkL~DF 568 (770)
.|||||||+||+|.+.+-.++ .+.+..-..++.|++.|+.|||+ +||+||||||+||||..+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999998765 46677778899999999999999 999999999999999766 78999999
Q ss_pred cccccccCCCCCceecccccccCCCCceeeccCC---CCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccc
Q 004174 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 645 (770)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~---~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~ 645 (770)
|+|+..+... .+.+.||||.|.|||++..+. +..++|+||+||+||-+|+|.+||....... .+.. .+
T Consensus 324 GlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~e----QI 394 (475)
T KOG0615|consen 324 GLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKE----QI 394 (475)
T ss_pred chhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHH----HH
Confidence 9999887543 334589999999999998764 3348899999999999999999998654322 1111 11
Q ss_pred cCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 646 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 646 ~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..|+... -|. ....-.++...++.++|..||++||++.|+|++
T Consensus 395 ~~G~y~f--~p~----~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 395 LKGRYAF--GPL----QWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hcCcccc--cCh----hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1222111 010 111223455667788999999999999999974
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=393.50 Aligned_cols=251 Identities=32% Similarity=0.505 Sum_probs=204.5
Q ss_pred cceeecccCceEEEEEEeCCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecC-ceEEEEeecCC
Q 004174 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-NLLLVYDFLSR 501 (770)
Q Consensus 426 ~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-~~~LV~E~~~g 501 (770)
..+.||.|+||+||+|.+.....||||++.... ...+.|.+|+.+|.+++|||||+++|+|.+.. .+++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 344599999999999999544449999998643 23679999999999999999999999999887 79999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc-eEEecccCCCeeeCCCC-ceEEccccccccccCCCC
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-VIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~-IiHrDLKp~NILL~~~~-~vkL~DFGla~~~~~~~~ 579 (770)
|+|.++++.. ....+++..++.++.+||+||.|||+ ++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 9999999874 22579999999999999999999999 66 99999999999999998 99999999998776542
Q ss_pred CceecccccccCCCCceeec--cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 580 HITCTDVAGTFGYLAPEYFM--YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~--~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||....+......+.. .+.
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~------~~~-------- 263 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVV------GGL-------- 263 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh------cCC--------
Confidence 1222368999999999999 56899999999999999999999999998776221111110 010
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
...++......+..++..||+.||..||++.+++..|+..
T Consensus 264 -Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 264 -RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred -CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 1111122334556666679999999999999999998743
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=393.65 Aligned_cols=247 Identities=28% Similarity=0.444 Sum_probs=208.0
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCC----ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~----~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
..|...++||+|||+.||.+.. ..|..||+|++.+ .....+...+||+|.+.|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 3588889999999999999997 7899999999976 4466788999999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
|+|.+++|..+++..+ .+++.+++.++.||+.||.|||+ ++|||||||..|+||+++.++||+|||||..+..
T Consensus 98 ELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999997443 69999999999999999999999 9999999999999999999999999999998875
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
..... .+.||||.|+|||++.....+..+||||+|||||-||.|++||+...-++....+.-....+ |
T Consensus 171 ~~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~----------P 238 (592)
T KOG0575|consen 171 DGERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSM----------P 238 (592)
T ss_pred ccccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccc----------c
Confidence 53322 23799999999999999999999999999999999999999998765443332222111100 1
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. .-..+.. .++..+|+.+|.+|||+.+||.+
T Consensus 239 ~----~ls~~A~---dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 239 S----HLSAEAK---DLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred c----ccCHHHH---HHHHHHhcCCcccCCCHHHHhcC
Confidence 0 1112233 34456899999999999999973
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=375.59 Aligned_cols=241 Identities=29% Similarity=0.420 Sum_probs=199.8
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.++||+|+||+||.++. ++++.||+|++++.. ...+....|..||..++||+||+++..|++.+++|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 45789999999999999999986 468999999998743 4567788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
+||+.||.|...|++.+ .|++..++.++.+|+.||.|||+ ++||||||||+|||||.+|+++|+||||++..-
T Consensus 104 ld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999998765 58999999999999999999999 999999999999999999999999999998554
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
..... ..+++||+.|||||++....|+..+|+|||||++|||++|.+||...+.......+...+ +
T Consensus 177 ~~~~~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-------~----- 242 (357)
T KOG0598|consen 177 KDGDA--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-------L----- 242 (357)
T ss_pred cCCCc--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-------C-----
Confidence 43222 234899999999999999999999999999999999999999998876544333322111 0
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCC
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARP 686 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RP 686 (770)
.....+..... ..+....|+++|++|-
T Consensus 243 -~~~p~~ls~~a---rdll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 -PLPPGYLSEEA---RDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCCccCCHHH---HHHHHHHhccCHHHhc
Confidence 00111122222 3334458899999996
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=371.75 Aligned_cols=203 Identities=30% Similarity=0.536 Sum_probs=182.5
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
..+|...+.||+|+||+||+|.+. ++..||||.+... ....+.+..|+.+|+.++|||||.|++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356888888999999999999974 6899999988654 456777899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC------CceEEccccc
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD------FEPQLSDFGL 570 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~------~~vkL~DFGl 570 (770)
|||.||+|.++|+..+ .+++..++.++.||+.||++||+ ++||||||||.||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999998765 58999999999999999999999 899999999999999765 4589999999
Q ss_pred cccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccc
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 633 (770)
|+.+..... ..+.+|++.|||||+++.++|+.|+|+||+|++||+|++|+.||....+.+
T Consensus 162 AR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 162 ARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred hhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 999875432 234799999999999999999999999999999999999999998766543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=364.15 Aligned_cols=258 Identities=28% Similarity=0.402 Sum_probs=211.8
Q ss_pred cCcccceeecccCceEEEEEE-eCCCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcCCCceeEEee-EEeecCc-eEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLG-FCFEDNN-LLLV 495 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~-~~~~~~~-~~LV 495 (770)
.+|.+.+.||+|.||.||++. +.+|..+|.|.++- +......+..|+.+|++|+|||||++++ .|.+++. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 357888999999999999996 57999999998874 3356678999999999999999999999 5666666 8999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA-QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~-~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
|||+.+|+|...++..+.....+++..+++++.|++.||.++|+.-. .-|+||||||.||+|+.+|.+||+||||++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999998887777899999999999999999999998442 23899999999999999999999999999998
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
...... ....+|||.||+||.++..+|+.||||||+||++|||+.-++||.+++-. .| ...+..|....+.
T Consensus 179 ~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~---~L----~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 179 SSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL---SL----CKKIEQGDYPPLP 249 (375)
T ss_pred cchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH---HH----HHHHHcCCCCCCc
Confidence 775443 34479999999999999999999999999999999999999999886321 11 1122333322222
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
+......+..++..|+..||+.||+...++..+.
T Consensus 250 --------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 250 --------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred --------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1233455666777899999999999655555443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=378.84 Aligned_cols=251 Identities=27% Similarity=0.460 Sum_probs=207.5
Q ss_pred ccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCh
Q 004174 425 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (770)
Q Consensus 425 ~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL 504 (770)
...+.||+|-||.||.|.++....||+|.++......+.|.+|+.+|++|+|+|||+++++|..+..+|||||||+.|+|
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 34678999999999999997777999999998777778999999999999999999999999998899999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceec
Q 004174 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (770)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~ 584 (770)
.++|+... ...+...+.+.++.|||+|++||++ +++|||||.+.|||++++..+||+|||||+....+.. ....
T Consensus 289 l~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y-~~~~ 362 (468)
T KOG0197|consen 289 LDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY-TASE 362 (468)
T ss_pred HHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCce-eecC
Confidence 99998622 2468889999999999999999999 9999999999999999999999999999995444322 2222
Q ss_pred ccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCC
Q 004174 585 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 663 (770)
Q Consensus 585 ~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~ 663 (770)
...-..-|.|||.+..++++.|||||||||+||||+| |+.||......+....+. .|. .+.- +
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-------~Gy--Rlp~-------P 426 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-------RGY--RLPR-------P 426 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-------ccC--cCCC-------C
Confidence 2233457999999999999999999999999999999 999998765443322222 221 1111 2
Q ss_pred hHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 664 YDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 664 ~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
......+..++..||+.+|++|||+..+...|..
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~ 460 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLED 460 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence 2334456667788999999999999988877754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=346.18 Aligned_cols=263 Identities=24% Similarity=0.308 Sum_probs=207.8
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
.|.....+|+|+||.||+++.+ +|+.||||++..++ ...+-.++||++|++|+|+|+|.|+++|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4667789999999999999865 69999999997654 3455678999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
++. ++.+-|.... ..++...+.+++.|++.|+.|+|+ +++|||||||+||||+.++.+||||||+|+.+....
T Consensus 83 ~dh-TvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 83 CDH-TVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred cch-HHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 988 5555555443 468889999999999999999999 889999999999999999999999999999887532
Q ss_pred CCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhc--------cccc-CC
Q 004174 579 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK--------PILS-SG 648 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~--------~~~~-~g 648 (770)
..+++.+.|.+|.|||.+.+ .+|+..+|||++||++.||++|.+-|.+.+...+..++.... .++. ++
T Consensus 156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 23566889999999999986 689999999999999999999999999888776665553211 1111 11
Q ss_pred ccccccCcccCCCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 KVTQLLDPALGNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ~l~~lld~~l~~~~~-----~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+..+.=|......+ .....-++.++..||+.||.+|++.++++.+
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 122211111111101 1122245566678999999999999998863
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=353.65 Aligned_cols=260 Identities=28% Similarity=0.442 Sum_probs=206.7
Q ss_pred hcCcccceeecccCceEEEEEE-eCCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 421 TSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.++|.+.+.||.|..++||+|. .+.+..||||++..+. ...+.+.+|+..++.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4568889999999999999997 5778999999997543 457889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
||.+|++.+++...-. ..+.+..+..|+.++++||.|||+ +|.||||||+.||||+.+|.+||+|||.+-.+-..
T Consensus 105 fMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999986544 458999999999999999999999 89999999999999999999999999998655443
Q ss_pred CCC-cee-cccccccCCCCceeecc--CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcc-cccCCcccc
Q 004174 578 SSH-ITC-TDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP-ILSSGKVTQ 652 (770)
Q Consensus 578 ~~~-~~~-~~~~GT~~YlAPE~~~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~-~~~~g~l~~ 652 (770)
... ... ..++||++|||||+++. ..|+.|+|||||||+.+||.+|..||....|.....+.....+ .+. ..
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~----t~ 255 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL----TS 255 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc----cc
Confidence 222 122 45799999999999653 3799999999999999999999999988766433221111111 000 11
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
.++..-...+ -..+...+-.||++||.+|||++++++
T Consensus 256 ~~~~d~~k~~----~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 256 GLDKDEDKKF----SKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cCChHHhhhh----cHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1111111111 123344445699999999999999987
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=365.91 Aligned_cols=251 Identities=27% Similarity=0.380 Sum_probs=206.7
Q ss_pred hhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~ 493 (770)
..++|...+.||.|+|++||+|.. .+++.||||++.+. +..++....|-++|.+| .||.|++|+.-|++...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 346788899999999999999985 47999999999763 34455677899999999 7999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+|+||+++|+|.++|++.+ .|++...+.++.+|+.||+|||+ +|||||||||+|||||.++++||+|||-|+.
T Consensus 151 FvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeecccccc
Confidence 9999999999999998875 58899999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCC---------ce--ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhc
Q 004174 574 ASTSSSH---------IT--CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 642 (770)
Q Consensus 574 ~~~~~~~---------~~--~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~ 642 (770)
+...... .. ...++||..|.+||++..+..+..+|||+|||+||+||.|.+||.+.+.--.-..++-
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~-- 301 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA-- 301 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH--
Confidence 7653222 11 1448999999999999999999999999999999999999999987654222111111
Q ss_pred ccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 643 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 643 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
++-.+...++ +....++.+.|..||.+|++..+|-++
T Consensus 302 -----------l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 302 -----------LDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -----------hcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence 1111222222 233344456789999999999988775
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=362.58 Aligned_cols=259 Identities=24% Similarity=0.435 Sum_probs=202.2
Q ss_pred hcCcccceeecccCceEEEEEEe------CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecC-
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN- 490 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~- 490 (770)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.. ......+.+|+.++..+ +||||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46789999999999999999973 23568999999753 24456789999999999 8999999999987644
Q ss_pred ceEEEEeecCCCChhhhhccCCCC--------------------------------------------------------
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKD-------------------------------------------------------- 514 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~-------------------------------------------------------- 514 (770)
.+++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 589999999999999998653210
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceecccccccCC
Q 004174 515 --PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592 (770)
Q Consensus 515 --~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y 592 (770)
...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 1357888999999999999999999 89999999999999999999999999999865433222222234567899
Q ss_pred CCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHH
Q 004174 593 LAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMV 671 (770)
Q Consensus 593 lAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~ 671 (770)
+|||++....++.++|||||||+||||++ |..||........ +.. .+..+... .. +......+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~----~~~~~~~~-----~~----~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQ----RLKDGTRM-----RA----PENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHH----HHhcCCCC-----CC----CCCCCHHHH
Confidence 99999998999999999999999999997 9999976543211 111 01111110 01 111123455
Q ss_pred HHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 672 LASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 672 ~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.++..||+.+|.+||++.+|++.|+.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHH
Confidence 67778999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=339.62 Aligned_cols=200 Identities=30% Similarity=0.444 Sum_probs=182.8
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|...+.||.|+||.|.+++.+ +|..||+|++.+.. ...+...+|..+|+.+.||++++|++.|.+.+.+||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 45788899999999999999865 68899999998754 44567888999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||++||.|..+|++.+ .|++..++.++.||+.||+|||+ ++|++|||||+|||||.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 9999999999998765 58999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 633 (770)
. + -+.||||.|+|||+++...|+.++|+|+|||++|||+.|.+||...++..
T Consensus 197 r----T-~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~ 248 (355)
T KOG0616|consen 197 R----T-WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ 248 (355)
T ss_pred c----E-EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH
Confidence 3 2 23799999999999999999999999999999999999999999887743
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=361.02 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=204.7
Q ss_pred HHHHHhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeec
Q 004174 415 QDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFED 489 (770)
Q Consensus 415 ~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 489 (770)
+......++|.+..+||+|+||.||+|..+ +|..+|+|++++++ ..++....|-++|....+|+||+|+..|++.
T Consensus 134 ~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 134 RRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK 213 (550)
T ss_pred ccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence 333456789999999999999999999864 69999999999865 4567788899999999999999999999999
Q ss_pred CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccc
Q 004174 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (770)
Q Consensus 490 ~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 569 (770)
+++||||||++||++..+|.... .|++..++.++.+++.|+.-||+ .|+|||||||+|+|||..|++||+|||
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFG 286 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFG 286 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeecccc
Confidence 99999999999999999997664 68999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCC-----------------------CC-----Cce-----------------ecccccccCCCCceeeccCCCC
Q 004174 570 LAKWASTS-----------------------SS-----HIT-----------------CTDVAGTFGYLAPEYFMYGKVN 604 (770)
Q Consensus 570 la~~~~~~-----------------------~~-----~~~-----------------~~~~~GT~~YlAPE~~~~~~~s 604 (770)
|+.-+... .. ... ....+|||.|+|||++.+..|+
T Consensus 287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~ 366 (550)
T KOG0605|consen 287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG 366 (550)
T ss_pred ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence 98632210 00 000 0125799999999999999999
Q ss_pred CcceEeechHHHHHHHhCCCCCCCCCccch-hhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCC
Q 004174 605 DKIDVYAFGVVLLELLTGRKPISNDHPKGQ-ESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPR 683 (770)
Q Consensus 605 ~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~-~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~ 683 (770)
..+|+||||||+||||.|.+||..+.+... ..++.|...+...... ...++.. .++.+|+. ||+
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~-----------~~s~eA~---DLI~rll~-d~~ 431 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV-----------DLSDEAK---DLITRLLC-DPE 431 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC-----------cccHHHH---HHHHHHhc-CHH
Confidence 999999999999999999999999988664 3566675433221110 0112333 34445555 999
Q ss_pred CCCC
Q 004174 684 ARPQ 687 (770)
Q Consensus 684 ~RPs 687 (770)
+|--
T Consensus 432 ~RLG 435 (550)
T KOG0605|consen 432 NRLG 435 (550)
T ss_pred HhcC
Confidence 9987
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=367.65 Aligned_cols=240 Identities=24% Similarity=0.398 Sum_probs=200.9
Q ss_pred hhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~ 493 (770)
..++|.+.++||+|.||+|+++..+ +++.||||++++. ++.++..+.|.+|+.... ||++++|+.+|++.+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4568999999999999999999865 6789999999975 467788899999998886 999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+||||+.||++..+.+. ..|++..++.|+.+|+.||+|||+ ++|||||||.+|||||.+|++||+|||+++.
T Consensus 446 fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence 99999999995544432 358999999999999999999999 9999999999999999999999999999986
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
...... ...+++|||.|||||++....|+..+|+|||||+|||||.|..||.+++..+.-
T Consensus 518 ~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F------------------ 577 (694)
T KOG0694|consen 518 GMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF------------------ 577 (694)
T ss_pred cCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH------------------
Confidence 543322 234589999999999999999999999999999999999999999987653321
Q ss_pred cCcccCCC--CChHHHHHHHHHHHhhcccCCCCCCCH
Q 004174 654 LDPALGNN--YDYDQMERMVLASILCIRRDPRARPQM 688 (770)
Q Consensus 654 ld~~l~~~--~~~~~~~~l~~~a~~Cl~~dP~~RPs~ 688 (770)
|..+.++ |+.......+.++...|.++|++|.-+
T Consensus 578 -dsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 578 -DSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -HHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1111111 222333445556667899999999987
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=355.40 Aligned_cols=263 Identities=26% Similarity=0.351 Sum_probs=207.4
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec--CceEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLV 495 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~LV 495 (770)
+.|..++.||+|.||.||+|.. .+|+.||+|.++.. ........+||.||++|.||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 3466678899999999999984 68999999999754 35567788999999999999999999998876 689999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
+|||+. +|.-++.... ..|+..++..++.||+.||+|+|. ++|+|||||.+|||||++|.+||+|||||+++.
T Consensus 197 FeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999987 9998887543 469999999999999999999999 999999999999999999999999999999887
Q ss_pred CCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccc---
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT--- 651 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~--- 651 (770)
...... ++..+-|+.|.|||.+.+. .|+.++|+||.||||.||++|++.|.+.....|...+.-.........+.
T Consensus 270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 655432 4567889999999998865 69999999999999999999999999987777766553222111111111
Q ss_pred ----cccCc------ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 652 ----QLLDP------ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 652 ----~lld~------~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
..+.+ .+.+.+ .......+.++-.+|..||.+|.|+.++|+
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~-~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETF-KDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHHh-ccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111 111000 001122334444578889999999999986
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=347.86 Aligned_cols=263 Identities=25% Similarity=0.407 Sum_probs=203.0
Q ss_pred cCcccceeecccCceEEEEEEeCC-----------------CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPD-----------------GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISL 482 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~-----------------g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l 482 (770)
++|.+.+.||+|+||.||+|.+++ +..||+|+++.. .....+|.+|+.++..++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568889999999999999997532 346999999763 3456789999999999999999999
Q ss_pred eeEEeecCceEEEEeecCCCChhhhhccCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEE
Q 004174 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547 (770)
Q Consensus 483 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~---------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiH 547 (770)
+++|.+.+..++||||+++|+|.+++..... ....++|..++.++.||+.||.|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 9999999999999999999999998864321 11347889999999999999999999 88999
Q ss_pred ecccCCCeeeCCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh--CCCC
Q 004174 548 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKP 625 (770)
Q Consensus 548 rDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt--G~~P 625 (770)
|||||+|||++.++.+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++ |..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986644332222223456889999999998999999999999999999987 5677
Q ss_pred CCCCCccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 626 ISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 626 f~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
|....... ...+....+......... ..+......+..++..||+.+|.+||++.+|.+.|+
T Consensus 242 ~~~~~~~~---~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQ---VIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHH---HHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 76543322 111111111111000000 001112245666778899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=346.99 Aligned_cols=255 Identities=27% Similarity=0.421 Sum_probs=198.3
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecC--ceEEEEe
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NLLLVYD 497 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~~~LV~E 497 (770)
.+|...+.||+|.||.||++... +|...|||.+.... ...+.+.+|+.+|.+++|||||+++|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45677889999999999999865 48999999987542 22567899999999999999999999855544 6899999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC-CCceEEccccccccccC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWAST 576 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-~~~vkL~DFGla~~~~~ 576 (770)
|+++|+|.+++.+.+. .|++..++.++.||++||.|||+ ++||||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999987653 58999999999999999999999 99999999999999999 79999999999987764
Q ss_pred CCCC-ceecccccccCCCCceeeccCCC-CCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 577 SSSH-ITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 577 ~~~~-~~~~~~~GT~~YlAPE~~~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
.... .....+.||+.|||||++..+.. ..++|||||||+++||+||++||... ......+.+ ....+..
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~---ig~~~~~---- 241 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLL---IGREDSL---- 241 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHH---HhccCCC----
Confidence 1111 12234789999999999997543 35999999999999999999999763 111111111 1111111
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
|.+... .......+...|+.++|.+|||+.++|++.-
T Consensus 242 -P~ip~~----ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 242 -PEIPDS----LSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred -CCCCcc----cCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 122222 2222333445799999999999999998653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=359.14 Aligned_cols=248 Identities=25% Similarity=0.412 Sum_probs=205.4
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhH-HHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDV-IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~-~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
.|.....||+|+.|.||.|.. .+++.||||++....+. .+-+++|+.+|+..+|+|||++++.|...+.+|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 355567899999999999974 57889999999876644 4457899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
||+|.+.+... .+++.++..|+.+++.||+|||. ++|||||||.+||||+.+|.+||+|||++..+.....
T Consensus 354 ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 354 GGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 99999998754 38899999999999999999999 9999999999999999999999999999987766543
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 660 (770)
.....+|||.|||||++....|+.|+||||||++.+||+-|.+||-..++.....++.- .|. |.+..
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~------ng~------P~lk~ 491 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------NGT------PKLKN 491 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh------cCC------CCcCC
Confidence 23457999999999999999999999999999999999999999988776554444321 111 11111
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 661 ~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.......+-.+..+||+.|+++||++.++|++
T Consensus 492 --~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 492 --PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred --ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 11111122334457999999999999999984
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=354.75 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=203.7
Q ss_pred HhhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC----h--hHHHHHHHHHHHHHhcC-CCceeEEeeEEeecC
Q 004174 419 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----E--DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDN 490 (770)
Q Consensus 419 ~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~--~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~ 490 (770)
...+.|.+.+.||+|+||+|++|.. .+|..||||++... . ...+.+.+|+.+++.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456899999999999999999975 47899999987653 1 23456678999999999 999999999999999
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC-CceEEcccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFG 569 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~-~~vkL~DFG 569 (770)
.+++||||+.||+|.+++...+ .+.+.+++.++.|++.|++|||+ ++|+||||||+||||+.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999998733 58889999999999999999999 999999999999999999 999999999
Q ss_pred ccccccCCCCCceecccccccCCCCceeeccCC-CC-CcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccC
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK-VN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 647 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~-~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 647 (770)
++..... ......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.+.+.......+ ..
T Consensus 167 ~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki-------~~ 237 (370)
T KOG0583|consen 167 LSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI-------RK 237 (370)
T ss_pred cccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH-------hc
Confidence 9987741 112334579999999999999877 86 7899999999999999999999874432222111 11
Q ss_pred C--ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 648 G--KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 648 g--~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
+ .+...+. ...+..++..||..+|.+|+++.+|++
T Consensus 238 ~~~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 238 GEFKIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CCccCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1 1111110 234455667899999999999999985
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=357.20 Aligned_cols=260 Identities=28% Similarity=0.460 Sum_probs=206.0
Q ss_pred hhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
-.+++.+...||+|.||+||+|.+.. .||||+++. ..+..+.|.+|+.+|++-+|.||+-+.|||..... .||.
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred CHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence 34456678899999999999999843 599999985 44678899999999999999999999999988766 9999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
-||+|-+|+.+||-.. ..|.....+.|+.||++|+.|||. ++|||||||..||||.+++.|||+||||+.....
T Consensus 467 qwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred hhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence 9999999999998654 468999999999999999999999 9999999999999999999999999999975443
Q ss_pred CCCCceecccccccCCCCceeecc---CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
-..........|...|||||+++. .+|+..+||||||||+|||+||..||..... ++ +.|. ...|. -.
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-dq---Iifm---VGrG~--l~ 611 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-DQ---IIFM---VGRGY--LM 611 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-hh---eEEE---ecccc--cC
Confidence 333333344568889999999974 3699999999999999999999999984332 22 1121 11111 11
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCCC
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 700 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~~ 700 (770)
.|.... ..+..+.|..+...||..++++||.+.+|+..|.....
T Consensus 612 pd~s~~---~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 612 PDLSKI---RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccchhh---hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 122111 12233445555667999999999999999997765443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=355.47 Aligned_cols=264 Identities=22% Similarity=0.308 Sum_probs=210.0
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHH--HHHHHHHHhcC-CCceeEEeeEEeecC-ceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEF--VLEIEIITTLH-HKNIISLLGFCFEDN-NLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~--~~Ei~iL~~l~-HpnIv~l~~~~~~~~-~~~LV 495 (770)
-++|.+.+.||.|.||.||+|.. .+|..||||.++..-...+++ ++|+.-|++|+ ||||++|.+.+.+.+ .+|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 45788899999999999999985 478899999998654434443 57999999999 999999999999988 99999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
||||+. +|+++++... ..|++..++.|+.||++||+|+|+ +|+.|||+||+|||+..+..+||+|||+|+...
T Consensus 89 fE~Md~-NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhhhh-hHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence 999966 9999998763 589999999999999999999999 999999999999999999999999999999776
Q ss_pred CCCCCceecccccccCCCCceeec-cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccc-----cCC-
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL-----SSG- 648 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~-~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~-----~~g- 648 (770)
... .++..+-|..|.|||++. .+-|+.+.|+|++|||++|+.+-++-|.+.+...+...+.-..... ..|
T Consensus 162 Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 SKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred cCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 544 345678999999999875 6679999999999999999999999998877655554443221100 000
Q ss_pred ccccccCcccCC-------CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 KVTQLLDPALGN-------NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ~l~~lld~~l~~-------~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
++...++=.+.. ..-.......+.++..|+..||.+|||+.+.|++
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111101100 0011244566677778999999999999999985
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=340.83 Aligned_cols=251 Identities=23% Similarity=0.315 Sum_probs=199.6
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.|...+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+.++..++|+||++++++|.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999985 578999999986532 233467889999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+++|+|.+.+..... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999999988764332 358899999999999999999999 89999999999999999999999999999875432
Q ss_pred CCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
.. .....||+.|+|||++.+..++.++|||||||+||||++|+.||...........+. . .+..+.
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~--~-~~~~~~-------- 221 (285)
T cd05631 156 ET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD--R-RVKEDQ-------- 221 (285)
T ss_pred Ce---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH--H-Hhhccc--------
Confidence 21 223579999999999999999999999999999999999999998654322111110 0 000000
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 694 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs-----~~eVL~~ 694 (770)
..+.......+..++..||+.||.+||+ +.+++++
T Consensus 222 --~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 --EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred --ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0011111234455667899999999997 7888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=324.77 Aligned_cols=263 Identities=26% Similarity=0.361 Sum_probs=212.8
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.+|...+.||+|.||.||+|++ .+|+.||||.++..+ .......+||..|+.++|+||+.|+++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577788999999999999985 579999999998643 335678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
||+. +|+..|+... ..++...+..++.++++||+|||. +.|+||||||.|+||+.+|.+||+|||+|+.+...
T Consensus 82 fm~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9976 9999997654 478899999999999999999999 88999999999999999999999999999988776
Q ss_pred CCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCc---cccc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK---VTQL 653 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~---l~~l 653 (770)
...... .+-|..|.|||.+.+. .|+..+|+||.||++.||+-|.+-|.+++..+|...+.-+........ +..+
T Consensus 155 ~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 155 NRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred Cccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 544332 3789999999988754 699999999999999999999998888877776665543322221111 1111
Q ss_pred cC---------cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 654 LD---------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 654 ld---------~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.| +.+.. .-.......+.+...++..||.+|.++.++|++
T Consensus 233 pdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 22211 222333445666678999999999999999975
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=354.28 Aligned_cols=239 Identities=31% Similarity=0.504 Sum_probs=200.0
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCChhh
Q 004174 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 506 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~ 506 (770)
.+-||.|+.|.||+|.+ .++.||||.++.- -..+|..|++|+||||+.+.|+|.....+|||||||..|-|.+
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~el------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVREL------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhh------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 35689999999999998 6678999977532 2247888999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceeccc
Q 004174 507 NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586 (770)
Q Consensus 507 ~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 586 (770)
.|+... .+.-.....|..+||.|+.|||. +.|||||||.-||||+.+..+||+|||-++......+. ..+
T Consensus 202 VLka~~----~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk---MSF 271 (904)
T KOG4721|consen 202 VLKAGR----PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK---MSF 271 (904)
T ss_pred HHhccC----ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhhhhh---hhh
Confidence 997654 46778888999999999999999 89999999999999999999999999999877665332 348
Q ss_pred ccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCChHH
Q 004174 587 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQ 666 (770)
Q Consensus 587 ~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~ 666 (770)
+||..|||||++.+...++|+|||||||||||||||..||.+-+. ..+.|.- | ...|.-..+...
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIwGV-----G------sNsL~LpvPstc 336 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWGV-----G------SNSLHLPVPSTC 336 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEEec-----c------CCcccccCcccC
Confidence 999999999999999999999999999999999999999976432 2233321 1 111212234455
Q ss_pred HHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 667 MERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 667 ~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+-+.+++.+||+..|.+||++.+|+.+|.-
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 5667778889999999999999999998864
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=348.84 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=203.5
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||.||+|... +++.||||+++... .....+.+|++++..++||||+++++++...+..||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999875 58899999997532 34567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999996543 57899999999999999999999 8999999999999999999999999999976544
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchh-hHHHhhcccccCCccccccC
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE-SLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~lv~~~~~~~~~g~l~~lld 655 (770)
......||+.|+|||++....++.++|||||||++|||++|+.||......... .+..|... +.. ....+
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~---~~~~~ 224 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET-LQR---PVYDD 224 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-ccC---CCCCc
Confidence 122357999999999999889999999999999999999999999876543322 12222111 000 00000
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
+. ......+..++..||+.+|.+||++.+++++-
T Consensus 225 ~~------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 225 PR------FNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred cc------cccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 00 11123344555679999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=338.79 Aligned_cols=244 Identities=23% Similarity=0.348 Sum_probs=195.9
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEee----cCceEEEEee
Q 004174 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLLVYDF 498 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~LV~E~ 498 (770)
...||+|++|.||+|.. +|+.||||.++... ...+.|.+|+.+|.+++||||++++++|.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 78999999997542 235778899999999999999999999977 3468999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++|+|.+++.... .++|.....++.+++.||.|||+. .+++||||||+|||++.++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 99999999997543 588999999999999999999972 368899999999999999999999999998654322
Q ss_pred CCceecccccccCCCCceeecc--CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
. ...||+.|+|||++.. +.++.++|||||||++|||++|+.||...........+. ..+. .+
T Consensus 178 ~-----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~------~~~~-----~~ 241 (283)
T PHA02988 178 F-----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII------NKNN-----SL 241 (283)
T ss_pred c-----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------hcCC-----CC
Confidence 1 2468999999999975 689999999999999999999999998654332211110 0000 00
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+ +......+..++..||+.||.+||++.++++.|+.
T Consensus 242 ~~----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 242 KL----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred CC----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 11 11122345566678999999999999999998863
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=356.00 Aligned_cols=258 Identities=25% Similarity=0.413 Sum_probs=202.2
Q ss_pred cCcccceeecccCceEEEEEEe------CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCce
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 492 (770)
++|.+.+.||+|+||.||+|.. .++..||||+++... ...+.+.+|+.+|..+ +||||++++++|...+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4578889999999999999963 246689999997543 3456788999999999 899999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCC-----------------------------------------------------------
Q 004174 493 LLVYDFLSRGSLEENLHGNKK----------------------------------------------------------- 513 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~----------------------------------------------------------- 513 (770)
++||||+++|+|.+++.....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999999864321
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 514 ------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 514 ------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
....++|..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 01257889999999999999999999 899999999999999999999999999998665433222
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 660 (770)
......++..|+|||++....++.++|||||||++|||++ |..||....... ....+.. .+.. ...+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~----~~~~--~~~~---- 339 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIK----EGYR--MLSP---- 339 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHH----hCcc--CCCC----
Confidence 2222345678999999999999999999999999999998 899997643221 1111111 1100 0001
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 661 ~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.... ..+..++..||+.+|.+||++.+|+++|+.
T Consensus 340 ~~~~---~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 340 ECAP---SEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1112 245566678999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=371.65 Aligned_cols=258 Identities=27% Similarity=0.487 Sum_probs=212.7
Q ss_pred hcCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 492 (770)
+.+-...+.||+|+||.||+|... +...||||.++... +...+|.+|+++|..|+|||||+|+|.|.+++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 344566788999999999999842 34679999998644 4678999999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCC---------C-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCc
Q 004174 493 LLVYDFLSRGSLEENLHGNKK---------D-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 562 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~---------~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~ 562 (770)
+||+|||..|||.++|.-... . +.+++..+.+.|+.|||.|+.||-+ +.+|||||.++|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceE
Confidence 999999999999999964321 1 3458899999999999999999998 88999999999999999999
Q ss_pred eEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhh
Q 004174 563 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWA 641 (770)
Q Consensus 563 vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~ 641 (770)
|||+||||++-.-....+.......-...|||||.|++++|+++||||||||+|||+++ |+.||.+....+....
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~---- 717 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC---- 717 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH----
Confidence 99999999986554444333222334568999999999999999999999999999999 9999988665433222
Q ss_pred cccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 642 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 642 ~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+..|++-+ -+......+..+++.||+..|.+||++++|-..|+.
T Consensus 718 ---i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 718 ---IRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred ---HHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 23333311 133445677888889999999999999999998863
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=330.29 Aligned_cols=251 Identities=24% Similarity=0.426 Sum_probs=203.8
Q ss_pred cCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
++|.+.+.||+|+||.||++..+++..+|+|.++........+.+|+.+++.++||||++++++|...+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 45788899999999999999988888999999876555567889999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
|+|.++++... ..+++..+..++.+++.||.|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 84 GCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 99999987543 258899999999999999999999 89999999999999999999999999999765432211
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 660 (770)
......++..|+|||++....++.++||||||+++|||++ |+.||....... .+..... +. ....+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i~~----~~--~~~~~~~-- 225 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMISR----GF--RLYRPKL-- 225 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHC----CC--CCCCCCC--
Confidence 1112345678999999998899999999999999999999 999997654322 1111111 10 0011111
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 661 ~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
....+..++..||+.+|.+||++.++++.|
T Consensus 226 -----~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 -----ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -----CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 123466777889999999999999999877
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=330.73 Aligned_cols=255 Identities=21% Similarity=0.418 Sum_probs=207.6
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
.++|.+.+.||+|+||.||+|...++..||+|.+.......+.+.+|+.+++.++|+||+++++++...+..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 35788999999999999999998888899999988766667789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+|+|.+++..... ..+++..++.++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 85 KGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999875432 357899999999999999999999 89999999999999999999999999999876543221
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
......++..|+|||++..+.++.++|||||||++|+|++ |+.||....... ...+...... .+..
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~~~--------~~~~- 226 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQRGYR--------MPRM- 226 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHcCCC--------CCCC-
Confidence 1122346778999999998899999999999999999998 999997643322 1111111000 0100
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
. .....+..++..||+.+|++||++.+++++|+.
T Consensus 227 ~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 E----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred C----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1 112345667788999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.64 Aligned_cols=265 Identities=22% Similarity=0.287 Sum_probs=201.3
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
++|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+.+|+.++..++||||++++++|..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999875 6789999998753 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|++++.|..+.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99987766544321 358899999999999999999999 89999999999999999999999999999876443
Q ss_pred CCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhh-ccc--------ccCC
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA-KPI--------LSSG 648 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~-~~~--------~~~g 648 (770)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+... .+. ....
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred ccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 221 122357999999999999889999999999999999999999999875432221111110 000 0000
Q ss_pred ccccccCcccCCCCC------hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 KVTQLLDPALGNNYD------YDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ~l~~lld~~l~~~~~------~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.......+....... ......+..++..||+.||++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 010110011100000 0112346667778999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=348.51 Aligned_cols=247 Identities=28% Similarity=0.449 Sum_probs=206.6
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
.|.....||+|.||.||+|.. ..++.||+|++... ++..+++.+|+.+|.+++++||.++++.|..+..++++|||+
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 355667899999999999986 46889999999864 466788999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
.||++.+.|.... .+.+..+..|+.+++.||.|||. ++.+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 94 ~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred cCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999997543 34777778899999999999999 8999999999999999999999999999987766544
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
.. .+++|||.|||||+++...|+.|+||||||++.+||++|.+|+...+|.....++ ..-.-|.|.
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI------------pk~~PP~L~ 232 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI------------PKSAPPRLD 232 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec------------cCCCCCccc
Confidence 33 4589999999999999889999999999999999999999999988874322221 122223444
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+.+. ..+..++-.||.++|+.||++.++|++
T Consensus 233 ~~~S----~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 233 GDFS----PPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccC----HHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 3222 223344456999999999999999974
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=345.48 Aligned_cols=241 Identities=25% Similarity=0.357 Sum_probs=194.8
Q ss_pred eeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCC
Q 004174 428 NLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~gg 502 (770)
+.||+|+||.||++.. .+|+.||||+++.. ......+.+|+.++..++||||++++++|...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 47899999999753 234567888999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCce
Q 004174 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (770)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~ 582 (770)
+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~ 151 (323)
T cd05571 81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--T 151 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--c
Confidence 9999987543 58899999999999999999999 8999999999999999999999999999975432221 1
Q ss_pred ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCC
Q 004174 583 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 662 (770)
Q Consensus 583 ~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~ 662 (770)
.....||+.|+|||++....++.++|||||||++|||++|+.||...+.......+. .+. ..+....
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~-------~~~------~~~p~~~ 218 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-------MEE------IRFPRTL 218 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH-------cCC------CCCCCCC
Confidence 223579999999999999999999999999999999999999997644322111111 000 0111111
Q ss_pred ChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004174 663 DYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 694 (770)
Q Consensus 663 ~~~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~ 694 (770)
...+..++..||+.||.+|| ++.+++++
T Consensus 219 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 219 ----SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred ----CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 22344566789999999999 79998874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=354.45 Aligned_cols=258 Identities=24% Similarity=0.415 Sum_probs=201.7
Q ss_pred cCcccceeecccCceEEEEEEe------CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCce
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 492 (770)
++|.+.+.||+|+||.||+|.. .++..||||+++.. ......+.+|+.+++.+ +|+||++++++|...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 3678889999999999999873 23457999999753 34456788999999999 899999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCC-----------------------------------------------------------
Q 004174 493 LLVYDFLSRGSLEENLHGNKK----------------------------------------------------------- 513 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~----------------------------------------------------------- 513 (770)
++||||+++|+|.+++.....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999998854211
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceeccc
Q 004174 514 -------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586 (770)
Q Consensus 514 -------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 586 (770)
....+++..+++|+.||+.||.|||+ ++|+||||||+|||+++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 11247889999999999999999999 89999999999999999999999999999866543322222223
Q ss_pred ccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCChH
Q 004174 587 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 665 (770)
Q Consensus 587 ~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~ 665 (770)
.+++.|+|||++..+.++.++|||||||++|||++ |+.||............ ...+ ..+......
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~------~~~~-----~~~~~~~~~--- 340 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM------VKRG-----YQMSRPDFA--- 340 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH------HHcc-----cCccCCCCC---
Confidence 45678999999998999999999999999999997 99999765432211100 0000 000000111
Q ss_pred HHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 666 QMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 666 ~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
...+..++..||+.+|.+||++.+|+++|+.
T Consensus 341 -~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 341 -PPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred -CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 2345566678999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=346.48 Aligned_cols=244 Identities=26% Similarity=0.364 Sum_probs=199.8
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.++..++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56889999999999999999864 68899999997532 34567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999997543 57889999999999999999999 8999999999999999999999999999986644
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
.. ....||+.|+|||++....++.++|||||||++|||++|+.||....+......+ ..+.+
T Consensus 171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i-------~~~~~------ 232 (329)
T PTZ00263 171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI-------LAGRL------ 232 (329)
T ss_pred Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHH-------hcCCc------
Confidence 22 1257999999999999989999999999999999999999999765432211111 11110
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 694 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs-----~~eVL~~ 694 (770)
.+....+ ..+..++..||+.||.+||+ +.+++.+
T Consensus 233 ~~p~~~~----~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 KFPNWFD----GRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCCCC----HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0111111 23445667899999999997 6777765
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=329.72 Aligned_cols=256 Identities=25% Similarity=0.400 Sum_probs=207.5
Q ss_pred hhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
..++|.+.+.||+|+||.||+|...+++.||||.++......+++.+|+.+++.++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 34678899999999999999999878889999999876555678999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++++|.+++.... ...+++..+..++.+++.||.|||+ .+|+||||||+||+++.++.++|+|||+++.......
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999997543 2468999999999999999999999 8999999999999999999999999999987753322
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
.. .....++..|+|||++....++.++||||||+++|||++ |+.||........... ... ....
T Consensus 159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~---~~~---~~~~-------- 223 (261)
T cd05068 159 EA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ---VDQ---GYRM-------- 223 (261)
T ss_pred cc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH---HHc---CCCC--------
Confidence 11 111223457999999998899999999999999999999 9999976543211111 110 0000
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.........+..++.+|++.+|.+||++.++++.|+.
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0011123456667788999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=334.59 Aligned_cols=257 Identities=28% Similarity=0.478 Sum_probs=205.6
Q ss_pred cCcccceeecccCceEEEEEEeCC------CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~------g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
++|.+.+.||+|+||.||+|.... ...||+|.++.. ......|.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998532 257999998753 345567899999999999999999999999989999
Q ss_pred EEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC
Q 004174 494 LVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~ 561 (770)
++|||+++|+|.+++..... ....+++..++.++.|++.||.|||+ ++++||||||+|||+++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 99999999999999875421 11457889999999999999999999 8999999999999999999
Q ss_pred ceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHh
Q 004174 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 640 (770)
Q Consensus 562 ~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~ 640 (770)
.++|+|||+++...............+++.|+|||++..+.++.++|||||||++|||++ |..||...........+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~- 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR- 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 999999999986544332222233467889999999998999999999999999999998 999998755432221111
Q ss_pred hcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 641 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 641 ~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+.... .+......+..++..||+.+|.+||++.+|+++|+.
T Consensus 241 ------~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 241 ------SRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ------cCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111111 111223456667788999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.59 Aligned_cols=244 Identities=25% Similarity=0.305 Sum_probs=199.7
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999865 68999999987532 34566889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++|+|.+++...+ .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999997543 58899999999999999999999 8999999999999999999999999999986643
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
.. ....||+.|+|||++....++.++|||||||++|+|++|+.||...........+.. +..
T Consensus 154 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~-------~~~------ 215 (291)
T cd05612 154 RT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA-------GKL------ 215 (291)
T ss_pred Cc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCc------
Confidence 21 125799999999999988899999999999999999999999987543322111111 110
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 694 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs-----~~eVL~~ 694 (770)
.+.... ...+..++..||+.||.+||+ +.+++++
T Consensus 216 ~~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 EFPRHL----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCCccC----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 011111 123445667899999999995 8888865
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=352.46 Aligned_cols=246 Identities=29% Similarity=0.408 Sum_probs=203.9
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+. +...+.+.+|++|++.++|||||.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999864 6888999998754 3556778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+.| +|..+|...+ .++++.++.|+.+++.||.|||+ ++|+|||+||.||||+.++.+|+||||+|+.+...
T Consensus 82 ~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9977 9999997654 58999999999999999999999 89999999999999999999999999999988764
Q ss_pred CCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
.. ..+.+.|||.|||||.+..+.|+..+|+||+||+||||++|++||.... ...++. .+... |.
T Consensus 154 t~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---i~~Lv~---~I~~d--------~v 217 (808)
T KOG0597|consen 154 TS--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---ITQLVK---SILKD--------PV 217 (808)
T ss_pred ce--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---HHHHHH---HHhcC--------CC
Confidence 33 2345789999999999999999999999999999999999999997542 222221 11111 11
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. ++.........+.-..|.+||.+|-+-.+++.+
T Consensus 218 ~---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 K---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred C---CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 0 111222333444445789999999999988863
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=337.91 Aligned_cols=264 Identities=21% Similarity=0.325 Sum_probs=200.2
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
++|.+.+.||.|+||.||+|... +++.||+|+++... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56889999999999999999864 68899999987532 3345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++ +|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 975 9998886443 357889999999999999999999 899999999999999999999999999997654322
Q ss_pred CCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccc---------cCC
Q 004174 579 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL---------SSG 648 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~---------~~g 648 (770)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+....... ...
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred c--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 1 1223568999999998875 468999999999999999999999998765443322221111000 000
Q ss_pred ccccccCcccCCCC----ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 KVTQLLDPALGNNY----DYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ~l~~lld~~l~~~~----~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+...+.+...... ..........++..||+.||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11111111110000 00111234566678999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=331.48 Aligned_cols=254 Identities=19% Similarity=0.367 Sum_probs=202.2
Q ss_pred hcCcccceeecccCceEEEEEEeC----CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
.++|.+.+.||+|+||.||+|.++ .+..||+|+++.. ......|.+|+.++..++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356889999999999999999753 3568999999864 2445678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+|||++.++.++|+|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999987543 358899999999999999999999 89999999999999999999999999987654
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
...... ......++..|+|||++..+.++.++|||||||++|||++ |..||........ +... ..+..
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~~----~~~~~--- 226 (266)
T cd05064 158 KSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKAV----EDGFR--- 226 (266)
T ss_pred cccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHH----HCCCC---
Confidence 322111 1112345678999999999999999999999999999875 9999976543221 1111 11110
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
... +......+..++..||+.+|.+||++.+|++.|..
T Consensus 227 --~~~----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 --LPA----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred --CCC----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 001 11122345667778999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=340.83 Aligned_cols=201 Identities=26% Similarity=0.419 Sum_probs=176.9
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.++|.+.+.||+|+||.||++... +|..+|+|++... ....+.+.+|+++|..++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467999999999999999999865 6889999998753 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+++|+|.+++.... .+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999997543 478999999999999999999971 36999999999999999999999999999765432
Q ss_pred CCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 631 (770)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 158 ~~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~ 207 (331)
T cd06649 158 MA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA 207 (331)
T ss_pred cc----ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 21 235799999999999988999999999999999999999999975443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=346.00 Aligned_cols=254 Identities=23% Similarity=0.378 Sum_probs=197.4
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||+||++... +++.||||+++... .....+..|+.++..++||||+++++.+.+...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999864 68899999997532 34457788999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999997543 58899999999999999999999 8999999999999999999999999999975432
Q ss_pred CCCC---------------------------------ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCC
Q 004174 577 SSSH---------------------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 623 (770)
Q Consensus 577 ~~~~---------------------------------~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~ 623 (770)
.... ......+||+.|+|||++.+..++.++|||||||+||||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 0012357999999999999999999999999999999999999
Q ss_pred CCCCCCCccchhh-HHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 624 KPISNDHPKGQES-LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 624 ~Pf~~~~~~~~~~-lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.||....+..... +..|.... .+.+.. . ..+....++.. +.|...++..||++.+|+++
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~~~--------~~p~~~--~-~s~~~~~li~~-l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 234 PPFCSETPQETYKKVMNWKETL--------IFPPEV--P-ISEKAKDLILR-FCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCHHHHHHHHHcCcCcc--------cCCCcC--C-CCHHHHHHHHH-HcCChhhcCCCCCHHHHhCC
Confidence 9998765433221 11111110 011100 1 12333333332 23544556678999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=358.48 Aligned_cols=251 Identities=25% Similarity=0.358 Sum_probs=201.1
Q ss_pred cccceeecccCceEEEEEEeC-C-CCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 424 FLAENLIGKGGSSQVYKGCLP-D-GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~-~-g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
|.+.+.||+|+||.||+|... + +..||+|.+.... .....+.+|+.+|..++||||++++++|..++.+||||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 788899999999999999753 3 6778888775443 444567889999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+|+|.++|.........+++.++..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 999999886543333568899999999999999999999 89999999999999999999999999999876543332
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 660 (770)
......+||++|+|||++....++.++|||||||++|||++|+.||...........+.. +.... +
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~-------~~~~~-----~-- 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY-------GKYDP-----F-- 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCCCC-----C--
Confidence 223346799999999999999999999999999999999999999976443221111111 11110 0
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 661 ~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
+......+..++..||+.+|.+||++.+++.
T Consensus 292 --~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 --PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1111134555667899999999999999875
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=345.35 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=202.4
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||.||+|... +|+.||||+++... .....+..|++++..++||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999875 68999999997532 34567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999765 358899999999999999999999 8999999999999999999999999999986654
Q ss_pred CC---------------------------CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCC
Q 004174 577 SS---------------------------SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (770)
Q Consensus 577 ~~---------------------------~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~ 629 (770)
.. .........||+.|+|||++....++.++|||||||+||||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 33 001122357999999999999999999999999999999999999999876
Q ss_pred Cccchhh-HHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC-HHHHHHHh
Q 004174 630 HPKGQES-LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-MSLVLKLL 695 (770)
Q Consensus 630 ~~~~~~~-lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs-~~eVL~~L 695 (770)
....... +..|.... .+ +.. .. ....+..++..|++ +|.+||+ +.+++++.
T Consensus 234 ~~~~~~~~i~~~~~~~----~~-----p~~-~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 234 TLQETYNKIINWKESL----RF-----PPD-PP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred CHHHHHHHHhccCCcc----cC-----CCC-CC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 5332211 11111110 00 000 00 12234445556887 9999999 99999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=331.29 Aligned_cols=257 Identities=26% Similarity=0.457 Sum_probs=205.0
Q ss_pred hcCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 492 (770)
.++|.+.+.||+|+||.||+|... +++.||||+++... +..+.+.+|+++|..++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 346788899999999999999763 34789999997643 3567899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCc
Q 004174 493 LLVYDFLSRGSLEENLHGNKK----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 562 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~ 562 (770)
++||||+++++|.+++..... ....+++..+..++.|++.||.|||+ ++++||||||+|||++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 999999999999999975431 22457899999999999999999999 89999999999999999999
Q ss_pred eEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhh
Q 004174 563 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWA 641 (770)
Q Consensus 563 vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~ 641 (770)
++|+|||++................+++.|+|||++..+.++.++|||||||++|||++ |..||....... .+...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH
Confidence 99999999976543322111222356788999999999999999999999999999998 999997654322 22211
Q ss_pred cccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 642 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 642 ~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
. .+..... +......+..++..||+.+|.+||++.+|++.|.
T Consensus 238 ~----~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 T----QGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H----cCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 1111111 1112234556677899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=338.44 Aligned_cols=254 Identities=23% Similarity=0.410 Sum_probs=201.6
Q ss_pred cCcccceeecccCceEEEEEEeC-CCC----EEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~----~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
.+|...+.||+|+||.||+|.+. +|. .||||+++.. ....+++.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46889999999999999999853 333 4899998753 34567899999999999999999999999764 6789
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
|+||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999997543 358899999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
.............++..|+|||++....++.++|||||||++|||++ |+.||.+........... .+. .+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~--~~ 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE--RL 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-------CCC--CC
Confidence 65433332222345678999999999999999999999999999998 999997653322111111 110 00
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
..+ ......+..++..||+.+|.+||++.+++..|...
T Consensus 231 ~~~-------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 231 PQP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred CCC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000 11122455677789999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=341.24 Aligned_cols=241 Identities=26% Similarity=0.365 Sum_probs=195.0
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCC
Q 004174 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~gg 502 (770)
+.||+|+||.||++... +|+.||||+++.. ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999864 6899999999753 244567889999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCce
Q 004174 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (770)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~ 582 (770)
+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 151 (328)
T cd05593 81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--T 151 (328)
T ss_pred CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--c
Confidence 9999886543 58899999999999999999999 8999999999999999999999999999875432221 1
Q ss_pred ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCC
Q 004174 583 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 662 (770)
Q Consensus 583 ~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~ 662 (770)
.....||+.|+|||++....++.++|||||||++|||++|+.||...+.......+.. +. ..+...+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~-------~~------~~~p~~~ 218 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------ED------IKFPRTL 218 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc-------CC------ccCCCCC
Confidence 2235799999999999988999999999999999999999999976543222111110 00 0111111
Q ss_pred ChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004174 663 DYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 694 (770)
Q Consensus 663 ~~~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~ 694 (770)
...+..++..||+.+|.+|| ++.+++++
T Consensus 219 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 ----SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 22344556689999999997 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.32 Aligned_cols=258 Identities=21% Similarity=0.389 Sum_probs=203.1
Q ss_pred hhcCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 491 (770)
.+++|.+.+.||+|+||.||+|... .+..||||++.... ....++.+|+.+++.++||||+++++++..++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4677999999999999999998753 35679999986432 345678999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEE
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKD------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL 565 (770)
.++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998653221 2346788999999999999999999 89999999999999999999999
Q ss_pred ccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhccc
Q 004174 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPI 644 (770)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~ 644 (770)
+|||+++...............+++.|+|||++..+.++.++|||||||++|||++ |..||...........+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~----- 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM----- 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----
Confidence 99999976544322222122346788999999998899999999999999999999 788997654322111110
Q ss_pred ccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 645 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 645 ~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
.+..... +......+..++..||+.+|.+||++.++++.|+
T Consensus 236 --~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 --EGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred --cCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1111110 1111234566777899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=345.38 Aligned_cols=253 Identities=21% Similarity=0.337 Sum_probs=197.1
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.|...+.||+|+||+||+|.. .+++.||||+++.. ......+.+|++++..++||||++++++|.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999985 46889999999753 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+++|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999987543 47889999999999999999999 89999999999999999999999999997643110
Q ss_pred CC---------------------------------------------CceecccccccCCCCceeeccCCCCCcceEeec
Q 004174 578 SS---------------------------------------------HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAF 612 (770)
Q Consensus 578 ~~---------------------------------------------~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSl 612 (770)
.. .......+||+.|+|||++....++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 000123579999999999998899999999999
Q ss_pred hHHHHHHHhCCCCCCCCCccch-hhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 004174 613 GVVLLELLTGRKPISNDHPKGQ-ESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLV 691 (770)
Q Consensus 613 GvvL~eLltG~~Pf~~~~~~~~-~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eV 691 (770)
||++|||++|+.||....+... ..++.|..... + .+ ...+.. +...++.- +.|+..+|..||++.++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------~-~~--~~~~s~-~~~dli~~-ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENTLH-------I-PP--QVKLSP-EAVDLITK-LCCSAEERLGRNGADDI 302 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHccccccC-------C-CC--CCCCCH-HHHHHHHH-HccCcccccCCCCHHHH
Confidence 9999999999999987554322 12222211100 0 00 001122 22222222 24777888889999999
Q ss_pred HHH
Q 004174 692 LKL 694 (770)
Q Consensus 692 L~~ 694 (770)
+.+
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=338.70 Aligned_cols=239 Identities=26% Similarity=0.333 Sum_probs=191.4
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCh
Q 004174 430 IGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (770)
Q Consensus 430 LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL 504 (770)
||+|+||.||+|... +++.||+|+++.. ......+.+|+.++..++||||++++++|...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999864 6889999998742 34456788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceec
Q 004174 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (770)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~ 584 (770)
.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 151 (312)
T cd05585 81 FHHLQREG----RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTN 151 (312)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccc
Confidence 99997543 58899999999999999999999 8999999999999999999999999999975433222 123
Q ss_pred ccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCCh
Q 004174 585 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 664 (770)
Q Consensus 585 ~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~ 664 (770)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........... ... +. ..+....+
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~------~~~-~~------~~~~~~~~- 217 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK------ILQ-EP------LRFPDGFD- 217 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHH------HHc-CC------CCCCCcCC-
Confidence 35799999999999998999999999999999999999999976543221111 111 00 00111111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCC---HHHHHHH
Q 004174 665 DQMERMVLASILCIRRDPRARPQ---MSLVLKL 694 (770)
Q Consensus 665 ~~~~~l~~~a~~Cl~~dP~~RPs---~~eVL~~ 694 (770)
..+..++..||+.||.+||+ +.+++.+
T Consensus 218 ---~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 218 ---RDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred ---HHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 23445566799999999985 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=340.42 Aligned_cols=241 Identities=26% Similarity=0.373 Sum_probs=194.3
Q ss_pred eeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCC
Q 004174 428 NLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~gg 502 (770)
+.||+|+||.||++.. .+|+.||+|+++.. ......+.+|+.++..++||||++++++|...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999986 46899999999753 234566788999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCce
Q 004174 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (770)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~ 582 (770)
+|..++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 151 (323)
T cd05595 81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--T 151 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--c
Confidence 9998886543 58899999999999999999999 8999999999999999999999999999875432211 1
Q ss_pred ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCC
Q 004174 583 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 662 (770)
Q Consensus 583 ~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~ 662 (770)
.....||+.|+|||++.++.++.++|||||||++|||++|+.||...+.......+.. +. ..+...+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~-------~~------~~~p~~~ 218 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-------EE------IRFPRTL 218 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------CC------CCCCCCC
Confidence 2235799999999999999999999999999999999999999976543322111110 00 0011111
Q ss_pred ChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004174 663 DYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 694 (770)
Q Consensus 663 ~~~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~ 694 (770)
+ ..+..++..||+.+|.+|| ++.+++++
T Consensus 219 ~----~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 219 S----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred C----HHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1 2344555679999999998 88888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=333.21 Aligned_cols=263 Identities=22% Similarity=0.333 Sum_probs=194.7
Q ss_pred cCcccceeecccCceEEEEEEeC--CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhc---CCCceeEEeeEEee-----
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP--DGKELAVKILKPSE---DVIKEFVLEIEIITTL---HHKNIISLLGFCFE----- 488 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~--~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~----- 488 (770)
.+|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|+.++..+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999862 46889999986432 2334566788777766 69999999999853
Q ss_pred cCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccc
Q 004174 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (770)
Q Consensus 489 ~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 568 (770)
...+++||||+. ++|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 599998865432 358899999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC
Q 004174 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 648 (770)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 648 (770)
|+++...... ......||+.|+|||++....++.++|||||||++|||++|++||...........+..........
T Consensus 155 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 155 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred cceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 9998665432 1223578999999999998899999999999999999999999998765433222111110000000
Q ss_pred cccc---ccCcccCC--C-----CChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 649 KVTQ---LLDPALGN--N-----YDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 649 ~l~~---lld~~l~~--~-----~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
.+.. +....+.. . ...+....+..++..||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 00000000 0 00011233456677899999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.24 Aligned_cols=255 Identities=26% Similarity=0.448 Sum_probs=204.9
Q ss_pred hcCcccceeecccCceEEEEEEeC----CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
.++|.+.+.||+|+||.||+|.+. +...||||+++.. ......|..|+.++..++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 357889999999999999999864 2457999998754 3445678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 999999999999997543 368999999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
.............+++.|+|||++.+..++.++||||||+++|+|++ |..||....... +..... .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~----~~~---- 225 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAVE----DGY---- 225 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHHH----cCC----
Confidence 53222222222345678999999998899999999999999999998 999996543221 111111 000
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
..+ ........+..++..||+.+|++||++.+|+++|..
T Consensus 226 ~~~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 226 RLP-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred CCC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 000 011123446677788999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=343.42 Aligned_cols=245 Identities=23% Similarity=0.312 Sum_probs=199.3
Q ss_pred hcCcccceeecccCceEEEEEEeCC--CCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPD--GKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~--g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
.++|.+.+.||+|+||.||+|.... +..||+|++... ......+.+|+.++..++||||++++++|.+.+.+++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3468889999999999999997543 368999998643 2345678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 109 v~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999997543 58899999999999999999999 89999999999999999999999999999866
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
.... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...++......+. .+..
T Consensus 182 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~-------~~~~---- 245 (340)
T PTZ00426 182 DTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL-------EGII---- 245 (340)
T ss_pred CCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh-------cCCC----
Confidence 4321 23579999999999998889999999999999999999999998754422111111 1110
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 694 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~ 694 (770)
.+....+ ..+..++..||+.+|.+|+ ++.+++++
T Consensus 246 --~~p~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 --YFPKFLD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --CCCCCCC----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0111111 2234566789999999995 89998876
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=360.04 Aligned_cols=257 Identities=26% Similarity=0.376 Sum_probs=205.2
Q ss_pred HhhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC----
Q 004174 419 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN---- 490 (770)
Q Consensus 419 ~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~---- 490 (770)
...++|.+.+.||+|+||+||+|.. .+|+.||||++... ......+.+|+.++..++|+||++++..+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3456899999999999999999985 47899999998643 345667889999999999999999988775432
Q ss_pred ----ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEc
Q 004174 491 ----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (770)
Q Consensus 491 ----~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~ 566 (770)
.+++||||+++|+|.+++.........+++..+..++.|++.||.|||+ ++|+||||||+||||+.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEE
Confidence 3689999999999999997654444578999999999999999999999 899999999999999999999999
Q ss_pred cccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhccccc
Q 004174 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 646 (770)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~ 646 (770)
|||+++...............||+.|+|||++....++.++|||||||+||||++|+.||........... ..
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~------~~- 258 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK------TL- 258 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH------Hh-
Confidence 99999876543332223346799999999999999999999999999999999999999976543221111 01
Q ss_pred CCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 647 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 647 ~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+.. ++ + +......+..++..||+.+|.+||++.+++++
T Consensus 259 ~~~~----~~-~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGRY----DP-L----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCCC----CC-C----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111 11 1 11112345566678999999999999999864
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=325.87 Aligned_cols=254 Identities=24% Similarity=0.417 Sum_probs=204.8
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
.+|.+.+.||+|+||.||+|... .++.+|+|++.........+.+|++++..++||||++++++|..++.+++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 45888899999999999999864 58899999998766667789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+++|.+++..... ..+++..++.++.|++.||.|||+ ++++||||||+|||+++++.+||+|||++.........
T Consensus 86 ~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 86 YGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999865432 358999999999999999999999 89999999999999999999999999999876543221
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
. .....++..|+|||++.+..++.++|||||||++|||++ |..||...........+ . .+ ..+..
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~---~----~~-----~~~~~- 226 (263)
T cd05052 161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---E----KG-----YRMER- 226 (263)
T ss_pred c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---H----CC-----CCCCC-
Confidence 1 111234678999999998999999999999999999998 99999765432211111 1 00 00111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+......+..++..||+.+|.+||++.++++.|..
T Consensus 227 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 227 ---PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred ---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 11112345556678999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=341.02 Aligned_cols=252 Identities=21% Similarity=0.258 Sum_probs=198.9
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||.||++... +|+.||||+++... ...+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999864 78999999997532 34567888999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999997652 358999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCceecccccccCCCCceeec------cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFM------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~------~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 650 (770)
.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...........+. .....
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~------~~~~~ 227 (330)
T cd05601 155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM------NFQRF 227 (330)
T ss_pred CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHH------cCCCc
Confidence 3322 222357999999999987 4568899999999999999999999997654322211111 00000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 651 ~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+. .. ......+..++..|++ +|.+||++.+++++
T Consensus 228 ~~~~-----~~--~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 228 LKFP-----ED--PKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred cCCC-----CC--CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0000 00 0111223344456887 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.57 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=197.4
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||.||+|... +|+.||||+++.. ......+.+|+.++..++||||++++++|.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999864 6899999999753 234566788999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999987543 58999999999999999999999 8999999999999999999999999999875432
Q ss_pred CCCCc------------------------------------eecccccccCCCCceeeccCCCCCcceEeechHHHHHHH
Q 004174 577 SSSHI------------------------------------TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 620 (770)
Q Consensus 577 ~~~~~------------------------------------~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLl 620 (770)
..... .....+||+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 21100 001246999999999999999999999999999999999
Q ss_pred hCCCCCCCCCccchh-hHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC---HHHHHHH
Q 004174 621 TGRKPISNDHPKGQE-SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ---MSLVLKL 694 (770)
Q Consensus 621 tG~~Pf~~~~~~~~~-~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs---~~eVL~~ 694 (770)
+|+.||....+.... .+..|.... .+.. .....+.... ++..|+. +|.+|++ +.+++++
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~~~~~-------~~~~----~~~~s~~~~~---li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINWKETL-------QFPD----EVPLSPEAKD---LIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCcc-------CCCC----CCCCCHHHHH---HHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999999876543221 111221110 0000 0011222333 3344665 9999998 8888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.43 Aligned_cols=257 Identities=26% Similarity=0.439 Sum_probs=202.6
Q ss_pred cCcccceeecccCceEEEEEEe-----CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
++|++.+.||+|+||.||+|.. .++..+++|.++.. ......+.+|+++++.++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999974 35678999999753 2445678899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC
Q 004174 495 VYDFLSRGSLEENLHGNKK-------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~ 561 (770)
||||+++++|.+++..... ....+++..+..++.+++.||.|||+ ++|+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 9999999999999853321 12357889999999999999999999 8999999999999999999
Q ss_pred ceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHh
Q 004174 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 640 (770)
Q Consensus 562 ~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~ 640 (770)
.+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++ |..||....+......+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~- 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR- 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 999999999986644322222223456778999999998899999999999999999999 999997654322111111
Q ss_pred hcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 641 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 641 ~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+.... ... .....+..++..||+.+|.+||++.+|+++|.+
T Consensus 241 ------~~~~~~-----~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 ------KRQLLP-----CSE----DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ------cCCcCC-----CCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111000 111 112345556678999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=340.78 Aligned_cols=263 Identities=23% Similarity=0.355 Sum_probs=195.7
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC-----ceE
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----NLL 493 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-----~~~ 493 (770)
+|.+.+.||+|+||.||+|... +|+.||||+++.. ......+.+|+.+++.++||||+++++++...+ .+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788999999999999999864 6899999998742 234457889999999999999999999886432 479
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+||||+. ++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 68998886543 58999999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCC-CceecccccccCCCCceeecc--CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcc-------
Q 004174 574 ASTSSS-HITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP------- 643 (770)
Q Consensus 574 ~~~~~~-~~~~~~~~GT~~YlAPE~~~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~------- 643 (770)
...... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||...........+.....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 533221 122234579999999999875 6789999999999999999999999976543222111100000
Q ss_pred -cccCCccccccCc---c----cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 644 -ILSSGKVTQLLDP---A----LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 644 -~~~~g~l~~lld~---~----l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+........+.. . +...++ .....+..++..||+.+|.+||++.+++++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFP-NADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcC-CCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000000 0 000000 011234566778999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=337.11 Aligned_cols=241 Identities=27% Similarity=0.387 Sum_probs=193.2
Q ss_pred eeecccCceEEEEEEe----CCCCEEEEEEeCCCh-----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 428 NLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~----~~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+.||+|+||.||++.. .+++.||||+++... .....+.+|+++|+.++||||++++++|..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 357899999997532 2345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++|+|.+++.... .+.+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999987543 47888899999999999999999 899999999999999999999999999987543322
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
.. .....||+.|+|||++....++.++|||||||+||||++|+.||...+.......+. .+.. .+
T Consensus 155 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~-------~~~~------~~ 219 (323)
T cd05584 155 TV--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL-------KGKL------NL 219 (323)
T ss_pred Cc--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCC------CC
Confidence 21 223579999999999998889999999999999999999999997654322111111 1110 01
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 694 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~ 694 (770)
... ....+..++..||+.+|.+|| ++.+++++
T Consensus 220 ~~~----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 PPY----LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCC----CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 111 122345566789999999999 78888774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=342.05 Aligned_cols=258 Identities=24% Similarity=0.428 Sum_probs=201.9
Q ss_pred cCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec-Cc
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED-NN 491 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~-~~ 491 (770)
++|.+.+.||+|+||.||+|... +++.||+|+++.. ....+.+..|+.++..+ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46888999999999999999632 3578999998753 24456788999999999 899999999988654 56
Q ss_pred eEEEEeecCCCChhhhhccCCCC---------------------------------------------------------
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKD--------------------------------------------------------- 514 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~--------------------------------------------------------- 514 (770)
++++|||+++++|.+++......
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 88999999999999988643210
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceecccccccCCCC
Q 004174 515 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594 (770)
Q Consensus 515 ~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlA 594 (770)
...++|..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++..+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 1268999999999999999999999 8999999999999999999999999999987654333222233456788999
Q ss_pred ceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHH
Q 004174 595 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLA 673 (770)
Q Consensus 595 PE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~ 673 (770)
||++.+..++.++|||||||+||||++ |..||........ +.. .+..+.... . +......+..+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~----~~~~~~~~~-----~----~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCR----RLKEGTRMR-----A----PEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHH----HHhccCCCC-----C----CccCCHHHHHH
Confidence 999999999999999999999999998 9999976433221 111 111111000 0 11122346677
Q ss_pred HHhhcccCCCCCCCHHHHHHHhhC
Q 004174 674 SILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 674 a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+..||+.+|++||++.+|+++|..
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHH
Confidence 788999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.87 Aligned_cols=250 Identities=24% Similarity=0.407 Sum_probs=201.8
Q ss_pred CcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCC
Q 004174 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~gg 502 (770)
+|.+.+.||+|+||.||+|..+++..+|+|++.........+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 57788999999999999998877778999998765544567889999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCce
Q 004174 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (770)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~ 582 (770)
+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 85 ~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~- 157 (256)
T cd05059 85 CLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS- 157 (256)
T ss_pred CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc-
Confidence 9999987543 258999999999999999999999 889999999999999999999999999997654322211
Q ss_pred ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCC
Q 004174 583 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661 (770)
Q Consensus 583 ~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 661 (770)
.....++..|+|||++....++.++||||||+++|||++ |+.||........... .. .+ .....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---~~----~~-----~~~~~--- 222 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES---VS----AG-----YRLYR--- 222 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH---HH----cC-----CcCCC---
Confidence 111234567999999998999999999999999999999 8999976543221111 11 00 00001
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 662 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 662 ~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
+......+..++..||+.+|++||++.++++.|
T Consensus 223 -~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 -PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111233566777889999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=324.78 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=202.8
Q ss_pred cCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
++|.+.+.||+|+||.||+|...++..+|||.++........|.+|+.++..++||||++++++|...+..++||||+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 45788899999999999999887777899999886555557899999999999999999999999998899999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
|+|.+++.... ..+++..++.++.||+.||.|||+ .+++|+||||+|||++.++.+||+|||+++........
T Consensus 84 ~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 84 GCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 99999987543 258999999999999999999999 89999999999999999999999999999765433211
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 660 (770)
......++..|+|||++..+.++.++|||||||++|+|++ |..||...........+. .+.... .
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~~~-----~-- 222 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-------QGLRLY-----R-- 222 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-------cCCCCC-----C--
Confidence 1112345678999999998899999999999999999999 999997544321111111 110000 0
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 661 ~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
.......+..++..||+.+|.+||++.++++.|+
T Consensus 223 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 --PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0111245566777899999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=333.07 Aligned_cols=201 Identities=24% Similarity=0.428 Sum_probs=172.1
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.++|.+.+.||+|+||.||+|... +++.||||+++... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 568999999999999999999875 68899999987533 233467889999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+. ++|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 58888776433 357889999999999999999999 89999999999999999999999999999754332
Q ss_pred CCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCC
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 630 (770)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 157 SH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred Cc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 21 1223568999999999875 458899999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=328.98 Aligned_cols=258 Identities=26% Similarity=0.480 Sum_probs=205.3
Q ss_pred hcCcccceeecccCceEEEEEEe------CCCCEEEEEEeCCC-hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
..+|.+.+.||+|+||.||++.. .++..+|+|.+... ....+.+.+|++++..++||||++++++|...+.++
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 45788999999999999999974 23456899998754 345678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceE
Q 004174 494 LVYDFLSRGSLEENLHGNK---------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~---------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vk 564 (770)
+||||+++++|.+++.... .....+++..++.++.|++.||.|||+ ++++||||||+|||++.++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 9999999999999987443 122358999999999999999999999 8999999999999999999999
Q ss_pred EccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcc
Q 004174 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKP 643 (770)
Q Consensus 565 L~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~ 643 (770)
|+|||+++...............+++.|+|||++....++.++|||||||++|+|++ |..||........ ...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---~~~--- 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IEC--- 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH---
Confidence 999999986644332222223456788999999998899999999999999999998 9999976543221 111
Q ss_pred cccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 644 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 644 ~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+..+.... .....+ ..+..++..||+.+|.+||++.+|++.|+.
T Consensus 235 -i~~~~~~~-----~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~ 278 (288)
T cd05093 235 -ITQGRVLQ-----RPRTCP----KEVYDLMLGCWQREPHMRLNIKEIHSLLQN 278 (288)
T ss_pred -HHcCCcCC-----CCCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 11111111 111112 345667788999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=328.76 Aligned_cols=259 Identities=26% Similarity=0.412 Sum_probs=205.4
Q ss_pred hhcCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecC
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 490 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 490 (770)
..++|.+.+.||+|+||.||++... ....+|+|++... ......+.+|++++..+ +|+||++++++|..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 4457888999999999999999853 2367999998753 34456788999999999 7999999999999999
Q ss_pred ceEEEEeecCCCChhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC
Q 004174 491 NLLLVYDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 558 (770)
.++++|||+++|+|.+++.... .....+++..++.++.|++.||.|||+ ++|+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 9999999999999999986532 223468999999999999999999998 8999999999999999
Q ss_pred CCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhH
Q 004174 559 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 637 (770)
Q Consensus 559 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l 637 (770)
.++.+||+|||+++...............++..|+|||++....++.++|||||||++|||++ |..||...........
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 999999999999987654332222222345678999999998899999999999999999998 9999976543221111
Q ss_pred HHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 638 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 638 v~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.. .+. ....+......+..++..||+.+|.+|||+.++++.|..
T Consensus 247 ~~-------~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 247 LK-------EGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred HH-------cCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 10 110 001112223456667788999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=348.61 Aligned_cols=259 Identities=23% Similarity=0.397 Sum_probs=203.5
Q ss_pred hcCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCc
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNN 491 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~ 491 (770)
.++|.+.+.||+|+||.||+|... .+..||||+++... ...+.+.+|+.+|..+. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 457888999999999999999752 23479999997532 34567999999999996 9999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCC----------------------------------------------------------
Q 004174 492 LLLVYDFLSRGSLEENLHGNKK---------------------------------------------------------- 513 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~---------------------------------------------------------- 513 (770)
.+|||||+++|+|.++|+....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998864321
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC
Q 004174 514 ----------------------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 559 (770)
Q Consensus 514 ----------------------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~ 559 (770)
....+++..+..++.||+.||.|||+ .+|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 01247888999999999999999999 89999999999999999
Q ss_pred CCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHH
Q 004174 560 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLV 638 (770)
Q Consensus 560 ~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv 638 (770)
++.+||+|||+++...............+++.|+|||++....++.++|||||||++|||++ |..||........ +.
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--FY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--HH
Confidence 99999999999986644333222233457788999999998899999999999999999997 9999976432211 11
Q ss_pred HhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 639 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 639 ~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.. +..+. .... +......+..++..||+.+|++||++.+|.++|..
T Consensus 351 ~~----~~~~~-----~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 351 NK----IKSGY-----RMAK----PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred HH----HhcCC-----CCCC----CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 10 11110 0000 11122345667788999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=337.28 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=196.1
Q ss_pred CcccceeecccCceEEEEEEe----CCCCEEEEEEeCCC-----hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCce
Q 004174 423 NFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPS-----EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNL 492 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~----~~g~~vAVK~l~~~-----~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~ 492 (770)
+|.+.+.||+|+||.||++.. .+++.||+|+++.. ....+.+..|+.++..++ ||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999875 36889999998742 233456788999999994 99999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999986543 58899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 573 WASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
......... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||...........+. .....
T Consensus 154 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~~----- 225 (332)
T cd05614 154 EFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--RRILK----- 225 (332)
T ss_pred cccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--HHHhc-----
Confidence 654332221 1235799999999999865 47889999999999999999999997543322111111 00000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 694 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~ 694 (770)
.++.+....+ ..+..++..||+.||.+|| ++.+++++
T Consensus 226 --~~~~~~~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 --CDPPFPSFIG----PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --CCCCCCCCCC----HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1111111111 2334455679999999999 67788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=315.76 Aligned_cols=249 Identities=26% Similarity=0.378 Sum_probs=205.8
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.+.||+|.||.||.|+. +++-.||+|++.++. ....++.+|++|-+.|+||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 35688999999999999999986 467789999998654 3456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
+||..+|+|+..|..... ..|++.....++.|+|.||.|+|. ++||||||||+|+|++..+.+||+|||.+...+
T Consensus 101 lEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999985443 358888888999999999999999 889999999999999999999999999997665
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
... ..+.+||..|++||+..+..++..+|+|++|++.||++.|.+||......+...-+.- .++.+
T Consensus 176 ~~k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k----------~~~~~ 241 (281)
T KOG0580|consen 176 SNK----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK----------VDLKF 241 (281)
T ss_pred CCC----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH----------ccccC
Confidence 322 2347899999999999999999999999999999999999999987653222111111 11222
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
| ..-......++..|+..+|.+|....+|+.+-
T Consensus 242 p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 242 P-------STISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred C-------cccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 2 11122344566789999999999999998753
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=323.60 Aligned_cols=247 Identities=26% Similarity=0.409 Sum_probs=196.1
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCh
Q 004174 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL 504 (770)
+.||+|+||.||+|... +++.+|+|.+... .+....+.+|+++++.++||||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999864 7899999987643 35567899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceec
Q 004174 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (770)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~ 584 (770)
.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.............
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99986543 358899999999999999999999 899999999999999999999999999987654322111111
Q ss_pred ccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCC
Q 004174 585 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 663 (770)
Q Consensus 585 ~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~ 663 (770)
...++..|+|||++..+.++.++|||||||++|||++ |..||...........+.. +. .. ..+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-------~~-----~~----~~~ 218 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-------GV-----RL----PCP 218 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-------CC-----CC----CCc
Confidence 1233567999999999999999999999999999998 9999975443221111110 00 00 011
Q ss_pred hHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 664 YDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 664 ~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
......+..++..||+.+|.+||++.+|++.|+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111234566777899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.24 Aligned_cols=254 Identities=26% Similarity=0.423 Sum_probs=207.6
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChh-HHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~-~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
..+|.+.+.||.|+||.||+|...+++.+++|++..... ....+..|+.+++.++||||+++++++...+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 456888999999999999999988899999999986553 5678899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++++|.+++..... ..+++..++.++.+|+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 85 EKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999976432 458999999999999999999999 8899999999999999999999999999976644322
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
.. ....++..|+|||++..+.++.++||||||+++|+|++ |+.||....... ...+... +. ..
T Consensus 160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~----~~-----~~-- 223 (261)
T cd05148 160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQITA----GY-----RM-- 223 (261)
T ss_pred cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHHh----CC-----cC--
Confidence 11 12346778999999998899999999999999999998 899997654321 1111110 00 00
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.........+..++..||+.+|.+||++.++++.|+.
T Consensus 224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 --PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0111222456677788999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=330.82 Aligned_cols=262 Identities=24% Similarity=0.297 Sum_probs=201.6
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC-----ceEEEE
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----NLLLVY 496 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-----~~~LV~ 496 (770)
.|...+++|.|.||.||+|... +++.||||....+... -.+|+.+|+.+.|||||+|+-+|.... .+.|||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 3666799999999999999864 5789999988765432 236999999999999999999987532 356899
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC-CceEEcccccccccc
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWAS 575 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~-~~vkL~DFGla~~~~ 575 (770)
|||+. +|.+.++........++...+.-+..||++||.|||+ .+|+||||||.|||+|.+ |.+||||||.|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99987 9999998654444567888888999999999999999 999999999999999976 899999999999887
Q ss_pred CCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC------
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG------ 648 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g------ 648 (770)
....... ...|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+++...|..++.-........
T Consensus 178 ~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 178 KGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred cCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 7666544 4679999999988754 69999999999999999999999999987766655443221111110
Q ss_pred -ccccccCcccCCC-----CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 -KVTQLLDPALGNN-----YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 -~l~~lld~~l~~~-----~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+..+...|.+... +........+.+...+|+.+|.+|.++.+++.+
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1111111111111 111122344556678999999999999999864
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=342.89 Aligned_cols=203 Identities=27% Similarity=0.374 Sum_probs=174.7
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||.||++.. .+|+.||||++... ....+.+.+|++++..++||||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4788999999999999999985 47899999998653 234567888999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++|+|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999987543 57889999999999999999999 8999999999999999999999999999963321
Q ss_pred CCCC---------------------------------------------ceecccccccCCCCceeeccCCCCCcceEee
Q 004174 577 SSSH---------------------------------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYA 611 (770)
Q Consensus 577 ~~~~---------------------------------------------~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwS 611 (770)
.... ......+||+.|+|||++....++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 0001246999999999999889999999999
Q ss_pred chHHHHHHHhCCCCCCCCCc
Q 004174 612 FGVVLLELLTGRKPISNDHP 631 (770)
Q Consensus 612 lGvvL~eLltG~~Pf~~~~~ 631 (770)
|||+||||++|+.||....+
T Consensus 234 lGvil~elltG~~Pf~~~~~ 253 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENS 253 (377)
T ss_pred cchhhhhhhcCCCCCCCCCH
Confidence 99999999999999977554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=346.55 Aligned_cols=246 Identities=23% Similarity=0.314 Sum_probs=203.4
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
.-|.+.+.||+|+.|.|-+|.+ .+|+.+|||++.+. ......+.+||-||+.+.|||++++++++....++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3477889999999999999986 58999999999764 234456788999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||++||.|+++|...+ ++++.++.+++.||+.|+.|+|. .+|+||||||+|+|||..+++||+|||+|-.-..
T Consensus 92 Eyv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999998765 58899999999999999999999 8999999999999999999999999999976554
Q ss_pred CCCCceecccccccCCCCceeeccCCCC-CcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
+..- .+-||.|.|.|||++++.+|+ .++||||.||+||.||||+.||++++.......+. .|.+.-
T Consensus 165 gklL---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~-------~G~f~M--- 231 (786)
T KOG0588|consen 165 GKLL---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQ-------RGVFEM--- 231 (786)
T ss_pred Cccc---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHH-------cCcccC---
Confidence 4332 236999999999999999986 68999999999999999999999765443322222 121110
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. .+-..+.+. ++..|+..||..|-|+.+|+++
T Consensus 232 ---P-s~Is~eaQd---LLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 232 ---P-SNISSEAQD---LLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ---C-CcCCHHHHH---HHHHHhccCccccccHHHHhhC
Confidence 0 111223333 3346899999999999999985
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.16 Aligned_cols=249 Identities=35% Similarity=0.562 Sum_probs=192.7
Q ss_pred cceeecccCceEEEEEEeC-----CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 426 AENLIGKGGSSQVYKGCLP-----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 426 ~~~~LG~G~fG~Vy~a~~~-----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+.+.||.|.||.||+|.+. .+..|+||+++.. ....+.|.+|++.+.+++||||++++|+|...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999875 3568999999753 34578999999999999999999999999988889999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++|+|.++|..... ..+++..+..|+.||+.||.|||+ ++++|+||+++|||++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNK--EPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHTCT--TTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccccc--cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999987622 468999999999999999999999 889999999999999999999999999998763332
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
.........+...|+|||.+....++.++||||||+++|||++ |+.||...........+. .+....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~-------~~~~~~----- 225 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLK-------QGQRLP----- 225 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHH-------TTEETT-----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccce-----
Confidence 2222223457788999999999999999999999999999999 789987653322111111 111100
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
.+......+..++..||..+|.+||++.++++.|
T Consensus 226 ----~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ----IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0111123455667789999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=322.09 Aligned_cols=252 Identities=26% Similarity=0.437 Sum_probs=202.4
Q ss_pred cCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
++|.+.+.||+|+||.||+|..+++..+|+|.++........+.+|+.+++.++|+|++++++++. .+..+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 467888999999999999999888889999999875555567999999999999999999999885 4568999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
++|.+++..... ..+++..++.++.+++.||.|||+ ++|+||||||+||++++++.++|+|||++..........
T Consensus 85 ~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 85 GSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999975432 358899999999999999999999 889999999999999999999999999998664432211
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 660 (770)
.....++..|+|||++....++.++||||||+++|+|++ |..||....... ...+.... .. .
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~---~~------~---- 222 (260)
T cd05070 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQVERG---YR------M---- 222 (260)
T ss_pred -ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcC---CC------C----
Confidence 112345678999999988899999999999999999999 899997654322 11111100 00 0
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 661 ~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
..+.+....+..++..|+..+|.+|||+.++++.|+
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 258 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 011122234666778899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=342.92 Aligned_cols=202 Identities=24% Similarity=0.351 Sum_probs=174.3
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.|...+.||+|+||.||+|.. .+++.||||++.... .....+.+|++++..++||||++++++|.+++.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999986 468899999997532 345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999987543 47888999999999999999999 89999999999999999999999999997532100
Q ss_pred C---------------------------------------------CCceecccccccCCCCceeeccCCCCCcceEeec
Q 004174 578 S---------------------------------------------SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAF 612 (770)
Q Consensus 578 ~---------------------------------------------~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSl 612 (770)
. ........+||+.|+|||++....++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0000122579999999999998899999999999
Q ss_pred hHHHHHHHhCCCCCCCCCc
Q 004174 613 GVVLLELLTGRKPISNDHP 631 (770)
Q Consensus 613 GvvL~eLltG~~Pf~~~~~ 631 (770)
||+||||++|+.||...++
T Consensus 235 Gvil~elltG~~Pf~~~~~ 253 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTP 253 (382)
T ss_pred hHHHHHHHhCCCCCCCCCH
Confidence 9999999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=327.30 Aligned_cols=265 Identities=26% Similarity=0.384 Sum_probs=201.1
Q ss_pred cccceeecccCceEEEEEEe-----CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeec--CceEE
Q 004174 424 FLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLL 494 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~L 494 (770)
|...+.||+|+||+||++.. .++..||+|+++... .....|.+|+++|+.++||||++++++|... ..+++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988652 367899999997543 3567788999999999999999999998764 35899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||+++++|.+++... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999998643 48999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCce-ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 575 STSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 575 ~~~~~~~~-~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
........ .....++..|+|||++..+.++.++||||||+++|||++|..||....... .....+.........+.++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhh
Confidence 54322111 111345667999999998899999999999999999999999986543211 1111111111111111222
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
++.......+......+..++..||+.+|.+||++.+|++.|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~ 280 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 22211111122233456667788999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=328.24 Aligned_cols=258 Identities=24% Similarity=0.452 Sum_probs=205.8
Q ss_pred cCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
.+|.+.+.||+|+||.||+|... ++..+++|.++... ...+.+.+|+++++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45888899999999999999742 35678999987544 345678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCc
Q 004174 495 VYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 562 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~ 562 (770)
||||+++++|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 9999999999999965431 12358999999999999999999999 89999999999999999999
Q ss_pred eEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhh
Q 004174 563 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWA 641 (770)
Q Consensus 563 vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~ 641 (770)
++|+|||++................+++.|+|||++....++.++|||||||++|||+| |+.||....... .+..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIEC- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-
Confidence 99999999976544332222233457889999999998999999999999999999999 999997654422 1111
Q ss_pred cccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 642 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 642 ~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
+..+..... .......+..++.+||+.+|.+||++.+|+++|...
T Consensus 238 ---~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 238 ---ITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred ---HhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111111111 011123456677789999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=324.21 Aligned_cols=257 Identities=20% Similarity=0.381 Sum_probs=205.1
Q ss_pred hcCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 492 (770)
.++|.+.+.||+|+||.||+|... .+..||+|.+.... .....+.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 457889999999999999999864 24689999987543 4456788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKD------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~ 566 (770)
++||||+++|+|.+++...... ...++|..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence 9999999999999998754321 1347899999999999999999998 899999999999999999999999
Q ss_pred cccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccc
Q 004174 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPIL 645 (770)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~ 645 (770)
|||+++...............+|..|+|||++..+.++.++|||||||++|||++ |..||........ ..+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~~~--- 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LKFVI--- 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HHHHh---
Confidence 9999976544332222223457889999999998899999999999999999998 9999976543222 11111
Q ss_pred cCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 646 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 646 ~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
.+.... + +......+..++..||+.+|.+|||+.++++.|+
T Consensus 236 -~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 -DGGHLD-----L----PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -cCCCCC-----C----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111111 1 1111345666778899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=329.44 Aligned_cols=256 Identities=25% Similarity=0.420 Sum_probs=202.3
Q ss_pred CcccceeecccCceEEEEEEeC------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
+|.+.+.||+|+||.||+|... ....+++|.+.... .....+.+|+.++..++||||++++++|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999752 23578999887543 345678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCC
Q 004174 495 VYDFLSRGSLEENLHGNKK--------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 554 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~N 554 (770)
+|||+.+|+|.+++..... ....+++..++.++.|++.||.|||+ ++|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 9999999999998864321 12357899999999999999999998 899999999999
Q ss_pred eeeCCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccc
Q 004174 555 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKG 633 (770)
Q Consensus 555 ILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~ 633 (770)
||+++++.+||+|||+++...............++..|+|||++....++.++||||||+++|||++ |..||....+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999976544332222222356778999999988889999999999999999999 999997654322
Q ss_pred hhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 634 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 634 ~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+..+..... .. ..+......+..++..||+.+|.+||++.++++.|+.
T Consensus 238 ---~~~~~~~~~---------~~----~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 238 ---LFNLLKTGY---------RM----ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred ---HHHHHhCCC---------CC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 211111100 00 0111122356667788999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=321.20 Aligned_cols=254 Identities=22% Similarity=0.401 Sum_probs=205.0
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
.++|.+.+.||+|+||.||+|..++++.||+|.+.........+.+|+.+++.++|+||+++++++. .+..+++|||+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 4568889999999999999999888999999999876655678999999999999999999999874 467899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+++|.+++..... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 84 NGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999865432 468899999999999999999998 89999999999999999999999999999776532221
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
......++..|+|||++..+.++.++||||||+++|||++ |+.||........ ..... .+. .....
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~----~~~-----~~~~~ 225 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQNLE----RGY-----RMPRP 225 (260)
T ss_pred -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHH----cCC-----CCCCC
Confidence 1122346778999999998899999999999999999999 9999976543221 11111 000 00011
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
. .....+..++..||+.+|++||++.+++.+|+.
T Consensus 226 ~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 D----NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred C----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1 112346667778999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=323.80 Aligned_cols=254 Identities=25% Similarity=0.429 Sum_probs=204.3
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
.++|.+.+.||+|+||.||+|...++..||+|+++......+.+.+|+.++..++||||+++++++.+ ...++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 35688999999999999999988777789999998655555688999999999999999999998754 56899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+|+|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 84 KGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999975422 357899999999999999999999 89999999999999999999999999999766543221
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
. .....++..|+|||++..+.++.++|||||||++|||++ |..||...........+. .+. ...
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-------~~~-----~~~-- 223 (262)
T cd05071 159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGY-----RMP-- 223 (262)
T ss_pred c-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-------cCC-----CCC--
Confidence 1 122346778999999998899999999999999999999 888997654332211111 000 000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
...+....+..++..|++.+|.+||++.+++++|+.
T Consensus 224 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 224 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred --CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 011223456677888999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=339.98 Aligned_cols=245 Identities=24% Similarity=0.399 Sum_probs=190.4
Q ss_pred cccceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
|...+.||+|+||.||+|... +|+.||||++... ......+.+|+++++.++|+||++++++|..++.+++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 455678999999999999864 6899999998653 3456788999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+|+|.... .+.+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 156 ~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 156 GGSLEGTH--------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCcccccc--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 99986532 24567788899999999999999 8999999999999999999999999999986643321
Q ss_pred ceecccccccCCCCceeecc-----CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 581 ITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
......||..|+|||++.. ...+.++|||||||++|||++|+.||..........+...... +. .
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----~~-----~ 293 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM----SQ-----P 293 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc----cC-----C
Confidence 1223579999999998853 2245689999999999999999999974332222221111000 00 0
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+.. .......+..++..||+.+|.+||++.+++++
T Consensus 294 ~~~----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 PEA----PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCC----CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001 11122345566678999999999999999974
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=337.59 Aligned_cols=242 Identities=24% Similarity=0.360 Sum_probs=194.2
Q ss_pred eeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCC
Q 004174 428 NLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~gg 502 (770)
+.||+|+||.||++.. .+|+.||+|+++.. ......+..|++++..++||||++++++|...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 47899999999753 234567788999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCce
Q 004174 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (770)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~ 582 (770)
+|.+++.... .+++..+..++.||+.||.|||+ .++|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-- 152 (325)
T cd05594 81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-- 152 (325)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--
Confidence 9999886543 58899999999999999999995 158999999999999999999999999998754322221
Q ss_pred ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCC
Q 004174 583 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 662 (770)
Q Consensus 583 ~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~ 662 (770)
.....||+.|+|||++.++.++.++|||||||+||||++|+.||...........+.... ..+...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~-------------~~~p~~~ 219 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-------------IRFPRTL 219 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC-------------CCCCCCC
Confidence 223579999999999998999999999999999999999999997654332222211100 0011111
Q ss_pred ChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004174 663 DYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 694 (770)
Q Consensus 663 ~~~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~ 694 (770)
+ ..+..++..||+.||.+|+ ++.+++++
T Consensus 220 ~----~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 220 S----PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred C----HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 2 2344556679999999996 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=335.01 Aligned_cols=240 Identities=23% Similarity=0.336 Sum_probs=192.0
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCC-ceeEEeeEEeecCceEEEE
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHK-NIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~Hp-nIv~l~~~~~~~~~~~LV~ 496 (770)
+|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+..|++++..+.|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5788999999999999999864 5789999999753 24456788899999999765 6888999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999986543 47899999999999999999999 8999999999999999999999999999875322
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. ... .
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~-------~~~------~ 218 (324)
T cd05587 154 GGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM-------EHN------V 218 (324)
T ss_pred CCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-------cCC------C
Confidence 211 1223579999999999999999999999999999999999999997654322211111 000 0
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQM 688 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~ 688 (770)
.+.... ...+..++..||+.+|.+||+.
T Consensus 219 ~~~~~~----~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 SYPKSL----SKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCC----CHHHHHHHHHHhhcCHHHcCCC
Confidence 111111 2234556678999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=336.83 Aligned_cols=201 Identities=25% Similarity=0.429 Sum_probs=176.2
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.++|.+.+.||+|+||.||++... ++..+|+|++... ......+.+|++++..++||||++++++|.+++.+++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999875 6888999988753 3455679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+++|+|.+++.... .+++..+..++.+++.||.|||+. .+|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999997543 478899999999999999999971 46999999999999999999999999999765432
Q ss_pred CCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 631 (770)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 158 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 158 MA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred cc----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence 21 235789999999999988899999999999999999999999976543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=341.45 Aligned_cols=208 Identities=25% Similarity=0.336 Sum_probs=178.4
Q ss_pred HHHHHhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec
Q 004174 415 QDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489 (770)
Q Consensus 415 ~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 489 (770)
..+....++|.+.+.||+|+||.||++... +++.+|+|++... ......+.+|+.+++.++||||+++++++..+
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 344455678999999999999999999864 6889999998642 23345678899999999999999999999999
Q ss_pred CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccc
Q 004174 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (770)
Q Consensus 490 ~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 569 (770)
+.+++||||+++|+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG 187 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFG 187 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecc
Confidence 9999999999999999998643 37888999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCceeeccC----CCCCcceEeechHHHHHHHhCCCCCCCCCc
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYG----KVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 631 (770)
++........ .......||+.|+|||++... .++.++|||||||+||||++|+.||...+.
T Consensus 188 ~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~ 252 (370)
T cd05621 188 TCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252 (370)
T ss_pred cceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH
Confidence 9987643222 222346799999999998754 378899999999999999999999987654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.25 Aligned_cols=264 Identities=22% Similarity=0.254 Sum_probs=206.0
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEee--cCceEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLV 495 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~LV 495 (770)
++|...+.|++|.||.||+|.++ +++.||+|.++.+. ..--.-++||.+|.+++|||||.+..+..- -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45778899999999999999864 68899999998654 223356799999999999999999888754 3569999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
||||+. +|..++...+ ++|...++..+..|+++||.|||. +.|+||||||+|+|+++.|.+||+|||+|+.++
T Consensus 156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999987 9999998765 479999999999999999999999 889999999999999999999999999999888
Q ss_pred CCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
.... .++..+-|+.|.|||.+.+. .|++.+|+||+||++.||+++++-|.+.....+...+........+..+..+.
T Consensus 229 sp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 SPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred CCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 7643 34557889999999998855 59999999999999999999999999887666655443222111111111111
Q ss_pred C--------------cccCCCCChH-HHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 655 D--------------PALGNNYDYD-QMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 655 d--------------~~l~~~~~~~-~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. ..+...+... ..+.-..+....|..||.+|-|+.+.|++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 1 1111111111 11233344455788999999999999975
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=329.40 Aligned_cols=246 Identities=24% Similarity=0.379 Sum_probs=206.8
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
+|.+.+.||+|.||.|-+|.. ..|+.||||.++++ +...-.+.+||+||+.|+||||+.++.+|+..+.++||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 566778899999999999985 68999999999864 3556678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|..+|.|++++.+.+ .|++.+.+.++.||..|+.|+|+ ++++|||||.+|||||.++++||+||||+.++...
T Consensus 134 YaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 134 YASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred ecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999998765 58999999999999999999999 89999999999999999999999999999888665
Q ss_pred CCCceecccccccCCCCceeeccCCCC-CcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
... .++||+|-|.+||++.+..|. +.+|-|||||+||.|+.|..||++.+.+ .++.. +..|...+ |
T Consensus 207 kfL---qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lvrQ----Is~GaYrE---P 273 (668)
T KOG0611|consen 207 KFL---QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLVRQ----ISRGAYRE---P 273 (668)
T ss_pred cHH---HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHHHH----hhcccccC---C
Confidence 432 348999999999999988875 7899999999999999999999875432 22221 22232211 1
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
+......-++.+||..+|++|.|+.+|..+..
T Consensus 274 --------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 274 --------ETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred --------CCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 11122334557899999999999999998764
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=343.64 Aligned_cols=203 Identities=26% Similarity=0.353 Sum_probs=174.7
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||.||++... +++.||||++.... .....+.+|+++|..++||||+++++.|.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999864 68999999997532 23466889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|.....
T Consensus 81 E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 9999999999997543 57888899999999999999999 8999999999999999999999999999753210
Q ss_pred CC-----------------------------------------CCceecccccccCCCCceeeccCCCCCcceEeechHH
Q 004174 577 SS-----------------------------------------SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVV 615 (770)
Q Consensus 577 ~~-----------------------------------------~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvv 615 (770)
.. .........||+.|+|||++....++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 0000113579999999999999899999999999999
Q ss_pred HHHHHhCCCCCCCCCc
Q 004174 616 LLELLTGRKPISNDHP 631 (770)
Q Consensus 616 L~eLltG~~Pf~~~~~ 631 (770)
||||++|+.||....+
T Consensus 234 lyell~G~~Pf~~~~~ 249 (376)
T cd05598 234 LYEMLVGQPPFLADTP 249 (376)
T ss_pred eeehhhCCCCCCCCCH
Confidence 9999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=321.39 Aligned_cols=259 Identities=28% Similarity=0.422 Sum_probs=206.5
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCC----ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~----~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||.||+|... +++.||||.++. .......+.+|+++++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999864 789999998754 2344567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++|+|.+++.........+++..+..++.|++.||.|||+ ++++|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999886443333467889999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
.... .....|++.|+|||++.+..++.++|+||||+++|||++|+.||....... ..+..... .+. .+
T Consensus 159 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~----~~~-----~~ 226 (267)
T cd08228 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKIE----QCD-----YP 226 (267)
T ss_pred hhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHHh----cCC-----CC
Confidence 3221 123468899999999998889999999999999999999999996543211 11111111 101 01
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
.+. .......+..++..||+.+|.+||++.+|++.|+..
T Consensus 227 ~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 PLP---TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCC---hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 110 112224456667789999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=334.01 Aligned_cols=240 Identities=24% Similarity=0.332 Sum_probs=192.4
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEE
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
+|.+.+.||+|+||.||+|... +++.||||+++... .....+..|..++..+ +|++|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788999999999999999865 57899999987532 3345677788888877 5899999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++|+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999986543 48899999999999999999999 8999999999999999999999999999975432
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
... ......||+.|+|||++..+.++.++|||||||++|||++|+.||...+.......+. .+..
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~-------~~~~------ 218 (323)
T cd05616 154 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM-------EHNV------ 218 (323)
T ss_pred CCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCC------
Confidence 221 1233679999999999999999999999999999999999999998754432211111 0110
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQM 688 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~ 688 (770)
.+ +......+..++..||+.+|.+|++.
T Consensus 219 ~~----p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 AY----PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CC----CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 01 11112344556678999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=343.36 Aligned_cols=256 Identities=23% Similarity=0.267 Sum_probs=200.1
Q ss_pred HHhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004174 418 LSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 418 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 492 (770)
....++|.+.+.||+|+||.||++... +++.||+|++.... .....+.+|+.+++.++||||+++++++.+++.+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 345678999999999999999999864 68899999996432 3345578899999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
++||||+++|+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEecccee
Confidence 9999999999999998643 36788888999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCceecccccccCCCCceeeccC----CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC
Q 004174 573 WASTSSSHITCTDVAGTFGYLAPEYFMYG----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 648 (770)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~YlAPE~~~~~----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 648 (770)
....... .......||+.|+|||++... .++.++|||||||+||||++|+.||...+.......+.....
T Consensus 191 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~----- 264 (370)
T cd05596 191 KMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN----- 264 (370)
T ss_pred eccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC-----
Confidence 6643322 122335799999999998643 478999999999999999999999987654322111110000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCC--CCCHHHHHHHh
Q 004174 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA--RPQMSLVLKLL 695 (770)
Q Consensus 649 ~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~--RPs~~eVL~~L 695 (770)
. + .+.... .....+..++..||+.+|.+ ||++.+++++-
T Consensus 265 ~---~---~~~~~~--~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 265 S---L---TFPDDI--EISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred c---C---CCCCcC--CCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 0 0 000100 11123344556799989987 99999998863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=325.39 Aligned_cols=258 Identities=25% Similarity=0.423 Sum_probs=202.3
Q ss_pred hhcCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 491 (770)
.+++|.+.+.||+|+||.||+|... .+..|++|.+... ......|.+|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3567899999999999999999864 3567899988643 3345678999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC---ceEE
Q 004174 492 LLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQL 565 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~---~vkL 565 (770)
.++||||+++++|.+++..... ....++|..++.++.||+.||.|||+ ++++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999875432 22358999999999999999999999 8899999999999998654 5999
Q ss_pred ccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhccc
Q 004174 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPI 644 (770)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~ 644 (770)
+|||+++...............+++.|+|||++..+.++.++|||||||++|||++ |+.||...........+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~----- 235 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT----- 235 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----
Confidence 99999986643222111112234568999999998999999999999999999997 999997654432211111
Q ss_pred ccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 645 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 645 ~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
..... ..+......+..++..||+.+|++||++.+|+++|.
T Consensus 236 -~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 -GGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -cCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11110 011111234556677899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=334.89 Aligned_cols=244 Identities=23% Similarity=0.357 Sum_probs=192.8
Q ss_pred cccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHH---HhcCCCceeEEeeEEeecCceEEE
Q 004174 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEII---TTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL---~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+..|++++ ..++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567899999999999999864 68999999997532 3345666776665 466799999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++|+|...+.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988754 258999999999999999999999 899999999999999999999999999987543
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... .
T Consensus 153 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-------~------ 217 (324)
T cd05589 153 GFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND-------E------ 217 (324)
T ss_pred CCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------C------
Confidence 2221 122367999999999999889999999999999999999999999765432221111110 0
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 694 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~ 694 (770)
....... ...+..++..||+.||.+|| ++.+++++
T Consensus 218 ~~~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 VRYPRFL----SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCCCCC----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 0011111 23345566789999999999 56676664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=327.44 Aligned_cols=256 Identities=24% Similarity=0.387 Sum_probs=201.9
Q ss_pred cCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
.+|.+.+.||+|+||.||+|... +++.||||+++... .....+.+|+.++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34677889999999999999853 35789999997543 34567889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC
Q 004174 494 LVYDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~ 561 (770)
+++||+.+++|.+++.... .....+++..+..++.|++.||.|||+ ++|+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence 9999999999999985321 112357889999999999999999999 8999999999999999999
Q ss_pred ceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHh
Q 004174 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 640 (770)
Q Consensus 562 ~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~ 640 (770)
.+||+|||+++...............+++.|+|||++..+.++.++|||||||++|||++ |..||...........+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~- 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR- 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 999999999886544332222233456789999999998899999999999999999998 888987654322111111
Q ss_pred hcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 641 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 641 ~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
.+.... .+.+....+..++..||+.+|.+||++.+|+..|+
T Consensus 241 ------~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 241 ------NRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred ------cCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 111110 11122234556777899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=326.96 Aligned_cols=251 Identities=24% Similarity=0.309 Sum_probs=199.9
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
+|...++||+|+||.||++.. .+++.||||++.... .....+.+|+.+++.++||||++++++|..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477889999999999999986 468999999987532 223457889999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999988865332 358999999999999999999999 89999999999999999999999999999865433
Q ss_pred CCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
.. .....||+.|+|||++....++.++|||||||++|||++|+.||...........+. . .+..+.
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~--~-~~~~~~-------- 221 (285)
T cd05605 156 ET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE--R-RVKEDQ-------- 221 (285)
T ss_pred Cc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH--H-Hhhhcc--------
Confidence 22 123478999999999998899999999999999999999999998654322111111 0 000000
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 694 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~ 694 (770)
..+.......+..++..||+.||.+|| ++.+++++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 --EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 011111223455667789999999999 88888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=351.90 Aligned_cols=265 Identities=20% Similarity=0.274 Sum_probs=194.4
Q ss_pred hhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeec--------C
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED--------N 490 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--------~ 490 (770)
...+|.+.+.||+|+||.||+|.. .+++.||||++..... ...+|+.+|+.++||||++++++|... .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 346799999999999999999986 4688999998865432 234699999999999999999987532 2
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC-ceEEcccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFG 569 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-~vkL~DFG 569 (770)
.+++||||+++ +|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+||||+.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46799999975 7877765433333568999999999999999999999 8999999999999998664 69999999
Q ss_pred ccccccCCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhccccc--
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS-- 646 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~-- 646 (770)
+++........ ....||+.|+|||++.+. .|+.++|||||||+||||++|++||.+.........+........
T Consensus 217 la~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99876543222 235789999999998754 699999999999999999999999987654332211111100000
Q ss_pred -----CCcc-----ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 647 -----SGKV-----TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 647 -----~g~l-----~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.... .......+...++......+..++..||+.+|.+|||+.+++++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000 00000001111111122345667778999999999999999864
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=325.91 Aligned_cols=264 Identities=24% Similarity=0.385 Sum_probs=205.4
Q ss_pred hcCcccceeecccCceEEEEEEeCC-----------------CCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPD-----------------GKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIIS 481 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~-----------------g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~ 481 (770)
..+|.+.+.||+|+||.||+|...+ +..||+|++.... ...+.+.+|++++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999987532 2468999987543 45678999999999999999999
Q ss_pred EeeEEeecCceEEEEeecCCCChhhhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCC
Q 004174 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 554 (770)
Q Consensus 482 l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~-------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~N 554 (770)
++++|..++..+++|||+++++|.+++..... ....+++..++.++.|++.||.|||+ ++|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 99999999999999999999999999876541 11258999999999999999999999 899999999999
Q ss_pred eeeCCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh--CCCCCCCCCcc
Q 004174 555 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKPISNDHPK 632 (770)
Q Consensus 555 ILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt--G~~Pf~~~~~~ 632 (770)
||++.++.++|+|||++................+++.|+|||++..+.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999976544332222233456789999999998899999999999999999998 77888654321
Q ss_pred chhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 633 GQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 633 ~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
....+............... .+......+..++..||+.+|.+||++.+|++.|+
T Consensus 241 ---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 ---QVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---HHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11222211111111111010 11111245677788899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=345.40 Aligned_cols=253 Identities=30% Similarity=0.464 Sum_probs=201.6
Q ss_pred cCcccceeecccCceEEEEEEeCC--C--CE-EEEEEeCC----ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPD--G--KE-LAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~--g--~~-vAVK~l~~----~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 492 (770)
++-.+.+.||+|+||.||+|.+.. + .. ||||..+. .....++|++|.+++++++|||||+++|++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344456899999999999998642 2 23 89999984 356788999999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
++|||+|.||+|.++|+..+. .++..++..++.+.|.||+|||+ +++|||||-.+|+|++.++.+||+|||+++
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 999999999999999987653 58999999999999999999999 899999999999999999999999999987
Q ss_pred cccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 573 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
.......... ...-...|+|||.+..+.|+.++|||||||++||+++ |..||.+.........+. ..+...
T Consensus 311 ~~~~~~~~~~--~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~------~~~~r~ 382 (474)
T KOG0194|consen 311 AGSQYVMKKF--LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV------KNGYRM 382 (474)
T ss_pred CCcceeeccc--cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH------hcCccC
Confidence 6542111110 1124568999999999999999999999999999999 899998765543222210 111101
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
. .+......+..+...||..+|++||+|.++.+.|+.
T Consensus 383 ~---------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~ 419 (474)
T KOG0194|consen 383 P---------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEA 419 (474)
T ss_pred C---------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHH
Confidence 1 111222333444457999999999999999998864
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=341.01 Aligned_cols=250 Identities=25% Similarity=0.350 Sum_probs=208.8
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc-eEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~-~~LV~ 496 (770)
++|...+.||+|+||.++....+ +++.|++|.+... ........+|+.++++++|||||.+.+.|.+++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56888999999999999998754 6789999998743 3455578899999999999999999999999988 99999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
+|++||+|.+.|.+.+ ...|+++.+..++.|++.|+.|||+ +.|+|||||+.|||++.++.+||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998765 3579999999999999999999998 8899999999999999999999999999999887
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
.... ...++||+.|+.||++.+.+|+.|+|||||||++|||++-+++|...+.......+. + ..++|
T Consensus 159 ~~~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~---~--------~~~~P 225 (426)
T KOG0589|consen 159 EDSL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN---R--------GLYSP 225 (426)
T ss_pred chhh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh---h--------ccCCC
Confidence 6522 234789999999999999999999999999999999999999998765433222111 1 11122
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. +......+..++..|++.+|..||++.++|.+
T Consensus 226 l-----p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 L-----PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred C-----CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1 22223334445567999999999999999975
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=326.96 Aligned_cols=247 Identities=26% Similarity=0.347 Sum_probs=194.3
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCh
Q 004174 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (770)
Q Consensus 430 LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL 504 (770)
||+|+||+||++... +|+.||||++.... ...+.+..|+++++.++||||+++.++|...+.+++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 78899999987532 2345678899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceec
Q 004174 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (770)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~ 584 (770)
.+.+.........+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++......... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 98876443333568999999999999999999999 89999999999999999999999999999766443222 22
Q ss_pred ccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCCh
Q 004174 585 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 664 (770)
Q Consensus 585 ~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~ 664 (770)
...||+.|+|||++.++.++.++|||||||++|||++|+.||............ ...... ... .++.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~---------~~~--~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQRILN---------DSV--TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH--HHhhcc---------cCC--CCcc
Confidence 357999999999999999999999999999999999999999765432111110 000110 000 0111
Q ss_pred HHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004174 665 DQMERMVLASILCIRRDPRARP-----QMSLVLKL 694 (770)
Q Consensus 665 ~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~ 694 (770)
.....+..++..||+.+|.+|| ++.+++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 1223345566779999999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=335.02 Aligned_cols=248 Identities=21% Similarity=0.331 Sum_probs=192.4
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004174 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
++||+|+||.||++... +++.||||+++.. ....+.+..|+.++..+ +||||++++++|...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999864 6889999999753 23455688899999988 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
|+|.+++...+ .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-- 151 (329)
T cd05588 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-- 151 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--
Confidence 99998886543 58999999999999999999999 8999999999999999999999999999875322111
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccc--hhhHHHhhcccccCCccccccCcccC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG--QESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~--~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+....+..+.+ .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p 225 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIP 225 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCC
Confidence 1223679999999999999999999999999999999999999996432111 00111111111111110 111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCC------HHHHHHH
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQ------MSLVLKL 694 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs------~~eVL~~ 694 (770)
... ...+..++..||+.+|.+||+ +.+++++
T Consensus 226 ~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 226 RSL----SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCC----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 111 223455667899999999997 6777754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=321.81 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=199.8
Q ss_pred cccceeecccCceEEEEEEeCC----CCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc-----
Q 004174 424 FLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----- 491 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~~----g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~----- 491 (770)
|.+.+.||+|+||.||+|.... +..||||+++.. ......+.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998642 367999998753 2445688999999999999999999999876554
Q ss_pred -eEEEEeecCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccc
Q 004174 492 -LLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (770)
Q Consensus 492 -~~LV~E~~~ggsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 568 (770)
.+++|||+++|+|..++.... .....+++..+..++.|++.||.|||+ ++|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 799999999999999885432 223468999999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccC
Q 004174 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSS 647 (770)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~ 647 (770)
|+++...............++..|+|||++....++.++|||||||++|||++ |..||...... .+..+.. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~~----~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYLR----H 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----c
Confidence 99987654332222222345678999999988889999999999999999999 89999764432 1222111 1
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 648 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 648 g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+.... . +......+..++..||+.+|.+||++.+|++.|+.
T Consensus 231 ~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 231 GNRLK-----Q----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CCCCC-----C----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11000 1 11223356666778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=324.73 Aligned_cols=253 Identities=23% Similarity=0.424 Sum_probs=199.7
Q ss_pred cCcccceeecccCceEEEEEEeC-CCC----EEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~----~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
.+|.+.+.||+|+||.||+|... ++. .+++|.+... .....++..|+.++..+.||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 45778899999999999999863 444 4778887543 234567888999999999999999999985 456789
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
++||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++++||||||+|||++.++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 999999999999997543 358999999999999999999999 88999999999999999999999999999876
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
.............++..|+|||++..+.++.++|||||||++|||++ |+.||....+.....++ ..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-------~~~~~~-- 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-------EKGERL-- 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HCCCcC--
Confidence 54333333334567889999999998999999999999999999998 99999776543322221 111110
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
..+.. . ...+..++..||..+|.+||++.++++.|..
T Consensus 231 ~~~~~---~----~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 231 AQPQI---C----TIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred CCCCC---C----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 11111 1 1234556678999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.44 Aligned_cols=253 Identities=25% Similarity=0.441 Sum_probs=202.7
Q ss_pred cCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
++|.+...||+|+||.||+|...++..+|+|.+.......+.+.+|+.+++.++|||++++++++. .+..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 458888999999999999999877778999998866555677899999999999999999999885 4678999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
++|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 85 GSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 999999975432 357899999999999999999999 88999999999999999999999999999766433211
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 660 (770)
......++..|+|||++..+.++.++|||||||++|||++ |+.||........ ..+..... . +.
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~~~---~------~~--- 223 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQVERGY---R------MP--- 223 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCC---C------CC---
Confidence 1112346778999999998899999999999999999999 9999976543221 11111100 0 00
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 661 ~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+......+..++..||+.+|.+||++.+|++.|+.
T Consensus 224 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 -CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011122345566678999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=333.60 Aligned_cols=241 Identities=24% Similarity=0.349 Sum_probs=192.8
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004174 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
+.||+|+||.||+|... +++.||||+++.. ......+..|.+++..+ +||||++++++|...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999864 5789999999753 23456678899998876 799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
|+|...+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-- 151 (321)
T cd05591 81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-- 151 (321)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--
Confidence 99999886543 58899999999999999999999 8999999999999999999999999999875433222
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 661 (770)
......||+.|+|||++....++.++|||||||++|||++|+.||...+.......+. . +. . .....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~------~-~~---~---~~p~~ 218 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL------H-DD---V---LYPVW 218 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH------c-CC---C---CCCCC
Confidence 1233579999999999998899999999999999999999999998765322211111 0 00 0 00011
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCC-------CHHHHHHH
Q 004174 662 YDYDQMERMVLASILCIRRDPRARP-------QMSLVLKL 694 (770)
Q Consensus 662 ~~~~~~~~l~~~a~~Cl~~dP~~RP-------s~~eVL~~ 694 (770)
.+ ..+..++..||+.+|.+|| ++.+++++
T Consensus 219 ~~----~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 LS----KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CC----HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11 2344556679999999999 78888865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=317.98 Aligned_cols=258 Identities=28% Similarity=0.422 Sum_probs=207.6
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||.||+|... +|+.||+|.++.. ....+.+.+|+++++.++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999876 7899999988642 234678899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++|+|.+++.........+++..+..++.+++.||.|||+ .+|+||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999987544434568999999999999999999999 8999999999999999999999999999976644
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
.... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||......... +.. . +..+......
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~---~-~~~~~~~~~~-- 229 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCK---K-IEKCDYPPLP-- 229 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHH-HHh---h-hhcCCCCCCC--
Confidence 3221 12246899999999999888999999999999999999999999654321111 111 0 1111111110
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.......+..++..||..+|.+||++.+|+++|+.
T Consensus 230 ------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~ 264 (267)
T cd08224 230 ------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE 264 (267)
T ss_pred ------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence 11222345566778999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.86 Aligned_cols=255 Identities=23% Similarity=0.373 Sum_probs=197.3
Q ss_pred cccceeecccCceEEEEEEeCC-CC--EEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec------Cc
Q 004174 424 FLAENLIGKGGSSQVYKGCLPD-GK--ELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NN 491 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~~-g~--~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~~ 491 (770)
|.+.+.||+|+||.||+|...+ +. .+|+|.++.. ....+.+..|+.+++.++||||++++++|... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999998754 32 5899988753 45567889999999999999999999987542 24
Q ss_pred eEEEEeecCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 569 (770)
.+++|||+++|+|.+++.... .....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 789999999999998874322 223458999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCC
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSG 648 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g 648 (770)
+++...............+++.|+|||++....++.++|||||||++|||++ |+.||....... +... +..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~----~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYDY----LRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHcC
Confidence 9987654322111122346778999999998899999999999999999999 899997643321 1111 1111
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 649 ~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.... ........+..++..||+.+|++||++.++++.|..
T Consensus 231 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1100 011122345667778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.33 Aligned_cols=256 Identities=26% Similarity=0.445 Sum_probs=207.2
Q ss_pred hhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
..++|.+.+.||+|+||.||+|..++++.+|||.+.......+++.+|+.+++.++|+||+++++++......++||||+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 34679999999999999999999888889999999876666678999999999999999999999999889999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++++|.+++..... ..+++..+..++.+++.||.|||+ ++++|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 84 SKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred CCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999976432 358999999999999999999999 8899999999999999999999999999986653211
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
. ......++..|+|||.+.+..++.++|||||||++|+|++ |+.||........ ......... ...
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~~~~~~---------~~~ 225 (261)
T cd05034 159 T-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LEQVERGYR---------MPR 225 (261)
T ss_pred h-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCC---------CCC
Confidence 1 1112234678999999998889999999999999999999 9999976543221 111110000 000
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+......+..++..||+.+|.+||++.++++.|+.
T Consensus 226 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 ----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01112345667778999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=334.01 Aligned_cols=248 Identities=20% Similarity=0.328 Sum_probs=191.2
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004174 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
+.||+|+||.||+|... +++.||+|+++.. ......+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 6789999999753 23455678899888876 799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-- 151 (329)
T cd05618 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-- 151 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--
Confidence 99998886543 58899999999999999999999 8999999999999999999999999999975432221
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccc--hhhHHHhhcccccCCccccccCcccC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG--QESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~--~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+....+..+.. .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~-- 223 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------R-- 223 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------C--
Confidence 1223679999999999999999999999999999999999999996321111 00001111111111110 0
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCC------HHHHHHH
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQ------MSLVLKL 694 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs------~~eVL~~ 694 (770)
++......+..++..||+.||.+||+ +.+++++
T Consensus 224 --~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 224 --IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred --CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 11112233455667899999999998 4676654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=327.59 Aligned_cols=262 Identities=23% Similarity=0.382 Sum_probs=200.8
Q ss_pred cCcccceeecccCceEEEEEEeCC---------------CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEee
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPD---------------GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLG 484 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~---------------g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 484 (770)
++|.+.+.||+|+||.||++.... ...||||+++.. ......|.+|++++..++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578889999999999999987532 235899998753 345567999999999999999999999
Q ss_pred EEeecCceEEEEeecCCCChhhhhccCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCee
Q 004174 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKK--------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556 (770)
Q Consensus 485 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~--------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NIL 556 (770)
+|...+..++||||+++++|.+++..... ....+++..++.++.+++.||.|||+ ++++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 99999999999999999999999864321 11247889999999999999999999 89999999999999
Q ss_pred eCCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh--CCCCCCCCCccch
Q 004174 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKPISNDHPKGQ 634 (770)
Q Consensus 557 L~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt--G~~Pf~~~~~~~~ 634 (770)
++.++.+||+|||++................++..|+|||++..+.++.++|||||||++|+|++ |..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999976543322222222345778999999998999999999999999999998 6678865433221
Q ss_pred hhHHHhhcccccC-CccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 635 ESLVMWAKPILSS-GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 635 ~~lv~~~~~~~~~-g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
+......... +....... +......+..++..||+.+|.+||++.+|++.|+
T Consensus 242 ---~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 ---IENTGEFFRNQGRQIYLSQ-------TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ---HHHHHHhhhhccccccCCC-------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111110 00000000 1111235777788899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=324.46 Aligned_cols=270 Identities=26% Similarity=0.349 Sum_probs=199.3
Q ss_pred cCcccceeecccCceEEEEEEe-----CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEee--cCceE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLL 493 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~ 493 (770)
.+|.+.+.||+|+||.||++.. .++..||||.+.... ...+.+.+|++++..++||||+++++++.. ...++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688899999999999999974 357899999987543 456788999999999999999999998754 34689
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999997543 358999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCcee-cccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 574 ASTSSSHITC-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 574 ~~~~~~~~~~-~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
.......... ....++..|+|||++..+.++.++|||||||++|||++|..|+......-...+-...........+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 6543322111 112334569999999988999999999999999999999877643211000000000000000000000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+...............+..++..||..+|++|||+.+|++.|..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 111000001112223456677788999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=335.53 Aligned_cols=237 Identities=26% Similarity=0.370 Sum_probs=190.1
Q ss_pred eeecccCceEEEEEEe----CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 428 NLIGKGGSSQVYKGCL----PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~----~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
+.||+|+||.||++.. .+|+.||+|+++... .....+.+|+++|.+++||||++++++|..++.+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 368899999997532 234567789999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 99999998654 258999999999999999999999 89999999999999999999999999999865443221
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 660 (770)
.....||+.|+|||++....++.++|||||||++|||++|+.||...........+. .+.. .+..
T Consensus 155 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~-------~~~~------~~p~ 219 (318)
T cd05582 155 --AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL-------KAKL------GMPQ 219 (318)
T ss_pred --eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH-------cCCC------CCCC
Confidence 223679999999999998889999999999999999999999997654322111110 0000 0111
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHH
Q 004174 661 NYDYDQMERMVLASILCIRRDPRARPQMSL 690 (770)
Q Consensus 661 ~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~e 690 (770)
.. ...+..++..||+.||.+||++.+
T Consensus 220 ~~----~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FL----SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CC----CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11 123445567799999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=333.66 Aligned_cols=241 Identities=25% Similarity=0.379 Sum_probs=191.7
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004174 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
+.||+|+||.||+|... +++.||||+++.. ......+..|+.++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 6889999998753 23456778899998876 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-- 151 (320)
T cd05590 81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-- 151 (320)
T ss_pred chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--
Confidence 99999887543 58899999999999999999999 8999999999999999999999999999875432211
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 661 (770)
......||+.|+|||++....++.++|||||||++|||++|+.||...........+. .+.. .+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~-------~~~~------~~~~~ 218 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL-------NDEV------VYPTW 218 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh-------cCCC------CCCCC
Confidence 1223579999999999998899999999999999999999999997654322211111 1110 00111
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCH------HHHHHH
Q 004174 662 YDYDQMERMVLASILCIRRDPRARPQM------SLVLKL 694 (770)
Q Consensus 662 ~~~~~~~~l~~~a~~Cl~~dP~~RPs~------~eVL~~ 694 (770)
. ...+..++..||+.||.+||++ .+++++
T Consensus 219 ~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 219 L----SQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred C----CHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 1 1234455677999999999998 566543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.99 Aligned_cols=259 Identities=23% Similarity=0.408 Sum_probs=206.5
Q ss_pred hhcCcccceeecccCceEEEEEEeCC-----CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEee-cCc
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLPD-----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNN 491 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~~-----g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~ 491 (770)
..++|.+.+.||+|+||.||+|...+ +..|++|+++.. ....+.+.+|+.+++.++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45688999999999999999998755 688999998753 3456778999999999999999999998876 467
Q ss_pred eEEEEeecCCCChhhhhccCCCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKD----PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 567 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~D 567 (770)
.+++++|+++|+|.+++...... ...+++..++.++.+++.||.|||+ ++++||||||+|||++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998754322 1468999999999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhccccc
Q 004174 568 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILS 646 (770)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~ 646 (770)
||+++.+.............++..|+|||++....++.++|||||||++|||++ |+.||....+.. +..+.....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~- 236 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLKDGY- 236 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHHcCC-
Confidence 999986644333222223456778999999998889999999999999999999 999997654322 222211100
Q ss_pred CCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 647 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 647 ~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+. .... ....+..++..||+.+|++||++.++++.|..
T Consensus 237 --~~~------~~~~----~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 275 (280)
T cd05043 237 --RLA------QPIN----CPDELFAVMACCWALDPEERPSFSQLVQCLTD 275 (280)
T ss_pred --CCC------CCCc----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 000 0011 12345667778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=364.86 Aligned_cols=257 Identities=26% Similarity=0.463 Sum_probs=209.2
Q ss_pred cCcccceeecccCceEEEEEEeC--CCC----EEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP--DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~--~g~----~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
.+-...+.||+|+||.||.|... +|. .||||.++.. .....+|++|..+|+.++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 34566789999999999999853 343 4899999864 577889999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 570 (770)
+++|||+||+|..+|++.+. .+..++....+.++.+||+|+.||++ +++|||||..+|+||+....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999987632 24568899999999999999999999 8899999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCc
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGK 649 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 649 (770)
|+-+...........-.-...|||||.++.+.++.|+|||||||+|||++| |..||...+...... .| +..|+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~--~~----~~ggR 922 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL--DV----LEGGR 922 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH--HH----HhCCc
Confidence 994433322222111112347999999999999999999999999999999 999998765533222 12 22332
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 650 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 650 l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+ ..+....+.+..++..||+.+|++||++..|++.+..
T Consensus 923 L----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~ 960 (1025)
T KOG1095|consen 923 L----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPA 960 (1025)
T ss_pred c----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhh
Confidence 1 1234455677788889999999999999999996654
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=320.62 Aligned_cols=258 Identities=29% Similarity=0.442 Sum_probs=205.8
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||.||+|.. .+++.++||.+... .....++.+|+.+++.++||||++++++|..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999985 57899999987642 234568899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++++|.+++.........+++..++.++.+|+.||.|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999887543333568999999999999999999999 8999999999999999999999999999876654
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
.... .....|+..|+|||++....++.++|+||||+++|+|++|..||........ .+ .... .....+
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~---~~~~------~~~~~~ 226 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SL---CKKI------EQCDYP 226 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HH---hhhh------hcCCCC
Confidence 3221 1235689999999999988899999999999999999999999975432211 11 1100 011111
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+.. ......+..++..||+.+|.+||||.+|++.++.
T Consensus 227 ~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 227 PLPS---DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCCc---ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 1111 1122345566678999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=331.04 Aligned_cols=240 Identities=24% Similarity=0.367 Sum_probs=188.7
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004174 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
+.||+|+||.||+|... +++.||||+++... ...+.+..|..++..+ +||||+++++++..++.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999864 57899999997532 3345566777777654 799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~-- 151 (316)
T cd05592 81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-- 151 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--
Confidence 99999986543 58899999999999999999999 8999999999999999999999999999976533221
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 661 (770)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+... .+.+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-------------~~~~~~~ 218 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-------------RPHFPRW 218 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------------CCCCCCC
Confidence 223357999999999999889999999999999999999999999865432211111100 0111111
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHH-HHHH
Q 004174 662 YDYDQMERMVLASILCIRRDPRARPQMS-LVLK 693 (770)
Q Consensus 662 ~~~~~~~~l~~~a~~Cl~~dP~~RPs~~-eVL~ 693 (770)
. ...+..++..||+.+|.+||++. ++++
T Consensus 219 ~----~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 219 I----SKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred C----CHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1 12334555679999999999975 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=332.22 Aligned_cols=240 Identities=24% Similarity=0.382 Sum_probs=190.3
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004174 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
+.||+|+||.||+|... +++.||||+++.. ......+..|..++..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 5789999999753 23345667788888764 899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05619 81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-- 151 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence 99999986532 57899999999999999999999 8999999999999999999999999999875432221
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 661 (770)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.... +.+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-------------~~~~~~ 218 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-------------PCYPRW 218 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------CCCCcc
Confidence 1223579999999999998899999999999999999999999997654322211111110 111111
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHH-HHHH
Q 004174 662 YDYDQMERMVLASILCIRRDPRARPQMS-LVLK 693 (770)
Q Consensus 662 ~~~~~~~~l~~~a~~Cl~~dP~~RPs~~-eVL~ 693 (770)
. ...+..++..||+.+|.+||++. ++++
T Consensus 219 ~----~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 219 L----TREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred C----CHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1 12344556789999999999997 5554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=337.59 Aligned_cols=262 Identities=23% Similarity=0.275 Sum_probs=201.3
Q ss_pred CHHHHHHhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEe
Q 004174 413 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCF 487 (770)
Q Consensus 413 ~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 487 (770)
.+.++....++|.+.+.||+|+||.||++... +++.+|+|++... ......+.+|+.++..++||||+++++++.
T Consensus 34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 35556667789999999999999999999865 6889999998642 233456788999999999999999999999
Q ss_pred ecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcc
Q 004174 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 567 (770)
Q Consensus 488 ~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~D 567 (770)
.++.+++||||+++|+|.+++... .++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~D 185 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 185 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEe
Confidence 999999999999999999998643 37788889999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCceecccccccCCCCceeeccC----CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcc
Q 004174 568 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 643 (770)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~ 643 (770)
||+++....... .......||+.|+|||++... .++.++|||||||+||||++|+.||...+.......+.
T Consensus 186 fG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~---- 260 (371)
T cd05622 186 FGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM---- 260 (371)
T ss_pred CCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHH----
Confidence 999986643322 122346799999999998753 37899999999999999999999998755432221111
Q ss_pred cccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCC--CCCHHHHHHHhh
Q 004174 644 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA--RPQMSLVLKLLR 696 (770)
Q Consensus 644 ~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~--RPs~~eVL~~L~ 696 (770)
.......+.+ . ......+..++..|+...+.+ ||++.+++++..
T Consensus 261 --~~~~~~~~~~-----~--~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 261 --NHKNSLTFPD-----D--NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred --cCCCcccCCC-----c--CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 1000001111 0 011122334445688744433 789999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=314.53 Aligned_cols=246 Identities=25% Similarity=0.425 Sum_probs=197.5
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCChh
Q 004174 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~ 505 (770)
++||+|+||.||+|...+++.+|+|+++.. ......+.+|++++..++||||++++++|...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999888999999998753 344557889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceecc
Q 004174 506 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 585 (770)
Q Consensus 506 ~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~ 585 (770)
+++.... ..+.+..+..++.+++.||.|||+ ++++||||||+||+++.++.+||+|||++.......... ...
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~ 153 (250)
T cd05085 81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGL 153 (250)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccccc-CCC
Confidence 9986543 357899999999999999999999 899999999999999999999999999997544322111 111
Q ss_pred cccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCCh
Q 004174 586 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 664 (770)
Q Consensus 586 ~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~ 664 (770)
..+++.|+|||++..+.++.++||||||+++|+|++ |..||........... .. .+.. . ....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~---~~----~~~~-----~----~~~~ 217 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ---VE----KGYR-----M----SCPQ 217 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH---HH----cCCC-----C----CCCC
Confidence 244678999999998999999999999999999999 9999976533211111 11 0100 0 0111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 665 DQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 665 ~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
.....+..++..||+.+|++||++.++++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 12345666778899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=322.52 Aligned_cols=256 Identities=24% Similarity=0.428 Sum_probs=201.7
Q ss_pred cCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCC-hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
.+|...+.||+|+||.||++... ++..+++|.++.. ......+.+|++++..++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46778899999999999999632 3567899988754 3556789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCce
Q 004174 495 VYDFLSRGSLEENLHGNKK-----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~v 563 (770)
+|||+++|+|.+++..... ....+++..++.++.|++.||.|||+ ++++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 9999999999999875431 11358899999999999999999999 899999999999999999999
Q ss_pred EEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhc
Q 004174 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 642 (770)
Q Consensus 564 kL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~ 642 (770)
||+|||++................+++.|+|||++....++.++|||||||++|||++ |..||...........+..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-- 239 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ-- 239 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc--
Confidence 9999999976543322222222345788999999998999999999999999999998 9999966443222111110
Q ss_pred ccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 643 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 643 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
+. .. ...... ...+..++..||+.+|.+||++.+|++.|+
T Consensus 240 -----~~--~~---~~~~~~----~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 240 -----GR--EL---ERPRTC----PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -----Cc--cC---CCCCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00 00 000111 123456667899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=324.31 Aligned_cols=263 Identities=22% Similarity=0.369 Sum_probs=201.4
Q ss_pred cCcccceeecccCceEEEEEEeC-----------------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-----------------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISL 482 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-----------------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l 482 (770)
++|.+.+.||+|+||.||++... ++..+|+|+++.. ......+.+|+.++..++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999998532 2346899999753 3456789999999999999999999
Q ss_pred eeEEeecCceEEEEeecCCCChhhhhccCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCe
Q 004174 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD-------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 555 (770)
Q Consensus 483 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NI 555 (770)
++++...+..++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+ ++++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 99999999999999999999999998754321 1347888999999999999999999 8999999999999
Q ss_pred eeCCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh--CCCCCCCCCccc
Q 004174 556 LLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKPISNDHPKG 633 (770)
Q Consensus 556 LL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt--G~~Pf~~~~~~~ 633 (770)
|++.++.++|+|||+++...............+++.|+|||+...+.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986544322222222345678999999888899999999999999999998 778886543322
Q ss_pred hhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 634 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 634 ~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
.... ......... .....+. +......+..++..||+.+|.+||++.+|++.|+
T Consensus 242 ~~~~---~~~~~~~~~-~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 VIEN---TGEFFRDQG-RQVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHH---HHHHHhhcc-ccccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1110 101010000 0000000 1111245666778899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=314.94 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=203.1
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+|.+.+.||+|+||.||+|... +++.|++|.+... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999864 6899999998643 35567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++++|.+++..... ..+++..+..++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 999999999976422 468899999999999999999998 899999999999999999999999999998665432
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
.. .....|++.|+|||++..+.++.++|+|||||++|+|++|+.||...... ....+.. .+.... +
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~----~~~~~~-----~ 221 (256)
T cd08529 156 NF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALILKII----RGVFPP-----V 221 (256)
T ss_pred ch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH----cCCCCC-----C
Confidence 22 12356899999999999999999999999999999999999999765421 1111111 111111 1
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.......+..++..||+.+|++||++.++++.
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 ----SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11122345667778999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=331.71 Aligned_cols=241 Identities=24% Similarity=0.344 Sum_probs=190.0
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004174 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
+.||+|+||.||+|... +|+.||||+++.. ......+..|..++..+ +||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999865 6889999999753 23445667788888764 899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||+++.......
T Consensus 81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05620 81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-- 151 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--
Confidence 99999986542 57899999999999999999999 8999999999999999999999999999874322111
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 661 (770)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.. + .+.+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~-------~------~~~~~~~ 218 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-------D------TPHYPRW 218 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------C------CCCCCCC
Confidence 22346799999999999999999999999999999999999999976543221111110 0 0111111
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHH-HHHHH
Q 004174 662 YDYDQMERMVLASILCIRRDPRARPQMS-LVLKL 694 (770)
Q Consensus 662 ~~~~~~~~l~~~a~~Cl~~dP~~RPs~~-eVL~~ 694 (770)
.. ..+..++..||+.||.+||++. +++++
T Consensus 219 ~~----~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 219 IT----KESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred CC----HHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 11 2344556679999999999974 66543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=327.19 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=201.0
Q ss_pred cCcccceeecccCceEEEEEEeC--------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecC
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 490 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~--------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 490 (770)
++|.+.+.||+|+||.||++... ++..+|+|+++.. .....++..|++++..+ +||||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56889999999999999999742 2357999999854 34456788999999999 7999999999999999
Q ss_pred ceEEEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 558 (770)
..++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+ ++++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 99999999999999999975432 11358899999999999999999998 8999999999999999
Q ss_pred CCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhH
Q 004174 559 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 637 (770)
Q Consensus 559 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l 637 (770)
.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 999999999999976643221111111234578999999998889999999999999999998 8899965433221111
Q ss_pred HHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 638 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 638 v~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+. .+.... .+......+..++..||+.+|.+||++.+|++.|..
T Consensus 255 ~~-------~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 255 LK-------EGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred HH-------cCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 11 111000 111112344456678999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=341.87 Aligned_cols=195 Identities=22% Similarity=0.319 Sum_probs=169.2
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
.++|.+.+.||+|+||.||++.. .+++.||||... ...+.+|+++++.++||||++++++|......++|||++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 45799999999999999999986 468899999754 235678999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
. ++|..++.... .+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 166 ~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 166 K-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred C-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 5 68988886543 57899999999999999999999 8999999999999999999999999999975433221
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCC
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~ 629 (770)
. ......||+.|+|||++....++.++|||||||+||||++|+.||...
T Consensus 238 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~ 286 (391)
T PHA03212 238 N-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286 (391)
T ss_pred c-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence 1 122357999999999999889999999999999999999999887543
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.12 Aligned_cols=254 Identities=22% Similarity=0.412 Sum_probs=200.4
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCC----EEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~----~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
.++|...+.||+|+||+||+|.+ .+|. .||+|+++.. ......+.+|+.++..++||||++++++|.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 45788899999999999999984 3454 4899998753 3456788899999999999999999999975 4578
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
++|||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceee
Confidence 9999999999999997543 358999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
..............+++.|+|||++....++.++|||||||++|||++ |..||....... +..+.. .+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~~~~ 231 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLE----KGERLP 231 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----CCCcCC
Confidence 754333222222345678999999998899999999999999999998 999997643322 221111 111000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
. +......+..++..||+.+|.+||++.++++.|..
T Consensus 232 ~---------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~ 267 (279)
T cd05109 232 Q---------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR 267 (279)
T ss_pred C---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0 01112345566778999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=314.23 Aligned_cols=250 Identities=28% Similarity=0.481 Sum_probs=202.3
Q ss_pred eeecccCceEEEEEEeCC----CCEEEEEEeCCChh--HHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004174 428 NLIGKGGSSQVYKGCLPD----GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~----g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
+.||+|+||.||+|.... +..|++|+++.... ..+.+.+|++++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999998753 78899999986543 367899999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 502 GSLEENLHGNKKD-----PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 502 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
++|.+++...... ...+++..++.++.|++.||.|||+ ++++||||||+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999765211 2568999999999999999999999 8999999999999999999999999999987765
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
...........+++.|+|||.+....++.++|||||||++|||++ |..||....... +..... .+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~----~~~~~---- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYLR----KGYRL---- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH----cCCCC----
Confidence 432222233568899999999998899999999999999999999 699998763322 111111 01000
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
. .+......+..++..||+.+|.+||++.+++++|+
T Consensus 227 -~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -P----KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -C----CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 01111235566677899999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.46 Aligned_cols=256 Identities=23% Similarity=0.395 Sum_probs=202.8
Q ss_pred cCcccceeecccCceEEEEEEe------CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCce
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 492 (770)
++|.+.+.||+|+||.||++.. ..+..+|||+++.. ....+.+.+|+.+++++ +||||++++++|...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4688899999999999999974 13557999998754 34456789999999999 799999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
++||||+++|+|.++++.... ..+++.++..++.+++.||.|||+ ++|+|+||||+|||++.++.++|+|||+++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999975432 348999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 573 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
...............++..|+|||++..+.++.++|||||||++|||++ |..||........ ...... .+.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~~----~~~-- 261 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLIK----EGY-- 261 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHHH----cCC--
Confidence 6654332222222356788999999998999999999999999999998 9999976543211 111111 110
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+.. .......+..++..||..+|++||++.++++.|..
T Consensus 262 ---~~~~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 262 ---RMAQ----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ---cCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0000 01112345566778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=315.40 Aligned_cols=252 Identities=27% Similarity=0.508 Sum_probs=203.6
Q ss_pred cCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
.+|.+.+.||+|+||.||+|...++..+|+|++.........|.+|+++++.++||||+++++++......++||||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 46788899999999999999887788999999886554556789999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
++|.+++.... ..+++..+..++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++..........
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 84 GCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999987543 357899999999999999999999 889999999999999999999999999987654322111
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 660 (770)
.....++.+|+|||++..+.++.++||||||+++|||++ |+.||....... +.... ..+ .....+..
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~--~~~~~~~~-- 225 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVETI----NAG--FRLYKPRL-- 225 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHH----hCC--CCCCCCCC--
Confidence 112335678999999998899999999999999999998 999997644322 11111 001 01111111
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 661 ~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
....+..++..||+.+|++||++.++++.|.
T Consensus 226 -----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 -----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1245667788999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=315.30 Aligned_cols=254 Identities=22% Similarity=0.423 Sum_probs=204.7
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
.++|.+.+.||+|+||.||++...++..+|+|.+.........+.+|+.+++.++|+||+++++++.. ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 35788999999999999999988788889999998766666789999999999999999999999987 78899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+++|.+++..... ..+++..++.++.+++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 84 KGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999975432 457899999999999999999998 88999999999999999999999999999765432221
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
......++..|+|||++..+.++.++|+|||||++|+|++ |+.||...+... +..+.. .+.... .
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~----~~~~~~-----~- 224 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALE----RGYRMP-----R- 224 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHh----CCCCCC-----C-
Confidence 1112345678999999998889999999999999999999 999997654322 111111 110000 0
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.......+..++..||+.+|++||++.++++.|..
T Consensus 225 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 ---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112345566678999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=346.97 Aligned_cols=269 Identities=17% Similarity=0.220 Sum_probs=198.1
Q ss_pred HHHHHHhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC------CceeEEeeEE
Q 004174 414 YQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHH------KNIISLLGFC 486 (770)
Q Consensus 414 ~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H------pnIv~l~~~~ 486 (770)
.+++...+++|.+.+.||+|+||+||+|... .++.||||+++........+..|+.++..++| +++++++++|
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3445556789999999999999999999864 67889999997655555566778888877765 4589999998
Q ss_pred eec-CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC----
Q 004174 487 FED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---- 561 (770)
Q Consensus 487 ~~~-~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~---- 561 (770)
... .++++|||++ +++|.+++.... .+++..+..|+.||+.||.|||+. .+||||||||+||||+.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccc
Confidence 764 4688999988 778998886543 589999999999999999999961 4899999999999998765
Q ss_pred ------------ceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCC
Q 004174 562 ------------EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (770)
Q Consensus 562 ------------~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~ 629 (770)
.+||+|||++...... ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||...
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4999999988643221 22368999999999999999999999999999999999999999876
Q ss_pred CccchhhHHHhhccccc------------------CCccccccCcc-----cCCCC--ChHHHHHHHHHHHhhcccCCCC
Q 004174 630 HPKGQESLVMWAKPILS------------------SGKVTQLLDPA-----LGNNY--DYDQMERMVLASILCIRRDPRA 684 (770)
Q Consensus 630 ~~~~~~~lv~~~~~~~~------------------~g~l~~lld~~-----l~~~~--~~~~~~~l~~~a~~Cl~~dP~~ 684 (770)
+......++......+. .+.+....++. ..... .......+..++..||+.||.+
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 54333222211100000 00000000000 00000 0001233556778899999999
Q ss_pred CCCHHHHHHH
Q 004174 685 RPQMSLVLKL 694 (770)
Q Consensus 685 RPs~~eVL~~ 694 (770)
|||+.++|++
T Consensus 429 R~ta~e~L~H 438 (467)
T PTZ00284 429 RLNARQMTTH 438 (467)
T ss_pred CCCHHHHhcC
Confidence 9999999974
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.55 Aligned_cols=260 Identities=22% Similarity=0.392 Sum_probs=203.2
Q ss_pred hhcCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 491 (770)
.+++|.+.+.||+|+||.||+|... .+..||+|.++... .....+.+|+.+++.++||||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567899999999999999999743 24579999987543 334568899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEE
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKD------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL 565 (770)
.++||||+++|+|.+++...... ...+.+..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999753211 1345678889999999999999999 89999999999999999999999
Q ss_pred ccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhccc
Q 004174 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPI 644 (770)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~ 644 (770)
+|||+++...............++..|+|||++..+.++.++|||||||++|||++ |..||....... .....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~~--- 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKFV--- 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---
Confidence 99999986544322222222345778999999998899999999999999999999 788997543322 11111
Q ss_pred ccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 645 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 645 ~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
...+. .. . +......+..++..||+.+|++||++.++++.|+..
T Consensus 235 ~~~~~-~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 235 MDGGY-LD-----Q----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HcCCC-CC-----C----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11110 00 0 111124566677789999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=329.65 Aligned_cols=257 Identities=28% Similarity=0.351 Sum_probs=200.1
Q ss_pred HhhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh---------------hHHHHHHHHHHHHHhcCCCceeEE
Q 004174 419 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---------------DVIKEFVLEIEIITTLHHKNIISL 482 (770)
Q Consensus 419 ~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---------------~~~~~~~~Ei~iL~~l~HpnIv~l 482 (770)
...++|.+.+.||+|.||.|-+|.. .+++.||||++.+.+ ...+...+||.||++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 4457899999999999999999985 479999999997531 123578899999999999999999
Q ss_pred eeEEee--cCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC
Q 004174 483 LGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560 (770)
Q Consensus 483 ~~~~~~--~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~ 560 (770)
+.+..+ .+.+|||+|||..|.+...= .....+++.++++|+..++.||+|||. ++||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCC
Confidence 999865 36899999999998876432 122238999999999999999999999 999999999999999999
Q ss_pred CceEEccccccccccCCCCC---ceecccccccCCCCceeeccCC----CCCcceEeechHHHHHHHhCCCCCCCCCccc
Q 004174 561 FEPQLSDFGLAKWASTSSSH---ITCTDVAGTFGYLAPEYFMYGK----VNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (770)
Q Consensus 561 ~~vkL~DFGla~~~~~~~~~---~~~~~~~GT~~YlAPE~~~~~~----~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 633 (770)
|.+||+|||.+......... ......+|||.|+|||....+. .+.+.||||+||+||-|+.|+.||.++....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 99999999999866433111 1112258999999999988643 3568999999999999999999998754321
Q ss_pred hhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 634 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 634 ~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.. ..+++..|.-....+.-+.+-.+++.+|.+||++|-+..+|..+..-
T Consensus 327 l~---------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 327 LF---------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred HH---------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 11 11222222211122334455566678999999999999999887643
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=325.60 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=203.1
Q ss_pred hcCcccceeecccCceEEEEEEe--------CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL--------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~--------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 489 (770)
.++|.+.+.||+|+||.||+|.. .++..+|+|.++.. ......+.+|+.++..+ +||||++++++|...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 45678889999999999999963 13457999998753 34557889999999999 899999999999999
Q ss_pred CceEEEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee
Q 004174 490 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (770)
Q Consensus 490 ~~~~LV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 557 (770)
...++||||+++|+|.+++..... ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence 999999999999999999975421 12357889999999999999999999 899999999999999
Q ss_pred CCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhh
Q 004174 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 636 (770)
Q Consensus 558 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~ 636 (770)
+.++.+||+|||+++...............+++.|+|||++....++.++||||||+++|+|++ |..||..........
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 250 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 9999999999999987654333222222356778999999998899999999999999999998 888986543322111
Q ss_pred HHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 637 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 637 lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+ ..+.... .+......+..++..||+.+|.+||++.+|++.|..
T Consensus 251 ~~-------~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 251 LL-------KEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred HH-------HcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 11 1111000 011122345556678999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=323.31 Aligned_cols=252 Identities=25% Similarity=0.292 Sum_probs=202.3
Q ss_pred cCcccceeecccCceEEEEEEeCC-CCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||.|.-|+||++.+.+ +..+|+|++.+.. ....+...|-+||+.+.||+++.||..|+.+...||+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456778899999999999999754 5889999998643 44567778999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
|||+||+|..+++++.. ..|++..++.++.+++.||+|||. .|||+|||||+||||-++|++.|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999999886654 579999999999999999999999 9999999999999999999999999999764321
Q ss_pred C---------------------------------CCC---------------------ceecccccccCCCCceeeccCC
Q 004174 577 S---------------------------------SSH---------------------ITCTDVAGTFGYLAPEYFMYGK 602 (770)
Q Consensus 577 ~---------------------------------~~~---------------------~~~~~~~GT~~YlAPE~~~~~~ 602 (770)
. ... .....++||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 000 0112367999999999999999
Q ss_pred CCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCC
Q 004174 603 VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDP 682 (770)
Q Consensus 603 ~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP 682 (770)
.+.++|+|+|||+|||||.|..||.+.+.......+.-... .+.+ .......+..++...|.+||
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l-------------~Fp~--~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL-------------KFPE--EPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC-------------cCCC--CCcchhHHHHHHHHHhccCh
Confidence 99999999999999999999999998766543322211110 1111 11222334445567899999
Q ss_pred CCCCC----HHHHHH
Q 004174 683 RARPQ----MSLVLK 693 (770)
Q Consensus 683 ~~RPs----~~eVL~ 693 (770)
.+|-- +.||-+
T Consensus 377 ~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhhccccchHHhhc
Confidence 99998 677655
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=317.74 Aligned_cols=254 Identities=26% Similarity=0.452 Sum_probs=201.1
Q ss_pred cCcccceeecccCceEEEEEEeC-CC---CEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DG---KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g---~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
++|.+.+.||+|+||.||+|... ++ ..||||+++.. ......|..|+.+++.++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 35788999999999999999864 33 36999998753 45567899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 99999999999987543 358999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCceecccc---cccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 576 TSSSHITCTDVA---GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 576 ~~~~~~~~~~~~---GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
............ .+..|+|||++..+.++.++|||||||++|||++ |..||....... ...+..... .+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~~~~---~~~ 231 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIEQDY---RLP 231 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHHcCC---cCC
Confidence 433221111111 2457999999999999999999999999999987 999997654322 222211100 000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+.+....+..++..||+.+|.+||++.+|+..|+.
T Consensus 232 ----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 232 ----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 011112335566678999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.87 Aligned_cols=264 Identities=19% Similarity=0.332 Sum_probs=198.5
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
++|.+.+.||+|+||.||+|... +++.||+|+++... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56889999999999999999864 67889999987432 3345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++ +|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 8888876543 357889999999999999999999 899999999999999999999999999997654322
Q ss_pred CCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc----
Q 004174 579 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL---- 653 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l---- 653 (770)
.. .....+|+.|+|||++.. ..++.++|||||||++|+|+||+.||...+.......+...........+..+
T Consensus 159 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 KT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred cc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 21 123468999999998864 46899999999999999999999999876543332222211100000000000
Q ss_pred --cC---cccCCC----CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 654 --LD---PALGNN----YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 654 --ld---~~l~~~----~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+ +..... ...........++..||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00 000000 000011234456678999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=321.13 Aligned_cols=265 Identities=25% Similarity=0.385 Sum_probs=206.0
Q ss_pred cCHHHHHHhhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEe--
Q 004174 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCF-- 487 (770)
Q Consensus 412 f~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~-- 487 (770)
+.++.+..+.++|.+.+.||+|+||.||++.. .+++.+|+|++.........+.+|+.++..+ +||||++++++|.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34456666788999999999999999999986 4688999999876555556788999999999 6999999999884
Q ss_pred ---ecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceE
Q 004174 488 ---EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (770)
Q Consensus 488 ---~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vk 564 (770)
.++.+++||||+++++|.+++.........+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEE
Confidence 3456899999999999999886433333468899999999999999999999 8999999999999999999999
Q ss_pred EccccccccccCCCCCceecccccccCCCCceeecc-----CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHH
Q 004174 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (770)
Q Consensus 565 L~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~ 639 (770)
|+|||++........ ......|++.|+|||++.. ..++.++|||||||++|||++|+.||....+.... ..
T Consensus 165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~~ 240 (286)
T cd06638 165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--FK 240 (286)
T ss_pred EccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--hh
Confidence 999999976643221 1223469999999999853 45788999999999999999999999765432211 11
Q ss_pred hhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 640 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 640 ~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
. ..+....+.++. .....+..++..||+.+|++||++.++++++
T Consensus 241 ~-----~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 I-----PRNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred c-----cccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 000101111111 0112355667789999999999999999754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=316.51 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=200.6
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
++|.+.+.||+|+||.||++.. .+++.+|+|.+.... ...+.+.+|+++++.++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5788999999999999999986 468999999986432 234578899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||+++++|.+.+.... .+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999987543 47889999999999999999999 89999999999999999999999999999765
Q ss_pred cCCCCCce-ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 575 STSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 575 ~~~~~~~~-~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
........ .....|+..|+|||++.+..++.++||||||+++|||++|+.||......... .+... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~---~~~---- 224 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---FKIAT---QPT---- 224 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---HHHhc---cCC----
Confidence 43221111 12346888999999999888999999999999999999999999764332111 11100 000
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
.+.+.. .....+..++..||..+|.+||++.+++++.
T Consensus 225 -~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 225 -NPQLPS----HVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred -CCCCCc----cCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 011111 1122345566789999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=324.02 Aligned_cols=254 Identities=26% Similarity=0.427 Sum_probs=198.3
Q ss_pred cCcccceeecccCceEEEEEEeC-CCC--EEEEEEeCC--ChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGK--ELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~--~vAVK~l~~--~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV 495 (770)
++|.+.++||+|+||.||+|... ++. .+++|.++. .....+.+.+|+.++.++ +||||+++++++...+.+++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57889999999999999999864 333 478888874 234567899999999999 799999999999999999999
Q ss_pred EeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCce
Q 004174 496 YDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~v 563 (770)
|||+++++|.+++..... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 999999999999975431 11358899999999999999999999 899999999999999999999
Q ss_pred EEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhc
Q 004174 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 642 (770)
Q Consensus 564 kL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~ 642 (770)
||+|||++......... .....+..|+|||++....++.++|||||||++|||++ |..||........ .....
T Consensus 159 kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~---~~~~~ 232 (297)
T cd05089 159 KIADFGLSRGEEVYVKK---TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL---YEKLP 232 (297)
T ss_pred EECCcCCCccccceecc---CCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHh
Confidence 99999998643221111 11223567999999998889999999999999999998 9999976543221 11100
Q ss_pred ccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 643 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 643 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+ ..... +......+..++..||+.+|.+||++.++++.|..
T Consensus 233 ----~~-----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 274 (297)
T cd05089 233 ----QG-----YRMEK----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR 274 (297)
T ss_pred ----cC-----CCCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 00 00001 11112345566778999999999999999988854
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=316.95 Aligned_cols=255 Identities=25% Similarity=0.464 Sum_probs=202.4
Q ss_pred hcCcccceeecccCceEEEEEEeC-CC---CEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DG---KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g---~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
+++|...+.||+|+||.||+|... ++ ..+++|.++.. ......+.+|++++..++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888999999999999999864 33 36999998754 3446778999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||+++++|.+++.... ..+++..+..++.+++.||.|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999986543 358999999999999999999999 89999999999999999999999999999866
Q ss_pred cCCCCCcee-cccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 575 STSSSHITC-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 575 ~~~~~~~~~-~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
......... .....++.|+|||++..+.++.++|||||||++|||++ |+.||...........+ . .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i---~---~~~~~-- 229 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI---N---DGFRL-- 229 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH---h---cCCCC--
Confidence 543222111 11223457999999998899999999999999999998 99999765432211111 1 00000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+ ...+....+..++..||+.+|.+||++.+|++.|..
T Consensus 230 ---~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 230 ---P-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred ---C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0 011122345677788999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=321.03 Aligned_cols=246 Identities=25% Similarity=0.316 Sum_probs=191.7
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCh
Q 004174 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (770)
Q Consensus 430 LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL 504 (770)
||+|+||.||++..+ +|+.||+|++.... .....+..|++++..++||||++++++|..+..+++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999864 68999999986422 2234566799999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceec
Q 004174 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (770)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~ 584 (770)
.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++........ ..
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~ 152 (277)
T cd05607 81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---IT 152 (277)
T ss_pred HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---ee
Confidence 988865432 358899999999999999999999 8999999999999999999999999999976654321 22
Q ss_pred ccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCCh
Q 004174 585 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 664 (770)
Q Consensus 585 ~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~ 664 (770)
...||+.|+|||++..+.++.++|||||||++|||++|+.||...........+ ...... +.+.. ....+
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~--~~~~~~-~~~~~-----~~~~~-- 222 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL--KRRTLE-DEVKF-----EHQNF-- 222 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH--HHHhhc-ccccc-----ccccC--
Confidence 357899999999999889999999999999999999999999764332211111 111110 01000 00111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 665 DQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 665 ~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
...+..++..||+.+|.+||++.++++.+
T Consensus 223 --~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 223 --TEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred --CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 12345566779999999999997766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=317.66 Aligned_cols=254 Identities=25% Similarity=0.331 Sum_probs=191.2
Q ss_pred eeecccCceEEEEEEeCC---CCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCC
Q 004174 428 NLIGKGGSSQVYKGCLPD---GKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~---g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~gg 502 (770)
+.||+|+||.||+|...+ +..+|+|.++... .....+.+|+.+++.++||||++++++|.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998543 4579999987543 34457889999999999999999999999999999999999999
Q ss_pred ChhhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 503 SLEENLHGNKK-DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 503 sL~~~l~~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
+|.+++..... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975432 22346778888999999999999999 899999999999999999999999999997554332222
Q ss_pred eecccccccCCCCceeeccC-------CCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 582 TCTDVAGTFGYLAPEYFMYG-------KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~-------~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
......|+..|+|||++... .++.++|||||||++|||++ |+.||....+...... .+ .+....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~-~~------~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY-TV------REQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH-Hh------hcccCCC
Confidence 22234678899999998632 35789999999999999996 9999976443221110 00 0111122
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
.++.+... ..+ .+..++..|+ .+|++||++.+|+..|+
T Consensus 231 ~~~~~~~~-~~~---~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLP-LSD---RWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCC-CCh---HHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22222211 112 2334455688 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=321.52 Aligned_cols=257 Identities=25% Similarity=0.469 Sum_probs=203.5
Q ss_pred hcCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 492 (770)
.++|.+.+.||+|+||.||+|..+ ++..||+|++... ......+.+|+.+++.++||||++++++|..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999853 4678999998754 24456799999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCC
Q 004174 493 LLVYDFLSRGSLEENLHGNKK------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 554 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~N 554 (770)
++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+ ++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 999999999999999864321 12357889999999999999999999 899999999999
Q ss_pred eeeCCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccc
Q 004174 555 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKG 633 (770)
Q Consensus 555 ILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~ 633 (770)
||++.++.++|+|||++................++..|+|||++..+.++.++|||||||++|||++ |..||.......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876543322111122345678999999998899999999999999999998 888986544322
Q ss_pred hhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 634 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 634 ~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
..... ..+..... +......+..++.+||+.+|.+||++.++++.|+
T Consensus 241 ---~~~~~----~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 241 ---VIYYV----RDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred ---HHHHH----hcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 22111 11111110 1112245666778899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=329.83 Aligned_cols=248 Identities=21% Similarity=0.301 Sum_probs=191.5
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004174 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
+.||+|+||.||+|... +++.||||+++.. ....+.+..|+.++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999864 6789999999753 23456688899999888 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
|+|..++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 151 (327)
T cd05617 81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-- 151 (327)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--
Confidence 99998886543 58999999999999999999999 8999999999999999999999999999975332211
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 661 (770)
......||+.|+|||++.+..++.++|||||||+||||++|+.||.............+......... ..+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~p~~ 225 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP------IRIPRF 225 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC------CCCCCC
Confidence 12236799999999999999999999999999999999999999965332211111111111111000 001111
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCH------HHHHHH
Q 004174 662 YDYDQMERMVLASILCIRRDPRARPQM------SLVLKL 694 (770)
Q Consensus 662 ~~~~~~~~l~~~a~~Cl~~dP~~RPs~------~eVL~~ 694 (770)
. ...+..++..||+.||.+||++ .+++++
T Consensus 226 ~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 226 L----SVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred C----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 1 1234456677999999999984 566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.36 Aligned_cols=254 Identities=26% Similarity=0.422 Sum_probs=200.0
Q ss_pred HhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec------C
Q 004174 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFED------N 490 (770)
Q Consensus 419 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~------~ 490 (770)
.+++.|.+.+.||+|+||.||+|... +++.||+|++.........+.+|+.++..+ +||||++++++|... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 35677888899999999999999864 688999999976655556788999999998 699999999998753 4
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 570 (770)
.+++||||+++++|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 58999999999999999875432 358899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCceeec-----cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccc
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 645 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~ 645 (770)
+......... .....|++.|+|||++. ...++.++|||||||++|||++|..||....+........ .
T Consensus 158 ~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~-~---- 230 (272)
T cd06637 158 SAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-R---- 230 (272)
T ss_pred ceeccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh-c----
Confidence 9865432221 22357899999999986 3468889999999999999999999997544322211110 0
Q ss_pred cCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 646 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 646 ~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.. .+.+... .....+..++..||..+|.+||++.+++++
T Consensus 231 --~~-----~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 231 --NP-----APRLKSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred --CC-----CCCCCCC---CcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 0111100 111234556678999999999999999863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=335.71 Aligned_cols=204 Identities=25% Similarity=0.397 Sum_probs=176.7
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|...+.||+|+||.||++... +++.||||+++.. ......+.+|+.++..++||||+++++.|.+.+.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999864 6899999999743 234567888999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+||||+.++.++|+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999987543 58899999999999999999999 8999999999999999999999999999875432
Q ss_pred CCCC---------------------------------ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCC
Q 004174 577 SSSH---------------------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 623 (770)
Q Consensus 577 ~~~~---------------------------------~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~ 623 (770)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 1100 0011357999999999999999999999999999999999999
Q ss_pred CCCCCCCcc
Q 004174 624 KPISNDHPK 632 (770)
Q Consensus 624 ~Pf~~~~~~ 632 (770)
.||....+.
T Consensus 234 ~Pf~~~~~~ 242 (360)
T cd05627 234 PPFCSETPQ 242 (360)
T ss_pred CCCCCCCHH
Confidence 999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=339.55 Aligned_cols=261 Identities=22% Similarity=0.293 Sum_probs=198.6
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC-----ceE
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----NLL 493 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-----~~~ 493 (770)
+|.+.+.||+|+||.||++.. .+|+.||||++... ....+.+.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999986 47899999998643 234567889999999999999999999998776 789
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+||||+. ++|.+.+... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 5888877543 358999999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcc---------
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP--------- 643 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~--------- 643 (770)
....... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...++..+...+.....
T Consensus 153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 5443222 12234689999999998764 478999999999999999999999987665433222211100
Q ss_pred --------cccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 644 --------ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 644 --------~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
......-........ .........+..++..||+.||.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000000 0011112345567778999999999999999975
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=329.55 Aligned_cols=236 Identities=28% Similarity=0.350 Sum_probs=186.2
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHH-HHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004174 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
+.||+|+||+||+|... +|+.||||++.... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999874 78999999997532 23345555655 46789999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 151 (323)
T cd05575 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-- 151 (323)
T ss_pred CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--
Confidence 99999987543 58899999999999999999999 8999999999999999999999999999875432221
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 661 (770)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+. . +. ..+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~------~-~~------~~~~~~ 218 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL------N-KP------LRLKPN 218 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH------c-CC------CCCCCC
Confidence 2233579999999999999999999999999999999999999997654322111111 0 00 001111
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHH
Q 004174 662 YDYDQMERMVLASILCIRRDPRARPQMS 689 (770)
Q Consensus 662 ~~~~~~~~l~~~a~~Cl~~dP~~RPs~~ 689 (770)
. ...+..++..||+.+|.+||++.
T Consensus 219 ~----~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 I----SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C----CHHHHHHHHHHhhcCHHhCCCCC
Confidence 1 22345566679999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=330.24 Aligned_cols=241 Identities=22% Similarity=0.344 Sum_probs=193.1
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004174 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
+.||+|+||.||+|... +++.||||+++.. ......+..|+.++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 5789999999753 23456677899999888 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 151 (318)
T cd05570 81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-- 151 (318)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--
Confidence 99999886543 58999999999999999999999 8999999999999999999999999999875322221
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 661 (770)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+. .+. ..+...
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~-------~~~------~~~~~~ 218 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL-------EDE------VRYPRW 218 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH-------cCC------CCCCCc
Confidence 1223579999999999999999999999999999999999999997654322111110 000 001111
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCH-----HHHHHH
Q 004174 662 YDYDQMERMVLASILCIRRDPRARPQM-----SLVLKL 694 (770)
Q Consensus 662 ~~~~~~~~l~~~a~~Cl~~dP~~RPs~-----~eVL~~ 694 (770)
....+..++..||+.||.+||++ .+++++
T Consensus 219 ----~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 219 ----LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ----CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 12344556678999999999999 887764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=328.91 Aligned_cols=240 Identities=27% Similarity=0.326 Sum_probs=185.5
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhc---CCCceeEEeeEEeecCceEEEEeecCC
Q 004174 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL---HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 430 LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
||+|+||+||+|... +|+.||||++.... .....+..|..++..+ .||||++++++|...+.+++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999864 68999999986432 2334556677777665 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||+++.......
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-- 151 (330)
T cd05586 81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-- 151 (330)
T ss_pred ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--
Confidence 99999886543 58899999999999999999999 8999999999999999999999999999875433221
Q ss_pred eecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 660 (770)
......||+.|+|||++... .++.++|||||||+||||++|+.||...........+. .+.. .+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~-------~~~~------~~~~ 218 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA-------FGKV------RFPK 218 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH-------cCCC------CCCC
Confidence 12236799999999998755 48999999999999999999999997654322111111 1110 0111
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCC----CHHHHHHH
Q 004174 661 NYDYDQMERMVLASILCIRRDPRARP----QMSLVLKL 694 (770)
Q Consensus 661 ~~~~~~~~~l~~~a~~Cl~~dP~~RP----s~~eVL~~ 694 (770)
... ...+..++..||+.+|.+|| ++.+++++
T Consensus 219 ~~~---~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 219 NVL---SDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred ccC---CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 111 12334455679999999998 56666653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=321.05 Aligned_cols=265 Identities=28% Similarity=0.413 Sum_probs=208.8
Q ss_pred ccCHHHHHHhhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEee
Q 004174 411 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE 488 (770)
Q Consensus 411 ~f~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~ 488 (770)
.+++.++..++++|.+.+.||+|+||.||++.. .+++.+|+|++.........+.+|+.++..+ +|||+++++++|..
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 456677777899999999999999999999986 4688999999976655566788899999999 79999999999875
Q ss_pred c-----CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCce
Q 004174 489 D-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (770)
Q Consensus 489 ~-----~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~v 563 (770)
. +.+++||||+++++|.++++........+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 4 35899999999999999886543333468999999999999999999999 899999999999999999999
Q ss_pred EEccccccccccCCCCCceecccccccCCCCceeeccC-----CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHH
Q 004174 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (770)
Q Consensus 564 kL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~-----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv 638 (770)
||+|||++......... .....|+..|+|||++..+ .++.++|||||||++|||++|+.||....+... +.
T Consensus 168 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~ 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF 243 (291)
T ss_pred EEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH
Confidence 99999999865432221 1224689999999998644 368899999999999999999999976543221 11
Q ss_pred HhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 639 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 639 ~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+.. +....+.+ .......+..++..||+.+|++||++.+++++
T Consensus 244 ~~~~-----~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 KIPR-----NPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHhc-----CCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111 00011111 11122346667788999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=327.51 Aligned_cols=256 Identities=21% Similarity=0.290 Sum_probs=196.0
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||.||++... +++.||||++... ....+.+.+|+.++..++|+||++++++|.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999864 6899999999742 234456889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999996532 358899999999999999999999 8999999999999999999999999999876543
Q ss_pred CCCCceecccccccCCCCceeecc-----CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
.... ......||+.|+|||++.. +.++.++|||||||++|||++|+.||...........+. ......
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~------~~~~~~ 227 (331)
T cd05597 155 DGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM------NHKEHF 227 (331)
T ss_pred CCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH------cCCCcc
Confidence 3221 1122469999999999873 457889999999999999999999997654322211111 000000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+ .+. ... ..+....++.. ++|...++..||++.+++++
T Consensus 228 ~~-~~~-~~~-~~~~~~~li~~-ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 QF-PPD-VTD-VSEEAKDLIRR-LICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cC-CCc-cCC-CCHHHHHHHHH-HccCcccccCCCCHHHHhcC
Confidence 11 000 011 12333443332 34666666678999999986
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=313.48 Aligned_cols=250 Identities=30% Similarity=0.465 Sum_probs=204.5
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
.++|.+.+.||.|+||.||+|.. .|+.||||.++......+++.+|+.++..++|+||+++++++...+..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 35788899999999999999987 47899999998766567789999999999999999999999998899999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+++|.+++..... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 84 KGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999975432 358999999999999999999999 8999999999999999999999999999987633221
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
...++..|+|||++..+.++.++||||||+++|||++ |+.||....... +...... +.. ...
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~----~~~-----~~~- 220 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHVEK----GYR-----MEA- 220 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhc----CCC-----CCC-
Confidence 1235678999999998899999999999999999998 999997653322 1111111 000 000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+......+..++..||..+|.+||++.++++.|+.
T Consensus 221 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 ---PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ---ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 11112445566778999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=320.91 Aligned_cols=262 Identities=21% Similarity=0.308 Sum_probs=193.5
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhc---CCCceeEEeeEEeec-----C
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTL---HHKNIISLLGFCFED-----N 490 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~-----~ 490 (770)
+|.+.+.||+|+||.||+|... +|+.||+|+++... .....+.+|+.+++.+ +||||++++++|... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999864 68899999987532 2234556777777665 699999999998652 4
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 570 (770)
..++||||+++ +|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCc
Confidence 58999999975 89888865432 358999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhh-HHHhhcccccCCc
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES-LVMWAKPILSSGK 649 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~-lv~~~~~~~~~g~ 649 (770)
+........ .....||+.|+|||++.+..++.++|||||||++|||++|++||.......... +..+... .....
T Consensus 155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~-~~~~~ 230 (288)
T cd07863 155 ARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL-PPEDD 230 (288)
T ss_pred cccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCC-CChhh
Confidence 987654322 123568999999999998899999999999999999999999997654432211 1111000 00000
Q ss_pred cc-------cccCcccCC---CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 650 VT-------QLLDPALGN---NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 650 l~-------~lld~~l~~---~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+. ..+.+.... ....+....+..++..||+.||++||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 000000000 0001122345567778999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=320.73 Aligned_cols=250 Identities=23% Similarity=0.317 Sum_probs=197.5
Q ss_pred cccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 424 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
|...+.||+|+||+||+|.. .+++.+|+|++.... .....+.+|++++..++|+||+++.++|..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 67778999999999999986 468899999987532 2345578899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++++|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999988865432 358999999999999999999999 899999999999999999999999999997654322
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
. .....|++.|+|||++.+..++.++|+|||||++|||++|..||...........+. .. ...+. . ..
T Consensus 157 ~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~~-~~~~~--~----~~ 224 (285)
T cd05632 157 S---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--RR-VLETE--E----VY 224 (285)
T ss_pred c---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hh-hhccc--c----cc
Confidence 2 123579999999999998899999999999999999999999997654322211111 11 11000 0 01
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 694 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs-----~~eVL~~ 694 (770)
...+ ...+..++..||+.+|.+||+ +.+++.+
T Consensus 225 ~~~~----~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 225 SAKF----SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CccC----CHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 1111 223455667799999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=316.76 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=199.6
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
++|.+.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+.++..++||||++++++|..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688999999999999999986 578899999997543 34566888999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++++|.++++... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 89 GGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999999986432 57899999999999999999999 8999999999999999999999999999986643221
Q ss_pred CceecccccccCCCCceeec---cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 580 HITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
. .....|++.|+|||.+. ...++.++|||||||++|||++|+.||....+..... .+... .+ ..+
T Consensus 162 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~~~~~-----~~---~~~ 229 (267)
T cd06646 162 K--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LMSKS-----NF---QPP 229 (267)
T ss_pred c--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--eeecC-----CC---CCC
Confidence 1 12246899999999884 4457889999999999999999999996544322111 00000 00 001
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
.+.. .......+..++..||+.+|++||++.+++++|
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1110 011123455666789999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=322.83 Aligned_cols=264 Identities=22% Similarity=0.351 Sum_probs=201.6
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
++|.+.+.||+|+||.||++... ++..+|+|.++.. ......+.+|++++..++||||++++++|..++.+++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999864 6888999998753 34556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++++|.+++... ..+++..+..++.|++.||.|||+ ..+++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999999754 257899999999999999999996 1479999999999999999999999999987654322
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC----------
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG---------- 648 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g---------- 648 (770)
. ....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..................
T Consensus 155 ~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 A----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred c----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 1 23578999999999988889999999999999999999999997544322111111000000000
Q ss_pred -------ccccccCcccC---CCCC-hHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 649 -------KVTQLLDPALG---NNYD-YDQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 649 -------~l~~lld~~l~---~~~~-~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
...++.+.... ...+ ......+..++.+||+.+|.+||++.+|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00000000000 0000 00122356777889999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=328.95 Aligned_cols=236 Identities=28% Similarity=0.349 Sum_probs=185.5
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHH-HHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004174 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
++||+|+||.||+|... +|+.||+|++.... .....+..|.. +++.++||||++++++|.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999874 68899999987532 23345555654 67889999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
|+|...+.... .+.+..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 151 (321)
T cd05603 81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-- 151 (321)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--
Confidence 99998886532 47888899999999999999999 8999999999999999999999999999875322221
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 661 (770)
......||+.|+|||++....++.++|||||||++|||++|+.||...+.......+ .. +. + .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i------~~-~~--------~--~ 214 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI------LH-KP--------L--Q 214 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHH------hc-CC--------C--C
Confidence 123357999999999999889999999999999999999999999765432211111 00 00 0 0
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHH
Q 004174 662 YDYDQMERMVLASILCIRRDPRARPQMS 689 (770)
Q Consensus 662 ~~~~~~~~l~~~a~~Cl~~dP~~RPs~~ 689 (770)
.+......+..++..||+.+|.+||++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1111223455666789999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=312.85 Aligned_cols=248 Identities=29% Similarity=0.460 Sum_probs=196.2
Q ss_pred eeecccCceEEEEEEeC--C--CCEEEEEEeCCChh--HHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004174 428 NLIGKGGSSQVYKGCLP--D--GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~--~--g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
+.||+|+||.||+|... + +..+|+|.+..... ..+.+.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46899999999999752 2 36899999986543 5678999999999999999999999875 5578999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
|+|.+++.... .+++..+..++.|++.||.|||. .+++||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999997543 57899999999999999999998 889999999999999999999999999998765433221
Q ss_pred ee-cccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 582 TC-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 582 ~~-~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
.. ....++..|+|||++....++.++|||||||++|||++ |..||...+... +..+... +. ...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~~----~~--~~~----- 218 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLES----GE--RLP----- 218 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHc----CC--cCC-----
Confidence 11 11224567999999998899999999999999999998 999997654322 2222111 10 000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~ 699 (770)
.+......+..++..||..+|.+||++.++++.|+...
T Consensus 219 --~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 219 --RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01111234556777899999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=316.01 Aligned_cols=245 Identities=27% Similarity=0.416 Sum_probs=193.9
Q ss_pred eecccCceEEEEEEe---CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCC
Q 004174 429 LIGKGGSSQVYKGCL---PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (770)
Q Consensus 429 ~LG~G~fG~Vy~a~~---~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~gg 502 (770)
.||+|+||.||+|.+ .++..+|+|+++.. ....+.+.+|+.++..+.||||+++++++. .+.+++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 35788999998753 245678999999999999999999999985 45789999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCce
Q 004174 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (770)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~ 582 (770)
+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||.|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999986542 58899999999999999999999 8999999999999999999999999999987654432211
Q ss_pred e-cccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccCC
Q 004174 583 C-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660 (770)
Q Consensus 583 ~-~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 660 (770)
. ....++..|+|||++..+.++.++|||||||++|||++ |+.||...........+ ..+.... ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i-------~~~~~~~-----~~~ 221 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI-------ESGERME-----CPQ 221 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HCCCCCC-----CCC
Confidence 1 11234678999999988889999999999999999998 99999765432211111 1111101 111
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 661 ~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
. ....+..++..||+.+|++||++.+|.+.|+.
T Consensus 222 ~----~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 222 R----CPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred C----CCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1 12334556678999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=337.25 Aligned_cols=205 Identities=30% Similarity=0.441 Sum_probs=182.5
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-C-----CceeEEeeEEeecCceEEE
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-H-----KNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-H-----pnIv~l~~~~~~~~~~~LV 495 (770)
+|.++++||+|.||.|-+|.+ .+++.||||+++.......+...|+.+|..|+ | -|+|+++++|...+++|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 688999999999999999985 56999999999999999999999999999998 4 3899999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC--CceEEcccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--FEPQLSDFGLAKW 573 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~--~~vkL~DFGla~~ 573 (770)
+|.+.. +|+++|+.++- ..|+...++.++.||+.||.+||+ .+|||+||||+||||.+. ..+||+|||.|.+
T Consensus 267 fELL~~-NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ehhhhh-hHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999955 99999987765 458999999999999999999998 999999999999999654 4799999999987
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHH
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv 638 (770)
...... ..+-+..|.|||+|.+.+|+.+.||||||||+.||++|.+.|.+++...+...+
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I 400 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARI 400 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHH
Confidence 655332 356788999999999999999999999999999999999999888766655443
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=319.24 Aligned_cols=249 Identities=26% Similarity=0.406 Sum_probs=195.8
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
++|.+.++||+|+||.||+|.. .+++.||+|++... ......+.+|++++.+++||||++++++|...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577889999999999999985 57889999998653 34556799999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++++|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999996542 36788889999999999999999 899999999999999999999999999997654322
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchh-hHHHhhcccccCCccccccCcc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE-SLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~lv~~~~~~~~~g~l~~lld~~ 657 (770)
.....||..|+|||++....++.++|||||||++|+|++|+.||......... ....+..... .. ..+.
T Consensus 150 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~-----~~~~ 219 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DE-----DPPV 219 (279)
T ss_pred ----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-cc-----CCCC
Confidence 12357899999999999889999999999999999999999999753321110 0000000000 00 0011
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+.. ......+..++..||+.+|.+||++.+++++
T Consensus 220 ~~~---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 LPV---GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCC---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111 1112234556678999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=328.13 Aligned_cols=240 Identities=23% Similarity=0.336 Sum_probs=191.4
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEE
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~LV~ 496 (770)
+|...+.||+|+||.||+|... +|+.||||+++.. ....+.+..|+.++..+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4777899999999999999864 6899999999753 234456788999998886 577888999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999986543 58999999999999999999999 8999999999999999999999999999875432
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
... ......||+.|+|||++.++.++.++|||||||++|||++|+.||...........+.. +..
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~-------~~~------ 218 (323)
T cd05615 154 DGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME-------HNV------ 218 (323)
T ss_pred CCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCC------
Confidence 221 12235799999999999988999999999999999999999999987543221111110 000
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQM 688 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~ 688 (770)
.+.... ...+..++..||+.+|.+|++.
T Consensus 219 ~~p~~~----~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 SYPKSL----SKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCccC----CHHHHHHHHHHcccCHhhCCCC
Confidence 011111 2234556678999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=339.13 Aligned_cols=258 Identities=24% Similarity=0.404 Sum_probs=201.2
Q ss_pred cCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCce
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNL 492 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~ 492 (770)
++|.+.+.||+|+||.||+|.+. .++.||||+++.. ......+.+|+.+|..+. ||||++++++|...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 35677889999999999999853 3468999999854 234457899999999997 99999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCC-----------------------------------------------------------
Q 004174 493 LLVYDFLSRGSLEENLHGNKK----------------------------------------------------------- 513 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~----------------------------------------------------------- 513 (770)
++||||+++|+|.++++....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999975421
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC
Q 004174 514 -----------------------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (770)
Q Consensus 514 -----------------------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 558 (770)
....+++..+..++.||+.||.|||+ .+|+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEe
Confidence 11246788889999999999999998 8999999999999999
Q ss_pred CCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhH
Q 004174 559 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 637 (770)
Q Consensus 559 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l 637 (770)
.++.+||+|||+++...............+++.|+|||++....++.++|||||||++|||++ |..||...........
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~ 353 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN 353 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence 999999999999986543322222223457889999999998889999999999999999998 8999965432221110
Q ss_pred HHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 638 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 638 v~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
. +..+. .+. .+......+..++..||+.+|.+||++.+|++.|+.
T Consensus 354 ~------~~~~~-----~~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 354 A------IKRGY-----RMA----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred H------HHcCC-----CCC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 0 01110 000 011112345566678999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=322.74 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=198.4
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCC--EEEEEEeCC--ChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGK--ELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~--~vAVK~l~~--~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~L 494 (770)
.++|.+.+.||+|+||.||+|... ++. .+++|.++. .......+.+|++++.++ +||||++++++|..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 457888999999999999999864 454 457777764 234567888999999999 89999999999999999999
Q ss_pred EEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCc
Q 004174 495 VYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 562 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~ 562 (770)
||||+++|+|.+++..... ....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence 9999999999999975431 12357899999999999999999999 89999999999999999999
Q ss_pred eEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhh
Q 004174 563 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWA 641 (770)
Q Consensus 563 vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~ 641 (770)
+||+|||++........ .....++..|+|||++....++.++|||||||++|||+| |..||....... .....
T Consensus 163 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~ 236 (303)
T cd05088 163 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL 236 (303)
T ss_pred EEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HHHHH
Confidence 99999999864321111 111234668999999988889999999999999999998 999997554322 11111
Q ss_pred cccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 642 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 642 ~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
. .+. .... +......+..++..||+.+|++||++.++++.|..
T Consensus 237 ~----~~~-----~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 237 P----QGY-----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred h----cCC-----cCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1 000 0000 11112245567778999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=312.92 Aligned_cols=248 Identities=29% Similarity=0.450 Sum_probs=198.3
Q ss_pred cCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEe-ecCceEEEEeecC
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF-EDNNLLLVYDFLS 500 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-~~~~~~LV~E~~~ 500 (770)
.+|.+.+.||+|+||.||++.. .|..+|+|.++... ..+.+.+|+.+++.++|+|++++++++. .++..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 4688899999999999999976 57889999987543 3567899999999999999999999765 4567899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+++|.+++..... ..+++..+..++.+++.||.|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~- 157 (256)
T cd05082 84 KGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD- 157 (256)
T ss_pred CCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccCC-
Confidence 9999999875432 358899999999999999999999 8999999999999999999999999999875543221
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
...++..|+|||++....++.++|||||||++|||++ |+.||...... .+..+.. .+. .+.+.
T Consensus 158 ----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~----~~~-----~~~~~ 221 (256)
T cd05082 158 ----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVE----KGY-----KMDAP 221 (256)
T ss_pred ----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh----cCC-----CCCCC
Confidence 2345678999999998899999999999999999998 99999754322 1221111 110 00111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
. .....+..++..||+.+|.+||++.++++.|..
T Consensus 222 ~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 222 D----GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred C----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1 112344556678999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=315.43 Aligned_cols=255 Identities=24% Similarity=0.428 Sum_probs=202.5
Q ss_pred hcCcccceeecccCceEEEEEEeC-C---CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-D---GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~---g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
..+|.+.+.||+|+||.||+|... + +..+|+|.++.. ....+.+.+|+.++..++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 356888999999999999999853 2 337999998753 3455788999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+|||++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 999999999999997543 358999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCce-ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 575 STSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 575 ~~~~~~~~-~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
........ .....++..|+|||++.++.++.++|+|||||++|||++ |..||....... ...+..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~~~~---~~-- 228 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIEEGY---RL-- 228 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHhCCC---cC--
Confidence 54332211 111234568999999998899999999999999999887 999997654322 111111100 00
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+ . .......+..++..|++.+|.+||++.++++.|..
T Consensus 229 ---~-~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 229 ---P-A----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ---C-C----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0 0 11112345667778999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=323.26 Aligned_cols=257 Identities=25% Similarity=0.436 Sum_probs=201.0
Q ss_pred cCcccceeecccCceEEEEEEeC--------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecC
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 490 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~--------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 490 (770)
++|.+.+.||+|+||.||++... ....+|+|+++.. ......+.+|+.++..+ +||||++++++|...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46788999999999999999641 2457899998753 34566788999999999 6999999999999989
Q ss_pred ceEEEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 558 (770)
..++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 99999999999999999965321 12358999999999999999999999 8999999999999999
Q ss_pred CCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhH
Q 004174 559 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 637 (770)
Q Consensus 559 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l 637 (770)
.++.+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++ |..||...........
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999986654322111111234567999999998899999999999999999999 8999976543221111
Q ss_pred HHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 638 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 638 v~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+ ..+.... .+......+..++..||+.+|.+||++.++++.|..
T Consensus 249 ~-------~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 292 (314)
T cd05099 249 L-------REGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292 (314)
T ss_pred H-------HcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 1 1111000 011112344556678999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.77 Aligned_cols=252 Identities=32% Similarity=0.484 Sum_probs=198.9
Q ss_pred cccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHH---HHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVI---KEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~---~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
|.+.+.||+|+||+||++... +++.||+|++....... ....+|+.++..++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 677899999999999999975 46689999998765332 23456999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++++|.+++... ..+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++..... .
T Consensus 81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--N 151 (260)
T ss_dssp TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--T
T ss_pred cccccccccccc----cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--c
Confidence 999999999833 358999999999999999999999 8999999999999999999999999999976422 1
Q ss_pred CceecccccccCCCCceeec-cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 580 HITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~-~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
........+|..|+|||++. ...++.++||||||+++|+|++|..||.................. ......
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~- 223 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR-------PLPSSS- 223 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT-------HHHHHT-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc-------cccccc-
Confidence 22333467899999999998 788999999999999999999999999865222222211111000 000000
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.........+..++..||+.+|++||++.+++++
T Consensus 224 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 --QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp --TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred --cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000112556667778999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=330.28 Aligned_cols=199 Identities=27% Similarity=0.357 Sum_probs=170.2
Q ss_pred hhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC-----
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----- 490 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----- 490 (770)
..++|.+.+.||+|+||.||++.. .+|+.||||++... ......+.+|+.+++.++||||++++++|....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 357899999999999999999986 46899999998643 345567889999999999999999999986543
Q ss_pred -ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccc
Q 004174 491 -NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (770)
Q Consensus 491 -~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 569 (770)
.+|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCC
Confidence 47999999975 67666642 37788899999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCc
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 631 (770)
+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 169 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~ 227 (359)
T cd07876 169 LARTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH 227 (359)
T ss_pred CccccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 9976533221 2235789999999999988999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=319.99 Aligned_cols=250 Identities=25% Similarity=0.337 Sum_probs=197.5
Q ss_pred cccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
|...+.||+|+||.||++... +++.||||.+.... .....+.+|+.++..++|+||+++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677889999999999999864 68899999986532 2345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++++|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999998865432 358899999999999999999999 899999999999999999999999999997654332
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
.. ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.............. .... .. ...
T Consensus 157 ~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~---~~~~--~~----~~~ 224 (285)
T cd05630 157 TI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER---LVKE--VQ----EEY 224 (285)
T ss_pred cc---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh---hhhh--hh----hhc
Confidence 21 234799999999999989999999999999999999999999976433211111100 0000 00 001
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 694 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs-----~~eVL~~ 694 (770)
...++ ..+..++..||+.+|.+||+ +.+++++
T Consensus 225 ~~~~~----~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 225 SEKFS----PDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred CccCC----HHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 11111 23445566799999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=328.36 Aligned_cols=240 Identities=26% Similarity=0.326 Sum_probs=186.3
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHH-HHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004174 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
+.||+|+||.||+|... +++.||+|++.... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 67889999997532 22334444544 56788999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
|+|.+++.... .+.+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-- 151 (325)
T cd05602 81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-- 151 (325)
T ss_pred CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--
Confidence 99999987543 47788888999999999999999 8999999999999999999999999999975432221
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 661 (770)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. . +.. .+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~------~-~~~------~~~~~ 218 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL------N-KPL------QLKPN 218 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH------h-CCc------CCCCC
Confidence 1233679999999999999999999999999999999999999997654322111110 0 000 01111
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 662 YDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 662 ~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
. ...+..++..||+.+|.+||++.+.+.
T Consensus 219 ~----~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 219 I----TNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred C----CHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 1 223445556799999999999774443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=318.97 Aligned_cols=260 Identities=29% Similarity=0.426 Sum_probs=200.6
Q ss_pred cCcccceeecccCceEEEEEEe-----CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec--Cce
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 492 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~ 492 (770)
..|.+.+.||+|+||.||++.. .++..||+|.++.. ......+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999973 35788999998754 34456899999999999999999999999875 568
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||+ ++++||||||+|||++.++.++|+|||++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccc
Confidence 99999999999999986543 358999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCce-ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCcc---------chhhHHHhhc
Q 004174 573 WASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK---------GQESLVMWAK 642 (770)
Q Consensus 573 ~~~~~~~~~~-~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~---------~~~~lv~~~~ 642 (770)
.......... .....++..|+|||++.++.++.++|||||||++|||++++.|+...... .......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV- 236 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-
Confidence 7654332211 12345677899999998888999999999999999999988765331110 000000000
Q ss_pred ccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 643 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 643 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
..+..+.. ..........+..++..||+.+|.+||++.++++.|+.
T Consensus 237 ~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 237 RVLEEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHHHcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 00001100 00111223467777888999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=312.19 Aligned_cols=247 Identities=27% Similarity=0.459 Sum_probs=197.8
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCChh
Q 004174 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~ 505 (770)
+.||.|+||.||++...+++.|++|++.... .....+.+|+++++.+.|+||+++++++...+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 3689999999999998779999999987543 35678999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceecc
Q 004174 506 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 585 (770)
Q Consensus 506 ~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~ 585 (770)
+++.... ..+++..+..++.+++.||.|||+ ++++||||||+|||++.++.++|+|||++..............
T Consensus 81 ~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKK---NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 9986543 257889999999999999999999 8899999999999999999999999999976543221111111
Q ss_pred cccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCCh
Q 004174 586 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 664 (770)
Q Consensus 586 ~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~ 664 (770)
..++..|+|||++.++.++.++|||||||++|||+| |..||...........+.. +. ... .+.
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-------~~--~~~-------~~~ 218 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-------GY--RMP-------APQ 218 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-------CC--CCC-------CCc
Confidence 234667999999998899999999999999999999 8999976543222211110 00 000 011
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 665 DQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 665 ~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
.....+..++..||+.+|.+||++.+|++.|+
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11234566777899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=331.83 Aligned_cols=258 Identities=25% Similarity=0.420 Sum_probs=199.1
Q ss_pred cCcccceeecccCceEEEEEEe------CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec-Cc
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED-NN 491 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~-~~ 491 (770)
++|.+.+.||+|+||.||+|.. .+++.||||+++.. ......+.+|+.++..+ +||||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5688999999999999999963 35788999999753 34456788999999999 689999999988654 46
Q ss_pred eEEEEeecCCCChhhhhccCCC----------------------------------------------------------
Q 004174 492 LLLVYDFLSRGSLEENLHGNKK---------------------------------------------------------- 513 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~---------------------------------------------------------- 513 (770)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999999864321
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceeccccc
Q 004174 514 -----DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588 (770)
Q Consensus 514 -----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~G 588 (770)
....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 01246888899999999999999999 8999999999999999999999999999986543322222222345
Q ss_pred ccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCChHHH
Q 004174 589 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQM 667 (770)
Q Consensus 589 T~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~ 667 (770)
++.|+|||++....++.++|||||||++|+|++ |..||........ +.. .+..+.... ..... .
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~----~~~~~~~~~-----~~~~~----~ 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR----RLKEGTRMR-----APDYT----T 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHH----HHhccCCCC-----CCCCC----C
Confidence 678999999998899999999999999999997 9999976433211 111 011111000 00111 1
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 668 ERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 668 ~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
..+..++..||+.+|.+||++.+|+++|+.
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 245666778999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=332.02 Aligned_cols=194 Identities=25% Similarity=0.387 Sum_probs=166.3
Q ss_pred hhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
...+|.+.+.||+|+||.||+|... +++.||+|+.... ....|+.+++.++||||++++++|...+..++||||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 3457999999999999999999865 5778999986543 234689999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+. ++|.+++.... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 139 ~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 139 YS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred cC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 95 58888886533 368999999999999999999999 899999999999999999999999999997543322
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCC
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~ 628 (770)
. .....||+.|+|||++....++.++|||||||++|||+++..|+..
T Consensus 212 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 212 A---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred c---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 1 1235799999999999999999999999999999999996555433
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=312.91 Aligned_cols=245 Identities=26% Similarity=0.418 Sum_probs=192.9
Q ss_pred ecccCceEEEEEEeC---CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCh
Q 004174 430 IGKGGSSQVYKGCLP---DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (770)
Q Consensus 430 LG~G~fG~Vy~a~~~---~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL 504 (770)
||+|+||.||+|.+. .+..||+|++.... ...+.+.+|+.+++.++||||++++++|. ....++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999753 45679999997543 34567999999999999999999999985 4578999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCce-e
Q 004174 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT-C 583 (770)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~-~ 583 (770)
.+++.... ..+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++........... .
T Consensus 82 ~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 82 NKFLSGKK---DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99987533 368999999999999999999999 8999999999999999999999999999986544332211 1
Q ss_pred cccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCC
Q 004174 584 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 662 (770)
Q Consensus 584 ~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~ 662 (770)
....+++.|+|||++....++.++|||||||++|||++ |..||...........+. .+... ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~~---------~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-------QGKRL---------DC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-------CCCCC---------CC
Confidence 11234578999999988889999999999999999996 999997654432211111 11100 01
Q ss_pred ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 663 DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 663 ~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+......+..++..||..+|++||++.+|.+.|+.
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 11122344556678999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=328.73 Aligned_cols=237 Identities=28% Similarity=0.348 Sum_probs=186.5
Q ss_pred eeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHH-HHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004174 428 NLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
+.||+|+||.||+|.. .+|+.||||++... ......+..|.. +++.++||||++++++|..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4689999999999986 47899999999753 233445566655 46779999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 151 (325)
T cd05604 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-- 151 (325)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--
Confidence 99998886543 58899999999999999999999 8999999999999999999999999999875432211
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 661 (770)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+. . +.+ .+. ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~------~-~~~--~~~----~~ 218 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL------H-KPL--VLR----PG 218 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH------c-CCc--cCC----CC
Confidence 1223679999999999999999999999999999999999999997654322111110 0 000 001 11
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHHH
Q 004174 662 YDYDQMERMVLASILCIRRDPRARPQMSL 690 (770)
Q Consensus 662 ~~~~~~~~l~~~a~~Cl~~dP~~RPs~~e 690 (770)
....+..++..|++.+|.+||++.+
T Consensus 219 ----~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 219 ----ASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred ----CCHHHHHHHHHHhccCHHhcCCCCC
Confidence 1223445567799999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=322.87 Aligned_cols=264 Identities=20% Similarity=0.329 Sum_probs=198.8
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
++|.+.+.||.|+||.||+|... +++.||+|.++... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56889999999999999999864 68899999987432 3345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
++ ++|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 58998886543 357899999999999999999999 899999999999999999999999999997654322
Q ss_pred CCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC--
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD-- 655 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld-- 655 (770)
.. .....+++.|+|||++... .++.++|||||||++|||++|+.||...+.......+.-.........+..+++
T Consensus 159 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 159 KT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred Cc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 11 1224678999999988654 578899999999999999999999987654332221111110000011111100
Q ss_pred -------cccCCC----CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 656 -------PALGNN----YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 656 -------~~l~~~----~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+..... ........+..++..||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 000112234566778999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=326.15 Aligned_cols=203 Identities=24% Similarity=0.308 Sum_probs=175.6
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||.||++... +++.||+|++.... .....+.+|+.++..++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999864 67899999987522 33455788999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||++||+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999997533 358899999999999999999999 8999999999999999999999999999976654
Q ss_pred CCCCceecccccccCCCCceeecc-----CCCCCcceEeechHHHHHHHhCCCCCCCCCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 631 (770)
.... ......||+.|+|||++.. +.++.++|||||||+||||++|+.||...+.
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 213 (331)
T cd05624 155 DGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred CCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH
Confidence 3221 1223579999999999875 5688999999999999999999999976544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=318.90 Aligned_cols=266 Identities=26% Similarity=0.358 Sum_probs=203.1
Q ss_pred cCcccceeecccCceEEEEEEeC-----CCCEEEEEEeCCChh--HHHHHHHHHHHHHhcCCCceeEEeeEEee--cCce
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-----DGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNL 492 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-----~g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~ 492 (770)
.+|...+.||+|+||.||+|... +++.+|||+++.... ..+.|.+|+++++.+.||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677789999999999999853 468899999986554 47789999999999999999999999987 5678
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 99999999999999997543 258999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCce-ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccc---cCC
Q 004174 573 WASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL---SSG 648 (770)
Q Consensus 573 ~~~~~~~~~~-~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~---~~g 648 (770)
.......... .....++..|+|||++....++.++||||||+++|||++|+.||......... +..+.. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~----~~~~~~~~~~~~ 233 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR----MIGIAQGQMIVT 233 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc----ccccccccccHH
Confidence 7763322211 11234566799999999889999999999999999999999998653221100 000000 000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 649 ~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+...+........+......+..++.+||+.+|.+||++.+|+++|..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 0001111100000111112456677789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=335.77 Aligned_cols=198 Identities=23% Similarity=0.331 Sum_probs=172.4
Q ss_pred cCcccceeecccCceEEEEEEeC---CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~---~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
.+|.+.+.||+|+||.||++... .+..||||.+.... .+.+|+++|+.++||||++++++|......++|||+
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 46899999999999999999753 46789999887542 346799999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+. ++|.+++... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++.......
T Consensus 168 ~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 168 YK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred cC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 95 6888888433 358999999999999999999999 899999999999999999999999999998665543
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 631 (770)
.........||+.|+|||++....++.++|||||||+||||++|+.||.+...
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 33333346799999999999999999999999999999999999999977554
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=324.31 Aligned_cols=269 Identities=23% Similarity=0.326 Sum_probs=210.5
Q ss_pred HHhhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcCCCceeEEeeEEee-----
Q 004174 418 LSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----- 488 (770)
Q Consensus 418 ~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----- 488 (770)
......|...+.||+|+||.|+.+.. .+|+.||||.+.. .....++..+|+.+|+.++|+||+.+++.+..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 34455677788999999999999986 4789999998863 34567888999999999999999999999865
Q ss_pred cCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccc
Q 004174 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (770)
Q Consensus 489 ~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 568 (770)
-+..|+|+|+| +.+|...++... .++...+..++.||++||.|+|+ .+|+||||||+|+|++.+..+||+||
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccc
Confidence 35789999999 559999987553 48889999999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCceecccccccCCCCceeec-cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccC
Q 004174 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 647 (770)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~GT~~YlAPE~~~-~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 647 (770)
|+|+...........+..+.|..|.|||++. ...|+...||||.||+|.||++|++-|.+.+...|..++....+....
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 9999886543333446678999999999876 457999999999999999999999999998887777776554433322
Q ss_pred CccccccCccc-------C--CCCCh-----HHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 648 GKVTQLLDPAL-------G--NNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 648 g~l~~lld~~l-------~--~~~~~-----~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+..+-.... . ...++ ......+.+.-++|..||.+|+|+++.|++
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 22222211100 0 00011 111123334456999999999999999874
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=315.85 Aligned_cols=266 Identities=24% Similarity=0.307 Sum_probs=204.1
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChh---HHHHHHHHHHHHHhcCCCc-eeEEeeEEeecC------c
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSED---VIKEFVLEIEIITTLHHKN-IISLLGFCFEDN------N 491 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~---~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~------~ 491 (770)
.|...+.||+|+||+||+|.. .+|+.||+|.++...+ ......+|+.+|+.|+|+| |++|++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 455566799999999999985 5789999999986533 4566789999999999999 999999999877 7
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 571 (770)
++|||||++. +|.+++.........++...+..++.||+.||+|||+ ++|+||||||.||||+.+|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence 9999999966 9999997655322356668899999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcc
Q 004174 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650 (770)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 650 (770)
+...-... ..+..++|..|.|||++.+. .|+...||||+||++.||++++.-|.++....+...+--......+..+
T Consensus 168 ra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 86653322 23456899999999999876 6999999999999999999999999887764443332211111111111
Q ss_pred ---ccccCc--ccCCCC-C-------hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 651 ---TQLLDP--ALGNNY-D-------YDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 651 ---~~lld~--~l~~~~-~-------~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+.+- ...... . .........++..||+.+|.+|.++..++.+
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111110 000000 0 0111345667788999999999999999986
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.11 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=200.6
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCC--ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
+|.+.+.||+|+||.||++... +++.+|+|.++. .....+.+.+|+.+++.++|+||+++++++..++.+++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999864 688999999864 2345677889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++|+|.+++..... ..+++..++.++.|++.||.|||+ ++|+|+||||+|||++.++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999998864332 357899999999999999999999 8999999999999999999999999999976644322
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
. .....|++.|+|||++....++.++|+||||+++|+|++|..||...+.......+ ..+.... +.
T Consensus 156 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~~-----~~ 221 (255)
T cd08219 156 Y--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV-------CQGSYKP-----LP 221 (255)
T ss_pred c--cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHH-------hcCCCCC-----CC
Confidence 1 12356899999999999888999999999999999999999999765432211111 1111111 11
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.. ....+..++..||+.+|.+||++.+++..
T Consensus 222 ~~----~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 SH----YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cc----cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11 11234556678999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=330.15 Aligned_cols=250 Identities=26% Similarity=0.362 Sum_probs=205.6
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~L 494 (770)
...|.+.+.||+|.||.||++..+ +|+.+|+|++.+.. .....+.+|+.+|+++. |||||.+.+.|.+...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 346777889999999999999876 49999999997643 24568899999999998 9999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC----CceEEccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD----FEPQLSDFGL 570 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~----~~vkL~DFGl 570 (770)
|||++.||.|.+.|... .+++..+..++.|++.++.|||+ .+|+||||||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999765 28999999999999999999999 999999999999999543 4799999999
Q ss_pred cccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcc
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 650 (770)
+...... .....++||++|+|||++....|+..+||||+||++|.|++|.+||.+.........+.. +++
T Consensus 186 a~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~-------~~~ 255 (382)
T KOG0032|consen 186 AKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR-------GDF 255 (382)
T ss_pred ceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc-------CCC
Confidence 9988762 223457999999999999999999999999999999999999999988765443332221 121
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 651 ~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+-++. -....+....++..|+..||.+|+++.++|++
T Consensus 256 -~f~~~~-----w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -DFTSEP-----WDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -CCCCCC-----ccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 111111 11112334445567999999999999999985
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=325.14 Aligned_cols=203 Identities=25% Similarity=0.323 Sum_probs=174.1
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||.||++..+ +++.+|+|++.+. ......+..|+.++..++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999865 5788999998642 223445788999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 9999999999997533 258899999999999999999999 8999999999999999999999999999975543
Q ss_pred CCCCceecccccccCCCCceeec-----cCCCCCcceEeechHHHHHHHhCCCCCCCCCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 631 (770)
.... ......||+.|+|||++. .+.++.++|||||||+||||++|+.||...+.
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~ 213 (332)
T cd05623 155 DGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (332)
T ss_pred CCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence 2221 222357999999999986 34688999999999999999999999986543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=305.51 Aligned_cols=265 Identities=23% Similarity=0.330 Sum_probs=210.4
Q ss_pred HhhcCcccceeecccCceEEEEEE-eCCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc-----
Q 004174 419 SATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----- 491 (770)
Q Consensus 419 ~~t~~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~----- 491 (770)
...++|++.+.||+|||+.||++. ..++..||+|.+.... +..+..++|++..++++|||++++++++..+..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345689999999999999999998 4678899999988655 778889999999999999999999999876544
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 571 (770)
.||+++|...|+|.+.+...+.....+++.++++|+.+|++||.+||... .++.||||||.|||+.+.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 89999999999999999877766678999999999999999999999843 45999999999999999999999999998
Q ss_pred ccccCCCCCce-------ecccccccCCCCceeec---cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhh
Q 004174 572 KWASTSSSHIT-------CTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 641 (770)
Q Consensus 572 ~~~~~~~~~~~-------~~~~~GT~~YlAPE~~~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~ 641 (770)
....-...... ...-..|..|.|||.|. +...++++|||||||+||+|+.|..||+..-..+....
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla---- 252 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA---- 252 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE----
Confidence 75543211100 01124688999999986 44688999999999999999999999975433222110
Q ss_pred cccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 642 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 642 ~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
-...++++.- .-.....+.+.+++.+|++.||.+||++.+++..+..
T Consensus 253 -LAv~n~q~s~--------P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 253 -LAVQNAQISI--------PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred -Eeeecccccc--------CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 0111111111 1111245667778889999999999999999988754
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=311.34 Aligned_cols=249 Identities=27% Similarity=0.442 Sum_probs=202.8
Q ss_pred cCcccceeecccCceEEEEEEeCC-CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
++|...+.||.|+||.||+|...+ ++.+++|.+..... .+.+.+|+++++.++||||+++++++......+++|||++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 578888999999999999999754 88999999976544 6789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 82 AGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 999999986543 368999999999999999999999 88999999999999999999999999999876543321
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 660 (770)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||....+..... .... . ..+.+.
T Consensus 156 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~--~~~~-----~-----~~~~~~- 220 (256)
T cd06612 156 --RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF--MIPN-----K-----PPPTLS- 220 (256)
T ss_pred --cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh--hhcc-----C-----CCCCCC-
Confidence 123468899999999998899999999999999999999999997654322111 1000 0 000010
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 661 ~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
.+......+..++..||+.+|.+||++.+|++
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 -DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 01111234555667899999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=311.87 Aligned_cols=238 Identities=25% Similarity=0.419 Sum_probs=190.9
Q ss_pred eeecccCceEEEEEEeCCCC-----------EEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 428 NLIGKGGSSQVYKGCLPDGK-----------ELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~g~-----------~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
+.||+|+||.||+|...+.. .+++|++.........|.+|+.+++.++||||++++++|.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 36899999999999875432 57888887655447889999999999999999999999988 7789999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC-------ceEEcccc
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-------EPQLSDFG 569 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-------~vkL~DFG 569 (770)
||+++|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus 80 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 80 EYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999976432 58899999999999999999998 8999999999999999887 79999999
Q ss_pred ccccccCCCCCceecccccccCCCCceeeccC--CCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhccccc
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILS 646 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~--~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~ 646 (770)
++...... ....++..|+|||++... .++.++|||||||++|||++ |..||.............+.
T Consensus 154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~----- 222 (259)
T cd05037 154 IPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ----- 222 (259)
T ss_pred cccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC-----
Confidence 99765431 123577889999999876 78999999999999999999 68888665432221111100
Q ss_pred CCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 647 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 647 ~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
. .. +......+..++..||..+|.+||++.+|++.|.
T Consensus 223 --~--~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 --H--RL---------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --C--CC---------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 00 0001145566777899999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=327.92 Aligned_cols=263 Identities=25% Similarity=0.423 Sum_probs=213.8
Q ss_pred cCcccceeecccCceEEEEEEeCCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
+...+.+.||+|-||.|.++....+..||||+++... ...++|..|+.+|.+|+||||+.|+|+|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 3456788999999999999998788999999999754 45689999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++|+|.+++...... .+.-.....|+.||+.||+||.+ .++|||||.+.|+|++.++++||+|||+++-+-....
T Consensus 618 EnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred hcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 999999999866431 23445556799999999999999 8899999999999999999999999999996665555
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh--CCCCCCCCCccchhhHHHhhcccccCCccccc-cCc
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKPISNDHPKGQESLVMWAKPILSSGKVTQL-LDP 656 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt--G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l-ld~ 656 (770)
+......+-...|||||.+..++++.++|+|+||++|||+++ ...||..... +..+.-...++..+..... .-|
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCCcceeccCC
Confidence 554444566789999999999999999999999999999976 7889976433 3334333334433322222 222
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~ 699 (770)
. -....+.++++.||+++-.+||+++++..+|+.+.
T Consensus 770 ~-------~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 770 P-------ACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred C-------cCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 2 22345667788999999999999999999987543
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.31 Aligned_cols=248 Identities=27% Similarity=0.437 Sum_probs=193.1
Q ss_pred eeecccCceEEEEEEeC-CCC--EEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004174 428 NLIGKGGSSQVYKGCLP-DGK--ELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~-~g~--~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
++||+|+||.||+|... ++. .+++|.++.. ....+.+.+|++++.++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999874 343 4688888742 34567889999999999 799999999999999999999999999
Q ss_pred CChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccc
Q 004174 502 GSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (770)
Q Consensus 502 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 569 (770)
|+|.+++..... ....+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 999999875431 12357899999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCC
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSG 648 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g 648 (770)
++........ ......++.|+|||++....++.++|||||||++|||++ |..||........ ..... .+
T Consensus 158 l~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~~----~~ 227 (270)
T cd05047 158 LSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YEKLP----QG 227 (270)
T ss_pred Cccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH---HHHHh----CC
Confidence 9863321111 111234667999999998899999999999999999997 9999976443221 11110 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 649 ~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.. . .. .......+..++..||+.+|.+||++.+++..|..
T Consensus 228 ~~---~--~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 228 YR---L--EK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred CC---C--CC----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 00 0 00 11112345667788999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=315.66 Aligned_cols=250 Identities=26% Similarity=0.470 Sum_probs=196.3
Q ss_pred eeecccCceEEEEEEeCC-------CCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 428 NLIGKGGSSQVYKGCLPD-------GKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~-------g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+.||+|+||.||+|...+ ++.+|||.+.... .....+.+|+.+++.++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999886543 4567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC-----ceEEccccc
Q 004174 499 LSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-----EPQLSDFGL 570 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-----~vkL~DFGl 570 (770)
+++++|.+++..... ....+++..++.++.|++.||.|||+ .+++|+||||+|||++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975322 22457899999999999999999998 8899999999999999877 899999999
Q ss_pred cccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCc
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGK 649 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 649 (770)
++...............++..|+|||++..+.++.++|||||||++|||++ |+.||....... ..... ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~----~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV----TAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH----hcCC
Confidence 976543322222222346788999999999999999999999999999998 999997543321 11111 0110
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 650 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 650 l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
.. .........+..++..||+.+|.+||++.+|++.|+
T Consensus 231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00 001112234566777899999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.65 Aligned_cols=250 Identities=25% Similarity=0.428 Sum_probs=199.4
Q ss_pred CcccceeecccCceEEEEEEeCCCCEEEEEEeCCC-------hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~-------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
+|...+.||.|+||.||+|...+|+.+|||.++.. ......+.+|+++++.++|+||++++++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47788999999999999998888999999988642 12345688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999996542 47899999999999999999998 889999999999999999999999999997653
Q ss_pred CCCCC----ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 576 TSSSH----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 576 ~~~~~----~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
..... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+ .. ..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~--~~---~~~~-- 226 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI--GA---HRGL-- 226 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh--hh---ccCC--
Confidence 21111 1112356899999999999888999999999999999999999999764332211110 00 0000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
.+.+... ....+..++..||+.+|.+||++.++++
T Consensus 227 ---~~~~~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 ---MPRLPDS----FSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCCCCC----CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111111 2234556667899999999999999886
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=314.27 Aligned_cols=253 Identities=28% Similarity=0.383 Sum_probs=188.6
Q ss_pred eecccCceEEEEEEeCC---CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCC
Q 004174 429 LIGKGGSSQVYKGCLPD---GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 503 (770)
Q Consensus 429 ~LG~G~fG~Vy~a~~~~---g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggs 503 (770)
.||+|+||.||+|...+ ...+++|.+... ......|.+|+.+++.++||||++++++|.....+++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 346888887643 2445678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCce
Q 004174 504 LEENLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (770)
Q Consensus 504 L~~~l~~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~ 582 (770)
|.+++...... ...+.+.....++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999764321 2345678889999999999999999 8999999999999999999999999999875433222111
Q ss_pred ecccccccCCCCceeecc-------CCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 583 CTDVAGTFGYLAPEYFMY-------GKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 583 ~~~~~GT~~YlAPE~~~~-------~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
.....+++.|+|||++.. ..++.++|||||||++|||++ |..||....+... +.. . ... ....+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~-~---~~~-~~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LKQ-V---VRE-QDIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HHH-H---hhc-cCccCC
Confidence 222356778999998753 356789999999999999999 8889875433211 110 0 111 111222
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
.+.+...+. ..+..+...|+ .+|.+||++.+|+++|.
T Consensus 232 ~~~~~~~~~----~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQLDLKYS----DRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcccccCC----HHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222222222 23333445677 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.87 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=189.5
Q ss_pred eecccCceEEEEEEeCCC---CEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCC
Q 004174 429 LIGKGGSSQVYKGCLPDG---KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 503 (770)
Q Consensus 429 ~LG~G~fG~Vy~a~~~~g---~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggs 503 (770)
.||+|+||.||+|...++ ..+++|.++.. ....+.|.+|+.++..++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975433 34667776643 2456789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCcee
Q 004174 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583 (770)
Q Consensus 504 L~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~ 583 (770)
|.+++.........+.+..+..++.||+.||.|||+ .+++||||||+|||++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997654333456777888999999999999999 88999999999999999999999999998643222111112
Q ss_pred cccccccCCCCceeecc-------CCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 584 TDVAGTFGYLAPEYFMY-------GKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 584 ~~~~GT~~YlAPE~~~~-------~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
....|+..|+|||++.. ..++.++|||||||++|||++ |..||...........+ +. +....+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~------~~-~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV------IK-DQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------Hh-hcccccCC
Confidence 23568899999998853 245789999999999999997 57788654332211111 11 12223344
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
+.+...+. ..+..++..|| .+|++||++.+|++.|.
T Consensus 232 ~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 44433322 23333445688 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=318.60 Aligned_cols=256 Identities=26% Similarity=0.386 Sum_probs=202.9
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.++|.+.+.||+|+||+||++... +|+.||+|++... ....+.+.+|++++..++||||+++++++...+.+++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356888899999999999999864 6889999988643 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+++++|.+++...+ .+++..+..++.+++.||.|||+. ++++||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999886542 588999999999999999999961 47999999999999999999999999998654332
Q ss_pred CCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccc-----hhhHHHhhcccccCCcccc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG-----QESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~-----~~~lv~~~~~~~~~g~l~~ 652 (770)
.. ....|+..|+|||++..+.++.++|||||||++|+|++|+.||....... ...+..+....... .
T Consensus 158 ~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--- 229 (284)
T cd06620 158 IA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-P--- 229 (284)
T ss_pred cc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-c---
Confidence 21 23578999999999988899999999999999999999999998654321 11111111111110 0
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
.+.+.. .+....+..++..||+.+|.+||++.+++++.
T Consensus 230 --~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 --PPRLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --CCCCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 011111 11223455667789999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=311.42 Aligned_cols=248 Identities=28% Similarity=0.464 Sum_probs=197.5
Q ss_pred eeecccCceEEEEEEeCC--C--CEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004174 428 NLIGKGGSSQVYKGCLPD--G--KELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~--g--~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
+.||+|++|.||+|.+.+ + ..+|||.+.... ...+.+.+|+.++++++||||+++++++.. ..+++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 3 368999998644 456789999999999999999999999988 889999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
++|.+++..... ..++|..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976542 368999999999999999999999 899999999999999999999999999998775533221
Q ss_pred ee-cccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 582 TC-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 582 ~~-~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
.. ....++..|+|||++....++.++|||||||++|||++ |+.||...........+. . .+. .+..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~--~----~~~--~~~~---- 222 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID--K----EGE--RLER---- 222 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--h----cCC--cCCC----
Confidence 11 12457889999999998899999999999999999999 999997543322111110 0 000 0000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
+......+..++..||+.+|.+||++.+|++.|.
T Consensus 223 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 ---PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1111234556777899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=346.17 Aligned_cols=259 Identities=25% Similarity=0.329 Sum_probs=203.9
Q ss_pred hhcCcccceeecccCceEEEEEEeCCC-CEEEEEEeCC-ChhHHHHHHHHHHHHHhcC-CCceeEEeeE-Eee---c---
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLPDG-KELAVKILKP-SEDVIKEFVLEIEIITTLH-HKNIISLLGF-CFE---D--- 489 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g-~~vAVK~l~~-~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~-~~~---~--- 489 (770)
...++.++++|.+|||+.||+|.+..+ ..||+|++-. ++...+.+.+||++|++|+ |+|||.+++. ... +
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345678899999999999999997655 9999998754 5577888999999999998 9999999993 222 1
Q ss_pred CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccc
Q 004174 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (770)
Q Consensus 490 ~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 569 (770)
-+++|.||||.||.|-+++..... ..|++.++++|+.++++|+.+||... .+|||||||-+||||+.+++.||||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 257899999999999999986554 34999999999999999999999843 679999999999999999999999999
Q ss_pred ccccccCCCC-Ccee------cccccccCCCCceeec---cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHH
Q 004174 570 LAKWASTSSS-HITC------TDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (770)
Q Consensus 570 la~~~~~~~~-~~~~------~~~~GT~~YlAPE~~~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~ 639 (770)
.|.-...... .... -...-|+.|.|||++. +..+++|+|||+|||+||-|+....||+.....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------- 264 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------- 264 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------
Confidence 9863322221 1000 0124689999999875 557999999999999999999999999864221
Q ss_pred hhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCCC
Q 004174 640 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 700 (770)
Q Consensus 640 ~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~~ 700 (770)
.+++....-.....+..++..++..||+.+|.+||++-+|++.+.....
T Consensus 265 ------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 265 ------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 1112111111123456677778888999999999999999987655443
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.42 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=202.6
Q ss_pred cCcccceeecccCceEEEEEEeC--------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecC
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 490 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~--------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 490 (770)
.+|.+.+.||+|+||.||++... .+..||+|+++.. ....+.+.+|+.++.++ +||||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 35888999999999999999742 1236899988753 34567899999999999 7999999999999999
Q ss_pred ceEEEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 558 (770)
..+++|||+++|+|.+++..... ....++|..+..++.|++.||.|||+ ++|+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 99999999999999999875321 12358899999999999999999999 8999999999999999
Q ss_pred CCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhH
Q 004174 559 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 637 (770)
Q Consensus 559 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l 637 (770)
.++.+||+|||+++...............++..|+|||++....++.++|||||||++|||++ |..||...........
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999999999986654322222222334568999999998999999999999999999999 8999976543221111
Q ss_pred HHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004174 638 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699 (770)
Q Consensus 638 v~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~ 699 (770)
+. .+.... .+......+..++..||+.+|.+||++.++++.|....
T Consensus 249 ~~-------~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 249 LK-------EGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HH-------cCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 10 110000 11112234556777899999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=310.11 Aligned_cols=250 Identities=28% Similarity=0.420 Sum_probs=200.3
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCC------Ch---hHHHHHHHHHHHHHhcC-CCceeEEeeEEeecC
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP------SE---DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDN 490 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~------~~---~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~ 490 (770)
+.|...+.||.|..++|-++++ ++|+++|+|++.. ++ ...+.-.+|+.||+++. ||+|+.+.++|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3466678899999999999875 4789999998853 11 33455668999999985 999999999999999
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 570 (770)
.+++|+|.|+.|.|+++|... ..+++.+.+.|+.|++.|+.|||. ++|+||||||+|||++++.++||+|||+
T Consensus 97 F~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccce
Confidence 999999999999999999654 468999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCceeecc------CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhccc
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMY------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 644 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~ 644 (770)
|..+..... ....||||+|+|||.+.- ..|+..+|+|++||+||.||.|.+||-.....-...+++..+..
T Consensus 170 a~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 170 ACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ 246 (411)
T ss_pred eeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence 998876543 245799999999998852 35888999999999999999999999654322222333322222
Q ss_pred ccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 645 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 645 ~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+.+..+.. .......++..||+.||.+|-|+.|+|.+
T Consensus 247 F~speWad-------------is~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 247 FRSPEWAD-------------ISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cCCcchhh-------------ccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 22211111 12234456678999999999999999864
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=330.62 Aligned_cols=263 Identities=22% Similarity=0.262 Sum_probs=197.6
Q ss_pred HhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-----
Q 004174 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED----- 489 (770)
Q Consensus 419 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~----- 489 (770)
...++|.+.+.||+|+||.||++... .++.||||++... ......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999864 6889999999753 34456788999999999999999999998643
Q ss_pred -CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccc
Q 004174 490 -NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (770)
Q Consensus 490 -~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 568 (770)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+ ++|+||||||+||||+.++.+||+||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeC
Confidence 357999999965 67766642 37888999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhh-------
Q 004174 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA------- 641 (770)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~------- 641 (770)
|+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 164 g~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 164 GLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred cccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99986544322 22357899999999999889999999999999999999999999865432211110000
Q ss_pred ---------ccccc-CCccccccCcc------cC--CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 642 ---------KPILS-SGKVTQLLDPA------LG--NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 642 ---------~~~~~-~g~l~~lld~~------l~--~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..... ......+..+. .. ..........+..++..||+.||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000 00000000000 00 00011122345667788999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.49 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=199.3
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
.++|.+.+.||+|+||.||+|.. .+++.||+|+++... .....+.+|+.++..++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 34688889999999999999986 468899999987543 3445688899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++++|.+++.... .+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 88 CGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 99999999986543 58899999999999999999999 899999999999999999999999999987654322
Q ss_pred CCceecccccccCCCCceeec---cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 579 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
.. .....|++.|+|||++. .+.++.++|||||||++|+|++|..||....+......... . . ...
T Consensus 161 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~--~-----~---~~~ 228 (267)
T cd06645 161 AK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK--S-----N---FQP 228 (267)
T ss_pred cc--cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc--c-----C---CCC
Confidence 11 12357899999999974 45688999999999999999999999976543222111110 0 0 000
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+.+..... ....+..++..||+.+|++||++.+|+++
T Consensus 229 ~~~~~~~~--~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 229 PKLKDKMK--WSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CcccccCC--CCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 11111111 11234556678999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.43 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=200.5
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
.+|.+.+.||+|+||.||+|.. .+++.|++|.+.... ...+.+.+|+.+++.+.||||++++++|..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4788899999999999999985 468899999887543 34567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++++|.+++... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 100 ~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999998642 47889999999999999999999 8999999999999999999999999999876543221
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
. .....|++.|+|||++....++.++|||||||++|+|++|+.||....+... +..+.. .+. +.+.
T Consensus 172 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~~----~~~------~~~~ 237 (296)
T cd06654 172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIAT----NGT------PELQ 237 (296)
T ss_pred c--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHhc----CCC------CCCC
Confidence 1 1234689999999999988899999999999999999999999976554221 111110 000 0000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+......+..++..||..+|++||++.+++++
T Consensus 238 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 --NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 011122345556678999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=367.96 Aligned_cols=259 Identities=29% Similarity=0.532 Sum_probs=214.3
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
..|...++||+|+||.||+|.. .+|..||||.++..... ...|++++++++|||||+++++|.+.+..++||||++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 4577788999999999999986 57899999998754322 2346889999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+|+|.++++ .++|..+..|+.|++.||+|||..+..+|+||||||+||+++.++.+++. ||........
T Consensus 767 ~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 767 GKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 999999995 27899999999999999999996555899999999999999999888876 6655433221
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 660 (770)
....||+.|+|||++..+.++.++|||||||++|||+||+.||..... ....++.|............++|+.+..
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccC
Confidence 123689999999999999999999999999999999999999954322 3345667776655555666777877754
Q ss_pred C--CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 661 N--YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 661 ~--~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
. .+.+++..+..++..||+.+|++||+|.+|++.|+..
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 3 3456677788889999999999999999999999754
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=339.38 Aligned_cols=196 Identities=24% Similarity=0.321 Sum_probs=169.5
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
..+|.+.+.||+|+||.||+|... .++.||||... ...+.+|+++|++++|+||+++++++..++..+||||++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 457999999999999999999875 57889999643 234678999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
. ++|.+++.... ..++|..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.......
T Consensus 243 ~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 243 R-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred C-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 5 68988886433 368999999999999999999999 8999999999999999999999999999987654332
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCC
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~ 628 (770)
........||+.|+|||++.+..++.++|||||||+||||++|..|+..
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~ 364 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS 364 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence 2222336799999999999999999999999999999999998876543
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=309.68 Aligned_cols=247 Identities=30% Similarity=0.495 Sum_probs=198.2
Q ss_pred cCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
++|.+.+.||+|+||.||++.. .++.+|+|+++... ....+.+|+.++..++||||+++++++..+ ..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 4578899999999999999875 77889999987543 346788999999999999999999998764 57999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
++|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 83 GNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999975432 357899999999999999999998 899999999999999999999999999997643321
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 660 (770)
.....+..|+|||++..+.++.++|+|||||++|||++ |+.||...........+. .+.. .++
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~---~~~---- 218 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-------KGYR---MEP---- 218 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-------CCCC---CCC----
Confidence 11234678999999998899999999999999999998 999997654432211111 1100 000
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 661 ~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.......+..++..||+.+|++||++.++++.|+.
T Consensus 219 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 --PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11112345567778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=329.34 Aligned_cols=199 Identities=24% Similarity=0.344 Sum_probs=170.7
Q ss_pred hhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec------
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------ 489 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------ 489 (770)
..++|.+.+.||+|+||.||++... .++.||||++... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999864 6889999999753 34456788999999999999999999987543
Q ss_pred CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccc
Q 004174 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (770)
Q Consensus 490 ~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 569 (770)
...|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999965 77777642 37788999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCc
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 631 (770)
+++....... .....||+.|+|||++.+..++.++|||||||+||||++|+.||...+.
T Consensus 172 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 230 (364)
T cd07875 172 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 230 (364)
T ss_pred CccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH
Confidence 9986644322 1235789999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.20 Aligned_cols=253 Identities=23% Similarity=0.432 Sum_probs=201.1
Q ss_pred cCcccceeecccCceEEEEEEeC-CCC----EEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~----~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
.+|.+.+.||+|+||.||+|..+ +|. .+|+|.++... .....+.+|+.++..++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46788899999999999999854 333 58999887643 455788999999999999999999999987 78999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999997543 258999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
.............++..|+|||.+..+.++.++|||||||++|||++ |+.||...........+. .+. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~--~~ 230 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-------KGE--RL 230 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-------CCC--CC
Confidence 54333222222234678999999988899999999999999999999 999997754332211111 110 00
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
..+ ......+..++..||..+|.+||++.++++.|..
T Consensus 231 ~~~-------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~ 267 (279)
T cd05057 231 PQP-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSK 267 (279)
T ss_pred CCC-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 001 1111234556678999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.38 Aligned_cols=260 Identities=27% Similarity=0.434 Sum_probs=204.2
Q ss_pred CHHHHHHhhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEee--
Q 004174 413 NYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE-- 488 (770)
Q Consensus 413 ~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~-- 488 (770)
++.++....+.|.+.+.||.|+||.||+|.. .+++.+|+|++.........+..|+.++.++ +|+||++++++|..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 4556666778899999999999999999986 4688999999977666667788999999998 69999999999853
Q ss_pred ----cCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceE
Q 004174 489 ----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (770)
Q Consensus 489 ----~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vk 564 (770)
.+..+++|||+++|+|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.++
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence 4578999999999999999875432 347788899999999999999999 8999999999999999999999
Q ss_pred EccccccccccCCCCCceecccccccCCCCceeec-----cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHH
Q 004174 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (770)
Q Consensus 565 L~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~ 639 (770)
|+|||++......... .....|++.|+|||++. ...++.++|||||||++|||++|..||....+......+.
T Consensus 162 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 239 (282)
T cd06636 162 LVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP 239 (282)
T ss_pred EeeCcchhhhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh
Confidence 9999998765432211 12357899999999886 3468889999999999999999999997654322211111
Q ss_pred hhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 640 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 640 ~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+. ..+.+... .....+..++..||+.+|.+||++.+++++
T Consensus 240 ~~------------~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 240 RN------------PPPKLKSK---KWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred hC------------CCCCCccc---ccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 10 00111100 112345566678999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.61 Aligned_cols=257 Identities=27% Similarity=0.413 Sum_probs=203.2
Q ss_pred HhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecC------
Q 004174 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN------ 490 (770)
Q Consensus 419 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~------ 490 (770)
..+++|.+.+.||.|+||.||+|... +++.+++|++.........+.+|+.++.++ .|+||++++++|....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 35688999999999999999999874 678999999987666667899999999999 6999999999997654
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 570 (770)
.+++||||+++++|.+++.........+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999987544333568999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCceeecc-----CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccc
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 645 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~ 645 (770)
+......... .....|++.|+|||++.. ..++.++|||||||+||+|++|+.||....+... +....
T Consensus 160 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~---- 231 (275)
T cd06608 160 SAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFKIP---- 231 (275)
T ss_pred ceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHHhh----
Confidence 8765443221 123568999999998753 3477899999999999999999999975433211 11100
Q ss_pred cCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 646 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 646 ~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+.. +.+. ........+..++..||..||.+|||+.+++++
T Consensus 232 -~~~~-----~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 -RNPP-----PTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -ccCC-----CCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0100 0111 111123455667778999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=357.00 Aligned_cols=256 Identities=24% Similarity=0.357 Sum_probs=197.5
Q ss_pred HhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec--Cce
Q 004174 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 492 (770)
Q Consensus 419 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~ 492 (770)
...++|.+.+.||+|+||+||++... ++..+|+|++... ......|..|+.+|..|+|||||+++++|... ..+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 44578999999999999999999864 5778999998742 34567889999999999999999999998653 568
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC----CCceEEecccCCCeeeCC---------
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS----AQRVIHRDVKSSNILLSD--------- 559 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~----~~~IiHrDLKp~NILL~~--------- 559 (770)
||||||+++|+|.++|.........+++..++.|+.||+.||.|||+.+ .++||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999999754333346899999999999999999999832 145999999999999964
Q ss_pred --------CCceEEccccccccccCCCCCceecccccccCCCCceeecc--CCCCCcceEeechHHHHHHHhCCCCCCCC
Q 004174 560 --------DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISND 629 (770)
Q Consensus 560 --------~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~ 629 (770)
.+.+||+|||++........ .....||+.|+|||++.. ..++.++||||||||||||+||+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 23489999999986644322 123579999999999864 45889999999999999999999999754
Q ss_pred CccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 630 HPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 630 ~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
.... .++.-. ..+ +.+..... ...+..++..||+.+|.+||++.++|.
T Consensus 247 ~~~~--qli~~l----k~~-------p~lpi~~~---S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNFS--QLISEL----KRG-------PDLPIKGK---SKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcHH--HHHHHH----hcC-------CCCCcCCC---CHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 3321 111100 000 00100001 123455667899999999999999985
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=313.37 Aligned_cols=251 Identities=25% Similarity=0.401 Sum_probs=198.7
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
+.|.+.+.||.|+||.||+|... +++.+++|++.... ...+.+.+|+.+++.++||||++++++|..++.+++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 46888899999999999999874 58899999987543 55678899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++++|..++.... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++........
T Consensus 92 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 92 PGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 9999998876433 358899999999999999999999 8999999999999999999999999999875433221
Q ss_pred CceecccccccCCCCceeec-----cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 580 HITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
......+++.|+|||++. ...++.++|||||||++|||++|+.||...++.. ....+.. ..
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~~~-----~~----- 231 (292)
T cd06644 166 --RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIAK-----SE----- 231 (292)
T ss_pred --ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--HHHHHhc-----CC-----
Confidence 112356889999999985 3457889999999999999999999997654321 1111111 00
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+... .+......+..++..||+.+|++||++.+++++
T Consensus 232 ~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 232 PPTLS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CccCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 011112234556678999999999999999873
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=310.25 Aligned_cols=238 Identities=25% Similarity=0.463 Sum_probs=187.3
Q ss_pred eeecccCceEEEEEEeCC-------------CCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 428 NLIGKGGSSQVYKGCLPD-------------GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~-------------g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
+.||+|+||.||+|...+ ...+++|++.... .....|.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2358999887643 44557888999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCc-------eEEc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-------PQLS 566 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~-------vkL~ 566 (770)
+||||+++|+|..++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999998886433 358999999999999999999999 89999999999999987654 8999
Q ss_pred cccccccccCCCCCceecccccccCCCCceeec-cCCCCCcceEeechHHHHHHH-hCCCCCCCCCccchhhHHHhhccc
Q 004174 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELL-TGRKPISNDHPKGQESLVMWAKPI 644 (770)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~-~~~~s~ksDVwSlGvvL~eLl-tG~~Pf~~~~~~~~~~lv~~~~~~ 644 (770)
|||++...... ....++..|+|||++. ...++.++|||||||++|||+ +|..||........... +.
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~--~~--- 223 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF--YE--- 223 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH--Hh---
Confidence 99998655322 1246888999999987 456899999999999999998 58888865433221111 11
Q ss_pred ccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 645 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 645 ~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
+.. .... .....+..++..||+.||.+||++.+|++.|
T Consensus 224 ---~~~-~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 ---GQC-MLVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ---cCc-cCCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 0011 1123455677789999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=313.78 Aligned_cols=238 Identities=24% Similarity=0.421 Sum_probs=186.6
Q ss_pred eecccCceEEEEEEeCC-------------------------CCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEE
Q 004174 429 LIGKGGSSQVYKGCLPD-------------------------GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISL 482 (770)
Q Consensus 429 ~LG~G~fG~Vy~a~~~~-------------------------g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l 482 (770)
.||+|+||.||+|.... ...|++|++.... .....|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 1358999987543 345678899999999999999999
Q ss_pred eeEEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC-
Q 004174 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF- 561 (770)
Q Consensus 483 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~- 561 (770)
+++|.+.+..++||||+++|+|..++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCc
Confidence 999999999999999999999999886533 357899999999999999999999 8999999999999997643
Q ss_pred ------ceEEccccccccccCCCCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHH-hCCCCCCCCCccc
Q 004174 562 ------EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELL-TGRKPISNDHPKG 633 (770)
Q Consensus 562 ------~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLl-tG~~Pf~~~~~~~ 633 (770)
.++|+|||++...... ....++..|+|||++.. ..++.++|||||||++|||+ +|+.||....+..
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3799999988644321 12357888999999875 56899999999999999995 6999997654432
Q ss_pred hhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 634 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 634 ~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
......... . +.. .....+..++..||+.+|.+||++.+|++.|.
T Consensus 230 ~~~~~~~~~------~--------~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERFYEKKH------R--------LPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHHhcc------C--------CCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 211111000 0 000 01124566777899999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.61 Aligned_cols=248 Identities=28% Similarity=0.433 Sum_probs=201.4
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
++|.+.+.||.|+||.||+|... +++.+|+|++... ......+.+|+.+++.++|+||+++++++..+..+++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999864 6889999998754 24456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++++|.+++... .+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998643 58899999999999999999999 889999999999999999999999999998776542
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
.. .....|++.|+|||++.+..++.++|||||||++|+|+||+.||...++......+ ..+ ..+.+
T Consensus 153 ~~--~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~-------~~~-----~~~~~ 218 (274)
T cd06609 153 SK--RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI-------PKN-----NPPSL 218 (274)
T ss_pred cc--cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh-------hhc-----CCCCC
Confidence 21 12356889999999999888999999999999999999999999765432211111 001 11111
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.... ....+..++..||..+|++||++.+++++
T Consensus 219 ~~~~---~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 219 EGNK---FSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred cccc---cCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1110 11234455667999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=310.46 Aligned_cols=258 Identities=22% Similarity=0.330 Sum_probs=199.5
Q ss_pred HHHhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 417 LLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 417 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
++.+++++.....||+|+||.||+|... ++..|++|.+.... ...+.+.+|+.+++.++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3456677777789999999999999854 67889999887543 456789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC-CCceEEcccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKW 573 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-~~~vkL~DFGla~~ 573 (770)
||||+++++|.+++..... ....++..+..++.||+.||.|||+ ++|+||||||+||+++. ++.++|+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999875421 1112788888999999999999999 89999999999999976 67899999999976
Q ss_pred ccCCCCCceecccccccCCCCceeeccCC--CCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~--~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
....... .....|++.|+|||++..+. ++.++||||||+++|+|++|+.||....... ...|......
T Consensus 159 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~----- 228 (268)
T cd06624 159 LAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFK----- 228 (268)
T ss_pred cccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhc-----
Confidence 5432221 12245899999999987654 7889999999999999999999996532211 1111111000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+.+ +......+..++..||+.+|.+||++.+++++
T Consensus 229 --~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 --IHPEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --cCCCC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111 11122345566678999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=309.25 Aligned_cols=248 Identities=26% Similarity=0.415 Sum_probs=190.1
Q ss_pred eeecccCceEEEEEEeC----CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEee-cCceEEEEeecC
Q 004174 428 NLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLS 500 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~LV~E~~~ 500 (770)
+.||+|+||.||+|... ++..+|||.+... ....+.+.+|+.+++.++||||++++++|.. ++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999998542 3456788999999999999999999998764 556899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+|+|.+++.... ..+.+..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999997543 246778888999999999999999 89999999999999999999999999999755332111
Q ss_pred --ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhC-CCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 581 --ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG-RKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 581 --~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
.......+++.|+|||++....++.++|||||||++|||++| .+||....... +..+.. .+. .+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~~----~~~-----~~~ 222 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYLL----QGR-----RLL 222 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHh----cCC-----CCC
Confidence 111123567789999999988999999999999999999994 66675443221 111110 110 000
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
. +......+..++..||+.+|++||++.+|++.|+.
T Consensus 223 ~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 223 Q----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred C----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 0 01112345667778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.34 Aligned_cols=254 Identities=27% Similarity=0.426 Sum_probs=200.4
Q ss_pred CcccceeecccCceEEEEEEeCC--CCEEEEEEeCC-----------ChhHHHHHHHHHHHHHh-cCCCceeEEeeEEee
Q 004174 423 NFLAENLIGKGGSSQVYKGCLPD--GKELAVKILKP-----------SEDVIKEFVLEIEIITT-LHHKNIISLLGFCFE 488 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~~--g~~vAVK~l~~-----------~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~ 488 (770)
+|.+.+.||+|+||.||+|.... ++.+|+|.+.. ......++.+|+.++.. ++||||++++++|..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999754 68899998753 12345667889988875 799999999999999
Q ss_pred cCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccc
Q 004174 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (770)
Q Consensus 489 ~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 568 (770)
++..++||||+++++|.+++.........+++..++.++.|++.||.|||+ ..+++|+||+|+|||++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999999886433333568999999999999999999995 157999999999999999999999999
Q ss_pred cccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC
Q 004174 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 648 (770)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 648 (770)
|++....... ......|+..|+|||++..+.++.++||||||+++|||++|+.||...........+ ..+
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~-------~~~ 228 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI-------VEA 228 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHH-------hhc
Confidence 9998665433 223357899999999999888999999999999999999999999754332111110 011
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 649 ~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
... +..... ....+..++.+||+.||.+||++.+|..++.
T Consensus 229 ~~~----~~~~~~----~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYE----PLPEGM----YSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCC----cCCccc----CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111 111111 1234555667899999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.52 Aligned_cols=199 Identities=26% Similarity=0.432 Sum_probs=162.4
Q ss_pred ceeecccCceEEEEEEeC---CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEee--cCceEEEEeecCC
Q 004174 427 ENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYDFLSR 501 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~---~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~LV~E~~~g 501 (770)
.+.||+|+||.||+|... +++.||+|.+.... ....+.+|+.+++.++||||++++++|.. +...++||||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 357999999999999854 56789999987543 23457789999999999999999999864 4568999999964
Q ss_pred CChhhhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee----CCCCceEEccccccc
Q 004174 502 GSLEENLHGNK-----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAK 572 (770)
Q Consensus 502 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL----~~~~~vkL~DFGla~ 572 (770)
+|.+++.... .....+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 8888775321 122358899999999999999999999 899999999999999 456789999999998
Q ss_pred cccCCCCC-ceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCC
Q 004174 573 WASTSSSH-ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (770)
Q Consensus 573 ~~~~~~~~-~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 630 (770)
........ .......||+.|+|||++.+. .++.++|||||||++|||++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 76543221 112336789999999998764 58999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=309.13 Aligned_cols=252 Identities=26% Similarity=0.403 Sum_probs=199.4
Q ss_pred cCcccceeecccCceEEEEEEeCC----CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~----g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
++|.+.+.||+|+||.||+|...+ ...++||..... ....+.+.+|+.+++.+.||||++++++|.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457888999999999999998643 246899988754 3456789999999999999999999999865 567899
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++|+|.+++.... ..+++..++.++.+++.||.|||+ .+++||||||+|||++.++.++|+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999997543 358999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
...... .....+++.|+|||++....++.++|||||||++|||++ |..||........ ..+.. .+....
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~~----~~~~~~-- 228 (270)
T cd05056 159 DESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRIE----NGERLP-- 228 (270)
T ss_pred ccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHH----cCCcCC--
Confidence 442221 122345578999999988889999999999999999996 9999976543221 11111 111000
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.... ....+..++..|+..+|.+||++.++++.|..
T Consensus 229 ---~~~~----~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 229 ---MPPN----CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264 (270)
T ss_pred ---CCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1111 12345556678999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.94 Aligned_cols=264 Identities=25% Similarity=0.326 Sum_probs=200.1
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
++|...+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|+.+++.++||||++++++|......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999875 68999999886432 234568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|++++.|..++... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 99998888776533 258999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHH-Hhhccc-------ccCC
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV-MWAKPI-------LSSG 648 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv-~~~~~~-------~~~g 648 (770)
... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+ ...... +..+
T Consensus 154 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred ccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 321 123467889999999875 45789999999999999999999999865543221111 100000 0000
Q ss_pred c-cccccCcccCCCCCh-----HHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 K-VTQLLDPALGNNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ~-l~~lld~~l~~~~~~-----~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. ...+..+......+. .....+..++..||+.+|++||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 000001111000000 112345667788999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=305.46 Aligned_cols=250 Identities=26% Similarity=0.378 Sum_probs=202.8
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+|...+.||.|+||.||.+.. .+++.+++|.+... .....++.+|++++++++|+||+++++++.+.+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 578899999999999998875 46889999987642 35567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++++|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997543 2468999999999999999999999 889999999999999999999999999998665433
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
. ......|++.|+|||++.+..++.++||||||+++|||++|..||...........+. .+......
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-------~~~~~~~~---- 222 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV-------QGNYTPVV---- 222 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------cCCCCCCc----
Confidence 2 1223578999999999988889999999999999999999999997654322111111 11111110
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
......+..++..||+.+|.+||++.++++++
T Consensus 223 -----~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 -----SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -----cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11123455566789999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=311.67 Aligned_cols=249 Identities=26% Similarity=0.410 Sum_probs=196.7
Q ss_pred cccceeecccCceEEEEEEeC-CCCEEEEEEeCCC-hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004174 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
|.+.+.||.|+||.||+|... ++..+++|.+... ....+.+.+|+++++.++||||++++++|..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788999999999999875 5778899998754 35567889999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
++|..++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 87 ~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-- 158 (282)
T cd06643 87 GAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-- 158 (282)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence 99999876432 358999999999999999999999 8999999999999999999999999999876543221
Q ss_pred eecccccccCCCCceeec-----cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 582 TCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
......||+.|+|||++. ...++.++|||||||++|||++|+.||....+.... ..... +....+..+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~~~-----~~~~~~~~~ 231 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--LKIAK-----SEPPTLAQP 231 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--HHHhh-----cCCCCCCCc
Confidence 122357899999999984 345788999999999999999999999765432211 11110 000011111
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+ ...+..++..||+.+|.+||++.+++++
T Consensus 232 ---~~~----~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 ---SRW----SSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---ccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 1234556678999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=313.84 Aligned_cols=264 Identities=23% Similarity=0.313 Sum_probs=196.5
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+|.+.+.||+|+||.||+|... +++.||||+++... ...+.+.+|+.++..++||||+++++++..++.+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999864 68999999987532 2346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
++ ++|.+++..... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 589888865432 2468999999999999999999999 899999999999999999999999999997654322
Q ss_pred CCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhH--HHhhccc---cc----CC
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL--VMWAKPI---LS----SG 648 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l--v~~~~~~---~~----~g 648 (770)
. ......+++.|+|||++... .++.++|||||||++|+|+||+.||........... ..+..+. +. ..
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 R--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred c--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 1 11224678999999988754 578999999999999999999999986543211110 0000000 00 00
Q ss_pred c----cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 K----VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ~----l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. +.......+... .......+..++..||+.||.+|||+.+|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSA-VKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHh-cCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 000000000000 00112234566778999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=306.00 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=199.0
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEee-cCceEEEEe
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYD 497 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~LV~E 497 (770)
+|.+.+.||+|++|.||++... +++.+|+|.+... ....+.+.+|+++++.++|+|++++++.+.. +..+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999864 5789999998643 2445678899999999999999999998764 446799999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+++++|.+++..... ..+++.++..++.+++.||.|||+ .+|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999875432 358999999999999999999999 89999999999999999999999999999876443
Q ss_pred CCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
... .....|++.|+|||++....++.++|||||||++|+|++|+.||...+........ ..+.+..
T Consensus 156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~-------~~~~~~~----- 221 (257)
T cd08223 156 CDM--ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI-------IEGKLPP----- 221 (257)
T ss_pred CCc--cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------HhcCCCC-----
Confidence 221 22356899999999999999999999999999999999999999754432211110 0111111
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+ +......+..++..||+.+|.+||++.+++++
T Consensus 222 ~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 M----PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred C----ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1 11122345567778999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=326.55 Aligned_cols=260 Identities=22% Similarity=0.283 Sum_probs=194.3
Q ss_pred hhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeec------
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED------ 489 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------ 489 (770)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.+|+.++||||++++++|...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 456789999999999999999985 468899999987532 3345678899999999999999999988543
Q ss_pred CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccc
Q 004174 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (770)
Q Consensus 490 ~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 569 (770)
...+++++++ +++|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCc
Confidence 3578999988 7799888753 248899999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHH-Hhhcc----
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV-MWAKP---- 643 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv-~~~~~---- 643 (770)
+++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+ .....
T Consensus 164 ~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 164 LARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred cceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 998654422 23578999999999876 46899999999999999999999999765432211110 00000
Q ss_pred ---cccCCccccccCcccCCCCCh-------HHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 644 ---ILSSGKVTQLLDPALGNNYDY-------DQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 644 ---~~~~g~l~~lld~~l~~~~~~-------~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+........+. .+...... .....+..++..||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000 00000000 001224566678999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=318.08 Aligned_cols=256 Identities=25% Similarity=0.450 Sum_probs=200.1
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCC----EEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~----~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
.++|...+.||+|+||.||+|... +|. .+|+|++.... .....+.+|+.++..++||||++++++|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 346778899999999999999853 444 57999887543 3345788999999999999999999999754 578
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+++||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccccc
Confidence 9999999999999987543 358899999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
..............++..|+|||++.+..++.++|||||||++|||++ |..||..........++. .+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~-- 229 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-------KGER-- 229 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------CCCC--
Confidence 654333222222446778999999998899999999999999999997 999997643322211111 1110
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~ 699 (770)
...+ . .....+..++..||..+|++||++.++++.|....
T Consensus 230 ~~~~---~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 230 LPQP---P----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred CCCC---C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0000 0 11234556677899999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=306.06 Aligned_cols=252 Identities=26% Similarity=0.399 Sum_probs=202.9
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
++|.+.+.||.|+||.||+|... +++.+++|++.... ...+.+.+|+++++.++||||+++++++...+.++++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57889999999999999999864 57889999987543 35678899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++++|.+++.... ..+++..+..++.|++.||.|||+ ++|+|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 83 GGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999887542 358899999999999999999999 8999999999999999999999999999976544221
Q ss_pred CceecccccccCCCCceeeccC---CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 580 HITCTDVAGTFGYLAPEYFMYG---KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~---~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
......++..|+|||++... .++.++|||||||++|||++|+.||....+....... ....+ ..+
T Consensus 157 --~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~--~~~~~--------~~~ 224 (262)
T cd06613 157 --KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI--SKSNF--------PPP 224 (262)
T ss_pred --ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhccC--------CCc
Confidence 11235688999999999876 8899999999999999999999999765433221111 11000 001
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
.+. ........+..++.+||..+|.+||++.+|+.
T Consensus 225 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111 11222345667778899999999999999885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.79 Aligned_cols=246 Identities=28% Similarity=0.429 Sum_probs=198.9
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
.|...+.||+|+||.||+|... ++..||+|++... ....+.+.+|+.+++.++||||++++++|..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3566778999999999999864 5788999998743 345567899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++++|.+++.. ..+.+..+..++.+++.||.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999998853 247899999999999999999999 8999999999999999999999999999976654321
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
......|+..|+|||++....++.++|||||||++|||++|+.||....+.... .+. ..+. .+.+.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~----~~~~-----~~~~~ 222 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---FLI----PKNS-----PPTLE 222 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---hhh----hcCC-----CCCCC
Confidence 112246889999999999889999999999999999999999999754432211 110 0010 11111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
......+..++..||+.+|.+||++.+|+++
T Consensus 223 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 ----GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1222345566678999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=310.40 Aligned_cols=256 Identities=24% Similarity=0.394 Sum_probs=202.6
Q ss_pred cCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
++|.....||+|+||.||+|... +.+.+++|.+.... .....+.+|++++.+++|+||++++++|.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999853 34679999987543 24678999999999999999999999999989999
Q ss_pred EEEeecCCCChhhhhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKD-----PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~-----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 568 (770)
+||||+++|+|.+++...... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999755421 1258999999999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccC
Q 004174 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSS 647 (770)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~ 647 (770)
|+++....... .......++..|+|||.+..+.++.++||||||+++|+|++ |..||....... .+.... .
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~~----~ 233 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRLQ----A 233 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHHH----c
Confidence 99875433221 11223456788999999998889999999999999999999 888996543221 111111 1
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 648 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 648 g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
+.+... ........+..++..||+.+|.+||++.+++..|.
T Consensus 234 ~~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111100 01111235666778899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=308.68 Aligned_cols=248 Identities=25% Similarity=0.426 Sum_probs=197.3
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 491 (770)
.|.+...||.|+||.||+|... +++.+|+|.+.... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999864 68899999886421 223568899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 571 (770)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999996543 57889999999999999999999 88999999999999999999999999999
Q ss_pred ccccCCCCCc----eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccC
Q 004174 572 KWASTSSSHI----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 647 (770)
Q Consensus 572 ~~~~~~~~~~----~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 647 (770)
+......... ......|+..|+|||++..+.++.++|+|||||++|+|++|+.||....... .. ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~-~~~~----- 225 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--AI-FKIG----- 225 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--HH-HHHh-----
Confidence 8665321111 1112468899999999998889999999999999999999999997643211 11 1000
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 648 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 648 g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
....+.+. ......+..++..||+.+|.+||++.+|++
T Consensus 226 ----~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 ----ENASPEIP----SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----ccCCCcCC----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 01111111 112234555667899999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=308.06 Aligned_cols=254 Identities=26% Similarity=0.369 Sum_probs=202.3
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEee--cCceEEEE
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVY 496 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~LV~ 496 (770)
+|.+.+.||.|+||.||++.. .+++.+|+|+++.. ....+.+..|+.+++.++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999985 46889999998643 3455678899999999999999999998864 34689999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||+++++|.+++.........+++..++.++.+|+.||.|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999765433457899999999999999999999321 288999999999999999999999999999876
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
...... .....|++.|+|||++....++.++|+||||+++|+|++|+.||...+.. .+.... ..+..
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~----~~~~~---- 227 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKI----KEGKF---- 227 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHH----hcCCC----
Confidence 554321 12356899999999999888999999999999999999999999865421 111111 11111
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+. .+......+..++..|++.+|.+||++.+|+++
T Consensus 228 -~~----~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 -RR----IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -CC----CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11 111223455666778999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=311.56 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=193.4
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHH-HHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEI-ITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~i-L~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
++|.+.+.||+|+||.||++... +|+.||||+++... .....+..|+.+ ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47889999999999999999864 69999999987542 334556667765 666789999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-ceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
|++ |+|.+++.........+++..++.++.||+.||.|||+ + +++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 58888876543333578999999999999999999998 5 899999999999999999999999999986643
Q ss_pred CCCCceecccccccCCCCceeecc----CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMY----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
... .....|+..|+|||++.. ..++.++|+|||||++|+|++|+.||...... ...+..... +.
T Consensus 157 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~-----~~--- 224 (283)
T cd06617 157 SVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQVVE-----EP--- 224 (283)
T ss_pred ccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHHHHh-----cC---
Confidence 221 122468999999998864 45788999999999999999999999643221 111111100 00
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
.+.+... .....+..++..||..+|.+||++.++++
T Consensus 225 --~~~~~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 --SPQLPAE---KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --CCCCCcc---ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111100 11234555667899999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=308.58 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=193.9
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC------hhHHHHHHHHHHHHHhcCCCceeEEeeEEee--cCce
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNL 492 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~ 492 (770)
.+|...+.||+|+||.||+|... +++.|++|++... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999864 6889999988642 1345678899999999999999999999875 3568
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
+++|||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999999997543 47889999999999999999998 889999999999999999999999999997
Q ss_pred cccCCCCC-ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 573 WASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 573 ~~~~~~~~-~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
........ .......++..|+|||++....++.++|||||||++|||++|+.||........... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~------~~~~~--- 225 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK------IATQP--- 225 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH------HhcCC---
Confidence 65432111 111224688999999999988899999999999999999999999976533211110 00000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+.+.... ...+..+ +.||..+|++||++.+|+++
T Consensus 226 --~~~~~~~~~----~~~~~~l-i~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 --TNPQLPSHI----SEHARDF-LGCIFVEARHRPSAEELLRH 261 (266)
T ss_pred --CCCCCchhc----CHHHHHH-HHHhcCChhhCcCHHHHhcC
Confidence 111111111 1122222 36888999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=309.50 Aligned_cols=254 Identities=27% Similarity=0.437 Sum_probs=197.8
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-----------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecC
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-----------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 490 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-----------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 490 (770)
+|...+.||.|+||.||+|.. .+|+.+|+|.++... ...+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467789999999999999985 468899999886321 12356788999999999999999999999999
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 570 (770)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+ ++++||||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999765 258899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCceeeccCC--CCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 648 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~--~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 648 (770)
++...............|+..|+|||++.... ++.++|+||||+++|+|++|..||....... .+.... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~-----~~ 227 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--AMFKLG-----NK 227 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--HHHHhh-----cc
Confidence 97654432222223356899999999988654 8899999999999999999999996543221 111100 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.....+.+..... ....+..++..||+.+|.+||++.+|+++
T Consensus 228 ~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 RSAPPIPPDVSMN----LSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCcCCcccccc----CCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0011111111111 12344455668999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=311.90 Aligned_cols=253 Identities=23% Similarity=0.400 Sum_probs=198.7
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
++|.+.+.||+|+||.||++... +|+.||+|.++.. ......+.+|++++..++||||++++++|...+.+++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999875 7899999988753 34457899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++++|..++.... ....+++..+..++.+++.||.|||+ ..+|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999886532 12368999999999999999999996 1589999999999999999999999999997654322
Q ss_pred CCceecccccccCCCCceeeccC------CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~------~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
. ....|++.|+|||++... .++.++|||||||++|+|++|+.||............. ....+..
T Consensus 158 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~~-- 227 (286)
T cd06622 158 A----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS----AIVDGDP-- 227 (286)
T ss_pred c----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH----HHhhcCC--
Confidence 2 224688999999998544 35889999999999999999999997543322111100 0001110
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+.+ +......+..++..||+.+|.+||++.+++..
T Consensus 228 ---~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 228 ---PTL----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---CCC----CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111 11223345566678999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=317.91 Aligned_cols=198 Identities=27% Similarity=0.433 Sum_probs=161.7
Q ss_pred ceeecccCceEEEEEEeC---CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEee--cCceEEEEeecCC
Q 004174 427 ENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYDFLSR 501 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~---~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~LV~E~~~g 501 (770)
...||+|+||.||+|... ++..||+|.+.... ....+.+|+.+++.++||||++++++|.. +...++||||+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 357999999999999864 45789999987543 23467889999999999999999999854 4578999999865
Q ss_pred CChhhhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee----CCCCceEEccccccc
Q 004174 502 GSLEENLHGNK-----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAK 572 (770)
Q Consensus 502 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL----~~~~~vkL~DFGla~ 572 (770)
+|.+++.... .....+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 7877764321 122358899999999999999999999 899999999999999 566789999999998
Q ss_pred cccCCCCC-ceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCC
Q 004174 573 WASTSSSH-ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISND 629 (770)
Q Consensus 573 ~~~~~~~~-~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~ 629 (770)
........ .......||+.|+|||++.+. .++.++|||||||++|||+||++||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76543221 112235789999999998764 5899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=304.86 Aligned_cols=257 Identities=27% Similarity=0.423 Sum_probs=203.8
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
++|.+.+.||.|+||+||+|.. .++..+++|++.... ...+.+.+|+.+++.++|+||+++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688999999999999999985 468899999987532 3567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++++|.+++..... ...+++..+..++.|++.||.|||+ ++|+||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999975422 1358899999999999999999998 899999999999999999999999999998665543
Q ss_pred CCc--eecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 579 SHI--TCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 579 ~~~--~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
... ......|+..|+|||++... .++.++|+|||||++|+|++|+.||....+... ....... ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~----------~~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQN----------DP 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhcC----------CC
Confidence 221 11234689999999999877 789999999999999999999999976544221 1111110 00
Q ss_pred cccCCCCC-hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 656 PALGNNYD-YDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 656 ~~l~~~~~-~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+.+..... ......+..++..||+.+|.+||++.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11111100 1122445566678999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=319.31 Aligned_cols=199 Identities=23% Similarity=0.321 Sum_probs=166.1
Q ss_pred cceeeccc--CceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 426 AENLIGKG--GSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 426 ~~~~LG~G--~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
+.++||+| +|++||++.. .+|+.||||+++.. ......+.+|+++++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 7899999986 57899999999753 344566778999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++|+|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.++++|||.+........
T Consensus 82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999865432 358899999999999999999999 8999999999999999999999999987543321110
Q ss_pred C-----ceecccccccCCCCceeecc--CCCCCcceEeechHHHHHHHhCCCCCCCC
Q 004174 580 H-----ITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISND 629 (770)
Q Consensus 580 ~-----~~~~~~~GT~~YlAPE~~~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~ 629 (770)
. .......++..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0 00112356788999999976 35899999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=310.88 Aligned_cols=259 Identities=27% Similarity=0.390 Sum_probs=203.1
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeec--CceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~LV~ 496 (770)
++|...+.||.|++|.||++... +++.+|+|++.... .....+.+|+++++.++||||++++++|... +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888999999999999999974 68899999987543 3567789999999999999999999998653 4689999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++++|.+++.........+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999876543334568899999999999999999999 8999999999999999999999999999875543
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCc--cchhhHHHhhcccccCCcccccc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP--KGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~--~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
... ....++..|+|||.+....++.++|||||||++|+|++|..||..... .....+..|.... ....+.
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 229 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPELK 229 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cchhhc
Confidence 221 124678899999999988999999999999999999999999986532 1112222222110 000110
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+ .... .......+..++..||+.+|.+|||+.+|+++
T Consensus 230 ~-~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 230 D-EPGN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred c-CCCC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0 0000 11223456677788999999999999999973
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=313.02 Aligned_cols=265 Identities=22% Similarity=0.350 Sum_probs=196.7
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.++|.+.+.||.|+||.||+|... +++.||||.+.... .....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 367889999999999999999865 68899999986532 223457789999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+.+ +|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 9975 9999887543 257899999999999999999999 89999999999999999999999999998754322
Q ss_pred CCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCc-cchhhHHHhhcccccCCcccc---
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHP-KGQESLVMWAKPILSSGKVTQ--- 652 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~-~~~~~lv~~~~~~~~~g~l~~--- 652 (770)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||..... ..+...+..............
T Consensus 157 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 157 SK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred Cc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 11 1122357889999999875 4588999999999999999999999975542 111111110000000000000
Q ss_pred -----------ccCcccCCCC-ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 653 -----------LLDPALGNNY-DYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 653 -----------lld~~l~~~~-~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.....+.... .......+..++..||+.+|.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000000 01112445567778999999999999998863
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=310.10 Aligned_cols=246 Identities=26% Similarity=0.423 Sum_probs=201.3
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
.|...+.||.|+||.||+|... ++..||||++... ......+.+|+.+++.+.||||++++++|.+++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667788999999999999864 5889999998753 345678899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++|+|.+++... .+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999988642 47888999999999999999999 8999999999999999999999999999976644322
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
. .....++..|+|||++.+..++.++|+|||||++|||++|..||....+......+ ..+. .
T Consensus 157 ~--~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-------~~~~---------~ 218 (277)
T cd06640 157 K--RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-------PKNN---------P 218 (277)
T ss_pred c--cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-------hcCC---------C
Confidence 1 12246889999999999888999999999999999999999999765443211111 0000 0
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..........+..++..||+.+|.+||++.+++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11122334456677788999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=304.44 Aligned_cols=250 Identities=31% Similarity=0.522 Sum_probs=199.6
Q ss_pred cccceeecccCceEEEEEEeCC-----CCEEEEEEeCCChh--HHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 424 FLAENLIGKGGSSQVYKGCLPD-----GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~~-----g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
|.+.+.||.|+||.||++...+ +..+|+|+++.... ..+.+.+|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3467889999999999998753 48899999976543 5778999999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++++|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999975432 128999999999999999999999 8999999999999999999999999999987655
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
...... ....+++.|+|||.+....++.++||||||+++|+|++ |+.||........ ..... .+....
T Consensus 156 ~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~---~~~~~----~~~~~~--- 224 (258)
T smart00219 156 DDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV---LEYLK----KGYRLP--- 224 (258)
T ss_pred cccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHh----cCCCCC---
Confidence 422211 12347789999999988889999999999999999999 8889876433221 11111 111000
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
... .....+..++..|+..+|.+|||+.++++.|
T Consensus 225 --~~~----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 --KPE----NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCC----cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 001 1223455566789999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=340.40 Aligned_cols=267 Identities=25% Similarity=0.428 Sum_probs=221.4
Q ss_pred cccCHHHHHHhhcCc---------ccceeecccCceEEEEEEeC----CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc
Q 004174 410 RLFNYQDLLSATSNF---------LAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTL 474 (770)
Q Consensus 410 ~~f~~~~l~~~t~~f---------~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l 474 (770)
..++|++-..+...| .++++||.|.||.||+|.++ ....||||.++.. +....+|+.|..||.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 455666655555544 46799999999999999974 2357999999964 56778999999999999
Q ss_pred CCCceeEEeeEEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCC
Q 004174 475 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 554 (770)
Q Consensus 475 ~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~N 554 (770)
.||||++|.|+.......++|.|||++|+|+.+|+.+. ..|.+.+..-++.+|+.|+.||-+ .++|||||...|
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARN 761 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARN 761 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhh
Confidence 99999999999999999999999999999999998765 359999999999999999999998 999999999999
Q ss_pred eeeCCCCceEEccccccccccCCCCCceeccccc--ccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCc
Q 004174 555 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG--TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 631 (770)
Q Consensus 555 ILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~G--T~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~ 631 (770)
||++.+...|++||||++.+.++.. ..++..-| ...|.|||.+.+.+++.++|||||||+|||.++ |.+||-+...
T Consensus 762 ILVNsnLvCKVsDFGLSRvledd~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN 840 (996)
T KOG0196|consen 762 ILVNSNLVCKVSDFGLSRVLEDDPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 840 (996)
T ss_pred eeeccceEEEeccccceeecccCCC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence 9999999999999999998866552 22222223 357999999999999999999999999999998 9999987765
Q ss_pred cchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004174 632 KGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699 (770)
Q Consensus 632 ~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~ 699 (770)
.+....++. ...-..+.+....+.++++.||++|-.+||.+.+|+.+|.+..
T Consensus 841 QdVIkaIe~----------------gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 841 QDVIKAIEQ----------------GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred HHHHHHHHh----------------ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 443333221 1111224456678889999999999999999999999987543
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=349.30 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=198.6
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||.||+|... +|+.||||+++.. ....++|.+|++++..++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999864 6899999998753 234567999999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccc
Q 004174 497 DFLSRGSLEENLHGNKK-------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~-------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 569 (770)
||++||+|.+++..... ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 12345678889999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCC----------------CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccc
Q 004174 570 LAKWASTSSS----------------HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (770)
Q Consensus 570 la~~~~~~~~----------------~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 633 (770)
+++....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986621100 011122579999999999999999999999999999999999999997643221
Q ss_pred hhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC-HHHHHHHhh
Q 004174 634 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-MSLVLKLLR 696 (770)
Q Consensus 634 ~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs-~~eVL~~L~ 696 (770)
.. +.......... .+ ..+....+..++..|++.+|++||+ +.++++.|.
T Consensus 239 i~----~~~~i~~P~~~----~p------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le 288 (932)
T PRK13184 239 IS----YRDVILSPIEV----AP------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLE 288 (932)
T ss_pred hh----hhhhccChhhc----cc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11 11000000000 00 0011123455667899999999976 556655554
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.08 Aligned_cols=264 Identities=26% Similarity=0.361 Sum_probs=199.6
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
++|.+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++..++||||++++++|..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999875 58999999986432 245678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+++++|.++.... ..+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 99999988876543 248999999999999999999999 89999999999999999999999999999866443
Q ss_pred CCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhh-HHHhhcccccCC-------
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES-LVMWAKPILSSG------- 648 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~-lv~~~~~~~~~g------- 648 (770)
.. ......++..|+|||++.. ..++.++|||||||++|||++|++||.......... +..+........
T Consensus 154 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 GE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred cc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 32 1223568899999999875 357889999999999999999999997654322111 111111000000
Q ss_pred c-cccccCcccCCCC-----ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 K-VTQLLDPALGNNY-----DYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ~-l~~lld~~l~~~~-----~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. ......+...... .......+..++..||+.+|.+||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0 0000000000000 01123446667788999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=306.59 Aligned_cols=252 Identities=25% Similarity=0.410 Sum_probs=200.2
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
+|...+.||+|+||.||+|.. .+++.+|+|++.... ...+.+.+|+.+++.++|+||++++++|.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 578999999986422 245788999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC-ceEEcccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKW 573 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-~vkL~DFGla~~ 573 (770)
||||+++++|.+++.... .+++..+..++.|++.||.|||+ ++++|+||||+||+++.++ .++|+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999987543 57899999999999999999999 8999999999999998775 599999999977
Q ss_pred ccCCCCC--ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 574 ASTSSSH--ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 574 ~~~~~~~--~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
....... .......||..|+|||++....++.++||||||+++|+|++|+.||...........+.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------ 227 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT------ 227 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC------
Confidence 6543211 11123468899999999988889999999999999999999999997554332222221110000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
..+ ..+......+..++..||+.+|.+||++.++++
T Consensus 228 --~~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 --TAP----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --CCC----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 001 111222344556677899999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=314.11 Aligned_cols=248 Identities=25% Similarity=0.408 Sum_probs=199.9
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
.+|.+.+.||.|+||.||+|.. .+|+.|++|.+.... ...+.+.+|+.+++.++||||++++++|...+.+++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 3588899999999999999985 578999999886533 34567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++++|.+++... .+++.++..++.+++.||.|||+ ++++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999988642 47899999999999999999999 8999999999999999999999999999876543322
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
. .....|++.|+|||.+....++.++|||||||++|+|++|+.||...++......+. .. ....+..
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~-~~------~~~~~~~---- 237 (296)
T cd06655 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TN------GTPELQN---- 237 (296)
T ss_pred c--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hc------CCcccCC----
Confidence 1 123468999999999998889999999999999999999999997765432221111 00 0000000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
+......+..++..||..+|.+||++.++++
T Consensus 238 ---~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 238 ---PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ---cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0111123445567899999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=309.13 Aligned_cols=204 Identities=28% Similarity=0.389 Sum_probs=180.9
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|...++||+|.||.|.++.. .+|+.||||++++. .+.+..-+.|-++|...+||++..|...|+..+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 5677889999999999999875 47999999999874 345566778999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||..||.|+-+|.+.+ .|++...+.+..+|+.||.|||+ ++||+||||.+|+|||.+|++||+||||++..-.
T Consensus 248 eyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 248 EYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999999987643 58899999999999999999999 8999999999999999999999999999985433
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccch
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~ 634 (770)
.. .+..++||||.|+|||++....|+..+|+|.+||++|||++|+.||...+....
T Consensus 321 ~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL 376 (516)
T KOG0690|consen 321 YG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL 376 (516)
T ss_pred cc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH
Confidence 22 233458999999999999999999999999999999999999999987655443
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=311.50 Aligned_cols=265 Identities=27% Similarity=0.382 Sum_probs=201.5
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
++|.+.+.||+|+||.||+|... +++.|+||+++.. ....+.+.+|+++++.++|+||++++++|..++.+++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999875 5889999998753 2345778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|++++.|..++... ..+++..+..++.+|+.||.|||+ .+++||||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99987776655432 347899999999999999999999 89999999999999999999999999999876554
Q ss_pred CCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhc-ccc--------cC
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK-PIL--------SS 647 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~-~~~--------~~ 647 (770)
... ......++..|+|||++... .++.++||||||+++|+|++|+.||................ ... ..
T Consensus 154 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred ccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 321 22335788999999999888 88999999999999999999999997654322111111100 000 00
Q ss_pred Ccc-----ccccCcc-cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 648 GKV-----TQLLDPA-LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 648 g~l-----~~lld~~-l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+.. ....++. +...++......+..++..||..+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 0000000 0001111123556677788999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=314.33 Aligned_cols=248 Identities=26% Similarity=0.404 Sum_probs=199.6
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
.+|.+.+.||+|+||.||+|.. .+++.||+|.+.... ...+.+.+|+.+++.++||||++++++|..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5788999999999999999985 478999999987533 34567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++++|.+++... .+++..+..++.+++.||.|||+ .+++||||||+|||++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998642 47889999999999999999999 8999999999999999999999999999876543322
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
. .....+++.|+|||++....++.++|+|||||++|+|++|..||...++...... . ...+ ...+..
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~-----~~~~-~~~~~~---- 237 (297)
T cd06656 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-I-----ATNG-TPELQN---- 237 (297)
T ss_pred C--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-e-----ccCC-CCCCCC----
Confidence 1 1234688999999999988899999999999999999999999976544221110 0 0000 000000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
.......+..++..||+.+|.+||++.++++
T Consensus 238 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 238 ---PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111223445667899999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=304.91 Aligned_cols=247 Identities=27% Similarity=0.428 Sum_probs=198.8
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
+|...+.||+|+||.||+|... +++.|++|.+.... ...+.+.+|+.+++.++|+||+++++++..+..++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3677789999999999999875 78999999886432 3567899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999987542 47899999999999999999999 899999999999999999999999999987664
Q ss_pred CCCCCceecccccccCCCCceeeccCC-CCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~-~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
... ......|++.|+|||++.... ++.++|+|||||++|+|++|+.||....+.. .+..+.. .....
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~----~~~~~--- 221 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AVFKIGR----SKELP--- 221 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HHHHHHh----cccCC---
Confidence 433 112356899999999998776 8999999999999999999999997654211 1111111 00110
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+ +......+..++..||+.+|.+||++.+++++
T Consensus 222 --~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 222 --PI----PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred --Cc----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11 11112334556678999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=310.89 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=200.0
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
.++|.+.+.||.|+||.||+|... ++..+|+|++.... ...+.|..|+++++.++||||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888999999999999999864 68899999987543 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++++|.+++.... ..+++..+..++.|++.||.|||+ ++|+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 99999999986543 358999999999999999999999 899999999999999999999999999987654322
Q ss_pred CCceecccccccCCCCceeec-----cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
.. .....||+.|+|||++. ...++.++|||||||++|||++|+.||........ +..+.. +..
T Consensus 158 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~-----~~~--- 225 (280)
T cd06611 158 QK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKILK-----SEP--- 225 (280)
T ss_pred cc--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHHhc-----CCC---
Confidence 21 12356899999999975 34577899999999999999999999976543221 111111 100
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+.+.. +......+..++..||+.+|.+||++.+|+++
T Consensus 226 --~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 --PTLDQ--PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --CCcCC--cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 01100 00111234455667999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=310.86 Aligned_cols=238 Identities=22% Similarity=0.382 Sum_probs=187.3
Q ss_pred eeecccCceEEEEEEeCC--------CCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 428 NLIGKGGSSQVYKGCLPD--------GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~--------g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+.||+|+||.||+|.... ...+++|.+.... ...+.+.+|+.+++.+.||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999997532 2348888886543 4456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCc--------eEEccccc
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--------PQLSDFGL 570 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~--------vkL~DFGl 570 (770)
+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999997554 257899999999999999999999 89999999999999987765 59999998
Q ss_pred cccccCCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCC-CCCCCCCccchhhHHHhhcccccCC
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGR-KPISNDHPKGQESLVMWAKPILSSG 648 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~-~Pf~~~~~~~~~~lv~~~~~~~~~g 648 (770)
+...... ....+++.|+|||++... .++.++|||||||++|||++|. .||....+........ ...
T Consensus 155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~------~~~ 222 (258)
T cd05078 155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE------DRH 222 (258)
T ss_pred ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH------ccc
Confidence 8654321 124688999999999864 5899999999999999999984 6665443322111110 000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 649 ~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
.++......+..++..||+.+|++||++.++++.|
T Consensus 223 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 223 ------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 01111123456677789999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.31 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=200.7
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+|.+.+.||+|+||.||++.. .+|+.||+|.+... ....+++.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999985 46889999998642 34556889999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+.+++|.+.+..... ..+++..++.++.|++.||.|||+ ++++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999875432 357899999999999999999999 899999999999999999999999999997654432
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
.. .....|++.|+|||++..+.++.++|+|||||++++|++|+.||.......... .+. .+.... .
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~--~~~-----~~~~~~-----~ 221 (256)
T cd08218 156 EL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL--KII-----RGSYPP-----V 221 (256)
T ss_pred hh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHH--HHh-----cCCCCC-----C
Confidence 21 122468899999999998899999999999999999999999997654322111 111 011100 1
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.......+..++..||+.+|.+||++.+|+++
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 ----SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ----cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11122345566678999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=307.74 Aligned_cols=255 Identities=24% Similarity=0.399 Sum_probs=198.4
Q ss_pred cccceeecccCceEEEEEEeC----CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC------
Q 004174 424 FLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 490 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------ 490 (770)
|.+.+.||+|+||.||+|... +++.+|||+++.. ....+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999753 4688999998753 345667889999999999999999999886532
Q ss_pred ceEEEEeecCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 568 (770)
..+++++|+.+|+|.+++.... .....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998875322 222357889999999999999999999 88999999999999999999999999
Q ss_pred cccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccC
Q 004174 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSS 647 (770)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~ 647 (770)
|+++...............+++.|++||.+..+.++.++|||||||++|||++ |+.||...... .+..+.. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~---~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLI---KG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHH---cC
Confidence 99986644332222222345678999999998889999999999999999999 89999765432 1211111 00
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 648 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 648 g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.... ........+..++..||+.+|.+||++.++++.|+.
T Consensus 232 ~~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 232 NRLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred CcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0000 011223456777788999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=309.60 Aligned_cols=264 Identities=22% Similarity=0.303 Sum_probs=200.6
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+|.+.+.||.|+||.||+|... +|+.|+||++... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999864 6899999998753 23456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+ +++|.+++.... ..+++..++.++.||+.||.|||+ ++++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987543 358999999999999999999999 899999999999999999999999999998765433
Q ss_pred CCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHH-hhc-------cccc-CC
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM-WAK-------PILS-SG 648 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~-~~~-------~~~~-~g 648 (770)
. .......|+..|+|||++... .++.++|||||||++|||++|.+||...........+. ... +... ..
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 2 112235689999999998754 46899999999999999999988887654322111110 000 0000 00
Q ss_pred ccccccCcccC----CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 KVTQLLDPALG----NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ~l~~lld~~l~----~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
....+..+.-. .....+....+..++..||+.+|.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00001122566677788999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=305.75 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=193.9
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC------hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec--Cce
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 492 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~ 492 (770)
++|.+.+.||+|+||.||+|... +|+.||||.+... ....+.+.+|+.++..++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57889999999999999999864 5899999988532 23456788999999999999999999998763 468
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999999986542 47888899999999999999999 889999999999999999999999999997
Q ss_pred cccCCCCC-ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 573 WASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 573 ~~~~~~~~-~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
........ .......|+..|+|||++.+..++.++|||||||++|||++|+.||............ ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~------~~~---- 224 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI------ATQ---- 224 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH------hcC----
Confidence 65432111 1112346899999999998888999999999999999999999999754322111100 000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
...+.+ +......+..++..|+ .+|.+||++++|+++
T Consensus 225 -~~~~~~----~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~ 261 (265)
T cd06652 225 -PTNPVL----PPHVSDHCRDFLKRIF-VEAKLRPSADELLRH 261 (265)
T ss_pred -CCCCCC----chhhCHHHHHHHHHHh-cChhhCCCHHHHhcC
Confidence 001111 2222233444445677 489999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=304.88 Aligned_cols=251 Identities=27% Similarity=0.389 Sum_probs=199.1
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
+++|.+.+.||+|.|+.||++.. ++|+.+|+|+++.. ....+++.+|++|-..|+||||++|.+.+.+....|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45678888999999999999864 57999999988642 346778899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC---CCceEEcccccccc
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLAKW 573 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~~~vkL~DFGla~~ 573 (770)
|+|.|++|..-|-.. ..+++..+-.++.||+++|.|+|. ++|||||+||+|+||.. ..-+||+|||+|..
T Consensus 90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999998766543 357888888999999999999999 89999999999999953 34589999999998
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
+.... ....++|||+|||||++...+|+..+|||+.||+||-||.|++||.+.+.. .+..... .|...
T Consensus 163 l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I~----~g~yd-- 230 (355)
T KOG0033|consen 163 VNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQIK----AGAYD-- 230 (355)
T ss_pred eCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHHh----ccccC--
Confidence 87332 234578999999999999999999999999999999999999999874432 2221111 11100
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+++.- ...-.+..+. ++.+||..||.+|-|+.|.|++
T Consensus 231 ~~~~~-w~~is~~Ak~---LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 231 YPSPE-WDTVTPEAKS---LIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CCCcc-cCcCCHHHHH---HHHHHhccChhhhccHHHHhCC
Confidence 01100 0111233333 4456999999999999999875
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=313.62 Aligned_cols=255 Identities=23% Similarity=0.310 Sum_probs=199.0
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||.||++... +++.|++|.+.... .....+.+|+++++.++||||+++++.+..++.+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47889999999999999999864 57899999987542 33457889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||++|++|.+++.... .+++..+..++.+++.||.|||+ ++++||||||+|||++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999996543 58899999999999999999999 8999999999999999999999999999874221
Q ss_pred CCCC-------------ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcc
Q 004174 577 SSSH-------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 643 (770)
Q Consensus 577 ~~~~-------------~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~ 643 (770)
.... .......|+..|+|||++....++.++|+|||||++|||++|..||.+..+.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~--- 230 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS--- 230 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---
Confidence 1000 011124578899999999988999999999999999999999999976543221111100
Q ss_pred cccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 644 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 644 ~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+. ...+.... .....+..++..||+.+|++||++..++++|..
T Consensus 231 ----~~---~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 ----DD---IEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ----cc---cCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 00 00111111 112234566678999999999997666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.53 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=199.3
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+|...+.||+|+||.||++.. .+++.+|||.+... ....+.+.+|+++++.++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478889999999999999986 46889999998653 34567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC-CceEEccccccccccCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWASTS 577 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~-~~vkL~DFGla~~~~~~ 577 (770)
+++++|.+++..... ..+++..+..++.+++.||.|||+ ++++|+||||+||+++.+ +.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999975432 358899999999999999999999 899999999999999855 45899999999876543
Q ss_pred CCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
... ....|+..|+|||++....++.++||||||+++|+|++|+.||...+.... ..+.. . +....+.
T Consensus 156 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~---~-~~~~~~~--- 222 (256)
T cd08220 156 SKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLKIM---S-GTFAPIS--- 222 (256)
T ss_pred ccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHHHH---h-cCCCCCC---
Confidence 221 124689999999999988899999999999999999999999976543221 11111 0 1111111
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. .....+..++..||+.+|.+||++.+++.+
T Consensus 223 --~----~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 --D----RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --C----CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1 112334566678999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=315.44 Aligned_cols=252 Identities=26% Similarity=0.331 Sum_probs=200.2
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|...+.||+|+||.||+|... +++.||+|.+.... ...+.+..|++++..++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999875 58999999997543 34567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+.+++|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCCC--CccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999999875432 468999999999999999999999 8999999999999999999999999999875533
Q ss_pred CCCCc---------------------------eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCC
Q 004174 577 SSSHI---------------------------TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (770)
Q Consensus 577 ~~~~~---------------------------~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~ 629 (770)
..... ......||..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 21110 111246899999999999888999999999999999999999999765
Q ss_pred CccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC----HHHHHH
Q 004174 630 HPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ----MSLVLK 693 (770)
Q Consensus 630 ~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs----~~eVL~ 693 (770)
+.......+. +..............+..++..||+.+|++||+ +.+++.
T Consensus 236 ~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRDETFSNIL---------------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chHHHHHHHh---------------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 4322111100 000000001112345666677899999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=325.71 Aligned_cols=243 Identities=28% Similarity=0.404 Sum_probs=198.0
Q ss_pred cccceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 424 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
|.-.+.||.|+||.||.|.+ .+...||||.+.-+ .....+++.|+..|.+++|||++.+.|||..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 44457799999999999986 46778999999643 45667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
|-| +-.++|.-.+ .++-+.++..|..+.+.||.|||+ ++.||||||..||||++.|.|||+|||.|......
T Consensus 108 ClG-SAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 108 CLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred Hhc-cHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 955 7777775433 368889999999999999999999 88999999999999999999999999999766543
Q ss_pred CCceecccccccCCCCceeec---cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 579 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
..++|||.|||||++. .|.|+-|+|||||||++.||.-.++|+..++.... +..-+ +--.
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA--LYHIA----------QNes 242 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIA----------QNES 242 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH--HHHHH----------hcCC
Confidence 2378999999999874 67899999999999999999999999887654322 21111 1112
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
|.|. ..+.......++-.||++-|.+|||..+++++
T Consensus 243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 2232 22333444555567999999999999998874
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=333.07 Aligned_cols=203 Identities=21% Similarity=0.249 Sum_probs=161.6
Q ss_pred hhcCcccceeecccCceEEEEEEeCC--CCEEE------------------EEEeCCChhHHHHHHHHHHHHHhcCCCce
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLPD--GKELA------------------VKILKPSEDVIKEFVLEIEIITTLHHKNI 479 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~~--g~~vA------------------VK~l~~~~~~~~~~~~Ei~iL~~l~HpnI 479 (770)
..++|.+.+.||+|+||+||++.... +...+ .|.++........+.+|+.+|..++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35689999999999999999986432 22122 22222233455678899999999999999
Q ss_pred eEEeeEEeecCceEEEEeecCCCChhhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC
Q 004174 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (770)
Q Consensus 480 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 558 (770)
+++++++...+..|+|++++. ++|.+++..... .........++.|+.||+.||.|||+ ++||||||||+||||+
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence 999999999999999999995 577777654321 11223456677899999999999999 8999999999999999
Q ss_pred CCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCC-CCC
Q 004174 559 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRK-PIS 627 (770)
Q Consensus 559 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~-Pf~ 627 (770)
.++.+||+|||+++.+....... .....||+.|+|||++.+..++.++|||||||+||||++|.. ||.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~ 370 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG 370 (501)
T ss_pred CCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence 99999999999998765432221 123579999999999999999999999999999999999875 444
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=310.92 Aligned_cols=263 Identities=23% Similarity=0.286 Sum_probs=198.7
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
+|...+.||+|+||.||+|... +|+.||||.++... .....+..|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999864 68999999997543 2345677899999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+ +|+|.+++.... ..+++..+..++.||++||.|||+ ++|+|+||||+|||++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 889999997543 258999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHH-Hhhccccc-----CC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV-MWAKPILS-----SG 648 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv-~~~~~~~~-----~g 648 (770)
...... ....+++.|+|||++.. ..++.++|||||||++|||++|.+||...........+ ........ ..
T Consensus 154 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 154 SPNRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCCccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 432221 22357889999998864 45789999999999999999998888765432211111 00000000 00
Q ss_pred ccccccCcccCCCC-----ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 KVTQLLDPALGNNY-----DYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ~l~~lld~~l~~~~-----~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+............ .......+..++..||+.+|.+||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000000 11123456677788999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.00 Aligned_cols=244 Identities=27% Similarity=0.375 Sum_probs=199.3
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||.||++... +++.+|+|++.... ...+.+.+|+++++.++||||+++++++..++.+++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999864 68999999987532 34567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||+|+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999987553 58899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
. .....|++.|+|||++....++.++||||||+++|+|++|+.||...........+ ..+..
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~~------ 215 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI-------LEGKV------ 215 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------hcCCc------
Confidence 3 12356899999999998888999999999999999999999999765421111110 01110
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 694 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~ 694 (770)
.+.... ...+..++..||..+|.+|| ++.+++++
T Consensus 216 ~~~~~~----~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 216 RFPSFF----SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred cCCccC----CHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 111111 23445566789999999999 77777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.73 Aligned_cols=266 Identities=21% Similarity=0.252 Sum_probs=195.5
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCc-----
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNN----- 491 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~----- 491 (770)
++|.+.+.||+|+||.||+|... +|+.||||.++... .....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999864 68999999886532 23467888999999995 6999999999987665
Q ss_pred eEEEEeecCCCChhhhhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC-CCceEEcccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFG 569 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-~~~vkL~DFG 569 (770)
.|+||||+++ +|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 898888654322 3468999999999999999999999 89999999999999998 8899999999
Q ss_pred ccccccCCCCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhh-HHHhhc-cccc
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES-LVMWAK-PILS 646 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~-lv~~~~-~~~~ 646 (770)
++......... .....+++.|+|||++.. ..++.++||||||+++|+|++|..||.......... +..... +...
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 99765432221 122357889999998865 457899999999999999999999997654322111 111000 0000
Q ss_pred ----CCc------cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 647 ----SGK------VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 647 ----~g~------l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
... ........+. .........+..++..||+.+|.+||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hCcchhhccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 0000000000 0001122345567778999999999999998863
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=297.05 Aligned_cols=251 Identities=29% Similarity=0.414 Sum_probs=204.4
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeec--CceEEEE
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVY 496 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~LV~ 496 (770)
+|...+.||+|++|.||+|... +++.+++|++.... ...+.+.+|+.++++++||||+++++++... +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999975 68999999987654 4567899999999999999999999999988 8899999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++++|.+++.... .+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999987543 68999999999999999999999 8999999999999999999999999999987765
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
...........++..|+|||++....++.++||||||+++|+|++|+.||..... ... ..+. ....+...
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~-~~~~--~~~~~~~~----- 223 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMA-ALYK--IGSSGEPP----- 223 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHH-HHHh--ccccCCCc-----
Confidence 5431112335789999999999988899999999999999999999999976551 111 1111 11001111
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+......+..++..|++.+|.+||++.+++++
T Consensus 224 ----~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 224 ----EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ----CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1111123456666778999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=309.75 Aligned_cols=263 Identities=21% Similarity=0.260 Sum_probs=194.0
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+|.+.+.||+|+||.||+|... +|+.+|+|+++... .....+.+|+.+++.++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999864 68999999987532 2345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++ +|.+++.... ..+++..++.++.||++||.|||+ ++|+||||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CDQ-DLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 974 8888776432 358999999999999999999999 899999999999999999999999999998654332
Q ss_pred CCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccc-hhhHHHhhcccccC---Cccccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKG-QESLVMWAKPILSS---GKVTQL 653 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~-~~~lv~~~~~~~~~---g~l~~l 653 (770)
.. .....+++.|+|||++.+. .++.++|||||||++|+|+||..||....... ....+.-....... ..+..+
T Consensus 154 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 21 1234678999999998765 47899999999999999999998865433211 11000000000000 000000
Q ss_pred cCcc----cCCCC-----ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 654 LDPA----LGNNY-----DYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 654 ld~~----l~~~~-----~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+.. ..... .......+..++..||+.||.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000 00000 01112344556778999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.70 Aligned_cols=245 Identities=28% Similarity=0.455 Sum_probs=198.3
Q ss_pred cccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 424 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
|...+.||.|+||.||+|.. .++..+|||++.... .....+.+|+.++..++||||++++++|..++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 66778999999999999985 468899999986432 445678899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+++|.+++... .+++..+..++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 86 ~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 86 GGSALDLLEPG-----PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999988632 47899999999999999999999 8999999999999999999999999999876644321
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 660 (770)
......|+..|+|||++....++.++|+|||||++|+|++|..||....+......+ ..+.. +.+..
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------~~~~~-----~~~~~ 223 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI-------PKNNP-----PTLEG 223 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH-------hcCCC-----CCCCc
Confidence 112246889999999999888999999999999999999999999754432111111 01110 11111
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 661 ~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.....+..++..||+.+|.+||++.+++++
T Consensus 224 ----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 ----NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 122344556678999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=314.91 Aligned_cols=246 Identities=20% Similarity=0.323 Sum_probs=204.8
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.-|.+++.||+|.|..|-+|.+ -+|..||||++.+.+ -....+.+|++.|+.++|||||+||.+......+|||.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4477788999999999999875 489999999997643 345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC-CCCceEEccccccccccC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~-~~~~vkL~DFGla~~~~~ 576 (770)
+=++|+|+++|.+.. ..+.+....+++.||+.|+.|+|+ ..+|||||||+||.+. .-|-+||+|||++..+..
T Consensus 98 LGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999997554 468999999999999999999999 8899999999999875 557899999999976665
Q ss_pred CCCCceecccccccCCCCceeeccCCCC-CcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
.... ++.||.+.|.|||++.+..|+ +++|||||||+||.|++|++||+..+..+....++-.+.
T Consensus 172 G~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY------------ 236 (864)
T KOG4717|consen 172 GKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY------------ 236 (864)
T ss_pred cchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc------------
Confidence 4332 347999999999999999887 589999999999999999999987654433333322111
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
..+......+-.++..||.+||++|.+.++|..
T Consensus 237 -----tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 -----TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred -----cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 113334456666777899999999999999875
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.19 Aligned_cols=203 Identities=24% Similarity=0.420 Sum_probs=171.0
Q ss_pred hhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++++|.+.+.||+|+||.||+|.. .+|+.||+|++.... .....+.+|+.++..++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 467899999999999999999986 468899999986532 33346778999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+. ++|.+.+.... ..+.+..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 67877765432 347788899999999999999999 8999999999999999999999999999975433
Q ss_pred CCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 631 (770)
.... .....+++.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 156 PSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred CCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 2211 1234578999999998754 578899999999999999999999976543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=322.05 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=205.0
Q ss_pred hhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~LV 495 (770)
....|.+++.||+||.+.||++...+.+.||+|.+.. +.....-|.+|+.+|.+|+ |.+||+|++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3456888999999999999999887778888887653 4466788999999999996 89999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||= ..+|..+|...... ...| .++.+..|++.|+.++|+ +||||-||||.|+|+-. |.+||+|||+|..+.
T Consensus 439 mE~G-d~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred eecc-cccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 9976 45999999876542 3345 778899999999999999 99999999999999964 689999999999998
Q ss_pred CCCCCceecccccccCCCCceeeccC-----------CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhccc
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYG-----------KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 644 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~-----------~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~ 644 (770)
.+.+.+.....+||+.||+||.+... +.+.++|||||||+||+|+.|++||.... . .|+
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n--~~a--- 580 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----N--QIA--- 580 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----H--HHH---
Confidence 88887777778999999999988633 35678999999999999999999996421 1 122
Q ss_pred ccCCccccccCcccCCCCChH-HHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 645 LSSGKVTQLLDPALGNNYDYD-QMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 645 ~~~g~l~~lld~~l~~~~~~~-~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
++..+.||.-.-+|+.- .-..++.++..||.+||++||+..++|++
T Consensus 581 ----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 ----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 33445555433333211 11126777788999999999999999974
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=296.14 Aligned_cols=249 Identities=31% Similarity=0.468 Sum_probs=203.0
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
+|...+.||+|++|.||++... +++.+++|++.... ...+.+.+|+++++.++|+|++++++++..++..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4777899999999999999875 68899999998654 366789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+++|.+++.... ..+++..+..++.+++.||.|||+ .+++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999987643 368999999999999999999999 8999999999999999999999999999987655432
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 660 (770)
.....|+..|+|||++....++.++|+||||+++|+|++|+.||...+......... . .....+..+
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~-----~~~~~~~~~---- 220 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA--T-----NGPPGLRNP---- 220 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH--h-----cCCCCcCcc----
Confidence 223578999999999998889999999999999999999999997654322111110 0 011111111
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 661 ~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. .....+..++..||+.+|.+||++.+++++
T Consensus 221 -~--~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 -E--KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -c--ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 012345556678999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=315.99 Aligned_cols=205 Identities=26% Similarity=0.357 Sum_probs=182.0
Q ss_pred HhhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 419 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 419 ~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
...+.|+.-++||+||||.||-+.. .+|+.||+|.+.+.. ......++|-.||.+++.++||.|-..|++.+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 3456788899999999999998875 579999999886432 33445778999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
||+..|.||+|.-+|...+. ..|++..++.++.+|+.||++||+ .+||+|||||+|||||+.|+++|+|+|||..
T Consensus 262 lVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEe
Confidence 99999999999999987654 579999999999999999999999 9999999999999999999999999999987
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 631 (770)
+....... ..+||.||||||+++++.|+...|+|||||+||||+.|+.||.....
T Consensus 337 i~~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 337 IPEGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred cCCCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 77654432 35899999999999999999999999999999999999999976543
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=303.35 Aligned_cols=247 Identities=26% Similarity=0.354 Sum_probs=200.7
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
+|.+.+.||.|+||.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999875 68999999997532 456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+.+++|.+++... ..+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998654 358899999999999999999999 88999999999999999999999999998766543
Q ss_pred CCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
.. .....|+..|+|||++....++.++|+||||+++|+|++|+.||..........+..- ... ..+.
T Consensus 154 ~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~------~~~~ 220 (258)
T cd05578 154 TL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK----QET------ADVL 220 (258)
T ss_pred cc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH----hcc------cccc
Confidence 21 1235688999999999988899999999999999999999999987654322222111 100 0000
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCH--HHHHH
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQM--SLVLK 693 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~--~eVL~ 693 (770)
.+......+..++..||+.+|.+||++ .++++
T Consensus 221 ----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 221 ----YPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ----CcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 111122455566678999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.02 Aligned_cols=246 Identities=26% Similarity=0.450 Sum_probs=197.8
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcC---CCceeEEeeEEeecCceEEEE
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~LV~ 496 (770)
.|...+.||+|+||.||+|.. .+++.||+|.++.. ......+.+|+.+++.++ |||+++++++|..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999986 57899999998653 345567889999999997 999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++++|.+++... .+++..+..++.+++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999988542 58899999999999999999999 8999999999999999999999999999987655
Q ss_pred CCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
.... .....|+..|+|||++..+ .++.++|+|||||++|+|++|+.||........ +.+.. .. ..
T Consensus 154 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~~----~~-----~~ 219 (277)
T cd06917 154 NSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MMLIP----KS-----KP 219 (277)
T ss_pred Cccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hhccc----cC-----CC
Confidence 4322 2235789999999998755 468899999999999999999999976543211 11110 00 11
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
+.+... .....+..++..||+.+|.+||++.++++
T Consensus 220 ~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 220 PRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111111 02234556667899999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.35 Aligned_cols=205 Identities=27% Similarity=0.419 Sum_probs=171.2
Q ss_pred CcccceeecccCceEEEEEEeC---CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec--CceE
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP---DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLL 493 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~---~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~ 493 (770)
.|.+.+.||+|+||.||+|... +++.||+|++... ......+.+|+.++..++||||++++++|... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3778899999999999999864 4789999999863 23346778899999999999999999999988 7899
Q ss_pred EEEeecCCCChhhhhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC----CCceEEccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD----DFEPQLSDF 568 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~----~~~vkL~DF 568 (770)
+||||+++ +|.+.+...... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 777776533222 2368899999999999999999999 89999999999999999 899999999
Q ss_pred cccccccCCCC-CceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCc
Q 004174 569 GLAKWASTSSS-HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (770)
Q Consensus 569 Gla~~~~~~~~-~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 631 (770)
|++........ ........+|+.|+|||++.+. .++.++|||||||++|+|++|++||.....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99987654322 1122235789999999988764 588999999999999999999999986554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.18 Aligned_cols=254 Identities=24% Similarity=0.414 Sum_probs=212.3
Q ss_pred cCcccceeecccCceEEEEEEeCC-CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
.+......||-|-||.||.|.++. ...||||.++.+...+++|+.|..+|+.++|||+|+|+|+|.....+|||.|||.
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 345567899999999999999864 5679999999888888999999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
.|+|.++|.+..+ ..++-...++++.||..|+.||.. +++|||||...|.|+.++..+|++||||++++..+...
T Consensus 347 yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT 421 (1157)
T KOG4278|consen 347 YGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT 421 (1157)
T ss_pred CccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence 9999999987554 346667788999999999999998 89999999999999999999999999999988664322
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
......-..-|.|||-+.+..++.|+|||+|||+|||+.| |..||.+-+-.. +..++.+...
T Consensus 422 -AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq----------------VY~LLEkgyR 484 (1157)
T KOG4278|consen 422 -AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYGLLEKGYR 484 (1157)
T ss_pred -cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH----------------HHHHHhcccc
Confidence 1111223557999999999999999999999999999999 999997643211 2233334444
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+.+......+..+++.||+.+|.+||++.++-+.|+.
T Consensus 485 M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 485 MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 44455666778888889999999999999998776543
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=311.42 Aligned_cols=244 Identities=26% Similarity=0.400 Sum_probs=194.2
Q ss_pred ceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCh
Q 004174 427 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL 504 (770)
...||+|+||.||++... ++..||||.+.... ...+.+.+|+.++..++||||+++++.|..++..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 356899999999999864 68899999986533 4456788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceec
Q 004174 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (770)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~ 584 (770)
.+++... .+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.++|+|||++......... ..
T Consensus 107 ~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~ 176 (292)
T cd06658 107 TDIVTHT-----RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RK 176 (292)
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--Cc
Confidence 9988532 47899999999999999999999 89999999999999999999999999998765433221 12
Q ss_pred ccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCCh
Q 004174 585 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 664 (770)
Q Consensus 585 ~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~ 664 (770)
...|++.|+|||++....++.++|||||||++|||++|+.||....+......+. ..+.+.+.....
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~------------~~~~~~~~~~~~- 243 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR------------DNLPPRVKDSHK- 243 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------hcCCCccccccc-
Confidence 3468999999999988889999999999999999999999997654322111110 011111111111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 665 DQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 665 ~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
....+..++..||..+|.+||++.+++++
T Consensus 244 -~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 -VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11233445567999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.37 Aligned_cols=264 Identities=23% Similarity=0.305 Sum_probs=198.7
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeec--CceEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLV 495 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~LV 495 (770)
++|.+.+.||.|+||.||+|..+ +++.+++|.++... .....+.+|+.++..++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999875 68899999997532 2334677899999999999999999999887 889999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++ +|.+++.... ..+++..++.++.||+.||.|||+ .+++|+||||+|||++.++.++|+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999975 9999886543 258999999999999999999999 889999999999999999999999999998665
Q ss_pred CCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHH-H---------hhc--
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV-M---------WAK-- 642 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv-~---------~~~-- 642 (770)
..... .....+++.|+|||++... .++.++||||||+++|+|++|+.||...........+ . |..
T Consensus 158 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 43221 2234678999999998754 4688999999999999999999999865432211111 0 100
Q ss_pred --ccccCCccccccCcccCCCCChH-HHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 643 --PILSSGKVTQLLDPALGNNYDYD-QMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 643 --~~~~~g~l~~lld~~l~~~~~~~-~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+..............+...+... ....+..++..||+.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000011111111111111111 23345556678999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=299.46 Aligned_cols=251 Identities=28% Similarity=0.458 Sum_probs=199.6
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+|.+.+.||+|+||.||+|... +++.|++|.++... ...+.+..|+.+++.++|+||+++++++...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 78899999987643 3677899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++++|.+++.... .+++..+..++.+++.||.|||+ .+|+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999987542 47889999999999999999999 899999999999999999999999999998765433
Q ss_pred CCce--ecccccccCCCCceeeccCC---CCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 579 SHIT--CTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 579 ~~~~--~~~~~GT~~YlAPE~~~~~~---~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
.... .....+++.|+|||++.... ++.++||||||+++|+|++|+.||........ ...... .+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~~~~~----~~~---- 223 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IMFHVG----AGH---- 223 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HHHHHh----cCC----
Confidence 2211 11246889999999998766 88999999999999999999999975432111 111100 010
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
.+.+.... .....+..++..||+.+|.+||++.+++.
T Consensus 224 -~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 -KPPIPDSL--QLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCccc--ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111 11233445667899999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=304.68 Aligned_cols=253 Identities=29% Similarity=0.428 Sum_probs=204.9
Q ss_pred hhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
.++.|...+.||+|+||.||+|... ++..+++|++.........+.+|++++..++|+||++++++|...+..++|+||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 4567888899999999999999976 688999999986655567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++++|.+++.... ..+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 97 MDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred cCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999998653 368999999999999999999999 899999999999999999999999999987554322
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
.. .....++..|+|||++....++.++|+|||||++|+|++|+.||....+..... .+.. .....+.++
T Consensus 171 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~--~~~~-----~~~~~~~~~-- 239 (286)
T cd06614 171 SK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF--LITT-----KGIPPLKNP-- 239 (286)
T ss_pred hh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHh-----cCCCCCcch--
Confidence 11 122457889999999988889999999999999999999999997654322111 1110 011111110
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
......+..++..||+.+|.+||++.+|+++
T Consensus 240 -----~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 240 -----EKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred -----hhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0012345556778999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=308.62 Aligned_cols=267 Identities=24% Similarity=0.322 Sum_probs=196.1
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC------
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 490 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------ 490 (770)
.++|.+.+.||+|+||.||+|... +++.||||.+... ......+.+|+.+++.++||||++++++|....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357899999999999999999864 6899999988643 223345678999999999999999999987654
Q ss_pred --ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccc
Q 004174 491 --NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (770)
Q Consensus 491 --~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 568 (770)
..++||||+.+ +|.+.+.... ..+++.++..++.||+.||.|||+ ++++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcC
Confidence 35999999965 8888876432 358999999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCC--ceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccc
Q 004174 569 GLAKWASTSSSH--ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 645 (770)
Q Consensus 569 Gla~~~~~~~~~--~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~ 645 (770)
|++......... .......++..|+|||++... .++.++||||||+++|||++|+.||....+......+......+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999866443221 111234678899999988754 47889999999999999999999998765433322222111100
Q ss_pred cCCccccc-----cCcc-cCCCC---------ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 646 SSGKVTQL-----LDPA-LGNNY---------DYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 646 ~~g~l~~l-----ld~~-l~~~~---------~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
........ .+.. +.... .......+..++..||+.+|.+||++.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000000 0000 00000 00011234567778999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.25 Aligned_cols=263 Identities=24% Similarity=0.318 Sum_probs=196.2
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+|...+.||.|+||.||+|... +|+.||||+++... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5788899999999999999864 68999999987532 2345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+. ++|.+++..... ..+++..+..++.|++.||+|||+ ++++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 589888865432 358899999999999999999999 899999999999999999999999999997654332
Q ss_pred CCceecccccccCCCCceeeccCC-CCCcceEeechHHHHHHHhCCCCCCCCCccchh-hHHHhhccccc----------
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE-SLVMWAKPILS---------- 646 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~-~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~lv~~~~~~~~---------- 646 (770)
.. .....+++.|+|||++.+.. ++.++|||||||++|||+||+.||......... ....+......
T Consensus 155 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 RT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred cc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 21 12245788999999887644 688999999999999999999999765432111 11111100000
Q ss_pred --CCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 647 --SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 647 --~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
...+.......+... .......+..++..||+.||.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000000 00011234456678999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=306.92 Aligned_cols=245 Identities=27% Similarity=0.409 Sum_probs=195.0
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
..|...+.||+|+||.||+|... +|+.||+|++... ....+.+.+|++++..++||||++++++|...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 34777889999999999999864 6899999988632 244567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+. |+|.+.+.... ..+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 57777765432 258999999999999999999999 8899999999999999999999999999876543
Q ss_pred CCCCceecccccccCCCCceeec---cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
.. ...|++.|+|||++. .+.++.++||||||+++|||++|+.||...+.......+.+ +..
T Consensus 168 ~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~-------~~~--- 231 (307)
T cd06607 168 AN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------NDS--- 231 (307)
T ss_pred CC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-------CCC---
Confidence 21 246889999999884 45688999999999999999999999976543221111110 000
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+.+. .......+..++..||+.+|.+||++.+|+.+
T Consensus 232 --~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 --PTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0110 11122345666678999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.61 Aligned_cols=245 Identities=25% Similarity=0.378 Sum_probs=194.8
Q ss_pred cceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCC
Q 004174 426 AENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 503 (770)
Q Consensus 426 ~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggs 503 (770)
....||+|+||.||++... +++.||+|++.... ...+.+.+|+.++..++||||++++++|..++..++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999864 68999999986533 345678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCcee
Q 004174 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583 (770)
Q Consensus 504 L~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~ 583 (770)
|..++.. ..+++..+..++.|++.||.|||+ ++++||||||+|||++.++.++|+|||++......... .
T Consensus 105 L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~ 174 (297)
T cd06659 105 LTDIVSQ-----TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--R 174 (297)
T ss_pred HHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--c
Confidence 9987753 247899999999999999999999 88999999999999999999999999998755433221 1
Q ss_pred cccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCC
Q 004174 584 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 663 (770)
Q Consensus 584 ~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~ 663 (770)
....|++.|+|||++....++.++|||||||++|||++|+.||....+......+. . .. .+.... .
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~----~~-----~~~~~~--~ 240 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR---D----SP-----PPKLKN--A 240 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---c----cC-----CCCccc--c
Confidence 23568999999999998899999999999999999999999997654322211111 0 00 000000 0
Q ss_pred hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 664 YDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 664 ~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
......+..++..||+.+|.+||++.+++++
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0111234456678999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.25 Aligned_cols=254 Identities=27% Similarity=0.429 Sum_probs=201.0
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
++|...+.||.|+||.||++... +++.+++|++... ......+.+|+++++.++||||++++++|...+.+++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999875 6899999998754 34567789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++++|.+++.... ..+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999987543 368889999999999999999997 3679999999999999999999999999987654322
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
.. ...++..|+|||++....++.++||||||+++|+|++|+.||....... ............. ..+.+
T Consensus 156 ~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~------~~~~~ 224 (265)
T cd06605 156 AK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNE------PPPRL 224 (265)
T ss_pred hh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcC------CCCCC
Confidence 21 1568899999999998899999999999999999999999997543211 1111111111110 00111
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
... .....+..++..||..+|.+||++.+++.+
T Consensus 225 ~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 PSG---KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred Chh---hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111 022335566678999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=297.59 Aligned_cols=252 Identities=23% Similarity=0.399 Sum_probs=205.9
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
++|.+.+.||+|++|.||+|... +++.|+||++.... .....+.+|+.++..++|+||+++++++...+.+++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999875 58999999987654 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++++|.+++... ..+++..+..++.|++.||.|||+. .+++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999754 3588999999999999999999962 679999999999999999999999999998765433
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
... ....++..|+|||++....++.++|+||||+++|+|++|+.||..........+..+... +. .+.+
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~-----~~~~ 223 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD----GP-----PPSL 223 (264)
T ss_pred Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc----CC-----CCCC
Confidence 322 234688999999999988999999999999999999999999977653222233222211 00 0111
Q ss_pred CCCCChH-HHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 659 GNNYDYD-QMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 659 ~~~~~~~-~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+.. ....+..++..||..+|.+||++.+++++
T Consensus 224 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 ----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 23456666678999999999999999973
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=292.46 Aligned_cols=263 Identities=26% Similarity=0.403 Sum_probs=203.5
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEEee
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+......||.|..|.|+++... +|..+|||.+... .+..++++..++++...+ .|+||+.+|||..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 3455678999999999999864 6889999999764 466788889999887776 89999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
|.. -++.++.... .++++..+-++...++.||.||.. .++|||||+||+|||||+.|++||||||++.++-...
T Consensus 173 Ms~-C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 173 MST-CAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHH-HHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 943 5666665544 368888889999999999999987 4889999999999999999999999999998877665
Q ss_pred CCceecccccccCCCCceeecc---CCCCCcceEeechHHHHHHHhCCCCCCCCCccc-hhhHHHhhcccccCCcccccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG-QESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~-~~~lv~~~~~~~~~g~l~~ll 654 (770)
.+.. .+|-+.|||||.+.- .+|+.++|||||||+|+||.||+.||.+.+..- ....+.. . .
T Consensus 247 Ahtr---sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln--------~----e 311 (391)
T KOG0983|consen 247 AHTR---SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN--------E----E 311 (391)
T ss_pred cccc---ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh--------c----C
Confidence 5443 579999999999963 479999999999999999999999998754321 1111111 1 1
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh------hCCCCchhhhhhh
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL------RGDADVTKWARLQ 708 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L------~~~~~~~~~~~~~ 708 (770)
.|.|..... .......+...||++|+++||...++|++- ....+++.|....
T Consensus 312 PP~L~~~~g--FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF~dV 369 (391)
T KOG0983|consen 312 PPLLPGHMG--FSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASWFKDV 369 (391)
T ss_pred CCCCCcccC--cCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHHHHHH
Confidence 133322211 111233344579999999999999999742 1235566786644
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=304.50 Aligned_cols=263 Identities=24% Similarity=0.318 Sum_probs=199.5
Q ss_pred cccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec--CceEEEEe
Q 004174 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVYD 497 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~LV~E 497 (770)
|.+.+.||.|+||.||+|... +|+.+|+|++... ......+.+|+++++.++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999865 5889999999865 24456788999999999999999999999888 88999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+++ +|.+++.... ..+++..++.++.||+.||.|||+ .+++|+||||+|||+++++.++|+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 8988886542 368999999999999999999999 89999999999999999999999999999876554
Q ss_pred CCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc---
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL--- 653 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l--- 653 (770)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..............+
T Consensus 154 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 154 NSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred Ccc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 321 1223467889999998764 45789999999999999999999999876543222111110000000000000
Q ss_pred -----------cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 654 -----------LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 654 -----------ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
....+...+.......+..++..||+.+|.+||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000111113456778888999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=314.21 Aligned_cols=263 Identities=22% Similarity=0.287 Sum_probs=198.6
Q ss_pred HhhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-----
Q 004174 419 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED----- 489 (770)
Q Consensus 419 ~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~----- 489 (770)
...++|...+.||+|+||.||+|.. .+|+.||||++... ......+.+|+.+++.++||||++++++|...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3457899999999999999999986 47899999998642 34456788899999999999999999998643
Q ss_pred -CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccc
Q 004174 490 -NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (770)
Q Consensus 490 -~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 568 (770)
...++||||+.+ +|.+.+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccC
Confidence 357999999964 88887753 27888999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHH-H--------
Q 004174 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV-M-------- 639 (770)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv-~-------- 639 (770)
|++........ .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+ .
T Consensus 163 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 163 GLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239 (353)
T ss_pred ccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 99987654322 12346899999999999999999999999999999999999999765432211110 0
Q ss_pred -----------hhc--ccccCCccccccCccc----CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 640 -----------WAK--PILSSGKVTQLLDPAL----GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 640 -----------~~~--~~~~~g~l~~lld~~l----~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+.. +......+..++...+ ...........+..++..||+.||.+||++.++|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0000000111111111 000011223445667788999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=303.66 Aligned_cols=265 Identities=21% Similarity=0.336 Sum_probs=198.4
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
+|...+.||.|++|.||+|... +|+.||||+++... .....+.+|+.+++.++||||++++++|...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999975 68899999987543 33466788999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++ +|.+++..... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 88888865432 2468999999999999999999998 8999999999999999999999999999976543222
Q ss_pred CceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC-cc
Q 004174 580 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD-PA 657 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld-~~ 657 (770)
. .....+|+.|++||++... .++.++|||||||++|+|++|+.||...+.......+.-.........+..+.+ +.
T Consensus 156 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 T--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred c--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1 1224678999999998654 578899999999999999999999987654322111100000000000000000 00
Q ss_pred cCCCC-----------ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 658 LGNNY-----------DYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 658 l~~~~-----------~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+...+ .......+..++..|++.+|.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 01112345566778999999999999999853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=326.03 Aligned_cols=251 Identities=27% Similarity=0.430 Sum_probs=200.0
Q ss_pred cCcccceeecccCceEEEEEEeCC-CCEEEEEEeCC-ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAVK~l~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
+.|.++..||.|+||.||+|..++ +-..|-|++.. +....++|+-||+||..+.||+||+|++.|+..+.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 347788899999999999998764 33456787753 5577899999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
.||-....+.... ..|.+.++..++.+++.||.|||+ ++|||||||..|||++-+|.++|+|||.+-.... .
T Consensus 112 ~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t 183 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T 183 (1187)
T ss_pred CCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh--H
Confidence 9999998877655 368999999999999999999999 8999999999999999999999999999743322 2
Q ss_pred CceecccccccCCCCceeec-----cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 580 HITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
......+.|||+|||||+++ ..+|+.++||||||++|.||..+.+|-..-++... ++..++ ..-.-++
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV--llKiaK-----SePPTLl 256 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAK-----SEPPTLL 256 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH--HHHHhh-----cCCCccc
Confidence 22334589999999999875 45799999999999999999999999876554221 111111 0111122
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.| .........+...||..||+.||++.+++++
T Consensus 257 qP-------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 QP-------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred Cc-------chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 21 1222333445567999999999999999985
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=316.42 Aligned_cols=266 Identities=22% Similarity=0.336 Sum_probs=196.8
Q ss_pred hhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-----Cc
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 491 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~ 491 (770)
.+++|.+.+.||+|+||.||+|.. .+|+.||||++... ......+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 357899999999999999999985 47899999998742 24556788999999999999999999987654 35
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 571 (770)
.++||||+.+ +|.+.+... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELMET-DLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccce
Confidence 7999999965 888777532 58999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCc-eecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCc
Q 004174 572 KWASTSSSHI-TCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 649 (770)
Q Consensus 572 ~~~~~~~~~~-~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 649 (770)
.......... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||...+.......+.-.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 7654332211 1123578999999998754 4689999999999999999999999976543221111000000000000
Q ss_pred cccccCccc---------CCCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 650 VTQLLDPAL---------GNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 650 l~~lld~~l---------~~~~~-----~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+..+.+... ..... ......+..++..||+.+|.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111010000 00000 0112345677788999999999999999975
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=305.93 Aligned_cols=249 Identities=27% Similarity=0.414 Sum_probs=199.8
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
++|.+.+.||+|+||.||++.. .+++.|++|.+.... ...+.+.+|+.+++.++||||++++++|...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788899999999999999985 468899999986433 44567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++++|.+++... .+++..+..++.+++.||.|||+ ++++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998643 47899999999999999999999 8999999999999999999999999999875544322
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
. .....|++.|+|||++..+.++.++|+|||||++|+|++|+.||....+......+ ...+. +.+.
T Consensus 171 ~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~~~------~~~~ 236 (293)
T cd06647 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGT------PELQ 236 (293)
T ss_pred c--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcCCC------CCCC
Confidence 1 12246889999999998888999999999999999999999999765442211110 00000 0000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
........+..++..||..+|.+||++.+++.+
T Consensus 237 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 --NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011112234456678999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=304.97 Aligned_cols=262 Identities=23% Similarity=0.313 Sum_probs=196.9
Q ss_pred cccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
|.+.+.||.|++|.||+|... +|+.||+|++.... .....+.+|+++++.++|||++++++++..++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999864 79999999987532 33467889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
+ ++|.+++..... ..+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 689998875442 358999999999999999999999 8999999999999999999999999999976543221
Q ss_pred CceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhh-HHHhhcccc--------c-CC
Q 004174 580 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES-LVMWAKPIL--------S-SG 648 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~-lv~~~~~~~--------~-~g 648 (770)
. .....+++.|+|||++..+ .++.++|||||||++|+|++|+.||.......... ...+..... . .+
T Consensus 155 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 T--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred c--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 1 1223578899999988754 57889999999999999999999997654322111 111100000 0 00
Q ss_pred ---ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 ---KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ---~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+.....+... .........+..++..||+.+|.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000 0011112456667788999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=299.23 Aligned_cols=249 Identities=23% Similarity=0.389 Sum_probs=198.6
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+|.+.+.||+|+||.||+|... +|..+|+|.+... ....+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999865 5889999998653 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC-ceEEccccccccccCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTS 577 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-~vkL~DFGla~~~~~~ 577 (770)
+++++|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++ .++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999875432 357899999999999999999999 8899999999999998885 4699999999766543
Q ss_pred CCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
... .....|++.|+|||++....++.++|+|||||++|||++|+.||........ +. ... .+.+..+
T Consensus 156 ~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~---~~~-~~~~~~~---- 222 (257)
T cd08225 156 MEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL---VL---KIC-QGYFAPI---- 222 (257)
T ss_pred ccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---HH---HHh-cccCCCC----
Confidence 221 1224689999999999988899999999999999999999999975433211 11 111 1111111
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.. .....+..++.+||+.+|.+||++.+++++
T Consensus 223 -~~----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 -SP----NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CC----CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11 112345556678999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=305.86 Aligned_cols=255 Identities=25% Similarity=0.373 Sum_probs=192.8
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEEee
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+|...+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++. |+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999864 68999999987532 44567889999999996 99999999999999999999999
Q ss_pred cCCCChhhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 499 LSRGSLEENLHGN-KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 499 ~~ggsL~~~l~~~-~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
+.. +|.++.... ......+++..+..++.+++.||+|||+. .+|+||||||+|||++.++.++|+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 655543211 11124689999999999999999999961 48999999999999999999999999999765443
Q ss_pred CCCceecccccccCCCCceeeccC---CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYG---KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~---~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
... ....|++.|+|||++... .++.++|||||||++|||++|+.||...... ...+ ..... +.
T Consensus 162 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~----~~~~~-~~----- 227 (288)
T cd06616 162 IAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-FDQL----TQVVK-GD----- 227 (288)
T ss_pred Ccc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-HHHH----hhhcC-CC-----
Confidence 222 224689999999999866 6899999999999999999999999754311 0111 10000 00
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+.+...........+..++..||+.+|.+||++.+|+++
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111112223356667778999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=305.44 Aligned_cols=264 Identities=21% Similarity=0.289 Sum_probs=195.4
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
++|.+.+.||+|+||.||+|... +|+.||+|.+.... ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 47889999999999999999864 68899999986532 334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC-CCceEEccccccccccC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWAST 576 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-~~~vkL~DFGla~~~~~ 576 (770)
|++ ++|.+.+..... ..+++..+..++.||+.||.|||+ ++++||||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 588887754332 346788888999999999999999 89999999999999985 55799999999976543
Q ss_pred CCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCc------
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK------ 649 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~------ 649 (770)
.... .....+++.|+|||++... .++.++|||||||++|+|+||+.||.......................
T Consensus 156 ~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 PVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred Cccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 3211 1234678999999988754 578999999999999999999999976543222111100000000000
Q ss_pred cccc-------cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 650 VTQL-------LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 650 l~~l-------ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+... ....+. .........+..++..|++.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred chhhhhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 000000 0001112335567778999999999999999973
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=322.02 Aligned_cols=244 Identities=26% Similarity=0.396 Sum_probs=198.6
Q ss_pred eeecccCceEEEEEEeCC-CCEEEEEEeCC-ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCChh
Q 004174 428 NLIGKGGSSQVYKGCLPD-GKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~-g~~vAVK~l~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~ 505 (770)
-+||+|.||+||.|++.+ ...+|||-+.. .....+-+..||.+.+.|+|.|||+++|.|.+++.+-+.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 379999999999999754 55789998864 3356677889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC-CCCceEEccccccccccCCCCCce
Q 004174 506 ENLHGNKKDPAAF--GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHIT 582 (770)
Q Consensus 506 ~~l~~~~~~~~~l--~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~-~~~~vkL~DFGla~~~~~~~~~~~ 582 (770)
.+|...- .++ .+...-.+.+||++||.|||. +.|||||||-.|||++ ..|.+||+|||-++.+..-.. .
T Consensus 661 sLLrskW---GPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~ 732 (1226)
T KOG4279|consen 661 SLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--C 732 (1226)
T ss_pred HHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCc--c
Confidence 9997543 244 778888999999999999999 8899999999999995 578999999999998765433 2
Q ss_pred ecccccccCCCCceeeccC--CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCC
Q 004174 583 CTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660 (770)
Q Consensus 583 ~~~~~GT~~YlAPE~~~~~--~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 660 (770)
..++.||+.|||||++..| .|+.++|||||||++.||.||++||....... ..|+. -|-+ ....
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---AAMFk-----VGmy------KvHP 798 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---AAMFK-----VGMY------KVHP 798 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---Hhhhh-----hcce------ecCC
Confidence 2347899999999999977 58899999999999999999999996543211 11111 1100 0112
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 661 ~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
..+.+.......+++.|+..+|.+||++.++|+
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 345555667777888999999999999999986
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=294.34 Aligned_cols=251 Identities=27% Similarity=0.410 Sum_probs=204.2
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+|.+.+.||.|+||.||++... +++.+++|++.... .....+.+|+++++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999864 68899999997542 4567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++++|.+++.........+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997654333578999999999999999999999 899999999999999999999999999998765543
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
. ......|++.|+|||++....++.++|+||||+++++|++|+.||........... . . .+.... +
T Consensus 158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~--~----~-~~~~~~-----~ 223 (258)
T cd08215 158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK--I----L-KGQYPP-----I 223 (258)
T ss_pred c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH--H----h-cCCCCC-----C
Confidence 1 22235789999999999988899999999999999999999999976543221111 0 0 011111 1
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.. .....+..++..||..+|.+||++.+++++
T Consensus 224 ~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 PS----QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CC----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 122345556678999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=305.85 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=207.2
Q ss_pred cccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCC
Q 004174 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~gg 502 (770)
|.+.+.||+|.||.||+|.++ +|+.+|||.+... ....++..|+.|+.++..|++|++||.|.....+++|||||..|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 566788999999999999864 7999999998754 45688999999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCce
Q 004174 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (770)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~ 582 (770)
++.+.+.-.. .++++.++..|+...++||+|||. ..-||||||..||||+.+|.+||+|||.|..+..... .
T Consensus 114 SiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--K 185 (502)
T KOG0574|consen 114 SISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--K 185 (502)
T ss_pred cHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHH--h
Confidence 9999997554 479999999999999999999998 7789999999999999999999999999977655433 2
Q ss_pred ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCC
Q 004174 583 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 662 (770)
Q Consensus 583 ~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~ 662 (770)
..++.|||.|||||++..-.|+.++||||||++..||..|++||.+-+|...... +.... .|.+ ..
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-------IPT~P-----PPTF--~K 251 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-------IPTKP-----PPTF--KK 251 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-------ccCCC-----CCCC--CC
Confidence 3457999999999999999999999999999999999999999988776332111 11100 0111 11
Q ss_pred ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 663 DYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 663 ~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+.........++..||-+.|++|-|+.+++++
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 33344455667778999999999999999875
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=297.83 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=203.5
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+|.+.+.||.|+||.||++... +++.+++|.+... ......+.+|+.+++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999754 7889999998753 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++++|.+++.........+++..++.++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999987643333568999999999999999999999 899999999999999999999999999998776542
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
. ....+++.|+|||++....++.++|+||||+++|+|++|+.||...+.......+ ..+....+
T Consensus 158 ~----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~~~----- 221 (256)
T cd08530 158 A----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV-------QRGKYPPI----- 221 (256)
T ss_pred c----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------hcCCCCCC-----
Confidence 1 1246889999999999888999999999999999999999999765432211111 11111111
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.......+..++..||+.+|.+||++.+++++
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 ----PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ----chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11223446667778999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=307.83 Aligned_cols=265 Identities=25% Similarity=0.332 Sum_probs=196.6
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeec--CceEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLL 494 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~L 494 (770)
.++|.+.+.||+|+||.||+|... +|+.||+|+++... .....+.+|+.++.+++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999864 68999999986432 2234567899999999999999999998765 46899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||+.+ +|.+++.... ..+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999965 8888886543 368999999999999999999999 88999999999999999999999999999876
Q ss_pred cCCCCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
...... .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||...++......+.-............+
T Consensus 159 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 543221 122346888999999865 45889999999999999999999999876554332222111000000000000
Q ss_pred cC-----c-ccCCC-CC------hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 654 LD-----P-ALGNN-YD------YDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 654 ld-----~-~l~~~-~~------~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
-+ . .+... +. .........++..||+.||++||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 0 00000 00 0012334556778999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=297.26 Aligned_cols=241 Identities=25% Similarity=0.322 Sum_probs=193.5
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCh
Q 004174 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (770)
Q Consensus 430 LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL 504 (770)
||.|+||.||++... +++.+|+|++.... ...+.+.+|+.+++.++||||+++++++.+++..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 48899999986532 3456789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceec
Q 004174 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (770)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~ 584 (770)
.+++.... .+++..+..++.||+.||.|||+ ++++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~~ 150 (262)
T cd05572 81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TW 150 (262)
T ss_pred HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---cc
Confidence 99997543 47899999999999999999999 8999999999999999999999999999987654321 12
Q ss_pred ccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCCh
Q 004174 585 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 664 (770)
Q Consensus 585 ~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~ 664 (770)
...|++.|+|||++....++.++|+||||+++|+|++|..||............. ..... ....++.
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~---------~~~~~~~ 217 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND----ILKGN---------GKLEFPN 217 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH----HhccC---------CCCCCCc
Confidence 2468999999999988889999999999999999999999997654211111110 00000 0001111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 004174 665 DQMERMVLASILCIRRDPRARPQ-----MSLVLK 693 (770)
Q Consensus 665 ~~~~~l~~~a~~Cl~~dP~~RPs-----~~eVL~ 693 (770)
.....+..++..||+.+|.+||+ +.++++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11335566777899999999999 677765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=300.94 Aligned_cols=260 Identities=23% Similarity=0.281 Sum_probs=192.8
Q ss_pred cccceeecccCceEEEEEEe-CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeec--CceEEEEe
Q 004174 424 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLH-HKNIISLLGFCFED--NNLLLVYD 497 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~--~~~~LV~E 497 (770)
|.+.+.||+|+||.||+|.. .+++.||+|+++.. ........+|+.++.++. |+||++++++|.+. +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56788999999999999985 46889999998753 222334567889999886 99999999999987 88999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|++ |+|.+.+.... ..++|..++.++.|++.||.|||+ .+++||||||+||+++. +.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 58888876533 368999999999999999999999 89999999999999999 99999999999866443
Q ss_pred CCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhh-HHHhhcc-------cccCC
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES-LVMWAKP-------ILSSG 648 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~-lv~~~~~-------~~~~g 648 (770)
... ....+++.|+|||++.. +.++.++|||||||++|||++|..||...+...... ...+... .....
T Consensus 153 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 153 PPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred CCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence 222 22468899999997754 457889999999999999999999997654322111 1000000 00000
Q ss_pred ccccccCcccC-CC---CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 KVTQLLDPALG-NN---YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ~l~~lld~~l~-~~---~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
....+..+... .. ........+..++..||+.+|.+||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000 00 001223556777788999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=312.88 Aligned_cols=266 Identities=24% Similarity=0.313 Sum_probs=197.6
Q ss_pred hhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec--Cce
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED--NNL 492 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~--~~~ 492 (770)
..++|.+.+.||+|+||.||+|... +|+.+|||.+... ......+.+|+.++.++ +||||++++++|... ..+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888999999999999999865 6889999988542 23445677899999999 999999999998653 368
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
++||||++ ++|..++... .+.|..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 5999888643 57889999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC---ceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC
Q 004174 573 WASTSSSH---ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 648 (770)
Q Consensus 573 ~~~~~~~~---~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 648 (770)
........ .......||+.|+|||++.. ..++.++|||||||++|+|++|+.||....+......+..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 66543321 12223568999999998864 457889999999999999999999997654432211111111000000
Q ss_pred c--------cccccCcccCC------CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 K--------VTQLLDPALGN------NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ~--------l~~lld~~l~~------~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. ...+++..... .........+..++..||+.+|.+||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 00011100000 0000122356667788999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=314.39 Aligned_cols=253 Identities=27% Similarity=0.454 Sum_probs=206.2
Q ss_pred hcCcccceeecccCceEEEEEEeC---CCC--EEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP---DGK--ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~---~g~--~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
.+.....++||.|-||.||+|... .|. .||||..+.+ .+..+.|++|.-+++.+.||||++|+|+|.+ ...+
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 334456788999999999999852 233 5899999864 3668899999999999999999999999976 5679
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+|||+++-|.|..+|+.++. .++......++.||+.||.|||+ .++|||||..+|||+....-+||+||||+++
T Consensus 467 ivmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred EEEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhh
Confidence 99999999999999987663 68888889999999999999999 8999999999999999999999999999999
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
+......... ...-..-|||||-+....++.++|||-|||++||++. |..||.+-...... ..++.|.-
T Consensus 541 ~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------~~iEnGeR-- 610 (974)
T KOG4257|consen 541 LEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------GHIENGER-- 610 (974)
T ss_pred ccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------EEecCCCC--
Confidence 9876655443 2334557999999999999999999999999999998 99999875432211 11223321
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+ ..+....-.+..++.+||..+|.+||.+.++...|..
T Consensus 611 l-------P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 611 L-------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred C-------CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 1 1123334566778889999999999999998877654
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.36 Aligned_cols=242 Identities=25% Similarity=0.321 Sum_probs=185.5
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHH---hcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 429 LIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIIT---TLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 429 ~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~---~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
+||+|+||.||++... +++.+|+|.+.... .....+.+|..++. ..+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 68899999886432 22233445544443 3479999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++........
T Consensus 81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 999999886543 58999999999999999999999 8899999999999999999999999999875543221
Q ss_pred ceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 581 ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
....||+.|+|||.+.. ..++.++|||||||++|+|++|+.||..........+.... . .....+.
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~-------~~~~~~~ 219 (279)
T cd05633 153 ---HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---L-------TVNVELP 219 (279)
T ss_pred ---cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---h-------cCCcCCc
Confidence 22468999999999874 45899999999999999999999999765433222211110 0 0111111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHHh
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKLL 695 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~L 695 (770)
.. ....+..++..||+.+|.+|| ++.+++++.
T Consensus 220 ~~----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 220 DS----FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred cc----cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 11 123445556789999999999 599998863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.29 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=197.0
Q ss_pred cccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004174 424 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
|...+.||+|++|.||++.. .+++.+++|++.... ...+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457899999999999985 478899999886433 3456688999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
++|.+++.. ..+++..+..++.|++.||.|||+ ++|+||||+|+||+++.++.++|+|||++.........
T Consensus 101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~- 171 (285)
T cd06648 101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR- 171 (285)
T ss_pred CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-
Confidence 999999865 247899999999999999999999 89999999999999999999999999988755433221
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 661 (770)
.....|++.|+|||++....++.++|||||||++|||++|+.||...++......+... . .+.+..
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-------~-----~~~~~~- 237 (285)
T cd06648 172 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-------L-----PPKLKN- 237 (285)
T ss_pred -cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-------C-----CCCCcc-
Confidence 12246899999999998888999999999999999999999999765442222111110 0 011110
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 662 YDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 662 ~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
.......+..++..||+.+|.+||++.++++
T Consensus 238 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 -LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0011234566677899999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=303.43 Aligned_cols=267 Identities=24% Similarity=0.333 Sum_probs=197.6
Q ss_pred HhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecC----
Q 004174 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN---- 490 (770)
Q Consensus 419 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~---- 490 (770)
...++|.+.+.||+|+||.||+|..+ +|+.||||+++... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35678999999999999999999975 58899999997532 33456778999999999999999999987654
Q ss_pred ------ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceE
Q 004174 491 ------NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (770)
Q Consensus 491 ------~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vk 564 (770)
.+++|+||+++ +|...+.... ..+++..++.++.||+.||.|||+ .+|+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEE
Confidence 78999999976 7777776432 368999999999999999999999 8999999999999999999999
Q ss_pred EccccccccccCCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcc
Q 004174 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 643 (770)
Q Consensus 565 L~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~ 643 (770)
|+|||++......... ......++..|+|||++... .++.++|||||||++|||++|++||...........+.....
T Consensus 157 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~ 235 (302)
T cd07864 157 LADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235 (302)
T ss_pred eCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999999876543321 11223568889999988643 578899999999999999999999976543222111111000
Q ss_pred cccCCccccc--------cCc------ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 644 ILSSGKVTQL--------LDP------ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 644 ~~~~g~l~~l--------ld~------~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.........+ .++ .+..... .....+..++..||+.+|.+||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000000 000 0000000 012345667778999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=313.14 Aligned_cols=266 Identities=23% Similarity=0.326 Sum_probs=199.4
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEee----cCce
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNL 492 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~ 492 (770)
.++|.+.+.||.|+||.||+|... +|+.||+|++.... ...+.+.+|+.+++.++||||++++++|.. ...+
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 468999999999999999999864 68999999987532 345677889999999999999999998763 3468
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
++||||+. |+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 58999886442 48999999999999999999999 899999999999999999999999999997
Q ss_pred cccCCCCC--ceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccc----
Q 004174 573 WASTSSSH--ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL---- 645 (770)
Q Consensus 573 ~~~~~~~~--~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~---- 645 (770)
........ .......|+..|+|||++.. ..++.++|||||||++|||++|+.||...+.......+.-.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 66443221 11123578999999999865 468999999999999999999999997765433222111100000
Q ss_pred ----cCCccccccCcc-cCCCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 646 ----SSGKVTQLLDPA-LGNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 646 ----~~g~l~~lld~~-l~~~~~-----~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
....+...++.. ...... ......+..++..||+.+|.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000011111000 000011 1123456677788999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=320.56 Aligned_cols=246 Identities=26% Similarity=0.411 Sum_probs=204.8
Q ss_pred cceeecccCceEEEEEEeC--CCC--EEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 426 AENLIGKGGSSQVYKGCLP--DGK--ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 426 ~~~~LG~G~fG~Vy~a~~~--~g~--~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
..++||+|.||.|++|.+. +|+ .||||+++... ....+|++|+.+|.+|+|+|+++|||+..+ ....||||++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3467999999999999864 455 57999998754 467899999999999999999999999987 6789999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
+.|+|.+.|+... ...|.......++.|||.||.||.. +++|||||...||||...-.+||+||||.+-+.....
T Consensus 193 plGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred ccchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999998733 3568888899999999999999999 8999999999999999999999999999998877665
Q ss_pred Cceecc-cccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 580 HITCTD-VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 580 ~~~~~~-~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
++.+.. ..-.+.|+|||.+..++++.++|||+|||+||||+| |..||-+......... +|..
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~----------------iD~~ 331 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN----------------IDAG 331 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHh----------------cccc
Confidence 554332 344568999999999999999999999999999999 8999977544322222 2211
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
-.-.-+....+++..++..||..+|.+||++..|.+
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 111224556788889999999999999999999863
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=296.83 Aligned_cols=259 Identities=24% Similarity=0.329 Sum_probs=194.7
Q ss_pred cccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhc---CCCceeEEeeEEeecCc-----
Q 004174 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTL---HHKNIISLLGFCFEDNN----- 491 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~~~----- 491 (770)
|.+.+.||+|+||.||+|... +++.||+|+++.. ......+.+|+.++..+ .||||++++++|...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999976 4899999999743 22345567788877766 59999999999988776
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 571 (770)
.+++|||+.+ +|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 9999999975 89988865432 358999999999999999999999 88999999999999999999999999999
Q ss_pred ccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCc--
Q 004174 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK-- 649 (770)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~-- 649 (770)
......... ....++..|+|||++....++.++|||||||++|||++|++||...........+ .......+.
T Consensus 155 ~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 229 (287)
T cd07838 155 RIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI--FDVIGLPSEEE 229 (287)
T ss_pred eeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHH--HHHcCCCChHh
Confidence 776443221 2245788999999999889999999999999999999999999865543221111 100000000
Q ss_pred c-------ccccCcccCC---CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 650 V-------TQLLDPALGN---NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 650 l-------~~lld~~l~~---~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
. ...+...... ....+....+..++..||+.+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 0000000000 001122344556777899999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=305.09 Aligned_cols=244 Identities=27% Similarity=0.414 Sum_probs=193.7
Q ss_pred cccceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 424 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
|...+.||+|+||.||+|.. .++..+|+|++... ......+.+|+.+++.++|||+++++++|..++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 56678899999999999986 46889999998642 24456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+.+ +|.+.+.... ..+++..+..++.+++.||.|||+ ++|+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~g-~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 975 7887775432 358999999999999999999999 89999999999999999999999999998754332
Q ss_pred CCceecccccccCCCCceeec---cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 579 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
....|++.|+|||++. .+.++.++|||||||++|||++|+.||......... ..+... +.
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~~~~----~~------ 241 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIAQN----ES------ 241 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH--HHHHhc----cC------
Confidence 1246899999999974 457899999999999999999999999764322211 111110 00
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
+... .......+..++..||+.+|.+||++.+|++++
T Consensus 242 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 242 PTLQ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred CCCC---CccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 0000 111223455666789999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=298.07 Aligned_cols=243 Identities=25% Similarity=0.337 Sum_probs=190.4
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCh
Q 004174 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (770)
Q Consensus 430 LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL 504 (770)
||+|+||+||++... +|+.||+|++.... .....+..|+++++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999754 68999999986432 2345677899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceec
Q 004174 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (770)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~ 584 (770)
.+++..... ..+++..++.++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~ 152 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IK 152 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cc
Confidence 999876543 358999999999999999999999 8999999999999999999999999999976644221 12
Q ss_pred ccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCCh
Q 004174 585 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 664 (770)
Q Consensus 585 ~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~ 664 (770)
...++..|+|||++.++.++.++|||||||++|+|++|+.||...........+. ..... ....+...+
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~-------~~~~~~~~~-- 221 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--RRTLE-------MAVEYPDKF-- 221 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--hcccc-------ccccCCccC--
Confidence 2467889999999998889999999999999999999999997654321111110 00000 000011111
Q ss_pred HHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 004174 665 DQMERMVLASILCIRRDPRARP-----QMSLVLK 693 (770)
Q Consensus 665 ~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~ 693 (770)
...+..++..||+.+|.+|| ++.+++.
T Consensus 222 --~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 --SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred --CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 22345566789999999999 6666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=290.29 Aligned_cols=246 Identities=29% Similarity=0.472 Sum_probs=200.7
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+|.+.+.||+|++|.||++... +++.|++|.+.... .....+.+|++++.+++|||++++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 67899999997654 4667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998754 358999999999999999999999 899999999999999999999999999998765543
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
.. .....++..|+|||++....++.++||||||+++|+|++|+.||...... ...|.... ... +.+
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~~~~~~~---~~~-----~~~ 219 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AALFRIVQ---DDH-----PPL 219 (254)
T ss_pred cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHhc---cCC-----CCC
Confidence 32 12356899999999998888899999999999999999999999754321 11111110 000 111
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
.. .....+..++..||..+|++||++.+++.
T Consensus 220 ~~----~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 PE----GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CC----CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11 11234455667899999999999999885
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=299.63 Aligned_cols=262 Identities=22% Similarity=0.290 Sum_probs=199.4
Q ss_pred cccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
|.+.+.||.|++|.||+|... +++.+++|.++... .....+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 556788999999999999864 68899999987543 34567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++ +|.+++.... ..+++..+..++.+++.||.|||+ ++|+|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 75 8888886543 368999999999999999999999 8999999999999999999999999999987655431
Q ss_pred CceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC---
Q 004174 580 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD--- 655 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld--- 655 (770)
......++..|+|||.+... .++.++|+||||+++|+|++|+.||...+.......+.-............+.+
T Consensus 154 --~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 154 --PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred --cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 12234688899999998876 789999999999999999999999976554222111100000000000000000
Q ss_pred c---ccC-------CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 656 P---ALG-------NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 656 ~---~l~-------~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. .+. .....+....+..++..||+.+|.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 000 00011223456677888999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=310.64 Aligned_cols=263 Identities=21% Similarity=0.318 Sum_probs=197.2
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-----Cc
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 491 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~ 491 (770)
.++|.+.+.||+|+||+||+|.. .+++.||||.+... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45789999999999999999986 46899999998752 23456778899999999999999999988654 35
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 571 (770)
.++||||+. ++|.+++... ..+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 899999996 6898888643 258899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHH-hhcc------
Q 004174 572 KWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM-WAKP------ 643 (770)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~-~~~~------ 643 (770)
........ ......++..|+|||++.. ..++.++|||||||++|+|++|+.||...+.......+. ....
T Consensus 156 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 86654321 1123468899999998875 468999999999999999999999997654322111110 0000
Q ss_pred -cccCCcccccc-------CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 644 -ILSSGKVTQLL-------DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 644 -~~~~g~l~~ll-------d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
....+.....+ ++.+.. ........+..++..||+.+|.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000000 000000 001123445677788999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=297.69 Aligned_cols=261 Identities=23% Similarity=0.328 Sum_probs=196.6
Q ss_pred cccceeecccCceEEEEEEeC-CCCEEEEEEeCCChh--HHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEEeec
Q 004174 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED--VIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
|.+.+.||.|+||.||+|... +++.|+||.+..... ......+|+..+..++ ||||++++++|..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999975 578899999875422 2234567999999999 999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
+|+|.+.+.... ...+++..+..++.|++.+|.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 889999887543 2468999999999999999999999 8999999999999999999999999999986654322
Q ss_pred CceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHH-H---------hhcccccCC
Q 004174 580 HITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV-M---------WAKPILSSG 648 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv-~---------~~~~~~~~g 648 (770)
. ....++..|+|||++.. ..++.++|+||||++++||++|+.||............ . |........
T Consensus 155 ~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 Y---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred c---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 2 23468899999998854 45889999999999999999999999765432221110 0 100000000
Q ss_pred ccccccC----cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 KVTQLLD----PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ~l~~lld----~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+...+. ..+..... .....+..++..||+.+|.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 00000001 113456677888999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=305.50 Aligned_cols=260 Identities=24% Similarity=0.312 Sum_probs=192.0
Q ss_pred eeeccc--CceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004174 428 NLIGKG--GSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 428 ~~LG~G--~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
..||+| +||+||++.. .+|+.||||++... ....+.+.+|+.+++.++||||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999986 47999999998743 24457888999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
++|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++++|||.+..........
T Consensus 84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999876532 358899999999999999999998 899999999999999999999999998654332211110
Q ss_pred --e---ecccccccCCCCceeeccC--CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhc-ccc--------
Q 004174 582 --T---CTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK-PIL-------- 645 (770)
Q Consensus 582 --~---~~~~~GT~~YlAPE~~~~~--~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~-~~~-------- 645 (770)
. .....++..|+|||++.++ .++.++|||||||++|||++|+.||......... ..... +..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCcccccc
Confidence 0 0112356679999999764 4789999999999999999999999765432111 10000 000
Q ss_pred -----------------------cCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 646 -----------------------SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 646 -----------------------~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+......+..+...........+..++..||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000001111111111122334456778888999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=294.39 Aligned_cols=250 Identities=23% Similarity=0.358 Sum_probs=194.8
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC------hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec--Cce
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 492 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~ 492 (770)
.+|.+.+.||+|+||.||+|.. .+++.||+|++... ......+.+|+++++.++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4789999999999999999986 46899999987532 23456788999999999999999999998764 458
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
+++|||+++++|.+++.... .+++..+..++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999986543 47888999999999999999998 899999999999999999999999999998
Q ss_pred cccCCCCC-ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 573 WASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 573 ~~~~~~~~-~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
........ .......|+..|+|||++....++.++|+|||||++|+|++|+.||........ ...... .+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~----~~--- 225 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--IFKIAT----QP--- 225 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--HHHHHc----CC---
Confidence 65432111 111235689999999999988899999999999999999999999975432211 111100 00
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+.+ +......+..++..||+ +|..||+..+++.+
T Consensus 226 --~~~~~----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 --TKPML----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred --CCCCC----CcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 01111 11222345555567888 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.61 Aligned_cols=255 Identities=17% Similarity=0.189 Sum_probs=182.9
Q ss_pred hcCcccceeecccCceEEEEEEeCC----CCEEEEEEeCCChhH------------HHHHHHHHHHHHhcCCCceeEEee
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPSEDV------------IKEFVLEIEIITTLHHKNIISLLG 484 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~----g~~vAVK~l~~~~~~------------~~~~~~Ei~iL~~l~HpnIv~l~~ 484 (770)
.++|.+.++||+|+||.||+|...+ +..+|+|+....... ......++..+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3579999999999999999998644 456677765432211 011223344556678999999999
Q ss_pred EEeecC----ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC
Q 004174 485 FCFEDN----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560 (770)
Q Consensus 485 ~~~~~~----~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~ 560 (770)
++.... ..+++++++.. ++.+.+.... .+++..+..|+.|++.||.|||+ ++|+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCC
Confidence 876543 34677887743 6666665332 35688889999999999999999 899999999999999999
Q ss_pred CceEEccccccccccCCCCC-----ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchh
Q 004174 561 FEPQLSDFGLAKWASTSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635 (770)
Q Consensus 561 ~~vkL~DFGla~~~~~~~~~-----~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~ 635 (770)
+.++|+|||+|+........ .......||+.|+|||++.+..++.++|||||||+||||++|+.||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 99999999999866432211 1112246999999999999999999999999999999999999999876332211
Q ss_pred -h--HHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 636 -S--LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 636 -~--lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
. ...+.... ..++ +..... ...+..++..|++.+|++||++.++++.|
T Consensus 243 ~~~~~~~~~~~~-~~~~--------~~~~~~---~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFIKRL-HEGK--------IKIKNA---NKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHHHHHh-hhhh--------hccCCC---CHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1 01111111 1111 110111 24455666779999999999999999876
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.29 Aligned_cols=248 Identities=27% Similarity=0.354 Sum_probs=201.0
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~LV 495 (770)
++|.+.+.||+|+||.||+|... +|+.||+|++... ......+.+|++++..++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999864 7899999998752 234567889999999999 99999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++++|.+++.... .+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999997543 58999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCC------------------ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhH
Q 004174 576 TSSSH------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637 (770)
Q Consensus 576 ~~~~~------------------~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l 637 (770)
..... .......|+..|+|||++....++.++||||||+++++|++|+.||....... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~ 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---T 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---H
Confidence 43321 11223568899999999988889999999999999999999999997654211 1
Q ss_pred HHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCH----HHHHH
Q 004174 638 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQM----SLVLK 693 (770)
Q Consensus 638 v~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~----~eVL~ 693 (770)
...... . ...++......+..++..||+.+|.+||++ .++++
T Consensus 231 ~~~~~~----~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 FQKILK----L----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHh----c----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111000 0 001111113446667778999999999999 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.42 Aligned_cols=245 Identities=25% Similarity=0.401 Sum_probs=194.6
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCh
Q 004174 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (770)
Q Consensus 430 LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL 504 (770)
||.|+||.||++... +|+.+++|++.... .....+.+|++++..++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 48999999997543 3556788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC-----
Q 004174 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----- 579 (770)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~----- 579 (770)
.+++.... .+++..+..++.||+.||.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99997543 58899999999999999999999 8999999999999999999999999999876543321
Q ss_pred -CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 580 -HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 580 -~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
........++..|+|||++....++.++||||||+++|+|++|..||....+......+. .+... . +
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-------~~~~~-~--~-- 221 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL-------NGKIE-W--P-- 221 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-------cCCcC-C--C--
Confidence 011223568889999999998889999999999999999999999997654322111111 01100 0 0
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
. .......+..++..||+.+|.+||++..+.+.|.
T Consensus 222 -~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 222 -E--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -c--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 0001234556667899999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=302.56 Aligned_cols=261 Identities=25% Similarity=0.295 Sum_probs=192.6
Q ss_pred cceeecccCceEEEEEEeCCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCC
Q 004174 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (770)
Q Consensus 426 ~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~gg 502 (770)
+.+.+|.|+++.||++.. +++.||||+++.. ....+.+.+|+++++.++||||++++++|...+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344556666766776655 7899999998753 355678999999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC---
Q 004174 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--- 579 (770)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~--- 579 (770)
+|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999975432 357889999999999999999999 8999999999999999999999999999875532211
Q ss_pred --CceecccccccCCCCceeecc--CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhc----ccccCC---
Q 004174 580 --HITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK----PILSSG--- 648 (770)
Q Consensus 580 --~~~~~~~~GT~~YlAPE~~~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~----~~~~~g--- 648 (770)
........++..|+|||++.. ..++.++|||||||++|||++|+.||........ +..... ..+...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchh
Confidence 111122457889999999875 3588999999999999999999999986543211 111000 000000
Q ss_pred ----cccc----ccCcccC----CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 ----KVTQ----LLDPALG----NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ----~l~~----lld~~l~----~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.... ..++... ..........+..++..||+.+|.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 0111100 01111223455667778999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.52 Aligned_cols=266 Identities=21% Similarity=0.289 Sum_probs=196.2
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecC------
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 490 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------ 490 (770)
.++|.+.+.||.|+||.||+|... +++.+|||++.... .....+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999864 68899999886422 22346778999999999999999999875533
Q ss_pred --ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccc
Q 004174 491 --NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (770)
Q Consensus 491 --~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 568 (770)
.+++||||+.+ +|...+.... ..+++..+..++.|+++||.|||+ ++|+||||||+|||++.++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcC
Confidence 46999999965 7777776432 368999999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCC---------ceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHH
Q 004174 569 GLAKWASTSSSH---------ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (770)
Q Consensus 569 Gla~~~~~~~~~---------~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv 638 (770)
|++......... ...+...|++.|+|||++... .++.++|||||||++|||++|++||.+.........+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999765432211 112234678899999988654 5889999999999999999999999865543322221
Q ss_pred HhhcccccCC------cccccc--------CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 639 MWAKPILSSG------KVTQLL--------DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 639 ~~~~~~~~~g------~l~~ll--------d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.......... .+.... .+.+...+ ......+..++..||+.+|.+|||+.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1110000000 000100 00000000 1112456677788999999999999998753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=313.54 Aligned_cols=246 Identities=25% Similarity=0.400 Sum_probs=201.9
Q ss_pred hhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
....|.+.+.||+|.|+.|.+|.+. ++..||||++.+.. .....+.+|+++|+.|+|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3567889999999999999999864 79999999998643 3445588999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+.+|.++++|...+. .....+..++.|+..|++|||+ ++|||||||++||||+.+.++||+|||++.++.
T Consensus 134 ~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999987764 4457888999999999999999 899999999999999999999999999999887
Q ss_pred CCCCCceecccccccCCCCceeeccCCCC-CcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
.... ..+.+|++.|.|||++++.+|+ +.+|+||+|++||-|+.|..||++..-++-..
T Consensus 207 ~~~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~------------------ 265 (596)
T KOG0586|consen 207 YGLM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP------------------ 265 (596)
T ss_pred cccc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc------------------
Confidence 4332 2347999999999999988764 78999999999999999999998765433211
Q ss_pred CcccCCCC--ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 655 DPALGNNY--DYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 655 d~~l~~~~--~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+.+.+.+ ++.-...+-.++...|-.+|.+|+++.++.+.
T Consensus 266 -rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 266 -RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1111111 11112233344455788899999999998764
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=310.23 Aligned_cols=259 Identities=21% Similarity=0.326 Sum_probs=192.5
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC------
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 490 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------ 490 (770)
.++|...+.||+|+||.||+|.. .+|+.||||++... ......+.+|+.++..++||||++++++|....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 37899999999999999999986 46899999998643 233456889999999999999999999987543
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 570 (770)
.+++|+||+.. +|...+. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46999999964 7776542 247899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhccccc---
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS--- 646 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~--- 646 (770)
++...... ....+|+.|+|||++.. ..++.++|||||||++|||++|+.||...+.......+.+......
T Consensus 164 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 164 ARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 97653321 22467899999999876 4688999999999999999999999987543222211111100000
Q ss_pred -----CCccccccC--cccC-CCC---ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 647 -----SGKVTQLLD--PALG-NNY---DYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 647 -----~g~l~~lld--~~l~-~~~---~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.......+. +... ... .......+..++..||+.||.+||++.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 0000 000 00112345567778999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=320.53 Aligned_cols=201 Identities=31% Similarity=0.449 Sum_probs=173.9
Q ss_pred cccceeecccCceEEEEEE-eCCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec------CceEE
Q 004174 424 FLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NNLLL 494 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~-~~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~~~~L 494 (770)
|...+.||+||||.||+|. ..+|+.||||.++.. ....+...+|+++|++|+|+|||++++.-.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4556789999999999999 458999999999863 34567788999999999999999999886543 35789
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC--CCC--ceEEccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDF--EPQLSDFGL 570 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~--~~~--~vkL~DFGl 570 (770)
|||||.||+|+..|.... +...|++.+.+.++..++.||.|||+ ++|+||||||.||++- .+| ..||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999997653 34579999999999999999999998 8999999999999993 333 369999999
Q ss_pred cccccCCCCCceecccccccCCCCceeec-cCCCCCcceEeechHHHHHHHhCCCCCCCCCc
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~-~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 631 (770)
|+-++... .+..++||+.|++||++. .+.|+..+|.|||||++|+.+||..||.....
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 99887765 445689999999999998 48899999999999999999999999976443
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=300.61 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=193.6
Q ss_pred hcCcccceeecccCceEEEEEEeCC-CCEEEEEEeCCCh--hHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~LV~ 496 (770)
.++|.+.+.||+|+||.||+|..++ ++.||||+++... .....+..|+.++..+. ||||++++++|......++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3567889999999999999999764 8999999997542 34556777888777775 999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+. ++|.+++.... ..+++..+..++.+++.||.|||+. .+|+||||+|+||+++.++.+||+|||++.....
T Consensus 94 e~~~-~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9985 47777765432 3689999999999999999999961 4899999999999999999999999999976644
Q ss_pred CCCCceecccccccCCCCceeeccCC----CCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGK----VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~----~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
.... ....+++.|+|||++.... ++.++||||||+++|+|++|+.||...... ...+..+... ....
T Consensus 168 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~-----~~~~ 238 (296)
T cd06618 168 SKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKILQE-----EPPS 238 (296)
T ss_pred CCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHhcC-----CCCC
Confidence 3222 2235788999999987543 889999999999999999999999653221 1111111110 0000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+.. .......+..++..||+.+|.+||++.+++++
T Consensus 239 -----~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 -----LPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -----CCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 00122345667788999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=317.56 Aligned_cols=242 Identities=26% Similarity=0.438 Sum_probs=192.3
Q ss_pred ceeecccCceEEEEEEeC-CCCEEEEEEeC-----CChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc--eEEEEee
Q 004174 427 ENLIGKGGSSQVYKGCLP-DGKELAVKILK-----PSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN--LLLVYDF 498 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~-----~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~--~~LV~E~ 498 (770)
..+||+|+|-+||+|.+. +|.+||--.++ ......++|..|+++|+.|+||||++++.++.+... +.+|.|+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 457999999999999864 57777744333 344567899999999999999999999999988665 7899999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC-CCceEEccccccccccCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-~~~vkL~DFGla~~~~~~ 577 (770)
|..|+|..++.+.+. .....+..|+.||++||.|||+.. .+|||||||-.||||+. .|.|||+|+|||......
T Consensus 125 ~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999987764 677889999999999999999976 79999999999999975 589999999999987664
Q ss_pred CCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
... .++|||.|||||++. ..|++.+||||||++++||+|+..||.-.....+ +..- ..+|.-..-+
T Consensus 200 ~ak----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ--IYKK----V~SGiKP~sl--- 265 (632)
T KOG0584|consen 200 HAK----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ--IYKK----VTSGIKPAAL--- 265 (632)
T ss_pred ccc----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH--HHHH----HHcCCCHHHh---
Confidence 332 368999999999988 8899999999999999999999999975433222 1111 1122211111
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
......+++. ++-.||.. ..+||++.++|+
T Consensus 266 --~kV~dPevr~---fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 266 --SKVKDPEVRE---FIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred --hccCCHHHHH---HHHHHhcC-chhccCHHHHhh
Confidence 1122233333 44579999 999999999997
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=306.42 Aligned_cols=264 Identities=23% Similarity=0.299 Sum_probs=200.5
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC-----ceE
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----NLL 493 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-----~~~ 493 (770)
+|.+.+.||.|+||.||+|... +++.+|||++... ....+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999875 5899999998753 345578899999999999999999999998775 789
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+||||+++ +|.+++.... .+++..+..++.+|+.||.|||+ ++|+||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~~-~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchhh-hHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999974 8988886543 68999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCC-ceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC---
Q 004174 574 ASTSSSH-ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG--- 648 (770)
Q Consensus 574 ~~~~~~~-~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g--- 648 (770)
....... .......+|+.|+|||++... .++.++|+||||+++|+|++|+.||...........+.-........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 7554310 112234688999999999887 79999999999999999999999998765432222111110000000
Q ss_pred -----ccccccCc-ccCCCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 -----KVTQLLDP-ALGNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 -----~l~~lld~-~l~~~~~-----~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.....+.. ....... ......+..++..||+.+|.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000 0000000 0112345567778999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=305.78 Aligned_cols=264 Identities=22% Similarity=0.266 Sum_probs=194.7
Q ss_pred cCcc-cceeecccCceEEEEEEeC-CCCEEEEEEeCCChhH---------------HHHHHHHHHHHHhcCCCceeEEee
Q 004174 422 SNFL-AENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDV---------------IKEFVLEIEIITTLHHKNIISLLG 484 (770)
Q Consensus 422 ~~f~-~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~---------------~~~~~~Ei~iL~~l~HpnIv~l~~ 484 (770)
++|. +.+.||.|+||.||+|... +++.||||+++..... ...+.+|++++..++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4555 4578999999999999864 6899999998653211 125778999999999999999999
Q ss_pred EEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceE
Q 004174 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (770)
Q Consensus 485 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vk 564 (770)
+|...+..++||||+. |+|.+++... ..+++.....++.|++.||.|||+ .+|+||||+|+|||++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEE
Confidence 9999999999999997 5899988643 258899999999999999999999 8999999999999999999999
Q ss_pred EccccccccccCCCC------------CceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCc
Q 004174 565 LSDFGLAKWASTSSS------------HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (770)
Q Consensus 565 L~DFGla~~~~~~~~------------~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 631 (770)
|+|||++........ ........+++.|+|||++.+. .++.++|||||||++|||++|+.||...+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999986652110 0111223578899999998754 478999999999999999999999987654
Q ss_pred cchhhHHHhhcccccCCcccccc------------CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 632 KGQESLVMWAKPILSSGKVTQLL------------DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 632 ~~~~~lv~~~~~~~~~g~l~~ll------------d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
......+...........+.... .+.+... .......+..++..||+.+|.+||++.+++.+
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 33221111000000000000000 0000000 01112345567778999999999999999964
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=291.64 Aligned_cols=243 Identities=23% Similarity=0.280 Sum_probs=187.1
Q ss_pred eeecccCceEEEEEEe-CCCCEEEEEEeCCCh----hHHHHHHHHHHHH-HhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004174 428 NLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEII-TTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL-~~l~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
+.||.|+||.||+|.. .+|+.||||+++... .....+..|..++ ....|+|+++++++|..++.+++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999986 468899999997543 2223344555444 455899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999986543 57889999999999999999999 8999999999999999999999999999875433
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 661 (770)
.....|++.|+|||++.++.++.++||||||+++|+|++|..||...........+. .+... ....+
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~~~--~~~~~--- 216 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL-------SRRIN--WPEEV--- 216 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------hcccC--CCCcc---
Confidence 122468899999999988889999999999999999999999997654322111111 00000 00001
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 662 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 662 ~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
.......+..++..||+.+|.+||++..+.++|.
T Consensus 217 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 -KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred -cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 1111234566677899999999998766655553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=294.87 Aligned_cols=241 Identities=25% Similarity=0.331 Sum_probs=185.0
Q ss_pred eecccCceEEEEEEe-CCCCEEEEEEeCCCh----hHHHHHHHHHH---HHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 429 LIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIE---IITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 429 ~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~---iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
+||+|+||.||++.. .+++.||+|++.... .....+..|.. ++....||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999986 468899999986532 11223444444 3444579999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
||+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++........
T Consensus 81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 99999988643 358999999999999999999999 8899999999999999999999999999875543221
Q ss_pred ceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
....|+..|+|||++..+ .++.++|||||||++|||++|+.||............ .... ...+.+.
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~---------~~~~~~~ 219 (278)
T cd05606 153 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTL---------TMAVELP 219 (278)
T ss_pred ---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HHhh---------ccCCCCC
Confidence 224789999999999755 6899999999999999999999999765332222111 0000 0011111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 694 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~ 694 (770)
... ...+..++..|+..+|.+|| ++.+++++
T Consensus 220 ~~~----s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 220 DSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CcC----CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 111 23455556689999999999 99999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=296.69 Aligned_cols=251 Identities=26% Similarity=0.358 Sum_probs=193.6
Q ss_pred CcccceeecccCceEEEEEEe----CCCCEEEEEEeCCCh-----hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCce
Q 004174 423 NFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~----~~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 492 (770)
+|.+.+.||.|+||.||++.. .+|+.||+|+++... ...+.+.+|+.++..+ +|+||++++++|..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 378999999997532 2346788899999999 599999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999987542 57888999999999999999999 899999999999999999999999999997
Q ss_pred cccCCCCCceecccccccCCCCceeeccC--CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcc
Q 004174 573 WASTSSSHITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650 (770)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~YlAPE~~~~~--~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 650 (770)
......... .....|+..|+|||++..+ .++.++||||||+++|+|++|..||.......... .+........
T Consensus 154 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~--~~~~~~~~~~-- 228 (290)
T cd05613 154 EFHEDEVER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA--EISRRILKSE-- 228 (290)
T ss_pred ecccccccc-cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHH--HHHHHhhccC--
Confidence 654432211 1235689999999998753 47889999999999999999999997543221111 1111111100
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004174 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 694 (770)
Q Consensus 651 ~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~ 694 (770)
+.. +......+..++..||+.+|.+|| ++.+++.+
T Consensus 229 -----~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 -----PPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -----CCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 001 111122445566789999999997 66766653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=308.51 Aligned_cols=270 Identities=24% Similarity=0.297 Sum_probs=201.2
Q ss_pred cccCHHHHHHhhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeE
Q 004174 410 RLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGF 485 (770)
Q Consensus 410 ~~f~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 485 (770)
+.....++...+++|.+.+.||+|+||.||+|.. .+|+.||+|+++... ...+.+.+|++++..++||||++++++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 3445567777889999999999999999999985 578999999987532 234678889999999999999999998
Q ss_pred Eeec------CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC
Q 004174 486 CFED------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 559 (770)
Q Consensus 486 ~~~~------~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~ 559 (770)
+... ...+++++++ +++|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~ 155 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNE 155 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcC
Confidence 8643 3478888887 77998887532 48899999999999999999999 89999999999999999
Q ss_pred CCceEEccccccccccCCCCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHH
Q 004174 560 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (770)
Q Consensus 560 ~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv 638 (770)
++.+||+|||++....... ....||+.|+|||++.. ..++.++|||||||++|||++|+.||...+.......+
T Consensus 156 ~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 230 (345)
T cd07877 156 DCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230 (345)
T ss_pred CCCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999987653321 22468999999998865 46889999999999999999999999765432221111
Q ss_pred Hhhccc--------ccCCcc-------ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 639 MWAKPI--------LSSGKV-------TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 639 ~~~~~~--------~~~g~l-------~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
...... +..... .......+... .......+..++..|++.+|.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhh-cCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 100000 000000 00000000000 00112345667778999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=302.87 Aligned_cols=264 Identities=22% Similarity=0.323 Sum_probs=198.2
Q ss_pred HHHHhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEee-cC
Q 004174 416 DLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DN 490 (770)
Q Consensus 416 ~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~ 490 (770)
++..++++|.+.+.||.|+||.||++... +++.||||++... ....+.+.+|++++..++||||++++++|.. .+
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 45567889999999999999999999854 7899999987642 2345678899999999999999999999876 56
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 570 (770)
..++||||+ +++|.+++... .+++..+..++.|++.||.|||+ ++|+||||+|+|||++.++.++|+|||+
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccc
Confidence 789999998 56898887532 47788888999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhh-HHHhh-------
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES-LVMWA------- 641 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~-lv~~~------- 641 (770)
+....... ....+++.|+|||++.. ..++.++|||||||++|+|++|+.||.......... +..+.
T Consensus 155 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 229 (328)
T cd07856 155 ARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229 (328)
T ss_pred ccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 87543321 22467889999998875 568999999999999999999999997654321111 11110
Q ss_pred -cccccCCccccccCc-ccCCCCCh-----HHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 642 -KPILSSGKVTQLLDP-ALGNNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 642 -~~~~~~g~l~~lld~-~l~~~~~~-----~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
...... ....++.. ......+. .....+..++..||+.+|++||++.+++..
T Consensus 230 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 230 INTICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHhccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00000000 00001111 112455666778999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=333.71 Aligned_cols=221 Identities=25% Similarity=0.298 Sum_probs=193.2
Q ss_pred CHHHHHHhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEe
Q 004174 413 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCF 487 (770)
Q Consensus 413 ~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 487 (770)
...++....++|.+.++||+|+||.|..+..+ +++.||+|++++.+ .....|..|-++|..-+.+-|++|.-.|+
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 35677778889999999999999999999864 68899999998732 34456888999999999999999999999
Q ss_pred ecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcc
Q 004174 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 567 (770)
Q Consensus 488 ~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~D 567 (770)
+++++|||||||+||+|..++.... .+++.-++.++.+|+.||+-||+ .|+|||||||+|||||..|++||+|
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeecc
Confidence 9999999999999999999997654 58889999999999999999999 9999999999999999999999999
Q ss_pred ccccccccCCCCCceecccccccCCCCceeec----c-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhh
Q 004174 568 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFM----Y-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 641 (770)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~----~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~ 641 (770)
||.+..+..+ +...+...+|||.|++||+++ + +.|+..+|+||+||++||||.|..||..+.-.+....++-.
T Consensus 219 FGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h 296 (1317)
T KOG0612|consen 219 FGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH 296 (1317)
T ss_pred chhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch
Confidence 9999877654 334455678999999999986 2 57999999999999999999999999987766655555544
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=295.61 Aligned_cols=254 Identities=26% Similarity=0.347 Sum_probs=196.7
Q ss_pred CcccceeecccCceEEEEEEe----CCCCEEEEEEeCCCh-----hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCce
Q 004174 423 NFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~----~~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 492 (770)
+|.+.+.||+|+||.||++.. .+++.||||+++... ...+.+.+|+.++..+ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999874 357889999987532 2345688999999999 599999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 9999999999999998643 257899999999999999999998 899999999999999999999999999987
Q ss_pred cccCCCCCceecccccccCCCCceeeccCC--CCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcc
Q 004174 573 WASTSSSHITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650 (770)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~--~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 650 (770)
.......... ....|+..|+|||++.... .+.++||||||+++|||++|..||.......... .........
T Consensus 154 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--~~~~~~~~~--- 227 (288)
T cd05583 154 EFLAEEEERA-YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS--EISRRILKS--- 227 (288)
T ss_pred cccccccccc-ccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHH--HHHHHHHcc---
Confidence 6544322111 2246899999999987665 7889999999999999999999996543221111 111111100
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 651 ~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+.....++ ..+..++..||+.+|.+|||+.++.+.|..
T Consensus 228 ----~~~~~~~~~----~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 ----KPPFPKTMS----AEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ----CCCCCcccC----HHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 011111111 234456678999999999999888777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=292.44 Aligned_cols=250 Identities=21% Similarity=0.346 Sum_probs=194.1
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCC------ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP------SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~------~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
+|.+.+.||+|+||.||++... .+..+++|+++. .......+..|+.++..++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999864 345566666653 123344677899999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++++|.+++.........+++..++.++.|++.||.|||+ ++++|+||||+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999887544334578999999999999999999999 89999999999999975 569999999997664
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
.... ......|++.|+|||++....++.++|+||||+++|+|++|..||...... ...... . .+. .
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~~~~---~-~~~-----~ 222 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL---SVVLRI---V-EGP-----T 222 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHHHH---H-cCC-----C
Confidence 4322 112356889999999998888999999999999999999999999654321 111110 0 111 1
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+.+ +......+..++..||+.+|++||++.+++++
T Consensus 223 ~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 223 PSL----PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCC----cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 111 11222345556678999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=290.42 Aligned_cols=247 Identities=24% Similarity=0.268 Sum_probs=187.5
Q ss_pred HHHhhcCcccceee--cccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCce
Q 004174 417 LLSATSNFLAENLI--GKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 417 l~~~t~~f~~~~~L--G~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 492 (770)
.....++|.+.+.+ |.|+||.||++.. .++..+|+|++...... . .|+.+...+ +||||++++++|...+..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~--~--~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN--A--IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc--h--hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 33344566666665 9999999999985 46889999998753211 1 122222222 699999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC-ceEEcccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLA 571 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-~vkL~DFGla 571 (770)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++ .++|+|||++
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 99999999999999997543 68999999999999999999999 8899999999999999988 9999999999
Q ss_pred ccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
....... ...|+..|+|||++....++.++|||||||++|||++|+.||....... .....|..... .. .
T Consensus 158 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~--~~-~ 227 (267)
T PHA03390 158 KIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQQ--KK-L 227 (267)
T ss_pred eecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhhc--cc-C
Confidence 7664322 2468999999999998899999999999999999999999998543322 11111111110 00 0
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC-HHHHHH
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-MSLVLK 693 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs-~~eVL~ 693 (770)
... ......+..++..||+.+|.+||+ +.++++
T Consensus 228 ~~~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 PFI---------KNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred Ccc---------cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 000 012223455556899999999996 688875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=299.94 Aligned_cols=242 Identities=24% Similarity=0.348 Sum_probs=194.5
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~L 494 (770)
..+|....+||+|+||.|.+|..+ +...||||+++++ .+.++--+.|-++|... +-|++++|..+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 447888999999999999999865 4567999999874 34455566788888877 46899999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||+.||+|-..+++.+ .|.+..+..++.+||-||-+||+ ++||+||||..||||+.+|++||+|||+++..
T Consensus 428 VMEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999999998765 47778888999999999999999 99999999999999999999999999999853
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
-- ...+..+++|||.|+|||++.+.+|+..+|+|||||+||||+.|++||++.+..+.-..++-..
T Consensus 501 i~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn------------ 566 (683)
T KOG0696|consen 501 IF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN------------ 566 (683)
T ss_pred cc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc------------
Confidence 32 2234456899999999999999999999999999999999999999999876544322222111
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCH
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQM 688 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~ 688 (770)
. .++.......+.+....|.+.|.+|.-.
T Consensus 567 ---v--syPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 567 ---V--SYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred ---C--cCcccccHHHHHHHHHHhhcCCccccCC
Confidence 0 1222222333444445678899988654
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=296.67 Aligned_cols=242 Identities=27% Similarity=0.397 Sum_probs=192.5
Q ss_pred eeecccCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCChh
Q 004174 428 NLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~ 505 (770)
..||+|+||.||++.. .+|..||||.+.... .....+.+|+.+++.++|+||++++++|..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5689999999999986 478999999886433 44567889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceecc
Q 004174 506 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 585 (770)
Q Consensus 506 ~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~ 585 (770)
+++... .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++......... ...
T Consensus 106 ~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~ 175 (292)
T cd06657 106 DIVTHT-----RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKS 175 (292)
T ss_pred HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc--ccc
Confidence 987532 47899999999999999999999 89999999999999999999999999998765443221 122
Q ss_pred cccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCChH
Q 004174 586 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 665 (770)
Q Consensus 586 ~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~ 665 (770)
..|++.|+|||++....++.++|+|||||++|+|++|..||...........+... +.+.+... ..
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~------------~~~~~~~~--~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN------------LPPKLKNL--HK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh------------CCcccCCc--cc
Confidence 46899999999998888999999999999999999999999764432211111100 00111000 00
Q ss_pred HHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 666 QMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 666 ~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
....+..++..||+.+|.+||++.++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 1123344566899999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=298.12 Aligned_cols=245 Identities=29% Similarity=0.419 Sum_probs=193.1
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCC----ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~----~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.|...+.||+|+||.||+|... ++..+|+|.+.. ......++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999864 678899998863 23445678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+. |+|.+.+.... ..+++..+..++.+++.||.|||+ .+++||||||+|||++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 996 58887775433 357899999999999999999999 89999999999999999999999999998765432
Q ss_pred CCCceecccccccCCCCceeec---cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
....|++.|+|||++. .+.++.++|||||||++|+|++|+.||........ +..+.. +..
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~-----~~~---- 231 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQ-----NES---- 231 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--HHHHhh-----cCC----
Confidence 1246889999999974 35688899999999999999999999876432211 111111 010
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
+... .......+..++..||+.+|.+||++.+++++.
T Consensus 232 -~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 -PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -CCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 1110 111223345566789999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=295.65 Aligned_cols=243 Identities=27% Similarity=0.439 Sum_probs=191.7
Q ss_pred cccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
|...+.||+|+||.||+|... +|..|++|++... ......+.+|++++..++|||+++++++|.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999864 6889999998642 24456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+. |+|.+.+.... ..+++..+..++.||+.||.|||+ ++++||||+|+||+++.++.++|+|||++......
T Consensus 103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~- 174 (313)
T cd06633 103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA- 174 (313)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC-
Confidence 96 57888775433 358899999999999999999999 89999999999999999999999999998643221
Q ss_pred CCceecccccccCCCCceeec---cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 579 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
....|+..|+|||++. .+.++.++|||||||++|+|++|..||.............. +.......
T Consensus 175 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~ 242 (313)
T cd06633 175 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------NDSPTLQS 242 (313)
T ss_pred -----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-------cCCCCCCc
Confidence 2356899999999984 45688999999999999999999999976543222211110 01111111
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..++ ..+..++..||+.+|.+||++.+++.+
T Consensus 243 ----~~~~----~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 ----NEWT----DSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----cccC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 234456678999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=329.00 Aligned_cols=254 Identities=27% Similarity=0.431 Sum_probs=191.5
Q ss_pred HhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEee-------
Q 004174 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE------- 488 (770)
Q Consensus 419 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------- 488 (770)
...++|....+||+||||.||+++.+ ||+.||||.+... ......+.+|+.+|.+|+|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567888899999999999999865 8999999998765 4566788999999999999999998742100
Q ss_pred -----------------------------------------------------------------------c--------
Q 004174 489 -----------------------------------------------------------------------D-------- 489 (770)
Q Consensus 489 -----------------------------------------------------------------------~-------- 489 (770)
+
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 004174 490 ---------------------------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536 (770)
Q Consensus 490 ---------------------------------~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~y 536 (770)
-.+||-||||+...|.+++..+.... .-...++++.+|++||.|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHH
Confidence 12678899999988888877654211 356778999999999999
Q ss_pred HHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc----------------CCCCCceecccccccCCCCceeecc
Q 004174 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS----------------TSSSHITCTDVAGTFGYLAPEYFMY 600 (770)
Q Consensus 537 LH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~----------------~~~~~~~~~~~~GT~~YlAPE~~~~ 600 (770)
+|+ +|||||||||.||+|+.++.+||+|||+|+... ........+..+||.-|+|||++..
T Consensus 713 IH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 999 899999999999999999999999999998621 0111112345789999999999975
Q ss_pred C---CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhh
Q 004174 601 G---KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILC 677 (770)
Q Consensus 601 ~---~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~C 677 (770)
. +|+.|+|+|||||||+||+. ||...- +....+. .++.|.+..- ..+..+.+..-..++.++
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL~----~LR~g~iP~~------~~f~~~~~~~e~slI~~L 854 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASILT----NLRKGSIPEP------ADFFDPEHPEEASLIRWL 854 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHHHH----hcccCCCCCC------cccccccchHHHHHHHHH
Confidence 5 49999999999999999984 675421 1111211 1233333332 112233344445566789
Q ss_pred cccCCCCCCCHHHHHH
Q 004174 678 IRRDPRARPQMSLVLK 693 (770)
Q Consensus 678 l~~dP~~RPs~~eVL~ 693 (770)
++.||.+|||+.++|.
T Consensus 855 l~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 855 LSHDPSKRPTATELLN 870 (1351)
T ss_pred hcCCCccCCCHHHHhh
Confidence 9999999999999986
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=305.58 Aligned_cols=265 Identities=22% Similarity=0.335 Sum_probs=193.4
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeec---------
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFED--------- 489 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--------- 489 (770)
..+|.+.+.||.|+||.||+|.. .+|+.||+|++.... ...+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36799999999999999999986 468999999886543 4557788999999999999999999876543
Q ss_pred -----CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC-CCCce
Q 004174 490 -----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEP 563 (770)
Q Consensus 490 -----~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~-~~~~v 563 (770)
...++||||++ ++|.+++... .+++..++.++.||+.||.|||+ .+|+||||||+||+++ .++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceE
Confidence 35799999997 5898887532 47899999999999999999999 8999999999999997 45678
Q ss_pred EEccccccccccCCCCCc-eecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhh
Q 004174 564 QLSDFGLAKWASTSSSHI-TCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 641 (770)
Q Consensus 564 kL~DFGla~~~~~~~~~~-~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~ 641 (770)
+|+|||++.......... ......|+..|+|||++.. ..++.++|||||||++|+|++|+.||....+..........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999997654322111 1122357889999998754 46888999999999999999999999766543322221111
Q ss_pred cccccCCccccccC---ccc-----CCCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 642 KPILSSGKVTQLLD---PAL-----GNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 642 ~~~~~~g~l~~lld---~~l-----~~~~~-----~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+.........+.+ ..+ ..... ......+..++..||+.+|.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 11111000000000 000 00000 0112345567778999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=300.50 Aligned_cols=262 Identities=21% Similarity=0.262 Sum_probs=190.9
Q ss_pred CcccceeecccCceEEEEEEeC-C--CCEEEEEEeCCC---hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec----Cc
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-D--GKELAVKILKPS---EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED----NN 491 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~--g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~----~~ 491 (770)
+|.+.+.||+|+||.||++... . +..||||++... ....+.+.+|++++..+ .||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999864 3 788999998742 23456788999999999 599999999976433 45
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 571 (770)
.+++++|+. ++|.+.+... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788999885 6899888643 358899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC--ceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC
Q 004174 572 KWASTSSSH--ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 648 (770)
Q Consensus 572 ~~~~~~~~~--~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 648 (770)
+........ .......||+.|+|||++.. ..++.++|||||||++|+|++|+.||...+.......+..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 865432211 11123578999999998765 468999999999999999999999997654322111111000000000
Q ss_pred ccccccC---------------cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 649 KVTQLLD---------------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 649 ~l~~lld---------------~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
.+..+.+ ..+.. ........+..++..||+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 00000 00001234556777899999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=303.83 Aligned_cols=260 Identities=22% Similarity=0.310 Sum_probs=194.4
Q ss_pred hhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC-----
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----- 490 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----- 490 (770)
..++|.+.+.||+|+||.||+|.. .+|..||||++... ......+.+|+.+++.++||||++++++|..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 467899999999999999999985 47899999998642 234567889999999999999999999987654
Q ss_pred -ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccc
Q 004174 491 -NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (770)
Q Consensus 491 -~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 569 (770)
.+++||||+ +++|.+++.. ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 7799888753 258899999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcc-----
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP----- 643 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~----- 643 (770)
++....... ....+++.|+|||++.. ..++.++|+|||||++|+|++|+.||...........+.-...
T Consensus 164 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 164 LARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred cccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 997654322 22467899999999875 4588999999999999999999999986543221111000000
Q ss_pred ---cccCCccccccC--cccCC----CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 644 ---ILSSGKVTQLLD--PALGN----NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 644 ---~~~~g~l~~lld--~~l~~----~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
.+.......... +.... .........+..++..|++.+|.+||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000 00000 000011223556777899999999999999986
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=291.77 Aligned_cols=261 Identities=23% Similarity=0.336 Sum_probs=198.5
Q ss_pred cccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
|...+.||+|+||.||+|... +++.+|+|++... ....+.+..|+.+++.++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999875 5899999999864 344567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
+ ++|.+++.... ..+++..+..++.+++.||.|||+ ++|+||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 59999997543 358999999999999999999999 8999999999999999999999999999986654322
Q ss_pred CceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHH-H---------hhcc-cc--
Q 004174 580 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV-M---------WAKP-IL-- 645 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv-~---------~~~~-~~-- 645 (770)
. .....++..|+|||++... .++.++|||||||++|||++|+.||...........+ . |... .+
T Consensus 154 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 T--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred c--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 1 1223567889999998776 7899999999999999999999999775432211110 0 0000 00
Q ss_pred cCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 646 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 646 ~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
................+ ......+..++..||+.+|.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 232 YKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000000000000 0113456777788999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=288.04 Aligned_cols=205 Identities=28% Similarity=0.475 Sum_probs=172.1
Q ss_pred HHHHHHhhcCcccceeecccCceEEEEEE-eCCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcC-CCceeEEeeEEeecC
Q 004174 414 YQDLLSATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE-DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDN 490 (770)
Q Consensus 414 ~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~ 490 (770)
|++++..|+ ++||+|+++.|--+. +.+|.+||||++.+.. ....+..+|++++.+.+ |+||++|++||+++.
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 556655553 579999999998876 5789999999997654 56778999999999986 999999999999999
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCc---eEEcc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSD 567 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~---vkL~D 567 (770)
.+|||||.|.||+|..+|++.+ .|++.++.++...|+.||.|||. +||.||||||+|||...... +||||
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRK----HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred eEEEEEecccCchHHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeec
Confidence 9999999999999999998765 59999999999999999999999 99999999999999976654 79999
Q ss_pred cccccccc--CCCC---CceecccccccCCCCceeec-----cCCCCCcceEeechHHHHHHHhCCCCCCCCC
Q 004174 568 FGLAKWAS--TSSS---HITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (770)
Q Consensus 568 FGla~~~~--~~~~---~~~~~~~~GT~~YlAPE~~~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 630 (770)
|.|..-.. .+-+ .....+.+|+..|||||+.. ...|+.++|.|||||+||-||+|++||.+..
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 98864322 1111 11112357888999999764 2368999999999999999999999998754
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=285.62 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=192.6
Q ss_pred hhcCcccc-eeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEee----cCce
Q 004174 420 ATSNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE----DNNL 492 (770)
Q Consensus 420 ~t~~f~~~-~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~----~~~~ 492 (770)
.|++|.+. .+||-|-.|.|-.+..+ +|+.+|+|++..+.. ..+|+++.-.. .|||||.++++|.. ...+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K----ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK----ARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHH----HHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 45666653 58999999999888754 788999999986643 34677765444 59999999998854 3468
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC---CCceEEcccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFG 569 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~~~vkL~DFG 569 (770)
.+|||+|+||.|+..++..+. ..|++.++-.|..||+.|+.|||+ .+|.||||||+|+|... |..+||+|||
T Consensus 135 LiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred EeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccc
Confidence 899999999999999987765 579999999999999999999999 99999999999999964 4568999999
Q ss_pred ccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCc
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 649 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 649 (770)
+|+....... ..+.+-||.|.|||++...+|+..+|+||+||++|-||+|.+||...+.....- - .+..+..|.
T Consensus 210 FAK~t~~~~~---L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp-g--Mk~rI~~gq 283 (400)
T KOG0604|consen 210 FAKETQEPGD---LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-G--MKRRIRTGQ 283 (400)
T ss_pred cccccCCCcc---ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh-h--HHhHhhccC
Confidence 9987654322 234688999999999999999999999999999999999999998765321100 0 001111111
Q ss_pred cccccCcccCCCCChHHH-HHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 650 VTQLLDPALGNNYDYDQM-ERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 650 l~~lld~~l~~~~~~~~~-~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. ++- +..++++ +....++...|+.+|.+|.|+.+++.+
T Consensus 284 y-~FP------~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 Y-EFP------EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred c-cCC------ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 0 011 1122232 233344555789999999999999874
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=324.09 Aligned_cols=145 Identities=31% Similarity=0.447 Sum_probs=131.5
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.+.||+|+||.||+|... +++.||||+++.. ......+..|+.++..++||||+++++++...+.+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367899999999999999999875 6899999999753 23456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
|||+.+++|.+++.... .+++..++.|+.||+.||.|||. ++||||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999997543 47889999999999999999999 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=304.56 Aligned_cols=261 Identities=23% Similarity=0.311 Sum_probs=197.1
Q ss_pred hhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc----
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN---- 491 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~---- 491 (770)
..++|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999874 6889999998753 2345667889999999999999999998876554
Q ss_pred --eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccc
Q 004174 492 --LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (770)
Q Consensus 492 --~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 569 (770)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999999 6699998864 258999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccc---
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL--- 645 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~--- 645 (770)
++...... .....+|..|+|||.+.. ..++.++|||||||++|||++|+.||...........+.-.....
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 99765432 122468899999999865 367899999999999999999999997654422211110000000
Q ss_pred -----cCCccccccCcccC-CCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 646 -----SSGKVTQLLDPALG-NNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 646 -----~~g~l~~lld~~l~-~~~~-----~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.......++..... .... ......+..++..||+.+|.+|||+.+|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000000000 0000 0113456777888999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=282.21 Aligned_cols=234 Identities=29% Similarity=0.359 Sum_probs=189.8
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCh
Q 004174 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (770)
Q Consensus 430 LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL 504 (770)
||.|+||.||++... +++.+++|+++... .....+..|+.+++.++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999865 58999999987543 3456889999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceec
Q 004174 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (770)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~ 584 (770)
.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~ 151 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTN 151 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--ccc
Confidence 99997543 58899999999999999999999 8999999999999999999999999999976654321 122
Q ss_pred ccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCCh
Q 004174 585 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 664 (770)
Q Consensus 585 ~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~ 664 (770)
...++..|+|||.+.....+.++|+||||+++|+|++|+.||...+. ..+..... . +. ..+ +.
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~---~-~~------~~~----~~ 214 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKIL---K-DP------LRF----PE 214 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHh---c-CC------CCC----CC
Confidence 35689999999999988899999999999999999999999976543 11111110 0 00 001 11
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCHH
Q 004174 665 DQMERMVLASILCIRRDPRARPQMS 689 (770)
Q Consensus 665 ~~~~~l~~~a~~Cl~~dP~~RPs~~ 689 (770)
.....+..++..||..+|++||++.
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCcc
Confidence 1123445666789999999999994
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=302.36 Aligned_cols=214 Identities=27% Similarity=0.405 Sum_probs=181.9
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
.-|..++.||-|+||.|.+++.. +...||+|.|++.+ ..+.....|-+||....++-||+|+-.|++.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 35778899999999999999854 46678999998653 33456778999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc---c
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK---W 573 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~---~ 573 (770)
||++||++-.+|.+.+ .|.+..++.++.++..|+++.|+ .|+|||||||.|||||.+|++||+||||+. |
T Consensus 709 dYIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred eccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeecccccccee
Confidence 9999999999997765 58999999999999999999999 999999999999999999999999999985 2
Q ss_pred ccCCC-----CCc--------------------------------eecccccccCCCCceeeccCCCCCcceEeechHHH
Q 004174 574 ASTSS-----SHI--------------------------------TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 616 (770)
Q Consensus 574 ~~~~~-----~~~--------------------------------~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL 616 (770)
..+.. .+. .....+||+.|+|||++....|+.-+|+||.||+|
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 21110 000 01124699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCccc-hhhHHHhhc
Q 004174 617 LELLTGRKPISNDHPKG-QESLVMWAK 642 (770)
Q Consensus 617 ~eLltG~~Pf~~~~~~~-~~~lv~~~~ 642 (770)
|||+.|++||..+.+.+ +..++.|..
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw~~ 888 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINWRN 888 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeehhh
Confidence 99999999999888755 445666643
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=306.11 Aligned_cols=260 Identities=26% Similarity=0.424 Sum_probs=215.8
Q ss_pred HHHHHHhhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEee---
Q 004174 414 YQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE--- 488 (770)
Q Consensus 414 ~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~--- 488 (770)
++.+..-++-|.+.++||.|.+|.||++.. ++|+..|+|++....+..+++..|.++|+.+ .|||++.++|+|..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 344445567799999999999999999984 5789999999998888778888999999988 59999999999875
Q ss_pred --cCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEc
Q 004174 489 --DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (770)
Q Consensus 489 --~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~ 566 (770)
++.+|||||||.+|+..|++++.. ...+.|..+..|+.+++.||.+||+ ..+||||||-.||||+.++.+||+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEe
Confidence 468999999999999999998766 4679999999999999999999999 889999999999999999999999
Q ss_pred cccccccccCCCCCceecccccccCCCCceeeccC-----CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhh
Q 004174 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 641 (770)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~-----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~ 641 (770)
|||.+..+...... ..+..|||.|||||++.-. .|+.++|+||||++..||--|.+|+.+.+|.-...++
T Consensus 166 DFGvSaQldsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I--- 240 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--- 240 (953)
T ss_pred eeeeeeeeeccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---
Confidence 99999877654433 3347899999999999633 4778999999999999999999999988774322111
Q ss_pred cccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 642 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 642 ~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. .-.-|.| .-+....+....++..||.+|-.+||++.++|++
T Consensus 241 ----p-----RNPPPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 ----P-----RNPPPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ----C-----CCCCccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1 1111222 2245566777778889999999999999999874
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-33 Score=311.31 Aligned_cols=251 Identities=25% Similarity=0.430 Sum_probs=207.6
Q ss_pred cccceeecccCceEEEEEEe-CCC----CEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 424 FLAENLIGKGGSSQVYKGCL-PDG----KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~-~~g----~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
...+++||.|+||+||+|.+ +.| -+||||++... .....+++.|.-+|..|.|||+++|+++|.... +.||.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 44568999999999999985 444 46899998754 355788999999999999999999999998765 89999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
+||+.|.|.++++..+ ..+.-...+.|..|||+||.|||. ++++||||-.+|||+.....+||.|||+++.+..
T Consensus 777 q~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 9999999999998765 368888999999999999999998 9999999999999999999999999999999887
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
...........-.+-|||=|.+....|+.++|||||||++||++| |..|+.+....+...+.. .|. .+-.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-------~ge--RLsq 921 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-------KGE--RLSQ 921 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-------ccc--cCCC
Confidence 766655444445667999999999999999999999999999999 999998876544433322 111 1111
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+......+..+++.||..|+..||+++++...+..
T Consensus 922 -------PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 922 -------PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred -------CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 22334456667788999999999999998876654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=292.56 Aligned_cols=259 Identities=27% Similarity=0.373 Sum_probs=193.3
Q ss_pred cceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHh--cCCCceeEEeeEEeecC----ceEEEEeec
Q 004174 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLGFCFEDN----NLLLVYDFL 499 (770)
Q Consensus 426 ~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~~----~~~LV~E~~ 499 (770)
...+||+|.||.||+|.+ +++.||||++. ......|.+|-+|.+. ++|+||++++++-.... .++||++|.
T Consensus 214 l~eli~~Grfg~V~KaqL-~~~~VAVKifp--~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQL-DNRLVAVKIFP--EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred hHHHhhcCccceeehhhc-cCceeEEEecC--HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 346789999999999998 55999999997 4556788888888765 57999999999876655 899999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc------CCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS------GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~------~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+.|+|.++|..+ .++|....+|+.-+++||+|||. +...+|+|||||++||||.+|++..|+|||||..
T Consensus 291 ~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 291 PKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred cCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 999999999865 48999999999999999999997 3346899999999999999999999999999998
Q ss_pred ccCCCCCceecccccccCCCCceeeccCC-CC-----CcceEeechHHHHHHHhCCCCCCCCCccc-hh-----------
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGK-VN-----DKIDVYAFGVVLLELLTGRKPISNDHPKG-QE----------- 635 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~-~s-----~ksDVwSlGvvL~eLltG~~Pf~~~~~~~-~~----------- 635 (770)
+............+||..|||||++.+.. +. .+.||||+|.|||||++...-+....+.. +.
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 87665544444478999999999987432 22 26999999999999999655443111110 00
Q ss_pred hHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 636 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 636 ~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.-.+|.. ......-..+.|.... ...+.-+...+-.||..||+.|.|+.=|.+++..
T Consensus 446 ~e~mq~~-VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~ 502 (534)
T KOG3653|consen 446 LEEMQEL-VVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAE 502 (534)
T ss_pred HHHHHHH-HHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHH
Confidence 0001100 0001111111111111 1334555566667999999999999988887754
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=288.82 Aligned_cols=257 Identities=28% Similarity=0.442 Sum_probs=196.9
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC--------hhHHHHHHHHHHHHHhcCCCceeEEeeEEee-cC
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--------EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DN 490 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~ 490 (770)
.++|.+..+||+|||+.||+|++ ...+.||||+-... +...+...+|.+|.+.|.||.||++++||.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 44688899999999999999985 45778999986532 2345678899999999999999999999864 56
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC---CCceEEcc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSD 567 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~~~vkL~D 567 (770)
.+|-|+|||+|.+|.-+|+..+ .+++.+++.|++||+.||.||.... .+|||-||||.||||.+ -|.+||+|
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence 7899999999999999997664 5899999999999999999999855 78999999999999954 47899999
Q ss_pred ccccccccCCCCC-----ceecccccccCCCCceeeccC----CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHH
Q 004174 568 FGLAKWASTSSSH-----ITCTDVAGTFGYLAPEYFMYG----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (770)
Q Consensus 568 FGla~~~~~~~~~-----~~~~~~~GT~~YlAPE~~~~~----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv 638 (770)
|||++.+...... .......||.+|++||.|.-+ +++.|+||||.||++|..|.|++||..+.. +..++
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdIL 694 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDIL 694 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHHH
Confidence 9999998765433 223347899999999999755 578899999999999999999999976533 22222
Q ss_pred HhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 639 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 639 ~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
. ...++....+.--..|. ...+.+ .++.+||+...++|-...++..
T Consensus 695 q-eNTIlkAtEVqFP~KPv-----VsseAk---aFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 695 Q-ENTILKATEVQFPPKPV-----VSSEAK---AFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred h-hhchhcceeccCCCCCc-----cCHHHH---HHHHHHHHhhhhhhhhHHHHcc
Confidence 1 11122111111111111 112222 3446799999999988766543
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-33 Score=301.42 Aligned_cols=208 Identities=27% Similarity=0.366 Sum_probs=183.7
Q ss_pred cCcccceeecccCceEEEEEEeCCCC-EEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPDGK-ELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~g~-~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
.++..+..||-||||.|=+.+.++.. .+|+|++++.. ...+....|-+||...+.|+||+||.-|.+..+.||+|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 35566778999999999998875433 48999998643 44567888999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
|-|-||.|+..|...+ .|.....+.++.++++|++|||+ ++||+|||||+|.||+.+|.+||.|||+|+.+..
T Consensus 500 EaClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999997664 58888899999999999999999 9999999999999999999999999999998876
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHH
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~ 639 (770)
..... +++|||.|.|||++.+...+.++|.||||+++||||+|.+||.+.++....+++.
T Consensus 573 g~KTw---TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL 632 (732)
T KOG0614|consen 573 GRKTW---TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL 632 (732)
T ss_pred CCcee---eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 54433 3899999999999999999999999999999999999999999988876665553
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=303.58 Aligned_cols=240 Identities=27% Similarity=0.355 Sum_probs=190.7
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEee
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+..|.+...+|.|+|+.|-++.. .+++..++|++.... .+..+|+.++... +||||+++.+.|.++.+.|+|||+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 45667777799999999988875 578899999997652 2334577666655 699999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee-CCCCceEEccccccccccCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL-~~~~~vkL~DFGla~~~~~~ 577 (770)
+.|+-|.+.+.... .+. .++..|+.+|+.|+.|||. +|||||||||+|||+ ++.++++|+|||.++.....
T Consensus 398 l~g~ell~ri~~~~----~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSKP----EFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred ccccHHHHHHHhcc----hhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999998886543 233 7788899999999999999 999999999999999 68999999999999877654
Q ss_pred CCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
+...+-|..|.|||++....|++++||||||++||+||+|+.||...... ..+. ..+..+.+...
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~----~~i~~~~~s~~---- 534 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIH----TRIQMPKFSEC---- 534 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHH----HhhcCCccccc----
Confidence 23357799999999999999999999999999999999999999765432 1111 11222222211
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
-.+..+. ++..||+.||.+||+|.+++.+
T Consensus 535 -----vS~~AKd---Ll~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 535 -----VSDEAKD---LLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -----cCHHHHH---HHHHhccCChhhCcChhhhccC
Confidence 1233333 4457999999999999998763
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-33 Score=326.95 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=196.2
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
-+|.....||.|.||.||-|.. .+|...|+|-++... ...+...+|..+|..|+|||+|+++|+-.+.+..+|.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 3566778999999999999985 568889999886432 345667889999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
||++|+|.+.+...+ ..++.....+..|++.||.|||+ +|||||||||.||||+.+|.+|++|||.|....+.
T Consensus 1315 yC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 999999999997543 35566677889999999999999 99999999999999999999999999999877654
Q ss_pred CCC--ceecccccccCCCCceeeccCC---CCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 578 SSH--ITCTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 578 ~~~--~~~~~~~GT~~YlAPE~~~~~~---~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
... .......||+.|||||++.+.+ -..+.||||||||++||+||+.||...+. +..+|+.- -.|...+
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---e~aIMy~V---~~gh~Pq 1461 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---EWAIMYHV---AAGHKPQ 1461 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---hhHHHhHH---hccCCCC
Confidence 211 1122368999999999997543 45689999999999999999999976543 33344321 1122222
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
+.. .... .-..++-.||+.||++|-++.+++++-
T Consensus 1462 ~P~-----~ls~----~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1462 IPE-----RLSS----EGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred Cch-----hhhH----hHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 211 1111 111233469999999998888888754
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-33 Score=283.54 Aligned_cols=253 Identities=26% Similarity=0.337 Sum_probs=193.3
Q ss_pred cceeecccCceEEEEEEe-CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004174 426 AENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 426 ~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
-...||.|+||+|++-.+ +.|+..|||+++... ...++++.|.+...+- +.||||+++|.+..++..|+.||+|+-
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~ 147 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI 147 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh
Confidence 356799999999999765 579999999998643 5667888898865554 689999999999999999999999954
Q ss_pred CChhhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 502 GSLEENLHGN-KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 502 gsL~~~l~~~-~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+|..+...- ......+++...-.|....+.||.||.. ...||||||||+||||+..|.+||||||++..+..+...
T Consensus 148 -SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk 224 (361)
T KOG1006|consen 148 -SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK 224 (361)
T ss_pred -hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHh
Confidence 776554311 1122468888889999999999999987 478999999999999999999999999999877654332
Q ss_pred ceecccccccCCCCceeecc--CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 581 ITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
+..+|-..|||||.+.. ..|+.+|||||||++|||+.||+.||...+. ..+++.+ .-.|....++.+
T Consensus 225 ---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-vfeql~~-----Vv~gdpp~l~~~-- 293 (361)
T KOG1006|consen 225 ---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-VFEQLCQ-----VVIGDPPILLFD-- 293 (361)
T ss_pred ---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-HHHHHHH-----HHcCCCCeecCc--
Confidence 23578899999999973 3599999999999999999999999976543 1111111 112222222221
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
....+....++.++..|+.+|-..||...+++++
T Consensus 294 --~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 --KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred --ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1123344456677778999999999999988763
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=275.23 Aligned_cols=219 Identities=21% Similarity=0.188 Sum_probs=173.8
Q ss_pred cCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCChhhhhccC
Q 004174 433 GGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGN 511 (770)
Q Consensus 433 G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~ 511 (770)
|.||.||++... +++.||+|+++... .+.+|...+....||||+++++++...+..++||||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 899999999864 78899999997653 2334555566667999999999999999999999999999999998654
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceecccccccC
Q 004174 512 KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 591 (770)
Q Consensus 512 ~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~ 591 (770)
. .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++....... ....++..
T Consensus 80 ~----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 80 L----NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred c----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 2 48899999999999999999999 899999999999999999999999999886554321 12356778
Q ss_pred CCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHH
Q 004174 592 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMV 671 (770)
Q Consensus 592 YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~ 671 (770)
|+|||++..+.++.++|||||||++|||++|+.||......... .....+...+ ...+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~-----------------~~~~~~~~~~----~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT-----------------HTTLNIPEWV----SEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhccc-----------------ccccCCcccC----CHHHH
Confidence 99999998888999999999999999999999987542211000 0000011111 12344
Q ss_pred HHHHhhcccCCCCCCCH
Q 004174 672 LASILCIRRDPRARPQM 688 (770)
Q Consensus 672 ~~a~~Cl~~dP~~RPs~ 688 (770)
.++..|++.||.+||++
T Consensus 207 ~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 207 SLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHccCCHHHhcCC
Confidence 56677999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=310.07 Aligned_cols=256 Identities=29% Similarity=0.454 Sum_probs=202.9
Q ss_pred CcccceeecccCceEEEEEEeC----C----CCEEEEEEeCCCh--hHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCc
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP----D----GKELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNN 491 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~----~----g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~ 491 (770)
+..+.+.||+|.||.|++|... . ...||||.++... ...+.+..|+++|+.+. |+||+.++|+|...+.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 3345568999999999999842 1 4579999998643 55788999999999994 9999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCC---CC-C--------CCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC
Q 004174 492 LLLVYDFLSRGSLEENLHGNK---KD-P--------AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 559 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~---~~-~--------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~ 559 (770)
+++|+||+..|+|.++|...+ .. . ..++....+.++.|||.|++||++ .++|||||-.+||||..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecC
Confidence 999999999999999998765 00 0 138889999999999999999999 88999999999999999
Q ss_pred CCceEEccccccccccCCCCCceecccccc--cCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhh
Q 004174 560 DFEPQLSDFGLAKWASTSSSHITCTDVAGT--FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 636 (770)
Q Consensus 560 ~~~vkL~DFGla~~~~~~~~~~~~~~~~GT--~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~ 636 (770)
+..+||+|||+|+.......... ..-.|| ..|||||.+....|+.++|||||||+||||+| |..||.+... ...
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~~~ 530 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--TEE 530 (609)
T ss_pred CCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--HHH
Confidence 99999999999986655443321 112232 34999999999999999999999999999999 9999976221 122
Q ss_pred HHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 637 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 637 lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+..+ +..|... ..+......+..++..||+.+|++||++.++.+.|..
T Consensus 531 l~~~----l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 531 LLEF----LKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHHH----HhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 2222 2333211 1122334556677888999999999999999998875
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=276.95 Aligned_cols=205 Identities=28% Similarity=0.423 Sum_probs=172.5
Q ss_pred cCcccceeecccCceEEEEEEeC---C--CCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEee-cCce
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP---D--GKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNL 492 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~---~--g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~ 492 (770)
..|...+.||+|.||.||+|.-. + .+.+|||.++... .......+|+.+++.++|||++.|..+|.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 45788899999999999999632 2 3479999998653 234567899999999999999999999988 7789
Q ss_pred EEEEeecCCCChhhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC----CceEEcc
Q 004174 493 LLVYDFLSRGSLEENLHGNKK-DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD----FEPQLSD 567 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~----~~vkL~D 567 (770)
+|++||.+. +|+..|+-... ....++-..+..|+.||+.|+.|||+ +-|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999987 99998864322 22468888999999999999999999 779999999999999877 8999999
Q ss_pred ccccccccCCCCCc-eecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCC
Q 004174 568 FGLAKWASTSSSHI-TCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (770)
Q Consensus 568 FGla~~~~~~~~~~-~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 630 (770)
||+++.+.+.-... ....++-|..|.|||.+.+. .|+.+.|||+.||++.||||-.+-|.+..
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 99999887654333 23347889999999998865 69999999999999999999998887643
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=287.79 Aligned_cols=244 Identities=25% Similarity=0.365 Sum_probs=190.5
Q ss_pred cceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004174 426 AENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 426 ~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
.+++||.|-||+||-|.+ ++|+.||||++.+- ......+.+|+.||..++||.||.|.-.|+..+..++|||.+.|
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 368999999999999986 58999999999652 23447788999999999999999999999999999999999966
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC---CceEEccccccccccCCC
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~---~~vkL~DFGla~~~~~~~ 578 (770)
.-|+-.|...+ ..+++.....++.||+.||.|||. ++|+|.||||+||||... ..+||||||+|++.+...
T Consensus 648 DMLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 648 DMLEMILSSEK---GRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hHHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 44444454333 468888889999999999999999 999999999999999543 469999999999988754
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
-. ..++|||.|+|||+++...|+..-|+||.||++|--|+|..||..+... ...++-+.......
T Consensus 722 FR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNAaFMyPp~---------- 786 (888)
T KOG4236|consen 722 FR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNAAFMYPPN---------- 786 (888)
T ss_pred hh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHhhccccccCCC----------
Confidence 43 3479999999999999999999999999999999999999999765321 11111111111111
Q ss_pred CCCCChHHH-HHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 659 GNNYDYDQM-ERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 659 ~~~~~~~~~-~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
++.++ ...+.++...|+..=++|-+...-+.+
T Consensus 787 ----PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 787 ----PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred ----chhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 11111 123344445667777788888877764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=278.65 Aligned_cols=263 Identities=20% Similarity=0.295 Sum_probs=205.0
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC--C----ceeEEeeEEeecCceE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHH--K----NIISLLGFCFEDNNLL 493 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H--p----nIv~l~~~~~~~~~~~ 493 (770)
+++|.+..++|+|.||.|-.+... .+..||||+++.-....+..+-|+++|.++.+ | -+|.+.+||...++.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 778999999999999999998754 47889999999887888888899999999942 3 3889999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC--------------
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-------------- 559 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-------------- 559 (770)
+|+|.+ |-+++++|..+.. .+|+...++.++.|+++++.|||+ .+++|.||||+|||+.+
T Consensus 168 ivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccc
Confidence 999998 6699999987654 568899999999999999999999 89999999999999942
Q ss_pred ------CCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccc
Q 004174 560 ------DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (770)
Q Consensus 560 ------~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 633 (770)
+..++|+|||.|.+-.... ..++.|..|.|||++.+-.++.++||||+||+|+||.||...|+.-+..+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 2458999999998665433 23678999999999999999999999999999999999999998765433
Q ss_pred hhhHHHhhc-c-------------cccCCc-----------cccccCcccC----CCCChHHHHHHHHHHHhhcccCCCC
Q 004174 634 QESLVMWAK-P-------------ILSSGK-----------VTQLLDPALG----NNYDYDQMERMVLASILCIRRDPRA 684 (770)
Q Consensus 634 ~~~lv~~~~-~-------------~~~~g~-----------l~~lld~~l~----~~~~~~~~~~l~~~a~~Cl~~dP~~ 684 (770)
...+..-.. | .+..|. ....+++... ......+...++.++..+|..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 211111000 0 011111 0111111100 0112344556778888899999999
Q ss_pred CCCHHHHHHH
Q 004174 685 RPQMSLVLKL 694 (770)
Q Consensus 685 RPs~~eVL~~ 694 (770)
|+|+.|+|.+
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=265.71 Aligned_cols=237 Identities=30% Similarity=0.406 Sum_probs=191.1
Q ss_pred CceEEEEEEeC-CCCEEEEEEeCCChh-H-HHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCChhhhhcc
Q 004174 434 GSSQVYKGCLP-DGKELAVKILKPSED-V-IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHG 510 (770)
Q Consensus 434 ~fG~Vy~a~~~-~g~~vAVK~l~~~~~-~-~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~ 510 (770)
+||.||+|... +|+.+++|++..... . .+.+.+|++.++.++|+||+++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 68999999975 589999999976432 2 67899999999999999999999999999999999999999999999875
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceeccccccc
Q 004174 511 NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590 (770)
Q Consensus 511 ~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~ 590 (770)
.. .+++..+..++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++....... ......++.
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 43 27899999999999999999999 899999999999999999999999999998766542 122356889
Q ss_pred CCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHH
Q 004174 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERM 670 (770)
Q Consensus 591 ~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l 670 (770)
.|++||.+....++.++||||||+++++|++|..||..... ...+..+... +..... .........+
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~~----~~~~~~-------~~~~~~~~~~ 217 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIGK----PKPPFP-------PPEWKISPEA 217 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhc----cCCCCc-------cccccCCHHH
Confidence 99999999988899999999999999999999999976321 1222221111 000000 0000022456
Q ss_pred HHHHHhhcccCCCCCCCHHHHHH
Q 004174 671 VLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 671 ~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
..++.+|+..+|.+||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 66778899999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=275.05 Aligned_cols=267 Identities=28% Similarity=0.394 Sum_probs=202.7
Q ss_pred HhhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHh--cCCCceeEEeeEEeecC----ce
Q 004174 419 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLGFCFEDN----NL 492 (770)
Q Consensus 419 ~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~~----~~ 492 (770)
+...+..+.+.||+|-||.||+|.+ .|..||||++...++ ..+.+|.+|... |+|+||+.+++.-..++ .+
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE--~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE--RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch--hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 4455677889999999999999998 778899999975433 566778888765 59999999998765543 58
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-----CCCCceEEecccCCCeeeCCCCceEEcc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS-----GSAQRVIHRDVKSSNILLSDDFEPQLSD 567 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-----~~~~~IiHrDLKp~NILL~~~~~vkL~D 567 (770)
+||.+|.+.|+|+|+|... .++-...++++.-+|.||+|||. ++...|.|||||+.|||+..++...|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 9999999999999999764 47889999999999999999996 3456799999999999999999999999
Q ss_pred ccccccccCCCCC--ceecccccccCCCCceeeccCC----C--CCcceEeechHHHHHHHhC----------CCCCCCC
Q 004174 568 FGLAKWASTSSSH--ITCTDVAGTFGYLAPEYFMYGK----V--NDKIDVYAFGVVLLELLTG----------RKPISND 629 (770)
Q Consensus 568 FGla~~~~~~~~~--~~~~~~~GT~~YlAPE~~~~~~----~--s~ksDVwSlGvvL~eLltG----------~~Pf~~~ 629 (770)
+|||-........ ......+||..|||||++...- + -..+||||||.|+||+... +.||.+.
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999876654322 3334578999999999986431 1 1259999999999999752 4677664
Q ss_pred CccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 630 HPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 630 ~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
-+.+...-.| +...-..++...++++ ....+.+..|..++..||..+|..|-|+-.|-+.|...
T Consensus 440 Vp~DPs~eeM--rkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 440 VPSDPSFEEM--RKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred CCCCCCHHHH--hcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 4433221111 1111111222222221 23567888999999999999999999998887777543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=298.99 Aligned_cols=262 Identities=18% Similarity=0.220 Sum_probs=168.8
Q ss_pred hhcCcccceeecccCceEEEEEEeC-C----CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeE------Eee
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP-D----GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF------CFE 488 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~----g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~------~~~ 488 (770)
..++|.+.+.||+|+||.||+|.+. + +..||||++...... +.+..| .+....+.++..++.. +..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 4678999999999999999999874 4 689999988643221 111111 1122222222222211 245
Q ss_pred cCceEEEEeecCCCChhhhhccCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccC
Q 004174 489 DNNLLLVYDFLSRGSLEENLHGNKKD----------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKS 552 (770)
Q Consensus 489 ~~~~~LV~E~~~ggsL~~~l~~~~~~----------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp 552 (770)
+..++|||||+.+++|.+++...... ........+..|+.||+.||.|||+ ++|+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCH
Confidence 66899999999999999998643210 0011233456799999999999999 8999999999
Q ss_pred CCeeeCC-CCceEEccccccccccCCCCCceecccccccCCCCceeeccC----------------------CCCCcceE
Q 004174 553 SNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG----------------------KVNDKIDV 609 (770)
Q Consensus 553 ~NILL~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~----------------------~~s~ksDV 609 (770)
+||||+. ++.+||+|||+|+........ ......||+.|+|||.+... .++.++||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 9999985 578999999999865443222 22346899999999965322 24456799
Q ss_pred eechHHHHHHHhCCCCCCCCCccc-------hhhHHHhhcccccCCccccccCcccCCCCC--hHHHHHHHHHHHhhccc
Q 004174 610 YAFGVVLLELLTGRKPISNDHPKG-------QESLVMWAKPILSSGKVTQLLDPALGNNYD--YDQMERMVLASILCIRR 680 (770)
Q Consensus 610 wSlGvvL~eLltG~~Pf~~~~~~~-------~~~lv~~~~~~~~~g~l~~lld~~l~~~~~--~~~~~~l~~~a~~Cl~~ 680 (770)
|||||+||||+++..|+......- ...+..|....... ..+.+...+. .........++..||+.
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccC
Confidence 999999999999876654321000 00111221111000 0000000000 00011223466789999
Q ss_pred CCCCCCCHHHHHHH
Q 004174 681 DPRARPQMSLVLKL 694 (770)
Q Consensus 681 dP~~RPs~~eVL~~ 694 (770)
||.+|||+.+++++
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999985
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=245.16 Aligned_cols=215 Identities=24% Similarity=0.355 Sum_probs=179.8
Q ss_pred cccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 424 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
|...+.||+|.||+||+|.. .+++.||+|.++..+ .......+||-+|+.++|.|||++++....+..+-+|+||+
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 44457899999999999985 468889999997543 34567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
.. +|..+..... ..++.+..+.++.|+++||.+.|+ ++++||||||.|+||+.+|++||+|||+++.++-...
T Consensus 84 dq-dlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 84 DQ-DLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hH-HHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 65 8888876443 357888999999999999999999 8999999999999999999999999999997765432
Q ss_pred CceecccccccCCCCceeeccCC-CCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccC
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSS 647 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~-~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~ 647 (770)
. +..-+-|..|.+|.++.+.+ |+...|+||.||++.|+.. |++.|.+.+-..+...+.|......+
T Consensus 157 c--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~e 224 (292)
T KOG0662|consen 157 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224 (292)
T ss_pred e--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcc
Confidence 2 22246799999999988664 8999999999999999998 77778877766666666665544433
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-31 Score=268.22 Aligned_cols=266 Identities=26% Similarity=0.369 Sum_probs=196.9
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeec--------C
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFED--------N 490 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--------~ 490 (770)
.|.-...||+|.||.||+|.. +.|+.||+|+.-- .+..-...++|+.+|..|+|+|++.++..|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 345567899999999999985 4678888876532 223445678999999999999999999988542 3
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 570 (770)
.+||||++++. +|.-+|.... ..|+..++.++..++..||.|+|. ..|+|||+|+.|+||+.++.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccc
Confidence 48999999977 8998886543 468999999999999999999999 8899999999999999999999999999
Q ss_pred cccccCCC--CCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccC
Q 004174 571 AKWASTSS--SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 647 (770)
Q Consensus 571 a~~~~~~~--~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 647 (770)
++.+.... ....+++.+-|+.|++||.+.+ ..|+++.|||..||++.||+||.+-|.+.....+..++.....-+..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 97665432 2233556778999999998874 47999999999999999999999999887766665555322111111
Q ss_pred Cc--------ccccc--CcccCCCC--ChHHHH------HHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 648 GK--------VTQLL--DPALGNNY--DYDQME------RMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 648 g~--------l~~ll--d~~l~~~~--~~~~~~------~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
.. +.+-+ .|.-.+.+ ..+-++ ..+.++-.++..||.+|+.+.+++.+-
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 00 00111 11000100 000011 223333457899999999999999754
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-31 Score=255.24 Aligned_cols=200 Identities=27% Similarity=0.385 Sum_probs=168.3
Q ss_pred ccceeecccCceEEEEEEe-CCCCEEEEEEeCC--ChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecC
Q 004174 425 LAENLIGKGGSSQVYKGCL-PDGKELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 425 ~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~--~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
.....||+|++|.|-+-++ .+|+..|+|.++. ..+..++.++|+++..+. .+|++|.++|........++.||.|.
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 3456789999999976654 5899999999875 356677888999886655 69999999999999999999999995
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
- +|..+..+--.....+++..+-+|+.-+..||.|||+ ...+||||+||+||||+.+|++||||||++..+.++...
T Consensus 129 t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk 205 (282)
T KOG0984|consen 129 T-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK 205 (282)
T ss_pred h-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH
Confidence 5 8888766544445678999999999999999999998 378999999999999999999999999999887665333
Q ss_pred ceecccccccCCCCceeecc----CCCCCcceEeechHHHHHHHhCCCCCCCCC
Q 004174 581 ITCTDVAGTFGYLAPEYFMY----GKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 630 (770)
. -..|-..|||||.+.. ..|+-|+||||||++++||.+++.||....
T Consensus 206 t---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 206 T---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred H---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 2 1467888999998863 379999999999999999999999997643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=264.73 Aligned_cols=199 Identities=23% Similarity=0.385 Sum_probs=174.1
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~L 494 (770)
.++|.+.++||+|.|..|..+.+. +.+.||+|++++. ++.......|-.+..+. +||++|-|..+|+....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 457889999999999999999864 6788999999852 34455566677777766 69999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
|.||++||+|--.+++.+ .++++.++.+..+|+.||.|||+ +|||+||||..|+|||..|++||+|+|+++..
T Consensus 329 vieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999988776654 58999999999999999999999 99999999999999999999999999999854
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCC
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~ 628 (770)
-... . +..+++|||.|+|||++.+..|...+|+|+|||+++||+.|+.||+-
T Consensus 402 l~~g-d-~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 402 LGPG-D-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CCCC-c-ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 3322 2 23458999999999999999999999999999999999999999974
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=278.27 Aligned_cols=238 Identities=26% Similarity=0.318 Sum_probs=200.5
Q ss_pred CCchhHHHHhhhccCcccccCHHHHHHhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHH
Q 004174 393 ELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEII 471 (770)
Q Consensus 393 ~~~~~l~~~~~~~~~~~~~f~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL 471 (770)
..+.....+++.+...--.|.+...+..-+.|.+....|+|-|++|.+|... -|..||||+++.++...+.=+.|++||
T Consensus 403 ~~~~~~~~L~DNWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiL 482 (752)
T KOG0670|consen 403 TVPRVNPGLQDNWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEIL 482 (752)
T ss_pred cccccCCccccCcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHH
Confidence 3355556677777776666666666667889999999999999999999864 578999999999988888889999999
Q ss_pred HhcC------CCceeEEeeEEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCce
Q 004174 472 TTLH------HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545 (770)
Q Consensus 472 ~~l~------HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~I 545 (770)
++|+ ..|+++|+..|...+++|||+|-+ ..+|.+.|...+.+ ..|....++.++.|++.||..|-+ .+|
T Consensus 483 kKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~---c~v 557 (752)
T KOG0670|consen 483 KKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKK---CGV 557 (752)
T ss_pred HHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHh---cCe
Confidence 9996 348999999999999999999988 45999999887654 568888999999999999999998 789
Q ss_pred EEecccCCCeeeCCC-CceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCC
Q 004174 546 IHRDVKSSNILLSDD-FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRK 624 (770)
Q Consensus 546 iHrDLKp~NILL~~~-~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~ 624 (770)
+|.||||.|||+++. ..+||||||.|........ +...-+..|.|||++.+-.|+...|+||.||+||||.||+.
T Consensus 558 lHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkI 633 (752)
T KOG0670|consen 558 LHADIKPDNILVNESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKI 633 (752)
T ss_pred eecccCccceEeccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccce
Confidence 999999999999865 5689999999987655332 22345678999999999999999999999999999999999
Q ss_pred CCCCCCccchhhHHH
Q 004174 625 PISNDHPKGQESLVM 639 (770)
Q Consensus 625 Pf~~~~~~~~~~lv~ 639 (770)
.|.+.....+..+.|
T Consensus 634 lFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 634 LFPGRTNNQMLRLFM 648 (752)
T ss_pred ecCCCCcHHHHHHHH
Confidence 998876555544444
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=283.27 Aligned_cols=205 Identities=22% Similarity=0.313 Sum_probs=155.4
Q ss_pred hhcCcccceeecccCceEEEEEEe-----------------CCCCEEEEEEeCCCh-hHHHH--------------HHHH
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCL-----------------PDGKELAVKILKPSE-DVIKE--------------FVLE 467 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~-----------------~~g~~vAVK~l~~~~-~~~~~--------------~~~E 467 (770)
..++|.+.++||+|+||.||+|.. ..++.||||.++... ...++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999963 245689999987533 12222 3346
Q ss_pred HHHHHhcCCCce-----eEEeeEEee--------cCceEEEEeecCCCChhhhhccCCC--------------------C
Q 004174 468 IEIITTLHHKNI-----ISLLGFCFE--------DNNLLLVYDFLSRGSLEENLHGNKK--------------------D 514 (770)
Q Consensus 468 i~iL~~l~HpnI-----v~l~~~~~~--------~~~~~LV~E~~~ggsL~~~l~~~~~--------------------~ 514 (770)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777776554 677887753 3568999999999999999875321 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceecccccccCCCC
Q 004174 515 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594 (770)
Q Consensus 515 ~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlA 594 (770)
...++|..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......... .....+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeC
Confidence 1235678899999999999999999 889999999999999999999999999997654322111 111245889999
Q ss_pred ceeeccCC--------------------C--CCcceEeechHHHHHHHhCCC-CCCC
Q 004174 595 PEYFMYGK--------------------V--NDKIDVYAFGVVLLELLTGRK-PISN 628 (770)
Q Consensus 595 PE~~~~~~--------------------~--s~ksDVwSlGvvL~eLltG~~-Pf~~ 628 (770)
||.+.... | ..+.||||+||+||+|++|.. ||..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 99876432 1 235799999999999999875 7754
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=263.28 Aligned_cols=264 Identities=23% Similarity=0.341 Sum_probs=213.6
Q ss_pred HHHHHHhhcCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeE
Q 004174 414 YQDLLSATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 485 (770)
Q Consensus 414 ~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 485 (770)
.+++.....+++...++-+|.||.||+|.+. +.+.|.+|.++.. .-....++.|--.+..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4566677778888899999999999999653 3456778888753 4566789999999999999999999999
Q ss_pred Eeec-CceEEEEeecCCCChhhhhccCC----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC
Q 004174 486 CFED-NNLLLVYDFLSRGSLEENLHGNK----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560 (770)
Q Consensus 486 ~~~~-~~~~LV~E~~~ggsL~~~l~~~~----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~ 560 (770)
+.++ ...+++|.++.-|+|..+|..-+ .....++..+...++.|++.|++|||+ ++|||.||..+|.+||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhh
Confidence 8764 57899999999999999997322 223456777888899999999999999 999999999999999999
Q ss_pred CceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHH
Q 004174 561 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (770)
Q Consensus 561 ~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~ 639 (770)
..+||+|=.+++-+-....+....+--....||+||.+.+..|+..+|+|||||+||||+| |+.|+..-+|.+.+..+.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk 512 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK 512 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence 9999999999987665555544333345667999999999999999999999999999999 999999888876655432
Q ss_pred hhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 640 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 640 ~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
-.. ++.+ +.+....+..++.-||...|++||++++++.=|.
T Consensus 513 dGy------RlaQ----------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 513 DGY------RLAQ----------PFNCPDELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred ccc------eecC----------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 111 1111 2334455666777899999999999999988765
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=258.93 Aligned_cols=264 Identities=23% Similarity=0.331 Sum_probs=197.1
Q ss_pred cccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeec-----CceEE
Q 004174 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NNLLL 494 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~~~L 494 (770)
...++.||-|+||.||...++ +|+.||+|.+..-- ...+.+.+|+.+|..++|.|++..++...-. .++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 345789999999999998864 79999999886532 4567899999999999999999988876433 25788
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
+.|+|.. +|.+.|- .+..++-..+.-++.||++||.|||+ .+|+||||||.|+|++.+..+||||||+++..
T Consensus 135 ~TELmQS-DLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHh-hhhheec----cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEeccccccccc
Confidence 9999955 7777764 34578888888899999999999999 89999999999999999999999999999976
Q ss_pred cCCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhc--------ccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK--------PIL 645 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~--------~~~ 645 (770)
....... ++.-+-|..|.|||++++. .|+.+.||||.||++.||+..+..|...+|..+..++.-.. ...
T Consensus 207 e~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 207 DQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred chhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 6544433 3345678999999999965 69999999999999999999999999988877665543211 000
Q ss_pred cCCccccccC-----cccCCCC----ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 646 SSGKVTQLLD-----PALGNNY----DYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 646 ~~g~l~~lld-----~~l~~~~----~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
-+|.-..++. |.+..-+ ....-..-+.+..+++..||++|-+..+.+..+-
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1111111111 1111000 0011122233445678899999999888877653
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=263.28 Aligned_cols=277 Identities=19% Similarity=0.316 Sum_probs=206.9
Q ss_pred CcccccCHHHHHHhhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-----C---C
Q 004174 407 ATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-----H---K 477 (770)
Q Consensus 407 ~~~~~f~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-----H---p 477 (770)
..++.....+.+ ...+|.+.+.||.|.|++||++.+ .+.+.||+|+.+......+..+.||.+|++++ | .
T Consensus 64 GGYHpV~IGD~F-~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~ 142 (590)
T KOG1290|consen 64 GGYHPVRIGDVF-NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKK 142 (590)
T ss_pred CCCceeeccccc-cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCc
Confidence 444444555543 246899999999999999999985 45778999999988888888999999999985 2 3
Q ss_pred ceeEEeeEEee----cCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCC
Q 004174 478 NIISLLGFCFE----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 553 (770)
Q Consensus 478 nIv~l~~~~~~----~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~ 553 (770)
+||+|+++|.. +.++|||+|++ |.+|..+|..... ..++...+.+|+.||+.||.|||.. .+|||.||||+
T Consensus 143 ~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPE 217 (590)
T KOG1290|consen 143 CVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPE 217 (590)
T ss_pred eeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcc
Confidence 69999999975 45899999999 7799999986654 4688899999999999999999985 47999999999
Q ss_pred CeeeCCC-------------------------------------------------------------------------
Q 004174 554 NILLSDD------------------------------------------------------------------------- 560 (770)
Q Consensus 554 NILL~~~------------------------------------------------------------------------- 560 (770)
||||..+
T Consensus 218 NvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~ 297 (590)
T KOG1290|consen 218 NVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEE 297 (590)
T ss_pred eeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccc
Confidence 9999310
Q ss_pred --------------------------------------------------------------------------------
Q 004174 561 -------------------------------------------------------------------------------- 560 (770)
Q Consensus 561 -------------------------------------------------------------------------------- 560 (770)
T Consensus 298 ~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n 377 (590)
T KOG1290|consen 298 PNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASN 377 (590)
T ss_pred ccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccc
Confidence
Q ss_pred -------------CceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCC
Q 004174 561 -------------FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPIS 627 (770)
Q Consensus 561 -------------~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~ 627 (770)
-.+||+|||-|.|.... ++....|..|.|||++.+..|+..+|||||+|++|||+||...|+
T Consensus 378 ~~v~p~~~~~~~di~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFe 452 (590)
T KOG1290|consen 378 PLVNPDIPLPECDIRVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFE 452 (590)
T ss_pred cccCCCCCCCccceeEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeec
Confidence 00345555555554332 123456889999999999999999999999999999999999997
Q ss_pred CCCccc----hhhH--H-----HhhcccccCCcc-ccccC-----------------cccCC--CCChHHHHHHHHHHHh
Q 004174 628 NDHPKG----QESL--V-----MWAKPILSSGKV-TQLLD-----------------PALGN--NYDYDQMERMVLASIL 676 (770)
Q Consensus 628 ~~~~~~----~~~l--v-----~~~~~~~~~g~l-~~lld-----------------~~l~~--~~~~~~~~~l~~~a~~ 676 (770)
...... ..++ + +..+.+...|+. .++++ ..|.. .+..++...+..+.+-
T Consensus 453 PhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~P 532 (590)
T KOG1290|consen 453 PHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSP 532 (590)
T ss_pred CCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHH
Confidence 543322 1111 1 111122222221 12222 11111 3356777888888888
Q ss_pred hcccCCCCCCCHHHHHHH
Q 004174 677 CIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 677 Cl~~dP~~RPs~~eVL~~ 694 (770)
||+.+|++|||+.+.|++
T Consensus 533 mLef~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 533 MLEFDPEKRPTAAQCLKH 550 (590)
T ss_pred HHhcCccccccHHHHhcC
Confidence 999999999999999874
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=286.74 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=185.0
Q ss_pred cccceeecccCceE-EEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004174 424 FLAENLIGKGGSSQ-VYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 424 f~~~~~LG~G~fG~-Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
|...+++|.|..|+ ||+|.. +|+.||||.+-. +...-..+|+..|+.- .|||||++++.-.+...+|+..|.|..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~--e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE--EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh--HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 33455689999876 699998 788999998863 3344567899999988 499999999998888999999999955
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC---C--CceEEccccccccccC
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---D--FEPQLSDFGLAKWAST 576 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~--~~vkL~DFGla~~~~~ 576 (770)
+|.+++...........-...+.+..|++.||++||+ .+||||||||.||||+. + ..++|+|||+++.+..
T Consensus 588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 9999998642111112214456789999999999999 88999999999999975 3 4689999999998876
Q ss_pred CCCCce-ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCC-ccccc
Q 004174 577 SSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSG-KVTQL 653 (770)
Q Consensus 577 ~~~~~~-~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g-~l~~l 653 (770)
+..... .....||-||+|||++....-+.++|||||||++|+.++ |.+||.+.-... .+++ ... .+..
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl-------~~~~~L~~- 734 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANIL-------TGNYTLVH- 734 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhh-------cCccceee-
Confidence 543322 334689999999999998888889999999999999999 599997643221 1111 111 1111
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+....+. ....++..|++.+|..||++.+||.+
T Consensus 735 ----L~~~~d~----eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 735 ----LEPLPDC----EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ----eccCchH----HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1111111 33345567999999999999999863
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=237.79 Aligned_cols=210 Identities=35% Similarity=0.606 Sum_probs=182.4
Q ss_pred ecccCceEEEEEEeCC-CCEEEEEEeCCChh--HHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCChhh
Q 004174 430 IGKGGSSQVYKGCLPD-GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 506 (770)
Q Consensus 430 LG~G~fG~Vy~a~~~~-g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~ 506 (770)
||+|.+|.||++...+ ++.+++|++..... ....+.+|+.++..+.|++|+++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 89999999987654 36789999999999999999999999999899999999999999999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC-CCceEEccccccccccCCCCCceecc
Q 004174 507 NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTD 585 (770)
Q Consensus 507 ~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-~~~vkL~DFGla~~~~~~~~~~~~~~ 585 (770)
++.... ..+++..+..++.+++.+|.|||+ .+++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 987542 357899999999999999999999 89999999999999999 89999999999986654321 1122
Q ss_pred cccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCCh
Q 004174 586 VAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 664 (770)
Q Consensus 586 ~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~ 664 (770)
..+...|++||.+... .++.+.|+|+||+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4678899999999877 888999999999999999
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 665 DQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 665 ~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
..+..++..|++.+|.+||++.++++.+
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3455566779999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=238.25 Aligned_cols=196 Identities=23% Similarity=0.440 Sum_probs=167.6
Q ss_pred hhcCcccceeecccCceEEEEEE-eCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CCceeEEeeEEeec--CceEEE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFED--NNLLLV 495 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~--~~~~LV 495 (770)
..++|.+.+.+|+|.++.||.|. ..+...++||++++-. .+.+.+|+.||..|+ ||||++|++...+. ....||
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 35688999999999999999997 3578889999998643 367889999999998 99999999998764 467899
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC-CceEEccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWA 574 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~-~~vkL~DFGla~~~ 574 (770)
+||+.+.+...+.. .++...++.++.+++.||.|+|+ +||+|||+||.|++||.. -.++|+|+|||.++
T Consensus 114 FE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999987776653 46677888999999999999999 999999999999999865 46999999999988
Q ss_pred cCCCCCceecccccccCCCCceeec-cCCCCCcceEeechHHHHHHHhCCCCCCCCC
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~-~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 630 (770)
....... -.+.+..|-.||.+. ...|+..-|+|||||+|..|+..+.||....
T Consensus 184 Hp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 184 HPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred CCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 7654332 246788899999876 5679999999999999999999999987544
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=265.07 Aligned_cols=197 Identities=24% Similarity=0.365 Sum_probs=170.1
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHH---------HHHHHHHHHHhcC---CCceeEEeeEEe
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIK---------EFVLEIEIITTLH---HKNIISLLGFCF 487 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~---------~~~~Ei~iL~~l~---HpnIv~l~~~~~ 487 (770)
..+|.....+|.|+||.|++|.++ +...|+||.+.++.-... ..-.||.||..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346888999999999999999975 467899999987543222 3456999999998 999999999999
Q ss_pred ecCceEEEEeecC-CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEc
Q 004174 488 EDNNLLLVYDFLS-RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (770)
Q Consensus 488 ~~~~~~LV~E~~~-ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~ 566 (770)
+++.+||+||--. |-+|+++|.... .+++.++..|+.||+.|+++||+ ++|||||||-+|+.++.+|-+||+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEe
Confidence 9999999999754 558999997654 58899999999999999999999 999999999999999999999999
Q ss_pred cccccccccCCCCCceecccccccCCCCceeeccCCCC-CcceEeechHHHHHHHhCCCCCCC
Q 004174 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISN 628 (770)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~ 628 (770)
|||.|-+.....- ..++||.+|.|||++.+.+|- ..-|||++|++||.++....||..
T Consensus 713 dfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 713 DFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9999977665433 347899999999999988874 568999999999999999988853
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-27 Score=238.07 Aligned_cols=198 Identities=35% Similarity=0.503 Sum_probs=172.8
Q ss_pred cccceeecccCceEEEEEEeCC-CCEEEEEEeCCChh--HHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 424 FLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~~-g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
|.+.+.||.|++|.||++...+ ++.+++|.+..... ..+.+.+|++.+..++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999764 88999999986542 57789999999999999999999999999899999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+++|.+++..... .+++..+..++.+++.+|.|||+ .+++|+||+|.||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999976432 17889999999999999999999 79999999999999999999999999999877554311
Q ss_pred ceecccccccCCCCceee-ccCCCCCcceEeechHHHHHHHhCCCCCCC
Q 004174 581 ITCTDVAGTFGYLAPEYF-MYGKVNDKIDVYAFGVVLLELLTGRKPISN 628 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~-~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~ 628 (770)
......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 155 -~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 -LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11235688899999998 666788899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-28 Score=266.84 Aligned_cols=252 Identities=27% Similarity=0.389 Sum_probs=203.1
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
.++|.....+|.|.+|.|||++. ..++..|||+++... +...-+.+|+-+++..+||||+.++|.+.....+++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 35678889999999999999986 478999999998654 5667788899999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+.+|+|.+..+..+ ++++.++..+.++.++||.|||+ ++-+|||||-.|||+++.|.+|++|||.+-.+....
T Consensus 94 cgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred cCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh
Confidence 99999999887654 68899999999999999999999 888999999999999999999999999987665443
Q ss_pred CCceecccccccCCCCceee---ccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 579 SHITCTDVAGTFGYLAPEYF---MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~---~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
.. ...+.||+.|||||+. ..+.|...+|||++|+...|+---++|....++.....+ .-+..+. .
T Consensus 167 ~K--rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L--mTkS~~q--------p 234 (829)
T KOG0576|consen 167 AK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL--MTKSGFQ--------P 234 (829)
T ss_pred hh--hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH--hhccCCC--------C
Confidence 32 2357999999999976 467899999999999999999988888766555322211 1111111 1
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
|.+.+... .-+.+..++..|+..+|++||++..+|.
T Consensus 235 p~lkDk~k--ws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLKDKTK--WSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CcccCCcc--chHHHHHHHHHHhcCCCccCCChhhhee
Confidence 22332222 2233445556799999999999987665
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=238.80 Aligned_cols=199 Identities=25% Similarity=0.360 Sum_probs=165.9
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec------C
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------N 490 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~ 490 (770)
..+|.....+|.|.- .|..+.+ -.++.||+|.+... ....++..+|..++..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 345666778899988 5666553 26889999987543 24456788999999999999999999998643 3
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 570 (770)
..|+|||||.. +|...++. .++-..+..|+.|++.|+.|||+ .+|+||||||+||++..+..+||.|||+
T Consensus 95 e~y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchh
Confidence 58999999955 99988872 25567788999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccc
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 633 (770)
|+..... ...+..+.|..|.|||++.+..|.+.+||||+||++.||++|+.-|.+.+...
T Consensus 165 ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~id 224 (369)
T KOG0665|consen 165 ARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHID 224 (369)
T ss_pred hcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHH
Confidence 9866554 23455789999999999998889999999999999999999999998655433
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-26 Score=228.28 Aligned_cols=196 Identities=26% Similarity=0.422 Sum_probs=163.2
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEeeE-EeecCceEEEEee
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGF-CFEDNNLLLVYDF 498 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~-~~~~~~~~LV~E~ 498 (770)
+.|.+.+.||+|.||.+-++.++ +.+.+++|-+...-...++|.+|...--.| .|.||+.-++. |+..+.+++++||
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 46788899999999999999875 577899999988778889999999876666 48999987764 6677788999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC--CCCceEEccccccccccC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~--~~~~vkL~DFGla~~~~~ 576 (770)
++.|+|...+... .+.+....+++.|++.||.|+|+ .++||||||.+||||- +...+||||||+....+.
T Consensus 104 aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 104 APRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred CccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999988653 47788889999999999999999 8999999999999993 334799999999876554
Q ss_pred CCCCceecccccccCCCCceeeccC-----CCCCcceEeechHHHHHHHhCCCCCCCCC
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~-----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 630 (770)
.... ..-+..|.+||..... ...+.+|||.||+++|..+||..|++...
T Consensus 176 tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~ 229 (378)
T KOG1345|consen 176 TVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS 229 (378)
T ss_pred eehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh
Confidence 3222 3456779999976532 35678999999999999999999998543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-26 Score=276.30 Aligned_cols=197 Identities=21% Similarity=0.278 Sum_probs=140.0
Q ss_pred hcCC-CceeEEeeEE-------eecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc
Q 004174 473 TLHH-KNIISLLGFC-------FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544 (770)
Q Consensus 473 ~l~H-pnIv~l~~~~-------~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ 544 (770)
.++| .||++++++| .....+++++||+ +++|.++|.... ..+++.+++.|+.||+.||.|||+ ++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHS---QG 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence 3455 5888888887 3335678889988 559999996432 358999999999999999999999 89
Q ss_pred eEEecccCCCeeeCC-------------------CCceEEccccccccccCCCC--------------CceecccccccC
Q 004174 545 VIHRDVKSSNILLSD-------------------DFEPQLSDFGLAKWASTSSS--------------HITCTDVAGTFG 591 (770)
Q Consensus 545 IiHrDLKp~NILL~~-------------------~~~vkL~DFGla~~~~~~~~--------------~~~~~~~~GT~~ 591 (770)
|+||||||+||||+. ++.+||+|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 44567777777754321000 000111468999
Q ss_pred CCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHH
Q 004174 592 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMV 671 (770)
Q Consensus 592 YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~ 671 (770)
|+|||++....|+.++|||||||+||||++|..|+..... .+...... .+.+.. ........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~---------~~~~~~-----~~~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHR---------VLPPQI-----LLNWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHh---------hcChhh-----hhcCHHHH
Confidence 9999999999999999999999999999999988753211 11110000 011110 00112234
Q ss_pred HHHHhhcccCCCCCCCHHHHHHH
Q 004174 672 LASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 672 ~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.++..||+.+|.+||+|.+|+++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 55678999999999999999874
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-25 Score=235.14 Aligned_cols=201 Identities=27% Similarity=0.393 Sum_probs=165.8
Q ss_pred HHhhcCcccceeecccCceEEEEEEeC----CCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCce
Q 004174 418 LSATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNL 492 (770)
Q Consensus 418 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~ 492 (770)
....+.|..++.||.|.|++||++.+. ..+.||+|.+.... ....+.+|+++|..+. +.||+++.+++..++..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 344567889999999999999999853 46789999886533 2356889999999996 89999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC-CCceEEcccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLA 571 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-~~~vkL~DFGla 571 (770)
.+|+||++.....+++. .++..++..++..++.||.++|. +|||||||||+|+|.+. .+.-.|+|||||
T Consensus 111 ~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred EEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhH
Confidence 99999999998888875 35678899999999999999999 99999999999999975 466789999999
Q ss_pred ccccCCC---------------------------------CCc---------eecccccccCCCCceeec-cCCCCCcce
Q 004174 572 KWASTSS---------------------------------SHI---------TCTDVAGTFGYLAPEYFM-YGKVNDKID 608 (770)
Q Consensus 572 ~~~~~~~---------------------------------~~~---------~~~~~~GT~~YlAPE~~~-~~~~s~ksD 608 (770)
...+... ... .....+||+||.|||++. ....++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 8321100 000 011257999999999886 456788999
Q ss_pred EeechHHHHHHHhCCCCCCCC
Q 004174 609 VYAFGVVLLELLTGRKPISND 629 (770)
Q Consensus 609 VwSlGvvL~eLltG~~Pf~~~ 629 (770)
|||.||+++-+++++.||...
T Consensus 261 iws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred eeeccceeehhhccccccccC
Confidence 999999999999999999653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=211.19 Aligned_cols=165 Identities=24% Similarity=0.229 Sum_probs=123.8
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
|+|.+++...+ ..++|..++.|+.||+.||.|||+ ++ ||+|||++.++.+++ ||+++......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc---
Confidence 68999997543 369999999999999999999998 54 999999999999999 99998765422
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 661 (770)
..||+.|+|||++.+..++.++|||||||++|||+||+.||......... +..+..... .. ++.- ..
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~------~~-~~~~-~~ 130 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI-LEILLNGMP------AD-DPRD-RS 130 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH-HHHHHHHhc------cC-Cccc-cc
Confidence 25899999999999999999999999999999999999999754332211 111111100 00 0000 00
Q ss_pred CChHHH--HHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 662 YDYDQM--ERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 662 ~~~~~~--~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
...... ..+..++..||+.+|.+||++.++++++.
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCR 167 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence 111111 24677788899999999999999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-23 Score=225.77 Aligned_cols=165 Identities=19% Similarity=0.162 Sum_probs=129.4
Q ss_pred hhcCcccceeecccCceEEEEEEeC--CCCEEEEEEeCCC------hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP--DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~--~g~~vAVK~l~~~------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 491 (770)
..++|.+.+.||+|+||+||+|.+. +++.+|||++... ......|.+|+++|..++|+|+++.+..+ +.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CC
Confidence 3467889999999999999999764 5777899986532 23456789999999999999998533222 46
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecc-cCCCeeeCCCCceEEccccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV-KSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDL-Kp~NILL~~~~~vkL~DFGl 570 (770)
.+|||||++|++|... ... . ...++.+++.||.|||+ ++|+|||| ||+|||++.++.+||+|||+
T Consensus 93 ~~LVmE~~~G~~L~~~-~~~-------~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RPH-------G---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred cEEEEEccCCCCHHHh-Ccc-------c---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 7999999999999732 110 0 14578899999999999 89999999 99999999999999999999
Q ss_pred cccccCCCCCce------ecccccccCCCCceeeccC
Q 004174 571 AKWASTSSSHIT------CTDVAGTFGYLAPEYFMYG 601 (770)
Q Consensus 571 a~~~~~~~~~~~------~~~~~GT~~YlAPE~~~~~ 601 (770)
|+.......... .+...+++.|+|||++.-.
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 987655432111 1346789999999998644
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.6e-22 Score=206.85 Aligned_cols=260 Identities=29% Similarity=0.417 Sum_probs=194.6
Q ss_pred cccceeecccCceEEEEEEeCCCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCC-ceeEEeeEEeecCceEEEEee
Q 004174 424 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHK-NIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~Hp-nIv~l~~~~~~~~~~~LV~E~ 498 (770)
|.+...||.|+||.||++... ..+++|.+.... .....+.+|+.++..+.|+ +|+++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667889999999999999876 789999997643 2467899999999999988 799999999777778999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC-ceEEccccccccccCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTS 577 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-~vkL~DFGla~~~~~~ 577 (770)
+.+++|.+++...... ..+.......++.+++.++.|+|. .+++|||+||+||+++..+ .++++|||++......
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999776544311 257888999999999999999999 8899999999999999988 7999999999865544
Q ss_pred CCCc----eecccccccCCCCceeecc---CCCCCcceEeechHHHHHHHhCCCCCCCCCcc-chhhHHHhhcccccCCc
Q 004174 578 SSHI----TCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK-GQESLVMWAKPILSSGK 649 (770)
Q Consensus 578 ~~~~----~~~~~~GT~~YlAPE~~~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~-~~~~lv~~~~~~~~~g~ 649 (770)
.... ......||..|+|||.+.. ..+....|+||+|++++++++|..||...... .............. .
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~ 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT--P 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC--c
Confidence 3221 2345789999999999987 57889999999999999999999997665431 01111110100000 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 650 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 650 l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.................+..+...|+..+|..|.++......
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001112344455567889999999998877654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=214.17 Aligned_cols=256 Identities=24% Similarity=0.281 Sum_probs=189.5
Q ss_pred CcccceeecccCceEEEEEEeCCC--CEEEEEEeCCChh-HHHHHHHHHHHHHhcCC----CceeEEeeEE-eecCceEE
Q 004174 423 NFLAENLIGKGGSSQVYKGCLPDG--KELAVKILKPSED-VIKEFVLEIEIITTLHH----KNIISLLGFC-FEDNNLLL 494 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~~g--~~vAVK~l~~~~~-~~~~~~~Ei~iL~~l~H----pnIv~l~~~~-~~~~~~~L 494 (770)
+|.+.+.||+|+||.||++..... ..+|+|+...... ....+..|+.++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999986553 4789998875432 12267789999998873 5889999988 47778899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC-----CceEEcccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-----FEPQLSDFG 569 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~-----~~vkL~DFG 569 (770)
||+.+ |.+|.++..... ...|+......|+.|++.+|.+||+ .|++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 889999876554 3579999999999999999999999 999999999999999765 468999999
Q ss_pred ccc--cccCCCCC--c-e---ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHH-Hh
Q 004174 570 LAK--WASTSSSH--I-T---CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV-MW 640 (770)
Q Consensus 570 la~--~~~~~~~~--~-~---~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv-~~ 640 (770)
+++ ........ . . ...+.||..|.++....+...+.+.|+||++.++.||+.|..|+............ ..
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 33222211 1 0 12356999999999999999999999999999999999999999665432221111 11
Q ss_pred hcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 641 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 641 ~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
... ..... + ......++..+ ...+-..+...+|....+...|+.
T Consensus 253 ~~~--------~~~~~-~-~~~~~~~~~~~---~~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 253 PRK--------LLTDR-F-GDLKPEEFAKI---LEYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred hhh--------hcccc-c-cCCChHHHHHH---HHHhhccCCcCCCCHHHHHHHHHH
Confidence 100 00000 1 11122233322 223445789999999998887653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.3e-22 Score=201.29 Aligned_cols=242 Identities=22% Similarity=0.401 Sum_probs=186.0
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCCh
Q 004174 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL 504 (770)
..|.+...|..|+|.+ .|..+++|+++..+ ...++|..|.-.|+.+.||||+.+++.|....++.++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 4577888999999998 56678888887532 4456899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEE-ecccCCCeeeCCCCceEEc--cccccccccCCCCCc
Q 004174 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH-RDVKSSNILLSDDFEPQLS--DFGLAKWASTSSSHI 581 (770)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiH-rDLKp~NILL~~~~~vkL~--DFGla~~~~~~~~~~ 581 (770)
+..|++... ...+-.++.+++..+++|+.|||+-. ++|- --|.+..++||++.+++|+ |--++.
T Consensus 275 ynvlhe~t~--vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfsf--------- 341 (448)
T KOG0195|consen 275 YNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------- 341 (448)
T ss_pred HHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceeee---------
Confidence 999997653 45677888999999999999999843 3443 4689999999999988875 322211
Q ss_pred eecccccccCCCCceeeccCCCC---CcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVN---DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s---~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
......-.|.|++||.++..+-+ ..+|+|||.++||||.|...||..-.+.+.--.+. + ..|
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-----l----------egl 406 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-----L----------EGL 406 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-----h----------ccc
Confidence 11123457889999999876544 47999999999999999999998876644221111 0 111
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
.-.++......+..++..|++.||.+||.+..|+-+|+..
T Consensus 407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 2223334445566677789999999999999999888653
|
|
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-20 Score=178.62 Aligned_cols=137 Identities=23% Similarity=0.369 Sum_probs=112.4
Q ss_pred EEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCcc------chhhhHHHHHHHHHHHhHhhhcCCc
Q 004174 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSS------LLSLVKAFDSVLAVYEGFCNLKQVD 91 (770)
Q Consensus 18 ~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~------~~~~~~~~~~~l~~~~~~C~~k~V~ 91 (770)
+|+||+|+|+.|..||+||++.+...|+.|++|||.++........... .....+...++++.+...|...++.
T Consensus 1 ~ILVavD~S~~s~~al~~a~~~a~~~~~~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 80 (146)
T cd01989 1 SVAVAVDKDKKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGKLEVASAYKQEEDKEAKELLLPYRCFCSRKGVQ 80 (146)
T ss_pred CEEEEecCccccHHHHHHHHHhccCCCCcEEEEEeccCcccCCCCccchHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCe
Confidence 4899999999999999999999988999999999986543221111100 0111233447888888899888999
Q ss_pred EEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004174 92 LKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (770)
Q Consensus 92 ~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~~g 155 (770)
++..++.|+++.++|+++|++.++++||||+|++ .|.++| .||+.||++++|++|||++|++|
T Consensus 81 ~~~~~~~g~~~~~~I~~~a~~~~~dlIV~Gs~g~~~l~~~~~g-ssva~~Vi~~a~~~c~Vlvv~~~ 146 (146)
T cd01989 81 CEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMKFKK-SDVASSVLKEAPDFCTVYVVSKG 146 (146)
T ss_pred EEEEEEeCCcHHHHHHHHHHHcCCCEEEEeccCCCceeecccC-CchhHHHHhcCCCCceEEEEeCc
Confidence 9999999889999999999999999999999998 345565 46999999999999999999997
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-21 Score=227.32 Aligned_cols=252 Identities=21% Similarity=0.247 Sum_probs=184.6
Q ss_pred cceeecccCceEEEEEEeC-CCCEEEEEEeC----CCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 426 AENLIGKGGSSQVYKGCLP-DGKELAVKILK----PSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 426 ~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~----~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
..+++|.|++|.|+..... ..+..+.|..+ ... .....+..|+.+-..++|||++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4678999999977766532 33333333322 221 222336678888888999999998888877776666799
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+++ +|+.++.... .+...++..++.|++.|+.|||. .||.|||||++|+++..+|.+||+|||.+......
T Consensus 402 ~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 9999987652 47788899999999999999999 99999999999999999999999999999876655
Q ss_pred CCC--ceecccccccCCCCceeeccCCCCC-cceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 578 SSH--ITCTDVAGTFGYLAPEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 578 ~~~--~~~~~~~GT~~YlAPE~~~~~~~s~-ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
... .....++|+-.|+|||.+....|++ ..||||.|++++.|++|+.||.......+.... . ...+......
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~--~---~~~~~~~~~~ 548 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT--N---NYSDQRNIFE 548 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh--h---cccccccccc
Confidence 443 4445688999999999999999987 599999999999999999999765443322100 0 0000000000
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
. ..........+...++..+|+.+|.+|-|+.+|++
T Consensus 549 ~---~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 549 G---PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred C---hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0 00011222334445556789999999999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.9e-21 Score=195.38 Aligned_cols=170 Identities=14% Similarity=0.174 Sum_probs=133.8
Q ss_pred hhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCCh----hHHHH------HHHHHHHHHhcCCCceeEEeeEEeec
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE----DVIKE------FVLEIEIITTLHHKNIISLLGFCFED 489 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~----~~~~~------~~~Ei~iL~~l~HpnIv~l~~~~~~~ 489 (770)
..++|...++||.|+||.||+... ++..+|||++++.. ..... +.+|+..+.++.|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 367899999999999999999766 67789999997532 22222 57899999999999999999886643
Q ss_pred --------CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC
Q 004174 490 --------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561 (770)
Q Consensus 490 --------~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~ 561 (770)
+..+|||||++|.+|.+... ++. ....+++.+|..||. .|++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC
Confidence 35899999999999988731 222 245689999999999 8999999999999999888
Q ss_pred ceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHH
Q 004174 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 620 (770)
Q Consensus 562 ~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLl 620 (770)
++|+|||........... ..++....|+.++|+|+||++|..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988644321111 11455566778999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-20 Score=189.26 Aligned_cols=140 Identities=20% Similarity=0.219 Sum_probs=108.8
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChh---H------------------------HHHHHHHHHHHHhcCCCce
Q 004174 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSED---V------------------------IKEFVLEIEIITTLHHKNI 479 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~---~------------------------~~~~~~Ei~iL~~l~HpnI 479 (770)
.+.||+|+||.||+|...+|+.||||+++.... . ......|+.++..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 468999999999999988899999999975421 0 1122359999999988776
Q ss_pred eEEeeEEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCceEEecccCCCeeeC
Q 004174 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL-HSGSAQRVIHRDVKSSNILLS 558 (770)
Q Consensus 480 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~IiHrDLKp~NILL~ 558 (770)
.....+.. ...+|||||++|++|...+... ..+++..+..++.|++.+|.|| |+ .+|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE
Confidence 43333222 2338999999998776543222 2578899999999999999999 67 7899999999999998
Q ss_pred CCCceEEccccccccccC
Q 004174 559 DDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 559 ~~~~vkL~DFGla~~~~~ 576 (770)
++.++|+|||+|.....
T Consensus 153 -~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 -DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred -CCcEEEEEccccccCCC
Confidence 47899999999975433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-20 Score=186.15 Aligned_cols=257 Identities=21% Similarity=0.268 Sum_probs=189.0
Q ss_pred hhcCcccceeecccCceEEEEEE-eCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC-CceeEEeeEEeecCceEEEEe
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~LV~E 497 (770)
..+.|.+.+.||.|+||.+|.|. ..+|..||||+-.... ...++..|..+...|++ ..|..+..|+.+...-.||||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 34679999999999999999998 4689999999876432 23467789999999985 677778888888888899999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC---CceEEccccccccc
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKWA 574 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~---~~vkL~DFGla~~~ 574 (770)
.+ |.+|++++.--. ..|+....+-++-|++.-++|+|. +++|||||||+|+|+.-+ ..+.|+|||||+.+
T Consensus 92 LL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhh
Confidence 98 889999886433 368899999999999999999999 889999999999999633 56899999999876
Q ss_pred cCCCCC--ce---ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCc
Q 004174 575 STSSSH--IT---CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 649 (770)
Q Consensus 575 ~~~~~~--~~---~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 649 (770)
-+..+. .. ..+..||..|.+--...+-..+.+-|+-|+|.+|.++.-|..||++..+.......... .+.+
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI----~EkK 240 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI----SEKK 240 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH----HHhh
Confidence 543222 21 23367999998877666667788899999999999999999999987654433322211 1111
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 650 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 650 l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
+.-.+ ..|+..++.+..- ...-|-..-=++-|...-+-+
T Consensus 241 ~s~~i-e~LC~G~P~EF~m----yl~Y~R~L~F~E~Pdy~ylrq 279 (341)
T KOG1163|consen 241 MSTPI-EVLCKGFPAEFAM----YLNYCRGLGFEEKPDYMYLRQ 279 (341)
T ss_pred cCCCH-HHHhCCCcHHHHH----HHHHHhhcCCCCCCcHHHHHH
Confidence 11111 1233334433322 223466666667777554444
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.9e-20 Score=190.88 Aligned_cols=202 Identities=23% Similarity=0.304 Sum_probs=169.4
Q ss_pred CcccceeecccCceEEEEEE-eCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEEeecC
Q 004174 423 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~-~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
+|.+.+.||+|.||.++.|. +-++++||||.-.... ..-++..|.+..+.|. .++|...+-|..++-+-.||+|++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC-CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 68999999999999999997 4578999999765322 2345667888888885 689999998888888889999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC-----CceEEcccccccccc
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-----FEPQLSDFGLAKWAS 575 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~-----~~vkL~DFGla~~~~ 575 (770)
|.+|+|++.-.+ ..|+...+..||.|++.-++|+|. +.+|+|||||+|+||... ..+.|+|||+|+.+.
T Consensus 107 GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 889999887544 369999999999999999999999 889999999999999643 358899999999886
Q ss_pred CCCCC--cee---cccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCcc
Q 004174 576 TSSSH--ITC---TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (770)
Q Consensus 576 ~~~~~--~~~---~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~ 632 (770)
+..+. +.+ ....||..||+---..+..-+.+-|+-|||-|+++.|-|..||.+....
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 65332 221 2357999999998888888999999999999999999999999876543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.5e-21 Score=221.49 Aligned_cols=251 Identities=22% Similarity=0.273 Sum_probs=181.1
Q ss_pred CcccceeecccCceEEEEEEeCCCCEEEEEEeCCCh--hHHHHHH---HHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIKEFV---LEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~--~~~~~~~---~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
+|...+.||.+.|=+|.+|.++.|. |+||++-+.. -....|. .|+. ...++|||.+++.-+-..+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6778899999999999999998887 9999986533 2233344 4444 556689999999988777788899999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc--cc
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW--AS 575 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~--~~ 575 (770)
|+.+ +|+|.|... ..+...+.++|+.|++.||.-+|. .||+|||||.+||||+.-+-+.|+||.--|. ++
T Consensus 102 yvkh-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9966 999999654 357788899999999999999999 9999999999999999999999999976652 22
Q ss_pred CCCCC---ceecccccccCCCCceeeccC----------C-CCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHh
Q 004174 576 TSSSH---ITCTDVAGTFGYLAPEYFMYG----------K-VNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 640 (770)
Q Consensus 576 ~~~~~---~~~~~~~GT~~YlAPE~~~~~----------~-~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~ 640 (770)
.+... ....+...-.+|+|||.|... . .+++.||||+||+++||++ |++||.. ..|..+
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aY 247 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAY 247 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhH
Confidence 22111 111222334579999988542 1 6778999999999999999 8999853 222221
Q ss_pred hcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004174 641 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699 (770)
Q Consensus 641 ~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~ 699 (770)
. .|. .......| ...... .+-.+++.|+++||.+|-++++.|+.-+|..
T Consensus 248 r-----~~~-~~~~e~~L-e~Ied~---~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 248 R-----SGN-ADDPEQLL-EKIEDV---SLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred h-----ccC-ccCHHHHH-HhCcCc---cHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 1 111 01011111 111111 2333456799999999999999998766543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=183.15 Aligned_cols=187 Identities=16% Similarity=0.100 Sum_probs=143.1
Q ss_pred ccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHH-----HHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEEee
Q 004174 425 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIK-----EFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 425 ~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~-----~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
.+...|++|+||+||.+.. .+..++.+.+........ .|.+|+++|.+|. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999998766 677888887776544333 5789999999995 5889999886 456999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecc-cCCCeeeCCCCceEEccccccccccCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV-KSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDL-Kp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
+.|.+|...+.. ....++.+++.+|.++|. +||+|||| ||+|||++.++.++|+|||+|......
T Consensus 80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999998754321 013477899999999999 89999999 799999999999999999999865543
Q ss_pred CCC---ce--------ecccccccCCCCceeeccC-CCC-CcceEeechHHHHHHHhCCCCCCCCC
Q 004174 578 SSH---IT--------CTDVAGTFGYLAPEYFMYG-KVN-DKIDVYAFGVVLLELLTGRKPISNDH 630 (770)
Q Consensus 578 ~~~---~~--------~~~~~GT~~YlAPE~~~~~-~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~ 630 (770)
... .. ..-...++.|++|+...-- ..+ ...++++.|..+|.++||+.|+-.+.
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 210 00 0012368889999854422 223 56799999999999999999876554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-19 Score=180.25 Aligned_cols=141 Identities=23% Similarity=0.240 Sum_probs=110.8
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChh---------------------------HHHHHHHHHHHHHhcCCCce
Q 004174 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSED---------------------------VIKEFVLEIEIITTLHHKNI 479 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~---------------------------~~~~~~~Ei~iL~~l~HpnI 479 (770)
.+.||+|+||.||+|...+|+.||||+++.... ....+..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999987899999999985421 01224578999999999987
Q ss_pred eEEeeEEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC
Q 004174 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 559 (770)
Q Consensus 480 v~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~ 559 (770)
.....+... ..+|||||++|+++....... ..++......++.+++.+|.+||+ ..||+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence 544444333 248999999988654432221 246778889999999999999997 26899999999999998
Q ss_pred CCceEEccccccccccC
Q 004174 560 DFEPQLSDFGLAKWAST 576 (770)
Q Consensus 560 ~~~vkL~DFGla~~~~~ 576 (770)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999976654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.7e-20 Score=208.39 Aligned_cols=185 Identities=30% Similarity=0.371 Sum_probs=158.4
Q ss_pred eecccCceEEEEEEe----CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEEeecC
Q 004174 429 LIGKGGSSQVYKGCL----PDGKELAVKILKPSE---DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 429 ~LG~G~fG~Vy~a~~----~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
++|+|.||.|+++.. ..|..||+|++++.. ........|..++...+ ||.+|++...|+.+..++++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998652 357789999987532 11125566888888887 9999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
||.|...+.... .+.......+...++-+++++|+ .+|+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhccccCC----chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 999999886553 47777788888999999999999 9999999999999999999999999999986644322
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~ 628 (770)
.+||..|||||++. .....+|+||||++++||+||..||..
T Consensus 153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 27999999999998 667789999999999999999999976
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.4e-18 Score=203.63 Aligned_cols=200 Identities=22% Similarity=0.255 Sum_probs=161.3
Q ss_pred HHHHhhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC---CCceeEEeeEEeecCce
Q 004174 416 DLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNL 492 (770)
Q Consensus 416 ~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~ 492 (770)
++......|.+.+.||+|+||.||+|...+|+.+|+|+-++...+ +|.--..++.+|+ -+-|..+..++...+..
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 444455678999999999999999999888999999999875432 1222223344444 23455556666667788
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC-------CCCceEE
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-------DDFEPQL 565 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~-------~~~~vkL 565 (770)
+||+||.+.|+|.+++... ..++|...+.++.|++..++.||. .+|||+||||+|.||. +..-++|
T Consensus 770 ~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred eeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEE
Confidence 9999999999999999844 368999999999999999999999 8999999999999994 2345899
Q ss_pred ccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCC
Q 004174 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRK 624 (770)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~ 624 (770)
+|||.+.-+.--........+++|-++--+|+..+..+++.+|.|.|.-+++-||.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999975544333345556789999999999999999999999999999999999975
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-17 Score=169.52 Aligned_cols=134 Identities=20% Similarity=0.246 Sum_probs=104.1
Q ss_pred cceeecccCceEEEEEEeCCCCEEEEEEeCCC-hhHHHHHHHHHHHHHhc-----CCCceeEEeeEEeecC---c-eEEE
Q 004174 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS-EDVIKEFVLEIEIITTL-----HHKNIISLLGFCFEDN---N-LLLV 495 (770)
Q Consensus 426 ~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~l-----~HpnIv~l~~~~~~~~---~-~~LV 495 (770)
-..+||+|+||.||. +++....+||++... ....+.+.+|+.++..+ .||||++++|++.++. . +.+|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 357899999999996 443333479988754 23456789999999999 5799999999998864 3 3378
Q ss_pred Eee--cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCceEEecccCCCeeeCC----CCceEEccc
Q 004174 496 YDF--LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL-EYLHSGSAQRVIHRDVKSSNILLSD----DFEPQLSDF 568 (770)
Q Consensus 496 ~E~--~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL-~yLH~~~~~~IiHrDLKp~NILL~~----~~~vkL~DF 568 (770)
+|| +.+|+|.+++... .+++. ..++.+++.++ .|||+ ++|+||||||+|||++. ++.++|+||
T Consensus 84 ~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred ecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 999 5579999999642 24444 35577888777 99999 89999999999999973 347999995
Q ss_pred ccc
Q 004174 569 GLA 571 (770)
Q Consensus 569 Gla 571 (770)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=177.02 Aligned_cols=200 Identities=23% Similarity=0.326 Sum_probs=132.6
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCC----------CceeEEeeE--
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHH----------KNIISLLGF-- 485 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~H----------pnIv~l~~~-- 485 (770)
.+...+.||.|+|+.||.+.+. +|+.+|||+.... ....+.+.+|.-....+.+ -.++-.++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3456789999999999999975 5899999987532 2456677777654444322 112211111
Q ss_pred -------EeecC--------ceEEEEeecCCCChhhhhc---cCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEE
Q 004174 486 -------CFEDN--------NLLLVYDFLSRGSLEENLH---GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547 (770)
Q Consensus 486 -------~~~~~--------~~~LV~E~~~ggsL~~~l~---~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiH 547 (770)
+.... ..+++|+-+ .++|.+++. ........+....+..+..|+++.+++||. .|++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence 11111 347888888 458888754 222222335556677888999999999999 99999
Q ss_pred ecccCCCeeeCCCCceEEccccccccccCCCCCceecccccccCCCCceeeccC--------CCCCcceEeechHHHHHH
Q 004174 548 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG--------KVNDKIDVYAFGVVLLEL 619 (770)
Q Consensus 548 rDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~--------~~s~ksDVwSlGvvL~eL 619 (770)
+||||+|+|++.+|.++|+||+.....+.... . ...+..|.+||..... .++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR----C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE----G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee----c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999988765543211 1 2356789999976432 578899999999999999
Q ss_pred HhCCCCCCCCCc
Q 004174 620 LTGRKPISNDHP 631 (770)
Q Consensus 620 ltG~~Pf~~~~~ 631 (770)
.+|+.||....+
T Consensus 244 WC~~lPf~~~~~ 255 (288)
T PF14531_consen 244 WCGRLPFGLSSP 255 (288)
T ss_dssp HHSS-STCCCGG
T ss_pred HHccCCCCCCCc
Confidence 999999986543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-17 Score=187.29 Aligned_cols=214 Identities=21% Similarity=0.387 Sum_probs=159.3
Q ss_pred HHhcCCCceeEEeeEEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCce-EEec
Q 004174 471 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV-IHRD 549 (770)
Q Consensus 471 L~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~I-iHrD 549 (770)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.... ..++|.....+...|+.||.|||+ -+| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHN---SPIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhc---Ccceeeee
Confidence 356889999999999999999999999999999999997633 468999999999999999999998 333 9999
Q ss_pred ccCCCeeeCCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCC-------CCCcceEeechHHHHHHHhC
Q 004174 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK-------VNDKIDVYAFGVVLLELLTG 622 (770)
Q Consensus 550 LKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~-------~s~ksDVwSlGvvL~eLltG 622 (770)
+++.|.+++..+.+||+|||+.................-..-|.|||.+.... .+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987764311111111123445699999987541 46679999999999999999
Q ss_pred CCCCCCCCccch-hhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 623 RKPISNDHPKGQ-ESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 623 ~~Pf~~~~~~~~-~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
..||........ ..++.+... .....+-|.+.... +....+..++..||..+|.+||++..|-..+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~ 223 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT 223 (484)
T ss_pred cCccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence 999986433222 234443222 01111222221111 222357777788999999999999998776654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-17 Score=171.62 Aligned_cols=144 Identities=19% Similarity=0.183 Sum_probs=112.3
Q ss_pred hcCcccceeecccCceEEEEEE--eCCCCEEEEEEeCCChh-------------------------HHHHHHHHHHHHHh
Q 004174 421 TSNFLAENLIGKGGSSQVYKGC--LPDGKELAVKILKPSED-------------------------VIKEFVLEIEIITT 473 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~--~~~g~~vAVK~l~~~~~-------------------------~~~~~~~Ei~iL~~ 473 (770)
...|.+.+.||+|+||.||+|. ..+|+.||||+++.... ....+..|+.++.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3357888999999999999998 56899999999874320 11235689999999
Q ss_pred cCCC--ceeEEeeEEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc-eEEecc
Q 004174 474 LHHK--NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-VIHRDV 550 (770)
Q Consensus 474 l~Hp--nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~-IiHrDL 550 (770)
+.+. .+.+++++ ...+|||||++|++|...+... ..+.......++.|++.+|.|||+ ++ |+||||
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Di 175 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDL 175 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCC
Confidence 9753 34444443 2358999999998887654322 134555677899999999999999 88 999999
Q ss_pred cCCCeeeCCCCceEEccccccccccC
Q 004174 551 KSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 551 Kp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+||+++ ++.++|+|||++.....
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhccCC
Confidence 99999999 88999999999875443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.7e-17 Score=163.87 Aligned_cols=145 Identities=20% Similarity=0.207 Sum_probs=113.6
Q ss_pred HHHHHhhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChh-----------------------HHHHHHHHHHHH
Q 004174 415 QDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-----------------------VIKEFVLEIEII 471 (770)
Q Consensus 415 ~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~-----------------------~~~~~~~Ei~iL 471 (770)
+++......|.+.+.||+|+||.||++...+|+.||||+++.... ....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 344444445888899999999999999988899999998764320 112366789999
Q ss_pred HhcCCCc--eeEEeeEEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEec
Q 004174 472 TTLHHKN--IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549 (770)
Q Consensus 472 ~~l~Hpn--Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrD 549 (770)
..+.|++ +...++. ...++||||++|++|...... .....++.+++.++.++|+ .+|+|||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~---~gi~H~D 150 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYK---HGIIHGD 150 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHH---CCCCcCC
Confidence 9998874 4444442 455899999999998765421 2345688999999999999 8999999
Q ss_pred ccCCCeeeCCCCceEEccccccccccC
Q 004174 550 VKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 550 LKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
|||+||+++.++.++|+|||++.....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999999965443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.6e-17 Score=164.90 Aligned_cols=133 Identities=23% Similarity=0.392 Sum_probs=113.6
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCCh---------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+.||+|++|.||+|.. .|..++||+..... .....+.+|++++..+.|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 77789999866421 1124578899999999999988877777777888999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
++|++|.+.+.... + .+..++.+++.+|.+||+ .+++|||++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999985321 2 778899999999999999 8999999999999999 78999999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-17 Score=195.33 Aligned_cols=169 Identities=30% Similarity=0.451 Sum_probs=127.8
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
++|..+++|..|++|.||...++ ..+.+|+|+-+. ....+. |+.....|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~lilRn------ilt~a~npfvv-------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NLILRN------ILTFAGNPFVV-------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhccccc-chhhhc------cccccCCccee--------------------
Confidence 47888999999999999999875 467788854432 211111 44444455544
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
|+-...+...+. ++. +++.+++|||+ .+|+|||+||+|.||+.-|++|++|||+++........
T Consensus 136 -gDc~tllk~~g~----lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 -GDCATLLKNIGP----LPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred -chhhhhcccCCC----Ccc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 566666654433 221 23788999999 99999999999999999999999999999854321110
Q ss_pred -------------ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccc
Q 004174 581 -------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (770)
Q Consensus 581 -------------~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 633 (770)
.....++||+.|+|||++....|+..+|+|++|+++||.+-|..||.++.+.+
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 11234689999999999999999999999999999999999999999986644
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=161.44 Aligned_cols=129 Identities=21% Similarity=0.360 Sum_probs=107.0
Q ss_pred eecccCceEEEEEEeCCCCEEEEEEeCCCh---------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 429 LIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 429 ~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
+||+|+||.||+|.. +|..+++|+..... ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 67889999865321 12356788999999999887665555666667789999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+|++|.+.+.... . .++.+++.+|.+||+ .+++|||++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999875321 0 689999999999999 8999999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-16 Score=185.81 Aligned_cols=139 Identities=19% Similarity=0.324 Sum_probs=113.2
Q ss_pred HhhcCcccceeecccCceEEEEEEeCCCCEEEEEEe-CC---Ch-----hHHHHHHHHHHHHHhcCCCceeEEeeEEeec
Q 004174 419 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKIL-KP---SE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFED 489 (770)
Q Consensus 419 ~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l-~~---~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 489 (770)
.....|...+.||+|+||.||+|.+.+. .+++|+. .. .. ...+.+.+|++++..++|++++....++...
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 3344566789999999999999987444 3444432 21 11 1235688999999999999999888888877
Q ss_pred CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccc
Q 004174 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (770)
Q Consensus 490 ~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 569 (770)
...++||||++|++|.+++. ....++.+++.+|.|||+ .+|+||||||+|||+ .++.++|+|||
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCc
Confidence 78899999999999999874 346789999999999999 899999999999999 67799999999
Q ss_pred ccccc
Q 004174 570 LAKWA 574 (770)
Q Consensus 570 la~~~ 574 (770)
+++..
T Consensus 473 la~~~ 477 (535)
T PRK09605 473 LGKYS 477 (535)
T ss_pred ccccC
Confidence 99753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.5e-17 Score=181.65 Aligned_cols=124 Identities=31% Similarity=0.505 Sum_probs=107.6
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 570 (770)
++|+.|+++.-.+|.++|.+... ....+|.....++.|++.|++| ++.+|||+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 58999999999999999975432 2457888999999999999999 5789999999999999999999999999
Q ss_pred cccccCCC----CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh
Q 004174 571 AKWASTSS----SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621 (770)
Q Consensus 571 a~~~~~~~----~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt 621 (770)
........ .....+...||..||+||.+.+..|+.|+||||||++|+||+.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87666554 1122344689999999999999999999999999999999997
|
|
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.5e-15 Score=142.18 Aligned_cols=132 Identities=16% Similarity=0.189 Sum_probs=97.3
Q ss_pred cEEEEEEcCCcc--hHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCC--ccc-hhhhHHHHHHHHHHHhHhh---hc
Q 004174 17 RTVVVGVKLDTH--SRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGK--SSL-LSLVKAFDSVLAVYEGFCN---LK 88 (770)
Q Consensus 17 r~I~VaVd~s~~--S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~--~~~-~~~~~~~~~~l~~~~~~C~---~k 88 (770)
++|+|++|+|+. +..||+||++.+.+.|..|++|||.++......... ... ....+..+...+.+++++. ..
T Consensus 3 ~~ILv~~D~s~~~~~~~a~~~a~~la~~~~~~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 82 (144)
T PRK15005 3 RTILVPIDISDSELTQRVISHVEAEAKIDDAEVHFLTVIPSLPYYASLGLAYSAELPAMDDLKAEAKSQLEEIIKKFKLP 82 (144)
T ss_pred ccEEEecCCCchhHHHHHHHHHHHHHhccCCeEEEEEEEccCcccccccccccccchHHHHHHHHHHHHHHHHHHHhCCC
Confidence 689999999998 579999999999889999999999975432111100 000 0011111222233344444 34
Q ss_pred CCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC--cccccCCCchHHHHhccCCCCcEEEEEe
Q 004174 89 QVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN--HHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (770)
Q Consensus 89 ~V~~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~--~r~~~~~~sVs~yc~~~ap~~C~V~vV~ 153 (770)
.+.++..+.. |++.+.|+++|+..++|++|||+++. .+.++| |++.++++++| |||++|+
T Consensus 83 ~~~~~~~v~~-G~p~~~I~~~a~~~~~DLIV~Gs~~~~~~~~llG--S~a~~vl~~a~--cpVlvVr 144 (144)
T PRK15005 83 TDRVHVHVEE-GSPKDRILELAKKIPADMIIIASHRPDITTYLLG--SNAAAVVRHAE--CSVLVVR 144 (144)
T ss_pred CCceEEEEeC-CCHHHHHHHHHHHcCCCEEEEeCCCCCchheeec--chHHHHHHhCC--CCEEEeC
Confidence 5677888877 89999999999999999999999864 556778 99999999998 9999985
|
|
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.4e-15 Score=142.37 Aligned_cols=131 Identities=18% Similarity=0.174 Sum_probs=95.3
Q ss_pred cEEEEEEcCCc--chHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCccc-h----hhhHHHHHHHHHHHhHhhhcC
Q 004174 17 RTVVVGVKLDT--HSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSL-L----SLVKAFDSVLAVYEGFCNLKQ 89 (770)
Q Consensus 17 r~I~VaVd~s~--~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~-~----~~~~~~~~~l~~~~~~C~~k~ 89 (770)
++|+|++|+|+ .|..||+||+..+ +.++.|++|||.++............ . ...+...+.+..+.......+
T Consensus 3 ~~ILv~vD~S~~~~s~~al~~A~~la-~~~~~l~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 81 (142)
T PRK15456 3 KTIIMPVDVFEMELSDKAVRHAEFLA-QDDGVIHLLHVLPGSASLSLHRFAADVRRFEEHLQHEAEERLQTMVSHFTIDP 81 (142)
T ss_pred ccEEEeccCCchhHHHHHHHHHHHHH-hcCCeEEEEEEecCcccccccccccchhhHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 68999999995 7999999999765 44679999999976532111100000 0 111112233444433333345
Q ss_pred CcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC--cccccCCCchHHHHhccCCCCcEEEEEe
Q 004174 90 VDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN--HHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (770)
Q Consensus 90 V~~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~--~r~~~~~~sVs~yc~~~ap~~C~V~vV~ 153 (770)
++++.++.. |++.+.|+++|+..++|++|||+||+ .+.++| |++.+++++++ |||++|+
T Consensus 82 ~~v~~~v~~-G~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~llG--S~a~~v~~~a~--~pVLvV~ 142 (142)
T PRK15456 82 SRIKQHVRF-GSVRDEVNELAEELGADVVVIGSRNPSISTHLLG--SNASSVIRHAN--LPVLVVR 142 (142)
T ss_pred cceEEEEcC-CChHHHHHHHHhhcCCCEEEEcCCCCCccceecC--ccHHHHHHcCC--CCEEEeC
Confidence 778888877 79999999999999999999999998 456678 99999999998 9999985
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.3e-15 Score=140.98 Aligned_cols=136 Identities=23% Similarity=0.255 Sum_probs=115.2
Q ss_pred cceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC--CceeEEeeEEeecCceEEEEeecCCCC
Q 004174 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLVYDFLSRGS 503 (770)
Q Consensus 426 ~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~LV~E~~~ggs 503 (770)
+.+.||.|.++.||++...+ ..+++|+...... ...+.+|+.++..++| .++.+++.++...+..+++|||++++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 35789999999999998744 7899999876544 5678899999999986 589999998888788999999999877
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 504 L~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
+... +......++.+++.+|.+||.....+++|+|++|.|||++..+.++++|||++...
T Consensus 80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 7654 34566778999999999999854457999999999999999899999999998644
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.7e-15 Score=143.05 Aligned_cols=135 Identities=13% Similarity=0.136 Sum_probs=98.7
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcc-cCCCCccchhhh-HHHHHHHHHHHhHhhhcCCcEE
Q 004174 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIV-DRDGKSSLLSLV-KAFDSVLAVYEGFCNLKQVDLK 93 (770)
Q Consensus 16 ~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~-~~~~~~~~~~~~-~~~~~~l~~~~~~C~~k~V~~~ 93 (770)
-++|+|++|+|+.|..||+||+..+...|..|++|||..+.... ............ .........++.++...++.+.
T Consensus 3 ~~~ILvavD~S~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 82 (144)
T PRK15118 3 YKHILIAVDLSPESKVLVEKAVSMARPYNAKVSLIHVDVNYSDLYTGLIDVNLGDMQKRISEETHHALTELSTNAGYPIT 82 (144)
T ss_pred ceEEEEEccCChhHHHHHHHHHHHHHhhCCEEEEEEEccChhhhhhhhhhcchHHHHHHHHHHHHHHHHHHHHhCCCCce
Confidence 37899999999999999999999887889999999995332111 000000000111 1122333445566666677776
Q ss_pred EEEEECCChhHHHHHHHHhcCCcEEEEccCCCcccccCCCchHHHHhccCCCCcEEEEEeC
Q 004174 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (770)
Q Consensus 94 ~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~~r~~~~~~sVs~yc~~~ap~~C~V~vV~~ 154 (770)
..+++.|++.++|+++|++.++|++|||+|+.....+| ||+.+++++++ |||++|+.
T Consensus 83 ~~~~~~G~p~~~I~~~a~~~~~DLIV~Gs~~~~~~~lg--Sva~~v~~~a~--~pVLvv~~ 139 (144)
T PRK15118 83 ETLSGSGDLGQVLVDAIKKYDMDLVVCGHHQDFWSKLM--SSARQLINTVH--VDMLIVPL 139 (144)
T ss_pred EEEEEecCHHHHHHHHHHHhCCCEEEEeCcccHHHHHH--HHHHHHHhhCC--CCEEEecC
Confidence 66666699999999999999999999999986222356 99999999998 99999974
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.6e-15 Score=158.42 Aligned_cols=145 Identities=28% Similarity=0.385 Sum_probs=109.8
Q ss_pred CCCceeEEeeEEee---------------------------cCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHH
Q 004174 475 HHKNIISLLGFCFE---------------------------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVA 527 (770)
Q Consensus 475 ~HpnIv~l~~~~~~---------------------------~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~ 527 (770)
+|||||+++++|.+ +..+|+||.-++. +|.+++-... .+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHH
Confidence 59999999887743 2358999988865 8999886543 4455667789
Q ss_pred HHHHHHHHHHHcCCCCceEEecccCCCeee--CCCC--ceEEccccccccccCCCCCce----ecccccccCCCCceeec
Q 004174 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILL--SDDF--EPQLSDFGLAKWASTSSSHIT----CTDVAGTFGYLAPEYFM 599 (770)
Q Consensus 528 ~qia~aL~yLH~~~~~~IiHrDLKp~NILL--~~~~--~vkL~DFGla~~~~~~~~~~~----~~~~~GT~~YlAPE~~~ 599 (770)
.|+++|+.|||+ +||.|||+|++|||| ++|+ .+.|+|||++---........ ..+.-|.-.-||||++.
T Consensus 348 aQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 999999999999 999999999999999 4444 367999999854333111111 11245777899999986
Q ss_pred cCC-----C-CCcceEeechHHHHHHHhCCCCCCC
Q 004174 600 YGK-----V-NDKIDVYAFGVVLLELLTGRKPISN 628 (770)
Q Consensus 600 ~~~-----~-s~ksDVwSlGvvL~eLltG~~Pf~~ 628 (770)
... . -.|+|.|+.|.+.||+++...||..
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 432 1 2489999999999999999999986
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.2e-15 Score=149.47 Aligned_cols=137 Identities=21% Similarity=0.262 Sum_probs=99.2
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChhH---HHH----------------------HHHHHHHHHhcCCCc--e
Q 004174 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV---IKE----------------------FVLEIEIITTLHHKN--I 479 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~---~~~----------------------~~~Ei~iL~~l~Hpn--I 479 (770)
.+.||+|+||.||+|...+|+.||||+++..... ... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998753211 111 134666666665432 4
Q ss_pred eEEeeEEeecCceEEEEeecCCCChhhh-hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC
Q 004174 480 ISLLGFCFEDNNLLLVYDFLSRGSLEEN-LHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (770)
Q Consensus 480 v~l~~~~~~~~~~~LV~E~~~ggsL~~~-l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 558 (770)
.+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++|. .++|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE
Confidence 444443 346999999999654322 21111 11 5677899999999999997 26799999999999999
Q ss_pred CCCceEEccccccccccC
Q 004174 559 DDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 559 ~~~~vkL~DFGla~~~~~ 576 (770)
++.++|+|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 88999999999965443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.9e-14 Score=133.04 Aligned_cols=120 Identities=16% Similarity=0.146 Sum_probs=99.5
Q ss_pred EEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCccchhhhHHHHHHHHHHHhHhhhcCCcEEEEEE
Q 004174 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKIC 97 (770)
Q Consensus 18 ~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~~~v~ 97 (770)
+|+|+||.++.|++||+||...+.+.+..|.+|||.++... ...+...+.++.+...++..++. ..++
T Consensus 1 ~Ilv~vd~s~~s~~al~~a~~la~~~~~~l~ll~v~~~~~~----------~~~~~~~~~l~~~~~~~~~~~~~--~~~~ 68 (124)
T cd01987 1 RILVCISGGPNAERLIRRAARLADRLKAPWYVVYVETPRLN----------RLSEAERRRLAEALRLAEELGAE--VVTL 68 (124)
T ss_pred CEEEEECCCcchHHHHHHHHHHHHHhCCCEEEEEEecCccc----------cCCHHHHHHHHHHHHHHHHcCCE--EEEE
Confidence 59999999999999999999998888999999999865421 11233345677777777766664 4566
Q ss_pred ECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEE
Q 004174 98 RGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAV 152 (770)
Q Consensus 98 ~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV 152 (770)
.++++.++|+++|+.+++++||||++++ .+.++| |++.++++++ ..|+|+||
T Consensus 69 ~~~~~~~~I~~~~~~~~~dllviG~~~~~~~~~~~~G--s~~~~v~~~a-~~~~v~v~ 123 (124)
T cd01987 69 PGDDVAEAIVEFAREHNVTQIVVGKSRRSRWRELFRG--SLVDRLLRRA-GNIDVHIV 123 (124)
T ss_pred eCCcHHHHHHHHHHHcCCCEEEeCCCCCchHHHHhcc--cHHHHHHHhC-CCCeEEEe
Confidence 7789999999999999999999999988 667888 9999999999 24999987
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.3e-14 Score=135.86 Aligned_cols=133 Identities=16% Similarity=0.177 Sum_probs=98.2
Q ss_pred cEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCccchhhhHHHH--HHHHHHHhHhhhcCCcEEE
Q 004174 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFD--SVLAVYEGFCNLKQVDLKL 94 (770)
Q Consensus 17 r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~C~~k~V~~~~ 94 (770)
++|+|++|.++.+..||+||+..+...|+.|++|||.+..................... .........+...+.....
T Consensus 3 ~~Ilv~~d~~~~~~~al~~a~~la~~~~~~i~~l~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (140)
T PF00582_consen 3 KRILVAIDGSEESRRALRFALELAKRSGAEITLLHVIPPPPQYSFSAAEDEESEEEAEEEEQARQAEAEEAEAEGGIVIE 82 (140)
T ss_dssp SEEEEEESSSHHHHHHHHHHHHHHHHHTCEEEEEEEEESCHCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSEEE
T ss_pred CEEEEEECCCHHHHHHHHHHHHHHHhhCCeEEEEEeeccccccccccccccccccccchhhhhhhHHHHHHhhhccceeE
Confidence 79999999999999999999999999999999999997653321110000000000000 0111111345555666677
Q ss_pred EEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEe
Q 004174 95 KICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (770)
Q Consensus 95 ~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~ 153 (770)
..+..+++.+.|+++++..++|+||||++++ .+.++| |++++|++++| |||+||+
T Consensus 83 ~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~~~~~~~~g--s~~~~l~~~~~--~pVlvv~ 140 (140)
T PF00582_consen 83 VVIESGDVADAIIEFAEEHNADLIVMGSRGRSGLERLLFG--SVAEKLLRHAP--CPVLVVP 140 (140)
T ss_dssp EEEEESSHHHHHHHHHHHTTCSEEEEESSSTTSTTTSSSH--HHHHHHHHHTS--SEEEEEE
T ss_pred EEEEeeccchhhhhccccccceeEEEeccCCCCccCCCcC--CHHHHHHHcCC--CCEEEeC
Confidence 7777799999999999999999999999996 556677 99999999999 9999985
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.3e-14 Score=147.16 Aligned_cols=134 Identities=14% Similarity=0.161 Sum_probs=104.5
Q ss_pred eeec-ccCceEEEEEEeCCCCEEEEEEeCCCh--------------hHHHHHHHHHHHHHhcCCCce--eEEeeEEeecC
Q 004174 428 NLIG-KGGSSQVYKGCLPDGKELAVKILKPSE--------------DVIKEFVLEIEIITTLHHKNI--ISLLGFCFEDN 490 (770)
Q Consensus 428 ~~LG-~G~fG~Vy~a~~~~g~~vAVK~l~~~~--------------~~~~~~~~Ei~iL~~l~HpnI--v~l~~~~~~~~ 490 (770)
..|| .||.|+||++.. .+..++||.+.... .....+.+|++++..|.|++| +..++++....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5688 899999999887 47789999885311 123467889999999998774 67777654432
Q ss_pred c----eEEEEeecCC-CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEE
Q 004174 491 N----LLLVYDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565 (770)
Q Consensus 491 ~----~~LV~E~~~g-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL 565 (770)
. .++||||++| .+|.+++... .++.. .+.+|+.+|.+||+ .||+||||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEE
Confidence 2 3599999997 6898887542 23433 35689999999999 99999999999999999889999
Q ss_pred ccccccccc
Q 004174 566 SDFGLAKWA 574 (770)
Q Consensus 566 ~DFGla~~~ 574 (770)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988653
|
|
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.6e-13 Score=128.88 Aligned_cols=129 Identities=19% Similarity=0.192 Sum_probs=107.5
Q ss_pred EEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCccchhhhHHHHHHHHHHHhHhhhcCCcEEEEEE
Q 004174 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKIC 97 (770)
Q Consensus 18 ~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~~~v~ 97 (770)
+|+|+||+++.+..||+||...+-..+..|+++||..+...... .......+...+.+..+..++...+++++..+.
T Consensus 1 ~ILv~vd~s~~~~~~l~~a~~la~~~~~~v~ll~v~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~ 77 (132)
T cd01988 1 RILVPVANPNTARDLLELAAALARAQNGEIIPLNVIEVPNHSSP---SQLEVNVQRARKLLRQAERIAASLGVPVHTIIR 77 (132)
T ss_pred CEEEecCCchhHHHHHHHHHHHhhcCCCeEEEEEEEecCCCCCc---chhHHHHHHHHHHHHHHHHHhhhcCCceEEEEE
Confidence 59999999999999999999999888999999999975432111 111122334457888888888888999998888
Q ss_pred ECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEe
Q 004174 98 RGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (770)
Q Consensus 98 ~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~ 153 (770)
.++++.+.|++.++.+++|+||||++++ .+.++| |++.+++++++ |||++|+
T Consensus 78 ~~~~~~~~I~~~a~~~~~dlIV~G~~~~~~~~~~~lG--s~~~~v~~~~~--~pvlvv~ 132 (132)
T cd01988 78 IDHDIASGILRTAKERQADLIIMGWHGSTSLRDRLFG--GVIDQVLESAP--CDVAVVK 132 (132)
T ss_pred ecCCHHHHHHHHHHhcCCCEEEEecCCCCCccceecC--chHHHHHhcCC--CCEEEeC
Confidence 8889999999999999999999999998 356778 99999999998 9999985
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.8e-15 Score=174.16 Aligned_cols=203 Identities=27% Similarity=0.342 Sum_probs=163.8
Q ss_pred CcccceeecccCceEEEEEEeCC--CCEEEEEEeCCC---hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEE
Q 004174 423 NFLAENLIGKGGSSQVYKGCLPD--GKELAVKILKPS---EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~~--g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~LV~ 496 (770)
.|.+.+.||+|.|+.|-...... ...+|+|.+... ....+....|..+-..+. |+|++.+++.....+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 34556679999999998776533 344566665433 344455566888877777 999999999999999999999
Q ss_pred eecCCCChhhhh-ccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCceEEecccCCCeeeCCCC-ceEEcccccccc
Q 004174 497 DFLSRGSLEENL-HGNKKDPAAFGWSERYKVAMGVAEALEYLH-SGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKW 573 (770)
Q Consensus 497 E~~~ggsL~~~l-~~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~IiHrDLKp~NILL~~~~-~vkL~DFGla~~ 573 (770)
+|..|+++.+.+ +... ...+....-.++.|+..+|.|+| . .++.||||||+|.+++..+ .++++|||+|..
T Consensus 101 ~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred CcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988 4322 13455566778999999999999 6 8899999999999999999 999999999988
Q ss_pred ccC-CCCCceeccccc-ccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCc
Q 004174 574 AST-SSSHITCTDVAG-TFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (770)
Q Consensus 574 ~~~-~~~~~~~~~~~G-T~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 631 (770)
+.. ..........+| ++.|.|||..... ......|+||.|+++.-+++|..|+.....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 877 444455555788 9999999999874 556789999999999999999999876544
|
|
| >PRK09982 universal stress protein UspD; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.9e-13 Score=131.29 Aligned_cols=129 Identities=15% Similarity=0.093 Sum_probs=92.3
Q ss_pred cEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCC-Cccc----hhhhHHHHHHHHHHHhHhhhcCCc
Q 004174 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDG-KSSL----LSLVKAFDSVLAVYEGFCNLKQVD 91 (770)
Q Consensus 17 r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~-~~~~----~~~~~~~~~~l~~~~~~C~~k~V~ 91 (770)
++|+|+||+|+.|..||+||+..+-..|..|++|||.++........ .... ....+..+..+..+...+. ...
T Consensus 4 k~ILvavD~S~~s~~al~~A~~lA~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~--~~~ 81 (142)
T PRK09982 4 KHIGVAISGNEEDALLVNKALELARHNDAHLTLIHIDDGLSELYPGIYFPATEDILQLLKNKSDNKLYKLTKNIQ--WPK 81 (142)
T ss_pred eEEEEEecCCcchHHHHHHHHHHHHHhCCeEEEEEEccCcchhchhhhccchHHHHHHHHHHHHHHHHHHHHhcC--CCc
Confidence 68999999999999999999999989999999999986542211110 0000 1111112233443333221 345
Q ss_pred EEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC--cccccCCCchHHHHhccCCCCcEEEEEeC
Q 004174 92 LKLKICRGTSIRKILVREAQSYSATKFIVGTAKN--HHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (770)
Q Consensus 92 ~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~--~r~~~~~~sVs~yc~~~ap~~C~V~vV~~ 154 (770)
++..+.. |++++.|+++|+..+||++|||+|+. .|.+ +|+.++++|++ |||++|+-
T Consensus 82 ~~~~v~~-G~p~~~I~~~A~~~~aDLIVmG~~~~~~~~~~----~va~~V~~~s~--~pVLvv~~ 139 (142)
T PRK09982 82 TKLRIER-GEMPETLLEIMQKEQCDLLVCGHHHSFINRLM----PAYRGMINKMS--ADLLIVPF 139 (142)
T ss_pred ceEEEEe-cCHHHHHHHHHHHcCCCEEEEeCChhHHHHHH----HHHHHHHhcCC--CCEEEecC
Confidence 6667777 89999999999999999999998732 2222 49999999998 99999974
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=4.1e-13 Score=152.25 Aligned_cols=141 Identities=21% Similarity=0.283 Sum_probs=99.6
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChh-H------------------------------H----------HHHH
Q 004174 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-V------------------------------I----------KEFV 465 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~-~------------------------------~----------~~~~ 465 (770)
.+.||.|++|.||+|.+.+|+.||||+.++.-. . . -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 468999999999999999999999999976410 0 0 0234
Q ss_pred HHHHHHHhcC-----CCceeEEeeEEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHH-HHHHHHc
Q 004174 466 LEIEIITTLH-----HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE-ALEYLHS 539 (770)
Q Consensus 466 ~Ei~iL~~l~-----HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~-aL~yLH~ 539 (770)
+|...+.+++ ++++.-..-+....+..+|||||++|++|.+....... .+ .+..++..++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHh
Confidence 4555455442 33332222222223457999999999999987653211 12 23456666665 4678888
Q ss_pred CCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 540 ~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
.|++|+|+||.||+++.++.++|+|||++..+..
T Consensus 276 ---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 ---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8999999999999999999999999999876543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=99.45 E-value=7.8e-13 Score=126.43 Aligned_cols=135 Identities=12% Similarity=0.115 Sum_probs=97.8
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCccchhhhHHH-HHHHHHHHhHhhhcCCcEEE
Q 004174 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF-DSVLAVYEGFCNLKQVDLKL 94 (770)
Q Consensus 16 ~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~C~~k~V~~~~ 94 (770)
-++|+|++|.|..+..||++|+..+.+.|..|+++||.++................+.. .+....++.++...++..+.
T Consensus 3 ~~~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 82 (142)
T PRK10116 3 YSNILVAVAVTPESQQLLAKAVSIARPVNGKISLITLASDPEMYNQFAAPMLEDLRSVMQEETQSFLDKLIQDADYPIEK 82 (142)
T ss_pred CceEEEEccCCcchHHHHHHHHHHHHHhCCEEEEEEEccCcccchhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCCCeEE
Confidence 37899999999999999999999988889999999998554221111110000111111 12333455556666776665
Q ss_pred EEEECCChhHHHHHHHHhcCCcEEEEccCCCcc-cccCCCchHHHHhccCCCCcEEEEEeC
Q 004174 95 KICRGTSIRKILVREAQSYSATKFIVGTAKNHH-TIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (770)
Q Consensus 95 ~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~~r-~~~~~~sVs~yc~~~ap~~C~V~vV~~ 154 (770)
.+++.|++.+.|+++|++.++|++|||++++.. ...+ ||+.+++++++ |||++|+-
T Consensus 83 ~~~~~G~~~~~I~~~a~~~~~DLiV~g~~~~~~~~~~~--s~a~~v~~~~~--~pVLvv~~ 139 (142)
T PRK10116 83 TFIAYGELSEHILEVCRKHHFDLVICGNHNHSFFSRAS--CSAKRVIASSE--VDVLLVPL 139 (142)
T ss_pred EEEecCCHHHHHHHHHHHhCCCEEEEcCCcchHHHHHH--HHHHHHHhcCC--CCEEEEeC
Confidence 566679999999999999999999999999721 1123 79999999998 99999973
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.8e-13 Score=153.85 Aligned_cols=143 Identities=19% Similarity=0.242 Sum_probs=91.6
Q ss_pred CcccceeecccCceEEEEEEeCC-CCEEEEEEeCCCh-----------------------------------hHHHH---
Q 004174 423 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSE-----------------------------------DVIKE--- 463 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~~-g~~vAVK~l~~~~-----------------------------------~~~~~--- 463 (770)
.|.. +.||.|++|.||+|.+++ |+.||||++++.- +..+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3555 789999999999999877 9999999998641 01112
Q ss_pred ---HHHHHHHHHhcC----CCceeEEeeEEee-cCceEEEEeecCCCChhhh--hccCCCCCCCCCHHHHHHHHHHHHHH
Q 004174 464 ---FVLEIEIITTLH----HKNIISLLGFCFE-DNNLLLVYDFLSRGSLEEN--LHGNKKDPAAFGWSERYKVAMGVAEA 533 (770)
Q Consensus 464 ---~~~Ei~iL~~l~----HpnIv~l~~~~~~-~~~~~LV~E~~~ggsL~~~--l~~~~~~~~~l~~~~~~~i~~qia~a 533 (770)
|.+|...+.+++ +.+.+.+-.++.+ ....+|||||++|+.|.+. +...+.....+....+..++.|+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 223333333332 3333332222221 3456899999999999874 32222111122222222333333
Q ss_pred HHHHHcCCCCceEEecccCCCeeeCCCC----ceEEccccccccccC
Q 004174 534 LEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDFGLAKWAST 576 (770)
Q Consensus 534 L~yLH~~~~~~IiHrDLKp~NILL~~~~----~vkL~DFGla~~~~~ 576 (770)
+. .|++|+|+||.||+++.++ .++++|||++..++.
T Consensus 277 ----f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ----FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33 7899999999999999888 899999999987754
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.2e-11 Score=133.61 Aligned_cols=136 Identities=10% Similarity=0.084 Sum_probs=104.2
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCC--CCccc----hhhhHHHHHHHHHHHhHhhhcC
Q 004174 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRD--GKSSL----LSLVKAFDSVLAVYEGFCNLKQ 89 (770)
Q Consensus 16 ~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~--~~~~~----~~~~~~~~~~l~~~~~~C~~k~ 89 (770)
-++|+|++|+|+.+..||+||+.-+...+..|++|||.++....... ..... ....+...+.++.+...+...+
T Consensus 3 ~~~ILv~~D~s~~~~~al~~a~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 82 (305)
T PRK11175 3 YQNILVVIDPNQDDQPALRRAVYLAQRNGGKITAFLPIYDFSYEMTTLLSPDEREAMRQGVISQRTAWIREQAKPYLDAG 82 (305)
T ss_pred cceEEEEcCCCccccHHHHHHHHHHHhcCCCEEEEEeccCchhhhhcccchhHHHHHHHHHHHHHHHHHHHHHHHHhhcC
Confidence 35799999999999999999999888889999999997543211100 00000 0011122244555555566678
Q ss_pred CcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004174 90 VDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (770)
Q Consensus 90 V~~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~~g 155 (770)
++++..+.++|++.++|+++|+..++|+||||+++. .+.++| |++..+++++| |||++|+.+
T Consensus 83 ~~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~~~~~~~~~g--s~~~~l~~~~~--~pvlvv~~~ 147 (305)
T PRK11175 83 IPIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQHDKLESVIFT--PTDWHLLRKCP--CPVLMVKDQ 147 (305)
T ss_pred CceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCCcHHHhhccC--hhHHHHHhcCC--CCEEEeccc
Confidence 999998888799999999999999999999999987 566778 99999999998 999999864
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=6e-12 Score=123.46 Aligned_cols=131 Identities=21% Similarity=0.193 Sum_probs=97.5
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCcee-EEeeEEeecCceEEEEeecCCCChh
Q 004174 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDFLSRGSLE 505 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~~~~~~~~~~~LV~E~~~ggsL~ 505 (770)
.+.|+.|.++.||++.. .+..|++|+..........+..|+.++..+.+.+++ +++.+. ....++||||++|.++.
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 35789999999999887 477899999876543334567899999998765554 444433 23458999999998876
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 506 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 506 ~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
..- . ....++.+++++|..||... ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 530 0 11235678999999999832 22369999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.3e-11 Score=110.67 Aligned_cols=127 Identities=17% Similarity=0.238 Sum_probs=102.6
Q ss_pred EEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCccchhhhHHHHHHHHHHHhHhhhcCCcEEEEEE
Q 004174 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKIC 97 (770)
Q Consensus 18 ~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~~~v~ 97 (770)
+|+|++|.++.+..+|+||++.+-..+..|.+|||.++...... ...........+.+..+...|...++.+...+.
T Consensus 1 ~ilv~i~~~~~~~~~l~~a~~~a~~~~~~i~~l~v~~~~~~~~~---~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 77 (130)
T cd00293 1 RILVAVDGSEESERALRWAARLARRLGAELVLLHVVDPPPSSAA---ELAELLEEEARALLEALREALAEAGVKVETVVL 77 (130)
T ss_pred CEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCCCCcch---hHHHHHHHHHHHHHHHHHHHHhcCCCceEEEEe
Confidence 48999999999999999999999999999999999865432111 111112334457778888888888999998888
Q ss_pred ECCChhHHHHHHHHhcCCcEEEEccCCCc---ccccCCCchHHHHhccCCCCcEEEEE
Q 004174 98 RGTSIRKILVREAQSYSATKFIVGTAKNH---HTIRSTTSLAKYCAKKLSKDCSVLAV 152 (770)
Q Consensus 98 ~~~d~~~~L~~~a~~~~a~~LVlG~~~~~---r~~~~~~sVs~yc~~~ap~~C~V~vV 152 (770)
. +++.++|+++++..++++||||++++. +.+.| +++++++++++ |||++|
T Consensus 78 ~-~~~~~~i~~~~~~~~~dlvvig~~~~~~~~~~~~~--~~~~~ll~~~~--~pvliv 130 (130)
T cd00293 78 E-GDPAEAILEAAEELGADLIVMGSRGRSGLRRLLLG--SVAERVLRHAP--CPVLVV 130 (130)
T ss_pred c-CCCHHHHHHHHHHcCCCEEEEcCCCCCccceeeec--cHHHHHHhCCC--CCEEeC
Confidence 7 667999999999999999999999872 34566 99999999987 999975
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.7e-12 Score=131.80 Aligned_cols=204 Identities=21% Similarity=0.302 Sum_probs=140.7
Q ss_pred HHHHhcCCCceeEEeeEEeec-----CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 004174 469 EIITTLHHKNIISLLGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543 (770)
Q Consensus 469 ~iL~~l~HpnIv~l~~~~~~~-----~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~ 543 (770)
+-|-++-|.|||++..|+.+. ....++.|||..|+|..+|++.+.....+......+|+.||+.||.|||++. .
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 345667799999999987553 3578999999999999999987766667778888899999999999999955 8
Q ss_pred ceEEecccCCCeeeCCCCceEEccccccccccCCCCC-ce--ecccccccCCCCceeeccCCCCCcceEeechHHHHHHH
Q 004174 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH-IT--CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 620 (770)
Q Consensus 544 ~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~-~~--~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLl 620 (770)
+|+|+.+.-.-|++..++-+||.----. ........ .. ...-.+-++|.|||+=.....+..+|||+||...+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 9999999999999999988887521110 00000000 00 00123678999999887778888999999999999998
Q ss_pred hCCCCCC-CCCccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 621 TGRKPIS-NDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 621 tG~~Pf~-~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
-|..--. .......+..+. +....+...+.. + .+..|++-.|..||+|..++.+
T Consensus 277 ilEiq~tnseS~~~~ee~ia---------~~i~~len~lqr----~-------~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIA---------NVIIGLENGLQR----G-------SITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceeehhhhhh---------hheeeccCcccc----C-------cCcccccCCCCCCcchhhhhcC
Confidence 8765322 111111111110 011111111111 1 1236999999999999988764
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.23 E-value=7.3e-11 Score=127.65 Aligned_cols=136 Identities=15% Similarity=0.130 Sum_probs=97.0
Q ss_pred CCcEEEEEEcCCcch-------HHHHHHHHhhccCC-CCEEEEEEeecCCCcccCC--CCccchhhhHH-HHHHHHHHHh
Q 004174 15 AGRTVVVGVKLDTHS-------RELLTWALVKVAQP-GDTVIALHVLANNAIVDRD--GKSSLLSLVKA-FDSVLAVYEG 83 (770)
Q Consensus 15 ~~r~I~VaVd~s~~S-------~~AL~WAl~~~~~~-gd~vvlvHV~~~~~~~~~~--~~~~~~~~~~~-~~~~l~~~~~ 83 (770)
..++|+||+|+++++ ..||++|+.-+..- +..|++|||.......... .........+. .......++.
T Consensus 151 ~~~~Ilva~D~s~~~~~~~~~~~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (305)
T PRK11175 151 EGGKILVAVNVASEEPYHDALNEKLVEEAIDLAEQLNHAEVHLVNAYPVTPINIAIELPEFDPSVYNDAIRGQHLLAMKA 230 (305)
T ss_pred CCCeEEEEeCCCCCccchhHHHHHHHHHHHHHHhhCcCCceEEEEEecCcchhccccccccchhhHHHHHHHHHHHHHHH
Confidence 357999999998763 67999999887765 8899999998644221100 00000011111 1123334555
Q ss_pred HhhhcCCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeC
Q 004174 84 FCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (770)
Q Consensus 84 ~C~~k~V~~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~~ 154 (770)
+.+..++..+...+..|++.+.|+++|+..++|+||||++++ .+.|+| |++++++++++ |||++|+.
T Consensus 231 ~~~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~~~~~~~~~llG--S~a~~v~~~~~--~pVLvv~~ 300 (305)
T PRK11175 231 LRQKFGIDEEQTHVEEGLPEEVIPDLAEHLDAELVILGTVGRTGLSAAFLG--NTAEHVIDHLN--CDLLAIKP 300 (305)
T ss_pred HHHHhCCChhheeeccCCHHHHHHHHHHHhCCCEEEECCCccCCCcceeec--chHHHHHhcCC--CCEEEEcC
Confidence 555556665434445589999999999999999999999988 667788 99999999998 99999964
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.9e-10 Score=114.87 Aligned_cols=136 Identities=18% Similarity=0.206 Sum_probs=98.9
Q ss_pred ceeecccCceEEEEEEeCC-------CCEEEEEEeCCC-------------h----------hHHHHHH----HHHHHHH
Q 004174 427 ENLIGKGGSSQVYKGCLPD-------GKELAVKILKPS-------------E----------DVIKEFV----LEIEIIT 472 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~-------g~~vAVK~l~~~-------------~----------~~~~~~~----~Ei~iL~ 472 (770)
...||.|--+.||.|...+ +..+|||+.+.+ + ...+.+. +|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998643 479999998631 0 0122233 7999999
Q ss_pred hcCC--CceeEEeeEEeecCceEEEEeecCCCChhh-hhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCceEEe
Q 004174 473 TLHH--KNIISLLGFCFEDNNLLLVYDFLSRGSLEE-NLHGNKKDPAAFGWSERYKVAMGVAEALEYL-HSGSAQRVIHR 548 (770)
Q Consensus 473 ~l~H--pnIv~l~~~~~~~~~~~LV~E~~~ggsL~~-~l~~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~IiHr 548 (770)
++.. -++..++++ ..-+|||||+.++.+.. .+.. ..++......+..+++.+|.+| |+ .+|||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 9863 456666654 35599999997754432 2221 1244455677889999999999 77 789999
Q ss_pred cccCCCeeeCCCCceEEcccccccccc
Q 004174 549 DVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 549 DLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
||++.|||++ ++.++|+|||.+....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 9999999997 4689999999886544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.6e-11 Score=136.77 Aligned_cols=247 Identities=22% Similarity=0.243 Sum_probs=173.8
Q ss_pred Ccccceeecc--cCceEEEEEEe---CCCCEEEEEEeCC--C-hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceE
Q 004174 423 NFLAENLIGK--GGSSQVYKGCL---PDGKELAVKILKP--S-EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 423 ~f~~~~~LG~--G~fG~Vy~a~~---~~g~~vAVK~l~~--~-~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~ 493 (770)
.|-+...+|. |.+|.||.+.. .++..+|+|.-+. . ....+.-.+|+....+++ |+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3556678899 99999999865 4678899987442 1 223344456776666664 999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCceEEecccCCCeeeCCC-CceEEccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE----ALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDF 568 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~----aL~yLH~~~~~~IiHrDLKp~NILL~~~-~~vkL~DF 568 (770)
+-.|++ +.+|..+.+.... .++....+.++..... ||.++|. .+++|-|+||.||++..+ ...+++||
T Consensus 195 iqtE~~-~~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeccc-cchhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCc
Confidence 999988 4688888876543 2444555556666666 9999999 889999999999999999 88999999
Q ss_pred cccccccCCCCCcee---cccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccc
Q 004174 569 GLAKWASTSSSHITC---TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 645 (770)
Q Consensus 569 Gla~~~~~~~~~~~~---~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~ 645 (770)
|+...+....-.... ....|..-|++||... +-++...|||+||.++++..+|..+...... ..|.. +
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~~--~ 338 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWSQ--L 338 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC------CCccc--c
Confidence 999877665422111 1225777899999877 6788999999999999999998776543311 01211 1
Q ss_pred cCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 646 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 646 ~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
+.+. +..++...-...+-....++++.+|..|++.+.++.
T Consensus 339 r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 RQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1111 111111111111222456789999999999887764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.1e-10 Score=115.84 Aligned_cols=141 Identities=20% Similarity=0.277 Sum_probs=111.1
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCChh--HHHHHHHHHHHHHhcCC--CceeEEeeEEeec---CceEEEEeecC
Q 004174 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHH--KNIISLLGFCFED---NNLLLVYDFLS 500 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~---~~~~LV~E~~~ 500 (770)
+.|+.|.++.||++...+|+.+++|+...... ....+..|++++..+++ .++.+++.++... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887778999999875433 45678899999999976 3456777776653 26689999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--------------------------------------- 541 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--------------------------------------- 541 (770)
|.+|.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9988876532 13667777788888888888888521
Q ss_pred --------------CCceEEecccCCCeeeCC--CCceEEcccccccc
Q 004174 542 --------------AQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKW 573 (770)
Q Consensus 542 --------------~~~IiHrDLKp~NILL~~--~~~vkL~DFGla~~ 573 (770)
...++|+|+++.|||++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0589 UspA Universal stress protein UspA and related nucleotide-binding proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.3e-09 Score=104.42 Aligned_cols=135 Identities=17% Similarity=0.188 Sum_probs=104.0
Q ss_pred CCcEEEEEEc-CCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCc-cc-------hhhhHHHHHHHHHHHhHh
Q 004174 15 AGRTVVVGVK-LDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKS-SL-------LSLVKAFDSVLAVYEGFC 85 (770)
Q Consensus 15 ~~r~I~VaVd-~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~-~~-------~~~~~~~~~~l~~~~~~C 85 (770)
..++|++++| .++.+..|+.+|+......+..+.++||............. .. ........+.+..++..-
T Consensus 4 ~~~~il~~~d~~s~~~~~a~~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (154)
T COG0589 4 MYKKILVAVDVGSEAAEKALEEAVALAKRLGAPLILLVVIDPLEPTALVSVALADAPIPLSEEELEEEAEELLAEAKALA 83 (154)
T ss_pred ccceEEEEeCCCCHHHHHHHHHHHHHHHhcCCeEEEEEEecccccccccccccccchhhhhHHHHHHHHHHHHHHHHHHH
Confidence 3578999999 99999999999999999999999999998554321111100 00 111223346666777777
Q ss_pred hhcCCcE-EEEEEECCCh-hHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeC
Q 004174 86 NLKQVDL-KLKICRGTSI-RKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (770)
Q Consensus 86 ~~k~V~~-~~~v~~~~d~-~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~~ 154 (770)
...++.. +..+.. |++ ...|++.+...++|++|||++|+ .+.++| ||+.+++++++ |||++|+-
T Consensus 84 ~~~~~~~~~~~~~~-g~~~~~~i~~~a~~~~adliV~G~~g~~~l~~~llG--svs~~v~~~~~--~pVlvv~~ 152 (154)
T COG0589 84 EAAGVPVVETEVVE-GSPSAEEILELAEEEDADLIVVGSRGRSGLSRLLLG--SVAEKVLRHAP--CPVLVVRS 152 (154)
T ss_pred HHcCCCeeEEEEec-CCCcHHHHHHHHHHhCCCEEEECCCCCccccceeee--hhHHHHHhcCC--CCEEEEcc
Confidence 7777884 777777 666 79999999999999999999987 455778 99999999998 99999974
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.2e-09 Score=107.42 Aligned_cols=130 Identities=24% Similarity=0.337 Sum_probs=99.8
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCC-----h----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPS-----E----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~-----~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
.++++|+-+.+|.+.+ -|.++++|.-.+. . -....-.+|..+|.+++--.|.-.+-++.+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3578999999999876 3445777754321 1 1234567899999999765655555566677788999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
++|..|.+.+... ...++..+-.-+.-||. .+|||+||.++||++..+. +.++||||+.+
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888643 13466677777788999 8999999999999998764 99999999863
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.7e-09 Score=104.44 Aligned_cols=141 Identities=22% Similarity=0.292 Sum_probs=105.1
Q ss_pred cceeecccCceEEEEEEeCCCCEEEEEEeCCC---------hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS---------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 426 ~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~---------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
...+|-+|+-+.|+++.. .|+.++||.-... .-..++..+|+++|.+++--.|.-..-+|.+.+.-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999987 7788888754321 123457788999999987655555555666777779999
Q ss_pred eecCC-CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC---ceEEccccccc
Q 004174 497 DFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLSDFGLAK 572 (770)
Q Consensus 497 E~~~g-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~---~vkL~DFGla~ 572 (770)
||++| .++.+++...... . ........++..|-+.+.-||. ..|||+||.++||+|..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~-~-~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED-E-SEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccC-c-ccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchh
Confidence 99977 4777777654322 1 1222226778888889999999 8899999999999996554 35899999984
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.2e-10 Score=127.96 Aligned_cols=196 Identities=22% Similarity=0.185 Sum_probs=146.9
Q ss_pred HHHhhcCcccceeecccCceEEEEEEe--CCCCEEEEEEeCCCh-hHHH--HHHHHHHHHHhc-CCCceeEEeeEEeecC
Q 004174 417 LLSATSNFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSE-DVIK--EFVLEIEIITTL-HHKNIISLLGFCFEDN 490 (770)
Q Consensus 417 l~~~t~~f~~~~~LG~G~fG~Vy~a~~--~~g~~vAVK~l~~~~-~~~~--~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 490 (770)
....+.+|.....||.|.|+.|+.... .++..|++|.+.+.- .... .-..|+-+...+ .|.+++.+...+....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 334456788899999999999998764 367889999876532 1111 123455555555 4888888888887778
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC-CceEEcccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFG 569 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~-~~vkL~DFG 569 (770)
..|+--||+.++++...+.. ...+....++.+..|++.++.++|+ ..++|+|+||+||++..+ +..++.|||
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred cccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccc
Confidence 88899999999998877622 2356778889999999999999998 889999999999999886 788999999
Q ss_pred ccccccCCCCCceecccccccCCC--CceeeccCCCCCcceEeechHHHHHHHhCCC
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYL--APEYFMYGKVNDKIDVYAFGVVLLELLTGRK 624 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~Yl--APE~~~~~~~s~ksDVwSlGvvL~eLltG~~ 624 (770)
+...+.-.. .....+-++. +|+......+..+.|+||||.-+.+.++|..
T Consensus 413 ~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 413 CWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred cccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 886422111 1122333444 5555556678889999999999999999865
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.4e-10 Score=134.88 Aligned_cols=206 Identities=23% Similarity=0.306 Sum_probs=147.7
Q ss_pred hhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChh----HHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED----VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~----~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
..+.|.+.+-+-+|.|+.++.+.-. .|...++|+...... ..+....+-.++-..++|.++...--+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3445666777888889988876532 344445555443221 12223333334444456777766555555678899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
+++|+.+++|...|+... ..+.+-.+..+..+..+++|||. ..++|||++|.|+|+..+++.+++|||.....
T Consensus 882 ~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccc
Confidence 999999999999998665 34444556677778999999998 66999999999999999999999999843321
Q ss_pred cCC---CCC--------------------------ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCC
Q 004174 575 STS---SSH--------------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625 (770)
Q Consensus 575 ~~~---~~~--------------------------~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~P 625 (770)
... ... .......||+.|++||...+......+|+|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 110 000 001225689999999999999999999999999999999999999
Q ss_pred CCCCCcc
Q 004174 626 ISNDHPK 632 (770)
Q Consensus 626 f~~~~~~ 632 (770)
|....+.
T Consensus 1035 ~na~tpq 1041 (1205)
T KOG0606|consen 1035 FNAETPQ 1041 (1205)
T ss_pred CCCcchh
Confidence 9876553
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=4.4e-09 Score=119.99 Aligned_cols=165 Identities=24% Similarity=0.295 Sum_probs=125.6
Q ss_pred eCCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHH
Q 004174 443 LPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWS 521 (770)
Q Consensus 443 ~~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~ 521 (770)
..++.+|.|..++.+. .......+-+.-|+.++||||++++..+...+.+|||.|-+. .|..++.+. +..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHH
Confidence 3478888888887544 344556778899999999999999999999999999999884 566666543 245
Q ss_pred HHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceecccccccCCCCceeeccC
Q 004174 522 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601 (770)
Q Consensus 522 ~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~ 601 (770)
.....+.||+.||.|||+. .+++|++|.-..|+++..|+.||++|-++......... .....---.|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCcc
Confidence 5666789999999999963 57999999999999999999999999887544332210 0011122346777765533
Q ss_pred CCCCcceEeechHHHHHHHhC
Q 004174 602 KVNDKIDVYAFGVVLLELLTG 622 (770)
Q Consensus 602 ~~s~ksDVwSlGvvL~eLltG 622 (770)
. -..|.|-|||+++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 346999999999999999
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.9e-08 Score=99.84 Aligned_cols=125 Identities=23% Similarity=0.306 Sum_probs=83.9
Q ss_pred EEEEEEeCCCCEEEEEEeCCC---------------h------------hHHHHHHHHHHHHHhcCCC--ceeEEeeEEe
Q 004174 437 QVYKGCLPDGKELAVKILKPS---------------E------------DVIKEFVLEIEIITTLHHK--NIISLLGFCF 487 (770)
Q Consensus 437 ~Vy~a~~~~g~~vAVK~l~~~---------------~------------~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~~~ 487 (770)
.||.|...+|..+|||+.+.. . .......+|.+.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999989999999998631 0 1123566799999999865 456666442
Q ss_pred ecCceEEEEeecC--CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHH-HHcCCCCceEEecccCCCeeeCCCCceE
Q 004174 488 EDNNLLLVYDFLS--RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY-LHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (770)
Q Consensus 488 ~~~~~~LV~E~~~--ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~y-LH~~~~~~IiHrDLKp~NILL~~~~~vk 564 (770)
.-+|||||++ |..+..+.... ++......++.+++..+.. +|. .||+|+||.+.|||++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEE
Confidence 3389999998 65555443221 1234456677788875555 567 899999999999999887 999
Q ss_pred Ecccccccccc
Q 004174 565 LSDFGLAKWAS 575 (770)
Q Consensus 565 L~DFGla~~~~ 575 (770)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=7.1e-08 Score=102.54 Aligned_cols=140 Identities=18% Similarity=0.167 Sum_probs=100.9
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCCh--hHHH----------HHHHHHHHHHhcCCC--ceeEEeeEEee-----
Q 004174 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIK----------EFVLEIEIITTLHHK--NIISLLGFCFE----- 488 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~--~~~~----------~~~~Ei~iL~~l~Hp--nIv~l~~~~~~----- 488 (770)
+.+-.-....|++... +|+.|.||...... ...+ .+.+|...+..|..- .+..+++++..
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444445677665 77889999875432 1122 377899999888533 33444555543
Q ss_pred cCceEEEEeecCCC-ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC-------C
Q 004174 489 DNNLLLVYDFLSRG-SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-------D 560 (770)
Q Consensus 489 ~~~~~LV~E~~~gg-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-------~ 560 (770)
....+||+|++++. +|.+++..... ...+...+..++.+++..+.-||. .||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCC
Confidence 23468999999986 89888753221 234566778899999999999999 99999999999999975 4
Q ss_pred CceEEcccccccc
Q 004174 561 FEPQLSDFGLAKW 573 (770)
Q Consensus 561 ~~vkL~DFGla~~ 573 (770)
+.+.|+||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6799999998753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.69 E-value=8.8e-08 Score=106.40 Aligned_cols=169 Identities=20% Similarity=0.279 Sum_probs=128.1
Q ss_pred ceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEee----cCceEEEEeecCC-CChhhh
Q 004174 435 SSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLLVYDFLSR-GSLEEN 507 (770)
Q Consensus 435 fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~LV~E~~~g-gsL~~~ 507 (770)
-.+.|++.. -||..|++|++.... ........-++.++++.|+|||++.++|.. +..++|||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356799875 489999999995432 222344556789999999999999998863 4568999999986 477776
Q ss_pred hccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 508 LHGNKK-----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 508 l~~~~~-----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
...... .+...++..+|.++.|+..||.++|+ .|+.-+-|.+.+||++.+-.++|+..|+......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 543221 22456788999999999999999999 8899999999999999998999998888766654
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCC
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~P 625 (770)
+... -+.. -.+-|.=-||.+++.|.||..-
T Consensus 446 d~~~----------------~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPTE----------------PLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCc----------------chhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 4311 1111 1246777899999999999543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.1e-07 Score=109.28 Aligned_cols=140 Identities=21% Similarity=0.272 Sum_probs=91.2
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCCh-------------------------------hHH----HH------HHH
Q 004174 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE-------------------------------DVI----KE------FVL 466 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~-------------------------------~~~----~~------~~~ 466 (770)
..|+.++-|.||+|.+++|+.||||+.++.- ... +. +.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6899999999999999999999999998630 011 11 222
Q ss_pred HHHHHHhcC-----CCceeEEeeEEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHH-HHHHHcC
Q 004174 467 EIEIITTLH-----HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA-LEYLHSG 540 (770)
Q Consensus 467 Ei~iL~~l~-----HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~a-L~yLH~~ 540 (770)
|..-+.+++ .+++.-..=|....+...|+|||++|-.+.+...... ..++... |+..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~---ia~~~~~~f~~q~~~- 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKE---LAELLVRAFLRQLLR- 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHH---HHHHHHHHHHHHHHh-
Confidence 333333332 3443333333333466799999999999998843221 1233222 22222222 112222
Q ss_pred CCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 541 ~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
.|++|.|.+|.||+++.+|.+.+.|||+....+.
T Consensus 284 --dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 --DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 5799999999999999999999999999876654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.3e-06 Score=95.09 Aligned_cols=194 Identities=17% Similarity=0.222 Sum_probs=126.0
Q ss_pred cceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEeeE------EeecCc-eEEEEe
Q 004174 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGF------CFEDNN-LLLVYD 497 (770)
Q Consensus 426 ~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~------~~~~~~-~~LV~E 497 (770)
..+.||+|+-+.+|-.- .-...+-|++.......+.- -+..|... .||-+-.=+.| .-.... .-++|.
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq--k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ--KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHH--HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 45789999999999632 22224558876543221111 11122222 34422211111 111222 567788
Q ss_pred ecCCCC-hhhhhc--cCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 498 FLSRGS-LEENLH--GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 498 ~~~ggs-L~~~l~--~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
.+++.. +..++. ..++.-..+.|...++++..++.+..-||. .|.+-+|+.++|+|+++++.+.|.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence 777642 222221 112233568999999999999999999999 88999999999999999999999985433333
Q ss_pred cCCCCCceecccccccCCCCceeec-----cCCCCCcceEeechHHHHHHHhC-CCCCCCC
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTG-RKPISND 629 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~-----~~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~ 629 (770)
.++.. ..-.+|...|++||.-. +..-+...|-|.|||++++||.| ++||.+-
T Consensus 168 ~ng~~---~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 168 ANGTL---HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred cCCce---EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 22222 12257999999999754 33567789999999999999995 9999864
|
|
| >PRK12652 putative monovalent cation/H+ antiporter subunit E; Reviewed | Back alignment and domain information |
|---|
Probab=98.58 E-value=4.7e-07 Score=99.52 Aligned_cols=104 Identities=13% Similarity=0.146 Sum_probs=81.2
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCC--CCEEEEEEeecCCCcccCCCCccchhhhHHHHHHHHHHHhHhhh------
Q 004174 16 GRTVVVGVKLDTHSRELLTWALVKVAQP--GDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNL------ 87 (770)
Q Consensus 16 ~r~I~VaVd~s~~S~~AL~WAl~~~~~~--gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~------ 87 (770)
-++|+|+||+|+.|..||..|++.+-.. +..|++|||.+....... ........+++++.++..+..
T Consensus 5 ykkILVavDGSe~S~~Al~~AielA~~~g~~AeL~lL~Vv~~~~~~~~-----~~~~~~~~eelle~~~~~~~~~l~~~~ 79 (357)
T PRK12652 5 ANRLLVPVADSVTVRQTVAYAVESAEEAAETPTVHLVAAASGRAVDPE-----GQDELAAAEELLERVEVWATEDLGDDA 79 (357)
T ss_pred cCeEEEEeCCCHHHHHHHHHHHHHHHhcCCCCEEEEEEEecCcccccc-----hhHHHHHHHHHHHHHHHHHHHhhhccc
Confidence 4789999999999999999999988774 589999999875432111 112223334566666666654
Q ss_pred cCCcEEEEEEEC-------CChhHHHHHHHHhcCCcEEEEccCC
Q 004174 88 KQVDLKLKICRG-------TSIRKILVREAQSYSATKFIVGTAK 124 (770)
Q Consensus 88 k~V~~~~~v~~~-------~d~~~~L~~~a~~~~a~~LVlG~~~ 124 (770)
.+|+++.+++.+ |+++++|+++|++.++|++|||-.-
T Consensus 80 ~gV~ve~~vv~~~~~~~~~G~pae~Iv~~Aee~~aDLIVm~~~~ 123 (357)
T PRK12652 80 SSVTIETALLGTDEYLFGPGDYAEVLIAYAEEHGIDRVVLDPEY 123 (357)
T ss_pred CCCceEEEEEeccccccCCCCHHHHHHHHHHHcCCCEEEECCCC
Confidence 489999999874 8999999999999999999999774
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.7e-07 Score=94.27 Aligned_cols=133 Identities=20% Similarity=0.214 Sum_probs=94.6
Q ss_pred cccceeecccCceEEEEEEeCCCCEEEEEEeCCC-----------------------hhHHHHHHHHHHHHHhcCCC--c
Q 004174 424 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS-----------------------EDVIKEFVLEIEIITTLHHK--N 478 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~-----------------------~~~~~~~~~Ei~iL~~l~Hp--n 478 (770)
..+...||-|--+.||.|..+.|.++|||.-+.. .-......+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4456889999999999999999999999976421 01133466799999999754 6
Q ss_pred eeEEeeEEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC
Q 004174 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (770)
Q Consensus 479 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 558 (770)
+.+.+++ +.-.+||||++|-.|...-- .-...-.|+..|++-+.-+-. .||||+|+.+-|||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEe
Confidence 6666665 45689999999976665421 111122233333333333334 7899999999999999
Q ss_pred CCCceEEccccccc
Q 004174 559 DDFEPQLSDFGLAK 572 (770)
Q Consensus 559 ~~~~vkL~DFGla~ 572 (770)
++|.+.++||--+.
T Consensus 237 ~dg~~~vIDwPQ~v 250 (304)
T COG0478 237 EDGDIVVIDWPQAV 250 (304)
T ss_pred cCCCEEEEeCcccc
Confidence 99999999996543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.6e-06 Score=99.52 Aligned_cols=174 Identities=21% Similarity=0.264 Sum_probs=108.4
Q ss_pred CCchhHHHHhhhccCcccccCHHHHHHhhcC---------cc--cceeecccCceEEEEEEeCCCCEEEEEEeCCC----
Q 004174 393 ELPKELEGLHEKYSATCRLFNYQDLLSATSN---------FL--AENLIGKGGSSQVYKGCLPDGKELAVKILKPS---- 457 (770)
Q Consensus 393 ~~~~~l~~~~~~~~~~~~~f~~~~l~~~t~~---------f~--~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~---- 457 (770)
-+|++.-.......+.+..|+++|+...-+. |. ..+.||.-..|.||+|.+++|+.||||+.++.
T Consensus 121 llP~Eyv~~L~~LqD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~ 200 (538)
T KOG1235|consen 121 LLPKEYVKTLSELQDQAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKL 200 (538)
T ss_pred cCcHHHHHHHHHHhccCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHH
Confidence 4555555445555666777777776554331 21 24689999999999999999999999998752
Q ss_pred ----------------------------hhHHHH------HHHHHH----HHHhcCCCc------eeEEeeEEeecCceE
Q 004174 458 ----------------------------EDVIKE------FVLEIE----IITTLHHKN------IISLLGFCFEDNNLL 493 (770)
Q Consensus 458 ----------------------------~~~~~~------~~~Ei~----iL~~l~Hpn------Iv~l~~~~~~~~~~~ 493 (770)
++..+. |.+|.+ +.+.+.|-+ |.+++-.+ .....
T Consensus 201 ~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RV 278 (538)
T KOG1235|consen 201 IMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRV 278 (538)
T ss_pred HHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceE
Confidence 111122 222332 222233444 33333222 34679
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC----CCceEEcccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD----DFEPQLSDFG 569 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~----~~~vkL~DFG 569 (770)
|+||||+|..+.+.-.-.. ..++-..+. ..+.++ |++.-...|++|.|-.|.||++.. ++.+.+-|||
T Consensus 279 LtME~~~G~~i~Dl~~i~~---~gi~~~~i~---~~l~~~--~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhG 350 (538)
T KOG1235|consen 279 LTMEYVDGIKINDLDAIDK---RGISPHDIL---NKLVEA--YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHG 350 (538)
T ss_pred EEEEecCCccCCCHHHHHH---cCCCHHHHH---HHHHHH--HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccc
Confidence 9999999998887643221 123333333 333322 222222267999999999999983 6789999999
Q ss_pred ccccccC
Q 004174 570 LAKWAST 576 (770)
Q Consensus 570 la~~~~~ 576 (770)
+......
T Consensus 351 l~~~is~ 357 (538)
T KOG1235|consen 351 LYAVISH 357 (538)
T ss_pred ccccccH
Confidence 9876654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.6e-07 Score=107.97 Aligned_cols=152 Identities=22% Similarity=0.360 Sum_probs=97.9
Q ss_pred HHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCcee-------cccccccCCCCceeec
Q 004174 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC-------TDVAGTFGYLAPEYFM 599 (770)
Q Consensus 527 ~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~-------~~~~GT~~YlAPE~~~ 599 (770)
+.+++.||.|+|.. .++||+.|.|++|.++.++..||+.|+++............ .-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34556999999983 67999999999999999999999999988654442111100 0013456799999999
Q ss_pred cCCCCCcceEeechHHHHHHHhCCCC-CCCCCccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhc
Q 004174 600 YGKVNDKIDVYAFGVVLLELLTGRKP-ISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCI 678 (770)
Q Consensus 600 ~~~~s~ksDVwSlGvvL~eLltG~~P-f~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl 678 (770)
....+.++|+|||||++|.+..|..+ |.............. ....+.. ....+.+.+..+. ..+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~---~~~~~~~------~~s~~~p~el~~~----l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN---LLNAGAF------GYSNNLPSELRES----LKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc---ccccccc------cccccCcHHHHHH----HHHHh
Confidence 98889999999999999999965554 433221111111100 0000000 0012233333333 33578
Q ss_pred ccCCCCCCCHHHHHH
Q 004174 679 RRDPRARPQMSLVLK 693 (770)
Q Consensus 679 ~~dP~~RPs~~eVL~ 693 (770)
..++.-||++.+++.
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 899999998877664
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.37 E-value=5e-06 Score=84.64 Aligned_cols=136 Identities=19% Similarity=0.140 Sum_probs=101.3
Q ss_pred ecccCceEEEEEEeCCCCEEEEEEeCCC-------hhHHHHHHHHHHHHHhcCC--CceeEEeeEEeec-----CceEEE
Q 004174 430 IGKGGSSQVYKGCLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTLHH--KNIISLLGFCFED-----NNLLLV 495 (770)
Q Consensus 430 LG~G~fG~Vy~a~~~~g~~vAVK~l~~~-------~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~-----~~~~LV 495 (770)
-|+||.+.|++-.. +|+.+-+|.-... .-....|.+|+..|..|.. -.+.++. ++... -..+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 47899999999766 5557889976521 1245689999999999863 2244444 33211 236899
Q ss_pred EeecCC-CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCc--eEEccccccc
Q 004174 496 YDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--PQLSDFGLAK 572 (770)
Q Consensus 496 ~E~~~g-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~--vkL~DFGla~ 572 (770)
+|-+.| -+|.+++..... ...+...+..++.+++.+|.-||+ .|+.|+|+.+.|||++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997764 488888755332 245667778999999999999999 99999999999999986666 9999997654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.9e-06 Score=88.17 Aligned_cols=123 Identities=19% Similarity=0.169 Sum_probs=90.7
Q ss_pred CCCEEEEEEeCCC--h------hHHHHHHHHHHHHHhcCC--CceeEEeeEEeecC----ceEEEEeecCCC-Chhhhhc
Q 004174 445 DGKELAVKILKPS--E------DVIKEFVLEIEIITTLHH--KNIISLLGFCFEDN----NLLLVYDFLSRG-SLEENLH 509 (770)
Q Consensus 445 ~g~~vAVK~l~~~--~------~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~----~~~LV~E~~~gg-sL~~~l~ 509 (770)
.++.+.+|.+... . -....+.+|...+..|.. -.+.+.+++..... ..+||+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 4566666654321 1 123467788888888753 33556666665532 358999999985 7999887
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC---ceEEccccccccc
Q 004174 510 GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLSDFGLAKWA 574 (770)
Q Consensus 510 ~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~---~vkL~DFGla~~~ 574 (770)
.... .+......++.+++..+.-||. .||+|+|+++.|||++.+. .+.++||+.++..
T Consensus 111 ~~~~----~~~~~~~~ll~~l~~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQ----LDPSQRRELLRALARLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcc----cchhhHHHHHHHHHHHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 5332 4456678899999999999999 9999999999999998887 8999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.1e-05 Score=82.61 Aligned_cols=136 Identities=15% Similarity=0.156 Sum_probs=90.5
Q ss_pred hhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHH----------HHHHHHHHHhcCC---CceeEEeeE-
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKE----------FVLEIEIITTLHH---KNIISLLGF- 485 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~----------~~~Ei~iL~~l~H---pnIv~l~~~- 485 (770)
..++|...+++-......|.+-.. +|+.+++|..+......++ ..+++..+..++. -.+..++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 356788888888888888887666 7788999988754321111 1223333333322 122222222
Q ss_pred ----EeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC
Q 004174 486 ----CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561 (770)
Q Consensus 486 ----~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~ 561 (770)
+......+|+|||++|..|.+... +.. .++..+..++.-||+ .|+.|+|+.|.|++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-
Confidence 222345679999999988876542 111 245667788999999 999999999999999865
Q ss_pred ceEEccccccc
Q 004174 562 EPQLSDFGLAK 572 (770)
Q Consensus 562 ~vkL~DFGla~ 572 (770)
.++++||+..+
T Consensus 172 ~i~iID~~~k~ 182 (229)
T PF06176_consen 172 GIRIIDTQGKR 182 (229)
T ss_pred cEEEEECcccc
Confidence 59999998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.4e-05 Score=83.00 Aligned_cols=138 Identities=17% Similarity=0.245 Sum_probs=85.9
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCc--eeEEeeEEeecCceEEEEeecCCCC-h
Q 004174 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN--IISLLGFCFEDNNLLLVYDFLSRGS-L 504 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~~~~~~LV~E~~~ggs-L 504 (770)
..||.|..+.||+. .|..+++|+..... ......+|.+++..+..-. +.+.++++...+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 57899999999984 35568889887533 2345688999999886433 4667777777777889999999963 1
Q ss_pred hhh---------------------hccCCCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHc-CCCCceEEecc
Q 004174 505 EEN---------------------LHGNKKDPAAFGWSERY-KVAM----------GVAE-ALEYLHS-GSAQRVIHRDV 550 (770)
Q Consensus 505 ~~~---------------------l~~~~~~~~~l~~~~~~-~i~~----------qia~-aL~yLH~-~~~~~IiHrDL 550 (770)
... ||..... ........ .+.. .+.. ...+|.. .....++|+|+
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~--~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCD--TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC--CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 111 1211000 11111100 0000 0111 1222221 12356799999
Q ss_pred cCCCeeeCCCCceEEccccccc
Q 004174 551 KSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 551 Kp~NILL~~~~~vkL~DFGla~ 572 (770)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.3e-05 Score=81.93 Aligned_cols=145 Identities=21% Similarity=0.293 Sum_probs=87.0
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCC--ceeEEeeEEee---cCceEEEEeecCC
Q 004174 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGFCFE---DNNLLLVYDFLSR 501 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~~~~---~~~~~LV~E~~~g 501 (770)
.+.|+.|..+.||+....+ ..+++|+.... .....+..|..++..+... .+.+++.++.. ....+++|++++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 3678999999999998866 68999998765 5667788899998888533 34566664432 2346899999999
Q ss_pred CChhh----------------hh---ccCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHc-
Q 004174 502 GSLEE----------------NL---HGNKKDPAAFGWSE---------RYKV------------AMGVAE-ALEYLHS- 539 (770)
Q Consensus 502 gsL~~----------------~l---~~~~~~~~~l~~~~---------~~~i------------~~qia~-aL~yLH~- 539 (770)
..+.. .+ +........+.+.. .... ...+.. .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88877 11 11110001111111 0000 111222 2333332
Q ss_pred ---CCCCceEEecccCCCeeeC-CCCceEEcccccccc
Q 004174 540 ---GSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKW 573 (770)
Q Consensus 540 ---~~~~~IiHrDLKp~NILL~-~~~~vkL~DFGla~~ 573 (770)
.....++|+|+.|.|||++ .++.+-|+||+.+.+
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2347799999999999999 566668999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK10490 sensor protein KdpD; Provisional | Back alignment and domain information |
|---|
Probab=98.18 E-value=2e-05 Score=97.61 Aligned_cols=128 Identities=16% Similarity=0.083 Sum_probs=100.1
Q ss_pred CCCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCccchhhhHHHHHHHHHHHhHhhhcCCcEE
Q 004174 14 GAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLK 93 (770)
Q Consensus 14 ~~~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~ 93 (770)
..+.+|+|+|+.++++..++++|.+-+.+-+..+++|||.++.... +.+.....+..+..+|++-+.+
T Consensus 248 ~~~eriLV~v~~~~~~~~lIr~~~rlA~~~~a~~~~l~V~~~~~~~----------~~~~~~~~l~~~~~lA~~lGa~-- 315 (895)
T PRK10490 248 HTRDAILLCIGHNTGSEKLVRTAARLAARLGSVWHAVYVETPRLHR----------LPEKKRRAILSALRLAQELGAE-- 315 (895)
T ss_pred CcCCeEEEEECCCcchHHHHHHHHHHHHhcCCCEEEEEEecCCcCc----------CCHHHHHHHHHHHHHHHHcCCE--
Confidence 3467899999999999999999999999999999999998653210 0111122233333577776666
Q ss_pred EEEEECCChhHHHHHHHHhcCCcEEEEccCCCcccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004174 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (770)
Q Consensus 94 ~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~~r~~~~~~sVs~yc~~~ap~~C~V~vV~~g 155 (770)
..++.|+|+.++|++.|+..+++.+|||.+++.+-| ..+||++.+++.++ .-.|.||...
T Consensus 316 ~~~~~~~dva~~i~~~A~~~~vt~IViG~s~~~~~~-~~~s~~~~l~r~~~-~idi~iv~~~ 375 (895)
T PRK10490 316 TATLSDPAEEKAVLRYAREHNLGKIIIGRRASRRWW-RRESFADRLARLGP-DLDLVIVALD 375 (895)
T ss_pred EEEEeCCCHHHHHHHHHHHhCCCEEEECCCCCCCCc-cCCCHHHHHHHhCC-CCCEEEEeCC
Confidence 557788999999999999999999999999886533 22599999999998 8899999643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.1e-05 Score=80.14 Aligned_cols=152 Identities=23% Similarity=0.251 Sum_probs=98.4
Q ss_pred CHHHHHHhhcCcccce---eecccCceEEEEEEeCCCCEEEEEEeCCChhH-------------------------HHHH
Q 004174 413 NYQDLLSATSNFLAEN---LIGKGGSSQVYKGCLPDGKELAVKILKPSEDV-------------------------IKEF 464 (770)
Q Consensus 413 ~~~~l~~~t~~f~~~~---~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~-------------------------~~~~ 464 (770)
++..+....+...+.. .|..|--+.||+|...++..+|||+++..... ....
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 4445555555555444 56678888999999888999999999742110 1123
Q ss_pred HHHHHHHHhcC--CCceeEEeeEEeecCceEEEEeecCCCChh-hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 004174 465 VLEIEIITTLH--HKNIISLLGFCFEDNNLLLVYDFLSRGSLE-ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541 (770)
Q Consensus 465 ~~Ei~iL~~l~--HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~-~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~ 541 (770)
..|+.-|.++. +-.+.+.+++. .-.|||||+....+- -.|.. ..+...+...+..++++.+.-|-.
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~-- 184 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYK-- 184 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHH--
Confidence 34666677764 34455555554 238999999654111 11111 122223556666777777766654
Q ss_pred CCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 542 ~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
..++||+||..-|||+. ++.+.|+|||-|....+
T Consensus 185 ~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 185 EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred hcCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 25799999999999999 88999999998865543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=8.2e-07 Score=100.99 Aligned_cols=185 Identities=22% Similarity=0.187 Sum_probs=134.6
Q ss_pred cceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCc-eeEEeeEEeecCceEEEEeecCCC-C
Q 004174 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVYDFLSRG-S 503 (770)
Q Consensus 426 ~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~LV~E~~~gg-s 503 (770)
.-+-+++|+++.+||.+---.+....+.+... ....-++++|.+++||| .+..++-+..+...+++++++.++ +
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 33456899999999876433334445655433 34456889999999999 777778787788899999999887 2
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCcee
Q 004174 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583 (770)
Q Consensus 504 L~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~ 583 (770)
-..... .....+...+...+...-+++|+|||+ -.-+||| ||+..+ +..+..||+....+.... ..
T Consensus 322 ~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~ 387 (829)
T KOG0576|consen 322 SALEMT---VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KP 387 (829)
T ss_pred ccccCC---hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---cc
Confidence 221111 111234444555666777889999998 3348888 887766 588999999887665543 23
Q ss_pred cccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCC
Q 004174 584 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628 (770)
Q Consensus 584 ~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~ 628 (770)
....+|+.++|||+.+.+.+..+.|.|++|+=-.+|--|-+|-..
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 346899999999999999999999999999877777778777543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.06 E-value=4e-05 Score=80.14 Aligned_cols=140 Identities=19% Similarity=0.157 Sum_probs=85.6
Q ss_pred ecccCc-eEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEEeecCCCChhhh
Q 004174 430 IGKGGS-SQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSLEEN 507 (770)
Q Consensus 430 LG~G~f-G~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~ 507 (770)
|-.|.. ..||+.... +..++||+..... ...+.+|++++..+. +--+.++++++...+..++|||+++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444555 788998764 4688999886543 345678999888884 34456777777666678999999999877643
Q ss_pred h-------------------ccCCCCCCCCCH--HHHHHHHH--------------------HHHHHHHHHHc----CCC
Q 004174 508 L-------------------HGNKKDPAAFGW--SERYKVAM--------------------GVAEALEYLHS----GSA 542 (770)
Q Consensus 508 l-------------------~~~~~~~~~l~~--~~~~~i~~--------------------qia~aL~yLH~----~~~ 542 (770)
. |........+.. ........ .+...+..|-. ...
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 111110111110 00000000 01111222211 112
Q ss_pred CceEEecccCCCeeeCCCCceEEccccccc
Q 004174 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 543 ~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
..++|+|+.|.|||++++..+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 458999999999999998778899998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.93 E-value=3.9e-05 Score=77.37 Aligned_cols=105 Identities=25% Similarity=0.253 Sum_probs=82.8
Q ss_pred HHHHHHHHhcCC-CceeEEeeEEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 004174 465 VLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543 (770)
Q Consensus 465 ~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~ 543 (770)
..|.-++..+.+ +++.+++|+|-. ++|.||...+++....... ..-...+|..|.+|+.++++.+.+|++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357888888876 699999999933 7899999887775421000 0112368999999999999999999986655
Q ss_pred ceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 544 ~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
.+.-.|++++|+-+++++.+|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 6777999999999999999999999776543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.0001 Score=76.46 Aligned_cols=142 Identities=21% Similarity=0.251 Sum_probs=83.3
Q ss_pred ceeecccCceEEEEEEeCC--CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCce-eEEeeEEeecCceEEEEeecCCCC
Q 004174 427 ENLIGKGGSSQVYKGCLPD--GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFLSRGS 503 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~--g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~LV~E~~~ggs 503 (770)
.+.|..|-...+|+....+ ++.|++|+........-...+|+.++..+...++ .++++.+. + .+||||++|.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence 3567788889999987654 6789999876543222233478888888854333 34444332 2 48999999977
Q ss_pred hhhh-----------------hccCCCCC--------CCCCHHHHHHHHH----------------------HHH---HH
Q 004174 504 LEEN-----------------LHGNKKDP--------AAFGWSERYKVAM----------------------GVA---EA 533 (770)
Q Consensus 504 L~~~-----------------l~~~~~~~--------~~l~~~~~~~i~~----------------------qia---~a 533 (770)
+... +|...... ....|..+..+.. .+. ..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 11111110 1111222222211 111 11
Q ss_pred H-HHHHcC-CCCceEEecccCCCeeeCC-CCceEEccccccc
Q 004174 534 L-EYLHSG-SAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAK 572 (770)
Q Consensus 534 L-~yLH~~-~~~~IiHrDLKp~NILL~~-~~~vkL~DFGla~ 572 (770)
| ..+-.. ....++|+|+.+.|||++. ++.+.|+||..|.
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 1 112211 2357999999999999997 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00019 Score=73.00 Aligned_cols=127 Identities=24% Similarity=0.392 Sum_probs=93.5
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCCh-----------------hHHHHHHHHHHHHHhcC------CCceeEEe
Q 004174 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-----------------DVIKEFVLEIEIITTLH------HKNIISLL 483 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~-----------------~~~~~~~~Ei~iL~~l~------HpnIv~l~ 483 (770)
...||+|+.-.||. +++.....||+..... ...+++.+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999999995 6777778999998654 23567777887777666 78899999
Q ss_pred eEEeecCceEEEEeecCCC------ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee
Q 004174 484 GFCFEDNNLLLVYDFLSRG------SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (770)
Q Consensus 484 ~~~~~~~~~~LV~E~~~gg------sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 557 (770)
|+..++-.+.+|+|.+.+. +|.+++... .++. ...+.+.++ ..||-. ..|+.+|++|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~~~~L~~f---~~~l~~---~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-ELRQALDEF---KRYLLD---HHIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HHHHHHHHH---HHHHHH---cCCeecCCCcccEEE
Confidence 9999999999999987543 577777433 2444 333344433 456666 779999999999999
Q ss_pred CCC--C--ceEEcc
Q 004174 558 SDD--F--EPQLSD 567 (770)
Q Consensus 558 ~~~--~--~vkL~D 567 (770)
... + .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 532 2 577887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.85 E-value=7e-05 Score=73.70 Aligned_cols=131 Identities=21% Similarity=0.268 Sum_probs=89.9
Q ss_pred cceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCChh
Q 004174 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505 (770)
Q Consensus 426 ~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~ 505 (770)
..+.||+|++|.||+|.+ .|..+|+|+-+.+ .....+..|.++|..+.--++.+=+-++-+ -++.|||+.|-.|.
T Consensus 26 v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d-s~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~L~ 100 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW-RGGEVALKVRRRD-SPRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhhcccccEEEEeec-cCceEEEEEecCC-cchhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcchh
Confidence 456799999999999988 5558999987754 345678889999999987776654433322 25569999998887
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccC-CCeeeCCCCceEEcccccccccc
Q 004174 506 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKS-SNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 506 ~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp-~NILL~~~~~vkL~DFGla~~~~ 575 (770)
++-... . .+-...+++.---|.. .||-|+.|.- ..++|.++..+.|+||.-|.+..
T Consensus 101 ~~~~~~-------~----rk~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 101 KLEIGG-------D----RKHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhhcc-------c----HHHHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhhcc
Confidence 765421 1 1223334444333444 7888988864 44445455599999999887443
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00014 Score=75.84 Aligned_cols=73 Identities=15% Similarity=0.224 Sum_probs=47.3
Q ss_pred eeecccCce-EEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCC---ceeEEeeEEeec---CceEEEEeecC
Q 004174 428 NLIGKGGSS-QVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK---NIISLLGFCFED---NNLLLVYDFLS 500 (770)
Q Consensus 428 ~~LG~G~fG-~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~l~~~~~~~---~~~~LV~E~~~ 500 (770)
+.|+.||.. .||+. +..+++|+.+.. .....+.+|.++|..+... -+.++++..... ...+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~-~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA-GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc-chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 567877776 48874 235788876542 2345788899999888532 233444443322 23488999999
Q ss_pred CCChh
Q 004174 501 RGSLE 505 (770)
Q Consensus 501 ggsL~ 505 (770)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 97774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2205 KdpD Osmosensitive K+ channel histidine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.0003 Score=82.69 Aligned_cols=131 Identities=17% Similarity=0.113 Sum_probs=103.9
Q ss_pred CCCCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCccchhhhHHHHHHHHHHHhHhhhcCCcE
Q 004174 13 SGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDL 92 (770)
Q Consensus 13 ~~~~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~ 92 (770)
.....+|+|+|+.++.|-..++||-+-+-+-+....+|||-.+..... .+.....++....+|++ ..-
T Consensus 245 ~~~~e~ilvcI~~~~~~e~liR~a~RlA~~~~a~~~av~v~~~~~~~~----------~~~~~~~l~~~~~Lae~--lGa 312 (890)
T COG2205 245 WAARERILVCISGSPGSEKLIRRAARLASRLHAKWTAVYVETPELHRL----------SEKEARRLHENLRLAEE--LGA 312 (890)
T ss_pred ccccceEEEEECCCCchHHHHHHHHHHHHHhCCCeEEEEEeccccccc----------cHHHHHHHHHHHHHHHH--hCC
Confidence 345679999999999999999999999999999999999986653211 11222344555556655 444
Q ss_pred EEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeCCeee
Q 004174 93 KLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVV 158 (770)
Q Consensus 93 ~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~~gk~~ 158 (770)
+.+.+.|+|+.++|+++|+.+++..+|||.+.+ .+.|.+ ++.++.+++++ ...|.+|..+...
T Consensus 313 e~~~l~~~dv~~~i~~ya~~~~~TkiViG~~~~~rw~~~~~~--~l~~~L~~~~~-~idv~ii~~~~~~ 378 (890)
T COG2205 313 EIVTLYGGDVAKAIARYAREHNATKIVIGRSRRSRWRRLFKG--SLADRLAREAP-GIDVHIVALDAPP 378 (890)
T ss_pred eEEEEeCCcHHHHHHHHHHHcCCeeEEeCCCcchHHHHHhcc--cHHHHHHhcCC-CceEEEeeCCCCc
Confidence 677888899999999999999999999999987 344456 99999999998 8899999876544
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00026 Score=87.22 Aligned_cols=149 Identities=15% Similarity=0.302 Sum_probs=92.7
Q ss_pred ceeecccCceEEEEEEeCCC---CEEEEEEeCCCh--hHHHHHHHHHHHHHhcC-CCce--eEEeeEEeec---CceEEE
Q 004174 427 ENLIGKGGSSQVYKGCLPDG---KELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNI--ISLLGFCFED---NNLLLV 495 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~g---~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~-HpnI--v~l~~~~~~~---~~~~LV 495 (770)
...|+.|.++.+|+....++ ..+++|+..... .....+.+|+++|+.+. |.++ .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999876543 467888765432 22356789999999996 6664 7788887664 467999
Q ss_pred EeecCCCChhhh-----------------------hccCCCCC-------CCCCH--HHHHHHH---------------H
Q 004174 496 YDFLSRGSLEEN-----------------------LHGNKKDP-------AAFGW--SERYKVA---------------M 528 (770)
Q Consensus 496 ~E~~~ggsL~~~-----------------------l~~~~~~~-------~~l~~--~~~~~i~---------------~ 528 (770)
|||++|..+.+. ||...... .+..+ .++..+. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999998653321 12111000 01111 1111111 1
Q ss_pred HHHHHHHHHHcCCC--------CceEEecccCCCeeeCCC-Cc-eEEcccccccccc
Q 004174 529 GVAEALEYLHSGSA--------QRVIHRDVKSSNILLSDD-FE-PQLSDFGLAKWAS 575 (770)
Q Consensus 529 qia~aL~yLH~~~~--------~~IiHrDLKp~NILL~~~-~~-vkL~DFGla~~~~ 575 (770)
.+...+.+|..+-+ ..+||+|+++.|||++.+ +. .-|.||+++.+.+
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 23344567744221 359999999999999853 33 4689999876543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00042 Score=70.22 Aligned_cols=132 Identities=21% Similarity=0.321 Sum_probs=94.2
Q ss_pred ccccCHHHHHHhhcCcccceeecccCc-eEEEEEEeCCCCEEEEEEeCC---C------------h-------hHHHHHH
Q 004174 409 CRLFNYQDLLSATSNFLAENLIGKGGS-SQVYKGCLPDGKELAVKILKP---S------------E-------DVIKEFV 465 (770)
Q Consensus 409 ~~~f~~~~l~~~t~~f~~~~~LG~G~f-G~Vy~a~~~~g~~vAVK~l~~---~------------~-------~~~~~~~ 465 (770)
...|+. .+.++...+.||.|.- |.||++.+ +|+.||+|+.+. . . ....-|.
T Consensus 29 L~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~ 102 (207)
T PF13095_consen 29 LEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFN 102 (207)
T ss_pred cCCcCC-----CCCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHH
Confidence 345555 2378889999999999 99999998 778999999431 0 0 1234578
Q ss_pred HHHHHHHhcC---CCce--eEEeeEEeec------------------CceEEEEeecCCCChhhhhccCCCCCCCCCHHH
Q 004174 466 LEIEIITTLH---HKNI--ISLLGFCFED------------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE 522 (770)
Q Consensus 466 ~Ei~iL~~l~---HpnI--v~l~~~~~~~------------------~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~ 522 (770)
.|.+...+|+ +.++ |+.+||..-. ..+.||.||++... .+..
T Consensus 103 ~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~-- 167 (207)
T PF13095_consen 103 CECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI-- 167 (207)
T ss_pred HHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch--
Confidence 8888877774 4456 8999987322 12467888876643 1122
Q ss_pred HHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccc
Q 004174 523 RYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (770)
Q Consensus 523 ~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 571 (770)
.-+.+|.+-|..+|. .+|+-+|+++.|.. .-+|+|||.+
T Consensus 168 --~~~~~~~~dl~~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 168 --RDIPQMLRDLKILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred --hHHHHHHHHHHHHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 234567777888999 89999999999986 3589999854
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00032 Score=75.84 Aligned_cols=141 Identities=25% Similarity=0.355 Sum_probs=85.9
Q ss_pred eeecccCceEEEEEEeCC-------CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCcee-EEeeEEeecCceEEEEeec
Q 004174 428 NLIGKGGSSQVYKGCLPD-------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~-------g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~~~~~~~~~~~LV~E~~ 499 (770)
+.|..|-...+|+....+ ++.+++|+.........+..+|.+++..+....+. ++++++. + .+||||+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhee
Confidence 456677778999987655 57899999876544444567888888888643333 4455543 2 4689999
Q ss_pred CCCChhhh-----------------hccCCCC--C-----CCCCHHHHHH--------------------------HHHH
Q 004174 500 SRGSLEEN-----------------LHGNKKD--P-----AAFGWSERYK--------------------------VAMG 529 (770)
Q Consensus 500 ~ggsL~~~-----------------l~~~~~~--~-----~~l~~~~~~~--------------------------i~~q 529 (770)
+|..+... +|..... . ...-|..+.. +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 98776431 1211111 0 0011111111 1112
Q ss_pred HHHHHHHHHc------CCCCceEEecccCCCeeeCCC----CceEEccccccc
Q 004174 530 VAEALEYLHS------GSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAK 572 (770)
Q Consensus 530 ia~aL~yLH~------~~~~~IiHrDLKp~NILL~~~----~~vkL~DFGla~ 572 (770)
+...+.+|-. .....++|+|+.+.|||++.+ +.+.|+||..|.
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 2223334432 244679999999999999875 789999998774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00096 Score=72.29 Aligned_cols=76 Identities=11% Similarity=0.016 Sum_probs=57.1
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC---CceeEEeeEEee---cCceEEEEeecC
Q 004174 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH---KNIISLLGFCFE---DNNLLLVYDFLS 500 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H---pnIv~l~~~~~~---~~~~~LV~E~~~ 500 (770)
.+.||.|..+.||+....++ .+++|..+. ......+..|.+.|+.|.. -.+.+++++|.. .+..+||||+++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 46799999999999876555 477787543 1133578889999998853 357788888754 356899999999
Q ss_pred CCCh
Q 004174 501 RGSL 504 (770)
Q Consensus 501 ggsL 504 (770)
|+++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0008 Score=70.99 Aligned_cols=137 Identities=13% Similarity=0.136 Sum_probs=79.6
Q ss_pred ecccCceEEEEEEeCCCCEEEEEEeCCChhHH-HHHHHHHHHHHhcCCCce-eEEeeEEeecCceEEEEeecCCCChhhh
Q 004174 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVI-KEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFLSRGSLEEN 507 (770)
Q Consensus 430 LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~-~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~LV~E~~~ggsL~~~ 507 (770)
+..|-.+.+|+... +++.+++|+........ -...+|.++++.+....+ .+++..+. -++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677788998764 67789999876433221 235778899998864333 33343331 3789999998766421
Q ss_pred -----------------hccCCCCCCCCCHHH-HHHHHHHH---------HHHHHHHHc-----CCCCceEEecccCCCe
Q 004174 508 -----------------LHGNKKDPAAFGWSE-RYKVAMGV---------AEALEYLHS-----GSAQRVIHRDVKSSNI 555 (770)
Q Consensus 508 -----------------l~~~~~~~~~l~~~~-~~~i~~qi---------a~aL~yLH~-----~~~~~IiHrDLKp~NI 555 (770)
||........++... +..+..++ ...+..+-. .....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 222211111222221 11111111 111222211 1124689999999999
Q ss_pred eeCCCCceEEccccccc
Q 004174 556 LLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 556 LL~~~~~vkL~DFGla~ 572 (770)
++++++ +.|+||..+.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999876 7899998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0022 Score=72.05 Aligned_cols=75 Identities=19% Similarity=0.233 Sum_probs=54.9
Q ss_pred ceeecccCceEEEEEEeCCC-CEEEEEEeCCC--------hhHHHHHHHHHHHHHhcC---CCceeEEeeEEeecCceEE
Q 004174 427 ENLIGKGGSSQVYKGCLPDG-KELAVKILKPS--------EDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~g-~~vAVK~l~~~--------~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~L 494 (770)
.+.||.|.+..||++...+| +.++||+-.+. ....+++..|.+.|..+. ..++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35789999999999998777 48999985421 123456777888888763 2456667766 3355799
Q ss_pred EEeecCCCC
Q 004174 495 VYDFLSRGS 503 (770)
Q Consensus 495 V~E~~~ggs 503 (770)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0019 Score=69.44 Aligned_cols=143 Identities=16% Similarity=0.180 Sum_probs=86.6
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCC--ceeEEeeE------EeecCceEEEEee
Q 004174 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGF------CFEDNNLLLVYDF 498 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~------~~~~~~~~LV~E~ 498 (770)
.+.|..|....+|+....+ ..+++|+... .....+..|++++..+.+. .+.+++.. ...++..++||+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 4567788888999987644 4689998875 2334566788888887532 24444431 2234567899999
Q ss_pred cCCCChhh--------------hhccCCC---C----CCCCCHHHHH----------HHHHHHHHHHHHHHc----CCCC
Q 004174 499 LSRGSLEE--------------NLHGNKK---D----PAAFGWSERY----------KVAMGVAEALEYLHS----GSAQ 543 (770)
Q Consensus 499 ~~ggsL~~--------------~l~~~~~---~----~~~l~~~~~~----------~i~~qia~aL~yLH~----~~~~ 543 (770)
++|..+.. .+|.... . .....|.... .....+..++.++.. ....
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99876532 0111000 0 0112222211 011123344455443 2235
Q ss_pred ceEEecccCCCeeeCCCCceEEccccccc
Q 004174 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 544 ~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
++||+|+.|.|||++++..+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 79999999999999988777899998774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0034 Score=68.38 Aligned_cols=142 Identities=18% Similarity=0.231 Sum_probs=77.4
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCC--ceeEEee------EEeecCceEEEEeec
Q 004174 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLG------FCFEDNNLLLVYDFL 499 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~------~~~~~~~~~LV~E~~ 499 (770)
+.|+.|....+|+....+| .+++|+... ...+....|+.++..|... .+.+.+. +....+..+++++|+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 4567787789999877555 688898762 1223334455555555321 1223332 122345679999999
Q ss_pred CCCChhh-----------h---hccCCCC-------CCCCCH-HHHHH------------HH-HHHHHHHHHHHc----C
Q 004174 500 SRGSLEE-----------N---LHGNKKD-------PAAFGW-SERYK------------VA-MGVAEALEYLHS----G 540 (770)
Q Consensus 500 ~ggsL~~-----------~---l~~~~~~-------~~~l~~-~~~~~------------i~-~qia~aL~yLH~----~ 540 (770)
+|..+.. . +|..... ...+.| ..... .+ ..+...+..+.. .
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 9975421 1 1111100 011112 11111 11 111122233321 1
Q ss_pred CCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 541 ~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
-+.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 24689999999999999866555799998874
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.00065 Score=72.69 Aligned_cols=150 Identities=21% Similarity=0.244 Sum_probs=101.2
Q ss_pred cccccCHHHHHHhhc---CcccceeecccCceEEEEEEeCCCCEEEEEEeCCCh----------h-------------HH
Q 004174 408 TCRLFNYQDLLSATS---NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE----------D-------------VI 461 (770)
Q Consensus 408 ~~~~f~~~~l~~~t~---~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~----------~-------------~~ 461 (770)
.+.-|+|--|....+ -+.+.+.||-|.-+.||.+-...|++.++|+-+... + ..
T Consensus 75 Ty~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSR 154 (465)
T KOG2268|consen 75 TYAGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSR 154 (465)
T ss_pred eeccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHH
Confidence 333445544444444 366789999999999999999999999999754211 0 01
Q ss_pred HHHHHHHHHHHhcC-C-CceeEEeeEEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 004174 462 KEFVLEIEIITTLH-H-KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539 (770)
Q Consensus 462 ~~~~~Ei~iL~~l~-H-pnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~ 539 (770)
-...+|+..|+.|. | --+.+.+++ +.-++|||++.|..|...-+-. ....++.-++++ +.-|-.
T Consensus 155 laa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-------d~~~ly~~lm~~---Iv~la~ 220 (465)
T KOG2268|consen 155 LAATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE-------DPPTLYDDLMGL---IVRLAN 220 (465)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecC-------ChHHHHHHHHHH---HHHHHH
Confidence 12456777888775 3 234445554 4558999999998887654321 223333333333 334445
Q ss_pred CCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 540 ~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
+|+||+|..-=||++++++.++++||--....
T Consensus 221 ---~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 221 ---HGLIHGDFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred ---cCceecccchheeEEecCCCEEEeechHhhcc
Confidence 89999999999999999999999999665433
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.003 Score=68.85 Aligned_cols=141 Identities=23% Similarity=0.255 Sum_probs=97.0
Q ss_pred cceeecccCceEEEEEEeCCCCEEEEEEeCCC--------------------------h-hHHHHHHHHHHHHHhcCCCc
Q 004174 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS--------------------------E-DVIKEFVLEIEIITTLHHKN 478 (770)
Q Consensus 426 ~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~--------------------------~-~~~~~~~~Ei~iL~~l~Hpn 478 (770)
+...|..|--+.||.+...+|..+|||+++.+ . ........|++-|.+|+.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 45678899999999999989999999998731 1 11223456888888887544
Q ss_pred eeEEeeEEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC
Q 004174 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (770)
Q Consensus 479 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 558 (770)
|.-.--.... .-+|||+|+.+.....-. -....++...+..+-.+++.-+.-|.+.| ++||.||.--|+|+-
T Consensus 228 IP~PePIlLk--~hVLVM~FlGrdgw~aPk----LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 228 IPCPEPILLK--NHVLVMEFLGRDGWAAPK----LKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCceeee--cceEeeeeccCCCCcCcc----cccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 3322222222 238999999542211111 11134667778888888888888887744 699999999999985
Q ss_pred CCCceEEcccccccccc
Q 004174 559 DDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 559 ~~~~vkL~DFGla~~~~ 575 (770)
+|.+.|+|.+-+....
T Consensus 300 -dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSVEHD 315 (520)
T ss_pred -CCEEEEEEccccccCC
Confidence 5689999988765433
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0043 Score=67.34 Aligned_cols=144 Identities=17% Similarity=0.186 Sum_probs=83.3
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCC--ceeEEeeE------EeecCceEEEEee
Q 004174 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGF------CFEDNNLLLVYDF 498 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~------~~~~~~~~LV~E~ 498 (770)
...++.|....+|+....+| .+++|+..... .......|++++..|... .+.+++.. ....+..+++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 45677787789999876555 57889876532 123445667777776422 23343332 1124567899999
Q ss_pred cCCCChhh--------------hhccCCCC---C-----CCCCHHHHHH------------HHHHHHHHHHHHHc----C
Q 004174 499 LSRGSLEE--------------NLHGNKKD---P-----AAFGWSERYK------------VAMGVAEALEYLHS----G 540 (770)
Q Consensus 499 ~~ggsL~~--------------~l~~~~~~---~-----~~l~~~~~~~------------i~~qia~aL~yLH~----~ 540 (770)
++|..+.. .+|..... + ..-.|..... ....+...+++|.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 99865421 11211000 0 0012221110 01123344555542 2
Q ss_pred CCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 541 ~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
...++||+|+.+.||+++.++.+.|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 34789999999999999988767899998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd01984 AANH_like Adenine nucleotide alpha hydrolases superfamily including N type ATP PPases, ATP sulphurylases Universal Stress Response protein and electron transfer flavoprotein (ETF) | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0013 Score=57.17 Aligned_cols=83 Identities=24% Similarity=0.212 Sum_probs=66.5
Q ss_pred EEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCccchhhhHHHHHHHHHHHhHhhhcCCcEEEEEEE
Q 004174 19 VVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICR 98 (770)
Q Consensus 19 I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~~~v~~ 98 (770)
|+|+++++..|..+|.||.... +.+..++++|+-
T Consensus 1 ilv~~sgg~dS~~~l~~~~~~~-~~~~~~~~~~~~--------------------------------------------- 34 (86)
T cd01984 1 ILVALSGGLDSSVLLHLAKRLK-SGGPEVVALVVV--------------------------------------------- 34 (86)
T ss_pred CEEEeeCCHHHHHHHHHHHHHH-hcCCCEEEEEeH---------------------------------------------
Confidence 6899999999999999999977 556677788774
Q ss_pred CCChhHHHHHHHHhcCCcEEEEccCCC--cccccCCCchHHHHhccCCCCcEEEE
Q 004174 99 GTSIRKILVREAQSYSATKFIVGTAKN--HHTIRSTTSLAKYCAKKLSKDCSVLA 151 (770)
Q Consensus 99 ~~d~~~~L~~~a~~~~a~~LVlG~~~~--~r~~~~~~sVs~yc~~~ap~~C~V~v 151 (770)
...+.+.+.|++.+++++++|+++. ...+.+..+++.++++.++ |||+.
T Consensus 35 --~~~~~~~~~a~~~~~~~Iv~G~~~~d~~~~~~~~~~~~~~~~~~~~--~~vl~ 85 (86)
T cd01984 35 --AFVRILKRLAAEEGADVIILGHNADDVAGRRLGASANVLVVIKGAG--IPVLT 85 (86)
T ss_pred --HHHHHHHHHHHHcCCCEEEEcCCchhhhhhccCchhhhhhcccccC--CceeC
Confidence 4567788889999999999999987 2222331278899999997 88873
|
The domain forms a apha/beta/apha fold which binds to Adenosine nucleotide. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0016 Score=79.57 Aligned_cols=195 Identities=18% Similarity=0.176 Sum_probs=130.4
Q ss_pred HHHHHHHHhcCCCceeEEeeEEeecCce----EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC
Q 004174 465 VLEIEIITTLHHKNIISLLGFCFEDNNL----LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540 (770)
Q Consensus 465 ~~Ei~iL~~l~HpnIv~l~~~~~~~~~~----~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~ 540 (770)
.-|++.+..+.|+|++.++.|-.+.-.. .+..+++..-++...++... ..+....+.+..++.+||.|+|.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----~i~~~~~r~~~~~~~~GL~~~h~- 304 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----SIPLETLRILHQKLLEGLAYLHS- 304 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----ccCHHHHHHHHHHHhhhHHHHHH-
Confidence 3466778888999999999998765432 23457788888888876543 46778888999999999999998
Q ss_pred CCCceEEecccCC---CeeeCCCCceEEc--cccccccccCCCCCceecccccccCCCCceeeccCCCCCc--ceEeech
Q 004174 541 SAQRVIHRDVKSS---NILLSDDFEPQLS--DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK--IDVYAFG 613 (770)
Q Consensus 541 ~~~~IiHrDLKp~---NILL~~~~~vkL~--DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~k--sDVwSlG 613 (770)
....|.-+..+ +--.+..+.+.++ ||+..+.+........ ..-+..|.+||......++.+ .|+|.+|
T Consensus 305 --~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 305 --LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred --hccceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHHH
Confidence 44444444444 4444556667766 9988876655433221 234556888888876665554 7999999
Q ss_pred HHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 614 VVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 614 vvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
.++..+..|..+-.... ....+++... .. .+......|+..++++|+++.+++.
T Consensus 380 ll~~~~~~~~~i~~~~~------------------~~~~~l~~~~----~~----~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSA------------------VPVSLLDVLS----TS----ELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHhhhhhcCccccccc------------------chhhhhcccc----ch----hhhhhhhhhcchhhhhccchhhhhh
Confidence 99999998765432110 0011111110 00 1223334699999999999999997
Q ss_pred Hh
Q 004174 694 LL 695 (770)
Q Consensus 694 ~L 695 (770)
+.
T Consensus 434 ~~ 435 (1351)
T KOG1035|consen 434 HP 435 (1351)
T ss_pred ch
Confidence 64
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.005 Score=68.13 Aligned_cols=142 Identities=15% Similarity=0.225 Sum_probs=83.8
Q ss_pred ceeecccCceEEEEEEeCC-----CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCcee-EEeeEEeecCceEEEEeecC
Q 004174 427 ENLIGKGGSSQVYKGCLPD-----GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~-----g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~~~~~~~~~~~LV~E~~~ 500 (770)
...|-.|-...+|+....+ ++.|++|+........-+-.+|..++..+..-++. ++++++.. . .|++|++
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~ 116 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH 116 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence 3455568888999986532 36899998875432222236788888888644443 44555532 2 5899998
Q ss_pred CCChhhh-----------------hccCCCC--CCCCCHHHHHHHHHHH-----------------HHHHHHH----Hc-
Q 004174 501 RGSLEEN-----------------LHGNKKD--PAAFGWSERYKVAMGV-----------------AEALEYL----HS- 539 (770)
Q Consensus 501 ggsL~~~-----------------l~~~~~~--~~~l~~~~~~~i~~qi-----------------a~aL~yL----H~- 539 (770)
+.+|... +|..... .....|..+.++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 2221110 1122244333333221 1112222 21
Q ss_pred CCCCceEEecccCCCeeeCC-CCceEEccccccc
Q 004174 540 GSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAK 572 (770)
Q Consensus 540 ~~~~~IiHrDLKp~NILL~~-~~~vkL~DFGla~ 572 (770)
.....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 22357899999999999986 4679999998774
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.012 Score=62.99 Aligned_cols=70 Identities=17% Similarity=0.104 Sum_probs=42.3
Q ss_pred ecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC--Cc-eeEEeeEEeecCceEEEEeecCCCCh
Q 004174 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KN-IISLLGFCFEDNNLLLVYDFLSRGSL 504 (770)
Q Consensus 430 LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H--pn-Iv~l~~~~~~~~~~~LV~E~~~ggsL 504 (770)
.+.|-...||.....+|..+++|.-+ .......+.+|.++|..+.. |- +.+++.. . .-+++|+++.|..+
T Consensus 19 ~~~g~~~~v~~i~~~~g~~~VlR~p~-~~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~--~--~~~~~y~~i~G~p~ 91 (276)
T cd05152 19 NESGLDFQVVFAKDTDGVPWVLRIPR-RPDVSERAAAEKRVLALVRKHLPVQVPDWRVH--T--PELIAYPKLPGVPA 91 (276)
T ss_pred cCCcceeEEEEEEcCCCCeEEEEecC-CHHHHHHHHHHHHHHHHHHhcCCCCCCceeee--c--CceEEEeccCCCcc
Confidence 34454556666544568899999876 33445677899999998863 21 1222211 1 22567777777544
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.00021 Score=88.43 Aligned_cols=163 Identities=10% Similarity=-0.040 Sum_probs=117.8
Q ss_pred HHHHHHHHHHHhcCCCceeEEeeEEee--cCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 004174 462 KEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539 (770)
Q Consensus 462 ~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~ 539 (770)
+....|.+.++...|+++.....-... ....+.+++|+.+|.+...|-+.......+...-+.....+...+..-.|.
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 344556666777889988765543322 345689999999999999987654443444444444444443555555554
Q ss_pred --CCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHH
Q 004174 540 --GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 617 (770)
Q Consensus 540 --~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~ 617 (770)
+...-.+|+++|+-|.+|..+..+|+.++|+.+...+... ..+...+++.|++|++...-+++.++|+|..|+-+|
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 2234578999999999999999999999999984333222 223357888899999998889999999999999999
Q ss_pred HHHhCCCCC
Q 004174 618 ELLTGRKPI 626 (770)
Q Consensus 618 eLltG~~Pf 626 (770)
++..|..+|
T Consensus 1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred HHhcccHHH
Confidence 998888876
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.015 Score=64.05 Aligned_cols=141 Identities=18% Similarity=0.291 Sum_probs=81.3
Q ss_pred eeecccCceEEEEEEeCC----CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCcee-EEeeEEeecCceEEEEeecCCC
Q 004174 428 NLIGKGGSSQVYKGCLPD----GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDFLSRG 502 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~----g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~~~~~~~~~~~LV~E~~~gg 502 (770)
+.|..|-...+|+....+ +..|++|+........-+-.+|..+++.+..-++. ++++++. ++ +|.+|+++.
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~ 95 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR 95 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence 455557778889876533 24799998865433223345788888888755553 4555552 22 589999877
Q ss_pred Chhh-----------------hhccCCCC--CCCCCHHHHHHHHHHH----------------------HHHHHH---HH
Q 004174 503 SLEE-----------------NLHGNKKD--PAAFGWSERYKVAMGV----------------------AEALEY---LH 538 (770)
Q Consensus 503 sL~~-----------------~l~~~~~~--~~~l~~~~~~~i~~qi----------------------a~aL~y---LH 538 (770)
.|.. .+|..... ...-.|..+.++..++ ..-+.. +.
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 6532 11221110 0111244333333222 111111 11
Q ss_pred -c-CCCCceEEecccCCCeeeCC-CCceEEccccccc
Q 004174 539 -S-GSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAK 572 (770)
Q Consensus 539 -~-~~~~~IiHrDLKp~NILL~~-~~~vkL~DFGla~ 572 (770)
. ..+.-++|.|+.+.|||+++ ++.++++||..|.
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1 11234799999999999974 5689999998774
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 770 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-55 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-55 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-46 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-46 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-33 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-22 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-22 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-21 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-16 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 410 bits (1055), Expect = e-138
Identities = 115/314 (36%), Positives = 181/314 (57%), Gaps = 5/314 (1%)
Query: 399 EGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE 458
E E + + F+ ++L A+ NF +N++G+GG +VYKG L DG +AVK LK
Sbjct: 7 EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER 66
Query: 459 D--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 516
+F E+E+I+ H+N++ L GFC LLVY +++ GS+ L +
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 517 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576
W +R ++A+G A L YLH ++IHRDVK++NILL ++FE + DFGLAK
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636
+H+T T V GT G++APEY GK ++K DV+ +GV+LLEL+TG++ +
Sbjct: 187 KDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 637 --LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694
L+ W K +L K+ L+D L NY +++E+++ ++LC + P RP+MS V+++
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
Query: 695 LRGDADVTKWARLQ 708
L GD +W Q
Sbjct: 306 LEGDGLAERWEEWQ 319
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 385 bits (990), Expect = e-128
Identities = 109/315 (34%), Positives = 174/315 (55%), Gaps = 6/315 (1%)
Query: 386 STDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPD 445
S +T + DL AT+NF + LIG G +VYKG L D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 446 GKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504
G ++A+K P S I+EF EIE ++ H +++SL+GFC E N ++L+Y ++ G+L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564
+ +L+G+ + W +R ++ +G A L YLH+ + +IHRDVKS NILL ++F P+
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 565 LSDFGLAKWA-STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 623
++DFG++K +H++ T V GT GY+ PEYF+ G++ +K DVY+FGVVL E+L R
Sbjct: 180 ITDFGISKKGTELDQTHLS-TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 624 KPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPR 683
I P+ +L WA ++G++ Q++DP L + + + + ++ C+
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 684 ARPQMSLVLKLLRGD 698
RP M VL L
Sbjct: 299 DRPSMGDVLWKLEYA 313
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 353 bits (908), Expect = e-116
Identities = 95/311 (30%), Positives = 159/311 (51%), Gaps = 23/311 (7%)
Query: 403 EKYSATCRLFNYQDLLSATSNF------LAENLIGKGGSSQVYKGCLPDGKELAVKILKP 456
E F++ +L + T+NF + N +G+GG VYKG + + +AVK L
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 457 SEDV-----IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGN 511
D+ ++F EI+++ H+N++ LLGF + ++L LVY ++ GSL + L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 512 KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
P W R K+A G A + +LH IHRD+KS+NILL + F ++SDFGLA
Sbjct: 125 DGTPP-LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 572 KWAST-SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630
+ + + + +T + + GT Y+APE + G++ K D+Y+FGVVLLE++TG + D
Sbjct: 181 RASEKFAQTVMT-SRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV--DE 236
Query: 631 PKGQESLVMWAKPILSS-GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMS 689
+ + L+ + I + +D + + D +E M + C+ RP +
Sbjct: 237 HREPQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 690 LVLKLLRGDAD 700
V +LL+
Sbjct: 296 KVQQLLQEMTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 1e-77
Identities = 73/318 (22%), Positives = 121/318 (38%), Gaps = 28/318 (8%)
Query: 400 GLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED 459
G H + ++ ++L + + +G V+K + +AVKI +
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDK 60
Query: 460 VIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----LLLVYDFLSRGSLEENLHGNKKDP 515
+ E+ + + H+NI+ +G + L L+ F +GSL + L N
Sbjct: 61 QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVS- 119
Query: 516 AAFGWSERYKVAMGVAEALEYLHS-------GSAQRVIHRDVKSSNILLSDDFEPQLSDF 568
W+E +A +A L YLH G + HRD+KS N+LL ++ ++DF
Sbjct: 120 ----WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175
Query: 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGR 623
GLA S GT Y+APE +ID+YA G+VL EL +
Sbjct: 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 624 KPISNDHPKGQESL--VMWAKPILSSGK---VTQLLDPALGNNYDYDQMERMVLASIL-C 677
+ + P L + V + P L + + M+ +I C
Sbjct: 236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEEC 295
Query: 678 IRRDPRARPQMSLVLKLL 695
D AR V + +
Sbjct: 296 WDHDAEARLSAGCVGERI 313
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 9e-62
Identities = 74/273 (27%), Positives = 128/273 (46%), Gaps = 29/273 (10%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
E ++G+G V K K++A+K ++ SE K F++E+ ++ ++H NI+ L G C
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIE-SESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
N + LV ++ GSL LHG + P + + + ++ + YLHS + +I
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 547 HRDVKSSNILLSDDFE-PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 605
HRD+K N+LL ++ DFG A T T+ G+ ++APE F ++
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 606 KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 665
K DV+++G++L E++T RKP + V P L N
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDE----------IGGPAFRIMWAVHNGTRPPLIKNLPKP 232
Query: 666 QMERMVLASIL--CIRRDPRARPQMSLVLKLLR 696
+ S++ C +DP RP M ++K++
Sbjct: 233 ------IESLMTRCWSKDPSQRPSMEEIVKIMT 259
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 8e-61
Identities = 65/319 (20%), Positives = 110/319 (34%), Gaps = 43/319 (13%)
Query: 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEII 471
+ N LIG+G VYKG L D + +AVK+ + + F+ E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR--QNFINEKNIY 59
Query: 472 TT--LHHKNIISLLGFCFEDN-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 524
+ H NI + LLV ++ GSL + L + D W
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD-----WVSSC 114
Query: 525 KVAMGVAEALEYLHSGSAQR------VIHRDVKSSNILLSDDFEPQLSDFGLAK------ 572
++A V L YLH+ + + HRD+ S N+L+ +D +SDFGL+
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 573 WASTSSSHITCTDVAGTFGYLAPEYFM-------YGKVNDKIDVYAFGVVLLELLTGRKP 625
GT Y+APE ++D+YA G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 626 ISNDHPKGQESL----VMWAKPILSSGK---VTQLLDPALGNNYDYDQMERMVLASIL-- 676
+ + + + P + + P + + + L +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 677 CIRRDPRARPQMSLVLKLL 695
C +D AR + +
Sbjct: 295 CWDQDAEARLTAQXAEERM 313
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 5e-60
Identities = 85/280 (30%), Positives = 134/280 (47%), Gaps = 37/280 (13%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLL 483
+ IG G V++ G ++AVKIL + + EF+ E+ I+ L H NI+ +
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
G + NL +V ++LSRGSL LH R +A VA+ + YLH+
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNP 158
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
++HR++KS N+L+ + ++ DFGL++ AST S AGT ++APE
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS---KSAAGTPEWMAPEVLRDEP 215
Query: 603 VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA------KPILSSGKVTQLLDP 656
N+K DVY+FGV+L EL T ++P N +P Q V+ A + + L+P
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNP-AQ---VVAAVGFKCKRLEIPRN-----LNP 266
Query: 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
+ +E C +P RP + ++ LLR
Sbjct: 267 QV-----AAIIEG-------CWTNEPWKRPSFATIMDLLR 294
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 3e-57
Identities = 82/290 (28%), Positives = 120/290 (41%), Gaps = 52/290 (17%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-----VIKEFVLEIEIITTLHHKNIIS 481
E +IG GG +VY+ G E+AVK + D I+ E ++ L H NII+
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L G C ++ NL LV +F G L L G + A+ +A + YLH +
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIP-----PDILVNWAVQIARGMNYLHDEA 125
Query: 542 AQRVIHRDVKSSNILLSDDFEPQ--------LSDFGLAKWASTSSSHITCTDVAGTFGYL 593
+IHRD+KSSNIL+ E ++DFGLA+ ++ AG + ++
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWM 181
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK-------PILS 646
APE + DV+++GV+L ELLTG P V + PI S
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-LA---VAYGVAMNKLALPIPS 237
Query: 647 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
+ ME C DP +RP + +L L
Sbjct: 238 T------CPEPF-----AKLMED-------CWNPDPHSRPSFTNILDQLT 269
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-56
Identities = 74/289 (25%), Positives = 123/289 (42%), Gaps = 46/289 (15%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSED--------VIKEFVLEIEIITTLHHK 477
E IGKGG V+KG + D +A+K L + +EF E+ I++ L+H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
NI+ L G N +V +F+ G L L WS + ++ + +A +EY+
Sbjct: 84 NIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP---IKWSVKLRLMLDIALGIEYM 138
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKWASTSSSHITCTDVAGTFGY 592
+ ++HRD++S NI L E ++DFGL++ + S + + G F +
Sbjct: 139 QN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV-----SGLLGNFQW 192
Query: 593 LAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK- 649
+APE +K D Y+F ++L +LTG P + + I G
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREEGLR 248
Query: 650 --VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
+ + P L + +E C DP+ RP S ++K L
Sbjct: 249 PTIPEDCPPRL-----RNVIEL-------CWSGDPKKRPHFSYIVKELS 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 6e-54
Identities = 76/279 (27%), Positives = 125/279 (44%), Gaps = 38/279 (13%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IG G VYKG ++AVK+L + ++ F E+ ++ H NI+ +G+
Sbjct: 32 IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
L +V + SL +LH ++ F + +A A ++YLH+ + +I
Sbjct: 90 TAPQ-LAIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLHA---KSII 142
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE---YFMYGKV 603
HRD+KS+NI L +D ++ DFGLA S S ++G+ ++APE
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 604 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA------KPILSSGKVTQLLDPA 657
+ + DVYAFG+VL EL+TG+ P SN + + Q ++ P LS KV
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLSPDLS--KVRSNCPKR 257
Query: 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
+ M C+++ RP +L +
Sbjct: 258 M-----KRLMAE-------CLKKKRDERPSFPRILAEIE 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-53
Identities = 54/284 (19%), Positives = 108/284 (38%), Gaps = 46/284 (16%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 483
+ + S +++KG G ++ VK+LK S ++F E + H N++ +L
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 484 GFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
G C + L+ ++ GSL LH S+ K A+ +A + +LH+
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLHT-L 130
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 599
+ + S ++++ +D ++S + ++APE
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKK 183
Query: 600 -YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP------KGQESLVMWAKPILSSGKVTQ 652
D+++F V+L EL+T P ++ E L +P + G
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL----RPTIPPG---- 235
Query: 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
+ P + M+ C+ DP RP+ +++ +L
Sbjct: 236 -ISPHV-----SKLMKI-------CMNEDPAKRPKFDMIVPILE 266
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-52
Identities = 59/290 (20%), Positives = 108/290 (37%), Gaps = 49/290 (16%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 483
LIGKG QVY G E+A++++ +ED +K F E+ H+N++ +
Sbjct: 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
G C +L ++ +L + K ++ ++A + + + YLH+ +
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMGYLHA---K 149
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAK---WASTSSSHITCTDVAGTFGYLAPEYFMY 600
++H+D+KS N+ D+ + ++DFGL G +LAPE
Sbjct: 150 GILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 601 GKV---------NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA-----KPILS 646
+ DV+A G + EL P ++W KP LS
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----EAIIWQMGTGMKPNLS 264
Query: 647 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
+ + D + C + RP + ++ +L
Sbjct: 265 QIGM----GKEI-----SDILLF-------CWAFEQEERPTFTKLMDMLE 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-50
Identities = 68/295 (23%), Positives = 115/295 (38%), Gaps = 34/295 (11%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLG 484
IGKG +V+ G G+++AVK+ +E+ + E EI T + H+NI+ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIA 98
Query: 485 FCFEDN----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
+ L L+ D+ GSL + L D K+A L +LH+
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLD-----AKSMLKLAYSSVSGLCHLHTE 153
Query: 541 SAQR-----VIHRDVKSSNILLSDDFEPQLSDFGLA--KWASTSSSHITCTDVAGTFGYL 593
+ HRD+KS NIL+ + ++D GLA + T+ I GT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 594 APE------YFMYGKVNDKIDVYAFGVVLLELLTGRKPISN----DHPKGQESLVMWAKP 643
PE + + D+Y+FG++L E+ P +
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 644 ILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKLLR 696
+ + L P+ N + D+ R + ++ C +P +R V K L
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLR-QMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 6e-50
Identities = 62/287 (21%), Positives = 116/287 (40%), Gaps = 40/287 (13%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKIL-KPSEDVIKEFVLEIEIITTLHHKNIISLLG 484
++GKG Q K G+ + +K L + E+ + F+ E++++ L H N++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
++D L + +++ G+L + + WS+R A +A + YLHS
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDSQ---YPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAK------------WASTSSSHITCTDVAGTFGY 592
+IHRD+ S N L+ ++ ++DFGLA+ + V G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 593 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK---PILSSGK 649
+APE ++K+DV++FG+VL E++ + P+ + +
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPN- 247
Query: 650 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
P+ + R C DP RP + L
Sbjct: 248 ----CPPSF-----FPITVR-------CCDLDPEKRPSFVKLEHWLE 278
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-49
Identities = 68/294 (23%), Positives = 114/294 (38%), Gaps = 34/294 (11%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLG 484
+GKG +V++G G+ +AVKI ++ K + E E+ T L H+NI+ +
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE--KSWFRETELYNTVMLRHENILGFIA 69
Query: 485 FC----FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L L+ + GSL + L D ++ + +A L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLD-----TVSCLRIVLSIASGLAHLHIE 124
Query: 541 SAQR-----VIHRDVKSSNILLSDDFEPQLSDFGLA--KWASTSSSHITCTDVAGTFGYL 593
+ HRD+KS NIL+ + + ++D GLA ST+ + GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 594 APE------YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH----PKGQESLVMWAKP 643
APE ++D++AFG+VL E+ P +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 644 ILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKLL 695
+ P + N + D LA ++ C ++P AR + K L
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLT-SLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 7e-48
Identities = 76/295 (25%), Positives = 120/295 (40%), Gaps = 34/295 (11%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLG 484
+ IGKG +V++G G+E+AVKI E+ + + E EI T L H+NI+ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIA 103
Query: 485 FCFEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
+DN L LV D+ GSL + L+ K+A+ A L +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT-----VEGMIKLALSTASGLAHLHME 158
Query: 541 SAQR-----VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH--ITCTDVAGTFGYL 593
+ HRD+KS NIL+ + ++D GLA +++ I GT Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 594 APE------YFMYGKVNDKIDVYAFGVVLLELLTGRKPISND----HPKGQESLVMWAKP 643
APE + + + D+YA G+V E+ P +
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 644 ILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKLLR 696
+ Q L P + N + + R V+A I+ C + AR + K L
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALR-VMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 77/283 (27%), Positives = 130/283 (45%), Gaps = 33/283 (11%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHH 476
+NF E IG+G S+VY+ CL DG +A+K ++ + + EI+++ L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEAL 534
N+I EDN L +V + G L + KK ER K + + AL
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI--PERTVWKYFVQLCSAL 149
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
E++HS +RV+HRD+K +N+ ++ +L D GL ++ S+ ++ + GT Y++
Sbjct: 150 EHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMS 204
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ-L 653
PE N K D+++ G +L E+ + P D SL K+ Q
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLCK---------KIEQCD 254
Query: 654 LDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKL 694
P ++Y + L ++ CI DP RP ++ V +
Sbjct: 255 YPPLPSDHYSEE------LRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-38
Identities = 73/300 (24%), Positives = 133/300 (44%), Gaps = 35/300 (11%)
Query: 402 HEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPS 457
H +S+ L + ++ IG+G + DG++ +K + + S
Sbjct: 4 HHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS 63
Query: 458 EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA 517
+E E+ ++ + H NI+ E+ +L +V D+ G L + ++ K
Sbjct: 64 SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL-- 121
Query: 518 FGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575
+ E + + AL+++H ++++HRD+KS NI L+ D QL DFG+A+ +
Sbjct: 122 --FQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176
Query: 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635
++ GT YL+PE N+K D++A G VL EL T + K
Sbjct: 177 STVEL-ARA-CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK--- 231
Query: 636 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLK 693
+LV+ K+ P + +Y YD L S++ +R+PR RP ++ +L+
Sbjct: 232 NLVL---------KIISGSFPPVSLHYSYD------LRSLVSQLFKRNPRDRPSVNSILE 276
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 76/291 (26%), Positives = 122/291 (41%), Gaps = 41/291 (14%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNII 480
++L +G+GG S V L DG A+K IL + +E E ++ +H NI+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 481 SLLGFCFEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
L+ +C + L+ F RG+L + K + + +G+ LE
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS----TSSSHITCTDVA---GT 589
+H+ + HRD+K +NILL D+ +P L D G A S +T D A T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 590 FGYLAPEYF---MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 646
Y APE F + ++++ DV++ G VL ++ G P KG +S+ +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVAL------- 258
Query: 647 SGKVTQLLDPALGNNYDYDQMERM--VLASIL--CIRRDPRARPQMSLVLK 693
A+ N Q R L +L + DP RP + L+L
Sbjct: 259 ----------AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS 299
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 65/292 (22%), Positives = 119/292 (40%), Gaps = 55/292 (18%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII 480
+F LIG GG QV+K DGK +K +K + + + E++ + L H NI+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER---EVKALAKLDHVNIV 67
Query: 481 SLLGFCFED-----------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 523
G C++ L + +F +G+LE+ + + + +
Sbjct: 68 HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK----LDKV 122
Query: 524 Y--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581
++ + + ++Y+HS +++I+RD+K SNI L D + ++ DFGL
Sbjct: 123 LALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179
Query: 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 641
GT Y++PE ++D+YA G++L ELL +
Sbjct: 180 R---SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE----TSKFFTDLR 232
Query: 642 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
I+S +D+ E+ +L + + P RP S +L+
Sbjct: 233 DGIISDI---------------FDKKEKTLLQK--LLSKKPEDRPNTSEILR 267
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 59/297 (19%), Positives = 117/297 (39%), Gaps = 47/297 (15%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKN 478
++F +G+GG V++ D A+K L E ++ + E++ + L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 479 IISLLGFCFEDNN------------LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 526
I+ E N L + + +L++ ++G S +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVCLHI 123
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK----------WAST 576
+ +AEA+E+LHS + ++HRD+K SNI + D ++ DFGL +
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636
++ T GT Y++PE + K+D+++ G++L ELL +P +
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---------YPFSTQM 231
Query: 637 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
+ + + K L E +++ + P RP+ +++
Sbjct: 232 ERVRTLTDVRNLKFPPLFT-------QKYPCEYVMVQD--MLSPSPMERPEAINIIE 279
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 65/267 (24%), Positives = 108/267 (40%), Gaps = 33/267 (12%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLG 484
IG+G VYKG E+A L K ++ + F E E++ L H NI+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 485 FCF----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
++LV + ++ G+L+ L K + + L++LH+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTR 148
Query: 541 SAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+ +IHRD+K NI ++ ++ D GLA S V GT ++APE +
Sbjct: 149 TPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE 203
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659
K ++ +DVYAFG+ +LE+ T P S Q ++SG D
Sbjct: 204 -EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR------RVTSGVKPASFDKVA- 255
Query: 660 NNYDYDQMERMVLASILCIRRDPRARP 686
+ ++ CIR++ R
Sbjct: 256 -----IPEVKEIIE--GCIRQNKDERY 275
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 72/264 (27%), Positives = 119/264 (45%), Gaps = 37/264 (14%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IGKG +V+KG K +A+KI L+ +ED I++ EI +++ + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 544
+D L ++ ++L GS + L E + + + L+YLHS ++
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEPGP-------LDETQIATILREILKGLDYLHS---EK 139
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
IHRD+K++N+LLS+ E +L+DFG+ + T T GT ++APE
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWMAPEVIKQSAY 196
Query: 604 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA-KPILSSGKVTQLLDPALGNNY 662
+ K D+++ G+ +EL G P S HP M I + P L NY
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELHP-------MKVLFLIPKNNP------PTLEGNY 243
Query: 663 DYDQMERMVLASILCIRRDPRARP 686
++ V C+ ++P RP
Sbjct: 244 S-KPLKEFV---EACLNKEPSFRP 263
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-35
Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 430 IGKGGSSQVYKGCL-PDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IG+G +V+ G L D +AVK + D+ +F+ E I+ H NI+ L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
+ + +V + + G L ++ A +EYL S + I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLES---KCCI 235
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKVN 604
HRD+ + N L+++ ++SDFG+++ + + APE YG+ +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGV--YAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 605 DKIDVYAFGVVLLELLT-GRKP 625
+ DV++FG++L E + G P
Sbjct: 294 SESDVWSFGILLWETFSLGASP 315
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-35
Identities = 53/251 (21%), Positives = 95/251 (37%), Gaps = 25/251 (9%)
Query: 396 KELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSS--QVYKG-CLPDGKELAVK 452
H + + ++ + +IGKG V P G+ + V+
Sbjct: 2 AHHHHHHMENLYFQGMSSFLP---EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVR 58
Query: 453 IL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLH 509
+ S +++ E+ + +H NI+ DN L +V F++ GS ++ +
Sbjct: 59 RINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC 118
Query: 510 GNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 567
+ D G +E + GV +AL+Y+H +HR VK+S+IL+S D + LS
Sbjct: 119 THFMD----GMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSG 171
Query: 568 FGLAKWASTS-----SSHITCTDVAGTFGYLAPEYFMYGKV--NDKIDVYAFGVVLLELL 620
+ H +L+PE + K D+Y+ G+ EL
Sbjct: 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231
Query: 621 TGRKPISNDHP 631
G P +
Sbjct: 232 NGHVPFKDMPA 242
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 64/286 (22%), Positives = 107/286 (37%), Gaps = 30/286 (10%)
Query: 419 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTL 474
S ++ IG G + K DGK L K L +E + V E+ ++ L
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 475 HHKNIISLLG-FCFEDNNLL-LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
H NI+ N L +V ++ G L + K+ +V +
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 533 ALEYLHS--GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
AL+ H V+HRD+K +N+ L +L DFGLA+ + +S GT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKTFVGTP 180
Query: 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650
Y++PE N+K D+++ G +L EL P + Q+ L K+
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAG---------KI 228
Query: 651 TQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKL 694
+ + Y + L I+ + RP + +L+
Sbjct: 229 REGKFRRIPYRYSDE------LNEIITRMLNLKDYHRPSVEEILEN 268
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 47/223 (21%), Positives = 86/223 (38%), Gaps = 43/223 (19%)
Query: 428 NLIGKGGSSQVYKGCLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN--IISL 482
IG GGSS+V++ + A+K + + + + EI + L + II L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 483 LGFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
+ D + +V +L + S++ W + EA
Sbjct: 94 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWE-------RKSYWKN-------MLEA 139
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
+ +H ++H D+K +N L+ D +L DFG+A ++ + GT Y+
Sbjct: 140 VHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 594 APEYFM-----------YGKVNDKIDVYAFGVVLLELLTGRKP 625
PE K++ K DV++ G +L + G+ P
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-34
Identities = 72/271 (26%), Positives = 114/271 (42%), Gaps = 27/271 (9%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IG G ++ V C P +++A+K L+ + + E + EI+ ++ HH NI+S
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGW--SERY--KVAMGVAEALEYLHSGSA 542
+ L LV LS GS+ + + E + V E LEYLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--- 139
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC---TDVAGTFGYLAPEYFM 599
IHRDVK+ NILL +D Q++DFG++ + +T GT ++APE
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 600 YGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658
+ + K D+++FG+ +EL TG P P M + L
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGAAPYHKYPP-------MKVLMLTLQNDPPSLETGVQ 252
Query: 659 GNNYDYD---QMERMVLASILCIRRDPRARP 686
+M+ LC+++DP RP
Sbjct: 253 DKEMLKKYGKSFRKMI---SLCLQKDPEKRP 280
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 53/205 (25%), Positives = 81/205 (39%), Gaps = 15/205 (7%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIIS 481
L+G+GG VY+ + +A+K++ + E L +++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
+ F D L + ++ L L + + + AL+ H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAH--- 151
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA-GTFGYLAPEYFMY 600
A HRDVK NIL+S D L DFG+A +T+ +T GT Y+APE F
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMAPERFSE 209
Query: 601 GKVNDKIDVYAFGVVLLELLTGRKP 625
+ D+YA VL E LTG P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPP 234
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 63/271 (23%), Positives = 121/271 (44%), Gaps = 39/271 (14%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLL 483
+G GG S VY ++A+K + E+ +K F E+ + L H+NI+S++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
ED+ LV +++ +L E + + + + +++ H
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAH---DM 130
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAPEYFMYGK 602
R++HRD+K NIL+ + ++ DFG+AK + S + +T T+ V GT Y +PE
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 603 VNDKIDVYAFGVVLLELLTGRKPISNDHPKG------QESLVMWAKPILSSGKVTQLLDP 656
++ D+Y+ G+VL E+L G P + + Q+S+ P +++ V + +
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-----PNVTT-DVRKDIPQ 242
Query: 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQ 687
+L ++L +D R +
Sbjct: 243 SL---------SNVILR---ATEKDKANRYK 261
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 69/301 (22%), Positives = 125/301 (41%), Gaps = 50/301 (16%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI 479
S+F ++G+G QV K D + A+K ++ +E+ + + E+ ++ +L+H+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 480 ISLLGFCFEDNN-------------LLLVYDFLSRGSLEENLH-GNKKDPAAFGWSERYK 525
+ E N L + ++ G+L + +H N W +
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----R 120
Query: 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC-- 583
+ + EAL Y+HS Q +IHRD+K NI + + ++ DFGLAK S +
Sbjct: 121 LFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 584 ----------TDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632
T GT Y+A E G N+KID+Y+ G++ E++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST------- 230
Query: 633 GQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 692
G E + + K L S + P +N + + ++ ++ DP RP +L
Sbjct: 231 GMERVNILKK--LRSVSIE--FPPDFDDNKMKVE--KKIIRLLID--HDPNKRPGARTLL 282
Query: 693 K 693
Sbjct: 283 N 283
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 64/272 (23%), Positives = 103/272 (37%), Gaps = 38/272 (13%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKE---FVLEIEIITTL-HH 476
+F + +G G +V+K DG+ AVK K+ + E+ + H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
+ L E L L + SL+++ + A+ ++ + AL +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL-CGPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
LHS Q ++H DVK +NI L +L DFGL T+ + G Y+APE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPE 226
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656
G DV++ G+ +LE+ + P G E W + L G L P
Sbjct: 227 LLQ-GSYGTAADVFSLGLTILEVACNMEL-----PHGGEG---WQQ--LRQGY----LPP 271
Query: 657 ALGNNYDYDQMERMVLASIL--CIRRDPRARP 686
+ L S+L + DP+ R
Sbjct: 272 EFTAGLSSE------LRSVLVMMLEPDPKLRA 297
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 47/223 (21%), Positives = 86/223 (38%), Gaps = 43/223 (19%)
Query: 428 NLIGKGGSSQVYKGCLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN--IISL 482
IG GGSS+V++ + A+K + + + + EI + L + II L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 483 LGFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
+ D + +V +L + S++ W + EA
Sbjct: 75 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWE-------RKSYWKN-------MLEA 120
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
+ +H ++H D+K +N L+ D +L DFG+A ++ + GT Y+
Sbjct: 121 VHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 594 APEYFM-----------YGKVNDKIDVYAFGVVLLELLTGRKP 625
PE K++ K DV++ G +L + G+ P
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISL 482
+GKG VY LA+K+L ++ V + E+EI + L H NI+ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHS 539
G+ + + L+ ++ G++ L K A +E +A AL Y HS
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE-------LANALSYCHS 127
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+RVIHRD+K N+LL E +++DFG + A +S C GT YL PE
Sbjct: 128 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIE 180
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632
++K+D+++ GV+ E L G+ P + +
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 57/293 (19%), Positives = 101/293 (34%), Gaps = 57/293 (19%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK---PSEDVIKEFVLEIEIITTL-H 475
T+ F IG G V+K DG A+K K + + E+ L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
H +++ ED+++L+ ++ + GSL + + N + + F +E + + V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQ-------------------LSDFGLAKWAST 576
Y+HS ++H D+K SNI +S P + D G S+
Sbjct: 130 YIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 577 SSSHITCTDVAGTFGYLAPEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQE 635
G +LA E + K D++A + ++ N
Sbjct: 187 PQVEE------GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235
Query: 636 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARP 686
W + + G++ P + + +L I DP RP
Sbjct: 236 ---QWHE--IRQGRL-----PRIPQVLSQE------FTELLKVMIHPDPERRP 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-32
Identities = 61/282 (21%), Positives = 113/282 (40%), Gaps = 34/282 (12%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIIS 481
+F ++++G G + + D +++AVK + P + E++++ H N+I
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVIR 82
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
+ + + L +L+E + ++ A E + L +LHS
Sbjct: 83 YFCTEKDRQFQYIAIE-LCAATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 542 AQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKW-ASTSSSHITCTDVAGTFGYLAP 595
++HRD+K NIL+S +SDFGL K A S + V GT G++AP
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 596 EYF---MYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 651
E +D+++ G V +++ G P +++ ++ L
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--RQANILLGACSLDCLHPE 253
Query: 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
+ D + +E+M I DP+ RP VLK
Sbjct: 254 KHEDVIA-----RELIEKM-------IAMDPQKRPSAKHVLK 283
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 16/215 (7%)
Query: 421 TSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI 479
F +G+G VYK G+ +A+K + D ++E + EI I+ ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-LQEIIKEISIMQQCDSPHV 86
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYL 537
+ G F++ +L +V ++ GS+ + + K +E + + LEYL
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK-----TLTEDEIATILQSTLKGLEYL 141
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPE 596
H R IHRD+K+ NILL+ + +L+DFG+ + T + T V GT ++APE
Sbjct: 142 HF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTPFWMAPE 195
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
N D+++ G+ +E+ G+ P ++ HP
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP 230
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 61/229 (26%), Positives = 107/229 (46%), Gaps = 25/229 (10%)
Query: 416 DLLSATSNFLAE---------NLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDV 460
+L+ A + + +IG+G VY G L DGK++ AVK L
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69
Query: 461 IKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFG 519
+ +F+ E I+ H N++SLLG C + + L+V ++ G L + +P
Sbjct: 70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-- 127
Query: 520 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579
+ + VA+ ++YL ++++ +HRD+ + N +L + F +++DFGLA+
Sbjct: 128 -KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183
Query: 580 HITCTDVAGTF--GYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ ++A E K K DV++FGV+L EL+T G P
Sbjct: 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 17/213 (7%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLL 483
++G GG S+V+ L D +++AVK+L+ F E + L+H I+++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 484 GFCFEDNNLL----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
+ +V +++ +L + +H +V +AL + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSH- 133
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAPEYF 598
+IHRDVK +NI++S ++ DFG+A+ + S + +T T V GT YL+PE
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
V+ + DVY+ G VL E+LTG P + D P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 65/321 (20%), Positives = 123/321 (38%), Gaps = 50/321 (15%)
Query: 424 FLAENLIGKGGSSQVYKGCL-PDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNII 480
F + +G G V+K P G +A K+ L+ + + + E++++ + I+
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 538
G + D + + + + GSL++ L + P E+ KV++ V + L YL
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP------EQILGKVSIAVIKGLTYLR 148
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
+++HRDVK SNIL++ E +L DFG++ S GT Y++PE
Sbjct: 149 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERL 202
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658
+ + D+++ G+ L+E+ GR PI K E + ++ + P
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 659 GNNYDYDQMERM-----VLASIL----------------------CIRRDPRARP----- 686
N +L I+ C+ ++P R
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322
Query: 687 -QMSLVLKLLRGDADVTKWAR 706
+ + + + D W
Sbjct: 323 MVHAFIKRSDAEEVDFAGWLC 343
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 46/223 (20%), Positives = 85/223 (38%), Gaps = 43/223 (19%)
Query: 428 NLIGKGGSSQVYKGCLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN--IISL 482
IG GGSS+V++ + A+K + + + + EI + L + II L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 483 LGFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
+ D + +V +L + S++ W + EA
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWE-------RKSYWKN-------MLEA 167
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
+ +H ++H D+K +N L+ D +L DFG+A ++ + G Y+
Sbjct: 168 VHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 594 APEYFM-----------YGKVNDKIDVYAFGVVLLELLTGRKP 625
PE K++ K DV++ G +L + G+ P
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 62/243 (25%), Positives = 104/243 (42%), Gaps = 26/243 (10%)
Query: 427 ENLIGKGGSSQVYKGC---LPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNII 480
+ +GKG V L D AVK L+ D ++F EI+I+ LH I+
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 481 SLLGFCFED--NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
G + +L LV ++L G L + L ++ S + + + +EYL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLG 144
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL----- 593
S +R +HRD+ + NIL+ + +++DFGLAK + G
Sbjct: 145 S---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV----VREPGQSPIFWY 197
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652
APE + + DV++FGVVL EL T K S ++ + + + ++ +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP--SAEFLRMMGCERDVPALSRLLE 255
Query: 653 LLD 655
LL+
Sbjct: 256 LLE 258
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-32
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
+IG+G VY G L DGK++ AVK L + +F+ E I+ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 481 SLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
SLLG C + + L+V ++ G L + +P + + VA+ +++L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKFL-- 208
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----A 594
++++ +HRD+ + N +L + F +++DFGLA+ T L A
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVKWMA 264
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
E K K DV++FGV+L EL+T G P
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-32
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IGKG V G G ++AVK +K + F+ E ++T L H N++ LLG
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 487 FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
E+ L +V +++++GSL + L + G K ++ V EA+EYL
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 310
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKV 603
+HRD+ + N+L+S+D ++SDFGL K + T G APE K
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKF 363
Query: 604 NDKIDVYAFGVVLLELLT-GRKP 625
+ K DV++FG++L E+ + GR P
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVP 386
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 8e-32
Identities = 55/201 (27%), Positives = 102/201 (50%), Gaps = 8/201 (3%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
++ +G G +VY+G +AVK LK ++EF+ E ++ + H N++ LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
C + ++ +F++ G+L + L + + +A ++ A+EYL +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEK---KNF 339
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 605
IHR++ + N L+ ++ +++DFGL++ T ++ + APE Y K +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 606 KIDVYAFGVVLLELLT-GRKP 625
K DV+AFGV+L E+ T G P
Sbjct: 399 KSDVWAFGVLLWEIATYGMSP 419
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 51/207 (24%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 427 ENLIGKGGSSQVYKGCL-PDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNI 479
++G G VYKG P+G+++ A+K L+ S KE + E ++ ++ + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
LLG C + L+ + G L + + +K + G + +A+ + YL
Sbjct: 80 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED 135
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+R++HRD+ + N+L+ +++DFGLAK ++A E +
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 600 YGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ + DV+++GV + EL+T G KP
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 61/254 (24%), Positives = 103/254 (40%), Gaps = 28/254 (11%)
Query: 383 SPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGC 442
P + D++ L ++L+ + +Y +Q +G+G +V++
Sbjct: 31 GPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPR------------VGRGSFGEVHRMK 78
Query: 443 -LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501
G + AVK + E E E+ L I+ L G E + + + L
Sbjct: 79 DKQTGFQCAVKKV-RLEVFRVE---ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134
Query: 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD- 560
GSL + + K E LEYLH+ +R++H DVK+ N+LLS D
Sbjct: 135 GSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDG 187
Query: 561 FEPQLSDFGLAK---WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 617
L DFG A S +T + GT ++APE M + K+D+++ ++L
Sbjct: 188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMML 247
Query: 618 ELLTGRKPISNDHP 631
+L G P +
Sbjct: 248 HMLNGCHPWTQYFR 261
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 62/294 (21%), Positives = 117/294 (39%), Gaps = 40/294 (13%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKI--LKPSEDVIKEFVLEIEII-TTLHHKNIISLLGF 485
+G+G V K +P G+ +AVK + K +++++I T+ ++ G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
F + ++ + + + SL++ E K+A+ + +ALE+LHS
Sbjct: 75 LFREGDVWICMELMD-TSLDKFYKQVIDKGQTI--PEDILGKIAVSIVKALEHLHS--KL 129
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
VIHRDVK SN+L++ + ++ DFG++ + + AG Y+APE
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPERINPELN 186
Query: 604 ND----KIDVYAFGVVLLELLTGRKPISN-DHPKGQESLVMWAKPILSSGKVTQLLDPAL 658
K D+++ G+ ++EL R P + P Q V+ P L
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS------------PQL 234
Query: 659 GNNYDYDQMERMVLASILCIRRDPRARP------QMSLVLKLLRGDADVTKWAR 706
+ + C++++ + RP Q DV + +
Sbjct: 235 PADKFSAEFVDFTSQ---CLKKNSKERPTYPELMQHPFFTLHESKGTDVASFVK 285
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 74/297 (24%), Positives = 125/297 (42%), Gaps = 57/297 (19%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKN 478
F L+G G QVYKG + G+ A+K++ + D +E EI ++ HH+N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 479 IISLLG------FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGV 530
I + G D+ L LV +F GS+ + + K + E + + +
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL----KEEWIAYICREI 138
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGT 589
L +LH +VIHRD+K N+LL+++ E +L DFG+ A+ T T GT
Sbjct: 139 LRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGT 192
Query: 590 FGYLAPEYFMYGKVND-----KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA--- 641
++APE + D K D+++ G+ +E+ G P+ + HP M A
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRALFL 245
Query: 642 -----KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
P L S K ++ + + C+ ++ RP ++K
Sbjct: 246 IPRNPAPRLKSKKWSKKF--------------QSFIE--SCLVKNHSQRPATEQLMK 286
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 68/285 (23%), Positives = 112/285 (39%), Gaps = 47/285 (16%)
Query: 427 ENLIGKGGSSQVYKGC---LPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNII 480
+GKG V L D AVK L+ +E+ +++F EIEI+ +L H NI+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 481 SLLGFCFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
G C+ L L+ ++L GSL + L +K+ + + + + +EYL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 131
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL----- 593
+ +R IHRD+ + NIL+ ++ ++ DFGL K G
Sbjct: 132 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK----VKEPGESPIFWY 184
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653
APE K + DV++FGVVL EL T + + + + + + + +L
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 654 LD------------PALGNNYDYDQMERMVLASILCIRRDPRARP 686
L + Y M C + RP
Sbjct: 245 LKNNGRLPRPDGCPDEI-----YMIMTE-------CWNNNVNQRP 277
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 21/209 (10%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IGKG V G G ++AVK +K + F+ E ++T L H N++ LLG
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 487 FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
E+ L +V +++++GSL + L + G K ++ V EA+EYL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKV 603
+HRD+ + N+L+S+D ++SDFGL K AS++ G APE K
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-------TGKLPVKWTAPEALREKKF 191
Query: 604 NDKIDVYAFGVVLLELLT-GRKP---ISN 628
+ K DV++FG++L E+ + GR P I
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRIPL 220
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 21/212 (9%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCF 487
+G G +VYK G A K+++ SE+ ++++++EIEI+ T H I+ LLG +
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 545
D L ++ +F G+++ + + G +E V + EAL +LHS +R+
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHS---KRI 138
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 604
IHRD+K+ N+L++ + + +L+DFG+ AK T + GT ++APE M +
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIGTPYWMAPEVVMCETMK 195
Query: 605 D-----KIDVYAFGVVLLELLTGRKPISNDHP 631
D K D+++ G+ L+E+ P +P
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 52/206 (25%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G G V G ++AVK++K EF E + + L H ++ G C
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
++ + +V +++S G L L + K S+ ++ V E + +L + + I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFL---ESHQFI 126
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL------APEYFMY 600
HRD+ + N L+ D ++SDFG+ ++ + + G APE F Y
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRY-------VLDDQYVSSVGTKFPVKWSAPEVFHY 179
Query: 601 GKVNDKIDVYAFGVVLLELLT-GRKP 625
K + K DV+AFG+++ E+ + G+ P
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLL 483
L+GKG + VY+ + G E+A+K++ +++ E++I L H +I+ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 484 GFCFED-NNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHS 539
FED N + LV + G + L K + A R+ + + + YLHS
Sbjct: 78 N-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEA-----RHFMHQ-IITGMLYLHS 130
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--HITCTDVAGTFGYLAPEY 597
++HRD+ SN+LL+ + +++DFGLA + C GT Y++PE
Sbjct: 131 ---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC----GTPNYISPEI 183
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKP 625
+ DV++ G + LL GR P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 68/285 (23%), Positives = 113/285 (39%), Gaps = 47/285 (16%)
Query: 427 ENLIGKGGSSQVYKGC---LPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNII 480
+GKG V L D AVK L+ +E+ +++F EIEI+ +L H NI+
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 481 SLLGFCFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
G C+ L L+ ++L GSL + L +K+ + + + + +EYL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 162
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL----- 593
+ +R IHRD+ + NIL+ ++ ++ DFGL K + G
Sbjct: 163 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK----VKEPGESPIFWY 215
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653
APE K + DV++FGVVL EL T + + + + + + + +L
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275
Query: 654 LD------------PALGNNYDYDQMERMVLASILCIRRDPRARP 686
L + Y M C + RP
Sbjct: 276 LKNNGRLPRPDGCPDEI-----YMIMTE-------CWNNNVNQRP 308
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 70/318 (22%), Positives = 137/318 (43%), Gaps = 55/318 (17%)
Query: 430 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 481
+G+G VY+G + D E A+K + S EF+ E ++ + +++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALE 535
LLG + L++ + ++RG L+ L + A ++A +A+ +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD--VAGTFGYL 593
YL +A + +HRD+ + N ++++DF ++ DFG+ + I TD G G L
Sbjct: 153 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-------IYETDYYRKGGKGLL 202
Query: 594 -----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISNDHPKGQESLVMWAKPI 644
+PE G DV++FGVVL E+ T +P +SN ++ L
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQVLRF----- 252
Query: 645 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKW 704
+ G + L P + ++ M C + +P+ RP ++ ++ + + +
Sbjct: 253 VMEGGL--LDKPDNCPDMLFELMRM-------CWQYNPKMRPSFLEIISSIKEEME-PGF 302
Query: 705 ARLQVNASEESEMLDDES 722
+ SEE+++ + E
Sbjct: 303 REVSFYYSEENKLPEPEE 320
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 16/209 (7%)
Query: 425 LAENLIGKGGSSQVYKGCL-PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNI 479
+A+ +G G V +G K++ A+K+LK + +E + E +I+ L + I
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
+ L+G C + L+LV + G L + L G +++ S ++ V+ ++YL
Sbjct: 73 VRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL-- 126
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEY 597
+ +HRD+ + N+LL + ++SDFGL+K S+ T AG + + APE
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT-ARSAGKWPLKWYAPEC 184
Query: 598 FMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ K + + DV+++GV + E L+ G+KP
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 50/217 (23%), Positives = 89/217 (41%), Gaps = 30/217 (13%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 485
++G+G ++ V++G G A+K+ + + E E++ L+HKNI+ L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 486 CFED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 540
E+ + +L+ +F GSL L A+G E V V + +L
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLRE- 130
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
++HR++K NI+ + Q L+DFG A+ + GT YL P+
Sbjct: 131 --NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD 185
Query: 597 YFMYGKVND--------KIDVYAFGVVLLELLTGRKP 625
+ + +D+++ GV TG P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 76/284 (26%), Positives = 117/284 (41%), Gaps = 53/284 (18%)
Query: 430 IGKGGSSQVYKGCL---PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 482
+G+G +V C DG AVK LK + EI+I+ TL+H++II
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 483 LGFCFED--NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
G C + +L LV +++ GSL + L + G ++ A + E + YLH+
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHA- 152
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----AP 595
Q IHRD+ + N+LL +D ++ DFGLAK + G AP
Sbjct: 153 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYAP 206
Query: 596 EYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654
E K DV++FGV L ELLT S P L+ A+ ++ ++T+LL
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP--PTKFLELIGIAQGQMTVLRLTELL 264
Query: 655 D------------PALGNNYDYDQMERMVLASILCIRRDPRARP 686
+ + Y M+ C + RP
Sbjct: 265 ERGERLPRPDKCPAEV-----YHLMKN-------CWETEASFRP 296
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 66/296 (22%), Positives = 118/296 (39%), Gaps = 45/296 (15%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEII-TTLHHKNIISLLGF 485
+G G QV+K G +AVK +++ K +++++++ + I+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
+ ++ + + + + + P ER K+ + + +AL YL
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPIP------ERILGKMTVAIVKALYYLKE--KH 144
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
VIHRDVK SNILL + + +L DFG++ AG Y+APE
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---KAKDRSAGCAAYMAPERIDPPDP 201
Query: 604 ND-----KIDVYAFGVVLLELLTGRKPISNDHPK-GQESLVMWAKPILSSGKVTQLLDPA 657
+ DV++ G+ L+EL TG+ P N + V+ +P P
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP------------PL 249
Query: 658 LGNNYDY-DQMERMVLASILCIRRDPRARP------QMSLVLKLLRGDADVTKWAR 706
L + + + V C+ +D R RP + S + + + DV W +
Sbjct: 250 LPGHMGFSGDFQSFVKD---CLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFK 302
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 487
IG+G S VY + G+E+A++ + + KE ++ EI ++ + NI++ L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 545
+ L +V ++L+ GSL + + E V +ALE+LHS +V
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHS---NQV 137
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 605
IHRD+KS NILL D +L+DFG A + + + GT ++APE
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 606 KIDVYAFGVVLLELLTGRKPISNDHP 631
K+D+++ G++ +E++ G P N++P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENP 221
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP---SEDVIKEFVLEIEIITTLHHKNI 479
++G+G V +G L DG L AVK +K S+ I+EF+ E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 480 ISLLGFCFEDN-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG--VAE 532
I LLG C E + +++ F+ G L L ++ + + + +A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV--AGTF 590
+EYL S + +HRD+ + N +L DD ++DFGL+K I D G
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK-------IYSGDYYRQGRI 208
Query: 591 GYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ A E K DV+AFGV + E+ T G P
Sbjct: 209 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLL 483
+GKG VY + +A+K+L S+ V + EIEI + L H NI+ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSG 540
+ + + L+ +F RG L + L + + +A E +A+AL Y H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-------LADALHYCHE- 132
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
++VIHRD+K N+L+ E +++DFG + A + C GT YL PE
Sbjct: 133 --RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLDYLPPEMIEG 186
Query: 601 GKVNDKIDVYAFGVVLLELLTGRKP 625
++K+D++ GV+ E L G P
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-31
Identities = 53/284 (18%), Positives = 93/284 (32%), Gaps = 32/284 (11%)
Query: 369 DSGAIVPVGNEIVSSPLSTDHDST---ELPKELEGLHEKYSATCRLFNYQ---DLLSATS 422
S V N IV +P L K + + C+L + + +
Sbjct: 6 SSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSK 65
Query: 423 NFLAENLIGKGGSSQVYKGC------LPDGKELAVKILKPSEDVIKEFVL---EIEIITT 473
+L+G+G +QVY+ + ++ +K+ KP+ EF + +E +
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKP 123
Query: 474 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP-AAFGWSERYKVAMGVAE 532
+ N +LV + S G+L ++ K P AM +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEP-----------QLSDFGLAKWASTSSSHI 581
+E +H +IH D+K N +L + F L D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
T T G+ E N +ID + + +L G
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
+ +IGKG VY G D + A+K L ++ F+ E ++ L+H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 481 SLLGFCF-EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
+L+G + ++ ++ G L + + +++P + + VA +EYL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV---KDLISFGLQVARGMEYL-- 140
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEY 597
+ Q+ +HRD+ + N +L + F +++DFGLA+ + + A E
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 598 FMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ K DV++FGV+L ELLT G P
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-31
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 33/219 (15%)
Query: 430 IGKGGSSQVYKGCL--PDGKEL--AVKILKP---SEDVIKEFVLEIEIITTLHHKNIISL 482
+GKG V + L DG + AVK+LK + I+EF+ E + H ++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 483 LGFCFED------NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEAL 534
+G +++ F+ G L L ++P + + +A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV--AGTFGY 592
EYL S++ IHRD+ + N +L++D ++DFGL++ I D G
Sbjct: 151 EYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK-------IYSGDYYRQGCASK 200
Query: 593 L-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
L A E DV+AFGV + E++T G+ P
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 72/287 (25%), Positives = 117/287 (40%), Gaps = 51/287 (17%)
Query: 427 ENLIGKGGSSQVYKGCLP-----DGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNI 479
+G+G +V G+++AVK LKP + I + EIEI+ L+H+NI
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 480 ISLLGFCFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+ G C ED + L+ +FL GSL+E L NK ++ K A+ + + ++YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYL 142
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL---- 593
S ++ +HRD+ + N+L+ + + ++ DFGL K T + T
Sbjct: 143 GS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT----VKDDRDSPVFW 195
Query: 594 -APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 651
APE M K DV++FGV L ELLT S ++ ++ ++
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP--MALFLKMIGPTHGQMTVTRLV 253
Query: 652 QLLD------------PALGNNYDYDQMERMVLASILCIRRDPRARP 686
L + Y M + C P R
Sbjct: 254 NTLKEGKRLPCPPNCPDEV-----YQLMRK-------CWEFQPSNRT 288
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 33/293 (11%), Positives = 71/293 (24%), Gaps = 51/293 (17%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLL 483
+ G S V+ + ++ A+K+ + S ++ L ++
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 484 GFC--------------------------FEDNNLLLVYDFL--SRGSLEENLHGNKKDP 515
+ N LL+ L L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 516 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575
G + + + L S + ++H N+ + D L D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 576 TSSSHITCTDVAGTFGYLAPEYFM--YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633
T + Y E+ ++ + G+ + + P P
Sbjct: 246 T-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 634 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP 686
+ S + + + A G+ + ++ L D R R
Sbjct: 301 KGSWKRPSLRVPGTD------SLAFGSCTPLPDFVKTLIGRFL--NFDRRRRL 345
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IG G V+ G + ++A+K ++ ++F+ E E++ L H ++ L G C
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
E + LV +F+ G L + L + F + + V E + YL VI
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYL---EEACVI 126
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKVN 604
HRD+ + N L+ ++ ++SDFG+ ++ + F +PE F + + +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 605 DKIDVYAFGVVLLELLT-GRKP 625
K DV++FGV++ E+ + G+ P
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIP 205
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP----SEDVIKEFVLEIEIITTLHHKN 478
+G G V +G P GK + AVK LKP + + +F+ E+ + +L H+N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+I L G + +V + GSL + L ++ F + A+ VAE + YL
Sbjct: 83 LIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYL- 137
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPE 596
++R IHRD+ + N+LL+ ++ DFGL + + H + + APE
Sbjct: 138 --ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-HRKVPFAWCAPE 194
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ D + FGV L E+ T G++P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-30
Identities = 54/200 (27%), Positives = 102/200 (51%), Gaps = 8/200 (4%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
E +G+G +V+ G +A+K LKP + F+ E +++ L H+ ++ L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
E+ + +V +++S+GSL + L G + +A +A + Y+ +
Sbjct: 249 SEE-PIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER---MNYV 302
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 606
HRD++++NIL+ ++ +++DFGLA+ + + + APE +YG+ K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 607 IDVYAFGVVLLELLT-GRKP 625
DV++FG++L EL T GR P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
E +IG G S +V G L P +++ A+K LK +E ++F+ E I+ H NII
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L G ++V +++ GSL+ L + F + + GV + YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYL--- 167
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----AP 595
S +HRD+ + N+L+ + ++SDFGL++ T G + AP
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD----AAYTTTGGKIPIRWTAP 223
Query: 596 EYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
E + + DV++FGVV+ E+L G +P
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-30
Identities = 54/268 (20%), Positives = 95/268 (35%), Gaps = 49/268 (18%)
Query: 429 LIGKGGSSQVYKG--CLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLG 484
I GG +Y +G+ + +K L S D + E + + + H +I+ +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 485 FCFEDNNLL-----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
F + +V +++ SL+ + +E + + AL YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLH- 199
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+ +++ D+K NI+L+++ + +L D G S + + GT G+ APE
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGY-----LYGTPGFQAPEIVR 250
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659
D+Y G L L + + G DP L
Sbjct: 251 -TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------LPEDDPVLK 292
Query: 660 NNYDYDQMERMVLASILCIRRDPRARPQ 687
YD R++ I DPR R
Sbjct: 293 ---TYDSYGRLLRR---AIDPDPRQRFT 314
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 51/206 (24%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G G V G ++A+K++K EF+ E +++ L H+ ++ L G C
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
+ + ++ ++++ G L L + F + ++ V EA+EYL +++ +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYL---ESKQFL 142
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL------APEYFMY 600
HRD+ + N L++D ++SDFGL+++ + + + G PE MY
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRY-------VLDDEYTSSVGSKFPVRWSPPEVLMY 195
Query: 601 GKVNDKIDVYAFGVVLLELLT-GRKP 625
K + K D++AFGV++ E+ + G+ P
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 425 LAENLIGKGGSSQVYKGCLPDGKEL---AVKILKP---SEDVIKEFVLEIEIITTLHHKN 478
L + +G G V KG K + AVKILK + E + E ++ L +
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
I+ ++G C E + +LV + G L + L N+ ++ V+ ++YL
Sbjct: 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYL- 133
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPE 596
+HRD+ + N+LL ++SDFGL+K ++ G + + APE
Sbjct: 134 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPE 190
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
Y K + K DV++FGV++ E + G+KP
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 17/212 (8%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEII-TTLHHKNIISLLGF 485
IG+G V K P G+ +AVK E K+ +++++++ + I+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
F + + + + +S S ++ E K+ + +AL +L
Sbjct: 90 LFREGDCWICMELMS-TSFDKFYKYVYSVLDD-VIPEEILGKITLATVKALNHLKE--NL 145
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
++IHRD+K SNILL +L DFG++ S I T AG Y+APE
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS---IAKTRDAGCRPYMAPERIDPSAS 202
Query: 604 ND----KIDVYAFGVVLLELLTGRKPISNDHP 631
+ DV++ G+ L EL TGR P +
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-30
Identities = 55/214 (25%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
E +G G +V+ ++AVK +KP ++ F+ E ++ TL H ++ L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
++ + ++ +F+++GSL + L ++ + + +AE + ++ + I
Sbjct: 253 TKE-PIYIITEFMAKGSLLDFLKSDEGSK--QPLPKLIDFSAQIAEGMAFI---EQRNYI 306
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWAS----TSSSH----ITCTDVAGTFGYLAPEYF 598
HRD++++NIL+S +++DFGLA+ T+ I T APE
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT---------APEAI 357
Query: 599 MYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 628
+G K DV++FG++L+E++T GR P +SN
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 59/229 (25%), Positives = 107/229 (46%), Gaps = 40/229 (17%)
Query: 430 IGKGGSSQVYKG----CLPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISL 482
+G+G +V+ P ++ AVK LK + K+F E E++T L H++I+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KVAMGV 530
G C + + L++V++++ G L + L + D + +A +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD--VAG 588
A + YL ++Q +HRD+ + N L+ + ++ DFG+++ + TD G
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-------DVYSTDYYRVG 192
Query: 589 TFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 628
L PE MY K + DV++FGV+L E+ T G++P +SN
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 427 ENLIGKGGSSQVYKGCLPDGK-ELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
++ +G G +VY+G +AVK LK ++EF+ E ++ + H N++ LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
C + ++ +F++ G+L + L + + +A ++ A+EYL +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----APEYFMY 600
IHRD+ + N L+ ++ +++DFGL++ + T A APE Y
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAKFPIKWTAPESLAY 186
Query: 601 GKVNDKIDVYAFGVVLLELLT-GRKP 625
K + K DV+AFGV+L E+ T G P
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 67/261 (25%), Positives = 120/261 (45%), Gaps = 30/261 (11%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 487
IG+G + V G+++AVK++ + +E + E+ I+ H N++ +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 545
L ++ +FL G+L + + + +E V V +AL YLH+ Q V
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVR-------LNEEQIATVCEAVLQALAYLHA---QGV 162
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 605
IHRD+KS +ILL+ D +LSDFG A S + GT ++APE
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRSLYAT 220
Query: 606 KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 665
++D+++ G++++E++ G P +D P +++ + S P L N++
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKR----LRDSPP------PKLKNSHKVS 268
Query: 666 QMERMVLASILCIRRDPRARP 686
+ R L + RDP+ R
Sbjct: 269 PVLRDFLE--RMLVRDPQERA 287
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 39/228 (17%)
Query: 430 IGKGGSSQVYKG----CLPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISL 482
+G+G +V+ LP+ ++ AVK LK SE ++F E E++T L H++I+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 483 LGFCFEDNNLLLVYDFLSRGSL-----------EENLHGNKKDPAAFGWSERYKVAMGVA 531
G C E LL+V++++ G L + G P G + VA VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV--AGT 589
+ YL + +HRD+ + N L+ ++ DFG+++ I TD G
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-------DIYSTDYYRVGG 218
Query: 590 FGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 628
L PE +Y K + DV++FGVVL E+ T G++P +SN
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 61/233 (26%), Positives = 102/233 (43%), Gaps = 41/233 (17%)
Query: 427 ENLIGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKN 478
+G+ +VYKG P + A+K LK + +EF E + L H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENL------------HGNKKDPAAFGWSERYKV 526
++ LLG +D L +++ + S G L E L ++ +A + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD- 585
+A +EYL S+ V+H+D+ + N+L+ D ++SD GL + + D
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-------EVYAADY 183
Query: 586 -VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 628
L APE MYGK + D++++GVVL E+ + G +P SN
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 236
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-30
Identities = 54/200 (27%), Positives = 102/200 (51%), Gaps = 8/200 (4%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
E +G+G +V+ G +A+K LKP + F+ E +++ L H+ ++ L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
E+ + +V +++S+GSL + L G + +A +A + Y+ +
Sbjct: 332 SEE-PIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER---MNYV 385
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 606
HRD++++NIL+ ++ +++DFGLA+ + + + APE +YG+ K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 607 IDVYAFGVVLLELLT-GRKP 625
DV++FG++L EL T GR P
Sbjct: 445 SDVWSFGILLTELTTKGRVP 464
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 430 IGKGGSSQVYKGCL-PDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 482
+G G VYKG P+G+++ A+K L+ S KE + E ++ ++ + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
LG C + L+ + G L + + +K + G + +A+ + YL
Sbjct: 83 LGICLTST-VQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED--- 135
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
+R++HRD+ + N+L+ +++DFGLAK ++A E ++
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 603 VNDKIDVYAFGVVLLELLT-GRKP 625
+ DV+++GV + EL+T G KP
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 483
+GKGG ++ ++ + A KI+ ++ +EI I +L H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 484 GFCFED-NNLLLVYDFLSRGSLEENLHGNKK--DPAAFGWSERYKVAMGVAEALEYLHSG 540
G FED + + +V + R SL E K +P A RY + + +YLH
Sbjct: 82 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-----RYYL-RQIVLGCQYLHR- 133
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--HITCTDVAGTFGYLAPEYF 598
RVIHRD+K N+ L++D E ++ DFGLA + C GT Y+APE
Sbjct: 134 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNYIAPEVL 187
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKP 625
+ ++DV++ G ++ LL G+ P
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 9e-30
Identities = 61/245 (24%), Positives = 116/245 (47%), Gaps = 16/245 (6%)
Query: 389 HDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGK 447
+P + +S L + + L + +A+ +G G V +G K
Sbjct: 303 DKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK 362
Query: 448 EL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 503
++ A+K+LK + +E + E +I+ L + I+ L+G C + L+LV + G
Sbjct: 363 QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 421
Query: 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563
L + L G +++ S ++ V+ ++YL + +HR++ + N+LL +
Sbjct: 422 LHKFLVGKREE---IPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYA 475
Query: 564 QLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
++SDFGL+K S+ T AG + APE + K + + DV+++GV + E L+
Sbjct: 476 KISDFGLSKALGADDSYYT-ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
Query: 622 -GRKP 625
G+KP
Sbjct: 535 YGQKP 539
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-29
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
++G+G ++ V++G G A+K+ + + E E++ L+HKNI+ L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 486 CFED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 540
E+ + +L+ +F GSL L A+G E V V + +L
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLRE- 130
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
++HR++K NI+ + Q L+DFG A+ + GT YL P+
Sbjct: 131 --NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD 185
Query: 597 YFM-----------YGKVNDKIDVYAFGVVLLELLTGRKP 625
+ YG +D+++ GV TG P
Sbjct: 186 MYERAVLRKDHQKKYGA---TVDLWSIGVTFYHAATGSLP 222
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 483
+GKGG ++ ++ + A KI+ ++ +EI I +L H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 484 GFCFED-NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
G FED + + +V + R SL E +P A RY + + +YLH
Sbjct: 108 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-----RYYL-RQIVLGCQYLHR- 159
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--HITCTDVAGTFGYLAPEYF 598
RVIHRD+K N+ L++D E ++ DFGLA + C GT Y+APE
Sbjct: 160 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNYIAPEVL 213
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKP 625
+ ++DV++ G ++ LL G+ P
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G G +V+ G ++AVK LK F+ E ++ L H+ ++ L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
++ + ++ +++ GSL + L ++ +A +AE + ++ + I
Sbjct: 78 TQE-PIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL------APEYFMY 600
HRD++++NIL+SD +++DFGLA+ I + G APE Y
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARL-------IEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 601 GKVNDKIDVYAFGVVLLELLT-GRKP---ISN 628
G K DV++FG++L E++T GR P ++N
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL---AVKILKP--SEDVIKEFVLEIEIITTLHHKNI 479
+ +IG G +VYKG L GK+ A+K LK +E +F+ E I+ H NI
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
I L G + ++++ +++ G+L++ L + F + + G+A ++YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYL-- 163
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----A 594
+ +HRD+ + NIL++ + ++SDFGL++ + G + A
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE----ATYTTSGGKIPIRWTA 218
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
PE Y K DV++FG+V+ E++T G +P
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
+ ++G G +V G L P KE+ A+K LK +E ++F+ E I+ H NII
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L G + +++V +++ GSL+ L + F + + G+A ++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYL--- 163
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----AP 595
S +HRD+ + NIL++ + ++SDFGL + G + +P
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE----AAYTTRGGKIPIRWTSP 219
Query: 596 EYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
E Y K DV+++G+VL E+++ G +P
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
++GKG VY G L + +A+K I + + EI + L HKNI+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 544
E+ + + + + GSL L + +E+ + E L+YLH +
Sbjct: 89 SENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQ 142
Query: 545 VIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
++HRD+K N+L+ + ++SDFG +K + + GT Y+APE G
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQYMAPEIIDKGPR 200
Query: 604 --NDKIDVYAFGVVLLELLTGRKPISN-DHP 631
D+++ G ++E+ TG+ P P
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFYELGEP 231
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 44/226 (19%), Positives = 93/226 (41%), Gaps = 33/226 (14%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILK------------------PSEDVIKEFVLEIEII 471
+ +G +++ C D K A+K + + +F E++II
Sbjct: 39 LNQGKFNKIIL-CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 472 TTLHHKNIISLLGFCFED-NNLLLVYDFLSRGSL----EENLHGNKKDPAAFGWSERYKV 526
T + ++ ++ G + + + ++Y+++ S+ E +K +
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586
V + Y+H+ + + HRDVK SNIL+ + +LSDFG +++ +
Sbjct: 157 IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR--- 211
Query: 587 AGTFGYLAPEYFMYGKV--NDKIDVYAFGVVLLELLTGRKPISNDH 630
GT+ ++ PE+F K+D+++ G+ L + P S
Sbjct: 212 -GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 25/221 (11%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLH 475
F IG G VY + + + +A+K + K S + ++ + E+ + L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEA 533
H N I G ++ LV ++ GS + L +KK E V G +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQG 166
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
L YLHS +IHRDVK+ NILLS+ +L DFG AS + + GT ++
Sbjct: 167 LAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGS---ASIMAPANS---FVGTPYWM 217
Query: 594 APEYFMYGKV---NDKIDVYAFGVVLLELLTGRKPISNDHP 631
APE + + K+DV++ G+ +EL + P+ N +
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
IG+G V++G P+ L A+K K S+ V ++F+ E + H +I+
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L+G +N + ++ + + G L L K + A ++ AL YL
Sbjct: 80 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYL--- 132
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL------A 594
++R +HRD+ + N+L+S + +L DFGL+++ + + A
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-------MEDSTYYKASKGKLPIKWMA 185
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
PE + + DV+ FGV + E+L G KP
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 430 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 481
+G G +VY+G D L AVK L SE +F++E II+ +H+NI+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLH 538
+G + ++ + ++ G L+ L + P++ + VA +A +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQL---SDFGLAKWASTSSSHITCTD--VAGTFGYL 593
IHRD+ + N LL+ ++ DFG+A+ I G L
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRASYYRKGGCAML 207
Query: 594 -----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
PE FM G K D ++FGV+L E+ + G P
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 50/207 (24%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 427 ENLIGKGGSSQVYKGCL-PDGKEL----AVKILK--PSEDVIKEFVLEIEIITTLHHKNI 479
++G G V+KG P+G+ + +K+++ + + I +L H +I
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
+ LLG C + L LV +L GSL +++ ++ G + +A+ + YL
Sbjct: 78 VRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYL-- 131
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
++HR++ + N+LL + Q++DFG+A + ++ ++A E
Sbjct: 132 -EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 600 YGKVNDKIDVYAFGVVLLELLT-GRKP 625
+GK + DV+++GV + EL+T G +P
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-29
Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 22/230 (9%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISL 482
+G G +V E A+KI+ S + + E+ ++ L H NI+ L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 540
F + N LV + G L + + K ++E + V + YLH
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMK------FNEVDAAVIIKQVLSGVTYLHK- 154
Query: 541 SAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
++HRD+K N+LL D ++ DFGL+ + GT Y+APE
Sbjct: 155 --HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEV 209
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 647
K ++K DV++ GV+L LL G P + V K S
Sbjct: 210 LR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS 258
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLLG 484
+GKG +V G+E AVK++ + + + E++++ L H NI+ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSA 542
F + LV + + G L + + K+ +SE ++ V + Y+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKR------FSEVDAARIIRQVLSGITYMHK--- 144
Query: 543 QRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+++HRD+K N+LL S D ++ DFGL+ S D GT Y+APE
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLH 201
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKP 625
G ++K DV++ GV+L LL+G P
Sbjct: 202 -GTYDEKCDVWSTGVILYILLSGCPP 226
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 50/224 (22%), Positives = 91/224 (40%), Gaps = 43/224 (19%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKEL--------AVKILKP-SEDVIKEFVLEIEIITTLHHK 477
+G+G ++++KG + + +K+L + + F +++ L HK
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+++ G C + +LV +F+ GSL+ L NK + +VA +A A+ +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMHFL 129
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQ--------LSDFGLAKWASTSSSHITCTDVAGT 589
+IH +V + NILL + + + LSD G++ V
Sbjct: 130 ---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI------------TVLPK 174
Query: 590 FGY------LAPEYFMYGKV-NDKIDVYAFGVVLLELLT-GRKP 625
+ PE K N D ++FG L E+ + G KP
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 430 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 481
+G G +VY+G D L AVK L SE +F++E II+ +H+NI+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLH 538
+G + ++ + ++ G L+ L + P++ + VA +A +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQL---SDFGLAKWASTSSSHITCTD--VAGTFGYL 593
IHRD+ + N LL+ ++ DFG+A+ I G L
Sbjct: 198 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRAGYYRKGGCAML 248
Query: 594 -----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
PE FM G K D ++FGV+L E+ + G P
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 67/307 (21%), Positives = 119/307 (38%), Gaps = 61/307 (19%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEI-ITTLHHKNII 480
+ ++E ++G G S V G+ +AVK + D ++EI++ + H N+I
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI--DFCDIALMEIKLLTESDDHPNVI 72
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
D L + + L +L+ E+ + + ++ + +A + +L
Sbjct: 73 RYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQ-------------LSDFGLAK--WASTSSSHIT 582
HS ++IHRD+K NIL+S +SDFGL K + SS
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 583 CTDVAGTFGYLAPEYFM-------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635
+ +GT G+ APE ++ ID+++ G V +L+ K HP G +
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK-----HPFGDK 243
Query: 636 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL---------CIRRDPRARP 686
I+ + D+M+ + S++ I DP RP
Sbjct: 244 YSRESN--IIR-------------GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP 288
Query: 687 QMSLVLK 693
VL+
Sbjct: 289 TAMKVLR 295
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 63/231 (27%), Positives = 111/231 (48%), Gaps = 42/231 (18%)
Query: 427 ENLIGKGGSSQVYKGCL-PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 480
+++IG+G QV K + DG + A+K +K S+D ++F E+E++ L HH NII
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KVAM 528
+LLG C L L ++ G+L + L ++ ++ A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD--V 586
VA ++YL S ++ IHRD+ + NIL+ +++ +++DFGL++ + V
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----------GQEVYV 196
Query: 587 AGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 628
T G L A E Y DV+++GV+L E+++ G P ++
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 25/222 (11%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTL-HHKNIISLL 483
++ +GG + VY+ + G+E A+K +L E+ + + E+ + L H NI+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 484 GFCF-------EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
L+ L +G L E L + K+ A+++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA--------- 587
+H +IHRD+K N+LLS+ +L DFG A S +
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 588 -GTFGYLAPEYF-MYGK--VNDKIDVYAFGVVLLELLTGRKP 625
T Y PE +Y + +K D++A G +L L + P
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
++G+G +VY+G G+++ AVK K + D ++F+ E I+ L H +I+
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L+G E+ ++ + G L L NK ++ + +A+ YL
Sbjct: 77 KLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKV---LTLVLYSLQICKAMAYL--- 129
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYL-----A 594
+ +HRD+ NIL++ +L DFGL+++ I D + L +
Sbjct: 130 ESINCVHRDIAVRNILVASPECVKLGDFGLSRY-------IEDEDYYKASVTRLPIKWMS 182
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
PE + + DV+ F V + E+L+ G++P
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 65/211 (30%), Positives = 90/211 (42%), Gaps = 25/211 (11%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKI-----LKPSEDVIKEFVL-EIEIITTLHHKNIISL 482
IGKG S V + G++ AVKI S + E + E I L H +I+ L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 540
L D L +V++F+ L + K+ A F +SE + EAL Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEI--VKRADAGFVYSEAVASHYMRQILEALRYCHD- 148
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE- 596
+IHRDVK +LL+ L FG+A S GT ++APE
Sbjct: 149 --NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGTPHFMAPEV 204
Query: 597 --YFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
YGK +DV+ GV+L LL+G P
Sbjct: 205 VKREPYGK---PVDVWGCGVILFILLSGCLP 232
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 57/238 (23%), Positives = 102/238 (42%), Gaps = 49/238 (20%)
Query: 430 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 481
IG+G +V++ LP AVK+LK S D+ +F E ++ + NI+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY----------------- 524
LLG C + L++++++ G L E L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 525 ---KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581
+A VA + YL S ++ +HRD+ + N L+ ++ +++DFGL++ +I
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-------NI 224
Query: 582 TCTD--VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 628
D A + PE Y + + DV+A+GVVL E+ + G +P +++
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-28
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
IG+G V++G P+ + A+K K S+ V ++F+ E + H +I+
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L+G +N + ++ + + G L L K + A ++ AL YL
Sbjct: 455 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYL--- 507
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV-AGTFGYL-----A 594
++R +HRD+ + N+L+S + +L DFGL+++ + + + G L A
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-------MEDSTYYKASKGKLPIKWMA 560
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
PE + + DV+ FGV + E+L G KP
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-28
Identities = 44/313 (14%), Positives = 97/313 (30%), Gaps = 48/313 (15%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL----KPSEDVIKEFVLEIEIITTL----HHKNI 479
++G+ + G+ V + +P + IK+ E+ + L + K
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 480 ISLLGFCFEDN-----------------------NLLLVYDFL--SRGSLEENLHGNKKD 514
L F F + + +Y + + + E L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 515 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574
+ R ++ + V L LH ++H ++ +I+L L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 575 STSSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISND 629
S+ A + + D + G+ + + P ++D
Sbjct: 262 GASAV-SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320
Query: 630 HPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMS 689
G + + + V LL+ L Y + +R++ + + R ++S
Sbjct: 321 AALGGSEWIFRSCKNIPQP-VRALLEGFL----RYPKEDRLLPLQAMETPEYEQLRTELS 375
Query: 690 LVLKLLRGDADVT 702
L L + D + T
Sbjct: 376 AALPLYQTDGEPT 388
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-28
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISL 482
++GKG +V K +E AVK++ + E+E++ L H NI+ L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 540
+ ++ +V + + G L + + K+ +SE ++ V + Y+H
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKR------FSEHDAARIIKQVFSGITYMHK- 139
Query: 541 SAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
++HRD+K NILL D + ++ DFGL+ ++ D GT Y+APE
Sbjct: 140 --HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEV 194
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKP 625
G ++K DV++ GV+L LL+G P
Sbjct: 195 LR-GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 56/238 (23%), Positives = 107/238 (44%), Gaps = 49/238 (20%)
Query: 430 IGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 481
+G+G +V K K AVK+LK S +++ + E ++ ++H ++I
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG------------ 529
L G C +D LLL+ ++ GSL L ++K + S + +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 530 --------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581
+++ ++YL + +++HRD+ + NIL+++ + ++SDFGL++ +
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD-------V 200
Query: 582 TCTD--VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 628
D V + G + A E + DV++FGV+L E++T G P I
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 63/253 (24%), Positives = 104/253 (41%), Gaps = 46/253 (18%)
Query: 408 TCRLFNYQDLLSATSNFLAENL---------IGKGGSSQVYKGC-LPDGKELAVKILKPS 457
++F + DL + + L +G G +V K++A++I+
Sbjct: 112 RNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKR 171
Query: 458 EDVIKEFVL---------EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL 508
+ I EIEI+ L+H II + F F+ + +V + + G L + +
Sbjct: 172 KFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV 230
Query: 509 HGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ-- 564
GNK+ E + A++YLH +IHRD+K N+LLS E
Sbjct: 231 VGNKR------LKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLI 281
Query: 565 -LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE------YFMYGKVNDKIDVYAFGVVLL 617
++DFG +K +S + GT YLAPE Y + +D ++ GV+L
Sbjct: 282 KITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNR---AVDCWSLGVILF 335
Query: 618 ELLTGRKPISNDH 630
L+G P S
Sbjct: 336 ICLSGYPPFSEHR 348
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-27
Identities = 59/219 (26%), Positives = 89/219 (40%), Gaps = 33/219 (15%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILK--------------PSEDVIKEFVLEIEII 471
+G G +V E A+K++K E +E EI ++
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 472 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMG 529
+L H NII L + LV +F G L E + K + E +
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK------FDECDAANIMKQ 154
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDV 586
+ + YLH ++HRD+K NILL + ++ DFGL+ + S D
Sbjct: 155 ILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDR 208
Query: 587 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
GT Y+APE K N+K DV++ GV++ LL G P
Sbjct: 209 LGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 51/226 (22%), Positives = 94/226 (41%), Gaps = 37/226 (16%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTL-HHK 477
+G G +V + + AVK+LK D + + E++I++ L H+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY----------KVA 527
NI++LLG C +L++ ++ G L L + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-- 585
VA+ + +L +++ IHRDV + N+LL++ ++ DFGLA+ I
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-------DIMNDSNY 220
Query: 586 VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ L APE + DV+++G++L E+ + G P
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 40/317 (12%), Positives = 93/317 (29%), Gaps = 71/317 (22%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL----KPSEDVIKE-------------------- 463
++G+ + G+ V + +P + IK+
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 464 -----FVLEIEIITTLHHKNIISLLGFC--FEDNNLLLVYDFL--SRGSLEENLHGNKKD 514
F+ +++ K +I + + +Y + + + E L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 515 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574
+ R ++ + V L LH ++H ++ +I+L L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 575 STSSSHITCTDVAGTFGYLAPEYFMY-----------GKVNDKIDVYAFGVVLLELLTGR 623
+ + G+ PE + D +A G+V+ +
Sbjct: 257 GAR------VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 624 KPISNDHPKGQESLVMWAKPILSSGK---VTQLLDPALGNNYDYDQMERMVLASILCIRR 680
PI+ D G + + + + L + +R++ +
Sbjct: 311 LPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRY--------PKEDRLLPLQAM---E 359
Query: 681 DP---RARPQMSLVLKL 694
P + R ++S L L
Sbjct: 360 TPEYEQLRTELSAALPL 376
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-27
Identities = 63/234 (26%), Positives = 108/234 (46%), Gaps = 44/234 (18%)
Query: 430 IGKGGSSQVYKGCLPDGKEL--------AVKILKP--SEDVIKEFVLEIEIITTL-HHKN 478
+G+G QV + AVK+LK +E + + V E+E++ + HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KV 526
II+LLG C +D L ++ ++ S+G+L E L + + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD- 585
+A +EYL ++Q+ IHRD+ + N+L++++ +++DFGLA+ I D
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-------DINNIDY 212
Query: 586 -VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISND 629
T G L APE + DV++FGV++ E+ T G P I +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 63/234 (26%), Positives = 108/234 (46%), Gaps = 44/234 (18%)
Query: 430 IGKGGSSQVYKGCLPDGKEL--------AVKILKP--SEDVIKEFVLEIEIITTL-HHKN 478
+G+G QV + AVK+LK +E + + V E+E++ + HKN
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KV 526
II+LLG C +D L ++ ++ S+G+L E L + + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD- 585
+A +EYL ++Q+ IHRD+ + N+L++++ +++DFGLA+ I D
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD-------INNIDY 258
Query: 586 -VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISND 629
T G L APE + DV++FGV++ E+ T G P I +
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 61/207 (29%), Positives = 90/207 (43%), Gaps = 28/207 (13%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCF 487
IG G S + E AVKI+ S+ E EIEI+ H NII+L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQHPNIITLKDVYD 86
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 545
+ + +V + + G L + + K +SER V + + +EYLH+ Q V
Sbjct: 87 DGKYVYVVTELMKGGELLDKILRQKF------FSEREASAVLFTITKTVEYLHA---QGV 137
Query: 546 IHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 599
+HRD+K SNIL D+ + DFG AK + T ++APE
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQ 195
Query: 600 -YGKVNDKIDVYAFGVVLLELLTGRKP 625
Y D+++ GV+L +LTG P
Sbjct: 196 GYDA---ACDIWSLGVLLYTMLTGYTP 219
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-27
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 23/223 (10%)
Query: 423 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNI 479
+ + +G GG V + G+++A+K + S + + LEI+I+ L+H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 480 ISLL------GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVA 531
+S ++ LL ++ G L + L+ + G E + ++
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDIS 131
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAG 588
AL YLH R+IHRD+K NI+L + + D G AK CT+ G
Sbjct: 132 SALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVG 185
Query: 589 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
T YLAPE K +D ++FG + E +TG +P +
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 59/248 (23%), Positives = 89/248 (35%), Gaps = 58/248 (23%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILK------PSEDVIKEFVLEIEIITTLHHKNIISL 482
IG+G V A+KI+ + ++ E+ ++ LHH NI L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 483 LGFCFEDNNLLLVYDFLSRGSL----------------------------------EENL 508
++ + LV + G L
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 509 HGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQ 564
++ F E+ + + AL YLH+ Q + HRD+K N L S FE +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIK 210
Query: 565 LSDFGLAKW--ASTSSSHITCTDVAGTFGYLAPE-----YFMYGKVNDKIDVYAFGVVLL 617
L DFGL+K + + T AGT ++APE YG K D ++ GV+L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP---KCDAWSAGVLLH 267
Query: 618 ELLTGRKP 625
LL G P
Sbjct: 268 LLLMGAVP 275
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 44/218 (20%)
Query: 427 ENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLG 484
++G G S+V+ GK A+K +K S + EI ++ + H+NI++L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 485 FCFED-NNLLLVYDFLS----------RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
+E + LV +S RG E KD + V V A
Sbjct: 74 I-YESTTHYYLVMQLVSGGELFDRILERGVYTE------KDAS--------LVIQQVLSA 118
Query: 534 LEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
++YLH ++HRD+K N+L ++ + ++DFGL+K + GT
Sbjct: 119 VKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTP 171
Query: 591 GYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 625
GY+APE Y K +D ++ GV+ LL G P
Sbjct: 172 GYVAPEVLAQKPYSK---AVDCWSIGVITYILLCGYPP 206
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G G V+ G E +K + S+ +++ EIE++ +L H NII +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 544
+ +N+ +V + G L E + + A SE Y ++ + AL Y HS Q
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKAL--SEGYVAELMKQMMNALAYFHS---QH 144
Query: 545 VIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
V+H+D+K NIL S ++ DFGLA+ + T+ AGT Y+APE F
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-R 200
Query: 602 KVNDKIDVYAFGVVLLELLTGRKP 625
V K D+++ GVV+ LLTG P
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 53/227 (23%), Positives = 104/227 (45%), Gaps = 28/227 (12%)
Query: 425 LAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISL 482
L++ ++G G + +V + G++ A+K+L S +E ++ +I+ +
Sbjct: 32 LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE----VDHHWQASGGPHIVCI 87
Query: 483 LGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALE 535
L +E+ LL++ + + G L + ++ AF +ER ++ + A++
Sbjct: 88 LDV-YENMHHGKRCLLIIMECMEGGELFSRIQ--ERGDQAF--TEREAAEIMRDIGTAIQ 142
Query: 536 YLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
+LHS + HRDVK N+L D +L+DFG AK + ++ C T Y
Sbjct: 143 FLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC----YTPYY 195
Query: 593 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639
+APE K + D+++ GV++ LL G P ++ + +
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK 242
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 64/234 (27%), Positives = 112/234 (47%), Gaps = 44/234 (18%)
Query: 430 IGKGGSSQVYKGCLPDGKEL--------AVKILKP--SEDVIKEFVLEIEIITTL-HHKN 478
+G+G QV + AVK+LK +E + + + E+E++ + HKN
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK----------VAM 528
II+LLG C +D L ++ ++ S+G+L E L + + ++ + V+
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 529 G--VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD- 585
VA +EYL ++++ IHRD+ + N+L+++D +++DFGLA+ I D
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-------DIHHIDY 246
Query: 586 -VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISND 629
T G L APE + DV++FGV+L E+ T G P + +
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 430 IGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 486
+G G V++ C+ G+ K + + K V EI I+ LHH +I+L
Sbjct: 59 LGSGAFGVVHR-CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA- 116
Query: 487 FED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
FED ++L+ +FLS G L + + +D + SE E L+++H
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRI--AAED---YKMSEAEVINYMRQACEGLKHMHE---H 168
Query: 544 RVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
++H D+K NI+ + DFGLA + T + APE
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDRE 225
Query: 602 KVNDKIDVYAFGVVLLELLTGRKP 625
V D++A GV+ LL+G P
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 55/226 (24%), Positives = 100/226 (44%), Gaps = 40/226 (17%)
Query: 430 IGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 480
+G+G QV + + AVK+LK + + + E++I+ + HH N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 481 SLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KVA 527
+LLG C + L+++ +F G+L L + + + + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV- 586
VA+ +E+L ++++ IHRD+ + NILLS+ ++ DFGLA+ I
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD-------IYKDPDY 204
Query: 587 -AGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
L APE + DV++FGV+L E+ + G P
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+GKG +V K +E AVK++ + E+E++ L H NI+ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
+ ++ +V + + G L + + K+ +SE ++ V + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKR------FSEHDAARIIKQVFSGITYMHK---H 140
Query: 544 RVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM- 599
++HRD+K NILL D + ++ DFGL+ ++ D GT Y+APE
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG 197
Query: 600 -YGKVNDKIDVYAFGVVLLELLTGRKP 625
Y + K DV++ GV+L LL+G P
Sbjct: 198 TYDE---KCDVWSAGVILYILLSGTPP 221
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 62/234 (26%), Positives = 110/234 (47%), Gaps = 40/234 (17%)
Query: 419 SATSNF-----LAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEII 471
S + F L E+++G+G ++V L +E AVKI++ I+ V E+E++
Sbjct: 5 SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEML 64
Query: 472 TTL-HHKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVA 527
H+N++ L+ F FE+ + LV++ + GS+ ++H + ++E V
Sbjct: 65 YQCQGHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIHKRRH------FNELEASVVV 117
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP---QLSDFGLAK-----WASTSSS 579
VA AL++LH+ + + HRD+K NIL + ++ DF L + S
Sbjct: 118 QDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 580 HITCTDVAGTFGYLAPE--------YFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
G+ Y+APE +Y K + D+++ GV+L LL+G P
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDK---RCDLWSLGVILYILLSGYPP 225
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 425 LAENLIGKGGSSQVYKGC-LPDGKELAVK-ILKPSEDVIKEFVLEIEIITTL-HHKNIIS 481
L + +G+G S K + AVK I K E ++ EI + H NI+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVK 70
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHS 539
L + + LV + L+ G L E + K +SE + + A+ ++H
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKH------FSETEASYIMRKLVSAVSHMHD 124
Query: 540 GSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
V+HRD+K N+L +D+ E ++ DFG A+ + + T Y APE
Sbjct: 125 ---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK--TPCFTLHYAAPE 179
Query: 597 YFM---YGKVNDKIDVYAFGVVLLELLTGRKP 625
Y + D+++ GV+L +L+G+ P
Sbjct: 180 LLNQNGYDE---SCDLWSLGVILYTMLSGQVP 208
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 38/227 (16%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPS----------EDVIKEFVLEIEIITTL-HHK 477
+G+G SS V + P KE AVKI+ + +++ + + E++I+ + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALE 535
NII L + LV+D + +G L + L SE+ K+ + E +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT------LSEKETRKIMRALLEVIC 138
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
LH ++HRD+K NILL DD +L+DFG + +V GT YLAP
Sbjct: 139 ALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAP 192
Query: 596 EYFM---------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633
E YGK ++D+++ GV++ LL G P +
Sbjct: 193 EIIECSMNDNHPGYGK---EVDMWSTGVIMYTLLAGSPPFWHRKQML 236
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 60/206 (29%), Positives = 86/206 (41%), Gaps = 26/206 (12%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 487
IG+G +V A K I K + + F EIEI+ +L H NII L F
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-F 75
Query: 488 ED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 544
ED ++ LV + + G L E + + + E ++ V A+ Y H
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRV------FRESDAARIMKDVLSAVAYCHK---LN 126
Query: 545 VIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 599
V HRD+K N L S D +L DFGLA GT Y++P+
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL 183
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKP 625
YG + D ++ GV++ LL G P
Sbjct: 184 YGP---ECDEWSAGVMMYVLLCGYPP 206
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 37/222 (16%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL---------EIEIITTLHHKNI 479
+G G +V K++A+KI+ + I EIEI+ L+H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYL 537
I + F F+ + +V + + G L + + GNK+ E + A++YL
Sbjct: 78 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR------LKEATCKLYFYQMLLAVQYL 130
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
H +IHRD+K N+LLS E ++DFG +K +S + GT YLA
Sbjct: 131 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLA 184
Query: 595 PE------YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630
PE Y + +D ++ GV+L L+G P S
Sbjct: 185 PEVLVSVGTAGYNR---AVDCWSLGVILFICLSGYPPFSEHR 223
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 54/228 (23%), Positives = 103/228 (45%), Gaps = 27/228 (11%)
Query: 424 FLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIIS 481
+ ++G G + +V + ++ A+K+L+ +E +E+ +I+
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVR 119
Query: 482 LLGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEAL 534
++ +E+ LL+V + L G L + + AF +ER ++ + EA+
Sbjct: 120 IVDV-YENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAF--TEREASEIMKSIGEAI 174
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEP---QLSDFGLAKWASTSSSHITCTDVAGTFG 591
+YLHS + HRDVK N+L + +L+DFG AK ++ + + T T
Sbjct: 175 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPY 228
Query: 592 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639
Y+APE K + D+++ GV++ LL G P ++H +
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 43/205 (20%), Positives = 83/205 (40%), Gaps = 24/205 (11%)
Query: 430 IGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 487
+G+G V++ C+ K K +K EI I+ H+NI+ L
Sbjct: 13 LGRGEFGIVHR-CVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 488 EDNNLLLVYDFLSRGSL-----EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
L+++++F+S + N+++ ++ V EAL++LHS
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSY--------VHQVCEALQFLHS--- 120
Query: 543 QRVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
+ H D++ NI+ + +FG A+ + + Y APE +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQH 177
Query: 601 GKVNDKIDVYAFGVVLLELLTGRKP 625
V+ D+++ G ++ LL+G P
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINP 202
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 52/227 (22%), Positives = 91/227 (40%), Gaps = 41/227 (18%)
Query: 430 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 480
+G G +V + + + AVK+LKP + + E+++++ L +H NI+
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG----------- 529
+LLG C L++ ++ G L L + S
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 530 ---VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586
VA+ + +L +++ IHRD+ + NILL+ ++ DFGLA+ I
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-------DIKNDSN 200
Query: 587 --AGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
L APE + DV+++G+ L EL + G P
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 51/232 (21%), Positives = 94/232 (40%), Gaps = 46/232 (19%)
Query: 430 IGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 480
+G G +V + AVK+LK + + E++++T L H+NI+
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG----------- 529
+LLG C + L++++ G L L ++ + + +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 530 --------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581
VA+ +E+L + +HRD+ + N+L++ ++ DFGLA+ I
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-------DI 222
Query: 582 TCTD--VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
V L APE G K DV+++G++L E+ + G P
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+GKG S V + G E A KI+ K S ++ E I L H NI+ L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
E++ LV+D ++ G L E++ + +SE + E++ Y HS
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREF------YSEADASHCIQQILESIAYCHS---N 124
Query: 544 RVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM- 599
++HR++K N+LL+ + L+DFGLA + S AGT GYL+PE
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKK 181
Query: 600 --YGKVNDKIDVYAFGVVLLELLTGRKP 625
Y K +D++A GV+L LL G P
Sbjct: 182 DPYSK---PVDIWACGVILYILLVGYPP 206
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 423 NFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNI 479
++G G QV+K C G +LA KI+K KE V EI ++ L H N+
Sbjct: 90 TVSKTEILGGGRFGQVHK-CEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANL 148
Query: 480 ISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEY 536
I L FE N+++LV +++ G L + + + + +E + E + +
Sbjct: 149 IQLYDA-FESKNDIVLVMEYVDGGELFDRI--IDES---YNLTELDTILFMKQICEGIRH 202
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYLA 594
+H ++H D+K NIL + Q+ DFGLA+ GT +LA
Sbjct: 203 MHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLA 256
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
PE Y V+ D+++ GV+ LL+G P
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-25
Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 25/206 (12%)
Query: 430 IGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 486
+G G V++ G A K + + KE V EI+ ++ L H +++L
Sbjct: 165 LGTGAFGVVHR-VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 487 FEDNNLLLVYDFLSRGSL-----EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
+DN ++++Y+F+S G L +E+ ++ + + V + L ++H
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY--------MRQVCKGLCHMHE-- 273
Query: 542 AQRVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+H D+K NI+ + +L DFGL S GT + APE
Sbjct: 274 -NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAE 329
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKP 625
V D+++ GV+ LL+G P
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 54/240 (22%), Positives = 100/240 (41%), Gaps = 27/240 (11%)
Query: 402 HEKYSATCRLFNYQDLLSATSNF-----LAENLIGKGGSSQVYKG-CLPDGKELAVKIL- 454
H +S+ L + NF L +G+G + V + G+E A K L
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 455 --KPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHG 510
+ +D E + EI ++ +I+L +E+ + ++L+ ++ + G +
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV-YENTSEIILILEYAAGGEIFSLCL- 121
Query: 511 NKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ---L 565
+ SE ++ + E + YLH ++H D+K NILLS + +
Sbjct: 122 -PELAEMV--SENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKI 175
Query: 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
DFG+++ + ++ GT YLAPE Y + D++ G++ LLT P
Sbjct: 176 VDFGMSRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 37/218 (16%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILK---------PSEDVIKEFVLEIEIITTLH-HKN 478
IG+G SS V + G E AVKI++ E+V + E I+ + H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEY 536
II+L+ + + LV+D + +G L + L SE+ + + EA+ +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA------LSEKETRSIMRSLLEAVSF 215
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
LH+ ++HRD+K NILL D+ + +LSDFG + ++ GT GYLAPE
Sbjct: 216 LHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPE 269
Query: 597 ---------YFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
+ YGK ++D++A GV+L LL G P
Sbjct: 270 ILKCSMDETHPGYGK---EVDLWACGVILFTLLAGSPP 304
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+GKG S V + G E A KI+ K S ++ E I L H NI+ L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
E++ LV+D ++ G L E++ + +SE + E++ Y HS
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREF------YSEADASHCIQQILESIAYCHS---N 147
Query: 544 RVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM- 599
++HR++K N+LL+ + L+DFGLA + S AGT GYL+PE
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKK 204
Query: 600 --YGKVNDKIDVYAFGVVLLELLTGRKP 625
Y K +D++A GV+L LL G P
Sbjct: 205 DPYSK---PVDIWACGVILYILLVGYPP 229
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+GKG S V + + G+E A I+ K S ++ E I L H NI+ L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
E+ + L++D ++ G L E++ + +SE + EA+ + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREY------YSEADASHCIQQILEAVLHCHQ---M 129
Query: 544 RVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM- 599
V+HR++K N+LL +L+DFGLA AGT GYL+PE
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--FGFAGTPGYLSPEVLRK 187
Query: 600 --YGKVNDKIDVYAFGVVLLELLTGRKP 625
YGK +D++A GV+L LL G P
Sbjct: 188 DPYGK---PVDLWACGVILYILLVGYPP 212
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 49/247 (19%), Positives = 93/247 (37%), Gaps = 32/247 (12%)
Query: 457 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 516
S + ++I + KN + L L + + +L++ +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD-WMNRRCSLE 159
Query: 517 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576
+ + +AEA+E+LHS + ++HRD+K SNI + D ++ DFGL
Sbjct: 160 DREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216
Query: 577 SSSHITC----------TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
T T GT Y++PE + K+D+++ G++L ELL
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST- 275
Query: 627 SNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP 686
E + + + + K L E M++ +L P RP
Sbjct: 276 ------QMERVRIITD--VRNLKFPLLFT-------QKYPQEHMMVQDMLS--PSPTERP 318
Query: 687 QMSLVLK 693
+ + +++
Sbjct: 319 EATDIIE 325
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 34/213 (15%)
Query: 429 LIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIK----EFVL-EIEIITTLHHKNI 479
++G+G S V +E A+KIL+ +IK +V E ++++ L H
Sbjct: 37 ILGEGSFSTVVLARELA---TSREYAIKILE-KRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 480 ISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALE 535
+ L F F+D+ L + G L + + F +E + ALE
Sbjct: 93 VKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-------IVSALE 144
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
YLH + +IHRD+K NILL++D Q++DFG AK S S GT Y++P
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 596 EYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 625
E K D++A G ++ +L+ G P
Sbjct: 202 ELLTEKSACKS---SDLWALGCIIYQLVAGLPP 231
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 430 IGKGGSSQVYKGCL--PDGKELAVKILK------PSEDVIKEFVL-EIEIITTLHHKNII 480
+G G + V K C G E A K +K V +E + E+ I+ + H N+I
Sbjct: 20 LGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 538
+L +++L+ + +S G L + L SE + + + YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
+ +++ H D+K NI+L D P L DFGLA ++ GT ++A
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVA 186
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
PE Y + + D+++ GV+ LL+G P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 487
+G+G +S VY+ K A+K+LK + D K EI ++ L H NII L F
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-KKIVRTEIGVLLRLSHPNIIKLKEI-F 117
Query: 488 ED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 544
E + LV + ++ G L + + +SER + EA+ YLH
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGY------YSERDAADAVKQILEAVAYLHE---NG 168
Query: 545 VIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 599
++HRD+K N+L + D +++DFGL+K V GT GY APE
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGC 225
Query: 600 -YGKVNDKIDVYAFGVVLLELLTGRKP 625
YG ++D+++ G++ LL G +P
Sbjct: 226 AYGP---EVDMWSVGIITYILLCGFEP 249
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILK-------PSEDVIKEFVLEIEIITTLHHKNIIS 481
+G G + V K GKE A K +K +E E+ I+ + H NII+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHS 539
L +++L+ + +S G L + L + +E + + + + YLHS
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKES------LTEDEATQFLKQILDGVHYLHS 126
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
+R+ H D+K NI+L D P L DFG+A + ++ GT ++AP
Sbjct: 127 ---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAP 180
Query: 596 EYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
E Y + + D+++ GV+ LL+G P
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 430 IGKGGSSQVYKGCL--PDGKELAVKILK------PSEDVIKEFVL-EIEIITTLHHKNII 480
+G G + V K C G E A K +K V +E + E+ I+ + H NII
Sbjct: 20 LGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 538
+L +++L+ + +S G L + L SE + + + YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
+ +++ H D+K NI+L D P L DFGLA ++ GT ++A
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVA 186
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
PE Y + + D+++ GV+ LL+G P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 46/220 (20%)
Query: 430 IGKGGSSQVYKGCL--PDGKELAVKILK------PSEDVIKEFVL-EIEIITTLHHKNII 480
+G G + V K C G + A K +K V +E + E+ I+ + H N+I
Sbjct: 19 LGSGQFAVVKK-CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 481 SLLGFCFED-NNLLLVYDFLS----------RGSLEENLHGNKKDPAAFGWSERYKVAMG 529
+L +E+ +++L+ + ++ + SL E ++ F
Sbjct: 78 TLHEV-YENKTDVILILELVAGGELFDFLAEKESLTE------EEATEF--------LKQ 122
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTD 585
+ + YLHS ++ H D+K NI+L D P+ + DFGLA + +
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 176
Query: 586 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
+ GT ++APE Y + + D+++ GV+ LL+G P
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 38/215 (17%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFV----LEIEIITTLHHKNIISLL 483
IGKG +V D K++ A+K + + V + V E++I+ L H +++L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 484 GFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAE---ALEY 536
+ F+D ++ +V D L G L +L N + + + E AL+Y
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-----F-----ICELVMALDY 130
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
L + QR+IHRD+K NILL + ++DF +A + T +AGT Y+APE
Sbjct: 131 LQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT---MAGTKPYMAPE 184
Query: 597 YFM------YGKVNDKIDVYAFGVVLLELLTGRKP 625
F Y +D ++ GV ELL GR+P
Sbjct: 185 MFSSRKGAGYSFA---VDWWSLGVTAYELLRGRRP 216
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 40/279 (14%), Positives = 84/279 (30%), Gaps = 57/279 (20%)
Query: 429 LIGKGGSSQVYKGCLPD---GKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIIS 481
G Q ++ D +++A+ + P +DV++E + ++ + +
Sbjct: 38 FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
+L L+V +++ GSL+E + A + +A A + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA------IRAMQSLAAAADAAH--- 146
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
V S + +S D G +
Sbjct: 147 RAGVALSIDHPSRVRVSID--------GDVV--------------LAYPATMPD------ 178
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661
N + D+ G L LL R P+ + + Q ++PA +
Sbjct: 179 -ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-------RDTAGQPIEPADIDR 230
Query: 662 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 700
Q+ + ++ D R +L+ + + A
Sbjct: 231 DIPFQISAVAAR---SVQGDGGIRSASTLLNLMQQATAV 266
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 56/267 (20%), Positives = 102/267 (38%), Gaps = 44/267 (16%)
Query: 382 SSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG 441
SS H S +P+ +L ++ S + L+G GG VY G
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62
Query: 442 C-LPDGKELAVKILK-------PSEDVIKEFVLEIEIITTLHHK--NIISLLGFCFEDNN 491
+ D +A+K ++ +E+ ++ + +I LL + ++
Sbjct: 63 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122
Query: 492 LLLV----------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
+L+ +DF+ RG+L+E V EA+ + H+
Sbjct: 123 FVLILERPEPVQDLFDFITERGALQEE--------------LARSFFWQVLEAVRHCHN- 167
Query: 541 SAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
V+HRD+K NIL+ + E +L DFG + GT Y PE+
Sbjct: 168 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 221
Query: 600 YGKVN-DKIDVYAFGVVLLELLTGRKP 625
Y + + V++ G++L +++ G P
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 3e-21
Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 36/233 (15%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNII 480
++F +IG+GG +VY D ++ A+K L + IK + L+ + ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD--KKRIKM---KQGETLALNERIML 243
Query: 481 SL-----------LGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYK 525
SL + + F L + D ++ G L +L + F +E
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE--- 300
Query: 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 585
+ LE++H+ + V++RD+K +NILL + ++SD GLA S H +
Sbjct: 301 ----IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 351
Query: 586 VAGTFGYLAPEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPISNDHPKGQESL 637
GT GY+APE G D D ++ G +L +LL G P K + +
Sbjct: 352 --GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 50/222 (22%), Positives = 86/222 (38%), Gaps = 46/222 (20%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL------KPSEDVIKEFV-LEIEIITTLH----H 476
L+GKGG V+ G L D ++A+K++ S LE+ ++ + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 477 KNIISLLGFCFEDNNLLLV----------YDFL-SRGSLEENLHGNKKDPAAFGWSERYK 525
+I LL + +LV +D++ +G L E
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG--------------PSRC 143
Query: 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCT 584
V A+++ HS + V+HRD+K NIL+ +L DFG
Sbjct: 144 FFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD- 199
Query: 585 DVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKP 625
GT Y PE+ + + V++ G++L +++ G P
Sbjct: 200 ---GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKE------FVLEIEIITTLHHKNIIS 481
++G+GG +V+ + +L A K L + +K+ ++E +I+ +H + I+S
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLN--KKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 482 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVAEALEYL 537
L + FE +L LV ++ G + +++ +D F E + A + LE+L
Sbjct: 250 LA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF--QEPRAIFYTAQ-IVSGLEHL 305
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
H + +I+RD+K N+LL DD ++SD GLA + T AGT G++APE
Sbjct: 306 HQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKG-YAGTPGFMAPEL 360
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKP 625
+ + + +D +A GV L E++ R P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 44/226 (19%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK---------PSEDVIKEFVLEIEIIT 472
+ + +G G V+ KE+ VK +K + + + LEI I++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 473 TLHHKNIISLLGFCFEDNNLLLV----------YDFLSRGSLEENLHGNKKDPAAFGWSE 522
+ H NII +L LV + F+ R H +P A
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-------HPRLDEPLA----- 132
Query: 523 RYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HI 581
Y + A+ YL + +IHRD+K NI++++DF +L DFG A + +
Sbjct: 133 SYIFRQ-LVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188
Query: 582 TCTDVAGTFGYLAPEYFMYGKVND--KIDVYAFGVVLLELLTGRKP 625
C GT Y APE M G ++++++ GV L L+ P
Sbjct: 189 FC----GTIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-20
Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 33/225 (14%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIK----EFVL-EIEIITTLH 475
F +G G +V + A+KIL + V+K E L E I+ ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 476 HKNIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVA 531
++ L F F+DN NL +V ++++ G + +L + A F Y A +
Sbjct: 100 FPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-----Y--AAQIV 151
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 591
EYLHS +I+RD+K N+L+ Q++DFG AK T T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWT-LCGTPE 203
Query: 592 YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633
LAPE + Y K +D +A GV++ E+ G P D P
Sbjct: 204 ALAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 5e-20
Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 56/229 (24%)
Query: 423 NFLAENLIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKN 478
L ++G+G +V+ K D ++L A+K+LK K + + + T ++
Sbjct: 27 ELLK--VLGQGSFGKVFLVKKISGSDARQLYAMKVLK------KATLKVRDRVRTKMERD 78
Query: 479 IISL--------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKV 526
I+ L + F+ + L L+ DFL G L L + F Y
Sbjct: 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-----Y-- 131
Query: 527 AMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
+AE AL++LHS +I+RD+K NILL ++ +L+DFGL+K I
Sbjct: 132 ---LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDH 179
Query: 584 TDVAGTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 625
A +F G Y+APE + + D ++FGV++ E+LTG P
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQS---ADWWSFGVLMFEMLTGTLP 225
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 9e-20
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 32/215 (14%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILK-----PSEDVIKEFVLEIEIITTLHHKNIISL 482
L+G+G +V + AVKILK + EI+++ L HKN+I L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 483 LGFCF--EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA--------E 532
+ + E + +V ++ G E + + A +
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE-----------MLDSVPEKRFPVCQAHGYFCQLID 120
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
LEYLHS Q ++H+D+K N+LL+ ++S G+A+ ++ TC G+ +
Sbjct: 121 GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 593 LAPEYFMYGKVND--KIDVYAFGVVLLELLTGRKP 625
PE K+D+++ GV L + TG P
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 71/277 (25%), Positives = 109/277 (39%), Gaps = 56/277 (20%)
Query: 385 LSTDHDSTELPKE--LEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVY--- 439
L D D L K ++ +Y T +DL ++ +IG+G +V
Sbjct: 32 LVYDLDFPALRKNKNIDNFLSRYKDTIN--KIRDLRMKAEDYEVVKVIGRGAFGEVQLVR 89
Query: 440 -KGCLPDGKELAVKILKPSEDVIK----EFVL-EIEIITTLHHKNIISLLGFCFEDN-NL 492
K K A+K+L E +IK F E +I+ + ++ L + F+D+ L
Sbjct: 90 HKS---TRKVYAMKLLSKFE-MIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYL 144
Query: 493 LLVYDF---------LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+V ++ +S + E A F +E V AL+ +HS
Sbjct: 145 YMVMEYMPGGDLVNLMSNYDVPE-------KWARFYTAE-------VVLALDAIHS---M 187
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE------- 596
IHRDVK N+LL +L+DFG + T V GT Y++PE
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGG 246
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633
YG+ D ++ GV L E+L G P D G
Sbjct: 247 DGYYGRE---CDWWSVGVFLYEMLVGDTPFYADSLVG 280
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
IGKG ++V + G+E+A+KI+ + + +++ E+ I+ L+H NI+ L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 486 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+ L L+ ++ S G + + L HG K+ A R + A++Y H +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA-----R-SKFRQIVSAVQYCHQ---K 133
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HITCTDVAGTFGYLAPEYFMYGK 602
R++HRD+K+ N+LL D +++DFG + + C G Y APE F GK
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAPPYAAPELFQ-GK 188
Query: 603 VND--KIDVYAFGVVLLELLTGRKP 625
D ++DV++ GV+L L++G P
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 66/236 (27%), Positives = 103/236 (43%), Gaps = 42/236 (17%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
+L L+GKG +V A+KILK KE ++ E+ TL ++
Sbjct: 151 EYLK--LLGKGTFGKVILVKEKATGRYYAMKILK------KEVIVAKDEVAHTLTENRVL 202
Query: 481 SL--------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAM 528
L + F+ + L V ++ + G L +L + D A F +E
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE------ 256
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
+ AL+YLHS + V++RD+K N++L D +++DFGL K I
Sbjct: 257 -IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK------EGIKDGATMK 307
Query: 589 TF----GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP-ISNDHPKGQESLVM 639
TF YLAPE +D + GVV+ E++ GR P + DH K E ++M
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 363
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-19
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 29/210 (13%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKE------FVLEIEIITTLHHKNIIS 481
++GKGG +V + ++ A K L+ + IK+ + E +I+ ++ + ++S
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLE--KKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 482 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDP-----AAFGWSERYKVAMGVAEALE 535
L + +E + L LV ++ G L+ +++ + A F +E + LE
Sbjct: 249 L-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-------ICCGLE 300
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
LH +R+++RD+K NILL D ++SD GLA V GT GY+AP
Sbjct: 301 DLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIKGRV-GTVGYMAP 354
Query: 596 EYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
E + D +A G +L E++ G+ P
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 20/216 (9%)
Query: 418 LSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK-PSEDVIKEFVL-EIEIITTL 474
+S++S F +G G + VYKG G +A+K +K SE+ + EI ++ L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 475 HHKNIISLLGFCFEDNNLLLVYDFLS---RGSLEENLHGNKKDPAAFGWSERYKVAMGVA 531
H+NI+ L +N L LV++F+ + ++ P + +
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDS--RTVGNTPRGLELNLVKYFQWQLL 118
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 591
+ L + H +++HRD+K N+L++ + +L DFGLA+ + + V T
Sbjct: 119 QGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLW 173
Query: 592 YLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGR 623
Y AP+ M Y ID+++ G +L E++TG+
Sbjct: 174 YRAPDVLMGSRTYST---SIDIWSCGCILAEMITGK 206
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 48/228 (21%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
++L L+GKG +V A+KIL+ KE ++ E+ T+ ++
Sbjct: 8 DYLK--LLGKGTFGKVILVREKATGRYYAMKILR------KEVIIAKDEVAHTVTESRVL 59
Query: 481 SL--------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAM 528
L + F+ + L V ++ + G L +L + + A F +E
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE------ 113
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
+ ALEYLHS + V++RD+K N++L D +++DFGL K I+
Sbjct: 114 -IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATMK 163
Query: 589 TF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISND 629
TF G YLAPE YG+ +D + GVV+ E++ GR P N
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLPFYNQ 208
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 5e-19
Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 430 IGKGGSSQVYKGC---LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G+G VYK D K+ A+K ++ + EI ++ L H N+ISL
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE-GTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 487 FE--DNNLLLVYDFLS---RGSLEENLHGNKKDPAA-FGWSERYKVAMGVAEALEYLHSG 540
D + L++D+ ++ + + + + + YLH+
Sbjct: 88 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA- 146
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWAST---SSSHITCTDVAGTFGYL 593
V+HRD+K +NIL+ + + ++D G A+ ++ + + V TF Y
Sbjct: 147 --NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--TFWYR 202
Query: 594 APEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 626
APE + Y K ID++A G + ELLT +PI
Sbjct: 203 APELLLGARHYTK---AIDIWAIGCIFAELLT-SEPI 235
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 9e-19
Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 47/232 (20%)
Query: 422 SNFLAENLIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIK----EFVL-EIEIIT 472
+F +G G +V+ + +G+ A+K+LK E V++ E E +++
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLS 61
Query: 473 TLHHKNIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAM 528
+ H II + F+D + ++ D++ G L L +++ A F +E
Sbjct: 62 IVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE------ 114
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
V ALEYLHS + +I+RD+K NILL + +++DFG AK DV
Sbjct: 115 -VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK---------YVPDVTY 161
Query: 589 TF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633
T G Y+APE Y K ID ++FG+++ E+L G P + +
Sbjct: 162 TLCGTPDYIAPEVVSTKPYNKS---IDWWSFGILIYEMLAGYTPFYDSNTMK 210
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 55/235 (23%), Positives = 97/235 (41%), Gaps = 53/235 (22%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL---------------------------KPSEDV 460
IGKG V D A+K+L
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 461 IKEFVLEIEIITTLHHKNIISLLGFCFE------DNNLLLVYDFLSRGSL-EENLHGNKK 513
I++ EI I+ L H N++ L E +++L +V++ +++G + E
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLS 135
Query: 514 DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
+ A + + +EYLH Q++IHRD+K SN+L+ +D +++DFG++
Sbjct: 136 EDQAR------FYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVN---DKIDVYAFGVVLLELLTGRKP 625
S + ++ T GT ++APE + +DV+A GV L + G+ P
Sbjct: 187 FKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 52/228 (22%)
Query: 423 NFLAENLIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFVLEIE-------II 471
L ++GKGG +V+ K + ++ A+K+LK + +I + I+
Sbjct: 20 ELLR--VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK--KAMIVRNAKDTAHTKAERNIL 75
Query: 472 TTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 527
+ H I+ L+ + F+ L L+ ++LS G L L D A F Y
Sbjct: 76 EEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-----Y--- 126
Query: 528 MGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584
+AE AL +LH + +I+RD+K NI+L+ +L+DFGL K I
Sbjct: 127 --LAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK------ESIHDG 175
Query: 585 DVAGTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 625
V TF G Y+APE M + + +D ++ G ++ ++LTG P
Sbjct: 176 TVTHTFCGTIEYMAPEILMRSGHNRA---VDWWSLGALMYDMLTGAPP 220
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 1e-18
Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 24/214 (11%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFV-----LEIEIITTLHH 476
+ IG+G V+K + +A+K ++ +D E V EI ++ L H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKH 60
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
KNI+ L D L LV++F + L++ + + L +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
HS + V+HRD+K N+L++ + E +L++FGLA+ + V T Y P+
Sbjct: 117 CHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPD 171
Query: 597 YFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 626
Y ID+++ G + EL +P+
Sbjct: 172 VLFGAKLYST---SIDMWSAGCIFAELANAGRPL 202
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 41/220 (18%)
Query: 429 LIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIKE----FVLEIEIITTLHHKNII 480
+IG+G S+V K G+ A+KI+ + + + F E +++ + I
Sbjct: 68 VIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 481 SLLGFCFEDN-NLLLVYDFLSRGSLEENL--HGNK--KDPAAFGWSERYKVAMGVAEALE 535
L F F+D L LV ++ G L L G + + A F +E + A++
Sbjct: 125 QLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE-------IVMAID 176
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
+H +HRD+K NILL +L+DFG + + V GT YL+P
Sbjct: 177 SVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSP 232
Query: 596 E----------YFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
E YG D +A GV E+ G+ P
Sbjct: 233 EILQAVGGGPGTGSYGPE---CDWWALGVFAYEMFYGQTP 269
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 49/225 (21%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
F+ ++GKG +V + + +L AVK+LK K+ +L+ ++ T+ K I+
Sbjct: 26 EFIR--VLGKGSFGKVMLARVKETGDLYAVKVLK------KDVILQDDDVECTMTEKRIL 77
Query: 481 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 527
SL L CF+ + L V +F++ G L ++ +++ A F +E
Sbjct: 78 SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE----- 132
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
+ AL +LH + +I+RD+K N+LL + +L+DFG+ K I
Sbjct: 133 --IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK------EGICNGVTT 181
Query: 588 GTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 625
TF G Y+APE YG +D +A GV+L E+L G P
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPA---VDWWAMGVLLYEMLCGHAP 223
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLLGF 485
IG+G V+K G+ +A+K SED VIK+ L EI ++ L H N+++LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
L LV+++ ++ L + + +A+ + H
Sbjct: 71 FRRKRRLHLVFEYCDH-TVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHK---HNC 123
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM----YG 601
IHRDVK NIL++ +L DFG A+ + D T Y +PE + YG
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFAR--LLTGPSDYYDDEVATRWYRSPELLVGDTQYG 181
Query: 602 KVNDKIDVYAFGVVLLELLTGR 623
+DV+A G V ELL+G
Sbjct: 182 P---PVDVWAIGCVFAELLSGV 200
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 65/225 (28%), Positives = 97/225 (43%), Gaps = 49/225 (21%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
+FL +IGKG +V + AVK+L+ K+ +L+ E + +N++
Sbjct: 41 HFLK--VIGKGSFGKVLLARHKAEEVFYAVKVLQ------KKAILKKKEEKHIMSERNVL 92
Query: 481 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 527
L F F+ + L V D+++ G L +L + A F +E
Sbjct: 93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE----- 147
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
+A AL YLHS +++RD+K NILL L+DFGL K +I
Sbjct: 148 --IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK------ENIEHNSTT 196
Query: 588 GTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 625
TF G YLAPE Y + +D + G VL E+L G P
Sbjct: 197 STFCGTPEYLAPEVLHKQPYDRT---VDWWCLGAVLYEMLYGLPP 238
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 39/225 (17%)
Query: 422 SNFLAENLIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIKE----FVLEIEIITT 473
+F +IG+G +V K K A+KIL E + + F E +++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVN 130
Query: 474 LHHKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKK----DPAAFGWSERYKVAM 528
K I +L + F+D NNL LV D+ G L L + + A F +E
Sbjct: 131 GDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE------ 183
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
+ A++ +H +HRD+K NIL+ + +L+DFG + + V G
Sbjct: 184 -MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-G 238
Query: 589 TFGYLAPEYFM--------YGKVNDKIDVYAFGVVLLELLTGRKP 625
T Y++PE YG D ++ GV + E+L G P
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPE---CDWWSLGVCMYEMLYGETP 280
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 50/228 (21%), Positives = 94/228 (41%), Gaps = 48/228 (21%)
Query: 424 FLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIIS 481
+ ++G G + +V + ++ A+K+L+ +E +E+ +I+
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVR 75
Query: 482 LLGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEAL 534
++ +E+ LL+V + L G L + + AF +ER ++ + EA+
Sbjct: 76 IVDV-YENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAF--TEREASEIMKSIGEAI 130
Query: 535 EYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 591
+YLHS + HRDVK N+L + +L+DFG AK + G
Sbjct: 131 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK------------ETTGE-- 173
Query: 592 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639
Y K D+++ GV++ LL G P ++H +
Sbjct: 174 -------KYDK---SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 211
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 49/225 (21%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
+ L +IG+G ++V L + A+K++K KE V + +I K++
Sbjct: 12 DLLR--VIGRGSYAKVLLVRLKKTDRIYAMKVVK------KELVNDDEDIDWVQTEKHVF 63
Query: 481 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 527
L CF+ ++ L V ++++ G L ++ +K + A F +E
Sbjct: 64 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE----- 118
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
++ AL YLH + +I+RD+K N+LL + +L+D+G+ K + D
Sbjct: 119 --ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------EGLRPGDTT 167
Query: 588 GTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 625
TF G Y+APE YG +D +A GV++ E++ GR P
Sbjct: 168 STFCGTPNYIAPEILRGEDYGFS---VDWWALGVLMFEMMAGRSP 209
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 43/226 (19%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
++GKG +V+ + A+K LK K+ VL ++ T+ K ++
Sbjct: 20 ILHK--MLGKGSFGKVFLAEFKKTNQFFAIKALK------KDVVLMDDDVECTMVEKRVL 71
Query: 481 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 527
SL + F+ NL V ++L+ G L ++ K A F +E
Sbjct: 72 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE----- 126
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
+ L++LHS + +++RD+K NILL D +++DFG+ K ++
Sbjct: 127 --IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK------ENMLGDAKT 175
Query: 588 GTF-G---YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
TF G Y+APE + K N +D ++FGV+L E+L G+ P
Sbjct: 176 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 483
IG G V + +A+K + +P ++ K E+ ++ ++HKNII LL
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 484 ------GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEY 536
F+D + +V + + + NL + ER + + +++
Sbjct: 93 FTPQKSLEEFQD--VYIVMELM-----DANLCQVIQME---LDHERMSYLLYQMLCGIKH 142
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
LHS +IHRD+K SNI++ D ++ DFGLA+ A TS T T Y APE
Sbjct: 143 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPE 196
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGR 623
+ + +D+++ G ++ E++ G
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 88.2 bits (218), Expect = 3e-18
Identities = 86/435 (19%), Positives = 154/435 (35%), Gaps = 56/435 (12%)
Query: 224 MNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPV 283
MN+ + V G+ ++ ++ + L+ V
Sbjct: 138 MNVHKRCVMNVPSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYV 197
Query: 284 QNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTR-- 341
+ + P + D+ + + W L
Sbjct: 198 KLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFM 257
Query: 342 -QPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEG 400
S+ + K S VP + L + ++ + +
Sbjct: 258 GSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKA 317
Query: 401 LHEKYSATCRLFNYQDLLSATS----NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILK 455
EK + T F+ NFL ++GKG +V EL AVKILK
Sbjct: 318 PEEKTANTISKFDNNGNRDRMKLTDFNFLM--VLGKGSFGKVMLSERKGTDELYAVKILK 375
Query: 456 PSEDVIKEFVLEI-EIITTLHHKNIISL---------LGFCFE-DNNLLLVYDFLSRGSL 504
K+ V++ ++ T+ K +++L L CF+ + L V ++++ G L
Sbjct: 376 ------KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429
Query: 505 EENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561
++ + A F +E +A L +L S + +I+RD+K N++L +
Sbjct: 430 MYHIQQVGRFKEPHAVFYAAE-------IAIGLFFLQS---KGIIYRDLKLDNVMLDSEG 479
Query: 562 EPQLSDFGLAKWASTSSSHITCTDVAGTF-G---YLAPE---YFMYGKVNDKIDVYAFGV 614
+++DFG+ K +I TF G Y+APE Y YGK +D +AFGV
Sbjct: 480 HIKIADFGMCK------ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS---VDWWAFGV 530
Query: 615 VLLELLTGRKPISND 629
+L E+L G+ P +
Sbjct: 531 LLYEMLAGQAPFEGE 545
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLL 483
L+G+G V K G+ +A+K S+D ++K+ + EI+++ L H+N+++LL
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGN-KKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
C + LV++F+ + + + + P + K + + + HS
Sbjct: 91 EVCKKKKRWYLVFEFV-----DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS--- 142
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM--- 599
+IHRD+K NIL+S +L DFG A+ + ++ D T Y APE +
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 600 -YGKVNDKIDVYAFGVVLLELLTGR 623
YGK +DV+A G ++ E+ G
Sbjct: 201 KYGK---AVDVWAIGCLVTEMFMGE 222
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 5e-18
Identities = 67/222 (30%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 416 DLLSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFV----L-EI 468
D+ S + + +G+G + VYK + +A+K I K+ + L EI
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 469 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 528
+++ L H NII LL +N+ LV+DF+ LE + K + S +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII---KDNSLVLTPSHIKAYML 119
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
+ LEYLH ++HRD+K +N+LL ++ +L+DFGLAK + + T V
Sbjct: 120 MTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-- 174
Query: 589 TFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 626
T Y APE YG +D++A G +L ELL R P
Sbjct: 175 TRWYRAPELLFGARMYGV---GVDMWAVGCILAELLL-RVPF 212
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 6e-18
Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 49/225 (21%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
+ L +IG+G ++V L + A++++K KE V + +I K++
Sbjct: 55 DLLR--VIGRGSYAKVLLVRLKKTDRIYAMRVVK------KELVNDDEDIDWVQTEKHVF 106
Query: 481 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 527
L CF+ ++ L V ++++ G L ++ +K + A F +E
Sbjct: 107 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE----- 161
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
++ AL YLH + +I+RD+K N+LL + +L+D+G+ K + D
Sbjct: 162 --ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------EGLRPGDTT 210
Query: 588 GTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 625
TF G Y+APE YG +D +A GV++ E++ GR P
Sbjct: 211 STFCGTPNYIAPEILRGEDYGFS---VDWWALGVLMFEMMAGRSP 252
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 43/222 (19%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
NFL ++GKG +V EL AVKILK K+ V++ ++ T+ K ++
Sbjct: 23 NFLM--VLGKGSFGKVMLSERKGTDELYAVKILK------KDVVIQDDDVECTMVEKRVL 74
Query: 481 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 527
+L L CF+ + L V ++++ G L ++ + A F +E
Sbjct: 75 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE----- 129
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
+A L +L S + +I+RD+K N++L + +++DFG+ K +I
Sbjct: 130 --IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK------ENIWDGVTT 178
Query: 588 GTF-G---YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
TF G Y+APE Y +D +AFGV+L E+L G+ P
Sbjct: 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 7e-18
Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 52/230 (22%)
Query: 423 NFLAENLIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFVLEI--EIITTLHH 476
L ++G G +V+ K D +L A+K+LK K +++ T
Sbjct: 57 ELLK--VLGTGAYGKVFLVRKISGHDTGKLYAMKVLK------KATIVQKAKTTEHTRTE 108
Query: 477 KNIISL---------LGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSER 523
+ ++ L + F+ L L+ D+++ G L +L ++
Sbjct: 109 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI----- 163
Query: 524 YKVAMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580
Y V E ALE+LH +I+RD+K NILL + L+DFGL+K +
Sbjct: 164 Y-----VGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215
Query: 581 ITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKP 625
GT Y+AP+ + K +D ++ GV++ ELLTG P
Sbjct: 216 RAYD-FCGTIEYMAPDIVRGGDSGHDKA---VDWWSLGVLMYELLTGASP 261
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 9e-18
Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 32/216 (14%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 483
+G G +V G G ++AVKIL S DV+ + EI+ + H +II L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76
Query: 484 GFCFE----DNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYL 537
++ + +V +++S G L + + HG ++ A R ++ + A++Y
Sbjct: 77 ---YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA-----R-RLFQQILSAVDYC 127
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HITCTDVAGTFGYLAPE 596
H V+HRD+K N+LL +++DFGL+ S +C G+ Y APE
Sbjct: 128 HR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPNYAAPE 180
Query: 597 YFMYGKVND--KIDVYAFGVVLLELLTGRKPISNDH 630
G++ ++D+++ GV+L LL G P ++H
Sbjct: 181 VIS-GRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 419 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFV-----LEIEIITT 473
+ +G+G VYK G+ +A+K ++ + E + EI ++
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE--DEGIPSTAIREISLLKE 75
Query: 474 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
LHH NI+SL+ + L LV++F+ + L++ L ++ S+ +
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL---DENKTGLQDSQIKIYLYQLLRG 131
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
+ + H R++HRD+K N+L++ D +L+DFGLA+ T V T Y
Sbjct: 132 VAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYR 186
Query: 594 APEYFM----YGKVNDKIDVYAFGVVLLELLTGR 623
AP+ M Y +D+++ G + E++TG+
Sbjct: 187 APDVLMGSKKYST---SVDIWSIGCIFAEMITGK 217
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 1e-17
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 483
IG G V + +A+K + +P ++ K E+ ++ ++HKNIISLL
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 484 ----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLH 538
E ++ LV + + + NL + ER + + +++LH
Sbjct: 130 FTPQKTLEEFQDVYLVMELM-----DANLCQVIQMEL---DHERMSYLLYQMLCGIKHLH 181
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
S +IHRD+K SNI++ D ++ DFGLA+ A TS T T Y APE
Sbjct: 182 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVI 235
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGR 623
+ + +D+++ G ++ E++ +
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 56/206 (27%), Positives = 84/206 (40%), Gaps = 24/206 (11%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 486
IG G + +AVK + I E V EI +L H NI+
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 487 FEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
+L ++ ++ S G L E + G + A R+ ++ + Y HS +
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEA-----RFFFQQLLS-GVSYCHS---MQ 136
Query: 545 VIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSS-HITCTDVAGTFGYLAPEYFMYG 601
+ HRD+K N LL P+L DFG +K + S T GT Y+APE +
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----GTPAYIAPEVLL-R 191
Query: 602 KVND--KIDVYAFGVVLLELLTGRKP 625
+ D DV++ GV L +L G P
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 485
+G+G +V + +AVKI+ D + EI I L+H+N++ G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 486 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
E N L ++ S G L + + +P A + +A + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRFFHQLMA-GVVYLHG---I 124
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----HITCTDVAGTFGYLAPEYFM 599
+ HRD+K N+LL + ++SDFGLA ++ + C GT Y+APE
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPELLK 180
Query: 600 YGKVND--KIDVYAFGVVLLELLTGRKP 625
+ +DV++ G+VL +L G P
Sbjct: 181 -RREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVK--ILKPSEDVIKEFVLEIEIITTLHHKNI 479
++ + +G+G + VYKG L A+K L+ E + E+ ++ L H NI
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG-VAEALEYLH 538
++L + +L LV+++L +++L D K+ + + L Y H
Sbjct: 63 VTLHDIIHTEKSLTLVFEYL-----DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
Q+V+HRD+K N+L+++ E +L+DFGLA+ S + V T Y P+
Sbjct: 118 R---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDIL 172
Query: 599 M----YGKVNDKIDVYAFGVVLLELLTGR 623
+ Y +ID++ G + E+ TGR
Sbjct: 173 LGSTDYST---QIDMWGVGCIFYEMATGR 198
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 51/215 (23%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHH 476
+++ +G G V G+++A+K + +P + I K E+ ++ + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 477 KNIISLL------GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-G 529
+N+I LL + LV F+ + +L + E+ + +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFS---EEKIQYLVYQ 134
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
+ + L+Y+HS V+HRD+K N+ +++D E ++ DFGLA+ A T T
Sbjct: 135 MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----TGYVVT 186
Query: 590 FGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGR 623
Y APE + + N +D+++ G ++ E+LTG+
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 44/230 (19%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKN 478
F E + G+G V G G +A+K +++ +E + ++ + LHH N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 479 IISLLGF-------CFEDNNLLLVYDFLSRGSLEENLH--------GNKKDPAAFGWSER 523
I+ L + D L +V ++ + + LH P
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEY-----VPDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 524 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHIT 582
+++ + LH S V HRD+K N+L+ D +L DFG AK S S ++
Sbjct: 136 FQLIRSIG----CLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 583 --CTDVAGTFGYLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
C+ Y APE Y +D+++ G + E++ G +PI
Sbjct: 191 YICSRY-----YRAPELIFGNQHYTT---AVDIWSVGCIFAEMMLG-EPI 231
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 6e-17
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFV-----LEIEIITTLHHK 477
+ IG+G VYK G+ A+K ++ ++ E + EI I+ L H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHS 60
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
NI+ L L+LV++ L + L++ L + + + Y
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
H +RV+HRD+K N+L++ + E +++DFGLA+ T V T Y AP+
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDV 171
Query: 598 FM----YGKVNDKIDVYAFGVVLLELLTGR 623
M Y ID+++ G + E++ G
Sbjct: 172 LMGSKKYST---TIDIWSVGCIFAEMVNGT 198
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 9e-17
Identities = 45/217 (20%), Positives = 85/217 (39%), Gaps = 30/217 (13%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-----EIEIITTLH 475
+ +G+G +VYK + +A+K ++ + +E V E+ ++ L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQ 91
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
H+NII L ++ L L++++ E +L + +
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKWASTSSSHITCTDVAGTF 590
+ HS +R +HRD+K N+LLS + + DFGLA+ T + T
Sbjct: 147 FCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TL 201
Query: 591 GYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGR 623
Y PE + Y +D+++ + E+L
Sbjct: 202 WYRPPEILLGSRHYST---SVDIWSIACIWAEMLMKT 235
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 9e-17
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 48/229 (20%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKN 478
++ +IG G VY+ G+ +A+K K +D K F E++I+ L H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQD--KRFKNRELQIMRKLDHCN 108
Query: 479 IISLLGF------CFEDNNLLLVYDFLSRGSLEENLH--------GNKKDPAAFGWSERY 524
I+ L F ++ L LV D+ + E ++ + P + Y
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 525 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHIT- 582
++ +A Y+HS + HRD+K N+LL D +L DFG AK +++
Sbjct: 164 QLFRSLA----YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 583 -CTDVAGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 626
C+ Y APE Y IDV++ G VL ELL G+ PI
Sbjct: 217 ICSRY-----YRAPELIFGATDYTS---SIDVWSAGCVLAELLLGQ-PI 256
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 84.1 bits (207), Expect = 1e-16
Identities = 106/663 (15%), Positives = 183/663 (27%), Gaps = 194/663 (29%)
Query: 125 NHHTIRSTTSLAKYCAKKL--------SKDCSVLAVNNG-KVVFQKEGCPSTAGESKGTE 175
+HH + T +Y K + + V + K + KE
Sbjct: 3 HHHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVS 62
Query: 176 DHRRNSLLDVIHRSIS------------------MSKITGQKNSK------------VVT 205
R L + MS I ++ +
Sbjct: 63 GTLR--LFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY 120
Query: 206 DDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEE 265
+D V L + L QAL++ R +N I G
Sbjct: 121 NDNQVFAKYNVSRL-QPYLKLRQALLELRPA-------KNVLIDG--------------- 157
Query: 266 ESPSDGGAGDESLAIVPVQNVEAASTS------ITMLVRQLPES--RPGWPLLRRAIFPD 317
G+G +A+ + + + + PE+ LL +
Sbjct: 158 ----VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNW 213
Query: 318 RRAPDRSS---LRKISVVQWALRLPTRQP---SYLANSDVKQITYDPGDNESINLN---- 367
D SS LR S+ RL +P L +V + + NL+
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNV----QNAKAWNAFNLSCKIL 269
Query: 368 ---GDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDL--LSATS 422
+ + H T P E++ L KY CR QDL T+
Sbjct: 270 LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY-LDCRP---QDLPREVLTT 325
Query: 423 NFLAENLIG---KGGSS--QVYKGCLPDGK----ELAVKILKPSE-------------DV 460
N ++I + G + +K D E ++ +L+P+E
Sbjct: 326 NPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA 385
Query: 461 -IKEFVLEI-----------EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL 508
I +L + ++ LH SL+ + + +
Sbjct: 386 HIPTILLSLIWFDVIKSDVMVVVNKLHKY---SLV---EKQPKESTIS-----------I 428
Query: 509 HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD-VKSSNILL---SDDFEPQ 564
Y LE + +HR V NI SDD P
Sbjct: 429 PS------------IY---------LELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPP 467
Query: 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY----FMYGKV-NDKIDVYAFGVV---L 616
D + S H+ + + F+ K+ +D A G + L
Sbjct: 468 YLD---QYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTL 524
Query: 617 LELLTGRKPISNDHPKGQESL------VMWAKPILSSGKVTQLLDPALGNNYD--YDQME 668
+L + I ++ PK + + + + L K T LL AL + +++
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAH 584
Query: 669 RMV 671
+ V
Sbjct: 585 KQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 70.3 bits (171), Expect = 2e-12
Identities = 57/498 (11%), Positives = 130/498 (26%), Gaps = 152/498 (30%)
Query: 344 SYLANSDVKQITYDPGDNESINL-------NGDSGAIVPVGNEIVSSPLSTDHD------ 390
S L+ ++ I + + V L ++
Sbjct: 44 SILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMV-----QKFVEEVLRINYKFLMSPI 98
Query: 391 STELPKELEGLHEKYSATC-RLFN---------------YQDLLSATSNFLAENLI---G 431
TE ++ + Y RL+N Y L A + G
Sbjct: 99 KTE-QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG 157
Query: 432 KGGSSQVYKGCLPDGKE-LAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 490
GS GK +A+ + S V + +I + L C
Sbjct: 158 VLGS----------GKTWVALDVCL-SYKVQCKMDFKIFWLN----------LKNCNSPE 196
Query: 491 NLL-----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR- 544
+L L+Y + + + L S +
Sbjct: 197 TVLEMLQKLLYQI--DPNWTSRSDHSSNIKLRIHSIQAEL--------RRLLKSKPYENC 246
Query: 545 -VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
++ +V+++ + F + C + T + +V
Sbjct: 247 LLVLLNVQNAKAW--NAF-----NLS-------------CKILLTT---------RFKQV 277
Query: 604 NDKIDVYAFGVVLLELLTGRKPISNDHPKG---QESLVMWAK-----------------P 643
D + + L+ H E + K P
Sbjct: 278 TDFLSAATTTHISLD----------HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP 327
Query: 644 ILSSGKVTQLLD-PALGNNY---DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699
S + D A +N+ + D++ ++ +S+ + +P +M L + A
Sbjct: 328 RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVL--EPAEYRKMFDRLSVFPPSA 385
Query: 700 DVTK------WARLQVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMS-SIEQS 752
+ W + + ++ ++ S ++ + + + + +E
Sbjct: 386 HIPTILLSLIWFDVI---KSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENE 442
Query: 753 VSLEDYLLGRWSRSSSFD 770
+L ++ ++ +FD
Sbjct: 443 YALHRSIVDHYNIPKTFD 460
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 485
+G+G +V + +AVKI+ D + EI I L+H+N++ G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 486 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
E N L ++ S G L + + +P A + +A + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRFFHQLMA-GVVYLHG---I 124
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----HITCTDVAGTFGYLAPEYFM 599
+ HRD+K N+LL + ++SDFGLA ++ + C GT Y+APE
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPELLK 180
Query: 600 YGKVND--KIDVYAFGVVLLELLTGRKP 625
+ +DV++ G+VL +L G P
Sbjct: 181 -RREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 483
+G+G +V +++A+K + D+ EI + L H +II L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 484 GFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 534
++++V +D++ + + E+ E + + A+
Sbjct: 76 DVITTPTDIVMVIEYAGGELFDYIVEKKRMTED--------------EGRRFFQQIICAI 121
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HITCTDVAGTFGYL 593
EY H +++HRD+K N+LL D+ +++DFGL+ + + +C G+ Y
Sbjct: 122 EYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYA 174
Query: 594 APEYFMYGKVND--KIDVYAFGVVLLELLTGRKP 625
APE GK+ ++DV++ G+VL +L GR P
Sbjct: 175 APEVIN-GKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCF 487
+G+G S+V++ + + +++ VKILKP + K+ EI+I+ L NII+L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNIITLAD-IV 100
Query: 488 ED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
+D LV++ ++ ++ F E K AL+Y HS
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK-------ALDYCHS---MG 150
Query: 545 VIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE----YFM 599
++HRDVK N+++ + + +L D+GLA++ + + + PE Y M
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQM 207
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKPI 626
Y +D+++ G +L ++ ++P
Sbjct: 208 YDY---SLDMWSLGCMLASMIFRKEPF 231
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 51/224 (22%), Positives = 95/224 (42%), Gaps = 39/224 (17%)
Query: 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNI 479
+ +IG G V++ L + E+A+K +L+ +E ++I+ + H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRE----LQIMRIVKHPNV 94
Query: 480 ISLLGFCF------EDNNLLLVYDFLSRGSLEENLH--------GNKKDPAAFGWSERYK 525
+ L F + ++ L LV ++ + E ++ + P Y+
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEY-----VPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCT 584
+ +A Y+HS + HRD+K N+LL +L DFG AK +
Sbjct: 150 LLRSLA----YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAK---ILIAGEPNV 199
Query: 585 DVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPI 626
+ Y APE ++G ID+++ G V+ EL+ G +P+
Sbjct: 200 SYICSRYYRAPE-LIFGATNYTTNIDIWSTGCVMAELMQG-QPL 241
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 35/221 (15%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVI--KEFVLEIEIITTLHHK 477
+ + IG+G V + +A+K + P E + + EI+I+ H+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 478 NIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM 528
NII + + ++ +V D + E +L+ + +
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSN------DHICYFL 134
Query: 529 -GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC-TDV 586
+ L+Y+HS + V+HRD+K SN+LL+ + ++ DFGLA+ A H T+
Sbjct: 135 YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 587 AGTFGYLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGR 623
T Y APE Y K ID+++ G +L E+L+ R
Sbjct: 192 VATRWYRAPEIMLNSKGYTK---SIDIWSVGCILAEMLSNR 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 41/221 (18%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKE-F----VLEIEIITTLHHKNIISLL 483
IG+G +V+K G+++A+K + + KE F + EI+I+ L H+N+++L+
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLI 82
Query: 484 GFCFED--------NNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
C ++ LV+DF L N+ F SE +V +
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------FTLSEIKRVMQMLLNG 136
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW----ASTSSSHITCTDVAGT 589
L Y+H +++HRD+K++N+L++ D +L+DFGLA+ ++ + T V T
Sbjct: 137 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV--T 191
Query: 590 FGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 626
Y PE + YG ID++ G ++ E+ T R PI
Sbjct: 192 LWYRPPELLLGERDYGP---PIDLWGAGCIMAEMWT-RSPI 228
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 39/212 (18%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 483
+G G V G ++A+K + +P + + K E+ ++ + H+N+I LL
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 484 ------GFCFEDNNLLLVYDFLSRGSLEENLHGN-KKDPAAFGWSERYKVAM-GVAEALE 535
F D LV F+ +L K + +R + + + + L
Sbjct: 93 FTPDETLDDFTD--FYLVMPFM-----GTDLGKLMKHEKLG---EDRIQFLVYQMLKGLR 142
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
Y+H+ +IHRD+K N+ +++D E ++ DFGLA+ A + T T Y AP
Sbjct: 143 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAP 194
Query: 596 E----YFMYGKVNDKIDVYAFGVVLLELLTGR 623
E + Y + +D+++ G ++ E++TG+
Sbjct: 195 EVILNWMRYTQ---TVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 35/210 (16%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 483
+G G V G +AVK + +P + +I K E+ ++ + H+N+I LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 484 ----GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM-GVAEAL 534
E N++ LV + +L+ K + + + + L
Sbjct: 97 FTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTD------DHVQFLIYQILRGL 145
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
+Y+HS +IHRD+K SN+ +++D E ++ DFGLA+ + T T Y A
Sbjct: 146 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-----TGYVATRWYRA 197
Query: 595 PEYFM-YGKVNDKIDVYAFGVVLLELLTGR 623
PE + + N +D+++ G ++ ELLTGR
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 483
+G G +V G G ++AVKIL S DV+ + EI+ + H +II L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
+++ +V +++S G L + + +G + + R ++ ++Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES-----RRLFQQILS-GVDYCHR-- 134
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HITCTDVAGTFGYLAPEYFMY 600
V+HRD+K N+LL +++DFGL+ S +C G+ Y APE
Sbjct: 135 -HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPNYAAPEVIS- 188
Query: 601 GKVND--KIDVYAFGVVLLELLTGRKP 625
G++ ++D+++ GV+L LL G P
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK------NII 480
+IGKG QV K + +A+K+++ + ++ EI I+ L + N+I
Sbjct: 104 VIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 481 SLLG-FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
+L F F N++ + ++ LS +L E + NK F K A + + L+ LH
Sbjct: 163 HMLENFTFR-NHICMTFELLSM-NLYELIKKNKFQG--FSLPLVRKFAHSILQCLDALHK 218
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
R+IH D+K NILL + DFG + T + F Y APE
Sbjct: 219 ---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRF-YRAPEV 270
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGR 623
+ + ID+++ G +L ELLTG
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 48/216 (22%), Positives = 82/216 (37%), Gaps = 36/216 (16%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVK-ILKPSEDVIKEFVL-----------EIEIITTLHHK 477
I G V G +G +A+K + D +L EI ++ HH
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 478 NIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVA 531
NI+ L + L LV + + +L D + + M +
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVISPQHIQYFMYHIL 144
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 591
L LH V+HRD+ NILL+D+ + + DF LA+ + ++ T
Sbjct: 145 LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK---THYVTHRW 198
Query: 592 YLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGR 623
Y APE + + K +D+++ G V+ E+ +
Sbjct: 199 YRAPELVMQFKGFTK---LVDMWSAGCVMAEMFNRK 231
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 41/218 (18%), Positives = 89/218 (40%), Gaps = 34/218 (15%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH----------- 475
+G G S V+ + + +A+KI++ + + EI+++ ++
Sbjct: 26 KLGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 476 HKNIISLLG-FCFEDNN---LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA 531
+I+ LL F + N +++V++ L +L + + +++ +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRG--IPLIYVKQISKQLL 141
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ------LSDFGLAKWASTSSSHITCTD 585
L+Y+H +IH D+K N+L+ P+ ++D G A W T+
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY-----DEHYTN 194
Query: 586 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 623
T Y +PE + D+++ ++ EL+TG
Sbjct: 195 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-15
Identities = 48/219 (21%), Positives = 94/219 (42%), Gaps = 42/219 (19%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVI--KEFVLEIEIITTLHHKNIISLL--- 483
+G+G V P G+ +A+K ++P + + + EI+I+ H+NII++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 484 --GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM-GVAEALEY 536
N + ++ + + + +LH + + + A++
Sbjct: 79 RPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSD------DHIQYFIYQTLRAVKV 127
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG----- 591
LH + VIHRD+K SN+L++ + + ++ DFGLA+ S++ + +
Sbjct: 128 LHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 592 ---YLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGR 623
Y APE Y + +DV++ G +L EL R
Sbjct: 185 TRWYRAPEVMLTSAKYSR---AMDVWSCGCILAELFLRR 220
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 53/226 (23%), Positives = 93/226 (41%), Gaps = 31/226 (13%)
Query: 419 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVL-----EIEII 471
ATS + IG G VYK G +A+K + P+ + E+ ++
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 472 TTLH---HKNIISLL-----GFCFEDNNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWS 521
L H N++ L+ + + LV++ + + + +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA------ 119
Query: 522 ERYKVAMG-VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580
E K M L++LH+ ++HRD+K NIL++ +L+DFGLA+ S
Sbjct: 120 ETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQ 173
Query: 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
+ T V T Y APE + +D+++ G + E+ RKP+
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 54/226 (23%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 419 SATSNFLAENLIGKGGSSQVYKG--CLPDGKELAVKILKPSEDVIKEFV----L-EIEII 471
A + IG+G +V+K G+ +A+K ++ +E + + E+ ++
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG--EEGMPLSTIREVAVL 65
Query: 472 TTLH---HKNIISLL-----GFCFEDNNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWS 521
L H N++ L + L LV++ + + + + +
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT------ 119
Query: 522 ERYKVAMG-VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580
E K M + L++LHS RV+HRD+K NIL++ + +L+DFGLA+ S
Sbjct: 120 ETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQ 173
Query: 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
+ T V T Y APE + +D+++ G + E+ RKP+
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 54/250 (21%), Positives = 87/250 (34%), Gaps = 58/250 (23%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKN 478
+ + +G G V + + GK A+K K +D + E++I+ L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK--KVLQD--PRYKNRELDIMKVLDHVN 61
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER--------------- 523
II L+ + + + + N +
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 524 ---YKVAMGVAE-------------------ALEYLHSGSAQRVIHRDVKSSNILL-SDD 560
+KV A+ ++HS + HRD+K N+L+ S D
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKD 178
Query: 561 FEPQLSDFGLAKWASTSSSHIT--CTDVAGTFGYLAPEYFMYGKVN--DKIDVYAFGVVL 616
+L DFG AK S + C+ Y APE M G ID+++ G V
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPE-LMLGATEYTPSIDLWSIGCVF 232
Query: 617 LELLTGRKPI 626
EL+ G KP+
Sbjct: 233 GELILG-KPL 241
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 428 NLIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTL------HHKNI 479
+LIGKG QV K + + +A+KI+K + + + +E+ ++ + I
Sbjct: 60 SLIGKGSFGQVVK-AYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 480 ISLLG-FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+ L F F N+L LV++ LS +L + L + K A + AL +L
Sbjct: 119 VHLKRHFMFR-NHLCLVFEMLSY-NLYDLLRNTNFRG--VSLNLTRKFAQQMCTALLFLA 174
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
+ +IH D+K NILL + + DFG +S + F Y +PE
Sbjct: 175 TPEL-SIIHCDLKPENILLCNPKRSAIKIVDFG----SSCQLGQRIYQYIQSRF-YRSPE 228
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGR 623
+ + ID+++ G +L+E+ TG
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 62/289 (21%), Positives = 106/289 (36%), Gaps = 58/289 (20%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHH 476
N++ ++LIG+G VY K +A+K + + ED+I K + EI I+ L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 477 KNIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG-V 530
II L + + L +V + + +L K P E K + +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLT-EEHIKTILYNL 138
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
++H +IHRD+K +N LL+ D ++ DFGLA+ ++ D+
Sbjct: 139 LLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 591 G--------------------YLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
Y APE Y K ID+++ G + ELL +
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK---SIDIWSTGCIFAELLNMLQSH 252
Query: 627 SNDHPKGQESLVMWAKPI---LSSGKVTQLLDPALGNNYDY-DQMERMV 671
ND P+ S ++ + + DQ+ +
Sbjct: 253 INDPTNR--------FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIF 293
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 44/221 (19%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLL---- 483
+G GG+ V+ K +A+K + ++ + L EI+II L H NI+ +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 484 ----------GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM- 528
G E N++ +V +++ E +L E ++ M
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLE------EHARLFMY 127
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITC-TDV 586
+ L+Y+HS + V+HRD+K +N+ + ++D ++ DFGLA+ SH ++
Sbjct: 128 QLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 587 AGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGR 623
T Y +P + Y K ID++A G + E+LTG+
Sbjct: 185 LVTKWYRSPRLLLSPNNYTK---AIDMWAAGCIFAEMLTGK 222
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 60/315 (19%), Positives = 112/315 (35%), Gaps = 64/315 (20%)
Query: 359 GDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLL 418
+ +SG V H S++ + H + R Y+
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDR---YEIR- 58
Query: 419 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTL 474
+LIG G V + + + +A+K IL+ ED+I K + EI I+ L
Sbjct: 59 ---------HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 475 HHKNIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM- 528
+H +++ +L + + L +V + + + + P K +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLT-ELHIKTLLY 163
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
+ ++Y+HS ++HRD+K +N L++ D ++ DFGLA+ + + ++
Sbjct: 164 NLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 589 TFG-------------------------YLAPEYFM----YGKVNDKIDVYAFGVVLLEL 619
Y APE + Y + IDV++ G + EL
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE---AIDVWSIGCIFAEL 277
Query: 620 LTGRKPISNDHPKGQ 634
L K H
Sbjct: 278 LNMIKENVAYHADRG 292
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 4/100 (4%)
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586
+ VA+ +E+L ++++ IHRD+ + NILLS+ ++ DFGLA+ ++ D
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 587 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
++APE + DV++FGV+L E+ + G P
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 23/99 (23%), Positives = 48/99 (48%), Gaps = 10/99 (10%)
Query: 430 IGKGGSSQVYKGCL------PDGKELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 480
+G+G QV + + +AVK+LK + + + E++I+ + HH N++
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 481 SLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAF 518
+LLG C + L+++ +F G+L L + + +
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 53/232 (22%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLH-HKNIISLLG 484
+GKG V+K G+ +AVK I ++ + EI I+T L H+NI++LL
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 485 FCFEDNN--LLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM-GVAEALEYL 537
DN+ + LV+D++ E +LH N +P + + + + ++YL
Sbjct: 77 VLRADNDRDVYLVFDYM-----ETDLHAVIRANILEP------VHKQYVVYQLIKVIKYL 125
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG------ 591
HSG ++HRD+K SNILL+ + +++DFGL++ ++
Sbjct: 126 HSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 592 -------------YLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
Y APE Y K ID+++ G +L E+L KPI
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTK---GIDMWSLGCILGEIL-CGKPI 230
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 48/222 (21%), Positives = 90/222 (40%), Gaps = 40/222 (18%)
Query: 429 LIGKGGSSQVYKGCL---PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK------NI 479
+G+G +V + C+ G+ +AVKI+K + + EI+++ L+
Sbjct: 21 TLGEGAFGKVVE-CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 480 ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+ +L FE ++ +V++ L S + + N P F K+A + +++ +LH
Sbjct: 80 VQMLE-WFEHHGHICIVFELLGL-STYDFIKENGFLP--FRLDHIRKMAYQICKSVNFLH 135
Query: 539 SGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFG------ 591
S ++ H D+K NIL D+ + + + I D FG
Sbjct: 136 S---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD----FGSATYDD 188
Query: 592 -----------YLAPEYFMYGKVNDKIDVYAFGVVLLELLTG 622
Y APE + + DV++ G +L+E G
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 46/222 (20%), Positives = 84/222 (37%), Gaps = 40/222 (18%)
Query: 429 LIGKGGSSQVYKGC--LPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHK------NI 479
+G+G +V + C GK A+KI++ + LEI ++ + K
Sbjct: 26 NLGEGTFGKVVE-CLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 480 ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+ + F ++ + ++ L + + E L N P + +A + AL +LH
Sbjct: 85 VLMSD-WFNFHGHMCIAFELLGK-NTFEFLKENNFQP--YPLPHVRHMAYQLCHALRFLH 140
Query: 539 SGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFG------ 591
++ H D+K NIL + +FE ++ + S ++ I D FG
Sbjct: 141 E---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD----FGSATFDH 193
Query: 592 -----------YLAPEYFMYGKVNDKIDVYAFGVVLLELLTG 622
Y PE + DV++ G +L E G
Sbjct: 194 EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 48/222 (21%), Positives = 85/222 (38%), Gaps = 36/222 (16%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTL-----HHKNIIS 481
+G G +V C + + K AVK+++ + + +E +I+ + ++ NI+
Sbjct: 42 KMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 482 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
G F +++ L+++ L SL E + N + F + + + +AL YL
Sbjct: 101 YHG-KFMYYDHMCLIFEPLGP-SLYEIITRNNYNG--FHIEDIKLYCIEILKALNYLRK- 155
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA--------GTFG- 591
+ H D+K NILL D + + TF
Sbjct: 156 --MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS 213
Query: 592 -----------YLAPEYFMYGKVNDKIDVYAFGVVLLELLTG 622
Y APE + + D+++FG VL EL TG
Sbjct: 214 DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 45/257 (17%), Positives = 90/257 (35%), Gaps = 74/257 (28%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH--------HKNII 480
+G G S V+ + K +A+K++K +E + + EI ++ ++ + ++
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 481 SLLGFCFE-----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
LL F+ ++ +V++ L L + + + K+ V + L+
Sbjct: 105 QLLD-DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQG--LPLPCVKKIIQQVLQGLD 160
Query: 536 YLHSGSAQRVIHRDVKSSNILL-------------------------------------- 557
YLH+ R+IH D+K NILL
Sbjct: 161 YLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 558 -----------SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 606
++ + +++D G A W + T Y + E + N
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTP 273
Query: 607 IDVYAFGVVLLELLTGR 623
D+++ + EL TG
Sbjct: 274 ADIWSTACMAFELATGD 290
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 41/180 (22%), Positives = 65/180 (36%), Gaps = 21/180 (11%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNII 480
NF IG G ++ G L + +A+K+ + LE L I
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-PQLHLEYRFYKQLGSGDGIP 68
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+ F +V + L SLE+ +L F +A+ + +EY+H
Sbjct: 69 QVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRT-----FSLKTVLMIAIQLISRMEYVH 122
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAK--WASTSSSHITCTDVAGTFG 591
S + +I+RDVK N L+ + DF LAK + HI + G
Sbjct: 123 S---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 38/173 (21%), Positives = 69/173 (39%), Gaps = 21/173 (12%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCF 487
IG+G +++G L + +++A+K +P + E L I ++ F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76
Query: 488 EDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
E + +LV D L SLE+ +L G K F A + ++ +H + +
Sbjct: 77 EGLHNVLVIDLLGP-SLEDLLDLCGRK-----FSVKTVAMAAKQMLARVQSIHE---KSL 127
Query: 546 IHRDVKSSNILLSDDFEPQ-----LSDFGLAK--WASTSSSHITCTDVAGTFG 591
++RD+K N L+ + DFG+ K + HI + G
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 8e-09
Identities = 42/273 (15%), Positives = 76/273 (27%), Gaps = 71/273 (26%)
Query: 418 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV---------IKEFVLEI 468
T IG+G +V++ D +A+KI+ +E + EI
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 469 EIITTLH---------HKNIISLLGFC------------------------------FED 489
I L + I L F+D
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ L +V +F G E + + + + +L ++ R HRD
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSS-----LATAKSILHQLTASLAVAE--ASLRFEHRD 187
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWAS--TSSSHITCTD-----------VAGTFGYLAPE 596
+ N+LL +L K ++ + ++ D V + +
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDED 247
Query: 597 YFMYGKVNDKIDVY-AFGVVLLELLTGRKPISN 628
F G + + D+Y P SN
Sbjct: 248 LFT-GDGDYQFDIYRLMKKENNNRWGEYHPYSN 279
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 33/184 (17%), Positives = 67/184 (36%), Gaps = 33/184 (17%)
Query: 423 NFLAENLIGKGGSSQVYKGC---------LPDGKELAVKILKPSEDVIKEF--------V 465
+ ++ + +Y+ P ++ ++K+ + E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 466 LEIEIITTLH---HKNIISLLGF-CFEDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFG 519
L++ L+ I + +GF +D LV L R SL+ ++
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHV----LS 157
Query: 520 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTS 577
+VA + +ALE+LH +H +V + NI + + + Q L+ +G A S
Sbjct: 158 ERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214
Query: 578 SSHI 581
H+
Sbjct: 215 GKHV 218
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 34/177 (19%), Positives = 65/177 (36%), Gaps = 34/177 (19%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEI-----------ITTLHH 476
IG GG +Y ++ A ++K + + L E+ I
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVK--VEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 477 KNIISLLGF----------CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 526
+ + LG + +V + L L++ N F S ++
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGT----FKKSTVLQL 156
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHI 581
+ + + LEY+H +H D+K++N+LL Q L+D+GL+ + +H
Sbjct: 157 GIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 43/171 (25%), Positives = 72/171 (42%), Gaps = 19/171 (11%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCF 487
IG G +Y G + G+E+A+K+ + + + +E +I + I ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 75
Query: 488 EDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
E + ++V + L SLE+ N K F +A + +EY+HS +
Sbjct: 76 EGDYNVMVMELLGP-SLEDLFNFCSRK-----FSLKTVLLLADQMISRIEYIHS---KNF 126
Query: 546 IHRDVKSSNILL---SDDFEPQLSDFGLAK--WASTSSSHITCTDVAGTFG 591
IHRDVK N L+ + DFGLAK + + HI + G
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 32/170 (18%), Positives = 64/170 (37%), Gaps = 35/170 (20%)
Query: 429 LIGKGGSSQVYKGCLPDGKELAVKI-----LKPSED-------------VIKEFVLEIEI 470
IG+GG +Y + + + ++PS++ E + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 471 ITTLHHKNIISLLGFCFEDNNLL----LVYDFLSRGSLEE--NLHGNKKDPAAFGWSERY 524
L + + G D N ++ D L++ + + F
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKR-----FSRKTVL 155
Query: 525 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAK 572
++++ + + LEY+H +H D+K+SN+LL+ Q L D+GLA
Sbjct: 156 QLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 42/218 (19%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCF 487
IG G ++Y G + +E+A+K+ + + E +I L I ++ F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLLYESKIYRILQGGTGIPNVRWFGV 73
Query: 488 EDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
E + +LV D L SLE+ N K +A + +E++HS +
Sbjct: 74 EGDYNVLVMDLLGP-SLEDLFNFCSRK-----LSLKTVLMLADQMINRVEFVHS---KSF 124
Query: 546 IHRDVKSSNILLSDDFEPQ---LSDFGLAK--WASTSSSHI---TCTDVAGTFGYLAPEY 597
+HRD+K N L+ + DFGLAK +++ HI ++ GT Y +
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS--- 181
Query: 598 FMYGKVN----------DKIDVYAFGVVLLELLTGRKP 625
VN D D+ + G VL+ L G P
Sbjct: 182 -----VNTHLGIEQSRRD--DLESLGYVLMYFLRGSLP 212
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 770 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 1mjh_A | 162 | Protein (ATP-binding domain of protein MJ0577); hy | 99.66 | |
| 3s3t_A | 146 | Nucleotide-binding protein, universal stress PROT | 99.66 | |
| 3hgm_A | 147 | Universal stress protein TEAD; rossman fold, signa | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 1tq8_A | 163 | Hypothetical protein RV1636; MTCY01B2.28, structur | 99.63 | |
| 2dum_A | 170 | Hypothetical protein PH0823; conserved hypothetica | 99.62 | |
| 3idf_A | 138 | USP-like protein; universal, stress, PSI, MCSG, st | 99.62 | |
| 3tnj_A | 150 | Universal stress protein (USP); structural genomic | 99.62 | |
| 3fdx_A | 143 | Putative filament protein / universal stress PROT; | 99.61 | |
| 3fg9_A | 156 | Protein of universal stress protein USPA family; A | 99.61 | |
| 3dlo_A | 155 | Universal stress protein; unknown function, struct | 99.61 | |
| 2z08_A | 137 | Universal stress protein family; uncharacterized c | 99.59 | |
| 2gm3_A | 175 | Unknown protein; AT3G01520, putative ethylene-resp | 99.59 | |
| 1jmv_A | 141 | USPA, universal stress protein A; chaperone; 1.85A | 99.49 | |
| 1q77_A | 138 | Hypothetical protein AQ_178; structural genomics, | 99.46 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.4 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.38 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.35 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.34 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 99.34 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.34 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.32 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.31 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.25 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 99.18 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.02 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.87 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.39 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.32 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.32 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.18 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.12 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.09 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.04 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.61 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.6 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.42 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.33 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.32 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.31 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.28 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.12 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.09 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.07 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.02 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.79 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.93 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.35 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.04 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 92.35 | |
| 3a2k_A | 464 | TRNA(Ile)-lysidine synthase; ligase, pseudo-knot, | 87.82 | |
| 1wy5_A | 317 | TILS, hypothetical UPF0072 protein AQ_1887; N-type | 86.59 | |
| 1k92_A | 455 | Argininosuccinate synthase, argininosuccinate SY; | 81.85 | |
| 2nz2_A | 413 | Argininosuccinate synthase; amino-acid biosynthesi | 80.6 | |
| 1ni5_A | 433 | Putative cell cycle protein MESJ; structural genom | 80.38 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=450.77 Aligned_cols=257 Identities=26% Similarity=0.464 Sum_probs=210.9
Q ss_pred cCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCC-hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
++|.+.+.||+|+||+||+|.+. ++..||||+++.. ....++|.+|+++|++++|||||+++|+|.+++.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888999999999999999853 4778999999864 4567789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEE
Q 004174 495 VYDFLSRGSLEENLHGNK---------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~---------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL 565 (770)
|||||++|+|.++|+..+ .....++|.+++.|+.||+.||.|||+ ++||||||||+||||+.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 999999999999997542 233579999999999999999999999 89999999999999999999999
Q ss_pred ccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhccc
Q 004174 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPI 644 (770)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~ 644 (770)
+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||...+.......+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~----- 244 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT----- 244 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-----
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----
Confidence 99999987655444333344679999999999999999999999999999999999 999998765432222211
Q ss_pred ccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 645 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 645 ~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+.... . +......+..++..||+.||.+||||.+|++.|+.
T Consensus 245 --~~~~~~-----~----p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 245 --QGRVLQ-----R----PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp --HTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --cCCCCC-----C----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111111 1 11122345667788999999999999999998864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=451.82 Aligned_cols=258 Identities=24% Similarity=0.412 Sum_probs=203.6
Q ss_pred cCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
++|.+.+.||+|+||.||+|.+. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46788899999999999999853 47889999998643 566789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCce
Q 004174 495 VYDFLSRGSLEENLHGNKK-----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~v 563 (770)
|||||++|+|.++|+.... ....++|.+++.|+.||+.||.|||+ ++||||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 9999999999999976432 12469999999999999999999999 899999999999999999999
Q ss_pred EEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhc
Q 004174 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 642 (770)
Q Consensus 564 kL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~ 642 (770)
||+|||+|+...........+...||+.|||||++.+..|+.++|||||||+||||+| |+.||...........+..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~-- 275 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ-- 275 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH--
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--
Confidence 9999999987765444444445789999999999999999999999999999999999 9999987654322222111
Q ss_pred ccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 643 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 643 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
+.. +.. +......+..++..||+.||.+||||.+|+++|+..
T Consensus 276 -----g~~-----~~~----p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 276 -----GRE-----LER----PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp -----TCC-----CCC----CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred -----CCC-----CCC----cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 110 011 111223456677789999999999999999998643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=449.77 Aligned_cols=258 Identities=26% Similarity=0.391 Sum_probs=210.8
Q ss_pred cCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
+++.+.+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34667789999999999999862 5678999999753 245678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC
Q 004174 494 LVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~ 561 (770)
||||||++|+|.++|+.... ....++|..++.|+.|||.||.|||+ ++||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCC
Confidence 99999999999999975431 12468999999999999999999999 8999999999999999999
Q ss_pred ceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHh
Q 004174 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 640 (770)
Q Consensus 562 ~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~ 640 (770)
.+||+|||+|+...........+...||+.|||||++.++.|+.++|||||||+||||+| |+.||.+.........+
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i-- 260 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI-- 260 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH--
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH--
Confidence 999999999987655443333445689999999999999999999999999999999999 89999876543222211
Q ss_pred hcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 641 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 641 ~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
..+..... +.+....+..++..||+.||.+||||.+|++.|+.-
T Consensus 261 -----~~~~~~~~---------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 261 -----RNRQVLPC---------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp -----HTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred -----HcCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11211111 112234466677889999999999999999999753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-52 Score=445.14 Aligned_cols=256 Identities=29% Similarity=0.481 Sum_probs=200.1
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.++|.+.+.||+|+||+||+|.+++ .||||+++. .....+.|.+|+.+|++++|||||+++++|.+ +.++||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3567788999999999999998743 599999974 34567889999999999999999999999865 57899999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
||+||+|.++|+... ..++|.++..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred cCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 999999999997543 369999999999999999999999 89999999999999999999999999999877654
Q ss_pred CCCceecccccccCCCCceeecc---CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
.........+||+.|||||++.. +.|+.++|||||||+||||+||+.||...+........ .. .+ ..
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~--~~----~~----~~ 255 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM--VG----RG----YA 255 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HH----TT----CC
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH--Hh----cC----CC
Confidence 43333445789999999999963 46999999999999999999999999875543222111 11 11 01
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
.|.+. ....+....+..++..||+.||.+||||.+|++.|+
T Consensus 256 ~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 256 SPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp CCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred CCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 11111 111122234556677899999999999999998875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=444.96 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=201.4
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.|.+|+.+|+.|+|||||+++++|.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999986 47999999999753 3556789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|++||+|.++|...+. ..+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999975432 357899999999999999999999 89999999999999999999999999999876432
Q ss_pred CCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
. ......+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+.......+. .+... .
T Consensus 179 ~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~-------~~~~~-----~ 244 (350)
T 4b9d_A 179 V--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII-------SGSFP-----P 244 (350)
T ss_dssp H--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-------HTCCC-----C
T ss_pred c--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-------cCCCC-----C
Confidence 1 12234689999999999999999999999999999999999999998765433222111 11111 1
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+...++ ..+..++..||+.||.+|||+.+++++
T Consensus 245 ~~~~~s----~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 245 VSLHYS----YDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCccCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111122 234456678999999999999999874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=439.16 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=207.1
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||+||+|.. .+|+.||||++.+. ....+.+.+|+++|+.++|||||+++++|.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999986 47999999999753 234577999999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||++||+|.++|...+ .+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999997653 58999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
.........++||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+.......+.. +.+
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~-------~~~------ 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK-------LEY------ 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------TCC------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-------CCC------
Confidence 5444444567999999999999999999999999999999999999999987654322222111 110
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 692 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL 692 (770)
.+...+. ..+..++..||+.||.+|||+.+++
T Consensus 252 ~~p~~~s----~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 DFPEKFF----PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCCTTCC----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCcccC----HHHHHHHHHHccCCHhHCcChHHHc
Confidence 1111122 2344566789999999999998864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=440.62 Aligned_cols=249 Identities=27% Similarity=0.373 Sum_probs=205.5
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
..|...+.||+|+||+||+|... +|+.||||+++... ...+.+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888999999999999999864 79999999996533 33456889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
+||+|.+++... .+++..+..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999999753 48999999999999999999999 8999999999999999999999999999987755433
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
. ....+||+.|||||++....|+.++|||||||+||||++|+.||.+.+.......+... ..+.+.
T Consensus 226 ~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~------------~~~~~~ 291 (346)
T 4fih_A 226 R--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN------------LPPRLK 291 (346)
T ss_dssp C--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------------SCCCCS
T ss_pred c--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC------------CCCCCC
Confidence 2 23478999999999999999999999999999999999999999876543332222110 001111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. .......+..++..||+.||.+|||+.+++++
T Consensus 292 ~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 292 N--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp C--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c--cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 01112234456678999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=437.23 Aligned_cols=250 Identities=23% Similarity=0.262 Sum_probs=201.8
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
+.|.+.+.||+|+||.||+|.+ .+|+.||||+++.... +.+|+.+|+.++|||||+++++|.+++.+|||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 4578889999999999999986 4699999999976432 2469999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC-ceEEccccccccccCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-~vkL~DFGla~~~~~~~~ 579 (770)
||+|.++|...+ .+++..+..|+.||+.||+|||+ ++||||||||+||||+.++ .+||+|||+|+.......
T Consensus 134 gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 134 GGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999997653 58999999999999999999999 8999999999999999987 699999999987754322
Q ss_pred C---ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 580 H---ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 580 ~---~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
. .....++||+.|||||++.+..|+.++|||||||+||||+||+.||...........+....+ .+.
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-----~~~----- 276 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP-----PIR----- 276 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC-----GGG-----
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC-----Cch-----
Confidence 1 122346899999999999999999999999999999999999999987655443322221110 000
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
.+.... ...+..++..||+.||.+|||+.|++++|.
T Consensus 277 ~~~~~~----s~~~~~li~~~L~~dP~~R~sa~el~~~l~ 312 (336)
T 4g3f_A 277 EIPPSC----APLTAQAIQEGLRKEPVHRASAMELRRKVG 312 (336)
T ss_dssp GSCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hcCccC----CHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 111111 223445567899999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=433.38 Aligned_cols=265 Identities=27% Similarity=0.336 Sum_probs=201.1
Q ss_pred cCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC----ceEEEEe
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----NLLLVYD 497 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----~~~LV~E 497 (770)
++|.+.+.||+|+||+||+|.+ +|+.||||+++........+..|+..+..++|||||+++++|.+++ .+|||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4578889999999999999988 6899999999765443333445666667899999999999998764 5799999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS-----AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
||++|+|.++|+.. .++|..+.+++.|++.||.|||+.+ ..+||||||||+||||+.++.+||+|||+|+
T Consensus 82 y~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999753 4899999999999999999999831 2489999999999999999999999999998
Q ss_pred cccCCCCCc--eecccccccCCCCceeeccC------CCCCcceEeechHHHHHHHhCCCCCCCCCccchh---------
Q 004174 573 WASTSSSHI--TCTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE--------- 635 (770)
Q Consensus 573 ~~~~~~~~~--~~~~~~GT~~YlAPE~~~~~------~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~--------- 635 (770)
......... .....+||+.|||||++.+. .|+.++|||||||+||||+||.+||.........
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 776543321 22336899999999999754 4778999999999999999998887543321110
Q ss_pred hHHHhhcccccCCccccccCcccCCCC-ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 636 SLVMWAKPILSSGKVTQLLDPALGNNY-DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 636 ~lv~~~~~~~~~g~l~~lld~~l~~~~-~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
....... .. ....++|.+.... ..+....+..++..||+.||.+||||.+|++.|+.
T Consensus 237 ~~~~~~~-~~----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 237 SVEEMRK-VV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CHHHHHH-HH----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHHH-HH----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 0000000 00 1111222222211 23456677888899999999999999999999863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=425.84 Aligned_cols=244 Identities=26% Similarity=0.382 Sum_probs=195.1
Q ss_pred ccceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcCCCceeEEeeEEee----cCceEEEE
Q 004174 425 LAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLLVY 496 (770)
Q Consensus 425 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~LV~ 496 (770)
.+.+.||+|+||+||+|.+. ++..||||++.. .....+.|.+|+++|+.|+|||||+++++|.+ .+.+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56778999999999999864 689999999864 33556789999999999999999999999975 34589999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc--eEEecccCCCeeeCC-CCceEEcccccccc
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSD-DFEPQLSDFGLAKW 573 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--IiHrDLKp~NILL~~-~~~vkL~DFGla~~ 573 (770)
|||+||+|.++|.... .+++..+..|+.||+.||.|||+ ++ ||||||||+||||+. ++.+||+|||+|+.
T Consensus 109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 9999999999997643 58999999999999999999998 55 999999999999974 78999999999986
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
..... ....+||+.|||||++. ++|+.++|||||||+||||+||+.||....... .+.... ..+.....
T Consensus 182 ~~~~~----~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~~~i----~~~~~~~~ 250 (290)
T 3fpq_A 182 KRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRV----TSGVKPAS 250 (290)
T ss_dssp CCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHH----TTTCCCGG
T ss_pred CCCCc----cCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHHHHH----HcCCCCCC
Confidence 54322 23468999999999886 579999999999999999999999997643322 111111 11111111
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
++ .... . .+..++..||+.||.+|||+.+++++
T Consensus 251 ~~----~~~~-~---~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 251 FD----KVAI-P---EVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GG----GCCC-H---HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CC----ccCC-H---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 1111 2 34456678999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=440.50 Aligned_cols=260 Identities=24% Similarity=0.386 Sum_probs=210.8
Q ss_pred hhcCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCC-CceeEEeeEEeec-
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHH-KNIISLLGFCFED- 489 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~- 489 (770)
..++|.+.+.||+|+||.||+|.+. .++.||||+++.. ....+.|.+|+.+|.+++| ||||+++|+|.+.
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 4567999999999999999999853 2468999999764 3456789999999999965 9999999999764
Q ss_pred CceEEEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee
Q 004174 490 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (770)
Q Consensus 490 ~~~~LV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 557 (770)
+.++||||||++|+|.++|+.... ....++|..++.|+.|||.||.|||+ ++||||||||+||||
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceee
Confidence 568999999999999999975421 12458999999999999999999999 899999999999999
Q ss_pred CCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhh
Q 004174 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 636 (770)
Q Consensus 558 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~ 636 (770)
+.++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||.+.......
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~- 297 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF- 297 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH-
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence 9999999999999998766555555556789999999999999999999999999999999998 99999875433211
Q ss_pred HHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 637 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 637 lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
... +..|.. +..... ....+..++..||+.||.+|||+.+|+++|..
T Consensus 298 -~~~----i~~g~~-----~~~p~~----~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 298 -CRR----LKEGTR-----MRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp -HHH----HHHTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHH----HHcCCC-----CCCCcc----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 111 111110 111111 12345566778999999999999999999853
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=442.62 Aligned_cols=249 Identities=27% Similarity=0.374 Sum_probs=206.0
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
+.|.+.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999864 79999999997543 34456889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
+||+|.+++... .+++..+..|+.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 231 ~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 231 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999999643 48999999999999999999999 8999999999999999999999999999987755433
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
. ....+||+.|||||++....|+.++|||||||+||||++|+.||.+.++......+... ..+.+.
T Consensus 303 ~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~------------~~~~~~ 368 (423)
T 4fie_A 303 R--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN------------LPPRLK 368 (423)
T ss_dssp C--BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------------CCCCCS
T ss_pred c--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC------------CCCCCc
Confidence 2 23478999999999999999999999999999999999999999876543332222110 011111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.. ......+..++..||+.||.+|||+.++|++
T Consensus 369 ~~--~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 369 NL--HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CT--TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cc--ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 10 0111234455678999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=418.35 Aligned_cols=245 Identities=21% Similarity=0.333 Sum_probs=189.3
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||+||+|.. .+|+.||||++++. ....+.+.+|+++|+.++|||||+++++|.+.+.+||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5899999999999999999986 47999999999753 234567999999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+ +|+|.+++...+ .+++.++..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 679999997653 58999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCceecccccccCCCCceeeccCCC-CCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
... ....+||+.|+|||++.+..| +.++|||||||+||||+||+.||.+.+.......+.. +..
T Consensus 165 ~~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~-------~~~----- 229 (275)
T 3hyh_A 165 GNF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN-------GVY----- 229 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------TCC-----
T ss_pred CCc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-------CCC-----
Confidence 332 234689999999999998776 5799999999999999999999986543222111111 110
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+....+ ..+..++..||+.||.+|||+.+++++
T Consensus 230 -~~p~~~s----~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 -TLPKFLS----PGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp -CCCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred -CCCCCCC----HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0111112 234456678999999999999999973
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=426.76 Aligned_cols=247 Identities=26% Similarity=0.355 Sum_probs=195.3
Q ss_pred cCcccceeecccCceEEEEEEe----CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~----~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
++|.+.+.||+|+||+||+|.. .+++.||||+++... .....+.+|+++|+.++|||||+++++|.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999975 257899999997532 233468889999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||++||+|.++|...+ .+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999997653 58999999999999999999999 89999999999999999999999999999865
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
...... ....+||+.|||||++....|+.++|||||||+||||+||+.||.+.+.......+.-. .+
T Consensus 177 ~~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-------~~---- 243 (304)
T 3ubd_A 177 IDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA-------KL---- 243 (304)
T ss_dssp ----CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------CC----
T ss_pred cCCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC-------CC----
Confidence 443222 23468999999999999999999999999999999999999999876543322222111 10
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 694 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs-----~~eVL~~ 694 (770)
.+....+ ..+..++..||+.||.+||| +++++++
T Consensus 244 --~~p~~~s----~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 244 --GMPQFLS----PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp --CCCTTSC----HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred --CCCCcCC----HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 0111112 23445667899999999998 4677653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=411.79 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=187.2
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc-------
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN------- 491 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~------- 491 (770)
++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+.+|+.|+|||||+++++|.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4689999999999999999986 47999999998643 3456789999999999999999999999976543
Q ss_pred -----eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEc
Q 004174 492 -----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (770)
Q Consensus 492 -----~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~ 566 (770)
+||||||+++|+|.+++...... ....+..++.|+.||+.||+|||+ ++||||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCC-ChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEc
Confidence 79999999999999999765432 235677789999999999999999 899999999999999999999999
Q ss_pred cccccccccCCCCC----------ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhh
Q 004174 567 DFGLAKWASTSSSH----------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636 (770)
Q Consensus 567 DFGla~~~~~~~~~----------~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~ 636 (770)
|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||+||||++ ||..... ...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~~~ 235 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--RVR 235 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--HHH
Confidence 99999876543221 11234689999999999999999999999999999999996 7754211 111
Q ss_pred HHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 637 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 637 lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+.. .......... .........++..||+.||.+|||+.+++++
T Consensus 236 ~~~~----~~~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 236 TLTD----VRNLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHH----HHTTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHH----HhcCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1110 1111111111 1111223446678999999999999999873
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=403.33 Aligned_cols=284 Identities=37% Similarity=0.675 Sum_probs=248.2
Q ss_pred ccCHHHHHHhhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeec
Q 004174 411 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFED 489 (770)
Q Consensus 411 ~f~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 489 (770)
.+.+.++...+++|.+.+.||+|+||.||+|...+|+.||||++.... ...+.+.+|+.+++.++||||++++++|...
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 345556667889999999999999999999998889999999987643 5567899999999999999999999999999
Q ss_pred CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccc
Q 004174 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (770)
Q Consensus 490 ~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 569 (770)
+..++||||+++|+|.+++.........++|..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999997665444569999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCc
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 649 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 649 (770)
+++...............||+.|+|||++..+.++.++|||||||++|||++|+.||....+.....+..|.......+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 99875543333233345799999999999999999999999999999999999999988777666667777666666777
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 650 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 650 l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+..++++.+......+....+..++..||+.||.+||++.+|+++|+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 888888888777788888889999999999999999999999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=404.09 Aligned_cols=298 Identities=37% Similarity=0.711 Sum_probs=256.3
Q ss_pred CcccccCHHHHHHhhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEee
Q 004174 407 ATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLG 484 (770)
Q Consensus 407 ~~~~~f~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~ 484 (770)
...+.|++.++...+++|.+.+.||+|+||.||+|...+|+.||||+++... .....+.+|+.++..++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 3456899999999999999999999999999999998889999999997643 22336889999999999999999999
Q ss_pred EEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceE
Q 004174 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (770)
Q Consensus 485 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vk 564 (770)
+|...+..++||||+++|+|.+++.........++|..+..|+.|++.||.|||+.+..+|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999987765556799999999999999999999993222999999999999999999999
Q ss_pred EccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCC--ccchhhHHHhhc
Q 004174 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH--PKGQESLVMWAK 642 (770)
Q Consensus 565 L~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~--~~~~~~lv~~~~ 642 (770)
|+|||++.......... .....||+.|+|||++..+.++.++|||||||++|+|++|+.||.... ......+..|..
T Consensus 175 l~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp ECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred eccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 99999998775543332 334579999999999998999999999999999999999999996321 122334566777
Q ss_pred ccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCCCchhhh
Q 004174 643 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWA 705 (770)
Q Consensus 643 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~~~~~~~ 705 (770)
.......+..+.+..+...+..+....+..++..||+.+|.+|||+.+|+++|++....++|.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~ 316 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE 316 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhh
Confidence 777778888888888888888888999999999999999999999999999999876655553
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=411.64 Aligned_cols=265 Identities=23% Similarity=0.337 Sum_probs=202.8
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEee------cC
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE------DN 490 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------~~ 490 (770)
.++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+.+|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 35799999999999999999986 47999999999754 3456778999999999999999999998764 36
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 570 (770)
.+|||||||+ |+|.+++...+ .+++..+..|+.||+.||.|||+ ++||||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecce
Confidence 7899999995 68999997543 69999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCC--CCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccC
Q 004174 571 AKWASTSS--SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 647 (770)
Q Consensus 571 a~~~~~~~--~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 647 (770)
|+.+.... ........+||+.|+|||++.+. .|+.++|||||||+||||++|++||.+.+...+...+.........
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 98764432 12223457899999999998865 5699999999999999999999999887655444333211111000
Q ss_pred Ccc--------ccccCcccCC--CCChH-----HHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 648 GKV--------TQLLDPALGN--NYDYD-----QMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 648 g~l--------~~lld~~l~~--~~~~~-----~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
... ...+. .+.. ..+.. ....+..++..||+.||.+|||+.++|++
T Consensus 285 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQ-SLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGTC-----CHHHHHH-SSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHhhhhhhhhhhhhhh-cCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00000 0000 00111 11234556678999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=400.74 Aligned_cols=200 Identities=27% Similarity=0.418 Sum_probs=171.9
Q ss_pred hhcCcccceeecccCceEEEEEEeC----CCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~L 494 (770)
..+.|.+.+.||+|+||+||+|..+ .++.||||++..... ..++.+|+++|..+ +||||++++++|.+.+++||
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 4678999999999999999999753 467899999876543 35678999999998 69999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC-CceEEcccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKW 573 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~-~~vkL~DFGla~~ 573 (770)
||||++||+|.+++. .+++.+++.++.||+.||.|||+ ++||||||||+||||+.+ +.+||+|||+|+.
T Consensus 98 vmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 98 AMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 999999999999983 37899999999999999999999 999999999999999876 7999999999986
Q ss_pred ccCCCCC--------------------------ceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCC
Q 004174 574 ASTSSSH--------------------------ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPI 626 (770)
Q Consensus 574 ~~~~~~~--------------------------~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf 626 (770)
....... ......+||+.|+|||++.+. .|+.++||||+||+||||+||+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 5432211 112335799999999999865 5899999999999999999999999
Q ss_pred CCCC
Q 004174 627 SNDH 630 (770)
Q Consensus 627 ~~~~ 630 (770)
....
T Consensus 248 ~~~~ 251 (361)
T 4f9c_A 248 YKAS 251 (361)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 6544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=421.00 Aligned_cols=252 Identities=22% Similarity=0.287 Sum_probs=207.2
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++... ...+.+.+|+.+|+.|+|||||+++++|.+.+.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36799999999999999999986 479999999987643 4567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC--CceEEccccccccccC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--FEPQLSDFGLAKWAST 576 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~--~~vkL~DFGla~~~~~ 576 (770)
|+||+|.++|.... ..+++.++..|+.||+.||.|||+ ++|+||||||+||||+.+ +.+||+|||+|+.+..
T Consensus 236 ~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999999986443 358999999999999999999999 899999999999999854 8999999999998765
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
... ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+.......+...... +.+
T Consensus 310 ~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~---------~~~ 377 (573)
T 3uto_A 310 KQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN---------MDD 377 (573)
T ss_dssp TSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC---------CCS
T ss_pred CCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC---------CCc
Confidence 432 23468999999999999999999999999999999999999999876544332222211100 001
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
....... ..+..++..||+.||.+||++.++|++
T Consensus 378 ~~~~~~s----~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 378 SAFSGIS----EDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp GGGTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccccCCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111112 234456678999999999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=420.22 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=198.7
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 492 (770)
.++|.+.++||+|+||.||+|... +|+.||||++++.. ........++.++..++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 467999999999999999999864 79999999996422 1222233446667778999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
||||||++||+|.++|...+ .|++..++.|+.||+.||.|||+ ++||||||||+||||+.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999997653 58999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 573 WASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
....... ...+||+.|||||++..+ .|+.++|||||||+||||++|++||.+........+...... ..
T Consensus 341 ~~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~----~~-- 410 (689)
T 3v5w_A 341 DFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----MA-- 410 (689)
T ss_dssp ECSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH----CC--
T ss_pred ecCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC----CC--
Confidence 7765432 236899999999999754 799999999999999999999999976544333222211100 00
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 694 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs-----~~eVL~~ 694 (770)
..+...+. ..+..++..||+.||.+|++ +.+|+++
T Consensus 411 ----~~~p~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 411 ----VELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ----CCCCTTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ----CCCCccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 01111122 23445567799999999998 6888764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=367.06 Aligned_cols=281 Identities=32% Similarity=0.581 Sum_probs=230.6
Q ss_pred cccccCHHHHHHhhcCcccc------eeecccCceEEEEEEeCCCCEEEEEEeCCC-----hhHHHHHHHHHHHHHhcCC
Q 004174 408 TCRLFNYQDLLSATSNFLAE------NLIGKGGSSQVYKGCLPDGKELAVKILKPS-----EDVIKEFVLEIEIITTLHH 476 (770)
Q Consensus 408 ~~~~f~~~~l~~~t~~f~~~------~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~-----~~~~~~~~~Ei~iL~~l~H 476 (770)
....|++.++..++++|... +.||+|+||.||+|.. +++.||||++... ....+.+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45789999999999999877 8999999999999987 6889999998642 3456789999999999999
Q ss_pred CceeEEeeEEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCee
Q 004174 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556 (770)
Q Consensus 477 pnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NIL 556 (770)
|||+++++++...+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEE
Confidence 9999999999999999999999999999999875432 2468999999999999999999999 89999999999999
Q ss_pred eCCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhh
Q 004174 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636 (770)
Q Consensus 557 L~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~ 636 (770)
++.++.+||+|||++................||+.|+|||++. +.++.++||||||+++|+|++|+.||..........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence 9999999999999998766544333334467999999999876 568999999999999999999999998654332211
Q ss_pred HHHhhccc-ccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 637 LVMWAKPI-LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 637 lv~~~~~~-~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+.... .....+...+++.+. .........+..++..||+.+|.+||++.+|+++|+.
T Consensus 245 --~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~ 303 (307)
T 2nru_A 245 --DIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303 (307)
T ss_dssp --HHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --HHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 111111 112234444555442 3455666778888899999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=379.94 Aligned_cols=268 Identities=25% Similarity=0.320 Sum_probs=209.2
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc----eEEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----LLLVY 496 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~----~~LV~ 496 (770)
.++|.+.+.||+|+||.||+|.. .++.||||+++........+..|+.++..++||||++++++|..... +++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 46799999999999999999987 47899999998766666677789999999999999999999988553 69999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC----------ceEEecccCCCeeeCCCCceEEc
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ----------RVIHRDVKSSNILLSDDFEPQLS 566 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~----------~IiHrDLKp~NILL~~~~~vkL~ 566 (770)
||+++|+|.+++... .+++..++.++.|++.||.|||+ . +|+||||||+|||++.++.+||+
T Consensus 102 e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred ecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 999999999999753 48999999999999999999998 6 99999999999999999999999
Q ss_pred cccccccccCCCCCceecccccccCCCCceeeccC-----CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhh
Q 004174 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 641 (770)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~-----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~ 641 (770)
|||+++...............||+.|+|||++... .++.++|||||||++|||+||+.||...............
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999877654443333446799999999999863 5667899999999999999999999875443221111100
Q ss_pred cccccCCcc-----ccccCcccCCCC-ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 642 KPILSSGKV-----TQLLDPALGNNY-DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 642 ~~~~~~g~l-----~~lld~~l~~~~-~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
........+ .....+.+.... .......+..++..||+.||.+|||+.+|++.|+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 000000000 000111111111 12345567778889999999999999999999874
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=378.76 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=209.6
Q ss_pred hcCcccceeecccCceEEEEEEe--------CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL--------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~--------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 489 (770)
.++|.+.+.||+|+||.||+|.. .++..||||+++.. ....+.+.+|+.+++.+ +||||++++++|...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 35788999999999999999975 23567999999864 34567899999999999 899999999999999
Q ss_pred CceEEEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee
Q 004174 490 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (770)
Q Consensus 490 ~~~~LV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 557 (770)
+.+|+||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 999999999999999999976532 12358999999999999999999999 899999999999999
Q ss_pred CCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhh
Q 004174 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 636 (770)
Q Consensus 558 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~ 636 (770)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||..........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999987655433333333567899999999999999999999999999999999 999998754432221
Q ss_pred HHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 637 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 637 lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+. .+.. +. .+......+..++..||+.+|.+||++.++++.|+.
T Consensus 317 ~~~-------~~~~-----~~----~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 317 LLK-------EGHR-----MD----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp HHH-------TTCC-----CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHh-------cCCC-----CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111 1110 00 111122345566678999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=366.66 Aligned_cols=258 Identities=25% Similarity=0.456 Sum_probs=207.8
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCC-ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
.++|.+.+.||+|+||.||+|... +++.||+|++.. .....+.|.+|++++..++||||++++++|.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 357899999999999999999864 689999998865 446678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999997643 368999999999999999999999 899999999999999999999999999998765432
Q ss_pred CCce------------ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhccccc
Q 004174 579 SHIT------------CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 646 (770)
Q Consensus 579 ~~~~------------~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~ 646 (770)
.... .....||+.|+|||++.+..++.++|||||||++|||++|..||....+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-------- 234 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-------- 234 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB--------
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh--------
Confidence 2210 11357999999999999999999999999999999999999999765443221100
Q ss_pred CCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 647 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 647 ~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
.....++.......+ ..+..++..||+.||.+||++.++++.|+..
T Consensus 235 --~~~~~~~~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 235 --NVRGFLDRYCPPNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp --CHHHHHHHTCCTTCC----TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --hhhccccccCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 001111111111111 2344566789999999999999999988643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=358.39 Aligned_cols=257 Identities=23% Similarity=0.383 Sum_probs=211.7
Q ss_pred hhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
..++|.+.+.||+|+||.||+|...++..||||+++......+.+.+|+.++..++||||++++++|...+..++||||+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 34679999999999999999999888889999999876656678999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 86 SNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp TTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred CCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999997543 358999999999999999999999 8999999999999999999999999999987655432
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
. ......+|+.|+|||++....++.++||||||+++|+|++ |+.||...........+.... ....+
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---------~~~~~-- 227 (268)
T 3sxs_A 160 V-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH---------RLYRP-- 227 (268)
T ss_dssp E-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC---------CCCCC--
T ss_pred h-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC---------CCCCC--
Confidence 2 2223456778999999998899999999999999999999 999997654432221111110 00011
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~ 699 (770)
.... ..+..++..||+.+|.+||++.++++.|+...
T Consensus 228 --~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 228 --HLAS---DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp --TTSC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred --CcCh---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1111 23555667899999999999999999997654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=364.82 Aligned_cols=250 Identities=25% Similarity=0.385 Sum_probs=205.7
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.+++.++||||++++++|...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999985 578999999986433 3456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++|+|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999754 48899999999999999999999 899999999999999999999999999998765543
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
.. .....||+.|+|||++....++.++|||||||++|||++|+.||....+......+.... ...+..
T Consensus 171 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-------~~~~~~--- 238 (297)
T 3fxz_A 171 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-------TPELQN--- 238 (297)
T ss_dssp CC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-------SCCCSC---
T ss_pred cc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------CCCCCC---
Confidence 32 233679999999999999999999999999999999999999998765433222211100 000000
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+......+..++..||+.||.+||++.+++++
T Consensus 239 ----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 239 ----PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11112334556678999999999999999974
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=371.81 Aligned_cols=248 Identities=25% Similarity=0.408 Sum_probs=205.6
Q ss_pred hhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
..++|.+.+.||+|+||.||+|.+ .+|+.||||++.. .....+.+.+|+.+++.++||||+++++++...+.+++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346899999999999999999986 5899999999965 335567889999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999997653 48899999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCceecccccccCCCCceeeccCCCC-CcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
.... ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.......+.. +..
T Consensus 166 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-------~~~---- 231 (328)
T 3fe3_A 166 VGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR-------GKY---- 231 (328)
T ss_dssp SSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CCC----
T ss_pred CCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCC----
Confidence 4322 2346899999999999988875 799999999999999999999987654332222211 110
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+ +......+..++..||+.||.+|||+.+++++
T Consensus 232 --~~----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 --RI----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp --CC----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred --CC----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 11112234456678999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=369.00 Aligned_cols=255 Identities=27% Similarity=0.414 Sum_probs=205.3
Q ss_pred hcCcccceeecccCceEEEEEEeC----CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
.++|.+.+.||+|+||.||+|.+. .+..||||+++.. ....+.|.+|+.++..++||||++++++|.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 357889999999999999999874 3456999999863 4556789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999996543 358999999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCC-ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 575 STSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 575 ~~~~~~-~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
...... .......+|+.|+|||++....++.++|||||||++|||++ |+.||...........+.. +.
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-------~~--- 271 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE-------GY--- 271 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT-------TC---
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-------CC---
Confidence 554322 12223456888999999999999999999999999999999 9999976544322211111 00
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
... .+......+..++..||+.||.+||++.+|++.|+.
T Consensus 272 --~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~ 310 (325)
T 3kul_A 272 --RLP----APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310 (325)
T ss_dssp --CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCC----CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 000 111122345566778999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=367.44 Aligned_cols=257 Identities=30% Similarity=0.494 Sum_probs=200.5
Q ss_pred HhhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 419 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 419 ~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
...++|.+.+.||+|+||.||+|.. +|+.||||++... ....+.+.+|+.++++++||||++++++|...+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3456799999999999999999987 6889999999754 35567899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc--eEEecccCCCeeeCCCCceEEcccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
|||+++|+|.+++..... ...+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||+++.
T Consensus 113 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999975431 1248999999999999999999999 77 99999999999999999999999999986
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
...... ......||+.|+|||++....++.++|||||||++|||++|+.||...........+..... .
T Consensus 189 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~---~------ 257 (309)
T 3p86_A 189 KASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK---R------ 257 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC---C------
T ss_pred cccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---C------
Confidence 544322 12235799999999999999999999999999999999999999987654332222111110 0
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
..+....+ ..+..++..||+.+|.+||++.++++.|+.
T Consensus 258 --~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~~L~~ 295 (309)
T 3p86_A 258 --LEIPRNLN----PQVAAIIEGCWTNEPWKRPSFATIMDLLRP 295 (309)
T ss_dssp --CCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 01111112 235556678999999999999999998864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=376.70 Aligned_cols=268 Identities=24% Similarity=0.392 Sum_probs=213.0
Q ss_pred cCHHHHHHhhcCcccceeecccCceEEEEEEe------CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEE
Q 004174 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISL 482 (770)
Q Consensus 412 f~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l 482 (770)
+.........++|.+.+.||+|+||.||+|.+ .+++.||||+++.. ....+.+.+|+.++..+ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 44445555678899999999999999999973 35678999999864 34567899999999999 79999999
Q ss_pred eeEEeecCc-eEEEEeecCCCChhhhhccCCCC-----------------------------------------------
Q 004174 483 LGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKD----------------------------------------------- 514 (770)
Q Consensus 483 ~~~~~~~~~-~~LV~E~~~ggsL~~~l~~~~~~----------------------------------------------- 514 (770)
+++|.+.+. +++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 89999999999999999765321
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 515 ---------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 515 ---------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
...+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1228999999999999999999999 8999999999999999999999999999987655444
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
........||+.|+|||++....++.++|||||||++|||++ |+.||............. ..+.. ...
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~------~~~~~-----~~~ 317 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------KEGTR-----MRA 317 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH------HHTCC-----CCC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH------HcCCC-----CCC
Confidence 444445678999999999999999999999999999999998 999997755432211111 00100 001
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.... ...+..++..||+.+|.+||++.+|+++|+.
T Consensus 318 ~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 318 PDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 1111 1235556678999999999999999999974
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=359.60 Aligned_cols=254 Identities=24% Similarity=0.444 Sum_probs=209.2
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
.++|.+.+.||+|+||.||+|...+++.||||++.......+.+.+|++++.+++||||++++++|.+.+..++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 35789999999999999999998888999999998766566789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 161 (269)
T 4hcu_A 89 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 161 (269)
T ss_dssp TCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence 999999997543 368999999999999999999999 8999999999999999999999999999986644221
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
.......+|+.|+|||++....++.++||||||+++|+|++ |+.||...........+. .+ ..+...
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~-------~~-----~~~~~~ 229 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-------TG-----FRLYKP 229 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-------TT-----CCCCCC
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-------cC-----ccCCCC
Confidence 11123457888999999999999999999999999999999 999998654432211111 00 000011
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
... ...+..++..||+.+|.+||++.+++++|+.
T Consensus 230 ~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 230 RLA----STHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CcC----CHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 111 2335556678999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=364.78 Aligned_cols=261 Identities=24% Similarity=0.348 Sum_probs=211.4
Q ss_pred cccCHHHHHHhhcC----------cccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCC
Q 004174 410 RLFNYQDLLSATSN----------FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHK 477 (770)
Q Consensus 410 ~~f~~~~l~~~t~~----------f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~Hp 477 (770)
..|+++++..+++. |...+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45778888777764 677789999999999999975 79999999997543 4456788999999999999
Q ss_pred ceeEEeeEEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee
Q 004174 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (770)
Q Consensus 478 nIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 557 (770)
||++++++|...+..++||||+++|+|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+|||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEE
Confidence 9999999999999999999999999999998642 48999999999999999999999 899999999999999
Q ss_pred CCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhH
Q 004174 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637 (770)
Q Consensus 558 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l 637 (770)
+.++.+||+|||++......... .....||+.|+|||++..+.++.++|||||||++|||++|+.||...........
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~ 252 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred CCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999876543322 2346799999999999999999999999999999999999999976543222111
Q ss_pred HHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 638 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 638 v~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+. . . ..+.+.. .......+..++..||+.||.+||++.+++++
T Consensus 253 ~~---~----~-----~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 253 LR---D----S-----PPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HH---H----S-----SCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred Hh---c----C-----CCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 0 0 0011100 01112234556678999999999999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=367.77 Aligned_cols=252 Identities=19% Similarity=0.242 Sum_probs=207.6
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
.++|.+.+.||+|+||.||+|... +++.||+|+++........+.+|+.++..++||||++++++|.+.+.+++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 468999999999999999999865 6889999999877666778899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC--CCceEEccccccccccCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~--~~~vkL~DFGla~~~~~~ 577 (770)
++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++......
T Consensus 84 ~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 84 SGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999996543 358999999999999999999999 89999999999999987 789999999999877543
Q ss_pred CCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
.. .....||+.|+|||++....++.++|||||||++|+|++|..||...........+...... +++.
T Consensus 158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---------~~~~ 225 (321)
T 1tki_A 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT---------FDEE 225 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC---------CCHH
T ss_pred Cc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCC---------CChh
Confidence 32 23367999999999999888999999999999999999999999875443222211111100 0000
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..... ...+..++..||..||.+|||+.+++++
T Consensus 226 ~~~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 AFKEI----SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00111 2345566678999999999999999984
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=372.90 Aligned_cols=213 Identities=25% Similarity=0.354 Sum_probs=189.1
Q ss_pred ccccCHHHHHHhhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-----CCceeEE
Q 004174 409 CRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-----HKNIISL 482 (770)
Q Consensus 409 ~~~f~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-----HpnIv~l 482 (770)
...|++++.....++|.+.+.||+|+||.||+|.. .+++.||||+++........+..|++++..+. ||||+++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34566666667788999999999999999999986 47899999999887777788899999999997 9999999
Q ss_pred eeEEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC---
Q 004174 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD--- 559 (770)
Q Consensus 483 ~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~--- 559 (770)
+++|...+..++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccc
Confidence 99999999999999999 8999999976543 358999999999999999999999 89999999999999975
Q ss_pred ----------------------CCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHH
Q 004174 560 ----------------------DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 617 (770)
Q Consensus 560 ----------------------~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~ 617 (770)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 7889999999998655432 2357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCcc
Q 004174 618 ELLTGRKPISNDHPK 632 (770)
Q Consensus 618 eLltG~~Pf~~~~~~ 632 (770)
||++|+.||......
T Consensus 251 ell~g~~pf~~~~~~ 265 (360)
T 3llt_A 251 ELYTGSLLFRTHEHM 265 (360)
T ss_dssp HHHHSSCSCCCSSHH
T ss_pred HHHHCCCCCCCCcHH
Confidence 999999999876543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=358.21 Aligned_cols=254 Identities=22% Similarity=0.406 Sum_probs=206.3
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
.++|.+.+.||+|+||.||+|...++..||||+++......+++.+|++++..++||||++++++|.+.+..++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 45788999999999999999998888899999998766556789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 175 (283)
T 3gen_A 103 NGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 175 (283)
T ss_dssp TCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence 999999997643 358999999999999999999999 8999999999999999999999999999986643211
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
.......+|+.|+|||++....++.++||||||+++|+|++ |+.||...........+... ......
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~------------~~~~~~ 243 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG------------LRLYRP 243 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT------------CCCCCC
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc------------cCCCCC
Confidence 11122457888999999999999999999999999999998 99999875543222211110 000001
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
... ...+..++..||+.+|.+||++.+++++|..
T Consensus 244 ~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 244 HLA----SEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CcC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 111 1345566678999999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=360.60 Aligned_cols=258 Identities=25% Similarity=0.423 Sum_probs=210.6
Q ss_pred hcCcccceeecccCceEEEEEEe------CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 492 (770)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+.+++.++||||++++++|.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 56789999999999999999985 24578999999753 35567899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccC
Q 004174 493 LLVYDFLSRGSLEENLHGNKK--------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKS 552 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp 552 (770)
++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccch
Confidence 999999999999999976543 12348999999999999999999999 8999999999
Q ss_pred CCeeeCCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCc
Q 004174 553 SNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 631 (770)
Q Consensus 553 ~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~ 631 (770)
+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987755443333334567889999999999999999999999999999999 9999987654
Q ss_pred cchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 632 KGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 632 ~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
......+.. +.. +.. +......+..++..||+.||.+||++.++++.|+.
T Consensus 259 ~~~~~~~~~-------~~~-----~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 259 ERLFNLLKT-------GHR-----MER----PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp GGHHHHHHT-------TCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHhhc-------CCc-----CCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 332222211 110 001 11112345566678999999999999999998864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=366.63 Aligned_cols=253 Identities=24% Similarity=0.340 Sum_probs=202.9
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.++|.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999865 78999999986543 334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999997543 58999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCceecccccccCCCCceeeccCCC-CCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
..........||+.|+|||++....+ +.++|||||||++|+|++|+.||......... ...|...... ..+
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~-------~~~ 230 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKTY-------LNP 230 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHTTCTT-------STT
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhccccc-------CCc
Confidence 33223334689999999999987775 77899999999999999999999765443222 1222111100 000
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.......+..++..||+.||.+|||+.+++++
T Consensus 231 ------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 ------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01112234456678999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=366.85 Aligned_cols=261 Identities=25% Similarity=0.435 Sum_probs=210.6
Q ss_pred hhcCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 491 (770)
..++|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+.+|+.++..++||||++++++|...+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578999999999999999999864 3478999999763 3556789999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEeccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKD--------------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 551 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLK 551 (770)
.++||||+++|+|.+++...... ...+++.+++.++.||+.||.|||+ ++|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 99999999999999999764321 1468999999999999999999999 899999999
Q ss_pred CCCeeeCCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCC
Q 004174 552 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDH 630 (770)
Q Consensus 552 p~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~ 630 (770)
|+|||++.++.+||+|||+++...............||+.|+|||++..+.++.++|||||||++|||++ |+.||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999987654332222334578999999999999999999999999999999999 999997654
Q ss_pred ccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004174 631 PKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699 (770)
Q Consensus 631 ~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~ 699 (770)
.......+ ..+.... +.... ...+..++..||+.+|.+||++.+|+++|+...
T Consensus 282 ~~~~~~~~-------~~~~~~~-----~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 282 HEEVIYYV-------RDGNILA-----CPENC----PLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp HHHHHHHH-------HTTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hHHHHHHH-------hCCCcCC-----CCCCC----CHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 32211111 1111111 11111 234556667899999999999999999997654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=360.79 Aligned_cols=265 Identities=22% Similarity=0.316 Sum_probs=203.3
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.++|.+.+.||+|+||+||+|...+|+.||||+++... .....+.+|+.+++.++||||++++++|.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 35789999999999999999999889999999997532 345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+++ +|.+.+.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9975 8888886543 358999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc---
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL--- 653 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l--- 653 (770)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...........+...
T Consensus 173 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 173 VRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp CC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred ccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 322 223578999999999876 56899999999999999999999999876554433222111000000000000
Q ss_pred ---cCcccC--CCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 654 ---LDPALG--NNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 654 ---ld~~l~--~~~~-----~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+.... .... ......+..++..||+.||.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000 0000 0112345566778999999999999999973
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=377.40 Aligned_cols=256 Identities=24% Similarity=0.408 Sum_probs=206.7
Q ss_pred hhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
..++|.+.+.||+|+||.||+|... +++.||||+++.. ......|.+|+.+++.++||||++++++|...+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3467889999999999999999975 7899999999754 345567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 192 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp ECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 9999999999997543 358899999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
...........+++.|+|||++..+.++.++|||||||+||||++ |..||...........+. .+.. +
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~~--~-- 334 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-------KGGR--L-- 334 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-------TTCC--C--
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCC--C--
Confidence 211111111345778999999999999999999999999999998 999998754432221111 1110 0
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.. +......+..++..||+.||.+|||+.+|++.|+.
T Consensus 335 -~~----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 335 -PC----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp -CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 00 11112345566678999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=367.54 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=204.0
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.+.||+|+||.||+|... +|+.||||++++. ......+.+|+.+|..++||||++++++|...+.+++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467999999999999999999864 6899999999753 23456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||++||+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999997543 58899999999999999999999 899999999999999999999999999998643
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+... .
T Consensus 157 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-------~------ 221 (337)
T 1o6l_A 157 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-------E------ 221 (337)
T ss_dssp CTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------C------
T ss_pred cCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-------C------
Confidence 3222 123468999999999999999999999999999999999999999765433222111110 0
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 694 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~ 694 (770)
..+.... ...+..++..||+.||.+|| ++.+|+++
T Consensus 222 ~~~p~~~----s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 IRFPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCCC----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 0011111 12345566779999999999 89999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=375.55 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=206.8
Q ss_pred cCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
++|.+.+.||+|+||.||+|... +++.||||+++.. ......+.+|+.++..++||||++++++|......+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56889999999999999999842 4678999999753 455668999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC---ceEEcc
Q 004174 494 LVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLSD 567 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~---~vkL~D 567 (770)
+||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+||||+.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECC
Confidence 99999999999999976432 22458999999999999999999999 8999999999999999555 599999
Q ss_pred ccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhccccc
Q 004174 568 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILS 646 (770)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~ 646 (770)
||+++...............||+.|+|||++..+.++.++|||||||++|||++ |..||...........+.
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~------- 300 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT------- 300 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-------
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------
Confidence 999986543322222233578999999999999999999999999999999998 999998754432221111
Q ss_pred CCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 647 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 647 ~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
.+... .. +......+..++..||+.+|.+||++.+|+++|+..
T Consensus 301 ~~~~~-----~~----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGGRM-----DP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCC-----CC----CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11100 00 111123455667789999999999999999998653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=369.43 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=204.4
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 492 (770)
.+.|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.+|..++||||++++++|.+.+.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999865 68999999997532 1357889999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC----ceEEccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 568 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~----~vkL~DF 568 (770)
++||||++||+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999654 358999999999999999999999 8999999999999998877 7999999
Q ss_pred cccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC
Q 004174 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 648 (770)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 648 (770)
|+++....... .....||+.|+|||++....++.++|||||||++|+|++|..||.+.........+.. +
T Consensus 164 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~-------~ 233 (361)
T 2yab_A 164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA-------V 233 (361)
T ss_dssp SSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT-------T
T ss_pred CCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------c
Confidence 99987655322 2336799999999999988999999999999999999999999987543322111110 0
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.. -+++...... ...+..++..||..||.+|||+.+++++
T Consensus 234 ~~--~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 234 SY--DFDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CC--CCCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CC--CCCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0011110111 1234456678999999999999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=365.68 Aligned_cols=256 Identities=22% Similarity=0.383 Sum_probs=201.2
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCE----EEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKE----LAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~----vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
.++|.+.+.||+|+||.||+|.+. +++. ||+|.++... ...+.|.+|+.+++.++||||++++++|... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 356899999999999999999853 4443 5888876432 4567899999999999999999999999875 578
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+|+||+.+|+|.+++.... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 9999999999999997654 368999999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
..............||+.|+|||++.++.++.++|||||||++|||++ |+.||...........+......
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-------- 238 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-------- 238 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--------
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC--------
Confidence 765544443344567889999999999999999999999999999999 99999876544332222211100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~ 699 (770)
..+......+..++..||+.+|.+||++.++++.|+...
T Consensus 239 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 239 --------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp --------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 011112234566777899999999999999999987543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=358.13 Aligned_cols=259 Identities=22% Similarity=0.362 Sum_probs=203.1
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCC----ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~----~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.+.||+|+||.||+|.. .+++.||||++.. .....+.+.+|+.++..++||||+++++++.+++.+++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 45799999999999999999986 4789999999853 345667899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999997653 58999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
..... ......||+.|+|||++....++.++|||||||++|||++|+.||......... ..... . ..... .
T Consensus 163 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~~~~----~-~~~~~-~ 233 (294)
T 4eqm_A 163 ETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA--IKHIQ----D-SVPNV-T 233 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH--HHHHS----S-CCCCH-H
T ss_pred ccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHhh----c-cCCCc-c
Confidence 43222 223357999999999999999999999999999999999999999765432211 11000 0 00000 0
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCC-CHHHHHHHhhCCC
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARP-QMSLVLKLLRGDA 699 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RP-s~~eVL~~L~~~~ 699 (770)
..+... ....+..++..||+.||.+|| ++.++.+.|....
T Consensus 234 ~~~~~~----~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 234 TDVRKD----IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHSCTT----SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred hhcccC----CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 011111 123455566789999999999 7999988886543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=366.66 Aligned_cols=261 Identities=23% Similarity=0.390 Sum_probs=209.1
Q ss_pred hhcCcccceeecccCceEEEEEEe------CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecC
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 490 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 490 (770)
..++|.+.+.||+|+||.||+|.. .++..||||+++... ...+.+.+|+.++..+ +||||++++++|...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 346799999999999999999985 245689999997532 3456899999999999 8999999999999999
Q ss_pred ceEEEEeecCCCChhhhhccCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEeccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKD-------------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 551 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLK 551 (770)
..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+ ++|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCC
Confidence 999999999999999999765321 1247999999999999999999999 899999999
Q ss_pred CCCeeeCCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCC
Q 004174 552 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDH 630 (770)
Q Consensus 552 p~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~ 630 (770)
|+||||+.++.+||+|||++................||+.|+|||++..+.++.++|||||||+||||+| |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987765554444445678999999999999999999999999999999998 999997764
Q ss_pred ccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 631 PKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 631 ~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
...... .... .+. .+.. +......+..++..||+.||.+||++.+++++|+..
T Consensus 280 ~~~~~~--~~~~----~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 280 VDANFY--KLIQ----NGF-----KMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp CSHHHH--HHHH----TTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cHHHHH--HHHh----cCC-----CCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 332211 1111 110 0001 111123455566789999999999999999999753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=355.37 Aligned_cols=261 Identities=25% Similarity=0.392 Sum_probs=202.0
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHh--cCCCceeEEeeEEeec----CceEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLGFCFED----NNLLL 494 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~----~~~~L 494 (770)
.++|.+.+.||+|+||.||+|.. +|+.||||++.... ...+..|.+++.. ++||||+++++++... ..+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 56899999999999999999987 78999999997543 3556667777776 7999999999997653 45899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCceEEecccCCCeeeCCCCceEEc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH--------SGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH--------~~~~~~IiHrDLKp~NILL~~~~~vkL~ 566 (770)
||||+++|+|.+++... .+++..++.++.||+.||.||| + ++|+||||||+|||++.++.+||+
T Consensus 84 v~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEEC
T ss_pred ehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEe
Confidence 99999999999999532 5899999999999999999999 6 899999999999999999999999
Q ss_pred cccccccccCCCCCce--ecccccccCCCCceeeccC------CCCCcceEeechHHHHHHHhC----------CCCCCC
Q 004174 567 DFGLAKWASTSSSHIT--CTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTG----------RKPISN 628 (770)
Q Consensus 567 DFGla~~~~~~~~~~~--~~~~~GT~~YlAPE~~~~~------~~s~ksDVwSlGvvL~eLltG----------~~Pf~~ 628 (770)
|||+++.......... .....||+.|+|||++... .++.++|||||||++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 9999987655433221 1234799999999999876 455799999999999999999 888866
Q ss_pred CCccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 629 DHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 629 ~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
..+......... ......+....+.. ..........+..++..||+.||.+|||+.+|++.|+.
T Consensus 236 ~~~~~~~~~~~~-~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 236 VVPNDPSFEDMR-KVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TSCSSCCHHHHH-HHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cCCCCcchhhhh-HHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 443322111110 00011111111100 11123455677788889999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=369.78 Aligned_cols=259 Identities=26% Similarity=0.413 Sum_probs=210.2
Q ss_pred hcCcccceeecccCceEEEEEEeC--------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~--------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 489 (770)
.++|.+.+.||+|+||.||+|... .+..||||+++.. ......+.+|++++..+ +||||++++++|...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467889999999999999999852 3457999999764 35567899999999999 899999999999999
Q ss_pred CceEEEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee
Q 004174 490 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (770)
Q Consensus 490 ~~~~LV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 557 (770)
+..++||||+++|+|.+++..... ....+++..++.|+.||+.||.|||+ ++|+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEE
Confidence 999999999999999999976542 12358999999999999999999999 899999999999999
Q ss_pred CCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhh
Q 004174 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 636 (770)
Q Consensus 558 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~ 636 (770)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||..........
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~ 304 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987765443333344568899999999999999999999999999999999 999997654332211
Q ss_pred HHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 637 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 637 lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
.+. .+... .. +......+..++..||+.+|.+||++.+|++.|+..
T Consensus 305 ~~~-------~~~~~-----~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 305 LLK-------EGHRM-----DK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp HHH-------TTCCC-----CC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH-------cCCCC-----CC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 11100 00 111123455666789999999999999999998653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=357.99 Aligned_cols=272 Identities=19% Similarity=0.281 Sum_probs=211.0
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecC--ceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~~~LV 495 (770)
.++|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+++++.++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 357899999999999999999875 58999999997533 34577889999999999999999999998765 78999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee----CCCCceEEcccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLA 571 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL----~~~~~vkL~DFGla 571 (770)
|||+++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999976532 2348999999999999999999999 899999999999999 78888999999999
Q ss_pred ccccCCCCCceecccccccCCCCceeec--------cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchh-hHHHhhc
Q 004174 572 KWASTSSSHITCTDVAGTFGYLAPEYFM--------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE-SLVMWAK 642 (770)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~YlAPE~~~--------~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~lv~~~~ 642 (770)
+........ ....||+.|+|||++. ...++.++|||||||++|||++|+.||......... .+.....
T Consensus 164 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 877554332 2357999999999986 578999999999999999999999999754432211 1111000
Q ss_pred ccccCCccc---ccc------Ccc--cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004174 643 PILSSGKVT---QLL------DPA--LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699 (770)
Q Consensus 643 ~~~~~g~l~---~ll------d~~--l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~ 699 (770)
.......+. ... .+. ............+..++..||+.||.+||++.+++++...+.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 000000000 000 001 112234455566777778899999999999999999887443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=373.10 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=196.3
Q ss_pred hcCcccceeecccCceEEEEEEeC----CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
.++|.+.+.||+|+||.||+|... ++..||||+++.. ....+.|.+|+.++.+++||||++++++|.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357889999999999999999864 5778999999753 4556789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999997543 368999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCc-eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 575 STSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 575 ~~~~~~~-~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
....... ......+|+.|+|||++..+.++.++|||||||+||||++ |+.||...........+. .+.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-------~~~--- 267 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-------EGY--- 267 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-------TTE---
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCC---
Confidence 5432211 1112346788999999999999999999999999999998 999997654322211111 000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
....+......+..++..||+.+|.+||++.+|++.|+..
T Consensus 268 ------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 268 ------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 0001112234566677889999999999999999998653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=363.25 Aligned_cols=262 Identities=25% Similarity=0.376 Sum_probs=200.8
Q ss_pred hcCcccceeecccCceEEEEEEe-----CCCCEEEEEEeCCC-hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec--Cce
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 492 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~ 492 (770)
.++|.+.+.||+|+||.||+|.+ .+++.||||++... ....+.+.+|+.++..++||||++++++|... ..+
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35789999999999999999973 36889999999764 35567899999999999999999999998653 568
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 99999999999999997653 358999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC-ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccch---------hhHHHhhc
Q 004174 573 WASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ---------ESLVMWAK 642 (770)
Q Consensus 573 ~~~~~~~~-~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~---------~~lv~~~~ 642 (770)
........ .......+|+.|+|||++....++.++|||||||++|||+||..||........ ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 76543322 112234578889999999999999999999999999999999999864321100 00000000
Q ss_pred ccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 643 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 643 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
..+..+. ....+......+..++..||+.+|.+|||+.++++.|+.
T Consensus 243 ~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 243 ELLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HHHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhccC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 0011100 011111222445667778999999999999999998864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=359.68 Aligned_cols=259 Identities=24% Similarity=0.385 Sum_probs=210.7
Q ss_pred hcCcccceeecccCceEEEEEEe------CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCc
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 491 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 491 (770)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|+.++..+ +||||++++++|...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 45789999999999999999974 356789999998643 4567899999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKD--------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 557 (770)
.++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence 99999999999999999765321 2358999999999999999999999 899999999999999
Q ss_pred CCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhh
Q 004174 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 636 (770)
Q Consensus 558 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~ 636 (770)
+.++.+||+|||++................||+.|+|||++....++.++|||||||++|||++ |+.||..........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 258 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence 9999999999999987766554444444568899999999999999999999999999999999 999997754332211
Q ss_pred HHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 637 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 637 lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.. ... + ..+.... .....+..++..||+.||.+||++.+++++|+.
T Consensus 259 ~~--~~~----~-----~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 259 KM--IKE----G-----FRMLSPE----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp HH--HHH----T-----CCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH--hcc----C-----CCCCCcc----cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 11 110 0 0000111 112345566678999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=366.73 Aligned_cols=251 Identities=26% Similarity=0.384 Sum_probs=203.1
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
.++|.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.+++.++||||++++++|.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999864 6899999999753 345677899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC---ceEEcccccccc
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLSDFGLAKW 573 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~---~vkL~DFGla~~ 573 (770)
||+++|+|.+.+... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||++..
T Consensus 108 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999998654 358999999999999999999999 8999999999999998654 599999999987
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
...... .....||+.|+|||++....++.++|||||||++|+|++|+.||...+.......+.. +... +
T Consensus 181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~-------~~~~-~ 249 (362)
T 2bdw_A 181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA-------GAYD-Y 249 (362)
T ss_dssp CTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------TCCC-C
T ss_pred ecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-------CCCC-C
Confidence 654332 2236799999999999988999999999999999999999999976543221111110 1100 0
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+.. ......+..++..||+.||.+||++.+++++
T Consensus 250 ~~~~~-----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PSPEW-----DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CTTGG-----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Ccccc-----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0112334556678999999999999999874
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=360.90 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=203.6
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 492 (770)
.+.|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.+|..++||||++++++|...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 346889999999999999999864 68999999987532 1357899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC----ceEEccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 568 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~----~vkL~DF 568 (770)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 9999999999999999654 358999999999999999999999 8999999999999999887 7999999
Q ss_pred cccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC
Q 004174 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 648 (770)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 648 (770)
|+++....... .....||+.|+|||++....++.++|||||||++|+|++|+.||...........+.....
T Consensus 163 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~----- 234 (326)
T 2y0a_A 163 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY----- 234 (326)
T ss_dssp TTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC-----
T ss_pred CCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC-----
Confidence 99987654322 2235799999999999989999999999999999999999999976543222111111000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. +.+...... ...+..++..||+.||.+|||+.+++++
T Consensus 235 ---~-~~~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 ---E-FEDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ---C-CCHHHHTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---C-cCccccccC----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 000000111 1234556678999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=360.77 Aligned_cols=261 Identities=23% Similarity=0.364 Sum_probs=193.6
Q ss_pred HhhcCcccceeecccCceEEEEEEeCC-C---CEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004174 419 SATSNFLAENLIGKGGSSQVYKGCLPD-G---KELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (770)
Q Consensus 419 ~~t~~f~~~~~LG~G~fG~Vy~a~~~~-g---~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 491 (770)
...++|.+.+.||+|+||.||+|.... + ..||||+++.. ....+.+.+|+.+++.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 445689999999999999999998653 3 27999999753 3556789999999999999999999999987765
Q ss_pred e------EEEEeecCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCce
Q 004174 492 L------LLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (770)
Q Consensus 492 ~------~LV~E~~~ggsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~v 563 (770)
. ++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCE
Confidence 5 99999999999999986432 223368999999999999999999999 899999999999999999999
Q ss_pred EEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhc
Q 004174 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 642 (770)
Q Consensus 564 kL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~ 642 (770)
||+|||+++...............+|+.|+|||++....++.++|||||||++|||++ |+.||...........+...
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~- 255 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG- 255 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC-
Confidence 9999999987655433333333567889999999999999999999999999999999 99999876543322221110
Q ss_pred ccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 643 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 643 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
... . .+......+..++..||+.||.+||++.++++.|+..
T Consensus 256 ------~~~-----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 256 ------NRL-----K----QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp ------CCC-----C----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCC-----C----CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000 0 0111223456677789999999999999999988753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=354.41 Aligned_cols=264 Identities=23% Similarity=0.337 Sum_probs=199.7
Q ss_pred cCcccceeecccCceEEEEEEeCCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
++|.+.+.||+|+||.||+|...+|+.||||+++... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5789999999999999999998889999999997543 2346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++ +|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 976 9999887543 358899999999999999999999 899999999999999999999999999998765432
Q ss_pred CCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcc---cc--
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV---TQ-- 652 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l---~~-- 652 (770)
.. .....||+.|+|||++... .++.++|||||||++|||++|+.||...........+...........+ ..
T Consensus 155 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 155 RK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cc--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence 21 2235789999999999754 5899999999999999999999999875433222111100000000000 00
Q ss_pred ccCcccCC-------CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 653 LLDPALGN-------NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 653 lld~~l~~-------~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..++.+.. .+.......+..++..||+.||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 01111100 0001112345566778999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=355.35 Aligned_cols=256 Identities=24% Similarity=0.399 Sum_probs=213.5
Q ss_pred hhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
..++|.+.+.||+|+||.||+|... ++..||||++.......+.+.+|+.+++.++||||++++++|.+.+..++||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 5678999999999999999999875 488999999988777788999999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++++|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 91 ~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 91 MTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred CCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999976433 468999999999999999999999 899999999999999999999999999998766443
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
. .......+|+.|+|||++....++.++||||||+++|+|++ |..||...........+.... ...
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~------------~~~ 232 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------------RME 232 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC------------CCC
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC------------CCC
Confidence 2 22334567889999999999999999999999999999999 999998765433222211100 000
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
. +......+..++..||+.||.+||++.++++.|+.
T Consensus 233 ~----~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 233 R----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C----CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 1 11112345566678999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=384.70 Aligned_cols=258 Identities=23% Similarity=0.392 Sum_probs=212.5
Q ss_pred hhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
..++|.+.+.||+|+||.||+|.+. ++..||||+++......+.|.+|+.+|+.++||||++++++|...+.++|||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3457889999999999999999975 488999999987666678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 298 MTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred cCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999976433 358999999999999999999999 899999999999999999999999999998765432
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
. .......+|+.|+|||++..+.++.++|||||||+||||++ |+.||...........+. .+.
T Consensus 373 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~-------- 436 (495)
T 1opk_A 373 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KDY-------- 436 (495)
T ss_dssp E-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-------TTC--------
T ss_pred e-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCC--------
Confidence 1 12223456789999999999999999999999999999999 999998765433222111 010
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~ 699 (770)
....+......+..++..||+.+|.+||++.+|++.|+...
T Consensus 437 -~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 00111112234556677899999999999999999998654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=370.61 Aligned_cols=248 Identities=25% Similarity=0.353 Sum_probs=199.4
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~L 494 (770)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. ......+.+|..++..+ +||||++++++|.+.+.+||
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999864 6899999999753 23456788999999988 69999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||++||+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 102 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999997653 58999999999999999999999 89999999999999999999999999999854
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
..... .....+||+.|+|||++....|+.++|||||||++|||++|+.||...+.......+... .+
T Consensus 175 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-------~~---- 241 (353)
T 3txo_A 175 ICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-------EV---- 241 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------CC----
T ss_pred ccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------CC----
Confidence 33222 223468999999999999889999999999999999999999999876543322222110 00
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCH------HHHHHH
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQM------SLVLKL 694 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~------~eVL~~ 694 (770)
.+... ....+..++..||+.||.+||++ .+++++
T Consensus 242 --~~p~~----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 242 --VYPTW----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp --CCCTT----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred --CCCCC----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 01111 12234556678999999999998 777764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=383.27 Aligned_cols=257 Identities=22% Similarity=0.410 Sum_probs=209.3
Q ss_pred hhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
..++|.+.+.||+|+||.||+|.++++..||||+++......+.|.+|+.+|+.++||||+++++++. .+..++||||+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 35678899999999999999999988899999999876666789999999999999999999999986 56789999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.......
T Consensus 265 ~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 265 AKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp TTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999975421 247889999999999999999999 8999999999999999999999999999987643211
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
.......+|+.|+|||++..+.++.++|||||||+||||+| |+.||...........+. .+. .+
T Consensus 340 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-------~~~--~~----- 404 (454)
T 1qcf_A 340 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-------RGY--RM----- 404 (454)
T ss_dssp -HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-------HTC--CC-----
T ss_pred -eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCC--CC-----
Confidence 11122356788999999999999999999999999999999 999998754332221111 010 00
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~ 699 (770)
..+......+..++..||+.||.+|||+.+|++.|+...
T Consensus 405 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 405 --PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred --CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 001112234566777899999999999999999997644
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=361.90 Aligned_cols=255 Identities=22% Similarity=0.408 Sum_probs=203.0
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCE----EEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKE----LAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~----vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
++|.+.+.||+|+||.||+|.+. +++. ||+|++.... .....+.+|+.++..++||||++++++|. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57899999999999999999864 4443 7888875432 33456788999999999999999999986 567899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999997543 368899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
.............||+.|+|||++..+.++.++|||||||++|||++ |+.||...........+........ ...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~ 241 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ----PQI 241 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC----CTT
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC----CCc
Confidence 66554444445678899999999999999999999999999999999 9999987654433333222111100 000
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~ 699 (770)
. ...+..++..||+.+|.+||++.++++.|+...
T Consensus 242 ~------------~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 242 C------------TIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp B------------CTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred C------------cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 112344566899999999999999999997643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=364.93 Aligned_cols=251 Identities=23% Similarity=0.363 Sum_probs=195.7
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCC--CceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.+.||+|+||.||++...+++.||||++... ....+.+.+|+.+|..++| |||+++++++..++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4579999999999999999999888999999998643 3456789999999999986 9999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|| +.+|+|.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+||||+ ++.+||+|||+++...
T Consensus 88 ~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 55889999997653 58899999999999999999999 8999999999999997 5789999999998776
Q ss_pred CCCCCceecccccccCCCCceeecc-----------CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhccc
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMY-----------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 644 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~-----------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~ 644 (770)
............||+.|+|||++.. +.++.++|||||||++|||++|+.||....... ..+..
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~----- 232 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLHA----- 232 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HHHHH-----
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-HHHHH-----
Confidence 5443333344689999999999865 678999999999999999999999997543211 11111
Q ss_pred ccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 645 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 645 ~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
++++.....++......+..++..||+.||.+|||+.+++++
T Consensus 233 --------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 233 --------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp --------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111111111111112345566678999999999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=360.50 Aligned_cols=258 Identities=21% Similarity=0.224 Sum_probs=206.3
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEee
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+|+.+++.+ +||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 46899999999999999999985 578999999987543 234688999999999 999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCc-----eEEcccccccc
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-----PQLSDFGLAKW 573 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~-----vkL~DFGla~~ 573 (770)
+ +++|.+++.... ..+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++. +||+|||+++.
T Consensus 87 ~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 87 L-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred C-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9 999999997642 368999999999999999999999 89999999999999998887 99999999987
Q ss_pred ccCCCCCc-----eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC
Q 004174 574 ASTSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 648 (770)
Q Consensus 574 ~~~~~~~~-----~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 648 (770)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~---- 235 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT---- 235 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH----
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh----
Confidence 65433221 123468999999999999999999999999999999999999999876544332222111100
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 649 ~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
.... ....+....+ .+..++..||+.+|.+||++.+|++.|+
T Consensus 236 ~~~~-~~~~~~~~~p-----~~~~li~~~l~~~p~~RP~~~~l~~~l~ 277 (330)
T 2izr_A 236 KRAT-PIEVLCENFP-----EMATYLRYVRRLDFFEKPDYDYLRKLFT 277 (330)
T ss_dssp HHHS-CHHHHTTTCH-----HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred hccC-CHHHHhccCh-----HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence 0000 0001111111 4556667899999999999999999886
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=362.29 Aligned_cols=244 Identities=23% Similarity=0.274 Sum_probs=192.2
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||+||+|... +|+.||||++... ......+..|+..+..+ +||||++++++|.+++.+++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999875 7999999998653 23444566666666655 8999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+ +++|.+++.... ..++|..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||++.....
T Consensus 137 e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 679999887653 368999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
... .....||++|+|||++.+ .++.++|||||||++|||++|..||..... ... +..+.. .+
T Consensus 210 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~-----~~~~~~----~~ 271 (311)
T 3p1a_A 210 AGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----WQQ-----LRQGYL----PP 271 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----HHH-----HTTTCC----CH
T ss_pred CCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHH-----HhccCC----Cc
Confidence 332 223579999999998874 799999999999999999999777654211 111 011111 11
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+.... ...+..++..||+.||.+|||+.+++++
T Consensus 272 ~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 272 EFTAGL----SSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccCC----CHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111111 2345566678999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=366.89 Aligned_cols=254 Identities=26% Similarity=0.337 Sum_probs=202.1
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
+.|.+.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.++..++||||++++++|.+.+.+++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4688999999999999999986 468999999986422 135778999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCc---eEEcccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLA 571 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~---vkL~DFGla 571 (770)
||||+++|+|.+.+.........+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999998886543333468999999999999999999999 89999999999999987655 999999999
Q ss_pred ccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
........ ......||+.|+|||++....++.++|||||||++|+|++|+.||..........+. . +...
T Consensus 181 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~---~-----~~~~ 250 (351)
T 3c0i_A 181 IQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGII---K-----GKYK 250 (351)
T ss_dssp EECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHH---H-----TCCC
T ss_pred eEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHH---c-----CCCC
Confidence 87655322 223467999999999999999999999999999999999999999764211111110 0 1000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+...... ...+..++..||+.||.+||++.+++++
T Consensus 251 --~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 --MNPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp --CCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --CCccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000000111 1344556678999999999999999973
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=368.85 Aligned_cols=249 Identities=27% Similarity=0.376 Sum_probs=203.5
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||.||++... +++.||||++.... .....+.+|+.+|..++||||++++++|.+.+.+++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57899999999999999999864 68899999997532 34567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+.||+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++....
T Consensus 95 e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999997543 58999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCceecccccccCCCCceeecc---CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
... ....+||+.|+|||++.. ..|+.++|||||||++|||++|+.||..........+........
T Consensus 168 ~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~-------- 236 (384)
T 4fr4_A 168 ETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV-------- 236 (384)
T ss_dssp TCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--------
T ss_pred CCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--------
Confidence 332 234689999999999974 458999999999999999999999998655444333322211100
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC-HHHHHHH
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-MSLVLKL 694 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs-~~eVL~~ 694 (770)
. .++......+..++..||+.||.+||+ +.+|+++
T Consensus 237 --~----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 237 --V----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp --C----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred --c----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 0 011111234556667899999999999 7777653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=378.13 Aligned_cols=263 Identities=22% Similarity=0.240 Sum_probs=209.0
Q ss_pred cCHHHHHHhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChh----HHHHHHHHHHHHHhcCCCceeEEeeEE
Q 004174 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED----VIKEFVLEIEIITTLHHKNIISLLGFC 486 (770)
Q Consensus 412 f~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~----~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 486 (770)
+.+.++...+++|.+.++||+|+||+||+|... +++.||||++++... ....+.+|+.++..++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 456677778899999999999999999999975 578899999975321 223488899999999999999999999
Q ss_pred eecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEc
Q 004174 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (770)
Q Consensus 487 ~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~ 566 (770)
.+.+.+||||||++||+|.+++.... ..+++..++.++.||+.||.|||+ ++||||||||+||||+.++.+||+
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEc
Confidence 99999999999999999999997643 358999999999999999999999 899999999999999999999999
Q ss_pred cccccccccCCCCCceecccccccCCCCceeec-----cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHH-h
Q 004174 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM-W 640 (770)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~-~ 640 (770)
|||+++........ .....+||+.|+|||++. .+.|+.++|||||||++|||++|+.||...+.......+. +
T Consensus 218 DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 296 (437)
T 4aw2_A 218 DFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 296 (437)
T ss_dssp CCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred chhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhc
Confidence 99999876543322 223468999999999997 5679999999999999999999999998765443322221 1
Q ss_pred hcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCC--CCCHHHHHHH
Q 004174 641 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA--RPQMSLVLKL 694 (770)
Q Consensus 641 ~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~--RPs~~eVL~~ 694 (770)
.... .+ |....... + .+..++..||..+|++ ||++.+++++
T Consensus 297 ~~~~----~~-----p~~~~~~s-~---~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 297 KERF----QF-----PTQVTDVS-E---NAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHC----CC-----CSSCCCSC-H---HHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccc----cC-----CcccccCC-H---HHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1100 00 10001111 2 2334455677777777 9999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.86 Aligned_cols=249 Identities=31% Similarity=0.480 Sum_probs=192.9
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCCh-----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.+.||+|+||.||+|.. .|+.||||+++... ...+.+.+|+++++.++||||++++++|...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46799999999999999999987 58899999987532 2356789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc---eEEecccCCCeeeCC--------CCceE
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR---VIHRDVKSSNILLSD--------DFEPQ 564 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~---IiHrDLKp~NILL~~--------~~~vk 564 (770)
|||+++++|.+++... .+++..++.++.|++.||.|||+ ++ |+||||||+|||++. ++.+|
T Consensus 85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp EECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred EEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceE
Confidence 9999999999998532 58999999999999999999999 66 999999999999986 67899
Q ss_pred EccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhccc
Q 004174 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 644 (770)
Q Consensus 565 L~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~ 644 (770)
|+|||++......... ...||+.|+|||++....++.++||||||+++|+|++|+.||...........+...
T Consensus 157 l~Dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--- 229 (271)
T 3dtc_A 157 ITDFGLAREWHRTTKM----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN--- 229 (271)
T ss_dssp ECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS---
T ss_pred EccCCccccccccccc----CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC---
Confidence 9999999866543222 357999999999999999999999999999999999999999865432221111100
Q ss_pred ccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 645 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 645 ~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.. .... +......+..++..||+.+|.+||++.+++++|+.
T Consensus 230 ----~~----~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 230 ----KL----ALPI----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ----CC----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ----CC----CCCC----CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 00 0001 11112345566778999999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=349.30 Aligned_cols=254 Identities=24% Similarity=0.429 Sum_probs=208.5
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
.++|.+.+.||+|+||.||+|...+++.||||+++......+.+.+|++++..++||||++++++|.+.+..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 45788999999999999999998888899999998766556789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 87 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 87 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp TCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 999999997643 358899999999999999999999 8999999999999999999999999999986643211
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
.......||+.|+|||++....++.++||||||+++|+|++ |+.||...........+. .+. .....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~-------~~~-----~~~~~ 227 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-------TGF-----RLYKP 227 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-------TTC-----CCCCC
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh-------cCC-----cCCCC
Confidence 11122457889999999998999999999999999999999 899997654322111111 010 00001
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
. .....+..++..||+.+|.+||++.++++.|+.
T Consensus 228 ~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 228 R----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred c----cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 1 112345556678999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=354.12 Aligned_cols=248 Identities=23% Similarity=0.371 Sum_probs=194.4
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh---------------------------hHHHHHHHHHHHHH
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---------------------------DVIKEFVLEIEIIT 472 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---------------------------~~~~~~~~Ei~iL~ 472 (770)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46799999999999999999986 468899999986542 12356889999999
Q ss_pred hcCCCceeEEeeEEee--cCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecc
Q 004174 473 TLHHKNIISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV 550 (770)
Q Consensus 473 ~l~HpnIv~l~~~~~~--~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDL 550 (770)
.++||||+++++++.+ .+..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+ ++|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCC
Confidence 9999999999999986 5679999999999999887542 358999999999999999999999 89999999
Q ss_pred cCCCeeeCCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCC---CCCcceEeechHHHHHHHhCCCCCC
Q 004174 551 KSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPIS 627 (770)
Q Consensus 551 Kp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~---~s~ksDVwSlGvvL~eLltG~~Pf~ 627 (770)
||+|||++.++.+||+|||+++....... ......||+.|+|||++.... ++.++|||||||++|+|++|+.||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99999999999999999999987654332 223467999999999998665 4778999999999999999999997
Q ss_pred CCCccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 628 NDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 628 ~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
..........+.. +.. .+ + ..... ...+..++..||+.||.+||++.++++
T Consensus 242 ~~~~~~~~~~~~~-------~~~-~~--~-~~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 242 DERIMCLHSKIKS-------QAL-EF--P-DQPDI----AEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSHHHHHHHHHH-------CCC-CC--C-SSSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccHHHHHHHHhc-------ccC-CC--C-Ccccc----CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 6543221111110 000 00 0 00111 234555667899999999999999976
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=349.30 Aligned_cols=260 Identities=18% Similarity=0.205 Sum_probs=207.3
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEee
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+|+.++..+ +|+|++++++++......++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 46799999999999999999985 578999999986543 234678899999999 799999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCc-----eEEcccccccc
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-----PQLSDFGLAKW 573 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~-----vkL~DFGla~~ 573 (770)
+ +++|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+++.
T Consensus 88 ~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 88 L-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9 999999997653 358999999999999999999999 89999999999999987776 99999999987
Q ss_pred ccCCCCC-----ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC
Q 004174 574 ASTSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 648 (770)
Q Consensus 574 ~~~~~~~-----~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 648 (770)
....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 7654322 11234679999999999999999999999999999999999999998765443332221111000000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 649 ~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.. +.+...+ ...+..++..||+.+|.+||++.+|++.|+.
T Consensus 241 ~~-----~~~~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~ 280 (298)
T 1csn_A 241 PL-----RELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280 (298)
T ss_dssp CH-----HHHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred cH-----HHHHhhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence 00 0111111 2345566678999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=373.45 Aligned_cols=252 Identities=25% Similarity=0.334 Sum_probs=203.0
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
.++|.+.+.||+|+||.||+|.. .+|+.+|+|++.... ...+.+.+|+.+++.++||||++++++|.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 56799999999999999999986 478999999987543 44567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC---CCCceEEcccccccc
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKW 573 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~---~~~~vkL~DFGla~~ 573 (770)
||+.||+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||++..
T Consensus 90 E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 90 DLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp CCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999997653 58999999999999999999999 8999999999999998 467899999999987
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
....... .....||+.|+|||++....|+.++|||||||++|+|++|+.||...+.......+.. +.. .+
T Consensus 163 ~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~-------~~~-~~ 232 (444)
T 3soa_A 163 VEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA-------GAY-DF 232 (444)
T ss_dssp CCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------TCC-CC
T ss_pred ecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-------CCC-CC
Confidence 6543322 2346899999999999988999999999999999999999999977543322221111 110 00
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+.. ... ...+..++..||+.||.+|||+.++|++
T Consensus 233 ~~~~~-~~~----s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 PSPEW-DTV----TPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CTTTT-TTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred Ccccc-ccC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 01100 011 1234456678999999999999999984
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=367.11 Aligned_cols=252 Identities=22% Similarity=0.276 Sum_probs=193.4
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
.++|.+.+.||+|+||.||++... +++.||||++.......+.+.+|+.+++.++||||++++++|.+.+.+++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 457999999999999999999875 7899999999876555577889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCc--eEEccccccccccCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--PQLSDFGLAKWASTS 577 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~--vkL~DFGla~~~~~~ 577 (770)
++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++. +||+|||+++.....
T Consensus 99 ~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 99 SGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999997543 58999999999999999999999 89999999999999987765 999999999754332
Q ss_pred CCCceecccccccCCCCceeeccCCCCCc-ceEeechHHHHHHHhCCCCCCCCCccchh-hHHHhhcccccCCccccccC
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPISNDHPKGQE-SLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~s~k-sDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~lv~~~~~~~~~g~l~~lld 655 (770)
.. .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......... ..+... .. ...
T Consensus 172 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~---~~-~~~----- 239 (361)
T 3uc3_A 172 SQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI---LS-VKY----- 239 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHH---HT-TCC-----
T ss_pred CC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHH---hc-CCC-----
Confidence 21 223579999999999998888766 89999999999999999999865443221 111110 00 000
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+.. .......+..++..||+.+|.+|||+.+++++
T Consensus 240 -~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 -SIPD--DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -CCCT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -CCCC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0000 00111344556678999999999999999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=350.44 Aligned_cols=264 Identities=22% Similarity=0.267 Sum_probs=199.1
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
++|.+.+.||+|+||+||+|... +|+.||||+++.. ......+.+|+.+++.++||||++++++|.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999874 6899999999743 3455788899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+++ +|.+.+.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9976 6666665432 358999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCceecccccccCCCCceeeccCC-CCCcceEeechHHHHHHHhCCCCCCCCCc-cchhhHHHhhcccccCCcc---cc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHP-KGQESLVMWAKPILSSGKV---TQ 652 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~-~s~ksDVwSlGvvL~eLltG~~Pf~~~~~-~~~~~lv~~~~~~~~~g~l---~~ 652 (770)
... .....||+.|+|||++.+.. ++.++|||||||++|||++|..||..... ......+...........+ ..
T Consensus 155 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 155 VRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ccc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 222 23357899999999998766 89999999999999999998888644332 1111111100000000000 00
Q ss_pred ccCc---------ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 653 LLDP---------ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 653 lld~---------~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+.+. .............+..++..||+.||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 00000111122344566678999999999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=353.69 Aligned_cols=266 Identities=21% Similarity=0.291 Sum_probs=199.8
Q ss_pred hhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC------hhHHHHHHHHHHHHHhcC---CCceeEEeeEEeec
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS------EDVIKEFVLEIEIITTLH---HKNIISLLGFCFED 489 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~------~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~ 489 (770)
.+++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ......+.+|+.+++.++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999996 57899999998632 122345667777776664 99999999999876
Q ss_pred C-----ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceE
Q 004174 490 N-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (770)
Q Consensus 490 ~-----~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vk 564 (770)
. ..++||||+. |+|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEE
Confidence 5 4899999997 599999976543 348999999999999999999999 8899999999999999999999
Q ss_pred EccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhccc
Q 004174 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 644 (770)
Q Consensus 565 L~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~ 644 (770)
|+|||+++........ ....||+.|+|||++....++.++|||||||++|||++|+.||...........+......
T Consensus 161 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 161 LADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp ECSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EeeCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999876543322 3468999999999999999999999999999999999999999876544332222111111
Q ss_pred ccCCcccccc---CcccCCC-------CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 645 LSSGKVTQLL---DPALGNN-------YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 645 ~~~g~l~~ll---d~~l~~~-------~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.....+.... ...+... ...+....+..++..||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 1111110000 0000000 001112345566678999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=357.99 Aligned_cols=245 Identities=25% Similarity=0.357 Sum_probs=202.8
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.+.||+|+||.||++... +|+.||||+++... ...+.+.+|+.++..++||||++++++|.+.+.+++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357999999999999999999864 78999999997532 2356788899999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||++||+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999997643 58999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
... ...+||+.|+|||++....++.++|||||||++|||++|+.||...+.......+.. +.+
T Consensus 158 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-------~~~----- 220 (318)
T 1fot_A 158 DVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-------AEL----- 220 (318)
T ss_dssp SCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-------CCC-----
T ss_pred Ccc-----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCC-----
Confidence 421 235799999999999999999999999999999999999999976543222111110 000
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 694 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~ 694 (770)
.+...++ ..+..++..||+.||.+|| ++.+++++
T Consensus 221 -~~p~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 -RFPPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -CCCTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCC----HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 0111111 2345566779999999999 88888864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=357.57 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=207.7
Q ss_pred hcCcccceeecccCceEEEEEEe--------CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL--------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~--------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 489 (770)
.++|.+.+.||+|+||.||+|.. .++..||||+++.. ....+.+.+|+.++..+ +||||++++++|...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 46789999999999999999985 35678999999764 35567899999999999 899999999999999
Q ss_pred CceEEEEeecCCCChhhhhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee
Q 004174 490 NNLLLVYDFLSRGSLEENLHGNKKD------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (770)
Q Consensus 490 ~~~~LV~E~~~ggsL~~~l~~~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 557 (770)
+..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 9999999999999999999765421 1348999999999999999999999 899999999999999
Q ss_pred CCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhh
Q 004174 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 636 (770)
Q Consensus 558 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~ 636 (770)
+.++.+||+|||++................+|+.|+|||++....++.++|||||||++|||++ |+.||..........
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 9999999999999987665433222333567889999999998899999999999999999999 999997654322211
Q ss_pred HHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 637 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 637 lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
.+.. +.. ..... .....+..++..||+.+|.+||++.++++.|+..
T Consensus 271 ~~~~-------~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 271 LLKE-------GHR-----MDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHH-------TCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhc-------CCC-----CCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1110 100 00111 1123455566789999999999999999998754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=375.71 Aligned_cols=263 Identities=21% Similarity=0.242 Sum_probs=208.9
Q ss_pred cCHHHHHHhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEE
Q 004174 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFC 486 (770)
Q Consensus 412 f~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 486 (770)
+.+++.....++|.+.+.||+|+||.||++... +|+.||||++++.. .....+.+|+.++..++||||++++++|
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 456666777899999999999999999999874 79999999997532 2234578899999999999999999999
Q ss_pred eecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEc
Q 004174 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (770)
Q Consensus 487 ~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~ 566 (770)
.+.+.+||||||++||+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++++||+
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEe
Confidence 99999999999999999999997543 258999999999999999999999 899999999999999999999999
Q ss_pred cccccccccCCCCCceecccccccCCCCceeec-------cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHH
Q 004174 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (770)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~-------~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~ 639 (770)
|||+++....... ......+||+.|+|||++. .+.|+.++|||||||++|||++|+.||...+.......+.
T Consensus 205 DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 283 (412)
T 2vd5_A 205 DFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283 (412)
T ss_dssp CCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred echhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999987654332 1223468999999999997 4578999999999999999999999998765433222221
Q ss_pred hhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCC---CCHHHHHHH
Q 004174 640 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRAR---PQMSLVLKL 694 (770)
Q Consensus 640 ~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~R---Ps~~eVL~~ 694 (770)
.....+ .-+.+...++ ..+..++..||. +|.+| |++.+++++
T Consensus 284 ~~~~~~--------~~p~~~~~~s----~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 284 HYKEHL--------SLPLVDEGVP----EEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp THHHHC--------CCC----CCC----HHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred hcccCc--------CCCccccCCC----HHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 110000 0011111112 234455567998 99998 689999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=357.46 Aligned_cols=267 Identities=24% Similarity=0.385 Sum_probs=212.5
Q ss_pred CHHHHHHhhcCcccceeecccCceEEEEEEe------CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhc-CCCceeEEe
Q 004174 413 NYQDLLSATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLL 483 (770)
Q Consensus 413 ~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l-~HpnIv~l~ 483 (770)
.........++|.+.+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|+.++..+ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3444445567899999999999999999974 356889999997643 4556899999999999 799999999
Q ss_pred eEEeecC-ceEEEEeecCCCChhhhhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecc
Q 004174 484 GFCFEDN-NLLLVYDFLSRGSLEENLHGNKKD------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV 550 (770)
Q Consensus 484 ~~~~~~~-~~~LV~E~~~ggsL~~~l~~~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDL 550 (770)
++|...+ .+++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccC
Confidence 9998755 489999999999999999765431 1238899999999999999999999 89999999
Q ss_pred cCCCeeeCCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCC
Q 004174 551 KSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISND 629 (770)
Q Consensus 551 Kp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~ 629 (770)
||+|||++.++.+||+|||+++...............||+.|+|||++....++.++|||||||++|||++ |+.||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987765544444445678999999999999999999999999999999998 99999765
Q ss_pred CccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 630 HPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 630 ~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
....... .... .+.. ....... ...+..++..||+.+|.+||++.+|+++|+.
T Consensus 255 ~~~~~~~--~~~~----~~~~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 307 (316)
T 2xir_A 255 KIDEEFC--RRLK----EGTR-----MRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 307 (316)
T ss_dssp CCSHHHH--HHHH----HTCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred chhHHHH--HHhc----cCcc-----CCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 4322111 1000 0100 0011111 2345556678999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=374.17 Aligned_cols=261 Identities=24% Similarity=0.289 Sum_probs=208.1
Q ss_pred CHHHHHHhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEe
Q 004174 413 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCF 487 (770)
Q Consensus 413 ~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 487 (770)
.+.++....++|.+.+.||+|+||.||+|... +++.||||++++.. .....+.+|+.++..++||||++++++|.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34566667889999999999999999999875 68899999997532 12235788999999999999999999999
Q ss_pred ecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcc
Q 004174 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 567 (770)
Q Consensus 488 ~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~D 567 (770)
+.+.+||||||++||+|.+++... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEec
Confidence 999999999999999999998653 48899999999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCceecccccccCCCCceeeccCC----CCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcc
Q 004174 568 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK----VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 643 (770)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~----~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~ 643 (770)
||+++....... ......+||+.|+|||++.... |+.++|||||||+||||++|+.||...+.......+.....
T Consensus 212 FG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 290 (410)
T 3v8s_A 212 FGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 290 (410)
T ss_dssp CTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred cceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc
Confidence 999987654322 2233468999999999998665 88999999999999999999999987654333222211110
Q ss_pred cccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCC--CCCHHHHHHHh
Q 004174 644 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA--RPQMSLVLKLL 695 (770)
Q Consensus 644 ~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~--RPs~~eVL~~L 695 (770)
.+. -|. ...+ . ..+..++..||+.+|.+ ||++.+|+++-
T Consensus 291 ~~~--------~p~-~~~~-s---~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 291 SLT--------FPD-DNDI-S---KEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp HCC--------CCT-TCCC-C---HHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred ccc--------CCC-cccc-c---HHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 000 000 0011 1 23444556799989988 99999999863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=369.43 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=195.5
Q ss_pred cCcccceeecccCceEEEEEEeCCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcC--CCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLH--HKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~~~~~LV~ 496 (770)
.+|.+.+.||+|+||.||+|...+++.||||++... ....+.+.+|+.+|..++ ||||+++++++...+.++|||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458999999999999999999888999999998643 355678999999999996 599999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
| +.+++|.+++.... .+++.++..|+.||+.||.|||+ ++|+||||||+||||+ ++.+||+|||+++....
T Consensus 136 E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 56889999997653 57899999999999999999999 8999999999999995 57999999999987755
Q ss_pred CCCCceecccccccCCCCceeecc-----------CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMY-----------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 645 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~-----------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~ 645 (770)
..........+||+.|+|||++.. ..++.++|||||||+||||++|+.||....... ..+..
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~~------ 279 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SKLHA------ 279 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHH------
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-HHHHH------
Confidence 433333344689999999999875 468999999999999999999999997543211 11111
Q ss_pred cCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 646 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 646 ~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
++++.....++......+..++..||+.||.+||++.+++++
T Consensus 280 -------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 280 -------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111111111111112345566678999999999999999974
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=372.63 Aligned_cols=250 Identities=29% Similarity=0.429 Sum_probs=204.0
Q ss_pred hhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC-ceEEEEee
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-NLLLVYDF 498 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-~~~LV~E~ 498 (770)
..++|.+.+.||+|+||.||+|.. .|+.||||+++... ..+.|.+|+.+|++++||||++++++|.... .+++||||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 346788999999999999999987 47899999998654 4578999999999999999999999987765 79999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 999999999986532 347899999999999999999999 899999999999999999999999999998543321
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
....+|+.|+|||++..+.++.++|||||||+||||+| |+.||...........+. .+.. ..
T Consensus 344 -----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-------~~~~-----~~ 406 (450)
T 1k9a_A 344 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYK-----MD 406 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-------TTCC-----CC
T ss_pred -----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCC-----CC
Confidence 12357889999999999999999999999999999998 999998765433222111 1110 00
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+......+..++..||+.||.+|||+.++++.|+.
T Consensus 407 ----~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 407 ----APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111122345566678999999999999999998864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=365.09 Aligned_cols=252 Identities=21% Similarity=0.244 Sum_probs=204.7
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... .....+.+|+.+|..++||||++++++|.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 457999999999999999999864 68999999997653 4456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC--CCceEEccccccccccC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKWAST 576 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~--~~~vkL~DFGla~~~~~ 576 (770)
+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999987543 358999999999999999999999 89999999999999974 47799999999987755
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
.... ....||+.|+|||++....++.++|||||||++|||++|+.||...........+... .. .+++
T Consensus 204 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~-------~~--~~~~ 271 (387)
T 1kob_A 204 DEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC-------DW--EFDE 271 (387)
T ss_dssp TSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC-------CC--CCCS
T ss_pred Ccce---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------CC--CCCc
Confidence 3322 2357999999999999999999999999999999999999999875432221111100 00 0111
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
...... ...+..++..||+.||.+||++.+++++
T Consensus 272 ~~~~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 DAFSSV----SPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp STTTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccC----CHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 111111 2345566678999999999999999985
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=367.60 Aligned_cols=265 Identities=18% Similarity=0.224 Sum_probs=202.9
Q ss_pred hhcCcccceeecccCceEEEEEEeCC------CCEEEEEEeCCChhH------------HHHHHHHHHHHHhcCCCceeE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPSEDV------------IKEFVLEIEIITTLHHKNIIS 481 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~~------g~~vAVK~l~~~~~~------------~~~~~~Ei~iL~~l~HpnIv~ 481 (770)
..++|.+.+.||+|+||.||+|.+.. ++.||||++...... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999998754 478999998764321 112345666777888999999
Q ss_pred EeeEEeec----CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee
Q 004174 482 LLGFCFED----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (770)
Q Consensus 482 l~~~~~~~----~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 557 (770)
++++|... ...+|||||+ +++|.+++.... ..+++..++.|+.||+.||.|||+ ++|+||||||+||||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEE
Confidence 99999875 4589999999 999999997643 368999999999999999999999 899999999999999
Q ss_pred C--CCCceEEccccccccccCCCCCce-----ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCC
Q 004174 558 S--DDFEPQLSDFGLAKWASTSSSHIT-----CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (770)
Q Consensus 558 ~--~~~~vkL~DFGla~~~~~~~~~~~-----~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 630 (770)
+ .++.+||+|||+++.......... .....||+.|+|||++.+..++.++|||||||+||||+||+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8 889999999999987654322111 123569999999999999899999999999999999999999998543
Q ss_pred ccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 631 PKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 631 ~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.... .+.+.... ....+..++++.+....... .+..++..||+.+|.+||++.+|+++|+.
T Consensus 266 ~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~~~---~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 266 KDPK--YVRDSKIR-YRENIASLMDKCFPAANAPG---EIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp TCHH--HHHHHHHH-HHHCHHHHHHHHSCTTCCCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred cCHH--HHHHHHHH-hhhhHHHHHHHhcccccCHH---HHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 2221 11111111 11234445555543222233 34455567999999999999999998864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=350.01 Aligned_cols=255 Identities=24% Similarity=0.408 Sum_probs=207.0
Q ss_pred hhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
..++|.+.+.||+|+||.||+|...++..||||+++......+.+.+|+++++.++||||+++++++. .+..++||||+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 34678999999999999999999888889999999876656678999999999999999999999986 45689999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++++|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 90 ENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp TTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999999964321 258899999999999999999999 8999999999999999999999999999987654322
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
.......+|+.|+|||++..+.++.++||||||+++|||++ |+.||...........+. .+. ....
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-------~~~-----~~~~ 231 (279)
T 1qpc_A 165 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-------RGY-----RMVR 231 (279)
T ss_dssp -ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTC-----CCCC
T ss_pred -ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-------ccc-----CCCC
Confidence 11223457889999999998999999999999999999999 999997654322111111 010 0011
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.... ...+..++..||+.+|.+||++.++++.|+.
T Consensus 232 ~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 232 PDNC----PEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cccc----cHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 1111 2345566678999999999999999998864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=358.78 Aligned_cols=252 Identities=21% Similarity=0.330 Sum_probs=197.3
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc------
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN------ 491 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~------ 491 (770)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. ....+.+.+|+.+|+.++||||++++++|.+.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457899999999999999999975 7999999998743 3456789999999999999999999999876542
Q ss_pred ---------------------------------------------------eEEEEeecCCCChhhhhccCCCCCCCCCH
Q 004174 492 ---------------------------------------------------LLLVYDFLSRGSLEENLHGNKKDPAAFGW 520 (770)
Q Consensus 492 ---------------------------------------------------~~LV~E~~~ggsL~~~l~~~~~~~~~l~~ 520 (770)
.++||||+++|+|.+++..... .....+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 7999999999999999986543 234577
Q ss_pred HHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC----------ceeccccccc
Q 004174 521 SERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH----------ITCTDVAGTF 590 (770)
Q Consensus 521 ~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~----------~~~~~~~GT~ 590 (770)
..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 7889999999999999999 89999999999999999999999999999877654221 1123357999
Q ss_pred CCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHH
Q 004174 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERM 670 (770)
Q Consensus 591 ~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l 670 (770)
.|+|||++.+..++.++|||||||++|||++|..|+.. ........ ..+..... .......+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~----~~~~~~~~---------~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDV----RNLKFPLL---------FTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHH----HTTCCCHH---------HHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHh----hccCCCcc---------cccCChhH
Confidence 99999999999999999999999999999998776521 11111100 00111000 01112334
Q ss_pred HHHHHhhcccCCCCCCCHHHHHHH
Q 004174 671 VLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 671 ~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..++..||+.||.+||++.+++++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 556678999999999999999974
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=363.52 Aligned_cols=208 Identities=23% Similarity=0.304 Sum_probs=179.8
Q ss_pred hhcCcccceeeccc--CceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 420 ATSNFLAENLIGKG--GSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 420 ~t~~f~~~~~LG~G--~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
..++|.+.+.||+| +||.||+|... +|+.||||+++.. ....+.+.+|+.+++.++||||++++++|.+.+.++
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35679999999999 99999999975 7999999999753 355677889999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+||||+++|+|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999999976532 358999999999999999999999 8999999999999999999999999999865
Q ss_pred ccCCCC-----CceecccccccCCCCceeecc--CCCCCcceEeechHHHHHHHhCCCCCCCCCcc
Q 004174 574 ASTSSS-----HITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (770)
Q Consensus 574 ~~~~~~-----~~~~~~~~GT~~YlAPE~~~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~ 632 (770)
...... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 243 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 432111 111122478999999999987 57999999999999999999999999875543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=366.35 Aligned_cols=249 Identities=23% Similarity=0.374 Sum_probs=202.4
Q ss_pred HhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCce
Q 004174 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 419 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 492 (770)
...++|.+.+.||+|+||.||+|... +|+.||||+++... .....+..|..++..+ +||||++++++|.+.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 35678999999999999999999975 68899999997532 3456678899999987 899999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
|+||||++||+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 99999999999999997643 58999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 573 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
........ ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+....
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------- 234 (345)
T 1xjd_A 167 ENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN---------- 234 (345)
T ss_dssp CCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred hcccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC----------
Confidence 64332221 234689999999999999999999999999999999999999998755432222111110
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHH-HHHH
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMS-LVLK 693 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~-eVL~ 693 (770)
+.+.... ...+..++..||+.||.+||++. +|++
T Consensus 235 ---~~~p~~~----s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 ---PFYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ---CCCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCCccc----CHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 1111111 12345566789999999999997 6654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=348.39 Aligned_cols=254 Identities=24% Similarity=0.369 Sum_probs=194.2
Q ss_pred hcCcccceeecccCceEEEEEEeCC----CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~----g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
.++|.+.+.||+|+||.||+|.... +..||||+++.. ....+.+.+|+.+++.++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4678999999999999999998642 457999998753 345678999999999999999999999984 567899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 93 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999997543 358999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
....... .....+|+.|+|||++....++.++|||||||++|||++ |..||...........+.. +...
T Consensus 167 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~-------~~~~-- 236 (281)
T 1mp8_A 167 EDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-------GERL-- 236 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-------TCCC--
T ss_pred Ccccccc-cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc-------CCCC--
Confidence 5433221 223457889999999998999999999999999999997 9999987654332221111 1100
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
.+.... ...+..++..||+.+|.+||++.++++.|+..
T Consensus 237 ---~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 237 ---PMPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ---CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011111 23455566789999999999999999998643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=357.89 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=193.6
Q ss_pred hcCcccceeecccCceEEEEEEe----CCCCEEEEEEeCCCh-----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~----~~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 491 (770)
.++|.+.+.||+|+||.||++.. .+|+.||||+++... .....+.+|+.+|+.++||||++++++|...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35789999999999999999986 478999999998642 344567889999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 571 (770)
+++||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999997543 58899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
+....... ......||+.|+|||++....++.++|||||||++|||++|+.||...........+... .
T Consensus 169 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-------~-- 237 (327)
T 3a62_A 169 KESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC-------K-- 237 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-------C--
T ss_pred cccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-------C--
Confidence 75433222 123367999999999999889999999999999999999999999875433221111100 0
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 694 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~ 694 (770)
..+... ....+..++..||+.||.+|| ++.+++++
T Consensus 238 ----~~~p~~----~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 ----LNLPPY----LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ----CCCCTT----SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ----CCCCCC----CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 001111 123345566789999999999 78888875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=377.40 Aligned_cols=256 Identities=25% Similarity=0.419 Sum_probs=203.5
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
.++|.+.+.||+|+||.||+|.+.++..||||+++......+.|.+|+.+|+.++||||+++++++.+ +..++||||++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 45688999999999999999999888889999998765556789999999999999999999999976 67899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+|+|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 262 ~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 262 KGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp TCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999974321 358899999999999999999999 89999999999999999999999999999876543221
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
......+|+.|+|||++..+.++.++|||||||+||||++ |+.||...........+. .+.. .
T Consensus 337 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-------~~~~-----~--- 400 (452)
T 1fmk_A 337 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYR-----M--- 400 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTCC-----C---
T ss_pred -cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCC-----C---
Confidence 1223457889999999999999999999999999999999 999998754432211111 1100 0
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~ 699 (770)
..+......+..++..||+.+|.+|||+.+|++.|+...
T Consensus 401 -~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 401 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 011112234556677899999999999999999997543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=359.47 Aligned_cols=251 Identities=18% Similarity=0.230 Sum_probs=200.5
Q ss_pred hhcCcccceeecccCceEEEEEE------eCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC---CCceeEEeeEEeecC
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGC------LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDN 490 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~------~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~ 490 (770)
..++|.+.+.||+|+||.||+|. ..+++.||||+++... ..++..|+.++..++ |+||+++++++...+
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 35679999999999999999994 4578899999998653 356778888888887 999999999999999
Q ss_pred ceEEEEeecCCCChhhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC----------
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKK-DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---------- 559 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---------- 559 (770)
..+|||||+++|+|.+++..... ....+++..++.|+.||+.||.|||+ ++||||||||+||||+.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999974322 22469999999999999999999999 89999999999999998
Q ss_pred -CCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHH
Q 004174 560 -DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (770)
Q Consensus 560 -~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv 638 (770)
++.+||+|||+|+..............+||++|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----- 292 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----- 292 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence 89999999999986654334444455789999999999999999999999999999999999999995432210
Q ss_pred HhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCC-CCHHHHHHHhh
Q 004174 639 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRAR-PQMSLVLKLLR 696 (770)
Q Consensus 639 ~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~R-Ps~~eVL~~L~ 696 (770)
| . +...+......+... .+...|++.+|.+| |++.++.+.|.
T Consensus 293 -~--------~----~~~~~~~~~~~~~~~---~~~~~~l~~~p~~r~~~~~~l~~~l~ 335 (365)
T 3e7e_A 293 -C--------K----PEGLFRRLPHLDMWN---EFFHVMLNIPDCHHLPSLDLLRQKLK 335 (365)
T ss_dssp -E--------E----ECSCCTTCSSHHHHH---HHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred -e--------e----echhccccCcHHHHH---HHHHHHcCCCCCCcchHHHHHHHHHH
Confidence 0 0 111111112233333 34456999999998 56777777665
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=356.93 Aligned_cols=269 Identities=20% Similarity=0.363 Sum_probs=213.2
Q ss_pred CHHHHHHhhcCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEee
Q 004174 413 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLG 484 (770)
Q Consensus 413 ~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~ 484 (770)
..++.....++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|+.+++.++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 33344456678999999999999999999753 36789999997543 45567899999999999999999999
Q ss_pred EEeecCceEEEEeecCCCChhhhhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC
Q 004174 485 FCFEDNNLLLVYDFLSRGSLEENLHGNK------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (770)
Q Consensus 485 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 558 (770)
++.+.+..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~ 172 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVA 172 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEEC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEc
Confidence 9999999999999999999999987532 112357899999999999999999999 8999999999999999
Q ss_pred CCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhH
Q 004174 559 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 637 (770)
Q Consensus 559 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l 637 (770)
.++.+||+|||++................||+.|+|||++.++.++.++|||||||++|+|++ |+.||...........
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 252 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence 999999999999986654333222233467899999999999999999999999999999999 8999976543221111
Q ss_pred HHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCCC
Q 004174 638 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 700 (770)
Q Consensus 638 v~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~~ 700 (770)
+. .+.... . .......+..++..||+.+|.+||++.++++.|+....
T Consensus 253 ~~-------~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 253 VM-------EGGLLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HH-------TTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HH-------cCCcCC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11 111111 0 11112335556678999999999999999999986543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=360.81 Aligned_cols=259 Identities=23% Similarity=0.365 Sum_probs=208.4
Q ss_pred hcCcccceeecccCceEEEEEEeCC------CCEEEEEEeCCCh--hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCc
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 491 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~------g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 491 (770)
.++|.+.+.||+|+||.||+|.... ++.||||+++... ...+.+.+|+.++..+ +||||++++++|...+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4678999999999999999998632 3479999997643 4567899999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC
Q 004174 492 LLLVYDFLSRGSLEENLHGNKK----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~ 561 (770)
.++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCC
Confidence 9999999999999999875321 12357999999999999999999999 8999999999999999999
Q ss_pred ceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHh
Q 004174 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 640 (770)
Q Consensus 562 ~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~ 640 (770)
.+||+|||++................||+.|+|||++....++.++|||||||++|||+| |..||............
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~-- 279 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL-- 279 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH--
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH--
Confidence 999999999987665544444444568899999999999999999999999999999999 99999765433221111
Q ss_pred hcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 641 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 641 ~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
..... ...... .....+..++..||+.+|.+||++.+|+++|+.
T Consensus 280 ~~~~~---------~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 280 VKDGY---------QMAQPA----FAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp HHHTC---------CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HhcCC---------CCCCCC----CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 11000 000001 112345556678999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=357.60 Aligned_cols=264 Identities=23% Similarity=0.362 Sum_probs=190.6
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.++|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467899999999999999999864 68999999987532 334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 498 FLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|++ |+|.+++.... .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999886432 223458999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccC-------
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS------- 647 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~------- 647 (770)
..... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||...........+.........
T Consensus 160 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 43222 223578999999999976 46899999999999999999999999876543332222110000000
Q ss_pred --------------CccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 648 --------------GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 648 --------------g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+.+.+.+...... ...+..++..||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPL----DGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCC----CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhcccccccC----CHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000011111111111 2345566778999999999999999863
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=358.78 Aligned_cols=263 Identities=25% Similarity=0.270 Sum_probs=201.3
Q ss_pred HHHHhhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC------hhHHHHHHHHHHHHHhcCCCceeEEeeEEee
Q 004174 416 DLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFE 488 (770)
Q Consensus 416 ~l~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~------~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 488 (770)
++....++|.+.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.+++.++||||++++++|.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 3445667899999999999999999986 46889999998642 3456789999999999999999999999999
Q ss_pred cCceEEEEeecCCCChhhhhccCCCC------------------------------------CCCCCHHHHHHHHHHHHH
Q 004174 489 DNNLLLVYDFLSRGSLEENLHGNKKD------------------------------------PAAFGWSERYKVAMGVAE 532 (770)
Q Consensus 489 ~~~~~LV~E~~~ggsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qia~ 532 (770)
.+..++||||+++|+|.+++...... ...+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998521110 112456778899999999
Q ss_pred HHHHHHcCCCCceEEecccCCCeeeCCCC--ceEEccccccccccCCCCC--ceecccccccCCCCceeecc--CCCCCc
Q 004174 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDF--EPQLSDFGLAKWASTSSSH--ITCTDVAGTFGYLAPEYFMY--GKVNDK 606 (770)
Q Consensus 533 aL~yLH~~~~~~IiHrDLKp~NILL~~~~--~vkL~DFGla~~~~~~~~~--~~~~~~~GT~~YlAPE~~~~--~~~s~k 606 (770)
||.|||+ ++|+||||||+|||++.++ .+||+|||++......... .......||+.|+|||++.. ..++.+
T Consensus 180 ~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 9999999 8999999999999998776 8999999999865432221 12234679999999999975 678999
Q ss_pred ceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCC
Q 004174 607 IDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP 686 (770)
Q Consensus 607 sDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RP 686 (770)
+|||||||++|||++|+.||...........+...... +..+.. ......+..++..||+.+|.+||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~--------~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC--------FENPNY-----NVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------TTSGGG-----GGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc--------cCCccc-----ccCCHHHHHHHHHHcCCChhHCC
Confidence 99999999999999999999765543222111111000 000100 01123445566789999999999
Q ss_pred CHHHHHHH
Q 004174 687 QMSLVLKL 694 (770)
Q Consensus 687 s~~eVL~~ 694 (770)
++.+++++
T Consensus 324 s~~~~l~h 331 (345)
T 3hko_A 324 DAMRALQH 331 (345)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 99999973
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=349.31 Aligned_cols=258 Identities=29% Similarity=0.472 Sum_probs=192.8
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.++|.+.+.||+|+||.||+|.... .+|||+++.. ....+.|.+|+.+++.++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4578999999999999999998643 5999999753 35567899999999999999999999976 5567899999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 100 WCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred ecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 999999999996543 468999999999999999999999 89999999999999999999999999999866543
Q ss_pred CCCceecccccccCCCCceeec---cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
..........||+.|+|||++. ...++.++|||||||++|+|++|+.||........ +..... .+.....+
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~----~~~~~~~~ 247 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVG----RGSLSPDL 247 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHH----HTSCCCCT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhc----ccccCcch
Confidence 3333334467999999999986 56788899999999999999999999976543222 111111 11111111
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
.. ........+..++..||+.+|.+||++.++++.|+..
T Consensus 248 ~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 248 SK-----VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp TS-----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred hh-----ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 00 1111224456666789999999999999999998754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=361.62 Aligned_cols=245 Identities=24% Similarity=0.310 Sum_probs=203.9
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.+|..++||||++++++|.+.+.+|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 467999999999999999999864 68999999997532 3356788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceecc
Confidence 99999999999997643 48999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
... ...+||+.|+|||++....++.++|||||||++|||++|+.||...+.......+.. +.+
T Consensus 193 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~-------~~~----- 255 (350)
T 1rdq_E 193 GRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS-------GKV----- 255 (350)
T ss_dssp SCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CCC-----
T ss_pred CCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc-------CCC-----
Confidence 432 235799999999999999999999999999999999999999987544322211111 110
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 694 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs-----~~eVL~~ 694 (770)
.+...+ ...+..++..||+.||.+||+ +.+|+++
T Consensus 256 -~~p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 -RFPSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -CCCTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCC----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 011111 233455667899999999998 8888874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=366.08 Aligned_cols=255 Identities=20% Similarity=0.313 Sum_probs=198.4
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~L 494 (770)
.++|.+.++||+|+||.||+|... +++.||||++++. ......+..|..++.++ +||||++++++|.+.+.++|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 457999999999999999999865 5788999999753 23345678899999887 89999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||+++|+|..++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999997643 58999999999999999999999 89999999999999999999999999999864
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchh--hHHHhhcccccCCcccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE--SLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~--~lv~~~~~~~~~g~l~~ 652 (770)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....+....+..+.
T Consensus 204 ~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--- 278 (396)
T 4dc2_A 204 LRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--- 278 (396)
T ss_dssp CCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC---
T ss_pred ccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc---
Confidence 33222 223468999999999999999999999999999999999999999753221100 00000000000000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCH------HHHHHH
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQM------SLVLKL 694 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~------~eVL~~ 694 (770)
..+... ....+..++..||+.||.+||++ .+|+++
T Consensus 279 ---~~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 279 ---IRIPRS----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp ---CCCCTT----SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ---cCCCCc----CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 011111 12234556678999999999995 566664
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=343.10 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=203.5
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
.++|.+.+.||+|+||.||+|... +|+.||+|++... ....+.+.+|+.+++.++||||++++++|...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999864 6899999998643 345678889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCc---eEEcccccccc
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLAKW 573 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~---vkL~DFGla~~ 573 (770)
||+++++|.+.+.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999887543 58999999999999999999999 89999999999999986655 99999999987
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
....... ....||+.|+|||++....++.++||||||+++|+|++|+.||...........+.... . ..
T Consensus 158 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-------~-~~ 226 (284)
T 3kk8_A 158 VNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA-------Y-DY 226 (284)
T ss_dssp CCSSCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-------C-CC
T ss_pred cccCccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc-------c-cC
Confidence 6543322 23579999999999999999999999999999999999999997654332222111110 0 00
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+.. ... ...+..++..||+.||.+||++.+++++
T Consensus 227 ~~~~~-~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 227 PSPEW-DTV----TPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CTTTT-TTS----CHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred Cchhh-ccc----CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000 011 1234556678999999999999999873
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=363.28 Aligned_cols=247 Identities=25% Similarity=0.303 Sum_probs=195.5
Q ss_pred cceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCCCC
Q 004174 426 AENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 503 (770)
Q Consensus 426 ~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ggs 503 (770)
..+.||+|+||.||+|.. .+|+.||||+++... ...+.+.+|+.++..++||||++++++|...+.++|||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 367899999999999986 478999999998654 556789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee--CCCCceEEccccccccccCCCCCc
Q 004174 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL--SDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 504 L~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL--~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++........
T Consensus 173 L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~- 245 (373)
T 2x4f_A 173 LFDRIIDES---YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL- 245 (373)
T ss_dssp EHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC-
T ss_pred HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc-
Confidence 999886543 358999999999999999999999 899999999999999 67789999999999876543322
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 661 (770)
....||+.|+|||++..+.++.++|||||||+||||++|+.||...........+. ...+ .+.... ...
T Consensus 246 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--~~~~------~~~~~~-~~~ 314 (373)
T 2x4f_A 246 --KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL--ACRW------DLEDEE-FQD 314 (373)
T ss_dssp --CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCC------CSCSGG-GTT
T ss_pred --ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccC------CCChhh-hcc
Confidence 23579999999999998899999999999999999999999998765432211111 1000 000000 011
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 662 YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 662 ~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+ ...+..++..||+.||.+||++.+++++
T Consensus 315 ~----~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 315 I----SEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp S----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C----CHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1 2345556678999999999999999983
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=350.89 Aligned_cols=264 Identities=24% Similarity=0.293 Sum_probs=199.0
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
++|.+.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.++..++||||++++++|...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57999999999999999999875 58999999986533 345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+++++|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999886543 58999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhccc--------ccCC
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI--------LSSG 648 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~--------~~~g 648 (770)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...... ....
T Consensus 156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 156 SDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred ccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 322 223579999999999975 56899999999999999999999999876543332222111000 0000
Q ss_pred -ccc--cccCcccCCCC---ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 -KVT--QLLDPALGNNY---DYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 -~l~--~lld~~l~~~~---~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
... .+.++...... .......+..++..||+.||.+|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 00000000000 00112335567778999999999999999974
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=345.53 Aligned_cols=251 Identities=31% Similarity=0.528 Sum_probs=199.9
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-----hH---HHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-----DV---IKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-----~~---~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 491 (770)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... .. .+.+.+|+.++..++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46799999999999999999986 478999999986432 11 167899999999999999999999986654
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc--eEEecccCCCeeeCCCCc-----eE
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFE-----PQ 564 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--IiHrDLKp~NILL~~~~~-----vk 564 (770)
++||||+++|+|.+.+.... ..+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 79999999999999887543 368999999999999999999999 77 999999999999988776 99
Q ss_pred EccccccccccCCCCCceecccccccCCCCceeec--cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhc
Q 004174 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM--YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 642 (770)
Q Consensus 565 L~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~--~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~ 642 (770)
|+|||+++..... .....||+.|+|||++. ...++.++|||||||++|||++|+.||................
T Consensus 170 l~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 244 (287)
T 4f0f_A 170 VADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244 (287)
T ss_dssp ECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH
T ss_pred eCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc
Confidence 9999999754332 23367999999999984 4568899999999999999999999998655433221111111
Q ss_pred ccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 643 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 643 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
. + ..+.+.. .....+..++..||+.||.+||++.++++.|+.
T Consensus 245 ~----~-----~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 245 E----G-----LRPTIPE----DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp S----C-----CCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred c----C-----CCCCCCc----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 0 0 0111111 112345566678999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=342.93 Aligned_cols=249 Identities=20% Similarity=0.360 Sum_probs=201.3
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec--CceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~LV 495 (770)
.++|.+.+.||+|+||.||+|.. +++.||||+++.. ....+.+.+|+.+++.++||||++++++|... +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 35788999999999999999998 5889999999754 35567899999999999999999999999887 788999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc--eEEecccCCCeeeCCCCceEEcccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
|||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999976432 358999999999999999999998 77 99999999999999999999999988754
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCC---cceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVND---KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~---ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 650 (770)
... ....||+.|+|||++....++. ++|||||||++|||++|+.||...........+. ..+
T Consensus 163 ~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~------~~~-- 227 (271)
T 3kmu_A 163 FQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA------LEG-- 227 (271)
T ss_dssp TSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHH------HSC--
T ss_pred ecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHH------hcC--
Confidence 322 2246899999999998765554 7999999999999999999997654322211111 000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 651 ~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
..+.+.... ...+..++..||+.||.+||++.++++.|+.
T Consensus 228 ---~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~L~~ 267 (271)
T 3kmu_A 228 ---LRPTIPPGI----SPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267 (271)
T ss_dssp ---CCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 011111112 2335556677999999999999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=359.48 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=188.1
Q ss_pred hhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
..++|.+.+.||+|+||.||+|... +++.||||+++... ..+.+.+|+.++..++||||++++++|...+..++||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 3567999999999999999999975 58899999998643 346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC---CCceEEcccccccccc
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLAKWAS 575 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~~~vkL~DFGla~~~~ 575 (770)
+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++...
T Consensus 130 ~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 130 VTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999997543 58999999999999999999999 89999999999999975 8899999999998765
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ +.... . .+.. ....
T Consensus 203 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~i---~-~~~~-~~~~ 272 (349)
T 2w4o_A 203 HQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFRRI---L-NCEY-YFIS 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHHHH---H-TTCC-CCCT
T ss_pred cccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHHHH---H-hCCC-ccCC
Confidence 4322 2235799999999999998999999999999999999999999976543221 11100 0 0000 0011
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+. .......+..++..||+.||.+||++.+++++
T Consensus 273 ~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 273 PW-----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ch-----hhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10 01112345566678999999999999999984
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=362.34 Aligned_cols=246 Identities=22% Similarity=0.333 Sum_probs=200.0
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+.+++.++||||++++++|...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36799999999999999999996 578999999987432 2235788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+ +|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 789999887543 58999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCceeeccCCC-CCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
..... ...+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......... .+..+.
T Consensus 160 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------~i~~~~----- 224 (336)
T 3h4j_B 160 DGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-------KVNSCV----- 224 (336)
T ss_dssp TSBTT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-------CCCSSC-----
T ss_pred CCccc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-------HHHcCC-----
Confidence 43322 23579999999999987776 689999999999999999999997653322110 000000
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+.... ...+..++..||+.||.+|||+.+++++
T Consensus 225 -~~~p~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 -YVMPDFL----SPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -CCCCTTS----CHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -CCCcccC----CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0011111 2234556678999999999999999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=350.76 Aligned_cols=267 Identities=25% Similarity=0.375 Sum_probs=199.5
Q ss_pred HHHhhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhc--CCCceeEEeeEEeec----C
Q 004174 417 LLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL--HHKNIISLLGFCFED----N 490 (770)
Q Consensus 417 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l--~HpnIv~l~~~~~~~----~ 490 (770)
.....++|.+.+.||+|+||.||+|.. .|+.||||++..... ..+..|.+++..+ +||||+++++++... .
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 334557899999999999999999987 489999999975443 3445566665554 899999999999887 6
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCceEEecccCCCeeeCCCCceEE
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS-----AQRVIHRDVKSSNILLSDDFEPQL 565 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----~~~IiHrDLKp~NILL~~~~~vkL 565 (770)
..++||||+++|+|.+++... .+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred ceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 899999999999999999653 4899999999999999999999820 129999999999999999999999
Q ss_pred ccccccccccCCCCCce--ecccccccCCCCceeeccCCCCCc------ceEeechHHHHHHHhC----------CCCCC
Q 004174 566 SDFGLAKWASTSSSHIT--CTDVAGTFGYLAPEYFMYGKVNDK------IDVYAFGVVLLELLTG----------RKPIS 627 (770)
Q Consensus 566 ~DFGla~~~~~~~~~~~--~~~~~GT~~YlAPE~~~~~~~s~k------sDVwSlGvvL~eLltG----------~~Pf~ 627 (770)
+|||+++.......... .....||+.|+|||++....++.+ +|||||||++|||++| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 99999976654332211 123579999999999987776665 9999999999999999 66665
Q ss_pred CCCccchhhHHHhhcccccCCccccccCcccCCCC-ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 628 NDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY-DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 628 ~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~-~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
...+........ ........ ..+.+.... ..+....+..++..||+.||.+||++.+|+++|+.
T Consensus 264 ~~~~~~~~~~~~--~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 264 DLVPSDPSYEDM--REIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp TTSCSSCCHHHH--HHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hhcCCCCchhhh--HHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 433222111000 00000000 111111111 12455667788889999999999999999999974
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.38 Aligned_cols=254 Identities=25% Similarity=0.400 Sum_probs=204.5
Q ss_pred hcCcccce-eecccCceEEEEEEeC---CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 421 TSNFLAEN-LIGKGGSSQVYKGCLP---DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 421 t~~f~~~~-~LG~G~fG~Vy~a~~~---~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
.++|.+.+ .||+|+||.||+|... ++..||||+++.. ....+.+.+|+.++..++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 34566665 9999999999999753 5788999999863 45677899999999999999999999999 5567999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 999999999999996443 368999999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCce-ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 575 STSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 575 ~~~~~~~~-~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
........ .....||+.|+|||++....++.++|||||||++|||++ |+.||...........+. .+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-------~~~~-- 231 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGKR-- 231 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-------TTCC--
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-------cCCc--
Confidence 54332211 122457899999999998899999999999999999998 999997754432221111 1110
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+.+ +......+..++..||+.+|.+||++.+++++|+.
T Consensus 232 ---~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 269 (287)
T 1u59_A 232 ---MEC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 269 (287)
T ss_dssp ---CCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCC----CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 011 11122345566678999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=358.92 Aligned_cols=255 Identities=20% Similarity=0.315 Sum_probs=200.0
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~L 494 (770)
.++|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+.+|+.++..+ +||||++++++|.+.+.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357899999999999999999875 6889999999753 34566788999999988 89999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 999999999999997543 58999999999999999999999 89999999999999999999999999999864
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchh--hHHHhhcccccCCcccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE--SLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~--~lv~~~~~~~~~g~l~~ 652 (770)
..... .....+||+.|+|||++....++.++|||||||++|||++|+.||......... .........+..+.
T Consensus 161 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--- 235 (345)
T 3a8x_A 161 LRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--- 235 (345)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC---
T ss_pred cCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC---
Confidence 33222 223468999999999999999999999999999999999999999753211100 00000000000010
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCH------HHHHHH
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQM------SLVLKL 694 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~------~eVL~~ 694 (770)
..+.... ...+..++..||+.||.+||++ .+++++
T Consensus 236 ---~~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 236 ---IRIPRSL----SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp ---CCCCTTS----CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred ---CCCCCCC----CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 0111111 2334556678999999999995 566653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=361.74 Aligned_cols=249 Identities=23% Similarity=0.306 Sum_probs=202.0
Q ss_pred hhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~ 493 (770)
..++|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+..|..++..+ +||||++++++|.+.+.+|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3468999999999999999999875 47899999997532 3456788999999988 7999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+||||++||+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 9999999999999997543 48999999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
...... .....+||+.|+|||++....++.++|||||||++|||++|+.||...+.......+.. +.+
T Consensus 171 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-------~~~--- 238 (353)
T 2i0e_A 171 NIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-------HNV--- 238 (353)
T ss_dssp CCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CCC---
T ss_pred cccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh-------CCC---
Confidence 433222 22346899999999999999999999999999999999999999987544322211111 000
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 694 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs-----~~eVL~~ 694 (770)
.+.... ...+..++..||+.||.+||+ +.+|+++
T Consensus 239 ---~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 239 ---AYPKSM----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ---CCCTTS----CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ---CCCCCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011111 234455667899999999995 5777764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=355.62 Aligned_cols=265 Identities=28% Similarity=0.367 Sum_probs=203.8
Q ss_pred cccceeecccCceEEEEEEe-----CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeec--CceEE
Q 004174 424 FLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLL 494 (770)
Q Consensus 424 f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~L 494 (770)
|.+.+.||+|+||.||++++ .+++.||||+++... ...+.+.+|+++++.++||||++++++|.+. ..+++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48899999999999999864 268899999998643 5567899999999999999999999999884 57899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||+++|+|.+++... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999754 38899999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCc-eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 575 STSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 575 ~~~~~~~-~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
....... ......||+.|+|||++....++.++|||||||++|+|++|+.||....... .....+.........+...
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHH
Confidence 6543221 1223568889999999999899999999999999999999999996532110 0000000000000011111
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+........+......+..++..||+.+|.+||++.++++.|+.
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 307 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 11111111122223456667778999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=351.11 Aligned_cols=260 Identities=25% Similarity=0.397 Sum_probs=196.5
Q ss_pred HhhcCcccceeecccCceEEEEEEeC----CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC-
Q 004174 419 SATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN- 490 (770)
Q Consensus 419 ~~t~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~- 490 (770)
...++|.+.+.||+|+||.||+|... ++..||||+++.. ....+.+.+|+.+++.++||||++++++|.+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 35678999999999999999999753 3458999999753 355678999999999999999999999998755
Q ss_pred ----ceEEEEeecCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceE
Q 004174 491 ----NLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (770)
Q Consensus 491 ----~~~LV~E~~~ggsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vk 564 (770)
..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEE
Confidence 4599999999999999985332 233568999999999999999999999 8999999999999999999999
Q ss_pred EccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcc
Q 004174 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKP 643 (770)
Q Consensus 565 L~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~ 643 (770)
|+|||++................+++.|+|||.+....++.++|||||||++|+|++ |..||...........+..
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~--- 264 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH--- 264 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT---
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc---
Confidence 999999987654433222233567889999999999999999999999999999999 9999977654332221110
Q ss_pred cccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 644 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 644 ~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+.. +.. +......+..++..||+.+|.+||++.+++++|+.
T Consensus 265 ----~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 265 ----GHR-----LKQ----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp ----TCC-----CCC----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCC-----CCC----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 100 001 11112345566678999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=355.06 Aligned_cols=256 Identities=22% Similarity=0.375 Sum_probs=198.2
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCE----EEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKE----LAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~----vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
.++|.+.+.||+|+||.||+|... +++. ||+|.+... ....+.+.+|+.++..++||||++++++|... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cce
Confidence 467999999999999999999853 4543 577777543 34567899999999999999999999999875 488
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+|++|+.+|+|.+++.... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 9999999999999997654 358999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
..............||+.|+|||++.+..++.++|||||||++|||++ |+.||...........+......
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-------- 238 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL-------- 238 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--------
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 755443333334567889999999999999999999999999999999 99999876544332222211100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~ 699 (770)
..+......+..++..||+.+|.+||++.++++.|....
T Consensus 239 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 239 --------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp --------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 001111224556667899999999999999999987644
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=349.74 Aligned_cols=252 Identities=27% Similarity=0.379 Sum_probs=197.6
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
++|.+.+.||+|+||.||++.. .++..+|+|++.... ...+.+.+|+++++.++||||++++++|.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 5688999999999999999986 468999999987543 3457889999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee---CCCCceEEcccccccccc
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL---~~~~~vkL~DFGla~~~~ 575 (770)
+++|+|.+.+.........+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999986543223468999999999999999999999 899999999999999 456789999999998665
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
.... .....||+.|+|||++. +.++.++|||||||++|||++|+.||.............+..+... .
T Consensus 179 ~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-----~--- 246 (285)
T 3is5_A 179 SDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA-----V--- 246 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----C---
T ss_pred Cccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc-----c---
Confidence 4322 22357999999999886 6789999999999999999999999987544332222221111100 0
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..... ...+..++..||+.||.+||++.+++++
T Consensus 247 --~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 247 --ECRPL----TPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp ----CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred --ccCcC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011 1234456678999999999999999863
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=350.95 Aligned_cols=253 Identities=29% Similarity=0.499 Sum_probs=196.8
Q ss_pred cCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
++|.+.+.||+|+||.||+|.. .++.||||++... ...+.|.+|+.+++.++||||+++++++. +..++||||+++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~ 83 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG 83 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence 5688999999999999999987 5788999999754 34578999999999999999999999987 457999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCc-eEEccccccccccCCCCC
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-PQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~-vkL~DFGla~~~~~~~~~ 580 (770)
|+|.+++..... ...+++..++.++.|++.||.|||+.+.++|+||||||+|||++.++. +||+|||++.......
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-- 160 (307)
T 2eva_A 84 GSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-- 160 (307)
T ss_dssp CBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--
Confidence 999999976532 124788999999999999999999855568999999999999988876 7999999997654321
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 660 (770)
....||+.|+|||++....++.++|||||||++|||++|+.||........ .+.|... .+.. +.+..
T Consensus 161 ---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~---~~~~-----~~~~~ 227 (307)
T 2eva_A 161 ---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVH---NGTR-----PPLIK 227 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHHH---TTCC-----CCCBT
T ss_pred ---ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHHh---cCCC-----CCccc
Confidence 224699999999999998999999999999999999999999976433221 1222111 1111 11111
Q ss_pred CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 661 ~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
..+ ..+..++..||+.+|.+||++.++++.|+..
T Consensus 228 ~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 228 NLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 112 2345566789999999999999999998753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=355.78 Aligned_cols=253 Identities=24% Similarity=0.389 Sum_probs=193.7
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc----
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN---- 491 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~---- 491 (770)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.. ......+.+|+.++..++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999986 57899999999753 3456688999999999999999999999987654
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 571 (770)
.++||||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 499999999999999997543 58999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC-ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcc
Q 004174 572 KWASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650 (770)
Q Consensus 572 ~~~~~~~~~-~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 650 (770)
+........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||............ .. ....
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~--~~----~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH--VR----EDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HH----CCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--hc----CCCC
Confidence 876543222 1222357999999999999999999999999999999999999999775543221111 10 0000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 651 ~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
. ........ ...+..++..||+.||.+||++.+++.
T Consensus 238 ~---~~~~~~~~----~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 238 P---PSARHEGL----SADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp C---HHHHSTTC----CHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred C---cccccCCC----CHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 0 00001111 223455667899999999998777665
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=345.21 Aligned_cols=246 Identities=28% Similarity=0.428 Sum_probs=199.6
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.+.||+|+||.||+|... ++..||||++.... .....+.+|+.+++.++||||++++++|.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467999999999999999999864 57899999986432 2346788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999997543 48899999999999999999999 899999999999999999999999999986554
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
.... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+....
T Consensus 161 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 223 (279)
T 3fdn_A 161 SSRR----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE------------- 223 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-------------
T ss_pred cccc----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-------------
Confidence 3321 23579999999999999899999999999999999999999998654332222211110
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+... ....+..++..||+.+|.+||++.+++++
T Consensus 224 ~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 FTFPDF----VTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCCTT----SCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCCc----CCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 001111 11234456678999999999999999984
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=359.20 Aligned_cols=271 Identities=25% Similarity=0.317 Sum_probs=207.2
Q ss_pred cCcccceeecccCceEEEEEEe-----CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEe--ecCceE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCF--EDNNLL 493 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--~~~~~~ 493 (770)
++|.+.+.||+|+||.||+|.+ .+++.||||++.... ...+.+.+|+++++.++||||+++++++. ..+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5789999999999999999983 468899999997654 55677999999999999999999999987 455689
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+||||+++++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999997543 258999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCc-eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 574 ASTSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 574 ~~~~~~~~-~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
........ ......||+.|+|||++....++.++|||||||++|+|++|+.||.......... ..+.........+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-MGCERDVPALSRLLE 255 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-CC----CCHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-cccccccccHHHHHH
Confidence 75443322 1223468889999999999999999999999999999999999986532110000 000000000000011
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~ 699 (770)
.+........+......+..++..||+.||.+||++.+++++|+...
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111111112222344566677899999999999999999997654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=361.28 Aligned_cols=251 Identities=23% Similarity=0.364 Sum_probs=189.6
Q ss_pred cCcccc-eeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHH-hcCCCceeEEeeEEee----cCceEE
Q 004174 422 SNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIIT-TLHHKNIISLLGFCFE----DNNLLL 494 (770)
Q Consensus 422 ~~f~~~-~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~-~l~HpnIv~l~~~~~~----~~~~~L 494 (770)
++|.+. ++||+|+||+||+|... +|+.||||+++.. ..+.+|+.++. ..+||||++++++|.. ...+||
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 456665 78999999999999864 6899999999754 34667888874 4589999999999876 567899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC---CCceEEcccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLA 571 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~~~vkL~DFGla 571 (770)
||||++||+|.+++..... ..+++..+..|+.||+.||.|||+ ++|+||||||+||||+. ++.+||+|||++
T Consensus 137 v~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999976432 358999999999999999999999 89999999999999987 789999999999
Q ss_pred ccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchh-hHHHhhcccccCCcc
Q 004174 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE-SLVMWAKPILSSGKV 650 (770)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~lv~~~~~~~~~g~l 650 (770)
+....... ....+||+.|+|||++....|+.++|||||||+||||++|+.||......... ..... +..+..
T Consensus 212 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----i~~~~~ 284 (400)
T 1nxk_A 212 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQY 284 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH----HHHTCC
T ss_pred cccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH----HHcCcc
Confidence 86654322 23467999999999999999999999999999999999999999876543211 00000 000110
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 651 ~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+..+.. ......+..++..||+.||.+|||+.+++++
T Consensus 285 -~~~~~~~-----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 -EFPNPEW-----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -CCCTTTT-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -cCCCccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000000 0112345556678999999999999999985
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=353.70 Aligned_cols=266 Identities=27% Similarity=0.390 Sum_probs=202.7
Q ss_pred cCcccceeecccCceEEEEEEe-----CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeec--Cce
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 492 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~ 492 (770)
+.|.+.+.||+|+||.||+|.+ .+++.||||+++... .....+.+|+.++..++||||++++++|... +.+
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3578899999999999999983 468899999997543 3457889999999999999999999999876 678
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccc
Confidence 99999999999999996543 358999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC-ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC---
Q 004174 573 WASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG--- 648 (770)
Q Consensus 573 ~~~~~~~~-~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g--- 648 (770)
........ .......||..|+|||++....++.++|||||||++|+|++|..|+..... .......+.....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMTVT 250 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGGHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccccCHH
Confidence 77654332 122335688899999999999999999999999999999999998643210 0000000000000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 649 ~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+...+........+......+..++..||+.||.+|||+.++++.|+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 0000000000111112222455667778999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.65 Aligned_cols=253 Identities=24% Similarity=0.341 Sum_probs=204.1
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.++|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999875 7899999998643 3456788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+++++|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999998654 358999999999999999999999 89999999999999999999999999999866443
Q ss_pred CCCceecccccccCCCCceeeccCCC-CCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
..........||+.|+|||++....+ +.++||||||+++|||++|+.||......... ...|..... ...+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~-------~~~~ 230 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKT-------YLNP 230 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHHTTCT-------TSTT
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhhhccc-------ccCc
Confidence 22222234679999999999987765 77899999999999999999999765443221 222221100 0000
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.......+..++..||+.||.+||++.+++++
T Consensus 231 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 231 ------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 00112234556678999999999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=365.85 Aligned_cols=206 Identities=29% Similarity=0.435 Sum_probs=167.7
Q ss_pred hhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecC--ce
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP---SEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDN--NL 492 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~--~~ 492 (770)
..++|.+.+.||+|+||.||+|.. .+|+.||||++.. .......+.+|+.++..+. ||||++++++|...+ .+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999986 4789999999864 3455677889999999997 999999999997654 68
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
|+||||++ |+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999997 5999998753 48899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCC-------------------CCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCcc
Q 004174 573 WASTSS-------------------SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (770)
Q Consensus 573 ~~~~~~-------------------~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~ 632 (770)
...... .....+..+||+.|+|||++.+ ..++.++|||||||+||||++|++||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 654311 1112234689999999999986 67999999999999999999999999876654
Q ss_pred ch
Q 004174 633 GQ 634 (770)
Q Consensus 633 ~~ 634 (770)
.+
T Consensus 238 ~~ 239 (388)
T 3oz6_A 238 NQ 239 (388)
T ss_dssp HH
T ss_pred HH
Confidence 33
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=357.83 Aligned_cols=264 Identities=20% Similarity=0.313 Sum_probs=196.4
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChh--HHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~--~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
++|.+.+.||+|+||.||+|... +++.||||+++.... ....+.+|+.+++.++||||++++++|...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999875 789999999975432 222456799999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
++ |+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 59999887653 358999999999999999999999 899999999999999999999999999998654332
Q ss_pred CCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc-
Q 004174 579 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP- 656 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~- 656 (770)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...........+......
T Consensus 155 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 155 KT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred cc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 22 223578999999999876 56899999999999999999999999876554433322211111111111111110
Q ss_pred --------ccCCCC----ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 657 --------ALGNNY----DYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 657 --------~l~~~~----~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
...... .......+..++..||+.||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 00112334566778999999999999999873
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=347.18 Aligned_cols=260 Identities=27% Similarity=0.433 Sum_probs=196.0
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCC----ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~----~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++. .......+.+|+.+++.++||||++++++|...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999986 5789999999974 235567899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++++|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999987533333468999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
..... .....||+.|+|||++....++.++||||||+++|+|++|+.||........ .+.... ..+....+.
T Consensus 188 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~~~~~~~~- 259 (310)
T 2wqm_A 188 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKKI----EQCDYPPLP- 259 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHHHHH----HTTCSCCCC-
T ss_pred CCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHHHHh----hcccCCCCc-
Confidence 43221 1235799999999999999999999999999999999999999976433211 111111 111111111
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
...+ ...+..++..||+.||.+||++.+|+++|+..
T Consensus 260 ---~~~~----~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 260 ---SDHY----SEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp ---TTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cccc----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0111 22455566789999999999999999998643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=342.02 Aligned_cols=255 Identities=22% Similarity=0.361 Sum_probs=202.1
Q ss_pred hhcCcccceeecccCceEEEEEEeCC----CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~~----g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
..++|.+.+.||+|+||.||+|.... +..||||+++.. ....+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 35679999999999999999998532 346999999864 3566789999999999999999999999865 5679
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 9999999999999997543 358999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
........ .....+|+.|+|||++....++.++||||||+++|||++ |+.||...........+......
T Consensus 163 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~-------- 233 (281)
T 3cc6_A 163 IEDEDYYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL-------- 233 (281)
T ss_dssp C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC--------
T ss_pred cccccccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC--------
Confidence 65433221 223467889999999998999999999999999999998 99999765443322222111000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
...... ...+..++..||+.+|.+||++.++++.|+..
T Consensus 234 ----~~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 234 ----PKPDLC----PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ----CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCC----CHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 000111 13355566789999999999999999998743
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=368.50 Aligned_cols=261 Identities=22% Similarity=0.242 Sum_probs=196.6
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC------
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 490 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------ 490 (770)
.++|.+.+.||+|+||.||+|... +|+.||||++.. .....+.+.+|+.+|+.++||||++++++|....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 568999999999999999999864 688999999975 3455678899999999999999999999996553
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 570 (770)
.+||||||+++ +|.+.+.. .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 57999999976 57666642 37899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhccc------
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI------ 644 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~------ 644 (770)
++....... .+..+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+...+...+......
T Consensus 211 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 211 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp C-----CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeecCCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 987654322 23468999999999999999999999999999999999999999876543332222110000
Q ss_pred ----------------ccCCccccccCcccCCCCC---hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 645 ----------------LSSGKVTQLLDPALGNNYD---YDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 645 ----------------~~~g~l~~lld~~l~~~~~---~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
...-.+..++...+..... ......+..++..||+.||.+|||+.+++++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000011111111100000 0113456677788999999999999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=349.93 Aligned_cols=251 Identities=23% Similarity=0.313 Sum_probs=204.2
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 492 (770)
.++|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.++..++||||++++++|.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456899999999999999999865 68999999987532 1367899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC----ceEEccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 568 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~----~vkL~DF 568 (770)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 9999999999999999754 358999999999999999999999 8999999999999999887 7999999
Q ss_pred cccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC
Q 004174 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 648 (770)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 648 (770)
|++......... ....||+.|+|||++....++.++|||||||++|+|++|+.||...........+. . +
T Consensus 164 g~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~--~-----~ 233 (321)
T 2a2a_A 164 GLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT--S-----V 233 (321)
T ss_dssp TTCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--T-----T
T ss_pred ccceecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--h-----c
Confidence 999876553322 23579999999999999999999999999999999999999997654322211111 0 0
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. ..+++.+.... ...+..++..||+.||.+|||+.+++++
T Consensus 234 ~--~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 234 S--YDFDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp C--CCCCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred c--cccChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00111111111 1235556678999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=342.67 Aligned_cols=249 Identities=26% Similarity=0.417 Sum_probs=182.2
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35799999999999999999986 578999999997432 2346789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999997543 368999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
..... .....||+.|+|||++....++.++||||||+++|||++|+.||........... ... . +
T Consensus 164 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~-~------~ 228 (278)
T 3cok_A 164 MPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK------VVL-A------D 228 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCS-S------C
T ss_pred CCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH------Hhh-c------c
Confidence 33221 1235799999999999988999999999999999999999999976543221110 000 0 0
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+...+ ...+..++..||+.||.+||++.+++++
T Consensus 229 ~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 229 YEMPSFL----SIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CCCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cCCcccc----CHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0111111 2244556678999999999999999863
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=343.82 Aligned_cols=254 Identities=25% Similarity=0.404 Sum_probs=198.9
Q ss_pred cCcccceeecccCceEEEEEEeCC----CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEee-cCceEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLL 494 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~----g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~L 494 (770)
.+|.+.+.||+|+||.||+|...+ +..+|+|.++.. ....+.+.+|+.++++++||||++++++|.. ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 468889999999999999998532 235899998753 3456789999999999999999999998654 567899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999997543 357899999999999999999999 89999999999999999999999999999866
Q ss_pred cCCCCC--ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 575 STSSSH--ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 575 ~~~~~~--~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
...... .......||+.|+|||.+....++.++||||||+++|+|++ |.+||...........+.....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~-------- 250 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-------- 250 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC--------
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC--------
Confidence 443211 11223567889999999999999999999999999999999 6666765443332211111000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
... .... ...+..++..||+.+|.+||++.++++.|+.
T Consensus 251 -~~~---~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 251 -LLQ---PEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp -CCC---CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCC---CccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 000 0111 1245556678999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=341.47 Aligned_cols=249 Identities=25% Similarity=0.308 Sum_probs=200.5
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
.++|.+.+.||+|+||.||+|... ++..+|+|++.... ...+.+.+|+++++.++||||++++++|.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 457999999999999999999865 57789999987532 4467889999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee---CCCCceEEcccccccccc
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL---~~~~~vkL~DFGla~~~~ 575 (770)
+++++|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999987543 58999999999999999999999 899999999999999 788999999999998765
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
..... ....||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+.. +... ...
T Consensus 161 ~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------~~~~-~~~ 228 (277)
T 3f3z_A 161 PGKMM---RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE-------GTFT-FPE 228 (277)
T ss_dssp TTSCB---CCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CCCC-CCH
T ss_pred Cccch---hccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-------CCCC-CCc
Confidence 43322 23579999999998864 599999999999999999999999976543222111111 0000 000
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
.. ... ....+..++..||+.||.+||++.++++
T Consensus 229 ~~-~~~----~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 KD-WLN----VSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HH-HTT----SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hh-hhc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000 1234555667899999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=351.91 Aligned_cols=258 Identities=25% Similarity=0.419 Sum_probs=202.3
Q ss_pred hcCcccceeecccCceEEEEEEe------CCCCEEEEEEeCC--ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 492 (770)
.++|.+.+.||+|+||.||+|.. .+++.||||++.. .......+.+|+.++..++||||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 45789999999999999999983 3577899999964 345667899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC---CCceEEc
Q 004174 493 LLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLS 566 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~~~vkL~ 566 (770)
++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976542 22458999999999999999999999 89999999999999984 4569999
Q ss_pred cccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccc
Q 004174 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPIL 645 (770)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~ 645 (770)
|||++................||+.|+|||++..+.++.++|||||||++|+|+| |+.||...........+.
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~------ 259 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT------ 259 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH------
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh------
Confidence 9999986654433333334578999999999999999999999999999999998 999997654322111111
Q ss_pred cCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 646 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 646 ~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+... ...... ...+..++..||+.+|.+||++.+++++|..
T Consensus 260 -~~~~~-----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 260 -SGGRM-----DPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp -TTCCC-----CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -cCCCC-----CCCCCC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 11100 011111 2345566678999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=346.86 Aligned_cols=258 Identities=23% Similarity=0.316 Sum_probs=205.1
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEee--cCceEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLL 494 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~L 494 (770)
.++|.+.+.||+|+||.||+|... +|+.||+|++... ....+.+.+|+.+++.++||||++++++|.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467999999999999999999874 7899999999753 3556789999999999999999999998854 567999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc-----eEEecccCCCeeeCCCCceEEcccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-----VIHRDVKSSNILLSDDFEPQLSDFG 569 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~-----IiHrDLKp~NILL~~~~~vkL~DFG 569 (770)
||||+++++|.+++.........+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999997644333568999999999999999999999 66 9999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCc
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 649 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 649 (770)
++........ ......||+.|+|||++....++.++||||||+++|+|++|+.||...........+ ..+.
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i-------~~~~ 232 (279)
T 2w5a_A 162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-------REGK 232 (279)
T ss_dssp HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTC
T ss_pred hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHH-------hhcc
Confidence 9987654321 112357999999999999889999999999999999999999999865432211111 1111
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004174 650 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699 (770)
Q Consensus 650 l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~ 699 (770)
... +...+ ...+..++..||+.+|.+||++.+|++.+....
T Consensus 233 ~~~-----~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 233 FRR-----IPYRY----SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp CCC-----CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ccc-----CCccc----CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 111 11111 234556667899999999999999998775443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=354.98 Aligned_cols=263 Identities=25% Similarity=0.372 Sum_probs=194.1
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHH--HHhcCCCceeEEeeEEee-----cCceE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEI--ITTLHHKNIISLLGFCFE-----DNNLL 493 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~i--L~~l~HpnIv~l~~~~~~-----~~~~~ 493 (770)
.++|.+.+.||+|+||.||+|.. +++.||||++..... ..+..|.++ +..++||||+++++++.. ...++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR--QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch--hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 46799999999999999999977 789999999975443 344444444 455899999999986643 23578
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC---------ceEEecccCCCeeeCCCCceE
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ---------RVIHRDVKSSNILLSDDFEPQ 564 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~---------~IiHrDLKp~NILL~~~~~vk 564 (770)
+||||+++|+|.+++... .+++..+..++.||+.||.|||+ . +|+||||||+||||+.++.+|
T Consensus 89 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred EEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEE
Confidence 999999999999999654 35889999999999999999998 6 999999999999999999999
Q ss_pred EccccccccccCCCC------CceecccccccCCCCceeecc-------CCCCCcceEeechHHHHHHHhCCCCCCCCCc
Q 004174 565 LSDFGLAKWASTSSS------HITCTDVAGTFGYLAPEYFMY-------GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (770)
Q Consensus 565 L~DFGla~~~~~~~~------~~~~~~~~GT~~YlAPE~~~~-------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 631 (770)
|+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987654321 111223579999999999986 4567789999999999999999777654332
Q ss_pred cchh-hHHH---hhcc-------cccCCccccccCcccCCC--CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 632 KGQE-SLVM---WAKP-------ILSSGKVTQLLDPALGNN--YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 632 ~~~~-~lv~---~~~~-------~~~~g~l~~lld~~l~~~--~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
.... .... ...+ ...... ..+.+... ........+..++..||+.||.+|||+.++++.|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSC----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccc----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 1110 0000 0000 000000 01111111 1223455677788899999999999999999998753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=357.53 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=176.8
Q ss_pred ceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEEeecCCCCh
Q 004174 427 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~LV~E~~~ggsL 504 (770)
.+.||+|+||.||+|... +|+.||||++... ....+.+|+.++..+. ||||++++++|.+....++||||+++|+|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 478999999999999874 6899999999643 4467788999999997 99999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC---ceEEccccccccccCCCCCc
Q 004174 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~---~vkL~DFGla~~~~~~~~~~ 581 (770)
.+++.... .+++..+..|+.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++........
T Consensus 94 ~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~- 165 (325)
T 3kn6_A 94 FERIKKKK----HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP- 165 (325)
T ss_dssp HHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-
Confidence 99997653 58999999999999999999999 8999999999999997665 8999999999866543322
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 661 (770)
.....||+.|+|||++....++.++|||||||++|+|++|+.||..................+..+.... ....
T Consensus 166 -~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~--- 239 (325)
T 3kn6_A 166 -LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF--EGEA--- 239 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC--CSHH---
T ss_pred -ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC--Cccc---
Confidence 2335789999999999999999999999999999999999999986543211100000001111111100 0000
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 662 YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 662 ~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.......+..++..||+.||.+||++.+++++
T Consensus 240 -~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 -WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp -HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred -ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 00112345566678999999999999998753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=371.06 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=194.1
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++.. ......+.+|+.++..++||||++++++|...+.++||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 35799999999999999999986 47899999999742 34456788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+ .++|+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999997543 58999999999999999999995 1679999999999999999999999999998644
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
.... .....+||+.|+|||++....++.++|||||||+||||++|+.||...+.......+..... .
T Consensus 301 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-----~------ 367 (446)
T 4ejn_A 301 KDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-----R------ 367 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----C------
T ss_pred CCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-----C------
Confidence 3322 22346899999999999999999999999999999999999999977544322222211100 0
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 694 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~ 694 (770)
+....+ ..+..++..||+.||.+|| ++.+++++
T Consensus 368 --~p~~~~----~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 368 --FPRTLG----PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp --CCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCccCC----HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 111111 2345566789999999999 99999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.25 Aligned_cols=250 Identities=22% Similarity=0.389 Sum_probs=199.6
Q ss_pred hcCcccceeecccCceEEEEEEeCC-C-------CEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPD-G-------KELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~-g-------~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 491 (770)
.++|.+.+.||+|+||.||+|.... + ..||+|++.... ...+.+.+|+.+++.++||||++++++|...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4578999999999999999998642 3 479999997543 556789999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCc--------e
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--------P 563 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~--------v 563 (770)
.++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccccee
Confidence 999999999999999997643 348999999999999999999999 89999999999999988887 9
Q ss_pred EEccccccccccCCCCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCC-CCCCCCCccchhhHHHhh
Q 004174 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGR-KPISNDHPKGQESLVMWA 641 (770)
Q Consensus 564 kL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~-~Pf~~~~~~~~~~lv~~~ 641 (770)
||+|||++...... ....||+.|+|||++.. ..++.++|||||||++|||++|. +||.............
T Consensus 161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~-- 232 (289)
T 4fvq_A 161 KLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-- 232 (289)
T ss_dssp EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH--
T ss_pred eeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh--
Confidence 99999998654321 22468999999999987 67999999999999999999955 4554432221111111
Q ss_pred cccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCCC
Q 004174 642 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 700 (770)
Q Consensus 642 ~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~~ 700 (770)
.. ..+.. .. ...+..++..||+.||.+||++.++++.|+....
T Consensus 233 ~~----~~~~~--------~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 233 DR----HQLPA--------PK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp TT----CCCCC--------CS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred cc----CCCCC--------CC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 00 00001 01 1124456678999999999999999999986554
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=351.09 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=198.9
Q ss_pred hcCcccceeecccCceEEEEEEeCC-----CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPD-----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~-----g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
.++|...+.||+|+||.||+|.... +..||||+++.. ......+.+|+.++..++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3568888999999999999998642 236999999753 345667999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999997543 368999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCc-eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 574 ASTSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 574 ~~~~~~~~-~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
........ ......+|+.|+|||++....++.++|||||||++|||++ |+.||...........+. .+..
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-------~~~~- 268 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-------DGFR- 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-------TTCC-
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-------CCCc-
Confidence 65432211 1122356889999999999999999999999999999999 999997654322111111 1100
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
.. .+......+..++..||+.+|.+||++.++++.|+..
T Consensus 269 ----~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 269 ----LP----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp ----CC----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----CC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 0111223455667789999999999999999998643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=341.94 Aligned_cols=253 Identities=23% Similarity=0.362 Sum_probs=198.8
Q ss_pred CcccceeecccCceEEEEEEeC-C---CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce-EEE
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-D---GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL-LLV 495 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~---g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~-~LV 495 (770)
.|...+.||+|+||.||+|... + +..+|+|++... ....+.+.+|+.+++.++||||++++++|.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4667799999999999999853 2 237999999753 34567899999999999999999999999876665 999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+.+|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999997643 368899999999999999999999 899999999999999999999999999997654
Q ss_pred CCC--CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCC-CCCCCccchhhHHHhhcccccCCcccc
Q 004174 576 TSS--SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP-ISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 576 ~~~--~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~P-f~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
... .........+|+.|+|||.+....++.++|||||||++|+|++|..| |...........+......
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-------- 247 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-------- 247 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC--------
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC--------
Confidence 322 11122235688999999999999999999999999999999995554 5444332222221111100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
..... ....+..++..||+.+|.+|||+.++++.|+.
T Consensus 248 ----~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~ 284 (298)
T 3pls_A 248 ----PQPEY----CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ 284 (298)
T ss_dssp ----CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCcc----chHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00111 11345566678999999999999999998864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=346.99 Aligned_cols=263 Identities=28% Similarity=0.378 Sum_probs=206.8
Q ss_pred HHhhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHh--cCCCceeEEeeEEeecC----c
Q 004174 418 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLGFCFEDN----N 491 (770)
Q Consensus 418 ~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~~----~ 491 (770)
....++|.+.+.||+|+||.||+|.. +|+.||||++... ....+.+|++++.. ++||||+++++++.... .
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 34567899999999999999999988 6899999999753 34667889999888 78999999999998876 7
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCceEEecccCCCeeeCCCCce
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH--------SGSAQRVIHRDVKSSNILLSDDFEP 563 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH--------~~~~~~IiHrDLKp~NILL~~~~~v 563 (770)
.++||||+++|+|.+++... .+++..++.++.|++.||.||| + ++|+||||||+||||+.++.+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSCE
T ss_pred eEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCCE
Confidence 99999999999999999753 4899999999999999999999 6 899999999999999999999
Q ss_pred EEccccccccccCCCCCc--eecccccccCCCCceeeccC------CCCCcceEeechHHHHHHHhC----------CCC
Q 004174 564 QLSDFGLAKWASTSSSHI--TCTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTG----------RKP 625 (770)
Q Consensus 564 kL~DFGla~~~~~~~~~~--~~~~~~GT~~YlAPE~~~~~------~~s~ksDVwSlGvvL~eLltG----------~~P 625 (770)
||+|||++.......... ......||+.|+|||++... .++.++|||||||++|||++| ..|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998765543221 12335799999999999865 234689999999999999999 778
Q ss_pred CCCCCccchhhHHHhhcccccCCccccccCcccCCC-CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 626 ISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN-YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 626 f~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~-~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
|....+..... ..+...... . .+.+.+... ...+....+..++..||+.||.+||++.+|+++|+.
T Consensus 267 ~~~~~~~~~~~-~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 267 YYDLVPSDPSV-EEMRKVVCE-Q----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp TTTTSCSSCCH-HHHHHHHTT-S----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccccCcCcccH-HHHHHHHHH-H----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 86654322111 011111111 1 111111111 123556677888889999999999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=369.27 Aligned_cols=247 Identities=23% Similarity=0.394 Sum_probs=203.3
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|+.+++.++||||+++++++...+.+++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999875 79999999997532 2356789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 9999999999999754 358999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCceeeccCCC-CCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
.... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+. .+..
T Consensus 168 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~-------~~~~---- 233 (476)
T 2y94_A 168 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC-------DGIF---- 233 (476)
T ss_dssp TTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH-------TTCC----
T ss_pred cccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh-------cCCc----
Confidence 4322 223579999999999987766 689999999999999999999998654332211111 1110
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
......+ ..+..++..||+.||.+|||+.+++++
T Consensus 234 --~~p~~~s----~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 234 --YTPQYLN----PSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp --CCCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred --CCCccCC----HHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0001111 234556678999999999999999973
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=356.76 Aligned_cols=252 Identities=29% Similarity=0.402 Sum_probs=198.6
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEee
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
.++|.+.+.||+|+||.||+|... +|+.||||+++.... .+.+|++++.++ +||||++++++|.+++..|+||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 457999999999999999999864 688999999976542 245688888888 799999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC----CceEEccccccccc
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAKWA 574 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~----~~vkL~DFGla~~~ 574 (770)
++||+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||+.++ +.+||+|||+++..
T Consensus 98 ~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 98 MKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999997543 58999999999999999999999 899999999999998543 34999999999876
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
...... ....+||+.|+|||++....|+.++|||||||++|||++|+.||..........+..... .+.+.
T Consensus 171 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~~~~~--- 241 (342)
T 2qr7_A 171 RAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG----SGKFS--- 241 (342)
T ss_dssp BCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH----HCCCC---
T ss_pred cCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc----cCCcc---
Confidence 544322 223689999999999998889999999999999999999999998643333222222111 11110
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+...+.......+..++..||+.||.+||++.+++++
T Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000111112334556678999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=357.03 Aligned_cols=263 Identities=19% Similarity=0.279 Sum_probs=204.9
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC--------CCceeEEeeEEe----
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH--------HKNIISLLGFCF---- 487 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~--------HpnIv~l~~~~~---- 487 (770)
.++|.+.+.||+|+||.||+|.. .+++.||||+++......+.+.+|+.+++.++ |+||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 46899999999999999999985 46889999999987777888999999999996 788999999997
Q ss_pred ecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-ceEEecccCCCeeeCCCC-----
Q 004174 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDF----- 561 (770)
Q Consensus 488 ~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~IiHrDLKp~NILL~~~~----- 561 (770)
....++|||||+ +++|.+.+..... ..+++..++.|+.||+.||.|||+ + +|+||||||+||||+.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhh
Confidence 456799999999 5677776654432 358999999999999999999999 7 899999999999999775
Q ss_pred --------------------------------------------ceEEccccccccccCCCCCceecccccccCCCCcee
Q 004174 562 --------------------------------------------EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597 (770)
Q Consensus 562 --------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~ 597 (770)
.+||+|||++....... ....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcccCChh
Confidence 79999999998765432 23579999999999
Q ss_pred eccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchh----hH---HHhhcc--------------cc-cCCccccccC
Q 004174 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE----SL---VMWAKP--------------IL-SSGKVTQLLD 655 (770)
Q Consensus 598 ~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~----~l---v~~~~~--------------~~-~~g~l~~lld 655 (770)
+.+..++.++|||||||+||||++|+.||......... .+ ...... .+ ..+.+..+.+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999865533211 00 000000 00 0011111100
Q ss_pred cc-------c--CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 656 PA-------L--GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 656 ~~-------l--~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.. + ...........+..++..||+.||.+|||+.+++++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00 0 012234555667788889999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=381.32 Aligned_cols=257 Identities=25% Similarity=0.422 Sum_probs=208.3
Q ss_pred hhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
..++|.+.+.||+|+||.||+|.+.++..||||+++......+.|.+|+.+|+.++||||++++++|.+ +..+|||||+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 456788999999999999999999888889999998765556789999999999999999999999976 6789999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
.+|+|.++|..... ..+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.......
T Consensus 344 ~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 344 SKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp TTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred cCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999974321 358899999999999999999999 8999999999999999999999999999986643211
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
.......+|..|+|||++..+.++.++|||||||+||||++ |+.||...........+. .+... .
T Consensus 419 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-------~~~~~-----~- 484 (535)
T 2h8h_A 419 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-------RGYRM-----P- 484 (535)
T ss_dssp -HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-------TTCCC-----C-
T ss_pred -ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCC-----C-
Confidence 11122356789999999999999999999999999999999 999997654332211111 11000 0
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~ 699 (770)
.+......+..++..||+.+|.+||++.+|+++|+...
T Consensus 485 ---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 485 ---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 01112234556677899999999999999999997643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=350.90 Aligned_cols=263 Identities=25% Similarity=0.370 Sum_probs=202.0
Q ss_pred hhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCC-ChhHHHHHHHHHHHHHhcCCCceeEEeeEEee----cCceE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLL 493 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~ 493 (770)
..++|.+.+.||+|+||.||++.. .+|+.||||++.. .....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 346799999999999999999986 5789999998864 34566789999999999999999999999973 34789
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+||||+++|+|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999997643334578999999999999999999999 8999999999999999999999999999875
Q ss_pred ccCCCCCc-------eecccccccCCCCceeeccCC---CCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcc
Q 004174 574 ASTSSSHI-------TCTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 643 (770)
Q Consensus 574 ~~~~~~~~-------~~~~~~GT~~YlAPE~~~~~~---~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~ 643 (770)
........ ......||+.|+|||++.... ++.++|||||||++|||++|+.||................
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~- 262 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN- 262 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-
Confidence 53211110 011245799999999987543 7899999999999999999999995421111111100000
Q ss_pred cccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004174 644 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699 (770)
Q Consensus 644 ~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~ 699 (770)
.. . + + ........+..++..||+.||.+||++.++++.|+...
T Consensus 263 ~~---~---~--~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 263 QL---S---I--P-----QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp C--------C--C-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred cC---C---C--C-----ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 00 0 0 0 00111234556667899999999999999999997654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.08 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=202.3
Q ss_pred hhcCcccce-eecccCceEEEEEEe---CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004174 420 ATSNFLAEN-LIGKGGSSQVYKGCL---PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 420 ~t~~f~~~~-~LG~G~fG~Vy~a~~---~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 492 (770)
..++|.+.+ .||+|+||.||+|.. .+++.||||+++... ...+.+.+|+.++..++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345688877 999999999999954 347889999997542 3467899999999999999999999999 66789
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
++||||+++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 99999999999999997643 48899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCce-ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCcc
Q 004174 573 WASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKV 650 (770)
Q Consensus 573 ~~~~~~~~~~-~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 650 (770)
.......... .....+|+.|+|||++....++.++||||||+++|+|++ |+.||...........+. .+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~ 238 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGER 238 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTCC
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCC
Confidence 7655433221 122356789999999998899999999999999999999 999998754432221111 1110
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 651 ~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+.+ +......+..++..||+.||.+||++.+|++.|+.
T Consensus 239 -----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 239 -----MGC----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp -----CCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 011 11122345566678999999999999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=376.64 Aligned_cols=253 Identities=24% Similarity=0.315 Sum_probs=205.8
Q ss_pred hhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
..++|.+.++||+|+||.||+|... +|+.||||++.... .....+.+|+.+|..++||||++++++|.+.+.+||
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4567999999999999999999874 79999999997532 234568899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||++||+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 262 VmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999999976542 358999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhh-HHHhhcccccCCccccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES-LVMWAKPILSSGKVTQL 653 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~-lv~~~~~~~~~g~l~~l 653 (770)
..... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.......... +...... .
T Consensus 337 ~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~----~----- 404 (576)
T 2acx_A 337 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----V----- 404 (576)
T ss_dssp CTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH----C-----
T ss_pred ccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc----c-----
Confidence 54332 223589999999999999899999999999999999999999998754432211 1111100 0
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 694 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~ 694 (770)
...+...+ ...+..++..||+.||.+|| ++.+|+++
T Consensus 405 -~~~~p~~~----s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 -PEEYSERF----SPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -CCCCCTTS----CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -cccCCccC----CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 00111111 23445566789999999999 78888875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=353.74 Aligned_cols=255 Identities=27% Similarity=0.439 Sum_probs=203.6
Q ss_pred HHHhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---------hHHHHHHHHHHHHHhc-CCCceeEEeeE
Q 004174 417 LLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---------DVIKEFVLEIEIITTL-HHKNIISLLGF 485 (770)
Q Consensus 417 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~l-~HpnIv~l~~~ 485 (770)
.....++|.+.+.||+|+||.||+|.+. +|+.||||+++... ...+.+.+|+.++..+ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3444567999999999999999999975 79999999986532 2356788999999999 79999999999
Q ss_pred EeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEE
Q 004174 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565 (770)
Q Consensus 486 ~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL 565 (770)
|...+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEE
Confidence 999999999999999999999997542 58999999999999999999999 89999999999999999999999
Q ss_pred ccccccccccCCCCCceecccccccCCCCceeecc------CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHH
Q 004174 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (770)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~ 639 (770)
+|||++........ .....||+.|+|||++.. ..++.++|||||||++|+|++|+.||...........+.
T Consensus 242 ~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~ 318 (365)
T 2y7j_A 242 SDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318 (365)
T ss_dssp CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 99999987654332 223679999999999863 358899999999999999999999997654322111111
Q ss_pred hhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 640 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 640 ~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+... ...+.. ... ...+..++..||+.||.+||++.+++++
T Consensus 319 -------~~~~~-~~~~~~-~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 319 -------EGQYQ-FSSPEW-DDR----SSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp -------HTCCC-CCHHHH-SSS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -------hCCCC-CCCccc-ccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01000 000000 011 1235556678999999999999999974
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=341.26 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=200.2
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
++|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.+++.++||||++++++|...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56899999999999999999875 68999999987532 13678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC----ceEEcccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDFG 569 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~----~vkL~DFG 569 (770)
+||||+++++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999997543 58999999999999999999999 8999999999999998877 79999999
Q ss_pred ccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCc
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 649 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 649 (770)
++........ .....||+.|+|||++....++.++||||||+++|+|++|+.||...........+.....
T Consensus 158 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------ 228 (283)
T 3bhy_A 158 IAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY------ 228 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC------
T ss_pred cceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhccc------
Confidence 9987654322 2235799999999999989999999999999999999999999977543221111110000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 650 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 650 l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
...+...... ...+..++..||+.||.+||++.+++++
T Consensus 229 ---~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 229 ---DFDEEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp ---CCCHHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred ---CCcchhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0001110111 2345556678999999999999999973
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=360.23 Aligned_cols=270 Identities=20% Similarity=0.300 Sum_probs=208.1
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecC--ceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~~~LV 495 (770)
.++|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+++++.++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357899999999999999999875 58999999997533 34577889999999999999999999998765 78999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee----CCCCceEEcccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLA 571 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL----~~~~~vkL~DFGla 571 (770)
|||+++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999975432 2348999999999999999999999 899999999999999 77888999999999
Q ss_pred ccccCCCCCceecccccccCCCCceeecc--------CCCCCcceEeechHHHHHHHhCCCCCCCCCccchh-hHHH-hh
Q 004174 572 KWASTSSSHITCTDVAGTFGYLAPEYFMY--------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE-SLVM-WA 641 (770)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~YlAPE~~~~--------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~lv~-~~ 641 (770)
+....... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||......... .... ..
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp EECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred eEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 87654322 223579999999999875 56788999999999999999999999754332211 1111 00
Q ss_pred --cccc--------cCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 642 --KPIL--------SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 642 --~~~~--------~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+.. ..+.+.-.-+..............+..++..||+.||++||++.++++.+..
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 0100 0000000000011122334556667778888999999999999999987754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=346.28 Aligned_cols=263 Identities=21% Similarity=0.314 Sum_probs=207.0
Q ss_pred hcCcccceeecccCceEEEEEEe--CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCc------eeEEeeEEeecCce
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN------IISLLGFCFEDNNL 492 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~--~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hpn------Iv~l~~~~~~~~~~ 492 (770)
.++|.+.+.||+|+||.||+|.. .+++.||||+++......+.+.+|+.++..++|++ +++++++|...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 45899999999999999999986 36889999999887777788999999999997654 99999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC-------------
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD------------- 559 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~------------- 559 (770)
++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 9999999 8899999976543 358899999999999999999999 89999999999999987
Q ss_pred ------CCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccc
Q 004174 560 ------DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (770)
Q Consensus 560 ------~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 633 (770)
++.+||+|||++....... ....||+.|+|||++....++.++|||||||++|||++|+.||...+...
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 6689999999998654432 23579999999999998899999999999999999999999998765433
Q ss_pred hhhHHHhhcccccC--------Cc------------------cccccCcccC-CCCChHHHHHHHHHHHhhcccCCCCCC
Q 004174 634 QESLVMWAKPILSS--------GK------------------VTQLLDPALG-NNYDYDQMERMVLASILCIRRDPRARP 686 (770)
Q Consensus 634 ~~~lv~~~~~~~~~--------g~------------------l~~lld~~l~-~~~~~~~~~~l~~~a~~Cl~~dP~~RP 686 (770)
....+......+.. .. +.....+... ..........+..++..||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 22221111000000 00 0000000000 011223455677788899999999999
Q ss_pred CHHHHHHH
Q 004174 687 QMSLVLKL 694 (770)
Q Consensus 687 s~~eVL~~ 694 (770)
|+.+++++
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999863
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=373.28 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=205.8
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.++||+|+||.||+|... +|+.||||+++... .....+.+|+.+|..++||||++++++|...+.+|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999874 69999999997532 2346788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||++||+|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999997665444579999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccch-hhHHHhhcccccCCcccccc
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ-ESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~-~~lv~~~~~~~~~g~l~~ll 654 (770)
..... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||........ ..+... ... +.
T Consensus 341 ~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~---i~~-~~----- 409 (543)
T 3c4z_A 341 AGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR---VLE-QA----- 409 (543)
T ss_dssp TTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHH---HHH-CC-----
T ss_pred CCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHH---Hhh-cc-----
Confidence 44322 2235899999999999999999999999999999999999999987543221 111111 000 00
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCH-----HHHHHH
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQM-----SLVLKL 694 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~-----~eVL~~ 694 (770)
..+...+ ...+..++..||+.||.+||++ .+|+++
T Consensus 410 -~~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 410 -VTYPDKF----SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp -CCCCTTS----CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred -cCCCccc----CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 0011111 2334455677999999999975 666653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=352.76 Aligned_cols=267 Identities=23% Similarity=0.324 Sum_probs=201.8
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEee--------
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFE-------- 488 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-------- 488 (770)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+.++..++||||++++++|..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35799999999999999999987 578999999986432 334578899999999999999999999987
Q ss_pred cCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccc
Q 004174 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (770)
Q Consensus 489 ~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 568 (770)
.+..++||||+++ +|.+.+.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 3468999999975 8888776543 358999999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCC--CceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccc
Q 004174 569 GLAKWASTSSS--HITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 645 (770)
Q Consensus 569 Gla~~~~~~~~--~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~ 645 (770)
|+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.......
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99987653221 122234678999999999875 458999999999999999999999998765443333222111111
Q ss_pred cCCccccc-----cCc---ccCCCCC-hHH------HHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 646 SSGKVTQL-----LDP---ALGNNYD-YDQ------MERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 646 ~~g~l~~l-----ld~---~l~~~~~-~~~------~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
........ .+. ....... .+. ...+..++..||+.||.+|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 11111110 000 0000000 111 1235567778999999999999999974
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=358.17 Aligned_cols=253 Identities=26% Similarity=0.441 Sum_probs=192.0
Q ss_pred CcccceeecccCceEEEEEEeC--CC--CEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEee-cCceEEE
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP--DG--KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLV 495 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~--~g--~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~LV 495 (770)
.|.+.+.||+|+||.||+|... ++ ..||||.++.. ....+.|.+|+.+++.++||||++++++|.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4777899999999999999853 22 36899998753 3567889999999999999999999998765 4578999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999997543 357899999999999999999999 899999999999999999999999999998664
Q ss_pred CCCCCc--eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 576 TSSSHI--TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 576 ~~~~~~--~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
...... ......+|+.|+|||++....++.++|||||||++|||+| |.+||...........+.. +. .
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~-------~~--~ 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-------GR--R 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT-------TC--C
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc-------CC--C
Confidence 432211 1223467889999999999999999999999999999999 7888876554332222111 11 0
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
...+ ... ...+..++..||+.+|.+||++.++++.|+.
T Consensus 315 ~~~p---~~~----~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 352 (373)
T 3c1x_A 315 LLQP---EYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352 (373)
T ss_dssp CCCC---TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC---CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0011 111 2345566678999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=342.32 Aligned_cols=246 Identities=22% Similarity=0.311 Sum_probs=198.3
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.+.||+|+||.||+|... +++.||||+++.. ......+.+|+.++..+ +||||++++++|.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999875 7999999999753 34567888999999999 899999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC----------------
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---------------- 559 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---------------- 559 (770)
|||+++|+|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997643322468999999999999999999999 89999999999999984
Q ss_pred ---CCceEEccccccccccCCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchh
Q 004174 560 ---DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635 (770)
Q Consensus 560 ---~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~ 635 (770)
...+||+|||++........ ..||+.|+|||++... .++.++|||||||++|+|++|.+|+.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSCC------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred cCCceEEEEcccccccccCCccc------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 44799999999987654322 3589999999999866 566899999999999999999987754311
Q ss_pred hHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 636 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 636 ~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
... +..+... .+....+ ..+..++..||+.||.+||++.+++++
T Consensus 237 -~~~-----~~~~~~~-----~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 -WHE-----IRQGRLP-----RIPQVLS----QEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -HHH-----HHTTCCC-----CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -HHH-----HHcCCCC-----CCCcccC----HHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111 1111111 1111122 344556678999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=361.17 Aligned_cols=245 Identities=26% Similarity=0.315 Sum_probs=190.4
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHH-HHhcCCCceeEEeeEEeecCceEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEI-ITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~i-L~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
.++|.+.+.||+|+||.||+|... +++.||||++++.. .....+..|..+ ++.++||||++++++|.+.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357899999999999999999875 68899999997532 334566777776 567899999999999999999999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||++||+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++++||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999997643 58899999999999999999999 89999999999999999999999999999864
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.. +.+
T Consensus 190 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-------~~~---- 256 (373)
T 2r5t_A 190 IEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN-------KPL---- 256 (373)
T ss_dssp BCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH-------SCC----
T ss_pred ccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-------ccc----
Confidence 33222 22346899999999999999999999999999999999999999986543322211111 000
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLV 691 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eV 691 (770)
.+..... ..+..++..||+.||.+||++.+.
T Consensus 257 --~~~~~~~----~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 257 --QLKPNIT----NSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp --CCCSSSC----HHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred --CCCCCCC----HHHHHHHHHHcccCHHhCCCCCCC
Confidence 0111111 234456678999999999998543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=353.36 Aligned_cols=265 Identities=24% Similarity=0.364 Sum_probs=199.6
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
.++|.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.+++.++||||++++++|...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357899999999999999999875 5899999998643 344567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999988765433 58999999999999999999999 8999999999999999999999999999986654
Q ss_pred CCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhh-ccc-------c-c
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA-KPI-------L-S 646 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~-~~~-------~-~ 646 (770)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+... ... + .
T Consensus 177 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 177 PGEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred Cccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 3221 2235799999999999865 7899999999999999999999999876543322111100 000 0 0
Q ss_pred CCccccccCcccCCCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 647 SGKVTQLLDPALGNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 647 ~g~l~~lld~~l~~~~~-----~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.........+.+..... ......+..++..||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000111111111111 1123456667778999999999999999873
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=352.59 Aligned_cols=264 Identities=19% Similarity=0.275 Sum_probs=193.0
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 45799999999999999999985 478899999997543 33567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee-----CCCCceEEcccccc
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-----SDDFEPQLSDFGLA 571 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL-----~~~~~vkL~DFGla 571 (770)
||+++ +|.+++.... .+++..++.|+.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 113 e~~~~-~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 113 EYAEN-DLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp ECCSE-EHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred ecCCC-CHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99975 9999997653 48999999999999999999999 899999999999999 45556999999999
Q ss_pred ccccCCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcc
Q 004174 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650 (770)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 650 (770)
+........ .....||+.|+|||++... .++.++|||||||++|||++|+.||...........+.-..........
T Consensus 185 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 185 RAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 876543222 2235789999999999865 4899999999999999999999999876543322221111000000000
Q ss_pred c------cccC--cccCCCC-----ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 651 T------QLLD--PALGNNY-----DYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 651 ~------~lld--~~l~~~~-----~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. .+.. +...... .......+..++..||+.||.+|||+.+++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0 0000 0000000 00012345567778999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=341.10 Aligned_cols=261 Identities=22% Similarity=0.291 Sum_probs=199.4
Q ss_pred hhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEE-eecCceEEEEe
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC-FEDNNLLLVYD 497 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~~~~~~~LV~E 497 (770)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+|+.++..++|++++..+.++ ...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 457899999999999999999986 578999999876432 224578899999999988877766665 56677899999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee---CCCCceEEccccccccc
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL---~~~~~vkL~DFGla~~~ 574 (770)
|+ +++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred cc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99 999999997543 358999999999999999999999 899999999999999 78899999999999876
Q ss_pred cCCCCCc-----eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCc
Q 004174 575 STSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 649 (770)
Q Consensus 575 ~~~~~~~-----~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 649 (770)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.................. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~ 234 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----K 234 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH----H
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc----c
Confidence 5543311 122467999999999999999999999999999999999999999875543322221111000 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 650 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 650 l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
... ..+.+...++ ..+..++..||+.+|.+||++.+|++.|+.
T Consensus 235 ~~~-~~~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 235 MST-PIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HHS-CHHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred ccc-hhhhhhccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 000 0001111111 345566678999999999999999998864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=349.72 Aligned_cols=254 Identities=26% Similarity=0.434 Sum_probs=200.8
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEE--EEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKEL--AVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~v--AVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV 495 (770)
++|.+.+.||+|+||.||+|... +|..+ |||+++.. ....+.+.+|++++..+ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57889999999999999999864 56544 99988753 34556789999999999 899999999999999999999
Q ss_pred EeecCCCChhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCce
Q 004174 496 YDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~v 563 (770)
|||+++|+|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999997653 223468999999999999999999999 899999999999999999999
Q ss_pred EEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhc
Q 004174 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 642 (770)
Q Consensus 564 kL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~ 642 (770)
||+|||+++........ ....+|+.|+|||++....++.++|||||||++|||++ |+.||........... ..
T Consensus 182 kL~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~---~~ 255 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK---LP 255 (327)
T ss_dssp EECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---GG
T ss_pred EEcccCcCccccccccc---cCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH---hh
Confidence 99999999744322111 22457889999999998899999999999999999998 9999976543221111 11
Q ss_pred ccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 643 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 643 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+. .... +......+..++..||+.+|.+||++.++++.|..
T Consensus 256 ----~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 256 ----QGY-----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp ----GTC-----CCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----cCC-----CCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 110 0001 11112345566778999999999999999998864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=349.67 Aligned_cols=255 Identities=20% Similarity=0.302 Sum_probs=200.4
Q ss_pred HhhcCcccc-eeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCce
Q 004174 419 SATSNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNL 492 (770)
Q Consensus 419 ~~t~~f~~~-~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~ 492 (770)
...+.|.+. +.||+|+||.||+|... +|+.||||+++.. ......+.+|+.++..+. ||||++++++|...+..
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 344567776 89999999999999865 6899999998753 244678899999999995 69999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC---CCceEEcccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFG 569 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~~~vkL~DFG 569 (770)
++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELA--EMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred EEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 999999999999999865422 468999999999999999999999 89999999999999987 7899999999
Q ss_pred ccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCc
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 649 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 649 (770)
+++....... .....||+.|+|||++....++.++|||||||++|+|++|+.||...........+.......
T Consensus 180 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---- 252 (327)
T 3lm5_A 180 MSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDY---- 252 (327)
T ss_dssp GCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC----
T ss_pred cccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccccc----
Confidence 9987654322 123579999999999999999999999999999999999999997754432221111111000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 650 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 650 l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. ..........+..++..||+.||.+||++.+++++
T Consensus 253 ----~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 253 ----S-----EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ----C-----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ----C-----chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 00011112334556678999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=351.05 Aligned_cols=268 Identities=25% Similarity=0.301 Sum_probs=198.4
Q ss_pred HhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004174 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (770)
Q Consensus 419 ~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 491 (770)
...++|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|+.++..++||||++++++|...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999874 68999999997532 123468899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 571 (770)
.++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999986 8988886543 368899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcc
Q 004174 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650 (770)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 650 (770)
+........ .....||+.|+|||++.+. .++.++|||||||++|||++|.+||...........+...........+
T Consensus 160 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 160 KSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp STTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eeccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 876543322 2335799999999999754 5899999999999999999999999876543322211111000000000
Q ss_pred c---cccCcccCC---CCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 651 T---QLLDPALGN---NYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 651 ~---~lld~~l~~---~~~-----~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
. .+.+..... ..+ ......+..++..||+.||.+|||+.+++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0 000000000 001 11124456677789999999999999999853
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=339.78 Aligned_cols=261 Identities=22% Similarity=0.295 Sum_probs=202.6
Q ss_pred hhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEE-eecCceEEEEe
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC-FEDNNLLLVYD 497 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~~~~~~~LV~E 497 (770)
..++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+|+.++..++|++++..+.++ ...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 357899999999999999999986 5789999999875432 24688999999999998877666655 55677899999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC---CCCceEEccccccccc
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKWA 574 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~---~~~~vkL~DFGla~~~ 574 (770)
|+ +++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 899999997443 358999999999999999999999 8999999999999994 8889999999999876
Q ss_pred cCCCCCc-----eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCc
Q 004174 575 STSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 649 (770)
Q Consensus 575 ~~~~~~~-----~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 649 (770)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.................. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~ 234 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----K 234 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH----H
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc----c
Confidence 6543311 123467999999999999999999999999999999999999999875433222111111000 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 650 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 650 l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
... ..+.+...++ ..+..++..||+.+|.+||++.+|++.|+.
T Consensus 235 ~~~-~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 235 MST-PIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HHS-CHHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred cCC-chHHHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 000 0001111122 345566678999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=356.75 Aligned_cols=200 Identities=25% Similarity=0.435 Sum_probs=177.8
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.++|.+.+.||+|+||.||+|... +++.||+|++... ....+.+.+|+.++..++||||++++++|..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999875 6899999999754 4556789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-ceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
|+++++|.+++.... .+++..+..++.+++.||.|||+ . +|+||||||+|||++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999997653 48899999999999999999998 5 799999999999999999999999999976543
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 631 (770)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 185 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 185 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp HC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred cc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 22 1235799999999999999999999999999999999999999986543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=354.82 Aligned_cols=264 Identities=17% Similarity=0.212 Sum_probs=196.7
Q ss_pred hcCcccceeecccCceEEEEEEeC----CCCEEEEEEeCCChh------------HHHHHHHHHHHHHhcCCCceeEEee
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSED------------VIKEFVLEIEIITTLHHKNIISLLG 484 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~~~------------~~~~~~~Ei~iL~~l~HpnIv~l~~ 484 (770)
.++|.+.+.||+|+||.||+|... ++..+|||++..... ....+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357899999999999999999975 578899999876431 1124667889999999999999999
Q ss_pred EEee----cCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC
Q 004174 485 FCFE----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560 (770)
Q Consensus 485 ~~~~----~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~ 560 (770)
++.. ....++||||+ +++|.+++.... .+++..++.|+.||+.||.|||+ ++|+||||||+||||+.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccC
Confidence 9988 67899999999 999999997653 68999999999999999999999 899999999999999887
Q ss_pred C--ceEEccccccccccCCCCC-----ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccc
Q 004174 561 F--EPQLSDFGLAKWASTSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (770)
Q Consensus 561 ~--~vkL~DFGla~~~~~~~~~-----~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 633 (770)
+ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 9999999999876432211 11133579999999999999899999999999999999999999996532221
Q ss_pred hhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 634 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 634 ~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
...... ... .. ..+...+....... .....+..++..||+.+|.+||++.+|++.|+..
T Consensus 268 ~~~~~~-~~~-~~-~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 VAVQTA-KTN-LL-DELPQSVLKWAPSG---SSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHH-HHH-HH-HTTTHHHHHHSCTT---SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHH-HHh-hc-ccccHHHHhhcccc---ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 111110 000 00 01111111111110 1123455566789999999999999999999753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=353.56 Aligned_cols=241 Identities=22% Similarity=0.358 Sum_probs=199.4
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh---------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecC
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 490 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 490 (770)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+.+|+.+++.++||||++++++|.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 45799999999999999999985 578899999997542 13346778999999999999999999999999
Q ss_pred ceEEEEeecCCC-ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccc
Q 004174 491 NLLLVYDFLSRG-SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (770)
Q Consensus 491 ~~~LV~E~~~gg-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 569 (770)
.+++||||+.+| +|.+++.... .+++..+..|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 999999999777 9999997543 58999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCceeeccCCC-CCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 648 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 648 (770)
++......... ....||+.|+|||++....+ +.++|||||||++|+|++|+.||...... . .
T Consensus 176 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~---~------ 238 (335)
T 3dls_A 176 SAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----V---E------ 238 (335)
T ss_dssp TCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----T---T------
T ss_pred cceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----H---h------
Confidence 99877654332 23579999999999988876 78999999999999999999999642110 0 0
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
....+ .... ...+..++..||+.||.+||++.+++++
T Consensus 239 ---~~~~~--~~~~----~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 ---AAIHP--PYLV----SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---TCCCC--SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---hccCC--Cccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0011 1234556678999999999999999985
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=350.53 Aligned_cols=256 Identities=24% Similarity=0.369 Sum_probs=194.6
Q ss_pred cCccc-ceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEe
Q 004174 422 SNFLA-ENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 422 ~~f~~-~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
+.|.+ .+.||+|+||.||+|.. .+++.||||++.... .....+.+|+.++.++ +||||++++++|.+.+.+++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 45777 47899999999999985 478999999997543 4467889999999985 79999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCc---eEEccccccccc
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLAKWA 574 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~---vkL~DFGla~~~ 574 (770)
|+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++...
T Consensus 92 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999997643 58899999999999999999999 89999999999999988776 999999999765
Q ss_pred cCCCC-----CceecccccccCCCCceeecc-----CCCCCcceEeechHHHHHHHhCCCCCCCCCccchh---------
Q 004174 575 STSSS-----HITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE--------- 635 (770)
Q Consensus 575 ~~~~~-----~~~~~~~~GT~~YlAPE~~~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~--------- 635 (770)
..... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||.........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 111123469999999999975 56899999999999999999999999876433210
Q ss_pred ---hHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 636 ---SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 636 ---~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+... +..+.. .+..+.. .. ....+..++..||+.||.+||++.+++++
T Consensus 245 ~~~~~~~~----i~~~~~-~~~~~~~-~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFES----IQEGKY-EFPDKDW-AH----ISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHH----HHHCCC-CCCHHHH-TT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHH----HhccCc-ccCchhc-cc----CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000 000100 0000000 00 12345566778999999999999999984
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=352.98 Aligned_cols=245 Identities=29% Similarity=0.420 Sum_probs=198.3
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
+.|...+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+++++.++||||++++++|...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588899999999999999986 57899999998643 244567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+. |+|.+.+.... ..+++..+..++.|++.||.|||+ ++|+||||||+||||+.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 58888876433 368999999999999999999999 8999999999999999999999999999986643
Q ss_pred CCCCceecccccccCCCCceeec---cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
. ....||+.|+|||++. .+.++.++|||||||++|||++|+.||...........+ .. +.
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~--~~-----~~---- 269 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQ-----NE---- 269 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HH-----SC----
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--Hh-----cC----
Confidence 2 2357999999999985 567999999999999999999999999765432211111 10 00
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+.+...... ..+..++..||+.+|.+|||+.+++++
T Consensus 270 -~~~~~~~~~~---~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 270 -SPALQSGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp -CCCCCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -CCCCCCCCCC---HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0111111111 234456678999999999999999974
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=360.44 Aligned_cols=253 Identities=26% Similarity=0.378 Sum_probs=190.8
Q ss_pred hhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh---------hHHHHHHHHHHHHHhcCCCceeEEeeEEeec
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFED 489 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 489 (770)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... .....+.+|+.+|++++||||++++++|. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 457899999999999999999986 468999999986431 22335889999999999999999999985 4
Q ss_pred CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC---ceEEc
Q 004174 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLS 566 (770)
Q Consensus 490 ~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~---~vkL~ 566 (770)
+..++||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++ .+||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred CceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEe
Confidence 56899999999999999987543 58999999999999999999999 8999999999999997544 59999
Q ss_pred cccccccccCCCCCceecccccccCCCCceeec---cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcc
Q 004174 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 643 (770)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~ 643 (770)
|||+++....... .....||+.|+|||++. ...++.++|||||||+||+|++|+.||.......... ..
T Consensus 285 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~--~~--- 356 (419)
T 3i6u_A 285 DFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK--DQ--- 356 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH--HH---
T ss_pred ecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH--HH---
Confidence 9999987654322 23367999999999985 3678889999999999999999999997654322111 10
Q ss_pred cccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHh
Q 004174 644 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695 (770)
Q Consensus 644 ~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L 695 (770)
+..+.... .+..... ....+..++..||+.||.+||++.+++++-
T Consensus 357 -i~~~~~~~--~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 357 -ITSGKYNF--IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp -HHTTCCCC--CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred -HhcCCCCC--Cchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 01111000 0000011 123455666789999999999999999853
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=360.93 Aligned_cols=267 Identities=20% Similarity=0.254 Sum_probs=196.9
Q ss_pred HHhhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-------
Q 004174 418 LSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED------- 489 (770)
Q Consensus 418 ~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------- 489 (770)
....++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+|+.+++.++||||++++++|...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 34567899999999999999999986 5799999999875432 234699999999999999999998543
Q ss_pred -------------------------------CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 004174 490 -------------------------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538 (770)
Q Consensus 490 -------------------------------~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH 538 (770)
..+++||||++ |+|.+.+.........+++..+..++.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34889999998 4888877643223346899999999999999999999
Q ss_pred cCCCCceEEecccCCCeeeC-CCCceEEccccccccccCCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHH
Q 004174 539 SGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVL 616 (770)
Q Consensus 539 ~~~~~~IiHrDLKp~NILL~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL 616 (770)
+ ++|+||||||+|||++ .++.+||+|||+++........ ....||+.|+|||++.+. .++.++|||||||++
T Consensus 159 ~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 S---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp T---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred H---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9 8999999999999997 6889999999999876544332 235789999999998765 489999999999999
Q ss_pred HHHHhCCCCCCCCCccchhhHHHhhc------------ccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCC
Q 004174 617 LELLTGRKPISNDHPKGQESLVMWAK------------PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA 684 (770)
Q Consensus 617 ~eLltG~~Pf~~~~~~~~~~lv~~~~------------~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~ 684 (770)
|||++|+.||.+.....+...+.... +....-.+..+........++......+..++..||+.||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 99999999998765433222111100 000000011110000000011112234566677899999999
Q ss_pred CCCHHHHHHH
Q 004174 685 RPQMSLVLKL 694 (770)
Q Consensus 685 RPs~~eVL~~ 694 (770)
|||+.+++++
T Consensus 313 R~t~~e~l~h 322 (383)
T 3eb0_A 313 RINPYEAMAH 322 (383)
T ss_dssp SCCHHHHHTS
T ss_pred CCCHHHHhcC
Confidence 9999999873
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=378.73 Aligned_cols=253 Identities=25% Similarity=0.398 Sum_probs=199.3
Q ss_pred cCcccce-eecccCceEEEEEEeC---CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 422 SNFLAEN-LIGKGGSSQVYKGCLP---DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 422 ~~f~~~~-~LG~G~fG~Vy~a~~~---~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
+++.+.+ .||+|+||.||+|.+. ++..||||+++.. ....+.|.+|+.+|+.++||||++++++|.. +.++||
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4455555 8999999999999763 4667999999864 2456889999999999999999999999976 679999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++|+|.+++.... ..+++..+..|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 414 ~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EECCTTCBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEeCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 99999999999997543 468999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCce-ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 576 TSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 576 ~~~~~~~-~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
....... .....+|+.|+|||++..+.++.++|||||||+||||++ |+.||...........+. .+...
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-------~~~~~-- 558 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGKRM-- 558 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-------TTCCC--
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCCCC--
Confidence 4332211 112346789999999999999999999999999999998 999998765433222111 11100
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
..+......+..++..||+.+|.+||++.+|++.|+.
T Consensus 559 -------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 559 -------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp -------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred -------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 0111122445567778999999999999999999863
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.41 Aligned_cols=245 Identities=26% Similarity=0.435 Sum_probs=200.1
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEee-----------
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----------- 488 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----------- 488 (770)
.++|.+.+.||+|+||.||+|... +|+.||||+++... ..+.+|++++..++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 457899999999999999999975 79999999997654 356789999999999999999999864
Q ss_pred -----cCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCce
Q 004174 489 -----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (770)
Q Consensus 489 -----~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~v 563 (770)
...+++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCE
Confidence 4458999999999999999975432 358999999999999999999999 899999999999999999999
Q ss_pred EEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcc
Q 004174 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 643 (770)
Q Consensus 564 kL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~ 643 (770)
||+|||++......... ....||+.|+|||++....++.++||||||+++|+|++|..||... .....
T Consensus 162 kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~---- 229 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFFT---- 229 (284)
T ss_dssp EECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHHH----
T ss_pred EECcchhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHHH----
Confidence 99999999876554322 2357999999999999989999999999999999999999887421 11110
Q ss_pred cccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 644 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 644 ~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+..+. +...++ ..+..++..||+.||.+||++.+++++|..
T Consensus 230 ~~~~~~--------~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 230 DLRDGI--------ISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp HHHTTC--------CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Hhhccc--------ccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 011111 111122 234456678999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=367.88 Aligned_cols=251 Identities=26% Similarity=0.365 Sum_probs=200.2
Q ss_pred hhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--------------hHHHHHHHHHHHHHhcCCCceeEEee
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--------------DVIKEFVLEIEIITTLHHKNIISLLG 484 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--------------~~~~~~~~Ei~iL~~l~HpnIv~l~~ 484 (770)
..++|.+.+.||+|+||+||+|... +++.||||+++... ...+.+.+|+.+|+.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3568999999999999999999864 68899999987532 23567899999999999999999999
Q ss_pred EEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC---
Q 004174 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF--- 561 (770)
Q Consensus 485 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~--- 561 (770)
+|.+...+++||||+++|+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999987543 58999999999999999999999 8999999999999998776
Q ss_pred ceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhh
Q 004174 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 641 (770)
Q Consensus 562 ~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~ 641 (770)
.+||+|||++........ .....||+.|+|||++. +.++.++|||||||++|+|++|+.||...........+...
T Consensus 187 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 262 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262 (504)
T ss_dssp SEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred cEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 699999999987755432 23357999999999987 57999999999999999999999999876543322222111
Q ss_pred cccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 642 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 642 ~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
...+ +....... ...+..++..||+.||.+|||+.+++++
T Consensus 263 ~~~~---------~~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 263 KYYF---------DFNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCCC---------CHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCC---------CccccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1000 00000011 1234556678999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=345.77 Aligned_cols=258 Identities=21% Similarity=0.281 Sum_probs=196.8
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++..++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999864 6889999999753 23457899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999997543 58999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
..... ......||+.|+|||++....++.++||||||+++|||++|+.||...........+ .... ....
T Consensus 186 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~---~~~~--- 255 (309)
T 2h34_A 186 DEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI---NQAI---PRPS--- 255 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH---HSCC---CCGG---
T ss_pred ccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh---ccCC---CCcc---
Confidence 43221 122357999999999999899999999999999999999999999765432111111 1000 0000
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCC-CHHHHHHHhhCCCC
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARP-QMSLVLKLLRGDAD 700 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RP-s~~eVL~~L~~~~~ 700 (770)
.+...++ ..+..++..||+.||.+|| ++.++++.|+....
T Consensus 256 -~~~~~~~----~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 256 -TVRPGIP----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp -GTSTTCC----THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred -ccCCCCC----HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 0111112 2344566789999999999 89999999875543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=362.87 Aligned_cols=201 Identities=27% Similarity=0.374 Sum_probs=178.1
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhc------CCCceeEEeeEEeecCceE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL------HHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l------~HpnIv~l~~~~~~~~~~~ 493 (770)
..+|.+.+.||+|+||.||+|... +++.||||+++........+.+|+.++..+ +|+||++++++|...+.++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 356899999999999999999864 688999999998877778889999999888 5679999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCc--eEEcccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--PQLSDFGLA 571 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~--vkL~DFGla 571 (770)
+||||+. ++|.+++..... ..+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++. +||+|||++
T Consensus 176 lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 9999996 699999876543 358999999999999999999999 89999999999999999887 999999999
Q ss_pred ccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCcc
Q 004174 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (770)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~ 632 (770)
....... ....||+.|+|||++.+..++.++|||||||+||||++|+.||...+..
T Consensus 250 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 250 CYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp EETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 7654332 2357999999999999999999999999999999999999999876543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=339.69 Aligned_cols=247 Identities=28% Similarity=0.464 Sum_probs=203.8
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
+.|.+.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++..++||||++++++|...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4588899999999999999986 46899999999754 34567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++++|.+++.. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999864 258999999999999999999999 899999999999999999999999999998765432
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
.. .....||+.|+|||++....++.++||||||+++|+|++|+.||...........+. .+. .+.+
T Consensus 174 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~-----~~~~ 239 (303)
T 3a7i_A 174 IK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-------KNN-----PPTL 239 (303)
T ss_dssp CC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-------HSC-----CCCC
T ss_pred cc--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh-------cCC-----CCCC
Confidence 22 223579999999999999999999999999999999999999997654322111111 011 1111
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
...++ ..+..++..||+.+|.+||++.+++++
T Consensus 240 ~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EGNYS----KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSSCC----HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccccC----HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11222 235556678999999999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=352.75 Aligned_cols=261 Identities=25% Similarity=0.377 Sum_probs=203.5
Q ss_pred cCcccceeecccCceEEEEEEe-----CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecC--ceE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NLL 493 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-----~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~~~ 493 (770)
++|.+.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4688999999999999999983 468899999997643 55678999999999999999999999987654 789
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+||||+++++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 121 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999997653 358999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCce-ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCcc---------chhhHHHhhcc
Q 004174 574 ASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK---------GQESLVMWAKP 643 (770)
Q Consensus 574 ~~~~~~~~~-~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~---------~~~~lv~~~~~ 643 (770)
......... .....+|..|+|||++....++.++|||||||++|||+||..||...... ...........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 765433211 12245778899999999889999999999999999999999998642100 00000000000
Q ss_pred cccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 644 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 644 ~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+..+. ....+......+..++..||+.+|.+||++.+|++.|+.
T Consensus 275 ~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 275 LLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HhhcCC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111110 001111222445667778999999999999999998864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=341.98 Aligned_cols=249 Identities=29% Similarity=0.444 Sum_probs=195.4
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-CceEEEEeec
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED-NNLLLVYDFL 499 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-~~~~LV~E~~ 499 (770)
.++|.+.+.||+|+||.||+|.. .|+.||||+++... ..+.+.+|+.++..++||||+++++++.+. +..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 46789999999999999999987 58899999998653 457889999999999999999999997654 4789999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++|+|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 172 (278)
T 1byg_A 98 AKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 172 (278)
T ss_dssp TTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccccc
Confidence 99999999975421 237899999999999999999999 8999999999999999999999999999976544221
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
...+|+.|+|||++....++.++||||||+++|+|++ |+.||...........+ ..+. ....
T Consensus 173 -----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~-------~~~~-----~~~~ 235 (278)
T 1byg_A 173 -----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKGY-----KMDA 235 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-------TTTC-----CCCC
T ss_pred -----CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------hcCC-----CCCC
Confidence 2367899999999999999999999999999999998 99999765432221111 1110 0111
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
... ....+..++..||+.||.+||++.++++.|+.
T Consensus 236 ~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 236 PDG----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccc----CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 111 12345556678999999999999999998864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=354.68 Aligned_cols=271 Identities=20% Similarity=0.238 Sum_probs=192.9
Q ss_pred HHHhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc----
Q 004174 417 LLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN---- 491 (770)
Q Consensus 417 l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~---- 491 (770)
.....++|.+.+.||+|+||.||+|... +|+.||||++.........+.+|+..+..++||||++++++|...+.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 3455678999999999999999999874 68999999987665555677888999999999999999999976544
Q ss_pred ---eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCceEEecccCCCeeeCC-CCceEE
Q 004174 492 ---LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH--SGSAQRVIHRDVKSSNILLSD-DFEPQL 565 (770)
Q Consensus 492 ---~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH--~~~~~~IiHrDLKp~NILL~~-~~~vkL 565 (770)
+++||||+++ +|.+.+.........+++..+..++.|++.||.||| + ++|+||||||+||||+. ++.+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEE
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEE
Confidence 8899999986 555554432222346889999999999999999999 7 89999999999999986 899999
Q ss_pred ccccccccccCCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhccc
Q 004174 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 644 (770)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~ 644 (770)
+|||+++........ ....||+.|+|||++... .++.++|||||||++|||++|+.||...........+......
T Consensus 174 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp CCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 999999876554332 235789999999998755 4899999999999999999999999876543322221110000
Q ss_pred c---------cCCccccccC------cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 645 L---------SSGKVTQLLD------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 645 ~---------~~g~l~~lld------~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. .......+.+ ..+...........+..++..||+.||.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 0000000000 000011111234556677788999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=367.37 Aligned_cols=193 Identities=23% Similarity=0.372 Sum_probs=154.7
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-----Cc
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 491 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~ 491 (770)
.++|.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.+|..++||||++++++|... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367999999999999999999864 7899999998653 34567899999999999999999999999543 56
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 571 (770)
+|+||||+ +|+|.+++... ..+++..++.++.||+.||.|||+ ++||||||||+||||+.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 56999998754 358999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC-------------------------ceecccccccCCCCceee-ccCCCCCcceEeechHHHHHHHh
Q 004174 572 KWASTSSSH-------------------------ITCTDVAGTFGYLAPEYF-MYGKVNDKIDVYAFGVVLLELLT 621 (770)
Q Consensus 572 ~~~~~~~~~-------------------------~~~~~~~GT~~YlAPE~~-~~~~~s~ksDVwSlGvvL~eLlt 621 (770)
+........ ...+..+||+.|+|||++ ....|+.++|||||||+||||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 876532211 122346789999999986 45679999999999999999999
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=354.30 Aligned_cols=261 Identities=16% Similarity=0.251 Sum_probs=201.6
Q ss_pred hcCcccceeecccCceEEEEEEeCC---------CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeE----------
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPD---------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS---------- 481 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~---------g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~---------- 481 (770)
.++|.+.+.||+|+||.||+|.... ++.||||++... +.+.+|++++..++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 3679999999999999999998753 789999999755 46788999999999999987
Q ss_pred -----EeeEEee-cCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCe
Q 004174 482 -----LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 555 (770)
Q Consensus 482 -----l~~~~~~-~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NI 555 (770)
+++++.. ++..++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NI 190 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENI 190 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHE
Confidence 6777776 67889999999 9999999986521 358999999999999999999999 8999999999999
Q ss_pred eeCCCC--ceEEccccccccccCCCCCc-----eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCC
Q 004174 556 LLSDDF--EPQLSDFGLAKWASTSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628 (770)
Q Consensus 556 LL~~~~--~vkL~DFGla~~~~~~~~~~-----~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~ 628 (770)
|++.++ .+||+|||+++......... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 89999999998765432211 11235799999999999998999999999999999999999999986
Q ss_pred CCccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 629 DHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 629 ~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
....... +........ .....+.+........ ...+..++..||+.||.+||++.+|++.|+.
T Consensus 271 ~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 271 CLPNTED-IMKQKQKFV--DKPGPFVGPCGHWIRP---SETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp GTTCHHH-HHHHHHHHH--HSCCCEECTTSCEECC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred CCcCHHH-HHHHHHhcc--CChhhhhhhccccCCC---cHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 5432211 111111000 1111222211111111 2345556678999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=342.24 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=200.4
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
.++|.+.+.||+|+||.||++... +|+.||||+++... ...+.+.+|+.++..++||||++++++|.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 457899999999999999999864 78999999997654 3345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee---CCCCceEEcccccccccc
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL---~~~~~vkL~DFGla~~~~ 575 (770)
+++++|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999987543 58899999999999999999999 899999999999999 788999999999997554
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
... .....||+.|+|||++....++.++|||||||++|+|++|+.||...........+. .+.. .+ .
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~-------~~~~-~~-~ 227 (304)
T 2jam_A 161 NGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIK-------EGYY-EF-E 227 (304)
T ss_dssp CBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-------HCCC-CC-C
T ss_pred CCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------cCCC-CC-C
Confidence 321 123579999999999999999999999999999999999999997654322111111 0100 00 0
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
...... ....+..++..||+.||.+||++.+++++
T Consensus 228 ~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 228 SPFWDD----ISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTTTTT----SCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccc----CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011111 12345556678999999999999999973
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=356.39 Aligned_cols=255 Identities=26% Similarity=0.363 Sum_probs=201.3
Q ss_pred hcCcccceeecccCceEEEEEEe----CCCCEEEEEEeCCCh-----hHHHHHHHHHHHHHhc-CCCceeEEeeEEeecC
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 490 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~----~~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 490 (770)
.++|.+.+.||+|+||.||++.. .+|+.||||+++... ...+.+.+|+.+|..+ +||||++++++|...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35789999999999999999986 478999999997532 2345677899999999 6999999999999999
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 570 (770)
.++|||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999999997543 58899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCceeeccC--CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 648 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~--~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 648 (770)
++........ ......||+.|+|||++..+ .++.++|||||||+||||++|+.||...........+. ......
T Consensus 206 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~~~~~- 281 (355)
T 1vzo_A 206 SKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRILKS- 281 (355)
T ss_dssp EEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHHHC-
T ss_pred CeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH--HHHhcc-
Confidence 9865433222 12336799999999999853 47899999999999999999999997654332211111 100000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHHhh
Q 004174 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKLLR 696 (770)
Q Consensus 649 ~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~L~ 696 (770)
.+.+ +......+..++..||+.||.+|| ++.+++++..
T Consensus 282 ------~~~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 282 ------EPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp ------CCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred ------CCCC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 0111 111123445566789999999999 9999998654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=363.73 Aligned_cols=242 Identities=13% Similarity=0.186 Sum_probs=188.1
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCC----ChhHHHHHHHHHH---HHHhcCCCceeEEe-------eE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP----SEDVIKEFVLEIE---IITTLHHKNIISLL-------GF 485 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~----~~~~~~~~~~Ei~---iL~~l~HpnIv~l~-------~~ 485 (770)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.. .....+.+.+|+. +|+.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788999999999999999996 5699999999863 3356678999994 55556899999998 66
Q ss_pred EeecC-----------------ceEEEEeecCCCChhhhhccCCCC---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCce
Q 004174 486 CFEDN-----------------NLLLVYDFLSRGSLEENLHGNKKD---PAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545 (770)
Q Consensus 486 ~~~~~-----------------~~~LV~E~~~ggsL~~~l~~~~~~---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~I 545 (770)
+...+ ..||||||+ +|+|.+++...... ...+++..++.|+.||+.||.|||+ ++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 55443 389999999 67999999754211 1234568888999999999999999 899
Q ss_pred EEecccCCCeeeCCCCceEEccccccccccCCCCCceecccccccCCCCceeeccC-----------CCCCcceEeechH
Q 004174 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----------KVNDKIDVYAFGV 614 (770)
Q Consensus 546 iHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~-----------~~s~ksDVwSlGv 614 (770)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++... .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999985432 2234578 999999999987 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 615 VLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 615 vL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
+||||++|+.||...........+ ... ....+ ..+..++..||+.||.+||++.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~---------------~~~--~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWI---------------FRS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGG---------------GSS--CCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccchhhh---------------hhh--ccCCC----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999765432211110 000 01112 23455667899999999999999987
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=339.75 Aligned_cols=245 Identities=25% Similarity=0.382 Sum_probs=201.6
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|++++..++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57899999999999999999875 57889999986432 23467889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999997643 48899999999999999999999 8999999999999999999999999999976544
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.. .. .
T Consensus 167 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-------~~------~ 229 (284)
T 2vgo_A 167 LRR----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN-------VD------L 229 (284)
T ss_dssp SCB----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-------TC------C
T ss_pred ccc----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc-------cc------c
Confidence 221 235799999999999999999999999999999999999999976543222111110 00 0
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+.... ...+..++..||+.+|.+||++.+++++
T Consensus 230 ~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 230 KFPPFL----SDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred CCCCcC----CHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 111111 2334556678999999999999999863
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=342.97 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=185.1
Q ss_pred hhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh--hH-HHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--DV-IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~--~~-~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
..++|.+.+.||+|+||.||+|.. .+|+.||||+++... .. .+.+..+...++.++||||++++++|.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 356899999999999999999986 578999999997642 22 33344555568888999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-ceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
|||+++ +|.+++.........+++..++.++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999975 8888776432233468999999999999999999998 7 8999999999999999999999999999876
Q ss_pred cCCCCCceecccccccCCCCceee----ccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYF----MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~----~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 650 (770)
...... ....||+.|+|||++ ....++.++|||||||++|+|++|+.||......... +..... ...
T Consensus 161 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~----~~~- 231 (290)
T 3fme_A 161 VDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-LKQVVE----EPS- 231 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-HHHHHH----SCC-
T ss_pred cccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-HHHHhc----cCC-
Confidence 553322 224799999999996 4567899999999999999999999999754322111 111111 000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 651 ~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
+.... ......+..++..||+.+|.+|||+.++++
T Consensus 232 -----~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 -----PQLPA---DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -----CCCCT---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCccc---ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 00100 111234556667899999999999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=348.47 Aligned_cols=261 Identities=25% Similarity=0.429 Sum_probs=200.6
Q ss_pred cCHHHHHHhhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEee-
Q 004174 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE- 488 (770)
Q Consensus 412 f~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~- 488 (770)
+++.++....++|.+.+.||+|+||.||+|.. .+|+.||||++.........+.+|+.++..+ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 34445555678999999999999999999986 4789999999987655667889999999999 79999999999987
Q ss_pred -----cCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCce
Q 004174 489 -----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (770)
Q Consensus 489 -----~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~v 563 (770)
.+.+++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCE
Confidence 4678999999999999999976432 358899999999999999999999 899999999999999999999
Q ss_pred EEccccccccccCCCCCceecccccccCCCCceeec-----cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHH
Q 004174 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (770)
Q Consensus 564 kL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv 638 (770)
||+|||++......... .....||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+
T Consensus 169 kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 246 (326)
T ss_dssp EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred EEeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence 99999999866543221 12357999999999987 567899999999999999999999999765432221111
Q ss_pred HhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 639 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 639 ~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. . +....+.. ..+ ...+..++..||..||.+||++.+++++
T Consensus 247 ~--~-----~~~~~~~~----~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 247 P--R-----NPAPRLKS----KKW----SKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp H--H-----SCCCCCSC----SCS----CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred h--c-----CccccCCc----ccc----CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1 0 00011111 111 1244556678999999999999999973
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=339.14 Aligned_cols=246 Identities=26% Similarity=0.386 Sum_probs=196.4
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcCCCceeEEeeEEee----cCceEE
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLL 494 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~L 494 (770)
.|.+.+.||+|+||.||+|.. .++..||+|++.. .....+.+.+|+.+++.++||||++++++|.. ...+++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 477888999999999999986 4688999999864 34556789999999999999999999999876 345899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc--eEEecccCCCeeeC-CCCceEEcccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLS-DDFEPQLSDFGLA 571 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--IiHrDLKp~NILL~-~~~~vkL~DFGla 571 (770)
||||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 999999999999997643 58899999999999999999999 66 99999999999997 7899999999999
Q ss_pred ccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
........ ....||+.|+|||++. +.++.++|||||||++|+|++|+.||........ +..... .+...
T Consensus 180 ~~~~~~~~----~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~----~~~~~ 248 (290)
T 1t4h_A 180 TLKRASFA----KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVT----SGVKP 248 (290)
T ss_dssp GGCCTTSB----EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHT----TTCCC
T ss_pred cccccccc----ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH--HHHHHh----ccCCc
Confidence 76544321 2357999999999886 5699999999999999999999999976443221 111111 11101
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..++ ... ...+..++..||+.||.+||++.+++++
T Consensus 249 ~~~~----~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 249 ASFD----KVA----IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGGG----GCC----CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccC----CCC----CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111 111 1235566678999999999999999974
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=357.18 Aligned_cols=252 Identities=13% Similarity=0.080 Sum_probs=180.5
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhc--CCCceeEEe-------eEEe
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL--HHKNIISLL-------GFCF 487 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l--~HpnIv~l~-------~~~~ 487 (770)
.+|.+.+.||+|+||.||+|.+. +|+.||||+++... ...+.+.+|+.++..| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45888999999999999999964 78999999998632 4456777886555555 699988855 4443
Q ss_pred ec-----------------CceEEEEeecCCCChhhhhccCCCCCCCCCHHHH------HHHHHHHHHHHHHHHcCCCCc
Q 004174 488 ED-----------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHSGSAQR 544 (770)
Q Consensus 488 ~~-----------------~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~------~~i~~qia~aL~yLH~~~~~~ 544 (770)
.. ..++|||||++ |+|.+++..... .+.+..+ ..++.||+.||.|||+ ++
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS---KG 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH---CC
Confidence 32 23799999998 899999976432 3455666 7788999999999999 89
Q ss_pred eEEecccCCCeeeCCCCceEEccccccccccCCCCCceecccccccCCCCceeecc--CCCCCcceEeechHHHHHHHhC
Q 004174 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTG 622 (770)
Q Consensus 545 IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~--~~~s~ksDVwSlGvvL~eLltG 622 (770)
|+||||||+||||+.++.+||+|||+++...... ....+|+.|+|||++.. ..++.++|||||||+||||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998664321 13467799999999987 6799999999999999999999
Q ss_pred CCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 623 RKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 623 ~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
+.||....+..... |............+..+. .......+..++..||+.||.+||++.++++
T Consensus 290 ~~Pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGS---WKRPSLRVPGTDSLAFGS-----CTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTC---CCBCCTTSCCCCSCCCTT-----SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccc---hhhhhhhhccccccchhh-----ccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99998764432111 111000000000000010 0112234555667899999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=339.67 Aligned_cols=248 Identities=25% Similarity=0.393 Sum_probs=203.4
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.+.||+|+||.||++... +++.+|+|++... ....+.+.+|+.+++.++||||++++++|.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357889999999999999999875 5889999998643 34567889999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++++|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999886543 58999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
..... .....||+.|+|||++....++.++||||||+++|+|++|+.||...........+.. +..
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------~~~----- 232 (294)
T 2rku_A 167 YDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK-------NEY----- 232 (294)
T ss_dssp STTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-------TCC-----
T ss_pred cCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh-------ccC-----
Confidence 43222 2235799999999999988899999999999999999999999976543221111110 000
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+....+ ..+..++..||+.||.+||++.+++++
T Consensus 233 -~~~~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 -SIPKHIN----PVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -CCCTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -CCccccC----HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0111111 234556678999999999999998863
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=348.55 Aligned_cols=262 Identities=23% Similarity=0.343 Sum_probs=198.4
Q ss_pred cccCHHHHHHhhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcC--CCceeEEee
Q 004174 410 RLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLH--HKNIISLLG 484 (770)
Q Consensus 410 ~~f~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~--HpnIv~l~~ 484 (770)
+.|.++.+....++|.+.+.||+|+||.||++...+++.||||++.. .....+.+.+|+.++..++ ||||+++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 34445555556778999999999999999999988899999999964 3456678999999999997 599999999
Q ss_pred EEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceE
Q 004174 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (770)
Q Consensus 485 ~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vk 564 (770)
++...+..++||| +.+++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||+++ +.+|
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~k 166 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLK 166 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEE
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEE
Confidence 9999999999999 56889999997643 58899999999999999999999 89999999999999964 8999
Q ss_pred EccccccccccCCCCCceecccccccCCCCceeecc-----------CCCCCcceEeechHHHHHHHhCCCCCCCCCccc
Q 004174 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-----------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (770)
Q Consensus 565 L~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~-----------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 633 (770)
|+|||++................||+.|+|||++.. ..++.++|||||||++|||++|+.||.......
T Consensus 167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (313)
T 3cek_A 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246 (313)
T ss_dssp ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH
Confidence 999999987655433333334579999999999875 478889999999999999999999997543221
Q ss_pred hhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 634 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 634 ~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+.... ++.....++......+..++..||+.||.+||++.+++++
T Consensus 247 -~~~~~~~-------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 247 -SKLHAII-------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -HHHHHHH-------------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHH-------------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1111111 1111111111112345556678999999999999999973
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=366.42 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=197.5
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
.+.|.+.+.||+|+||+||+|... ++..||||+++... .....+.+|+.+++.++||||++++++|.+.+.+++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 346889999999999999999875 78899999997532 33567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC---CceEEcccccccc
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKW 573 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~---~~vkL~DFGla~~ 573 (770)
||+++|+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.. +.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999887543 58999999999999999999999 899999999999999764 4599999999987
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
...... .....||+.|+|||++. +.|+.++|||||||++|+|++|+.||...........+......+
T Consensus 189 ~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-------- 256 (494)
T 3lij_A 189 FENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF-------- 256 (494)
T ss_dssp CBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--------
T ss_pred CCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------
Confidence 654332 23367999999999886 679999999999999999999999998765433222221111100
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+.. ... ...+..++..||+.+|.+|||+.+++++
T Consensus 257 ~~~~~-~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 257 DSPEW-KNV----SEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CSGGG-TTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred Cchhc-ccC----CHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 00110 011 1234456678999999999999999863
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=353.32 Aligned_cols=272 Identities=21% Similarity=0.272 Sum_probs=199.8
Q ss_pred CHHHHHHhhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCC------------hhHHHHHHHHHHHHHhcCCCcee
Q 004174 413 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS------------EDVIKEFVLEIEIITTLHHKNII 480 (770)
Q Consensus 413 ~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~------------~~~~~~~~~Ei~iL~~l~HpnIv 480 (770)
...++....++|.+.+.||+|+||.||+|...+|+.||||++... ....+.+.+|+.++..++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 356778889999999999999999999999888999999998531 22347899999999999999999
Q ss_pred EEeeEEeec-----CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCe
Q 004174 481 SLLGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 555 (770)
Q Consensus 481 ~l~~~~~~~-----~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NI 555 (770)
+++++|... ..+++||||+. |+|.+.+.... ..+++..+..++.||+.||.|||+ ++|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHE
Confidence 999999543 35899999997 58888887543 368999999999999999999999 8999999999999
Q ss_pred eeCCCCceEEccccccccccCCCCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccch
Q 004174 556 LLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (770)
Q Consensus 556 LL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~ 634 (770)
|++.++.+||+|||++......... ....||+.|+|||++.. ..++.++|||||||++|+|++|+.||........
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADANK---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEcCCCCEEEEecCccccccccccc---ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999755443222 23579999999999886 6799999999999999999999999987553322
Q ss_pred hhHH-Hhhccc-------ccCCccccccCcccCCCC-------ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 635 ESLV-MWAKPI-------LSSGKVTQLLDPALGNNY-------DYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 635 ~~lv-~~~~~~-------~~~g~l~~lld~~l~~~~-------~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
...+ ...... .........+...+.... .......+..++..||+.||.+|||+.+++++
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1111 100000 000000001111110000 01112335566778999999999999999974
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=367.46 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=202.7
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.+.||+|+||.||+|... +|+.||||++... ......+.+|+.+++.++||||++++++|.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 456899999999999999999875 7899999998643 24567899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee---CCCCceEEccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAK 572 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL---~~~~~vkL~DFGla~ 572 (770)
|||+.+|+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++.
T Consensus 105 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999987543 58999999999999999999999 899999999999999 567899999999998
Q ss_pred cccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 573 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........+.. +....
T Consensus 178 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-------~~~~~ 246 (484)
T 3nyv_A 178 HFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK-------GKYTF 246 (484)
T ss_dssp HBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CCCCC
T ss_pred Ecccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-------CCCCC
Confidence 7755432 223579999999999874 799999999999999999999999987654332222211 11000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+.. ......+..++..||+.+|.+|||+.+++++
T Consensus 247 -~~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 247 -ELPQW-----KKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -CSGGG-----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00000 0112344556678999999999999999973
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=365.42 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=200.0
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
.++|.+.+.||+|+||+||+|... +++.||||++... ......+.+|+++++.++||||++++++|.+.+.+++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 356889999999999999999864 7899999998642 234577899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC---CCCceEEcccccccc
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKW 573 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~---~~~~vkL~DFGla~~ 573 (770)
||+.+|+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999887543 58999999999999999999999 8999999999999995 456799999999987
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
...... .....||+.|+|||++. +.|+.++|||||||++|+|++|+.||...........+... .....
T Consensus 174 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-------~~~~~ 242 (486)
T 3mwu_A 174 FQQNTK---MKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG-------KYAFD 242 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGG-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------CCCSC
T ss_pred CCCCCc---cCCCcCCCCCCCHHHhC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------CCCCC
Confidence 654322 23357999999999987 46999999999999999999999999876543322221111 10000
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. +.. ......+..++..||+.+|.+|||+.+++++
T Consensus 243 ~-~~~-----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 L-PQW-----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp S-GGG-----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred C-ccc-----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 000 0111234556678999999999999999984
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=352.19 Aligned_cols=209 Identities=24% Similarity=0.329 Sum_probs=179.9
Q ss_pred HHHHHhhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CC-----ceeEEeeEEe
Q 004174 415 QDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HK-----NIISLLGFCF 487 (770)
Q Consensus 415 ~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-Hp-----nIv~l~~~~~ 487 (770)
.......++|.+.+.||+|+||.||+|... +++.||||+++........+..|+.++..++ |+ +|++++++|.
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 333445678999999999999999999864 6889999999987777788889999999885 54 4999999999
Q ss_pred ecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC--CCCceEE
Q 004174 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQL 565 (770)
Q Consensus 488 ~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~--~~~~vkL 565 (770)
..+..++||||+. |+|.+++..... ..+++..++.++.|++.||.|||... .+|+||||||+||||+ .++.+||
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEE
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEE
Confidence 9999999999996 599999976542 35899999999999999999999522 7899999999999994 5778999
Q ss_pred ccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCcc
Q 004174 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (770)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~ 632 (770)
+|||+++...... ....||+.|+|||++.+..++.++|||||||+||||++|+.||...+..
T Consensus 203 ~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 203 VDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp CCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999998765432 2357999999999999999999999999999999999999999876543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=363.36 Aligned_cols=262 Identities=23% Similarity=0.276 Sum_probs=193.9
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC------ceEEE
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------NLLLV 495 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------~~~LV 495 (770)
+|.+.+.||+|+||.||+|.+. +|+.||||++..... .+.+|+++|+.++||||++++++|.... .+++|
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 5888999999999999999974 689999999875432 2346999999999999999999986532 36799
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC-CceEEccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWA 574 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~-~~vkL~DFGla~~~ 574 (770)
|||+++ +|.+.+.........+++..++.++.||+.||.|||+ ++|+||||||+||||+.+ +.+||+|||+++..
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999976 6776665322223468999999999999999999999 899999999999999955 56899999999876
Q ss_pred cCCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhccccc-------
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS------- 646 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~------- 646 (770)
...... ....||+.|+|||++.+. .|+.++|||||||+||||++|+.||.+.+...+...+........
T Consensus 208 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 208 VRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred ccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 543322 235799999999998765 799999999999999999999999987654332221111000000
Q ss_pred CCccccccCcccCCC-----CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 647 SGKVTQLLDPALGNN-----YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 647 ~g~l~~lld~~l~~~-----~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
......+.-+.+... +.......+..++..||+.||.+||++.+++++
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 001111111111000 111112345667778999999999999999974
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=343.99 Aligned_cols=265 Identities=28% Similarity=0.438 Sum_probs=186.5
Q ss_pred hhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
..++|.+.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++..++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 457899999999999999999986 47899999998754 244567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 497 DFLSRGSLEENLHGN----KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 497 E~~~ggsL~~~l~~~----~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
||+++++|.+++... ......+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998631 1122468999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC---ceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC
Q 004174 573 WASTSSSH---ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 648 (770)
Q Consensus 573 ~~~~~~~~---~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 648 (770)
........ .......||+.|+|||++.. ..++.++|||||||++|||++|+.||................+ ..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~ 246 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP---PS 246 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC---CC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC---Cc
Confidence 66543211 11223579999999999875 5689999999999999999999999987654332211110000 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
......++.+...++ ..+..++..||+.||.+||++.+++++
T Consensus 247 ~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 247 LETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000111111112222 344556678999999999999999873
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=338.63 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=198.6
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-----hHHHHHHHHHHHHHhcCCCceeEEeeEEe--ecCce
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCF--EDNNL 492 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--~~~~~ 492 (770)
.++|.+.+.||+|+||.||++... +++.||||+++... .....+.+|+.+++.++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999864 68899999997532 34578999999999999999999999984 45689
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
++||||++++ |.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 7777765432 468999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCceecccccccCCCCceeeccCC--CCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcc
Q 004174 573 WASTSSSHITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650 (770)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~--~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 650 (770)
...............||+.|+|||++.... ++.++|||||||++|||++|+.||...........+.. +..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~-------~~~ 230 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK-------GSY 230 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------CCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc-------CCC
Confidence 775544334444567999999999987644 47799999999999999999999986543222111110 100
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 651 ~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+.... ...+..++..||+.||.+||++.+++++
T Consensus 231 ------~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ------AIPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ------CCCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------CCCCcc----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011111 2234556678999999999999999974
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=347.30 Aligned_cols=247 Identities=25% Similarity=0.396 Sum_probs=203.3
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|+.+++.++||||++++++|.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357889999999999999999875 5789999998643 34567889999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999987543 58999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
..... .....||+.|+|||++....++.++|||||||++|+|++|+.||...........+... .
T Consensus 193 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------~------ 257 (335)
T 2owb_A 193 YDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------E------ 257 (335)
T ss_dssp STTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-------C------
T ss_pred cCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC-------C------
Confidence 43222 22357999999999999889999999999999999999999999765432221111110 0
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
..+....+ ..+..++..||+.||.+||++.++++
T Consensus 258 ~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 258 YSIPKHIN----PVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CCCCTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCCccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111111 23445667899999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=352.75 Aligned_cols=259 Identities=22% Similarity=0.316 Sum_probs=195.2
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC------
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 490 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------ 490 (770)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.. .....+.+.+|+.+|+.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46799999999999999999986 4799999999964 2345678899999999999999999999997653
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 570 (770)
.+|+||||+ +++|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 88999998752 48899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccc----
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL---- 645 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~---- 645 (770)
++...... ....||+.|+|||++.. ..++.++|||||||++|||++|+.||.+.+...+...+.......
T Consensus 175 a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 175 ARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccccc-----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 98765422 23578999999999886 679999999999999999999999998765433322221110000
Q ss_pred ----cCCc-------cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 646 ----SSGK-------VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 646 ----~~g~-------l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.... +.......+.. ........+..++..||+.||.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000 00000000000 001112345556678999999999999999984
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=336.62 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=201.6
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----------hHHHHHHHHHHHHHhcC-CCceeEEeeEEee
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----------DVIKEFVLEIEIITTLH-HKNIISLLGFCFE 488 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----------~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~ 488 (770)
.++|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.++.++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 468999999999999999999874 68899999996432 23567889999999996 9999999999999
Q ss_pred cCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccc
Q 004174 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (770)
Q Consensus 489 ~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 568 (770)
.+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecc
Confidence 999999999999999999997542 58999999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCCceecccccccCCCCceeec------cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhc
Q 004174 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFM------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 642 (770)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~GT~~YlAPE~~~------~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~ 642 (770)
|++......... ....||+.|+|||++. ...++.++||||||+++|+|++|+.||...........+..
T Consensus 169 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-- 243 (298)
T 1phk_A 169 GFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS-- 243 (298)
T ss_dssp TTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--
T ss_pred cchhhcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc--
Confidence 999876543322 2357999999999985 45688999999999999999999999976543221111110
Q ss_pred ccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 643 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 643 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
+... ...+. .......+..++..||+.||.+||++.++++
T Consensus 244 -----~~~~-~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 244 -----GNYQ-FGSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -----TCCC-CCTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -----CCcc-cCccc-----ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1000 00000 0112234556667899999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=346.46 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=182.0
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC-hhHHHHHHHHHHHHHhcC-CCceeEEeeEEee--------c
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS-EDVIKEFVLEIEIITTLH-HKNIISLLGFCFE--------D 489 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~--------~ 489 (770)
..+|.+.+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+.++..+. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 45789999999999999999986 47899999988644 355678899999999996 9999999999943 3
Q ss_pred CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc--eEEecccCCCeeeCCCCceEEcc
Q 004174 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFEPQLSD 567 (770)
Q Consensus 490 ~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--IiHrDLKp~NILL~~~~~vkL~D 567 (770)
..+++||||+. |+|.+++..... ...+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEec
Confidence 45899999995 699998865221 1358999999999999999999999 77 99999999999999999999999
Q ss_pred ccccccccCCCCCc----------eecccccccCCCCceee---ccCCCCCcceEeechHHHHHHHhCCCCCCCCCccch
Q 004174 568 FGLAKWASTSSSHI----------TCTDVAGTFGYLAPEYF---MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (770)
Q Consensus 568 FGla~~~~~~~~~~----------~~~~~~GT~~YlAPE~~---~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~ 634 (770)
||+++......... ......||+.|+|||++ ....++.++|||||||++|+|++|+.||.......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~- 260 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR- 260 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence 99998765432211 01134699999999998 56678999999999999999999999997543211
Q ss_pred hhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 635 ESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 635 ~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+.. +.... ..... .. ..+..++..||+.+|.+||++.++++.|+.
T Consensus 261 --~~~--------~~~~~----~~~~~-~~---~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 261 --IVN--------GKYSI----PPHDT-QY---TVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp ---------------CCC----CTTCC-SS---GGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred --hhc--------CcccC----Ccccc-cc---hHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 100 00000 00001 11 124455677999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=357.31 Aligned_cols=199 Identities=25% Similarity=0.366 Sum_probs=167.7
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-----Cc
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 491 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~ 491 (770)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. ....+.+.+|+.+|+.++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999864 6889999999753 34567899999999999999999999999776 57
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 571 (770)
+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 999999996 5999999754 358999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC--------------------ceecccccccCCCCceee-ccCCCCCcceEeechHHHHHHHhCCCCCC
Q 004174 572 KWASTSSSH--------------------ITCTDVAGTFGYLAPEYF-MYGKVNDKIDVYAFGVVLLELLTGRKPIS 627 (770)
Q Consensus 572 ~~~~~~~~~--------------------~~~~~~~GT~~YlAPE~~-~~~~~s~ksDVwSlGvvL~eLltG~~Pf~ 627 (770)
+........ ...+..+||+.|+|||++ ....|+.++|||||||+||||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 876543221 112456899999999986 45569999999999999999998655543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=341.26 Aligned_cols=258 Identities=20% Similarity=0.320 Sum_probs=198.9
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CCceeEEeeEEee--cCceEEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFE--DNNLLLVY 496 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~--~~~~~LV~ 496 (770)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... .+.+.+|+.++..++ ||||+++++++.. ....++||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 36799999999999999999985 578999999998543 467889999999997 9999999999987 66789999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC-ceEEcccccccccc
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWAS 575 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-~vkL~DFGla~~~~ 575 (770)
||+.+++|.+++. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++...
T Consensus 113 e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999884 37889999999999999999999 8999999999999999776 89999999998765
Q ss_pred CCCCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcc--------ccc
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP--------ILS 646 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~--------~~~ 646 (770)
..... ....||+.|+|||++.. ..++.++|||||||++|||++|+.||....... ..+...... .+.
T Consensus 183 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 183 PGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp TTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHHHHHHHCHHHHHHHHH
T ss_pred CCCcc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHHHHHhcCCchhhhHHH
Confidence 44322 23579999999999986 679999999999999999999999996543221 111100000 000
Q ss_pred ------CCccccc--------cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 647 ------SGKVTQL--------LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 647 ------~g~l~~l--------ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
...+..+ ................+..++..||+.||.+|||+.+++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 00011111111123455667778999999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=349.07 Aligned_cols=261 Identities=21% Similarity=0.249 Sum_probs=192.9
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC------
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 490 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------ 490 (770)
.++|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.+++.++||||++++++|...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999864 6889999999653 355678899999999999999999999997665
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 570 (770)
..++||||+++ +|.+.+.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeec
Confidence 68999999975 78888852 37899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhc--------
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK-------- 642 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~-------- 642 (770)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.-..
T Consensus 174 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 174 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred ccccccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 986654321 223579999999999999999999999999999999999999998765432211111000
Q ss_pred --------------ccccCCccccccCcccCCCCC---hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 643 --------------PILSSGKVTQLLDPALGNNYD---YDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 643 --------------~~~~~g~l~~lld~~l~~~~~---~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+......+..++...+..... ......+..++..||+.||.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000001111111100000 1123456677788999999999999999984
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=335.93 Aligned_cols=247 Identities=23% Similarity=0.380 Sum_probs=194.2
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467999999999999999999875 79999999997532 2356788999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999997543 48899999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCceeeccCCC-CCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
.... .....||+.|+|||++....+ +.++||||||+++|+|++|+.||...........+. .+.
T Consensus 163 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------~~~----- 227 (276)
T 2h6d_A 163 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR-------GGV----- 227 (276)
T ss_dssp C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCC-----
T ss_pred CCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh-------cCc-----
Confidence 4322 123578999999999987765 589999999999999999999997653322111111 000
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+.... ...+..++..||+.||.+||++.+++++
T Consensus 228 -~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 -FYIPEYL----NRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -ccCchhc----CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0011111 1334556678999999999999999984
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=380.09 Aligned_cols=249 Identities=23% Similarity=0.309 Sum_probs=203.3
Q ss_pred hhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~ 493 (770)
..++|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+..|..+|..+ +||||++++++|.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4568999999999999999999864 6889999999753 23456788899999987 6999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
|||||++||+|.+++.... .+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 9999999999999998653 58999999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
...... .....+||+.|+|||++....|+.++|||||||+||||++|+.||...+.......+.. +.+
T Consensus 492 ~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~-------~~~--- 559 (674)
T 3pfq_A 492 NIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-------HNV--- 559 (674)
T ss_dssp CCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS-------SCC---
T ss_pred cccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh-------CCC---
Confidence 433222 22347899999999999999999999999999999999999999987654332222211 110
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCH-----HHHHHH
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQM-----SLVLKL 694 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~-----~eVL~~ 694 (770)
.+ +......+..++..||+.||.+||++ .+|+++
T Consensus 560 ---~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 560 ---AY----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ---CC----CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ---CC----CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 01 11112344556678999999999997 677653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=376.80 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=196.0
Q ss_pred ceeecccCceEEEEEEe---CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 427 ENLIGKGGSSQVYKGCL---PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~---~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
.+.||+|+||.||+|.+ ..++.||||+++.. ....+++.+|+.+|..++||||++++++|. .+.++|||||++
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~ 452 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAE 452 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCT
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccC
Confidence 35899999999999965 35678999999853 244678999999999999999999999996 456899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+|+|.+++.... .+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++........
T Consensus 453 ~g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 453 LGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp TEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 999999997543 58999999999999999999999 89999999999999999999999999999877544322
Q ss_pred -ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 581 -ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 581 -~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
.......||+.|+|||++....++.++|||||||+||||++ |+.||...........+. .+.... .
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-------~~~~~~-----~ 593 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMG-----C 593 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTCCCC-----C
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCCC-----C
Confidence 12223457889999999999999999999999999999998 999998765433222211 111000 1
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+......+..++..||+.||.+||++.+|++.|+.
T Consensus 594 ----p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 594 ----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11122445566778999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=358.49 Aligned_cols=263 Identities=21% Similarity=0.271 Sum_probs=193.9
Q ss_pred cCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc------eEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN------LLLV 495 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~------~~LV 495 (770)
.+|.+.+.||+|+||.||+|....+..+|+|++...... ..+|+.+++.++||||++++++|...+. +++|
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 468899999999999999999877777999988654322 2369999999999999999999976543 8899
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC-CCCceEEccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWA 574 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~-~~~~vkL~DFGla~~~ 574 (770)
|||++++ |.+.+.........+++..+..++.||+.||.|||+ ++|+||||||+||||+ .++.+||+|||+++..
T Consensus 117 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 117 LEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999874 444433221222468999999999999999999999 8999999999999998 7999999999999876
Q ss_pred cCCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhh------------
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA------------ 641 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~------------ 641 (770)
...... ....||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.+...+...+...
T Consensus 193 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 193 IAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 544332 235789999999998755 5999999999999999999999999876543322211100
Q ss_pred cccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 642 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 642 ~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+......+.......+...+.......+..++..||+.||.+|||+.+++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000011111100000000111122345666778999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=340.00 Aligned_cols=251 Identities=23% Similarity=0.369 Sum_probs=198.5
Q ss_pred hhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
..++|.+.+.||+|+||.||+|... +|+.||||++.... ..+.+.+|+.++..++||||+++++++...+..++||||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 3467999999999999999999875 58999999997643 346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+++++|.+++.... ..+++..+..++.+|+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 106 ~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 106 CGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred CCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999986432 358999999999999999999999 899999999999999999999999999998765432
Q ss_pred CCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 658 (770)
.. .....||+.|+|||++....++.++||||||+++|+|++|+.||...........+.. +....+..
T Consensus 180 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~--- 247 (314)
T 3com_A 180 AK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT-------NPPPTFRK--- 247 (314)
T ss_dssp SC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------SCCCCCSS---
T ss_pred cc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc-------CCCcccCC---
Confidence 22 2235799999999999998999999999999999999999999976543221111100 00000000
Q ss_pred CCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 659 ~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
.......+..++..||+.||.+||++.++++
T Consensus 248 ----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 ----PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ----GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1111234556667899999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=347.23 Aligned_cols=266 Identities=22% Similarity=0.326 Sum_probs=202.0
Q ss_pred hhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-----Cc
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 491 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~ 491 (770)
..++|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++..++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 4568999999999999999999864 6889999999753 34557899999999999999999999999765 36
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 571 (770)
.++||||+. |+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcce
Confidence 899999997 5999998653 48999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCc-eecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCc
Q 004174 572 KWASTSSSHI-TCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 649 (770)
Q Consensus 572 ~~~~~~~~~~-~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 649 (770)
.......... ......||+.|+|||++..+ .++.++|||||||++|+|++|+.||...........+...........
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 8765432221 12335899999999987644 589999999999999999999999987665443322211000000000
Q ss_pred cccccC--------cc-cCCCCCh-----HHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 650 VTQLLD--------PA-LGNNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 650 l~~lld--------~~-l~~~~~~-----~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+..+.+ .. .....+. .....+..++..||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00 0000010 112345567778999999999999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=339.71 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=195.9
Q ss_pred hcCcccceeecccCceEEEEEEeC--CCC--EEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP--DGK--ELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~--~g~--~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 492 (770)
.++|.+.+.||+|+||.||+|.+. +++ .||||+++.. ....+.+.+|+.++..++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357899999999999999999853 333 6899998753 345678999999999999999999999998754 8
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccc
Confidence 99999999999999997543 358899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCce-ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCcc
Q 004174 573 WASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKV 650 (770)
Q Consensus 573 ~~~~~~~~~~-~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 650 (770)
.......... .....+|+.|+|||++....++.++||||||+++|+|++ |+.||...........+. ..+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------~~~~~ 243 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------KEGER 243 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH------TSCCC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHH------ccCCC
Confidence 7755433221 223467889999999998889999999999999999999 999997654322111111 00000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004174 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699 (770)
Q Consensus 651 ~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~ 699 (770)
... .......+..++..||+.+|.+||++.+++++|+...
T Consensus 244 -----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 244 -----LPR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp -----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -----CCC----CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 000 1111234556667899999999999999999987543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.33 Aligned_cols=253 Identities=26% Similarity=0.433 Sum_probs=194.3
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEee-----------
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----------- 488 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----------- 488 (770)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++......+.+.+|+.+++.++||||++++++|.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 46799999999999999999986 478999999998777777889999999999999999999999865
Q ss_pred --cCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEc
Q 004174 489 --DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (770)
Q Consensus 489 --~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~ 566 (770)
.+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEe
Confidence 356899999999999999997543 357889999999999999999999 899999999999999999999999
Q ss_pred cccccccccCCCC------------CceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccc
Q 004174 567 DFGLAKWASTSSS------------HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (770)
Q Consensus 567 DFGla~~~~~~~~------------~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 633 (770)
|||++........ ........||+.|+|||++... .++.++|||||||++|||++ ||.... .
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~ 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--E 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--H
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--h
Confidence 9999986643210 1112235799999999999854 78999999999999999998 554321 1
Q ss_pred hhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 634 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 634 ~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
......... .. ...+...+.......+..++..||+.||.+||++.+++++
T Consensus 234 ~~~~~~~~~----~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 RVNILKKLR----SV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHH----ST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhcc----cc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111110 00 0111112222233445566778999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=341.28 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=195.0
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecC
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 490 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 490 (770)
.++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|+++++.++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 467999999999999999999864 68899999987532 2234588999999999999999999998765
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCc---eEEcc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSD 567 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~---vkL~D 567 (770)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|
T Consensus 88 ~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp SEEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred ceEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 489999999999999998654 358999999999999999999999 89999999999999987654 99999
Q ss_pred ccccccccCCCCCceecccccccCCCCceeec---cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhccc
Q 004174 568 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 644 (770)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~ 644 (770)
||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||......... ....
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~--- 232 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQI--- 232 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHHH---
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHHH---
Confidence 99998764421 122357999999999974 567899999999999999999999999765432211 1100
Q ss_pred ccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 645 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 645 ~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+... ..+..... ....+..++..||+.||.+||++.+++++
T Consensus 233 -~~~~~~--~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 233 -TSGKYN--FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp -HHTCCC--CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -HhCccc--cCchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 011100 00111111 12345566778999999999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=342.77 Aligned_cols=265 Identities=22% Similarity=0.334 Sum_probs=199.2
Q ss_pred hhcCcccceeecccCceEEEEEEe--CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhc---CCCceeEEeeEEe----
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSE---DVIKEFVLEIEIITTL---HHKNIISLLGFCF---- 487 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~--~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~---- 487 (770)
..++|.+.+.||+|+||.||+|.. .+|+.||||+++... .....+.+|+.+++.+ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999987 468899999986422 2223566777777766 8999999999997
Q ss_pred -ecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEc
Q 004174 488 -EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (770)
Q Consensus 488 -~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~ 566 (770)
.....++||||+. |+|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999997 599999976543 358999999999999999999999 899999999999999999999999
Q ss_pred cccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhccccc
Q 004174 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 646 (770)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~ 646 (770)
|||++....... ......||+.|+|||++....++.++|||||||++|+|++|+.||...........+........
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999997654322 12235799999999999999999999999999999999999999987654322211111000000
Q ss_pred CCcccc-------cc----CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 647 SGKVTQ-------LL----DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 647 ~g~l~~-------ll----d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
...+.. .+ ...+. .+.......+..++..||+.||.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGG-GTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCccccccchhhhcccCcchhh-hccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 00 00000 0111122344556678999999999999999863
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=341.48 Aligned_cols=263 Identities=19% Similarity=0.257 Sum_probs=203.1
Q ss_pred hcCcccceeecccCceEEEEEEeC-CC-CEEEEEEeCCChhHHHHHHHHHHHHHhcCCCc------eeEEeeEEeecCce
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DG-KELAVKILKPSEDVIKEFVLEIEIITTLHHKN------IISLLGFCFEDNNL 492 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g-~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hpn------Iv~l~~~~~~~~~~ 492 (770)
.++|.+.+.||+|+||.||+|... ++ +.||||+++......+.+.+|+.+++.++|++ ++.+++++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 468999999999999999999864 34 68999999987777788999999999998765 99999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee---------------
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL--------------- 557 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL--------------- 557 (770)
++||||+ +++|.+.+..... ..+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccc
Confidence 9999999 6677777765432 358999999999999999999999 899999999999999
Q ss_pred ----CCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccc
Q 004174 558 ----SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (770)
Q Consensus 558 ----~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 633 (770)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 567899999999998654432 23579999999999999999999999999999999999999998755432
Q ss_pred hhhHHHhhcccccCC------ccccccC--------------------cccC-CCCChHHHHHHHHHHHhhcccCCCCCC
Q 004174 634 QESLVMWAKPILSSG------KVTQLLD--------------------PALG-NNYDYDQMERMVLASILCIRRDPRARP 686 (770)
Q Consensus 634 ~~~lv~~~~~~~~~g------~l~~lld--------------------~~l~-~~~~~~~~~~l~~~a~~Cl~~dP~~RP 686 (770)
....+.......... ....+.. +... ..........+..++..||+.||.+||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 221111110000000 0000000 0000 011222344566777889999999999
Q ss_pred CHHHHHHH
Q 004174 687 QMSLVLKL 694 (770)
Q Consensus 687 s~~eVL~~ 694 (770)
|+.+++++
T Consensus 327 t~~e~l~h 334 (355)
T 2eu9_A 327 TLAEALLH 334 (355)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=344.76 Aligned_cols=264 Identities=20% Similarity=0.287 Sum_probs=203.0
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChh------------------HHHHHHHHHHHHHhcCCCceeEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED------------------VIKEFVLEIEIITTLHHKNIISL 482 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~------------------~~~~~~~Ei~iL~~l~HpnIv~l 482 (770)
.++|.+.+.||+|+||.||+|.. +|+.||||++..... ..+.+.+|+.++..++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999998 999999999874321 12789999999999999999999
Q ss_pred eeEEeecCceEEEEeecCCCChhhh------hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCee
Q 004174 483 LGFCFEDNNLLLVYDFLSRGSLEEN------LHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556 (770)
Q Consensus 483 ~~~~~~~~~~~LV~E~~~ggsL~~~------l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NIL 556 (770)
++++.+.+..++||||+++|+|.++ +.... ...+++..++.++.||+.||.|||+ .++|+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEE
Confidence 9999999999999999999999998 54321 2568999999999999999999996 267999999999999
Q ss_pred eCCCCceEEccccccccccCCCCCceecccccccCCCCceeeccC-CCCC-cceEeechHHHHHHHhCCCCCCCCCccc-
Q 004174 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVND-KIDVYAFGVVLLELLTGRKPISNDHPKG- 633 (770)
Q Consensus 557 L~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~-ksDVwSlGvvL~eLltG~~Pf~~~~~~~- 633 (770)
++.++.+||+|||++...... ......||+.|+|||++... .++. ++|||||||++|||++|+.||.......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999999876543 22346799999999999877 6766 9999999999999999999998755421
Q ss_pred hhhHHHhhcccccCCccccccCcccCC---CCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 634 QESLVMWAKPILSSGKVTQLLDPALGN---NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 634 ~~~lv~~~~~~~~~g~l~~lld~~l~~---~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
....+......+.. ....+..+.... .........+..++..||+.||.+||++.+++++
T Consensus 261 ~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 261 LFNNIRTKNIEYPL-DRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHHTSCCCCCCC-SSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHhccCcCCcc-chhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111100000000 000001000000 0001122345566678999999999999999984
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=334.01 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=196.0
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
+|....+||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.+++.++||||++++++|...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 345566899999999999986 468899999987643 456789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC-CCceEEccccccccccCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-~~~vkL~DFGla~~~~~~~~ 579 (770)
+++|.+++..... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999976432 2456788999999999999999999 89999999999999987 89999999999987654322
Q ss_pred CceecccccccCCCCceeeccCC--CCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~--~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
. .....||+.|+|||++..+. ++.++||||||+++|+|++|+.||......... . +..... ...+.
T Consensus 179 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~--~~~~~~-------~~~~~ 246 (295)
T 2clq_A 179 C--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-M--FKVGMF-------KVHPE 246 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-H--HHHHHH-------CCCCC
T ss_pred c--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-H--Hhhccc-------ccccc
Confidence 1 22357999999999997654 889999999999999999999999653321111 1 100000 00111
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+.... ...+..++..||+.||.+||++.+++++
T Consensus 247 ~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 247 IPESM----SAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCTTS----CHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ccccC----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111 2344556678999999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=360.16 Aligned_cols=260 Identities=23% Similarity=0.312 Sum_probs=204.2
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC-CceeEEeeEEeecCceEEEEee
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~LV~E~ 498 (770)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+|++++..++| ++|..+..++...+..+|||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 46899999999999999999986 5789999998865332 2457889999999987 5566666677778889999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee---CCCCceEEcccccccccc
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL---~~~~~vkL~DFGla~~~~ 575 (770)
+ +++|.+++.... ..+++..++.|+.||+.||.|||+ ++||||||||+|||| +.++.+||+|||+++...
T Consensus 85 ~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 85 L-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred C-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9 999999997543 358999999999999999999999 899999999999999 588999999999998776
Q ss_pred CCCCCc-----eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcc
Q 004174 576 TSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650 (770)
Q Consensus 576 ~~~~~~-----~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 650 (770)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...........+...... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~----~~ 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----KV 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH----HH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc----cc
Confidence 543321 122467999999999999999999999999999999999999999876554433322221110 01
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 651 ~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
...+. .+...++ ..+..++..||+.+|.+||++.+|+++|+.
T Consensus 234 ~~~~~-~l~~~~p----~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 234 ATSIE-ALCRGYP----TEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp HSCHH-HHHTTSC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred cccHH-HHhcCCc----HHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 11111 0111112 345566778999999999999999998764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.24 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=197.6
Q ss_pred hhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
..++|.+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++..++||||++++++|...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3467999999999999999999975 58999999987543 456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+++++|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999887533 358999999999999999999999 89999999999999999999999999997643221
Q ss_pred CCCceecccccccCCCCceeec-----cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
.. ......||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..... ...... ....
T Consensus 171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~-----~~~~ 241 (302)
T 2j7t_A 171 LQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL--LKIAKS-----DPPT 241 (302)
T ss_dssp HH--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHHHS-----CCCC
T ss_pred cc--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH--HHHhcc-----CCcc
Confidence 11 112257999999999984 567899999999999999999999999865432211 111110 0001
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
... +......+..++..||+.||.+||++.+++++
T Consensus 242 ~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 242 LLT-------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp CSS-------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred cCC-------ccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 100 11112345556678999999999999999874
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=348.53 Aligned_cols=260 Identities=23% Similarity=0.319 Sum_probs=183.8
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec------C
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------N 490 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~ 490 (770)
.++|.+.+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+.+++.++||||++++++|... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46899999999999999999985 57899999999753 34567889999999999999999999998654 5
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 570 (770)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 689999999 7899998864 258999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhccc-----
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI----- 644 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~----- 644 (770)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+...+...+......
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9865432 223579999999999886 67999999999999999999999999876543333222111000
Q ss_pred ---ccCCccccccCcccC-CCCChH-----HHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 645 ---LSSGKVTQLLDPALG-NNYDYD-----QMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 645 ---~~~g~l~~lld~~l~-~~~~~~-----~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+.......++..... ...... ....+..++..||+.||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000000000000 000111 11335566678999999999999999974
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=344.49 Aligned_cols=263 Identities=18% Similarity=0.303 Sum_probs=202.0
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-----------CCceeEEeeEEee
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-----------HKNIISLLGFCFE 488 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-----------HpnIv~l~~~~~~ 488 (770)
.++|.+.+.||+|+||.||+|.. .+++.||||++.........+.+|+.++..++ ||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 35799999999999999999986 57899999999987777788899999999886 8999999999986
Q ss_pred cC----ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-ceEEecccCCCeeeC-----
Q 004174 489 DN----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLS----- 558 (770)
Q Consensus 489 ~~----~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~IiHrDLKp~NILL~----- 558 (770)
.+ .+++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+ + +|+||||||+||||+
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCC
Confidence 54 789999999 8899999976433 358999999999999999999999 7 899999999999994
Q ss_pred -CCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccch---
Q 004174 559 -DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ--- 634 (770)
Q Consensus 559 -~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~--- 634 (770)
..+.+||+|||++....... ....||+.|+|||++.+..++.++|||||||+||||++|+.||........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 44589999999998765432 234799999999999999999999999999999999999999986542211
Q ss_pred -hh---HHHhhcc--------------cccC-CccccccC-------ccc--CCCCChHHHHHHHHHHHhhcccCCCCCC
Q 004174 635 -ES---LVMWAKP--------------ILSS-GKVTQLLD-------PAL--GNNYDYDQMERMVLASILCIRRDPRARP 686 (770)
Q Consensus 635 -~~---lv~~~~~--------------~~~~-g~l~~lld-------~~l--~~~~~~~~~~~l~~~a~~Cl~~dP~~RP 686 (770)
.. +...... .+.. +.+..+.. ..+ ...++......+..++..||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 11 1110000 0000 00000000 000 0123445566777888899999999999
Q ss_pred CHHHHHHH
Q 004174 687 QMSLVLKL 694 (770)
Q Consensus 687 s~~eVL~~ 694 (770)
|+.+++++
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=344.33 Aligned_cols=266 Identities=21% Similarity=0.293 Sum_probs=199.2
Q ss_pred hhcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-----Cc
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 491 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~ 491 (770)
..++|.+.+.||+|+||.||+|... +|+.||||+++.. ......+.+|+.+++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3568999999999999999999864 6899999999753 34566788999999999999999999998764 67
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 571 (770)
.++||||+. |+|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 899999997 5999988752 48999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCc--------eecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhc
Q 004174 572 KWASTSSSHI--------TCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 642 (770)
Q Consensus 572 ~~~~~~~~~~--------~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~ 642 (770)
.......... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||...+.......+.-..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 8765332111 1223578999999998765 678999999999999999999999998765432222111000
Q ss_pred cccc-CCcc--------ccccCcccC-CCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 643 PILS-SGKV--------TQLLDPALG-NNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 643 ~~~~-~g~l--------~~lld~~l~-~~~~-----~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.... .... .+.+..... .... ......+..++..||+.||.+|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0000 000000000 0000 0112344566778999999999999999973
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=341.97 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=171.8
Q ss_pred hcCcccc-eeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEee----cCceEE
Q 004174 421 TSNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLL 494 (770)
Q Consensus 421 t~~f~~~-~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~L 494 (770)
.++|.+. ++||+|+||.||+|... +|+.||||++........++ ...+..+.||||++++++|.. ...+++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~---~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEV---DHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHH---HHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHH---HHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 4678884 57999999999999875 68999999998654433332 234567799999999999976 445899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC---CCceEEcccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLA 571 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~~~vkL~DFGla 571 (770)
||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 104 v~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999986533 468999999999999999999999 89999999999999976 455999999999
Q ss_pred ccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
+....... ....||+.|+|||++....++.++|||||||++|+|++|+.||............ ...+..+..
T Consensus 179 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~- 250 (336)
T 3fhr_A 179 KETTQNAL----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRLGQY- 250 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eecccccc----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhcccc-
Confidence 86654322 2357899999999999889999999999999999999999999765432211000 000000000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+..+ ........+..++..||+.||.+|||+.+++++
T Consensus 251 ~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 251 GFPNP-----EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp CCCTT-----TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccCch-----hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 001112345556678999999999999999984
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=339.93 Aligned_cols=264 Identities=23% Similarity=0.344 Sum_probs=192.6
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEe-----------
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCF----------- 487 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~----------- 487 (770)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467999999999999999999975 58999999987543 56678999999999999999999999873
Q ss_pred ---ecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC-CCCce
Q 004174 488 ---EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEP 563 (770)
Q Consensus 488 ---~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~-~~~~v 563 (770)
+.+..++||||++ |+|.+++.. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 599999864 258899999999999999999999 8999999999999997 56799
Q ss_pred EEccccccccccCCCCC-ceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhh
Q 004174 564 QLSDFGLAKWASTSSSH-ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 641 (770)
Q Consensus 564 kL~DFGla~~~~~~~~~-~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~ 641 (770)
||+|||+++........ .......||+.|+|||++.. ..++.++|||||||++|||++|+.||...........+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999876432211 11223568999999998875 67899999999999999999999999876543322222111
Q ss_pred cccccCCcccccc-------CcccC-CCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 642 KPILSSGKVTQLL-------DPALG-NNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 642 ~~~~~~g~l~~ll-------d~~l~-~~~~-----~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
.+........++. ..... .... ......+..++..||+.||.+||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 1111100000000 00000 0000 011234566777899999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=346.49 Aligned_cols=259 Identities=22% Similarity=0.322 Sum_probs=195.2
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce----
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL---- 492 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~---- 492 (770)
.++|.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.+++.++||||++++++|...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999864 6899999999753 34567889999999999999999999999877655
Q ss_pred --EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccc
Q 004174 493 --LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 493 --~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 570 (770)
++||||+. ++|.+.+.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 588888732 38999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccc----
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL---- 645 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~---- 645 (770)
++...... ....||+.|+|||++.. ..++.++|||||||++|+|++|+.||...+.......+.-.....
T Consensus 191 a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 191 ARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccCc-----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 98654432 23578999999999986 679999999999999999999999998755332221111000000
Q ss_pred ----cCCccccccCcccC-CCCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 646 ----SSGKVTQLLDPALG-NNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 646 ----~~g~l~~lld~~l~-~~~~-----~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
........+..... .... ......+..++..||+.||.+|||+.+++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000000000 0000 0112345666778999999999999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=329.68 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=199.8
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
.++|.+.+.||+|+||.||+|... +++.||||++... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 467999999999999999999875 7899999998643 234678899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC---CceEEcccccccc
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKW 573 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~---~~vkL~DFGla~~ 573 (770)
||+++++|.+.+.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||++..
T Consensus 101 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999886543 58999999999999999999999 899999999999999754 4699999999987
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
....... ....||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+. .+.....
T Consensus 174 ~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------~~~~~~~ 242 (287)
T 2wei_A 174 FQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE-------TGKYAFD 242 (287)
T ss_dssp BCCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCCCCCC
T ss_pred ecCCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------cCCCCCC
Confidence 6543221 23468999999998874 58999999999999999999999998754322111111 1110000
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. +.. ..+ ...+..++..||+.+|.+||++.+++++
T Consensus 243 ~-~~~-~~~----~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 243 L-PQW-RTI----SDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp S-GGG-TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred c-hhh-hhc----CHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0 000 111 1235556678999999999999999973
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.34 Aligned_cols=258 Identities=22% Similarity=0.322 Sum_probs=195.2
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc-----
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----- 491 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~----- 491 (770)
.++|.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999864 6899999999753 3456788999999999999999999999987654
Q ss_pred -eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccc
Q 004174 492 -LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 492 -~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 570 (770)
+++||||+. ++|.+++.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 588887742 48899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhccc-----
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI----- 644 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~----- 644 (770)
+...... .....||+.|+|||++.. ..++.++|||||||++|+|++|+.||...+.......+.-....
T Consensus 173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9865432 123578999999999886 67899999999999999999999999876543221111100000
Q ss_pred ---ccCC-------ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 645 ---LSSG-------KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 645 ---~~~g-------~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+... .+.....+.+. .........+..++..||+.||.+||++.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 00000000000 0111223345566678999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=350.63 Aligned_cols=254 Identities=24% Similarity=0.352 Sum_probs=188.0
Q ss_pred CcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeecCC
Q 004174 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+|..+ +||||+++++++.+.+.+++||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 45667899999999998776678999999998753 345678999999987 89999999999999999999999995
Q ss_pred CChhhhhccCCCCCCC---CCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC-------------CceEE
Q 004174 502 GSLEENLHGNKKDPAA---FGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-------------FEPQL 565 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~---l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~-------------~~vkL 565 (770)
|+|.+++......... ..+..++.++.||+.||.|||+ ++|+||||||+||||+.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 6999999765432211 2344567899999999999999 899999999999999653 48999
Q ss_pred ccccccccccCCCCCc--eecccccccCCCCceeecc-------CCCCCcceEeechHHHHHHHh-CCCCCCCCCccchh
Q 004174 566 SDFGLAKWASTSSSHI--TCTDVAGTFGYLAPEYFMY-------GKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQE 635 (770)
Q Consensus 566 ~DFGla~~~~~~~~~~--~~~~~~GT~~YlAPE~~~~-------~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~ 635 (770)
+|||+++......... ......||++|+|||++.. ..++.++|||||||++|||++ |+.||....... .
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-~ 248 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-S 248 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-H
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-H
Confidence 9999998776543221 1223579999999999975 678999999999999999999 999997543322 1
Q ss_pred hHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 636 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 636 ~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+.. ....... +...........+..++..||+.||.+||++.+|+++
T Consensus 249 ~i~~---~~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 249 NIIR---GIFSLDE--------MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHHH---TCCCCCC--------CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHhc---CCCCccc--------ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 1111 1111000 1111123344566777888999999999999999974
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=338.45 Aligned_cols=255 Identities=25% Similarity=0.372 Sum_probs=177.0
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHH-HHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. ......+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367889999999999999999874 7899999999754 344456666766 677789999999999999999999999
Q ss_pred eecCCCChhhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-ceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 497 DFLSRGSLEENLHGNK-KDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||+++ +|.+++.... .....+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 8887775311 112468999999999999999999999 7 8999999999999999999999999999866
Q ss_pred cCCCCCceecccccccCCCCceee----ccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYF----MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~----~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 650 (770)
...... ....||+.|+|||++ ....++.++|||||||++|+|++|+.||........ . ..... .+..
T Consensus 177 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~----~~~~~-~~~~ 247 (327)
T 3aln_A 177 VDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-Q----LTQVV-KGDP 247 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCC-CSCC
T ss_pred cccccc---ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-H----HHHHh-cCCC
Confidence 543222 224799999999998 456789999999999999999999999976432110 0 11111 1111
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 651 ~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
.. +...........+..++..||+.||.+||++.++++
T Consensus 248 ~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 PQ-----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CC-----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC-----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11 111111112234556667899999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=339.18 Aligned_cols=256 Identities=21% Similarity=0.354 Sum_probs=197.1
Q ss_pred hhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
..++|.+.+.||+|+||.||+|.... .+|+|+++... ...+.+.+|+.++..++||||+++++++...+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 45789999999999999999998744 49999987532 33456788999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||++.....
T Consensus 109 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp BCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999997543 368999999999999999999999 8999999999999998 67999999999876532
Q ss_pred CCC---CceecccccccCCCCceeecc---------CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhccc
Q 004174 577 SSS---HITCTDVAGTFGYLAPEYFMY---------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 644 (770)
Q Consensus 577 ~~~---~~~~~~~~GT~~YlAPE~~~~---------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~ 644 (770)
... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||...........+
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~------ 255 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM------ 255 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH------
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh------
Confidence 211 111223469999999999874 45788999999999999999999999765432211111
Q ss_pred ccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCC
Q 004174 645 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 699 (770)
Q Consensus 645 ~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~ 699 (770)
..+........ ..+ ..+..++..||..+|.+||++.++++.|+...
T Consensus 256 -~~~~~~~~~~~----~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 256 -GTGMKPNLSQI----GMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp -HTTCCCCCCCS----SCC----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred -ccCCCCCCCcC----CCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 01111111110 111 22445667899999999999999999998654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=350.78 Aligned_cols=203 Identities=26% Similarity=0.423 Sum_probs=155.8
Q ss_pred Cccc-ceeecccCceEEEEEEeC---CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEee--cCceEEEE
Q 004174 423 NFLA-ENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVY 496 (770)
Q Consensus 423 ~f~~-~~~LG~G~fG~Vy~a~~~---~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~LV~ 496 (770)
.|.+ .++||+|+||.||+|... +++.||||++.... ....+.+|+.+|+.++||||++++++|.. ....++||
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 3555 458999999999999864 57899999997543 23467899999999999999999999965 66899999
Q ss_pred eecCCCChhhhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee----CCCCceEEcc
Q 004174 497 DFLSRGSLEENLHGNK-----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSD 567 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~-----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL----~~~~~vkL~D 567 (770)
||+.+ +|.+++.... .....+++..++.|+.||+.||.|||+ ++|+||||||+|||| +.++.+||+|
T Consensus 100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99965 8888775321 122358999999999999999999999 899999999999999 6778999999
Q ss_pred ccccccccCCCCC-ceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCC
Q 004174 568 FGLAKWASTSSSH-ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (770)
Q Consensus 568 FGla~~~~~~~~~-~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 630 (770)
||+++........ .......||+.|+|||++.+. .++.++|||||||+||||++|+.||....
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999876543221 222346899999999999874 58999999999999999999999997654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=365.48 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=201.8
Q ss_pred hhcCcccceeecccCceEEEEEEeC----CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
..++|.+.+.||+|+||.||+|.+. .+..||||+++.. ....+.|.+|+.++..++||||+++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 3467899999999999999999863 2457999998753 355678999999999999999999999985 46789
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 467 lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999997543 358999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
....... ......+|+.|+|||++....++.++|||||||++|||++ |..||...........+.. +...
T Consensus 541 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~-------~~~~- 611 (656)
T 2j0j_A 541 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-------GERL- 611 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH-------TCCC-
T ss_pred cCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-------CCCC-
Confidence 6543322 2223467889999999999999999999999999999997 9999987544322111111 1000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
.+... ....+..++..||+.||.+||++.+|++.|...
T Consensus 612 ----~~~~~----~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 612 ----PMPPN----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp ----CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCcc----ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 01111 123455667789999999999999999988643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.64 Aligned_cols=241 Identities=23% Similarity=0.370 Sum_probs=189.6
Q ss_pred hhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-------hHHHHHHHHHHHHHhc----CCCceeEEeeEEe
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-------DVIKEFVLEIEIITTL----HHKNIISLLGFCF 487 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~l----~HpnIv~l~~~~~ 487 (770)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... .....+.+|+.++.++ +||||++++++|.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 456899999999999999999986 478899999997543 1233466799999999 8999999999999
Q ss_pred ecCceEEEEee-cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC-CCCceEE
Q 004174 488 EDNNLLLVYDF-LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQL 565 (770)
Q Consensus 488 ~~~~~~LV~E~-~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~-~~~~vkL 565 (770)
..+..++|||| +.+++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEE
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEE
Confidence 99999999999 78999999997643 58999999999999999999999 8999999999999998 8899999
Q ss_pred ccccccccccCCCCCceecccccccCCCCceeeccCCCC-CcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhccc
Q 004174 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 644 (770)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~ 644 (770)
+|||++....... .....||+.|+|||++....+. .++|||||||++|||++|+.||.... .... ...
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~-~~~- 250 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EILE-AEL- 250 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHH-TCC-
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HHhh-hcc-
Confidence 9999998765432 2235799999999999877765 48999999999999999999996421 1111 000
Q ss_pred ccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 645 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 645 ~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+.... ...+..++..||+.+|.+||++.+++++
T Consensus 251 ------------~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 251 ------------HFPAHV----SPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ------------CCCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------------CCcccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111 2344556678999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=327.01 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=176.9
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--hHH-HHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVI-KEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~-~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ... +.+..+..++..++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467889999999999999999874 78999999997542 222 33444556788889999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-ceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
||+ ++.+..++.... ..+++..+..++.||+.||.|||+ + +|+||||||+|||++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 555655554322 358999999999999999999998 5 89999999999999999999999999997665
Q ss_pred CCCCCceecccccccCCCCceeec-----cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcc
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 650 (770)
..... ....||+.|+|||++. ...++.++|||||||++|||++|+.||....... ..+... .. +.
T Consensus 177 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~----~~-~~- 246 (318)
T 2dyl_A 177 DDKAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-EVLTKV----LQ-EE- 246 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HHHHHH----HH-SC-
T ss_pred CCccc---cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-HHHHHH----hc-cC-
Confidence 43222 2357999999999984 5578999999999999999999999997643211 111110 00 00
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 651 ~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+.+.... .....+..++..||+.||.+||++.+++++
T Consensus 247 ----~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 247 ----PPLLPGHM--GFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp ----CCCCCSSS--CCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ----CCCCCccC--CCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00111000 111234556678999999999999999873
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=338.29 Aligned_cols=243 Identities=22% Similarity=0.369 Sum_probs=197.4
Q ss_pred HHhhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-------hHHHHHHHHHHHHHhcC--CCceeEEeeEEe
Q 004174 418 LSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-------DVIKEFVLEIEIITTLH--HKNIISLLGFCF 487 (770)
Q Consensus 418 ~~~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~ 487 (770)
....++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+.+|+.++..++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34567899999999999999999985 478899999997532 12345778999999996 599999999999
Q ss_pred ecCceEEEEeecCC-CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC-CCCceEE
Q 004174 488 EDNNLLLVYDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQL 565 (770)
Q Consensus 488 ~~~~~~LV~E~~~g-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~-~~~~vkL 565 (770)
..+..++||||+.+ ++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++ +++.+||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEE
Confidence 99999999999986 89999997643 58899999999999999999999 8999999999999998 7889999
Q ss_pred ccccccccccCCCCCceecccccccCCCCceeeccCCC-CCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhccc
Q 004174 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 644 (770)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~ 644 (770)
+|||++....... .....||+.|+|||++....+ +.++|||||||++|||++|+.||.... .... .. .
T Consensus 192 ~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~~-~~-~ 260 (320)
T 3a99_A 192 IDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIR-GQ-V 260 (320)
T ss_dssp CCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHH-CC-C
T ss_pred eeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hhhc-cc-c
Confidence 9999998765432 223579999999999987766 678999999999999999999996431 1110 00 0
Q ss_pred ccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 645 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 645 ~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. +....+ ..+..++..||+.||.+||++.+++++
T Consensus 261 --------~----~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 261 --------F----FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --------C----CSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------c----ccccCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 111112 345566678999999999999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=343.96 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=186.6
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEEEeec
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
..+|...++||+|+||+||.....+|+.||||++..... ..+.+|+.+|+.+ +||||+++++++.+....+|||||+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 446888999999999997655556899999999975431 2356799999999 7999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC-----CCceEEccccccccc
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-----DFEPQLSDFGLAKWA 574 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-----~~~vkL~DFGla~~~ 574 (770)
. |+|.+++..... .+.+..+..++.||+.||.|||+ ++|+||||||+||||+. ...+||+|||+++..
T Consensus 101 ~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 101 A-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp S-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred C-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 6 599999976542 34555678899999999999999 89999999999999953 335789999999876
Q ss_pred cCCCCC-ceecccccccCCCCceeec---cCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCc
Q 004174 575 STSSSH-ITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGK 649 (770)
Q Consensus 575 ~~~~~~-~~~~~~~GT~~YlAPE~~~---~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 649 (770)
...... .......||++|+|||++. ...++.++|||||||++|||++ |..||......... .. .....
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~------~~~~~ 246 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-IL------LGACS 246 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HH------TTCCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HH------hccCC
Confidence 543211 2223467999999999997 4567889999999999999999 99999654322111 10 00000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 650 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 650 l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. .... ........+..++..||+.||.+||++.+|+++
T Consensus 247 ~-~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 247 L-DCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp C-TTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred c-cccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0 0000 011223335567778999999999999999964
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=356.57 Aligned_cols=236 Identities=21% Similarity=0.293 Sum_probs=189.7
Q ss_pred hcCcccceeecccCceEEEEEEeC--CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc-----
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP--DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----- 491 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~--~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~----- 491 (770)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... ......+.+|+.++..++||||++++++|...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999874 6899999998653 3556788999999999999999999999988766
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 571 (770)
.||||||++|++|.+++.. .+++..++.|+.||+.||.|||+ ++||||||||+||||+.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999987643 48999999999999999999999 899999999999999886 9999999999
Q ss_pred ccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
+..... ....||++|+|||++..+ ++.++|||||||+||+|++|..||....... +.
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------~~ 285 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------LP 285 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------CC
T ss_pred hhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc----------------cc
Confidence 876543 235799999999998765 4889999999999999999999886421110 00
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC-HHHHHHHhh
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-MSLVLKLLR 696 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs-~~eVL~~L~ 696 (770)
...........+..++..||+.||.+||+ +.++.+.|.
T Consensus 286 -------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 286 -------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp -------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 00000111234556777899999999996 555555454
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=351.86 Aligned_cols=259 Identities=23% Similarity=0.322 Sum_probs=198.5
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEee------cCce
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE------DNNL 492 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------~~~~ 492 (770)
++|.+.+.||+|+||.||+|.. .+|+.||||+++.. ....+.+.+|++++..++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999986 46899999998753 4556789999999999999999999999765 6778
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCc---eEEcccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFG 569 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~---vkL~DFG 569 (770)
++||||+++|+|.+++..... ...+++..++.|+.+++.||.|||+ ++|+||||||+|||++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 999999999999999976432 2358899999999999999999999 89999999999999987665 8999999
Q ss_pred ccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCc
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 649 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 649 (770)
++......... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ...|.......+.
T Consensus 170 ~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC----
T ss_pred ccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccc
Confidence 99877554322 336799999999999999999999999999999999999999975422 1122211111111
Q ss_pred cccccC----------c--ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 004174 650 VTQLLD----------P--ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 692 (770)
Q Consensus 650 l~~lld----------~--~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL 692 (770)
...... . .............+..++..||..||.+|||+.+++
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 000000 0 011123334556677777889999999999997643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.18 Aligned_cols=227 Identities=16% Similarity=0.187 Sum_probs=179.5
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999875 5899999999754 345678999999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||++|++|.+++... ....++..|+.||+.||.|||+ ++|+||||||+||||+.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999998532 2455788899999999999999 899999999999999999999998543
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
|++| ++.++|||||||+||||+||+.||........... ...... +.... ..
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~~~~~~-~~~~~--~~ 226 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AERDTA-GQPIE--PA 226 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---CCBCTT-SCBCC--HH
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---HHHHhc-cCCCC--hh
Confidence 3433 68899999999999999999999987654321100 000000 00000 00
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+.... ...+..++..||+.||.+| |+.++++.|..
T Consensus 227 ~~~~~~----~~~l~~li~~~l~~dP~~R-s~~el~~~L~~ 262 (286)
T 3uqc_A 227 DIDRDI----PFQISAVAARSVQGDGGIR-SASTLLNLMQQ 262 (286)
T ss_dssp HHCTTS----CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHH
T ss_pred hcccCC----CHHHHHHHHHHcccCCccC-CHHHHHHHHHH
Confidence 011111 2335566678999999999 99999999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=334.11 Aligned_cols=242 Identities=14% Similarity=0.189 Sum_probs=179.7
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCC-Cce---------------
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHH-KNI--------------- 479 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~H-pnI--------------- 479 (770)
+.+|...++||+|+||.||+|.+ .+|+.||||+++.. ....+.|.+|+.++..++| +|.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 44577889999999999999995 57999999999832 2335778999999999987 221
Q ss_pred eE------EeeEEee-----cCceEEEEeecCCCChhhhhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCce
Q 004174 480 IS------LLGFCFE-----DNNLLLVYDFLSRGSLEENLHGN---KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545 (770)
Q Consensus 480 v~------l~~~~~~-----~~~~~LV~E~~~ggsL~~~l~~~---~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~I 545 (770)
+. ++.++.. ...++++|+++ +++|.+++... ......+++..++.++.||+.||.|||+ ++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Confidence 11 1111111 22467777766 67999988421 1222468889999999999999999999 899
Q ss_pred EEecccCCCeeeCCCCceEEccccccccccCCCCCceecccccccCCCCceee----------ccCCCCCcceEeechHH
Q 004174 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF----------MYGKVNDKIDVYAFGVV 615 (770)
Q Consensus 546 iHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~----------~~~~~s~ksDVwSlGvv 615 (770)
+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ ....++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999865443 233578 999999999 55568899999999999
Q ss_pred HHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 616 LLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 616 L~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
||||++|+.||........... ++... ..++ ..+..++..||+.||.+||++.++++
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~---------------~~~~~--~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEW---------------IFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGG---------------GGSSC--CCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCcchhhhHHH---------------HHhhc--ccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999976543221110 01100 0112 34556667899999999999998876
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=311.23 Aligned_cols=231 Identities=23% Similarity=0.367 Sum_probs=175.8
Q ss_pred cCcccc-eeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHH-HhcCCCceeEEeeEEee----cCceEE
Q 004174 422 SNFLAE-NLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEII-TTLHHKNIISLLGFCFE----DNNLLL 494 (770)
Q Consensus 422 ~~f~~~-~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL-~~l~HpnIv~l~~~~~~----~~~~~L 494 (770)
++|.+. ++||+|+||.||+|.. .+++.||||+++.. ..+.+|+.++ +.++||||++++++|.. ...+++
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 456666 7899999999999986 47899999999754 3566788887 56689999999999987 678999
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC---CCceEEcccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLA 571 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~~~vkL~DFGla 571 (770)
||||+++|+|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 93 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999986532 368999999999999999999999 89999999999999998 788999999998
Q ss_pred ccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
.... ...++.++|||||||++|||++|+.||........... .......+..
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~- 219 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQY- 219 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC---SCCSSCTTCC-
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH---HHHHHhhccc-
Confidence 5432 24577899999999999999999999976543211000 0000000000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+..+ ... .....+..++..||+.||.+||++.+++++
T Consensus 220 ~~~~~-~~~----~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 220 EFPNP-EWS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCHH-HHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCch-hcc----cCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000 000 112345556678999999999999999974
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=320.15 Aligned_cols=190 Identities=21% Similarity=0.234 Sum_probs=160.6
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCCh---------hHHHHHHHHHHHHHhcC---------CCceeEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLH---------HKNIISL 482 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~l~---------HpnIv~l 482 (770)
.++|.+.+.||+|+||.||+|.. +|+.||||+++... ...+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45688999999999999999988 78999999997532 23477889999999886 6666666
Q ss_pred eeEE-----------------ee-------------cCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004174 483 LGFC-----------------FE-------------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532 (770)
Q Consensus 483 ~~~~-----------------~~-------------~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~ 532 (770)
.+.+ .+ .+.++|||||+++|++.+.+.. ..+++..++.|+.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 6653 32 6789999999999987777743 25799999999999999
Q ss_pred HHHHHH-cCCCCceEEecccCCCeeeCCCC--------------------ceEEccccccccccCCCCCceecccccccC
Q 004174 533 ALEYLH-SGSAQRVIHRDVKSSNILLSDDF--------------------EPQLSDFGLAKWASTSSSHITCTDVAGTFG 591 (770)
Q Consensus 533 aL~yLH-~~~~~~IiHrDLKp~NILL~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~~GT~~ 591 (770)
||.||| + ++|+||||||+||||+.++ .+||+|||+|+..... ...||+.
T Consensus 173 aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~ 242 (336)
T 2vuw_A 173 SLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDV 242 (336)
T ss_dssp HHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCC
T ss_pred HHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeec
Confidence 999999 8 8999999999999999887 8999999999876542 2479999
Q ss_pred CCCceeeccCCCCCcceEeechHH-HHHHHhCCCCCC
Q 004174 592 YLAPEYFMYGKVNDKIDVYAFGVV-LLELLTGRKPIS 627 (770)
Q Consensus 592 YlAPE~~~~~~~s~ksDVwSlGvv-L~eLltG~~Pf~ 627 (770)
|+|||++.+.. +.++||||||++ .+++++|..||.
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 99999998555 889999998777 778889999984
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-30 Score=297.98 Aligned_cols=185 Identities=17% Similarity=0.104 Sum_probs=131.4
Q ss_pred eecccCceEEEEEE-eCCCCEEEEEEeCCC-----------hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEE
Q 004174 429 LIGKGGSSQVYKGC-LPDGKELAVKILKPS-----------EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 429 ~LG~G~fG~Vy~a~-~~~g~~vAVK~l~~~-----------~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++.|++|.+..+. .-.|+.++||++... +...++|.+|+++|+++ .|+||+++++++.+++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35666776665543 235888999999642 23456799999999999 699999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||++|++|.+.|...+ .++.. +|+.||+.||.|||+ +|||||||||+||||+.++.+||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 99999999999997653 35443 589999999999999 999999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf 626 (770)
..... ....+||++|+|||++. +.+..++|+||+|+++++|.+|..|+
T Consensus 391 ~~~~~--~~t~vGTp~YmAPE~l~-g~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 391 QDCSW--PTNLVQSFFVFVNELFA-ENKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---CC--SHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCcc--ccCceechhhccHHHhC-CCCCCcccccccccchhhhccccchh
Confidence 54332 23478999999999987 56778899999999998887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.6e-27 Score=270.74 Aligned_cols=185 Identities=17% Similarity=0.217 Sum_probs=147.8
Q ss_pred ccceeecccCceEEEEEEeCCCCEEEEEEeCCCh---------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 425 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 425 ~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~---------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
...++||+|+||.||+|.. .++.+++|+..... ...+.+.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 67889999864321 1245689999999999999999777777788888999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||++|++|.+++.. +..++.|++.||.|||+ ++|+||||||+|||++. .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999864 35799999999999999 89999999999999998 99999999999775
Q ss_pred CCCCCc-----eecccccccCCCCceeecc--CCCCCcceEeechHHHHHHHhCCCCCC
Q 004174 576 TSSSHI-----TCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPIS 627 (770)
Q Consensus 576 ~~~~~~-----~~~~~~GT~~YlAPE~~~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~ 627 (770)
...... ......||+.|+|||++.. ..|+..+|+|+..+-.++.+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 432211 1134689999999999986 568889999999999999988887763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-23 Score=220.92 Aligned_cols=154 Identities=16% Similarity=0.123 Sum_probs=125.5
Q ss_pred CHHHHHHhhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCCh-------------------hHHHHHHHHHHHHHh
Q 004174 413 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-------------------DVIKEFVLEIEIITT 473 (770)
Q Consensus 413 ~~~~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~-------------------~~~~~~~~Ei~iL~~ 473 (770)
.+..+......|.+.+.||+|+||.||+|...+|+.||||+++... .....+.+|+.+++.
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 3445555566788889999999999999998779999999997432 135678999999999
Q ss_pred cCCCceeEEeeEEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCC
Q 004174 474 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 553 (770)
Q Consensus 474 l~HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~ 553 (770)
++ | +++.+++.. +..++||||++||+|.+ +.. .....++.|++.||.|||+ ++|+||||||+
T Consensus 161 l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~ 222 (282)
T 1zar_A 161 LQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQY 222 (282)
T ss_dssp TT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTT
T ss_pred cc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHH
Confidence 99 5 666665544 56799999999999998 521 2245799999999999999 89999999999
Q ss_pred CeeeCCCCceEEccccccccccCCCCCceecccccccCCCCceeecc
Q 004174 554 NILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600 (770)
Q Consensus 554 NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~ 600 (770)
|||++ ++.+||+|||+|+ .+..|.|||++..
T Consensus 223 NILl~-~~~vkl~DFG~a~---------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 223 NVLVS-EEGIWIIDFPQSV---------------EVGEEGWREILER 253 (282)
T ss_dssp SEEEE-TTEEEECCCTTCE---------------ETTSTTHHHHHHH
T ss_pred HEEEE-CCcEEEEECCCCe---------------ECCCCCHHHHHHH
Confidence 99999 9999999999985 3445789998853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.4e-19 Score=186.61 Aligned_cols=136 Identities=20% Similarity=0.199 Sum_probs=107.5
Q ss_pred CcccceeecccCceEEEEEEe-CCCCE--EEEEEeCCChh-------------------------HHHHHHHHHHHHHhc
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKE--LAVKILKPSED-------------------------VIKEFVLEIEIITTL 474 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~--vAVK~l~~~~~-------------------------~~~~~~~Ei~iL~~l 474 (770)
-|.+.+.||+|+||.||+|.. .+|+. ||||+++.... ....+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 366789999999999999987 68989 99999765321 123678899999999
Q ss_pred CCCce--eEEeeEEeecCceEEEEeecCC-C----ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCceE
Q 004174 475 HHKNI--ISLLGFCFEDNNLLLVYDFLSR-G----SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH-SGSAQRVI 546 (770)
Q Consensus 475 ~HpnI--v~l~~~~~~~~~~~LV~E~~~g-g----sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~Ii 546 (770)
+|+++ ..++.+ +..+|||||+.+ | +|.+.... .++..+..++.|++.||.||| + .+|+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~---~giv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQE---AELV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHT---SCEE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHH---CCEE
Confidence 88764 333332 356999999942 4 66655432 235567889999999999999 8 8999
Q ss_pred EecccCCCeeeCCCCceEEccccccccc
Q 004174 547 HRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 547 HrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999998 9999999999754
|
| >1mjh_A Protein (ATP-binding domain of protein MJ0577); hypothetical protein, structural genomics, functional assignment; HET: ATP; 1.70A {Methanocaldococcus jannaschii} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.66 E-value=5.9e-16 Score=149.49 Aligned_cols=135 Identities=16% Similarity=0.095 Sum_probs=107.1
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCC-----CcccCC--C--C-cc--------chhhhHHHHHH
Q 004174 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANN-----AIVDRD--G--K-SS--------LLSLVKAFDSV 77 (770)
Q Consensus 16 ~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~-----~~~~~~--~--~-~~--------~~~~~~~~~~~ 77 (770)
-++|+|++|+|+.|..||+||+..+.+.|+.|++|||.++. ...... . . .. .....+...+.
T Consensus 5 ~~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (162)
T 1mjh_A 5 YKKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKNK 84 (162)
T ss_dssp CCEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHHH
T ss_pred cceEEEEeCCCHHHHHHHHHHHHHHhhcCCeEEEEEEecCccccccccccccccccccccchhhhHHHHHHHHHHHHHHH
Confidence 47999999999999999999999988889999999998653 110000 0 0 11 01112233467
Q ss_pred HHHHHhHhhhcCCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeC
Q 004174 78 LAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (770)
Q Consensus 78 l~~~~~~C~~k~V~~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~~ 154 (770)
|+.+...+...+++++..+.. |++.++|+++|++.++|+||||++++ .+.++| ||+.+++++++ |||++|+.
T Consensus 85 l~~~~~~~~~~g~~~~~~v~~-G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~~G--Sv~~~vl~~~~--~pVlvv~~ 159 (162)
T 1mjh_A 85 MENIKKELEDVGFKVKDIIVV-GIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLG--SVTENVIKKSN--KPVLVVKR 159 (162)
T ss_dssp HHHHHHHHHHTTCEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSC--HHHHHHHHHCC--SCEEEECC
T ss_pred HHHHHHHHHHcCCceEEEEcC-CCHHHHHHHHHHHcCCCEEEEcCCCCCCccceEec--chHHHHHHhCC--CCEEEEeC
Confidence 778888888889999998887 79999999999999999999999987 566788 99999999998 99999975
Q ss_pred C
Q 004174 155 G 155 (770)
Q Consensus 155 g 155 (770)
+
T Consensus 160 ~ 160 (162)
T 1mjh_A 160 K 160 (162)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3s3t_A Nucleotide-binding protein, universal stress PROT family; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: ATP; 1.90A {Lactobacillus plantarum} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.66 E-value=3.3e-16 Score=148.28 Aligned_cols=133 Identities=15% Similarity=0.175 Sum_probs=108.1
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCcc----chhhhHHHHHHHHHHHhHhhhcCC-
Q 004174 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSS----LLSLVKAFDSVLAVYEGFCNLKQV- 90 (770)
Q Consensus 16 ~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~~~~C~~k~V- 90 (770)
-++|+|++|+|+.|..||+||+..+.+.|+.|++|||.++........... .....+.....++.+...+...++
T Consensus 5 ~~~ILv~~D~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~ 84 (146)
T 3s3t_A 5 YTNILVPVDSSDAAQAAFTEAVNIAQRHQANLTALYVVDDSAYHTPALDPVLSELLDAEAAHAKDAMRQRQQFVATTSAP 84 (146)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEEECCCCCCGGGHHHHHHHHHHHHHHHHHHHHHHHHHHTTSSCC
T ss_pred cceEEEEcCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccHHHHHHHHHHHHHHHHHHHHHHHhcCCc
Confidence 579999999999999999999999988899999999987653321110000 011123334778888888888889
Q ss_pred cEEEEEEECCChhHHHHH-HHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEe
Q 004174 91 DLKLKICRGTSIRKILVR-EAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (770)
Q Consensus 91 ~~~~~v~~~~d~~~~L~~-~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~ 153 (770)
.++..+.. |++.+.|++ +|+..++|+||||++++ .+.++| |++.+++++++ |||++|+
T Consensus 85 ~~~~~~~~-g~~~~~I~~~~a~~~~~dliV~G~~~~~~~~~~~~G--s~~~~vl~~~~--~pVlvV~ 146 (146)
T 3s3t_A 85 NLKTEISY-GIPKHTIEDYAKQHPEIDLIVLGATGTNSPHRVAVG--STTSYVVDHAP--CNVIVIR 146 (146)
T ss_dssp CCEEEEEE-ECHHHHHHHHHHHSTTCCEEEEESCCSSCTTTCSSC--HHHHHHHHHCS--SEEEEEC
T ss_pred ceEEEEec-CChHHHHHHHHHhhcCCCEEEECCCCCCCcceEEEc--chHHHHhccCC--CCEEEeC
Confidence 99999888 799999999 99999999999999987 556778 99999999998 9999985
|
| >3hgm_A Universal stress protein TEAD; rossman fold, signaling protein; HET: ATP; 1.90A {Halomonas elongata} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.64 E-value=5.5e-16 Score=146.73 Aligned_cols=131 Identities=15% Similarity=0.105 Sum_probs=107.0
Q ss_pred cEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCC-cccCCC-------CccchhhhHHHHHHHHHHHhHhhhc
Q 004174 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNA-IVDRDG-------KSSLLSLVKAFDSVLAVYEGFCNLK 88 (770)
Q Consensus 17 r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~-~~~~~~-------~~~~~~~~~~~~~~l~~~~~~C~~k 88 (770)
++|+|++|+|+.|..||+||+..+.+.|+.|++|||.++.. ...... ........+.....++.+...+...
T Consensus 3 ~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 82 (147)
T 3hgm_A 3 NRIMVPVDGSKGAVKALEKGVGLQQLTGAELYILCVFKHHSLLEASLSMARPEQLDIPDDALKDYATEIAVQAKTRATEL 82 (147)
T ss_dssp SEEEEECCSBHHHHHHHHHHHHHHHHHCCEEEEEEEECCHHHHHHTBSSCCCGGGCCCTTHHHHHHHHHHHHHHHHHHHT
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCcccccccccccChhhhhhHHHHHHHHHHHHHHHHHHHHHhc
Confidence 68999999999999999999999888899999999986543 100000 0012222344557888888899988
Q ss_pred CCcE---EEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEE
Q 004174 89 QVDL---KLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAV 152 (770)
Q Consensus 89 ~V~~---~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV 152 (770)
++.+ +..+.. |++.++|+++|+..++|++|||++++ .+.++| |++.+++++++ |||++|
T Consensus 83 g~~~~~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~G--s~~~~vl~~~~--~pVlvV 147 (147)
T 3hgm_A 83 GVPADKVRAFVKG-GRPSRTIVRFARKRECDLVVIGAQGTNGDKSLLLG--SVAQRVAGSAH--CPVLVV 147 (147)
T ss_dssp TCCGGGEEEEEEE-SCHHHHHHHHHHHTTCSEEEECSSCTTCCSCCCCC--HHHHHHHHHCS--SCEEEC
T ss_pred CCCccceEEEEec-CCHHHHHHHHHHHhCCCEEEEeCCCCccccceeec--cHHHHHHhhCC--CCEEEC
Confidence 9888 888887 79999999999999999999999987 556778 99999999998 999987
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.7e-16 Score=174.70 Aligned_cols=137 Identities=15% Similarity=0.151 Sum_probs=101.5
Q ss_pred cCcccceeecccCceEEEEEEeCCCCEEEEEEeCCCh---------------h--------HHHHHHHHHHHHHhcCCCc
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------------D--------VIKEFVLEIEIITTLHHKN 478 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~---------------~--------~~~~~~~Ei~iL~~l~Hpn 478 (770)
.-|.+.+.||.|+||.||+|...+|+.||||+++... . .......|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3488999999999999999999899999999986320 0 0011235677777776544
Q ss_pred eeEEeeEEeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC
Q 004174 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (770)
Q Consensus 479 Iv~l~~~~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 558 (770)
+.-..-+.. ...+|||||++|++|.++... .....++.||+.+|.|||+ .|||||||||.||||+
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEe
Confidence 322211111 233799999999988765421 2335688999999999999 8999999999999998
Q ss_pred CCC----------ceEEcccccccc
Q 004174 559 DDF----------EPQLSDFGLAKW 573 (770)
Q Consensus 559 ~~~----------~vkL~DFGla~~ 573 (770)
+++ .+.|+||+-+..
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCcccccccccceEEEEeCCccc
Confidence 776 389999997753
|
| >1tq8_A Hypothetical protein RV1636; MTCY01B2.28, structural target, NYSGXRC, PSI, protein structure initiative; 2.40A {Mycobacterium tuberculosis} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.63 E-value=1.2e-15 Score=148.41 Aligned_cols=137 Identities=15% Similarity=0.067 Sum_probs=104.8
Q ss_pred CCCCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEE--EeecCCCc-ccCCC-C-ccchhhhHHHHHHHHHHHhHhhh
Q 004174 13 SGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIAL--HVLANNAI-VDRDG-K-SSLLSLVKAFDSVLAVYEGFCNL 87 (770)
Q Consensus 13 ~~~~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlv--HV~~~~~~-~~~~~-~-~~~~~~~~~~~~~l~~~~~~C~~ 87 (770)
...-++|+|++|+|+.|..||+||+..+. .|+.|++| ||.++... ..... . .......+...+.|+.+...+..
T Consensus 14 ~~~~~~ILv~vD~s~~s~~al~~A~~lA~-~~a~l~ll~a~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 92 (163)
T 1tq8_A 14 LSAYKTVVVGTDGSDSSMRAVDRAAQIAG-ADAKLIIASAYLPQHEDARAADILKDESYKVTGTAPIYEILHDAKERAHN 92 (163)
T ss_dssp CCCCCEEEEECCSSHHHHHHHHHHHHHHT-TTSEEEEEEECCC--------------------CCTHHHHHHHHHHHHHT
T ss_pred cccCCEEEEEcCCCHHHHHHHHHHHHHhC-CCCEEEEEEeeeccCcccccccccccHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 34468999999999999999999999998 99999999 88754321 00000 0 00011222334677788888888
Q ss_pred cCCc-EEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004174 88 KQVD-LKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (770)
Q Consensus 88 k~V~-~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~~g 155 (770)
.+++ ++..+.. |++.++|+++|++.++|+||||++++ .+.++| ||+.+++++++ |||++|+..
T Consensus 93 ~gv~~v~~~v~~-G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lG--Sva~~vl~~a~--~PVlvV~~~ 159 (163)
T 1tq8_A 93 AGAKNVEERPIV-GAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLG--SVPANVSRRAK--VDVLIVHTT 159 (163)
T ss_dssp TTCCEEEEEEEC-SSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTB--BHHHHHHHHTT--CEEEEECCC
T ss_pred cCCCeEEEEEec-CCHHHHHHHHHHhcCCCEEEECCCCCCcccceeec--cHHHHHHHhCC--CCEEEEeCC
Confidence 8898 8888877 79999999999999999999999987 456778 99999999998 999999854
|
| >2dum_A Hypothetical protein PH0823; conserved hypothetical protein, putative universal protein A structural genomics, NPPSFA; 2.75A {Pyrococcus horikoshii} | Back alignment and structure |
|---|
Probab=99.62 E-value=3.6e-15 Score=145.22 Aligned_cols=135 Identities=14% Similarity=0.038 Sum_probs=106.7
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCC-CC------------ccchhhhHHHHHHHHHHH
Q 004174 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRD-GK------------SSLLSLVKAFDSVLAVYE 82 (770)
Q Consensus 16 ~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~-~~------------~~~~~~~~~~~~~l~~~~ 82 (770)
-++|+|++|+++.|..||+||+..+.+.|+.|++|||..+....... +. .......+.....|+.+.
T Consensus 5 ~~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 84 (170)
T 2dum_A 5 FRKVLFPTDFSEGAYRAVEVFEKRNKMEVGEVILLHVIDEGTLEELMDGYSFFYDNAEIELKDIKEKLKEEASRKLQEKA 84 (170)
T ss_dssp CSEEEEECCSSHHHHHHHHHHHHHCCSCCSEEEEEEEEETTGGGCCC------------CCTTSHHHHHHHHHHHHHHHH
T ss_pred cceEEEEecCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 57999999999999999999999999999999999998654221000 00 001112233346777777
Q ss_pred hHhhhcCCcEEE--EEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004174 83 GFCNLKQVDLKL--KICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (770)
Q Consensus 83 ~~C~~k~V~~~~--~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~~g 155 (770)
..+...+++++. .+.. |++.++|+++|+..++|+||||++++ .+.++| ||+.+++++++ |||++|+.+
T Consensus 85 ~~~~~~g~~~~~~~~~~~-g~~~~~I~~~a~~~~~DlIV~G~~g~~~~~~~~~G--sv~~~vl~~~~--~PVlvv~~~ 157 (170)
T 2dum_A 85 EEVKRAFRAKNVRTIIRF-GIPWDEIVKVAEEENVSLIILPSRGKLSLSHEFLG--STVMRVLRKTK--KPVLIIKEV 157 (170)
T ss_dssp HHHHHHTTCSEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCCCC--TTCCC--HHHHHHHHHCS--SCEEEECCC
T ss_pred HHHHHcCCceeeeeEEec-CChHHHHHHHHHHcCCCEEEECCCCCCccccceec--hHHHHHHHhCC--CCEEEEccC
Confidence 777778888887 7777 79999999999999999999999987 456778 99999999998 999999854
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} | Back alignment and structure |
|---|
Probab=99.62 E-value=1e-15 Score=143.66 Aligned_cols=129 Identities=13% Similarity=0.150 Sum_probs=104.5
Q ss_pred cEEEEEEcCCcchHHHHHHHHhhc-cCCCCEEEEEEeecCCCcccCCCC---ccchhhh-HHHHHHHHHHHhHhhhcCCc
Q 004174 17 RTVVVGVKLDTHSRELLTWALVKV-AQPGDTVIALHVLANNAIVDRDGK---SSLLSLV-KAFDSVLAVYEGFCNLKQVD 91 (770)
Q Consensus 17 r~I~VaVd~s~~S~~AL~WAl~~~-~~~gd~vvlvHV~~~~~~~~~~~~---~~~~~~~-~~~~~~l~~~~~~C~~k~V~ 91 (770)
++|+|++|+|+.|..||+||+..+ .+.|+.|++|||.++......... ....... +.....++.+...+...++.
T Consensus 2 ~~ILv~~D~s~~s~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~ 81 (138)
T 3idf_A 2 KKLLFAIDDTEACERAAQYILDMFGKDADCTLTLIHVKPEFMLYGEAVLAAYDEIEMKEEEKAKLLTQKFSTFFTEKGIN 81 (138)
T ss_dssp EEEEEECCSSHHHHHHHHHHHHHHTTCTTEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHhccCCCCEEEEEEEecCCCcccccccCcHHHHHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 589999999999999999999999 889999999999976532111000 0011112 33447788888888888999
Q ss_pred EEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEe
Q 004174 92 LKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (770)
Q Consensus 92 ~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~ 153 (770)
++..+.. |++.++|+++|+ ++|+||||++++ .+.+ | |++.+++++++ |||++|+
T Consensus 82 ~~~~v~~-g~~~~~I~~~a~--~~dliV~G~~~~~~~~~~~-G--s~~~~vl~~~~--~pVlvv~ 138 (138)
T 3idf_A 82 PFVVIKE-GEPVEMVLEEAK--DYNLLIIGSSENSFLNKIF-A--SHQDDFIQKAP--IPVLIVK 138 (138)
T ss_dssp CEEEEEE-SCHHHHHHHHHT--TCSEEEEECCTTSTTSSCC-C--CTTCHHHHHCS--SCEEEEC
T ss_pred eEEEEec-CChHHHHHHHHh--cCCEEEEeCCCcchHHHHh-C--cHHHHHHhcCC--CCEEEeC
Confidence 9999888 799999999999 899999999987 4555 7 99999999998 9999985
|
| >3tnj_A Universal stress protein (USP); structural genomics, PSI-biology, midwest center for structu genomics, MCSG, chaperone; HET: AMP; 2.00A {Nitrosomonas europaea} PDB: 2pfs_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=2.9e-15 Score=142.52 Aligned_cols=137 Identities=17% Similarity=0.161 Sum_probs=98.9
Q ss_pred CCCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcc----cCCCCcc-chhhhHHHHHHHHHHHhHhhhc
Q 004174 14 GAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIV----DRDGKSS-LLSLVKAFDSVLAVYEGFCNLK 88 (770)
Q Consensus 14 ~~~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~----~~~~~~~-~~~~~~~~~~~l~~~~~~C~~k 88 (770)
..-++|+|++|+|+.|..||+||+..+.+.|+.|++|||.++.... ....... .....+..+.....++.++...
T Consensus 4 ~~~~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 83 (150)
T 3tnj_A 4 SVYHHILLAVDFSSEDSQVVQKVRNLASQIGARLSLIHVLDNIPMPDTPYGTAIPLDTETTYDAMLDVEKQKLSQIGNTL 83 (150)
T ss_dssp CCCSEEEEECCCSTTHHHHHHHHHHHHHHHTCEEEEEEEEC--------CTTCCCSSSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred CccceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEEcCccccccccccccCcCHHHHHHHHHHHHHHHHHHHHHHc
Confidence 3468999999999999999999999998889999999998654321 1100000 1111223334455566667766
Q ss_pred CCc-EEEEEEECCChhHHHHHHHHhcCCcEEEEccCCCc--ccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004174 89 QVD-LKLKICRGTSIRKILVREAQSYSATKFIVGTAKNH--HTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (770)
Q Consensus 89 ~V~-~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~~--r~~~~~~sVs~yc~~~ap~~C~V~vV~~g 155 (770)
++. ++..+.. |++.++|+++|+..++|+||||++++. ..++| |++.+++++++ |||++|+..
T Consensus 84 ~~~~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~G--s~~~~vl~~~~--~pVlvv~~~ 148 (150)
T 3tnj_A 84 GIDPAHRWLVW-GEPREEIIRIAEQENVDLIVVGSHGRHGLALLLG--STANSVLHYAK--CDVLAVRLR 148 (150)
T ss_dssp TCCGGGEEEEE-SCHHHHHHHHHHHTTCSEEEEEEC--------CC--CHHHHHHHHCS--SEEEEEECC
T ss_pred CCCcceEEEec-CCHHHHHHHHHHHcCCCEEEEecCCCCCcCeEec--chHHHHHHhCC--CCEEEEeCC
Confidence 776 4666666 899999999999999999999999872 25677 99999999998 999999853
|
| >3fdx_A Putative filament protein / universal stress PROT; structural genomics, APC60640.1, universal protein F, PSI-2; HET: MSE ATP; 1.58A {Klebsiella pneumoniae subsp} PDB: 3fh0_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=2.9e-15 Score=141.23 Aligned_cols=132 Identities=14% Similarity=0.172 Sum_probs=102.8
Q ss_pred cEEEEEEcCCcc--hHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCcc---chhhhHHHHHHHHHHHhHhhhcC--
Q 004174 17 RTVVVGVKLDTH--SRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSS---LLSLVKAFDSVLAVYEGFCNLKQ-- 89 (770)
Q Consensus 17 r~I~VaVd~s~~--S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~C~~k~-- 89 (770)
++|+|++|+|+. |..||+||+..+.+.|+.|++|||.++........... .....+..++.+..++.++...+
T Consensus 2 k~ILv~vD~s~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 81 (143)
T 3fdx_A 2 NAILVPIDISDKEFTERIISHVESEARIDDAEVHFLTVIPSLPYYASLGMAYTAELPGMDELREGSETQLKEIAKKFSIP 81 (143)
T ss_dssp CEEEEECCTTCSSCCTTHHHHHHHHHHHHTCEEEEEEEECC----------------CHHHHHHHHHHHHHHHHTTSCCC
T ss_pred CEEEEEecCChHhhHHHHHHHHHHHHHhcCCeEEEEEEecCCcccccccccccchhhhHHHHHHHHHHHHHHHHHHcCCC
Confidence 789999999999 99999999999888899999999997643221111110 11123344567778888888764
Q ss_pred -CcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC--cccccCCCchHHHHhccCCCCcEEEEEe
Q 004174 90 -VDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN--HHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (770)
Q Consensus 90 -V~~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~--~r~~~~~~sVs~yc~~~ap~~C~V~vV~ 153 (770)
+.++..+.. |++.++|+++|+..++|+||||+++. .+.++| |++.+++++++ |||++|+
T Consensus 82 ~~~v~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~G--s~~~~v~~~~~--~pVlvv~ 143 (143)
T 3fdx_A 82 EDRMHFHVAE-GSPKDKILALAKSLPADLVIIASHRPDITTYLLG--SNAAAVVRHAE--CSVLVVR 143 (143)
T ss_dssp GGGEEEEEEE-SCHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSC--HHHHHHHHHCS--SEEEEEC
T ss_pred CCceEEEEEe-cChHHHHHHHHHHhCCCEEEEeCCCCCCeeeeec--cHHHHHHHhCC--CCEEEeC
Confidence 457888888 69999999999999999999999965 556778 99999999998 9999985
|
| >3fg9_A Protein of universal stress protein USPA family; APC60691, nucleotide- binding, lactobacillus plantarum WCFS1, structural genomics PSI-2; 1.47A {Lactobacillus plantarum} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.4e-15 Score=144.33 Aligned_cols=136 Identities=17% Similarity=0.242 Sum_probs=107.5
Q ss_pred CCCcEEEEEEc--CCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCcc--chhhhHHHHHHHHHHHhHhhhcC
Q 004174 14 GAGRTVVVGVK--LDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSS--LLSLVKAFDSVLAVYEGFCNLKQ 89 (770)
Q Consensus 14 ~~~r~I~VaVd--~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~C~~k~ 89 (770)
..-++|+|++| +|+.|..||+||+..+...|..|++|||.++........... .....+...+.|..+...+...+
T Consensus 13 ~~~~~ILv~vD~~~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g 92 (156)
T 3fg9_A 13 LVYRRILLTVDEDDNTSSERAFRYATTLAHDYDVPLGICSVLESEDINIFDSLTPSKIQAKRKHVEDVVAEYVQLAEQRG 92 (156)
T ss_dssp CCCC-EEEECCSCCCHHHHHHHHHHHHHHHHHTCCEEEEEEECCCCTTCCCSSHHHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccCceEEEEECCCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEeCCCccccccCCHHHHHHHHHHHHHHHHHHHHHHHHcC
Confidence 34689999999 999999999999998888899999999987653211111110 11122333477888888888889
Q ss_pred C-cEEEEEEECCChhHHHHHH-HHhcCCcEEEEccCCC--cccccCCCchHHHHhccCCCCcEEEEEe
Q 004174 90 V-DLKLKICRGTSIRKILVRE-AQSYSATKFIVGTAKN--HHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (770)
Q Consensus 90 V-~~~~~v~~~~d~~~~L~~~-a~~~~a~~LVlG~~~~--~r~~~~~~sVs~yc~~~ap~~C~V~vV~ 153 (770)
+ .++..+..+|++.++|+++ |+..++|+||||++++ .+.++| ||+.+++++++ |||++|+
T Consensus 93 ~~~~~~~v~~~g~~~~~I~~~~a~~~~~DlIV~G~~g~~~~~~~~G--s~~~~vl~~a~--~PVlvV~ 156 (156)
T 3fg9_A 93 VNQVEPLVYEGGDVDDVILEQVIPEFKPDLLVTGADTEFPHSKIAG--AIGPRLARKAP--ISVIVVR 156 (156)
T ss_dssp CSSEEEEEEECSCHHHHHHHTHHHHHCCSEEEEETTCCCTTSSSCS--CHHHHHHHHCS--SEEEEEC
T ss_pred CCceEEEEEeCCCHHHHHHHHHHHhcCCCEEEECCCCCCccceeec--chHHHHHHhCC--CCEEEeC
Confidence 9 5888888878999999999 9999999999999987 223777 99999999998 9999985
|
| >3dlo_A Universal stress protein; unknown function, structural genomics, PSI-2, protein struct initiative, midwest center for structural genomics; HET: MSE; 1.97A {Archaeoglobus fulgidus} PDB: 3qtb_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=2.1e-15 Score=145.36 Aligned_cols=128 Identities=17% Similarity=0.161 Sum_probs=106.9
Q ss_pred CCcEEEEEEcC-CcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCccchhhhHHHHHHHHHHHhHhhhcCCcEE
Q 004174 15 AGRTVVVGVKL-DTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLK 93 (770)
Q Consensus 15 ~~r~I~VaVd~-s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~ 93 (770)
.-++|+|++|+ |+.|..||+||+..+...|+.|++|||.++... ......+.....++.+...+...++.++
T Consensus 23 m~~~ILv~vD~~s~~s~~al~~A~~la~~~~a~l~llhV~~~~~~-------~~~~~~~~~~~~l~~~~~~~~~~g~~~~ 95 (155)
T 3dlo_A 23 IYMPIVVAVDKKSDRAERVLRFAAEEARLRGVPVYVVHSLPGGGR-------TKDEDIIEAKETLSWAVSIIRKEGAEGE 95 (155)
T ss_dssp CCCCEEEECCSSSHHHHHHHHHHHHHHHHHTCCEEEEEEECCSTT-------SCHHHHHHHHHHHHHHHHHHHHTTCCEE
T ss_pred ccCeEEEEECCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEcCCCc-------ccHHHHHHHHHHHHHHHHHHHhcCCCce
Confidence 35789999999 999999999999999888999999999865421 1122334445778888888888888888
Q ss_pred EEE-EECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEe
Q 004174 94 LKI-CRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (770)
Q Consensus 94 ~~v-~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~ 153 (770)
..+ +..|++.++|+++|+..++|+||||++++ .+.++| ||+.+++++++ |||++|+
T Consensus 96 ~~~~v~~G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lG--Sv~~~vl~~a~--~PVLvVr 155 (155)
T 3dlo_A 96 EHLLVRGKEPPDDIVDFADEVDAIAIVIGIRKRSPTGKLIFG--SVARDVILKAN--KPVICIK 155 (155)
T ss_dssp EEEEESSSCHHHHHHHHHHHTTCSEEEEECCEECTTSCEECC--HHHHHHHHHCS--SCEEEEC
T ss_pred EEEEecCCCHHHHHHHHHHHcCCCEEEECCCCCCCCCCEEec--cHHHHHHHhCC--CCEEEeC
Confidence 754 55689999999999999999999999987 456778 99999999998 9999985
|
| >2z08_A Universal stress protein family; uncharacterized conserved protein, structural genomics, unknown function, NPPSFA; HET: ATP; 1.55A {Thermus thermophilus} SCOP: c.26.2.4 PDB: 1wjg_A* 2z09_A* 2z3v_A | Back alignment and structure |
|---|
Probab=99.59 E-value=3.2e-15 Score=140.23 Aligned_cols=131 Identities=16% Similarity=0.146 Sum_probs=96.3
Q ss_pred cEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCccchhhhHHHHHHHHHHHhHhhhcCC-cEEEE
Q 004174 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQV-DLKLK 95 (770)
Q Consensus 17 r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V-~~~~~ 95 (770)
++|+|++|+|+.|..||+||+..+.+.|+.|++|||.++..... ....+........+.....++.++...++ .++..
T Consensus 3 ~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~g~~~~~~~ 81 (137)
T 2z08_A 3 KTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYL-GEPFFEEALRRRLERAEGVLEEARALTGVPKEDAL 81 (137)
T ss_dssp SEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECC---------------CHHHHHHHHHHHHHHHHHCCCGGGEE
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecCCCccc-cccchHHHHHHHHHHHHHHHHHHHHHcCCCccEEE
Confidence 68999999999999999999999888899999999986432100 00000000011111222333344444678 77777
Q ss_pred EEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEe
Q 004174 96 ICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (770)
Q Consensus 96 v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~ 153 (770)
+.. |++.++|+++|++.++|++|||++++ .+.++| |++.+++++++ |||++|+
T Consensus 82 ~~~-g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~G--s~~~~vl~~~~--~pVlvv~ 137 (137)
T 2z08_A 82 LLE-GVPAEAILQAARAEKADLIVMGTRGLGALGSLFLG--SQSQRVVAEAP--CPVLLVR 137 (137)
T ss_dssp EEE-SSHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSSC--HHHHHHHHHCS--SCEEEEC
T ss_pred EEe-cCHHHHHHHHHHHcCCCEEEECCCCCchhhhhhhc--cHHHHHHhcCC--CCEEEeC
Confidence 777 79999999999999999999999987 456778 99999999998 9999985
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.59 E-value=7.3e-15 Score=143.86 Aligned_cols=136 Identities=18% Similarity=0.316 Sum_probs=100.3
Q ss_pred CCcEEEEEEcCCc---------chHHHHHHHHhhccCC---CCEEEEEEeecCCCc-ccC-CC--Ccc-ch-----hhhH
Q 004174 15 AGRTVVVGVKLDT---------HSRELLTWALVKVAQP---GDTVIALHVLANNAI-VDR-DG--KSS-LL-----SLVK 72 (770)
Q Consensus 15 ~~r~I~VaVd~s~---------~S~~AL~WAl~~~~~~---gd~vvlvHV~~~~~~-~~~-~~--~~~-~~-----~~~~ 72 (770)
.-++|+|+||+|+ .|..||+||+..+++. |..|++|||.++... ... .. ... .. ...+
T Consensus 4 ~~~~ILv~vD~s~~~~~~~~~~~s~~al~~a~~la~~~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (175)
T 2gm3_A 4 EPTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKA 83 (175)
T ss_dssp -CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHHH
T ss_pred CccEEEEEECCCcccccccccHHHHHHHHHHHHHhhcccCCCCEEEEEEEeecccccccccccccCCHHHHHHHHHHHHH
Confidence 3579999999999 9999999999998764 789999999854321 100 00 000 00 0111
Q ss_pred HHHHHHHHHHhHhhhcCCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEE
Q 004174 73 AFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSV 149 (770)
Q Consensus 73 ~~~~~l~~~~~~C~~k~V~~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V 149 (770)
.....|+.+...+...++.++..+.. |++.++|+++|+..++|+||||++++ .+.++| ||+.+++++++ |||
T Consensus 84 ~~~~~l~~~~~~~~~~g~~~~~~v~~-G~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~~~~G--sva~~vl~~a~--~pV 158 (175)
T 2gm3_A 84 KGLHLLEFFVNKCHEIGVGCEAWIKT-GDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVG--TVSAFCVKHAE--CPV 158 (175)
T ss_dssp HHHHHHHHHHHHHHHHTCEEEEEEEE-SCHHHHHHHHHHHHCCSEEEEEECCCC----------CHHHHHHHHCS--SCE
T ss_pred HHHHHHHHHHHHHHHCCCceEEEEec-CCHHHHHHHHHHHhCCCEEEEeCCCCChhhhhhcC--chHHHHHhCCC--CCE
Confidence 23367777777788889999988888 79999999999999999999999987 466778 99999999998 999
Q ss_pred EEEeCC
Q 004174 150 LAVNNG 155 (770)
Q Consensus 150 ~vV~~g 155 (770)
++|+.+
T Consensus 159 lvv~~~ 164 (175)
T 2gm3_A 159 MTIKRN 164 (175)
T ss_dssp EEEECC
T ss_pred EEEcCC
Confidence 999864
|
| >1jmv_A USPA, universal stress protein A; chaperone; 1.85A {Haemophilus influenzae} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.49 E-value=3.5e-14 Score=133.53 Aligned_cols=132 Identities=13% Similarity=0.128 Sum_probs=94.6
Q ss_pred cEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecC-CCcccCCCCccchhhhH-HHHHHHHHHHhHhhhcCCcE-E
Q 004174 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLAN-NAIVDRDGKSSLLSLVK-AFDSVLAVYEGFCNLKQVDL-K 93 (770)
Q Consensus 17 r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~-~~~~~~~~~~~~~~~~~-~~~~~l~~~~~~C~~k~V~~-~ 93 (770)
++|+|++|+|+.|..||+||+..+...|+.|++|||.++ +...............+ ..+.....++.++...++.+ +
T Consensus 3 ~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 82 (141)
T 1jmv_A 3 KHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGLIDVNMSSMQDRISTETQKALLDLAESVDYPISE 82 (141)
T ss_dssp SEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCCEEHHHHHHTTCCCCHHHHHHHHHHHHSSSCCCC
T ss_pred ceEEEEecCchhhHHHHHHHHHHHHhcCCEEEEEEEecCchhhhccccccchHHHHHHHHHHHHHHHHHHHHHcCCCceE
Confidence 689999999999999999999998888999999999853 21111100000000000 00122334445566667766 3
Q ss_pred EEEEECCChhHHHHHHHHhcCCcEEEEccCCCc--ccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004174 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKNH--HTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (770)
Q Consensus 94 ~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~~--r~~~~~~sVs~yc~~~ap~~C~V~vV~~g 155 (770)
..+.. |++.+.|+++|+..++|+||||++ +. +. +| |++.+++++++ |||++|+.+
T Consensus 83 ~~~~~-g~~~~~I~~~a~~~~~dliV~G~~-~~~~~~-lg--s~~~~vl~~~~--~pVlvv~~~ 139 (141)
T 1jmv_A 83 KLSGS-GDLGQVLSDAIEQYDVDLLVTGHH-QDFWSK-LM--SSTRQVMNTIK--IDMLVVPLR 139 (141)
T ss_dssp EEEEE-ECHHHHHHHHHHHTTCCEEEEEEC-CCCHHH-HH--HHHHHHHTTCC--SEEEEEECC
T ss_pred EEEec-CCHHHHHHHHHHhcCCCEEEEeCC-Cchhhh-hc--chHHHHHhcCC--CCEEEeeCC
Confidence 44554 899999999999999999999999 61 11 36 99999999998 999999864
|
| >1q77_A Hypothetical protein AQ_178; structural genomics, universal stress protein, PSI, protein structure initiative; 2.70A {Aquifex aeolicus} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.46 E-value=1.7e-13 Score=128.47 Aligned_cols=125 Identities=10% Similarity=-0.047 Sum_probs=93.5
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEee-cC-C--Cccc--CCC--CccchhhhHHHHHHHHHHHhHh--
Q 004174 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVL-AN-N--AIVD--RDG--KSSLLSLVKAFDSVLAVYEGFC-- 85 (770)
Q Consensus 16 ~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~-~~-~--~~~~--~~~--~~~~~~~~~~~~~~l~~~~~~C-- 85 (770)
-++|+|++|+|+.|..||+||+..+.+.|+.|++|||. +. + .... ... ........+...+.|..+ ..|
T Consensus 4 ~~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~ 82 (138)
T 1q77_A 4 MKVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPFPPEIKEESKKRIERRLREV-WEKLT 82 (138)
T ss_dssp CEEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCCCCTHHHHHHHHHHHHHHHHH-HHHHH
T ss_pred ccEEEEEccCCHhHHHHHHHHHHHHHHcCCeEEEEEEecccccccccccccCCCCChHHHHHHHHHHHHHHHHH-HHHhh
Confidence 47899999999999999999999998889999999998 53 1 1000 000 001111122333566666 553
Q ss_pred hhcCCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCCcccccCCCchHHHHhccCCCCcEEEEEe
Q 004174 86 NLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (770)
Q Consensus 86 ~~k~V~~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~~r~~~~~~sVs~yc~~~ap~~C~V~vV~ 153 (770)
...+ .++..+.. |++.+.|+++|+..++|+||||++++ ||+.+++++++ |||++|+
T Consensus 83 ~~~~-~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~g~--------sv~~~vl~~a~--~PVlvv~ 138 (138)
T 1q77_A 83 GSTE-IPGVEYRI-GPLSEEVKKFVEGKGYELVVWACYPS--------AYLCKVIDGLN--LASLIVK 138 (138)
T ss_dssp SCCC-CCCEEEEC-SCHHHHHHHHHTTSCCSEEEECSCCG--------GGTHHHHHHSS--SEEEECC
T ss_pred ccCC-cceEEEEc-CCHHHHHHHHHHhcCCCEEEEeCCCC--------chHHHHHHhCC--CceEeeC
Confidence 3344 56666665 89999999999999999999999974 89999999998 9999985
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.1e-12 Score=138.94 Aligned_cols=132 Identities=14% Similarity=0.157 Sum_probs=99.9
Q ss_pred CCcEEEEEEcCCcc-------hHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCccchhh-hHHHHHHHHHHHhHhh
Q 004174 15 AGRTVVVGVKLDTH-------SRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSL-VKAFDSVLAVYEGFCN 86 (770)
Q Consensus 15 ~~r~I~VaVd~s~~-------S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~C~ 86 (770)
..++|+|++|+|+. |..||+||+..+...|..|++|||.++...... .+.... .+........++.++.
T Consensus 133 ~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~~~~ 209 (290)
T 3mt0_A 133 TGGKILAAVDVGNNDGEHRSLHAGIISHAYDIAGLAKATLHVISAHPSPMLSSA---DPTFQLSETIEARYREACRTFQA 209 (290)
T ss_dssp TTCEEEEEECTTCCSHHHHHHHHHHHHHHHHHHHHTTCEEEEEEEEC------------CHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCeEEEEECCCCcchhhhHHHHHHHHHHHHHHHHcCCeEEEEEEecCcccccc---CchhHHHHHHHHHHHHHHHHHHH
Confidence 46899999999999 999999999999888999999999875432111 111011 1122234445555666
Q ss_pred hcCCc-EEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeC
Q 004174 87 LKQVD-LKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (770)
Q Consensus 87 ~k~V~-~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~~ 154 (770)
..++. +...+.. |++.++|+++|+..++|+||||++++ .+.++| ||+.+++++++ |||++|+.
T Consensus 210 ~~g~~~~~~~v~~-g~~~~~I~~~a~~~~~dLiVmG~~g~~~~~~~~~G--sv~~~vl~~~~--~pVLvv~~ 276 (290)
T 3mt0_A 210 EYGFSDEQLHIEE-GPADVLIPRTAQKLDAVVTVIGTVARTGLSGALIG--NTAEVVLDTLE--SDVLVLKP 276 (290)
T ss_dssp HHTCCTTTEEEEE-SCHHHHHHHHHHHHTCSEEEEECCSSCCGGGCCSC--HHHHHHHTTCS--SEEEEECC
T ss_pred HcCCCcceEEEec-cCHHHHHHHHHHhcCCCEEEECCCCCcCCcceecc--hHHHHHHhcCC--CCEEEECC
Confidence 66773 4566666 79999999999999999999999988 566788 99999999998 99999974
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.38 E-value=2.1e-12 Score=138.31 Aligned_cols=139 Identities=11% Similarity=0.059 Sum_probs=109.1
Q ss_pred CCCCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCcc--ch----hhhHHHHHHHHHHHhHhh
Q 004174 13 SGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSS--LL----SLVKAFDSVLAVYEGFCN 86 (770)
Q Consensus 13 ~~~~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~--~~----~~~~~~~~~l~~~~~~C~ 86 (770)
|..-++|+|++|+|+.|..||+||+.-+.+.|..|++|||.++........... .. ...+...+.|..+...+.
T Consensus 4 M~~~k~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 83 (319)
T 3olq_A 4 MEKYQNLLVVIDPNQDDQPALRRAVYIVQRNGGRIKAFLPVYDLSYDMTTLLSPDERNAMRKGVINQKTAWIKQQARYYL 83 (319)
T ss_dssp -CCSCEEEEECCTTCSCCHHHHHHHHHHHHHCCEEEEEEEECCGGGGCTTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccceEEEEECCCcccHHHHHHHHHHHHHcCCeEEEEEEecccchhhccccChhhHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 445689999999999999999999999988899999999975432211111000 10 111222356677777777
Q ss_pred hcCCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004174 87 LKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (770)
Q Consensus 87 ~k~V~~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~~g 155 (770)
..++.++..+.+.|++...|+++|+..++|++|||+++. .+.++| |++.+++++++ |||++|+.+
T Consensus 84 ~~~v~~~~~~~~~g~~~~~i~~~a~~~~~DLiV~G~~g~~~~~~~~~G--s~~~~vl~~~~--~PVlvv~~~ 151 (319)
T 3olq_A 84 EAGIQIDIKVIWHNRPYEAIIEEVITDKHDLLIKMAHQHDKLGSLIFT--PLDWQLLRKCP--APVWMVKDK 151 (319)
T ss_dssp HTTCCEEEEEEECSCHHHHHHHHHHHHTCSEEEEEEBCC--CCSCBCC--HHHHHHHHHCS--SCEEEEESS
T ss_pred hcCCeEEEEEEecCChHHHHHHHHHhcCCCEEEEecCcCchhhccccc--ccHHHHHhcCC--CCEEEecCc
Confidence 889999999996799999999999999999999999987 556678 99999999998 999999864
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=2.1e-12 Score=138.07 Aligned_cols=134 Identities=11% Similarity=0.120 Sum_probs=104.8
Q ss_pred CCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCcc---chhhhHHHHHHHHHHHhHhhhc---
Q 004174 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSS---LLSLVKAFDSVLAVYEGFCNLK--- 88 (770)
Q Consensus 15 ~~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~C~~k--- 88 (770)
.-++|+|++|+|+.|..||+||+..+.+.|..|++|||.++....-...... .....+..++.++.+...|...
T Consensus 18 ~~~~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 97 (309)
T 3cis_A 18 SSLGIIVGIDDSPAAQVAVRWAARDAELRKIPLTLVHAVSPEVATWLEVPLPPGVLRWQQDHGRHLIDDALKVVEQASLR 97 (309)
T ss_dssp CTTEEEEECCSSHHHHHHHHHHHHHHHHHTCCEEEEEECCCCCCCTTCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHCSS
T ss_pred CCCeEEEEECCCHHHHHHHHHHHHHHHhcCCcEEEEEEecCcccccccCCCCchhhHHHHHHHHHHHHHHHHHHHHhccc
Confidence 4689999999999999999999999988899999999986432110011111 0111233346777777777765
Q ss_pred --CCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004174 89 --QVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (770)
Q Consensus 89 --~V~~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~~g 155 (770)
++.++..+.. |++.+.|+++|+ ++|+||||++++ .+.++| |++.+++++++ |||++|+.+
T Consensus 98 ~~~~~~~~~~~~-g~~~~~I~~~a~--~~DliV~G~~g~~~~~~~~~G--s~~~~vl~~~~--~PVlvv~~~ 162 (309)
T 3cis_A 98 AGPPTVHSEIVP-AAAVPTLVDMSK--DAVLMVVGCLGSGRWPGRLLG--SVSSGLLRHAH--CPVVIIHDE 162 (309)
T ss_dssp SCCSCEEEEEES-SCHHHHHHHHGG--GEEEEEEESSCTTCCTTCCSC--HHHHHHHHHCS--SCEEEECTT
T ss_pred CCCceEEEEEec-CCHHHHHHHHhc--CCCEEEECCCCCccccccccC--cHHHHHHHhCC--CCEEEEcCC
Confidence 8999988876 899999999998 699999999987 456778 99999999998 999999864
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.34 E-value=1.5e-12 Score=138.24 Aligned_cols=137 Identities=9% Similarity=0.031 Sum_probs=108.4
Q ss_pred CCCCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCcc----chhhhHHHHHHHHHHHhHhhhc
Q 004174 13 SGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSS----LLSLVKAFDSVLAVYEGFCNLK 88 (770)
Q Consensus 13 ~~~~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~~~~C~~k 88 (770)
+..-++|+|++|.|+.|..||+||+..+.+.|..|++|||.+............ .....+...+.|+.+...+...
T Consensus 19 m~m~~~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 98 (294)
T 3loq_A 19 YFQSNAMLLPTDLSENSFKVLEYLGDFKKVGVEEIGVLFVINLTKLSTVSGGIDIDHYIDEMSEKAEEVLPEVAQKIEAA 98 (294)
T ss_dssp SSTTCEEEEECCSCTGGGGGGGGHHHHHHTTCCEEEEECCEECTTC-----CCCTTHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHhhccEEEecCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecCcccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 445689999999999999999999999888899999999986653221111111 1122233447888888888888
Q ss_pred CCcEEE-EEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004174 89 QVDLKL-KICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (770)
Q Consensus 89 ~V~~~~-~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~~g 155 (770)
++.++. .+.+.|++.++| +++..++|+||||++++ .+.++| |++.+++++++ |||++|+.+
T Consensus 99 g~~~~~~~v~~~g~~~~~I--~a~~~~~DliV~G~~g~~~~~~~~~G--s~~~~vl~~~~--~PVlvv~~~ 163 (294)
T 3loq_A 99 GIKAEVIKPFPAGDPVVEI--IKASENYSFIAMGSRGASKFKKILLG--SVSEGVLHDSK--VPVYIFKHD 163 (294)
T ss_dssp TCEEEECSSCCEECHHHHH--HHHHTTSSEEEEECCCCCHHHHHHHC--CHHHHHHHHCS--SCEEEECCC
T ss_pred CCCcceeEeeccCChhHhe--eeccCCCCEEEEcCCCCccccceeec--cHHHHHHhcCC--CCEEEecCc
Confidence 999988 777348999999 88999999999999987 456678 99999999998 999999864
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=2.4e-12 Score=134.53 Aligned_cols=132 Identities=11% Similarity=0.024 Sum_probs=103.0
Q ss_pred cEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcc-cC-CCCc-c-----------chhhhHHHHHHHHHHH
Q 004174 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIV-DR-DGKS-S-----------LLSLVKAFDSVLAVYE 82 (770)
Q Consensus 17 r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~-~~-~~~~-~-----------~~~~~~~~~~~l~~~~ 82 (770)
++|+|++|+|+.|..||+||+..+.+.|..|++|||.++.... .. .+.. . .....+...+.++.+.
T Consensus 1 k~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 80 (268)
T 3ab8_A 1 MRILLATDGSPQARGAEALAEWLAYKLSAPLTVLFVVDTRLARIPELLDFGALTVPVPVLRTELERALALRGEAVLERVR 80 (268)
T ss_dssp CCEEEECCSCGGGHHHHHHHHHHHHHHTCCEEEEEEEEHHHHTHHHHC-------CHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcEEEEcCCCHHHHHHHHHHHHHHHHhCCcEEEEEEeccCCcccccccCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4799999999999999999999988889999999998543210 00 0000 0 0111223347788888
Q ss_pred hHhhhcCCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCCc----ccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004174 83 GFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNH----HTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (770)
Q Consensus 83 ~~C~~k~V~~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~~----r~~~~~~sVs~yc~~~ap~~C~V~vV~~g 155 (770)
..+...++.++..+.. |++.+.|+++ ..++|++|||++++. +.++| |++.+++++++ |||++|+.+
T Consensus 81 ~~~~~~g~~~~~~~~~-g~~~~~I~~~--~~~~dliV~G~~g~~~~~~~~~~G--s~~~~v~~~a~--~PVlvv~~~ 150 (268)
T 3ab8_A 81 QSALAAGVAVEAVLEE-GVPHEAILRR--ARAADLLVLGRSGEAHGDGFGGLG--STADRVLRASP--VPVLLAPGE 150 (268)
T ss_dssp HHHHHTTCCEEEEEEE-ECHHHHHHHH--HTTCSEEEEESSCTTSCTTCCSCC--HHHHHHHHHCS--SCEEEECSS
T ss_pred HHHHhCCCCeEEEEec-CCHHHHHHhh--ccCCCEEEEeccCCCccccccccc--hhHHHHHHhCC--CCEEEECCC
Confidence 8888889999998887 7999999999 778999999999753 45677 99999999998 999999864
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.34 E-value=2.7e-12 Score=136.06 Aligned_cols=122 Identities=13% Similarity=0.071 Sum_probs=103.4
Q ss_pred CCCCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCccchhhhHHHHHHHHHHHhHhhhcCCcE
Q 004174 13 SGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDL 92 (770)
Q Consensus 13 ~~~~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~ 92 (770)
|..-++|+|++|+|+.|..||+||+.-+.+.|..|++|||..+ +...+.+..+...+...++.+
T Consensus 4 M~~~~~ILv~~D~s~~s~~al~~A~~la~~~~a~l~ll~v~~~----------------~~~~~~l~~~~~~~~~~~~~~ 67 (290)
T 3mt0_A 4 MQAIRSILVVIEPDQLEGLALKRAQLIAGVTQSHLHLLVCEKR----------------RDHSAALNDLAQELREEGYSV 67 (290)
T ss_dssp TTTCCEEEEECCSSCSCCHHHHHHHHHHHHHCCEEEEEEECSS----------------SCCHHHHHHHHHHHHHTTCCE
T ss_pred hhhhceEEEEeCCCccchHHHHHHHHHHHhcCCeEEEEEeeCc----------------HHHHHHHHHHHHHHhhCCCeE
Confidence 3446899999999999999999999999988999999999863 011133444555556788999
Q ss_pred EEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeC
Q 004174 93 KLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (770)
Q Consensus 93 ~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~~ 154 (770)
+..+.++|++.+.|+++|+..++|++|||++++ .+.++| |++.+++++++ |||++|+.
T Consensus 68 ~~~~~~~g~~~~~i~~~a~~~~~dliV~G~~~~~~~~~~~~g--s~~~~vl~~~~--~PVlvv~~ 128 (290)
T 3mt0_A 68 STNQAWKDSLHQTIIAEQQAEGCGLIIKQHFPDNPLKKAILT--PDDWKLLRFAP--CPVLMTKT 128 (290)
T ss_dssp EEEEECSSSHHHHHHHHHHHHTCSEEEEECCCSCTTSTTSCC--HHHHHHHHHCS--SCEEEECC
T ss_pred EEEEEeCCCHHHHHHHHHHhcCCCEEEEecccCCchhhcccC--HHHHHHHhcCC--CCEEEecC
Confidence 999998899999999999999999999999987 456677 99999999998 99999984
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=5.7e-12 Score=134.77 Aligned_cols=131 Identities=17% Similarity=0.176 Sum_probs=98.1
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCccchhhhHHHHHHHHHHHh-Hhhh-cCCcEE
Q 004174 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEG-FCNL-KQVDLK 93 (770)
Q Consensus 16 ~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-~C~~-k~V~~~ 93 (770)
.++|+||+|+++.|..||+||+..+...|..|++|||..+..... ..........+...+.+..+.. ++.. .++.++
T Consensus 171 ~~~Ilv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 249 (309)
T 3cis_A 171 QAPVLVGVDGSSASELATAIAFDEASRRNVDLVALHAWSDVDVSE-WPGIDWPATQSMAEQVLAERLAGWQERYPNVAIT 249 (309)
T ss_dssp CCCEEEECCSSHHHHHHHHHHHHHHHHTTCCEEEEEESCSSCCTT-CSSCCHHHHHHHHHHHHHHHHTTHHHHCTTSCEE
T ss_pred CCeEEEEeCCChHHHHHHHHHHHHHHhcCCEEEEEEEeecccccC-CCcccHHHHHHHHHHHHHHHHHHHHhhCCCCcEE
Confidence 568999999999999999999999888899999999986543210 0011111112222233333332 3332 478888
Q ss_pred EEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeC
Q 004174 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (770)
Q Consensus 94 ~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~~ 154 (770)
..+.. |++.++|+++|+ ++|+||||++++ .+.++| ||+.+++++++ |||++|+.
T Consensus 250 ~~~~~-g~~~~~I~~~a~--~adliV~G~~~~~~~~~~l~G--sv~~~vl~~~~--~pVlvv~~ 306 (309)
T 3cis_A 250 RVVVR-DQPARQLVQRSE--EAQLVVVGSRGRGGYAGMLVG--SVGETVAQLAR--TPVIVARE 306 (309)
T ss_dssp EEEES-SCHHHHHHHHHT--TCSEEEEESSCSSCCTTCSSC--HHHHHHHHHCS--SCEEEECC
T ss_pred EEEEc-CCHHHHHHHhhC--CCCEEEECCCCCCCccccccC--cHHHHHHhcCC--CCEEEeCC
Confidence 88776 799999999998 799999999987 566778 99999999998 99999974
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.31 E-value=3.4e-12 Score=135.43 Aligned_cols=121 Identities=17% Similarity=0.241 Sum_probs=102.7
Q ss_pred CCCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCccchhhhHHHHHHHHHHHhHhhhcCCcEE
Q 004174 14 GAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLK 93 (770)
Q Consensus 14 ~~~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~ 93 (770)
...++|+|++|+++.|..||+||+..+...|..|.+|||.++.. ....++.+...+...+++++
T Consensus 168 ~~~~~Ilv~~d~s~~s~~al~~a~~la~~~~~~l~ll~v~~~~~----------------~~~~l~~~~~~l~~~~~~~~ 231 (294)
T 3loq_A 168 SLFDRVLVAYDFSKWADRALEYAKFVVKKTGGELHIIHVSEDGD----------------KTADLRVMEEVIGAEGIEVH 231 (294)
T ss_dssp CTTSEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEECSSSC----------------CHHHHHHHHHHHHHTTCCEE
T ss_pred ccCCEEEEEECCCHHHHHHHHHHHHHhhhcCCEEEEEEEccCch----------------HHHHHHHHHHHHHHcCCcEE
Confidence 34689999999999999999999999888899999999986532 12344556666667789988
Q ss_pred EEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004174 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (770)
Q Consensus 94 ~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~~g 155 (770)
..+.. |++.++|+++|+..++|+||||++++ .+.++| |++.+++++++ |||++|+.+
T Consensus 232 ~~~~~-g~~~~~I~~~a~~~~~dLlV~G~~~~~~~~~~~~G--s~~~~vl~~~~--~pvLvv~~~ 291 (294)
T 3loq_A 232 VHIES-GTPHKAILAKREEINATTIFMGSRGAGSVMTMILG--STSESVIRRSP--VPVFVCKRG 291 (294)
T ss_dssp EEEEC-SCHHHHHHHHHHHTTCSEEEEECCCCSCHHHHHHH--CHHHHHHHHCS--SCEEEECSC
T ss_pred EEEec-CCHHHHHHHHHHhcCcCEEEEeCCCCCCccceeeC--cHHHHHHhcCC--CCEEEECCC
Confidence 87776 79999999999999999999999987 455678 99999999998 999999865
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.25 E-value=1.3e-11 Score=132.26 Aligned_cols=135 Identities=13% Similarity=0.082 Sum_probs=100.2
Q ss_pred CCcEEEEEEcCCcc-------hHHHHHHHHhhccCC--CCEEEEEEeecCCCcccCCCCc--cc-hhhhHHHHHHHHHHH
Q 004174 15 AGRTVVVGVKLDTH-------SRELLTWALVKVAQP--GDTVIALHVLANNAIVDRDGKS--SL-LSLVKAFDSVLAVYE 82 (770)
Q Consensus 15 ~~r~I~VaVd~s~~-------S~~AL~WAl~~~~~~--gd~vvlvHV~~~~~~~~~~~~~--~~-~~~~~~~~~~l~~~~ 82 (770)
..++|+|++|++++ |..||+||+..+... |..|.+|||..+.......... .. ....+........++
T Consensus 155 ~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (319)
T 3olq_A 155 EYGTIVVAANLSNEESYHDALNLKLIELTNDLSHRIQKDPDVHLLSAYPVAPINIAIELPDFDPNLYNNALRGQHLIAMK 234 (319)
T ss_dssp TTCEEEEECCCSCCSTHHHHHHHHHHHHHHHHHHHHCSSCCEEEEEEECCCSCSCCTTCTTCCHHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEECCCCcchhHHHHHHHHHHHHHHHHHhccCCCeEEEEEeecCcchhhhccCCcccHHHHHHHHHHHHHHHHH
Confidence 46899999999994 699999999887766 9999999999765432111100 00 011122224445555
Q ss_pred hHhhhcCC-cEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeC
Q 004174 83 GFCNLKQV-DLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (770)
Q Consensus 83 ~~C~~k~V-~~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~~ 154 (770)
.++...++ .++..+.. |++.++|+++|+..++|+||||++++ .+.++| ||+.+++++++ |||++|+.
T Consensus 235 ~~~~~~~~~~~~~~v~~-g~~~~~I~~~a~~~~~dLiV~G~~g~~~~~~~~~G--sv~~~vl~~~~--~pVLvv~~ 305 (319)
T 3olq_A 235 ELRQKFSIPEEKTHVKE-GLPEQVIPQVCEELNAGIVVLGILGRTGLSAAFLG--NTAEQLIDHIK--CDLLAIKP 305 (319)
T ss_dssp HHHHHTTCCGGGEEEEE-SCHHHHHHHHHHHTTEEEEEEECCSCCSTHHHHHH--HHHHHHHTTCC--SEEEEECC
T ss_pred HHHHHhCCCcccEEEec-CCcHHHHHHHHHHhCCCEEEEeccCccCCcccccc--HHHHHHHhhCC--CCEEEECC
Confidence 66666665 34556666 79999999999999999999999987 456778 99999999998 99999975
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=2.4e-11 Score=126.32 Aligned_cols=143 Identities=17% Similarity=0.123 Sum_probs=112.3
Q ss_pred hhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEEe
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~LV~E 497 (770)
....|.+...++.|+++.||+... .+..+++|+..... .....+.+|+.++..+. +..+.++++++...+..|+|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 345688888889999999999876 46899999987421 22345888999999985 6778889999988889999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------------
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS------------------------------------ 541 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~------------------------------------ 541 (770)
|++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 91 ~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 91 EADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp CCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred ecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999876421 1223468889999999999811
Q ss_pred --------------------CCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 542 --------------------AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 542 --------------------~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876556799998774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.19 E-value=2.5e-11 Score=125.10 Aligned_cols=137 Identities=16% Similarity=0.081 Sum_probs=100.7
Q ss_pred CcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCc--eeEEeeEEeecCceEEEEeecC
Q 004174 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN--IISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~~~~~~LV~E~~~ 500 (770)
+|.+..+.+.|..+.||++...+|..+++|+.... ....+..|+.++..+.+.+ +.++++++..++..++||||++
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 34443333455669999998777888999998754 2345778999999986544 4568888887788999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--------------------------------------- 541 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--------------------------------------- 541 (770)
|.+|. ... .. ...++.+++..|..||+..
T Consensus 99 G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 99 GQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp SEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 98884 211 11 2356777888888888632
Q ss_pred ----------------CCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 542 ----------------AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 542 ----------------~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
...++|+|++|.|||++++..+.|+|||.+.+
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776667999998753
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=4.6e-11 Score=124.67 Aligned_cols=116 Identities=12% Similarity=0.039 Sum_probs=97.5
Q ss_pred CCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCccchhhhHHHHHHHHHHHhHhhhcCCcEEE
Q 004174 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKL 94 (770)
Q Consensus 15 ~~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~~ 94 (770)
..++|+|++|+++.|..||+||.......|..|.+|||.++. +.....++.+.......+++++.
T Consensus 153 ~~~~ilv~~d~s~~~~~al~~a~~la~~~~a~l~ll~v~~~~---------------~~~~~~l~~~~~~l~~~~~~~~~ 217 (268)
T 3ab8_A 153 ELEGALLGYDASESAVRALHALAPLARALGLGVRVVSVHEDP---------------ARAEAWALEAEAYLRDHGVEASA 217 (268)
T ss_dssp CCCEEEEECCSCHHHHHHHHHHHHHHHHHTCCEEEEEECSSH---------------HHHHHHHHHHHHHHHHTTCCEEE
T ss_pred CCCEEEEEECCCHHHHHHHHHHHHhhhcCCCEEEEEEEcCcH---------------HHHHHHHHHHHHHHHHcCCceEE
Confidence 357999999999999999999998877778999999998542 11234455666666677899888
Q ss_pred EEEECCChhHHHHHHHHhcCCcEEEEccCCCcccccCCCchHHHHhccCCCCcEEEEEe
Q 004174 95 KICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (770)
Q Consensus 95 ~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~~r~~~~~~sVs~yc~~~ap~~C~V~vV~ 153 (770)
.+.. |++.++|+++|+.. |+||||+ +..+.++| ||+.+++++++ |||++|+
T Consensus 218 ~~~~-g~~~~~i~~~a~~~--dliV~G~-~~~~~~~G--s~~~~vl~~~~--~pvlvv~ 268 (268)
T 3ab8_A 218 LVLG-GDAADHLLRLQGPG--DLLALGA-PVRRLVFG--STAERVIRNAQ--GPVLTAR 268 (268)
T ss_dssp EEEC-SCHHHHHHHHCCTT--EEEEEEC-CCSCCSSC--CHHHHHHHHCS--SCEEEEC
T ss_pred EEeC-CChHHHHHHHHHhC--CEEEECC-cccccEec--cHHHHHHhcCC--CCEEEeC
Confidence 8776 89999999999997 9999999 66778888 99999999998 9999985
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.02 E-value=1.2e-09 Score=118.96 Aligned_cols=142 Identities=14% Similarity=0.261 Sum_probs=107.9
Q ss_pred cceeecccCceEEEEEEeCCCCEEEEEEeC--CCh--hHHHHHHHHHHHHHhcC--CCceeEEeeEEeec---CceEEEE
Q 004174 426 AENLIGKGGSSQVYKGCLPDGKELAVKILK--PSE--DVIKEFVLEIEIITTLH--HKNIISLLGFCFED---NNLLLVY 496 (770)
Q Consensus 426 ~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~--~~~--~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~---~~~~LV~ 496 (770)
..+.|+.|.++.||+.... +..+++|+.. ... .....+.+|+.++..|. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567899999999998774 4678999876 432 22456788999999997 45678888888776 3489999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS----------------------------------- 541 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~----------------------------------- 541 (770)
||++|..+.+... ..++...+..++.+++..|..||...
T Consensus 121 e~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999987754221 23677888899999999999999721
Q ss_pred --------------------CCceEEecccCCCeeeCCCCc--eEEccccccccc
Q 004174 542 --------------------AQRVIHRDVKSSNILLSDDFE--PQLSDFGLAKWA 574 (770)
Q Consensus 542 --------------------~~~IiHrDLKp~NILL~~~~~--vkL~DFGla~~~ 574 (770)
...++|+|+++.|||++.++. +.|+||+.+.+.
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 257999999999999997753 689999988643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.87 E-value=6.9e-10 Score=118.19 Aligned_cols=184 Identities=18% Similarity=0.193 Sum_probs=123.4
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CCc--eeEEeeEEeecC---ceEEEEeecC
Q 004174 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKN--IISLLGFCFEDN---NLLLVYDFLS 500 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-Hpn--Iv~l~~~~~~~~---~~~LV~E~~~ 500 (770)
.+.++.|.+..||+.. ..+++|+.... .....+.+|.++|..+. +.. +.+++.+....+ ..|+||+|++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999852 46899987533 45567889999998884 322 334444443332 3588999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--------------------------------------- 541 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--------------------------------------- 541 (770)
|.+|.+... ..++..++..++.+++..|..||+..
T Consensus 100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 988875432 13566777788888888888888511
Q ss_pred ----------------CCceEEecccCCCeeeCC--CCceEEccccccccccCCCCCceecccccccCC---CCceeec-
Q 004174 542 ----------------AQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY---LAPEYFM- 599 (770)
Q Consensus 542 ----------------~~~IiHrDLKp~NILL~~--~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y---lAPE~~~- 599 (770)
...++|+|++|.|||++. +..+.|+||+.+....... +......+ ..|+.+.
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~------Dl~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN------DFISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH------HHHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH------HHHHHHhhccccCHHHHHH
Confidence 135899999999999988 4567899999987543310 01111111 2333211
Q ss_pred ----cCCC---------CCcceEeechHHHHHHHhCCCCCC
Q 004174 600 ----YGKV---------NDKIDVYAFGVVLLELLTGRKPIS 627 (770)
Q Consensus 600 ----~~~~---------s~ksDVwSlGvvL~eLltG~~Pf~ 627 (770)
++.. ....+.|++|.++|.+.+|..+|.
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1111 123689999999999999988773
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=1.9e-06 Score=91.81 Aligned_cols=137 Identities=20% Similarity=0.196 Sum_probs=95.1
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCC---ceeEEeeEEe-ecCceEEEEeecCCC
Q 004174 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK---NIISLLGFCF-EDNNLLLVYDFLSRG 502 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~l~~~~~-~~~~~~LV~E~~~gg 502 (770)
.+.++.|....||+. |..+++|+.. .......+.+|.++|..|.+. .+.+.+.++. ..+..++||||++|.
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456888999999987 5678999854 334567889999999999752 3556666664 345678999999998
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC------------------------------------------
Q 004174 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG------------------------------------------ 540 (770)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~------------------------------------------ 540 (770)
+|.+.... .++...+..++.+++..|..||+.
T Consensus 99 ~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 99 ILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp ECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88763211 123344444555555555555531
Q ss_pred ---------------CCCceEEecccCCCeeeCC---CCce-EEccccccccc
Q 004174 541 ---------------SAQRVIHRDVKSSNILLSD---DFEP-QLSDFGLAKWA 574 (770)
Q Consensus 541 ---------------~~~~IiHrDLKp~NILL~~---~~~v-kL~DFGla~~~ 574 (770)
....++|+|+++.|||++. ++.+ .|+||+.+...
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2245799999999999987 4554 79999987543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=1.3e-05 Score=83.01 Aligned_cols=135 Identities=19% Similarity=0.118 Sum_probs=94.9
Q ss_pred eecccCce-EEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceEEEEeecCCCChh
Q 004174 429 LIGKGGSS-QVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505 (770)
Q Consensus 429 ~LG~G~fG-~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~LV~E~~~ggsL~ 505 (770)
.+..|..| .||+.... ++..+++|+-... ....+.+|..+|..+. +--+.+++.++.+.+..++|||+++|.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 34445554 68987654 5678999987643 3456788999998885 333667888998888999999999998877
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------------------
Q 004174 506 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS-------------------------------------------- 541 (770)
Q Consensus 506 ~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-------------------------------------------- 541 (770)
+..... ......+..+++..|.-||...
T Consensus 109 ~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 109 QVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 654321 1223345555555566666411
Q ss_pred -----------CCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 542 -----------AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 542 -----------~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
...++|+|+.+.|||+++++.+-|+||+.+.+
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999877677999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=4.5e-06 Score=90.40 Aligned_cols=80 Identities=13% Similarity=0.104 Sum_probs=57.0
Q ss_pred ceee-cccCceEEEEEEeC-------CCCEEEEEEeCCChh----HHHHHHHHHHHHHhcCC---CceeEEeeEEeec--
Q 004174 427 ENLI-GKGGSSQVYKGCLP-------DGKELAVKILKPSED----VIKEFVLEIEIITTLHH---KNIISLLGFCFED-- 489 (770)
Q Consensus 427 ~~~L-G~G~fG~Vy~a~~~-------~g~~vAVK~l~~~~~----~~~~~~~Ei~iL~~l~H---pnIv~l~~~~~~~-- 489 (770)
.+.| +.|....+|+.... ++..+++|+...... ....+.+|+.++..|.. ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88889999998754 267899998764321 12456788888888752 3567788877655
Q ss_pred -CceEEEEeecCCCChhh
Q 004174 490 -NNLLLVYDFLSRGSLEE 506 (770)
Q Consensus 490 -~~~~LV~E~~~ggsL~~ 506 (770)
+..++||||++|..|.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.09 E-value=1.4e-05 Score=85.31 Aligned_cols=141 Identities=18% Similarity=0.285 Sum_probs=81.2
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC--CceeEEee------EEeecCceEEEEeec
Q 004174 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLG------FCFEDNNLLLVYDFL 499 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~------~~~~~~~~~LV~E~~ 499 (770)
..|+.|..+.||+....+| .+++|+...... .+..|+.++..|.. -.+.+++. +....+..++||+|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~~---~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPEK---KALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCHH---HHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCHH---HHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 4566677899999887555 599999986432 33345555555431 12333332 123456789999999
Q ss_pred CCCChh--------------hhhccCCC-C--C-------CCCCHHHHH-------------------------------
Q 004174 500 SRGSLE--------------ENLHGNKK-D--P-------AAFGWSERY------------------------------- 524 (770)
Q Consensus 500 ~ggsL~--------------~~l~~~~~-~--~-------~~l~~~~~~------------------------------- 524 (770)
+|..+. ..+|.... . + ....|...+
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 11221100 0 0 012332211
Q ss_pred HHHHHHHHHHHHHHc----------CCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 525 KVAMGVAEALEYLHS----------GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 525 ~i~~qia~aL~yLH~----------~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
.+...+..++.+|+. .....+||+|+++.|||++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223345666653 123789999999999999888899999998774
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=1.7e-05 Score=87.28 Aligned_cols=74 Identities=16% Similarity=0.139 Sum_probs=50.1
Q ss_pred ceeecccCceEEEEEEeC-CCCEEEEEEeCCChh--------HHHHHHHHHHHHHhcCC--Cc-eeEEeeEEeecCceEE
Q 004174 427 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED--------VIKEFVLEIEIITTLHH--KN-IISLLGFCFEDNNLLL 494 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~--------~~~~~~~Ei~iL~~l~H--pn-Iv~l~~~~~~~~~~~L 494 (770)
.+.||.|.++.||++... +++.++||....... ....+..|.++|..+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 568999999999999754 568899998754221 23456779999888742 33 3345543 3456689
Q ss_pred EEeecCCC
Q 004174 495 VYDFLSRG 502 (770)
Q Consensus 495 V~E~~~gg 502 (770)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.0003 Score=78.09 Aligned_cols=76 Identities=16% Similarity=0.196 Sum_probs=45.2
Q ss_pred CceEEecccCCCeeeCCCCceEEccccccccccCCCCCceeccccc--ccCCCCceeeccCC---CCCcceEeechHHHH
Q 004174 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG--TFGYLAPEYFMYGK---VNDKIDVYAFGVVLL 617 (770)
Q Consensus 543 ~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~G--T~~YlAPE~~~~~~---~s~ksDVwSlGvvL~ 617 (770)
..++|+|+++.|||++.++ ++|+||+.+.+..... .... ..+ ...|++|++..... -....++..+...+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGA--YLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHH--HHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHH--HHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 7899999999999998876 9999999887543210 0000 011 12355555443111 111234456666777
Q ss_pred HHHhC
Q 004174 618 ELLTG 622 (770)
Q Consensus 618 eLltG 622 (770)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 76654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.0003 Score=75.24 Aligned_cols=139 Identities=14% Similarity=0.191 Sum_probs=93.3
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC---CCceeEEeeEEeecCceEEEEeecCCCC
Q 004174 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLLVYDFLSRGS 503 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~LV~E~~~ggs 503 (770)
.+.|+.|.+..+|+... ++..+++|+.... ....+..|...|+.|. ...+.+++.++...+..++||||++|..
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 46789999999999876 5678999987643 3566888999988884 3567888888877788999999999986
Q ss_pred hhh-----------hhccCCCCC------------------CCCCHHHHH---HHH----------------HHHHHH-H
Q 004174 504 LEE-----------NLHGNKKDP------------------AAFGWSERY---KVA----------------MGVAEA-L 534 (770)
Q Consensus 504 L~~-----------~l~~~~~~~------------------~~l~~~~~~---~i~----------------~qia~a-L 534 (770)
+.. .||.....+ -.-+|...+ ++. ..++.. .
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 521 233322100 011454322 111 111111 2
Q ss_pred HHHHc-CCCCceEEecccCCCeeeCCCCceEEcccc
Q 004174 535 EYLHS-GSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (770)
Q Consensus 535 ~yLH~-~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 569 (770)
..|.. .....+||+|+.+.|++++.++ +.|+||.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23421 1236799999999999999887 8899984
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00033 Score=73.91 Aligned_cols=140 Identities=14% Similarity=0.101 Sum_probs=77.4
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCce-eEEeeEEeecCceEEEEeec-CCCCh
Q 004174 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFL-SRGSL 504 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~LV~E~~-~ggsL 504 (770)
.+.|+.|....+|+. ..+++|+........-...+|+.++..+...++ .++++++ .+.-++|+||+ +|.+|
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 578899999999998 558999887532222223468877777753222 3455443 33447899999 66554
Q ss_pred hh------------------hhccCCC-CCCCCC-HHHHHHHHHH--------------HHHHH----HHHHc-CCCCce
Q 004174 505 EE------------------NLHGNKK-DPAAFG-WSERYKVAMG--------------VAEAL----EYLHS-GSAQRV 545 (770)
Q Consensus 505 ~~------------------~l~~~~~-~~~~l~-~~~~~~i~~q--------------ia~aL----~yLH~-~~~~~I 545 (770)
.. .+|.... ....+. +.....+... +...+ ..|.. .....+
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 32 1122111 000011 1111111110 11111 12211 223568
Q ss_pred EEecccCCCeeeCCCCceEEccccccccc
Q 004174 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 546 iHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
+|+|+.+.||| ..++.+.|+||..+...
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 99999999999 55667899999887543
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.001 Score=69.64 Aligned_cols=78 Identities=19% Similarity=0.183 Sum_probs=56.8
Q ss_pred CcccceeecccCceEEEEEEeCCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCC---ceeEEeeEEeecCceEEEEee
Q 004174 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHK---NIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~Hp---nIv~l~~~~~~~~~~~LV~E~ 498 (770)
.......+|.|..+.||+....||+.|++|+..... .....|..|...|+.|.-- -+.+++++. .-++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 455677899999999999999999999999876432 2234577899999888521 234444432 34899999
Q ss_pred cCCCCh
Q 004174 499 LSRGSL 504 (770)
Q Consensus 499 ~~ggsL 504 (770)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00052 Score=72.77 Aligned_cols=144 Identities=17% Similarity=0.165 Sum_probs=80.8
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCc--eeEEeeE------EeecCceEEEEee
Q 004174 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN--IISLLGF------CFEDNNLLLVYDF 498 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~------~~~~~~~~LV~E~ 498 (770)
.+.|+.|....+|+....+| .+++|+.... .....+..|+.++..|...+ +.+++.. ....+..+++|+|
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 35677888899999887665 6889998752 11234556777777664212 2333321 1223567899999
Q ss_pred cCCCChhh--------------hhccCCC---CCC-----CCCHHHHHH------------HHHHHHHHHHHHHc----C
Q 004174 499 LSRGSLEE--------------NLHGNKK---DPA-----AFGWSERYK------------VAMGVAEALEYLHS----G 540 (770)
Q Consensus 499 ~~ggsL~~--------------~l~~~~~---~~~-----~l~~~~~~~------------i~~qia~aL~yLH~----~ 540 (770)
++|..+.. .+|.... .+. ...|...+. +...+...+.+|+. .
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99865421 1221110 000 012322110 01123445555553 1
Q ss_pred CCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 541 ~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
....+||+|+.+.|||++.+..+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23679999999999999877556899998774
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00036 Score=77.86 Aligned_cols=73 Identities=18% Similarity=0.228 Sum_probs=50.8
Q ss_pred ceeecccCceEEEEEEeCC--------CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCce-eEEeeEEeecCceEEEEe
Q 004174 427 ENLIGKGGSSQVYKGCLPD--------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~--------g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~LV~E 497 (770)
.+.|+.|....+|+...++ +..+++|+..... ....+..|..++..|...++ .++++.+.. .+|||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 4678888899999998653 5789999985421 12455679998888853333 566666532 38999
Q ss_pred ecCCCCh
Q 004174 498 FLSRGSL 504 (770)
Q Consensus 498 ~~~ggsL 504 (770)
|++|.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9987544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0014 Score=69.51 Aligned_cols=143 Identities=17% Similarity=0.248 Sum_probs=83.2
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCC--ceeEEeeE-----EeecCceEEEEeecC
Q 004174 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGF-----CFEDNNLLLVYDFLS 500 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~-----~~~~~~~~LV~E~~~ 500 (770)
..|+ |....||+....+|+.+++|+..........+..|..++..|... .+.+++.. ...++..+++|+|++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 4566 888899998776787899999975433345666788888777422 23444432 222456688999998
Q ss_pred CCChhh--------------hhccCCC-----CCCCCCHHHH----HHH---------------HHHHHHHHHHHHc---
Q 004174 501 RGSLEE--------------NLHGNKK-----DPAAFGWSER----YKV---------------AMGVAEALEYLHS--- 539 (770)
Q Consensus 501 ggsL~~--------------~l~~~~~-----~~~~l~~~~~----~~i---------------~~qia~aL~yLH~--- 539 (770)
|..+.. .+|.... ....+.+... ..+ ...+...+..|..
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 865421 0111100 0011222211 001 0111122223321
Q ss_pred -CCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 540 -GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 540 -~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
.....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1236789999999999999 4 899999987753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00097 Score=73.17 Aligned_cols=142 Identities=19% Similarity=0.238 Sum_probs=84.2
Q ss_pred ceeecccCceEEEEEEeC--------CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC-CceeEEeeEEeecCceEEEEe
Q 004174 427 ENLIGKGGSSQVYKGCLP--------DGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~--------~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~LV~E 497 (770)
.+.|..|-...+|+.... +++.+++|+..........+.+|..+++.|.. .-..++++++.. .+|||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 356777888899998864 35789999974432234566689999988852 223556666543 39999
Q ss_pred ecCCCChhhh-----------------hccCCC-CCCCC--CHHHHHHHHHHHHH-------------------HHHH--
Q 004174 498 FLSRGSLEEN-----------------LHGNKK-DPAAF--GWSERYKVAMGVAE-------------------ALEY-- 536 (770)
Q Consensus 498 ~~~ggsL~~~-----------------l~~~~~-~~~~l--~~~~~~~i~~qia~-------------------aL~y-- 536 (770)
|++|.+|... ||.... ..... -|.++.++..++.. .+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665421 121111 01112 24555555544321 2233
Q ss_pred --HHc-CCCCceEEecccCCCeeeCCC----CceEEccccccc
Q 004174 537 --LHS-GSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAK 572 (770)
Q Consensus 537 --LH~-~~~~~IiHrDLKp~NILL~~~----~~vkL~DFGla~ 572 (770)
|.. .....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 322 223579999999999999876 689999998774
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0017 Score=69.38 Aligned_cols=143 Identities=15% Similarity=0.135 Sum_probs=74.2
Q ss_pred eeecccCceE-EEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC--CceeEEeeEEeecCceEEEEeecCCCCh
Q 004174 428 NLIGKGGSSQ-VYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (770)
Q Consensus 428 ~~LG~G~fG~-Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~LV~E~~~ggsL 504 (770)
+.|+.|+... +|+....+|..+++|....... ..+..|+.++..+.. -.+.+++.+....+ +++||++.+..+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~--~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l 99 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG--GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF 99 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT--CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC--ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence 4566565554 6676654477888887654321 233456666666642 23455666543333 789999987666
Q ss_pred hhhhccC---------------------CCC-CCCCCHHHHH-------H-H------------HHHHHHHHHHHH---c
Q 004174 505 EENLHGN---------------------KKD-PAAFGWSERY-------K-V------------AMGVAEALEYLH---S 539 (770)
Q Consensus 505 ~~~l~~~---------------------~~~-~~~l~~~~~~-------~-i------------~~qia~aL~yLH---~ 539 (770)
.+.+... ... -..+...... . + ...+...+..|. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 5443211 000 0112111100 0 0 001112222221 1
Q ss_pred CCCCceEEecccCCCeeeCCC----CceEEccccccccc
Q 004174 540 GSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAKWA 574 (770)
Q Consensus 540 ~~~~~IiHrDLKp~NILL~~~----~~vkL~DFGla~~~ 574 (770)
.....++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 224689999999999999874 67899999988644
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00059 Score=74.17 Aligned_cols=74 Identities=18% Similarity=0.183 Sum_probs=46.2
Q ss_pred ceeecccCceEEEEEEeCC---------CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCc-eeEEeeEEeecCceEEEE
Q 004174 427 ENLIGKGGSSQVYKGCLPD---------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~---------g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~LV~ 496 (770)
...|+.|....+|+....+ +..+++|+.............|..++..+...+ ..++++.+ . -++||
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 4567888889999987654 268999998654332223457888888875333 34566544 2 27899
Q ss_pred eecCCCCh
Q 004174 497 DFLSRGSL 504 (770)
Q Consensus 497 E~~~ggsL 504 (770)
||++|..|
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99998644
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0013 Score=74.09 Aligned_cols=74 Identities=22% Similarity=0.181 Sum_probs=48.9
Q ss_pred ceeecccCceEEEEEEeCC-CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCce-eEEeeEEeecCceEEEEeecCCCCh
Q 004174 427 ENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFLSRGSL 504 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~-g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~LV~E~~~ggsL 504 (770)
.+.|+.|-...+|+....+ +..+++|+........-+..+|..++..|...++ .++++++. + .+||||++|.+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 4678888899999988755 4789999885432111112478899998875544 46666662 2 359999998555
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0028 Score=68.27 Aligned_cols=67 Identities=18% Similarity=0.184 Sum_probs=44.1
Q ss_pred ccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC---CCceeEEeeE------EeecCceEEEEeecCCC
Q 004174 432 KGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGF------CFEDNNLLLVYDFLSRG 502 (770)
Q Consensus 432 ~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~------~~~~~~~~LV~E~~~gg 502 (770)
.|....||+....+| .+++|+...... ..|+.++..|. -|++.+++.. +...+..++||+|++|.
T Consensus 33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 33 ADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp SCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred CccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 333689999987777 899998875431 34666666553 1224444432 23356789999999987
Q ss_pred Ch
Q 004174 503 SL 504 (770)
Q Consensus 503 sL 504 (770)
.+
T Consensus 107 ~~ 108 (339)
T 3i1a_A 107 NG 108 (339)
T ss_dssp BT
T ss_pred cC
Confidence 66
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.35 E-value=0.04 Score=61.17 Aligned_cols=141 Identities=14% Similarity=0.191 Sum_probs=84.6
Q ss_pred ceeecccCceEEEEEEeCC--------CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCc-eeEEeeEEeecCceEEEEe
Q 004174 427 ENLIGKGGSSQVYKGCLPD--------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~--------g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~LV~E 497 (770)
.+.|..|-...+|+....+ +..+++++........-+..+|..+++.+..-+ ..++++.+ .+ ++|||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~e 150 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEE 150 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEE
Confidence 4567778889999988653 688999997653222223356888888875322 34555433 22 78999
Q ss_pred ecCCCChhhh-----------------hccC-------CC--CCCCCCHHHHHHHHHHH-------------------HH
Q 004174 498 FLSRGSLEEN-----------------LHGN-------KK--DPAAFGWSERYKVAMGV-------------------AE 532 (770)
Q Consensus 498 ~~~ggsL~~~-----------------l~~~-------~~--~~~~l~~~~~~~i~~qi-------------------a~ 532 (770)
|++|..|... ||.. .. ...+..|.++.++..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 9998764310 1110 00 11122344444443322 12
Q ss_pred HHHHHHc---------------------CCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 533 ALEYLHS---------------------GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 533 aL~yLH~---------------------~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
.+..|.. .....++|+|+.+.||+ +.++.+.|+||..+.
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 2333321 12356899999999999 777889999998775
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.04 E-value=0.27 Score=53.88 Aligned_cols=29 Identities=34% Similarity=0.471 Sum_probs=24.5
Q ss_pred ceEEecccCCCeee------CCCCceEEccccccc
Q 004174 544 RVIHRDVKSSNILL------SDDFEPQLSDFGLAK 572 (770)
Q Consensus 544 ~IiHrDLKp~NILL------~~~~~vkL~DFGla~ 572 (770)
.++|+|+.+.|||+ +++..+.++||-+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 46799999999999 456779999998774
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=92.35 E-value=0.23 Score=49.81 Aligned_cols=98 Identities=18% Similarity=0.149 Sum_probs=64.6
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCce
Q 004174 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (770)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~~ 582 (770)
+|.+.|...+ .++++++++.++.|.+.+|.-+-... .+ ..+=+-|..|+|..+|.+-+.+ +.+.
T Consensus 34 SL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----------
Confidence 7999998665 48999999999999999887662100 11 1333457899999999887764 1110
Q ss_pred ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh
Q 004174 583 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621 (770)
Q Consensus 583 ~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt 621 (770)
.....+.|||... ...+.+.=|||||+++|.-+-
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123466888764 345678889999999999986
|
| >3a2k_A TRNA(Ile)-lysidine synthase; ligase, pseudo-knot, ligase/RNA complex; 3.65A {Geobacillus kaustophilus} | Back alignment and structure |
|---|
Probab=87.82 E-value=1.3 Score=49.52 Aligned_cols=97 Identities=21% Similarity=0.158 Sum_probs=64.9
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCccchhhhHHHHHHHHHHHhHhhhcCCcEEEE
Q 004174 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLK 95 (770)
Q Consensus 16 ~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~~~ 95 (770)
+.+|+||+.+..+|.-+|.++....-+.|-.|+++||-.... + ...+.-....+.+|+..+|.+...
T Consensus 18 ~~~vlVa~SGG~DS~~Ll~ll~~~~~~~~~~v~avhvdhglr--------g-----~~s~~~~~~v~~~~~~lgi~~~v~ 84 (464)
T 3a2k_A 18 GAAVIVGVSGGPDSLALLHVFLSLRDEWKLQVIAAHVDHMFR--------G-----RESEEEMEFVKRFCVERRILCETA 84 (464)
T ss_dssp SSBEEEECCSSHHHHHHHHHHHHHHHTTTCBCEEEEEECTTC--------T-----HHHHHHHHHHHHHHHHTTCEEEEE
T ss_pred CCEEEEEEcCcHHHHHHHHHHHHHHHHcCCeEEEEEEECCCC--------c-----cccHHHHHHHHHHHHHcCCcEEEE
Confidence 468999999999999888777665444688999999974321 0 111122345678899988887665
Q ss_pred EEECC----Ch------------hHHHHHHHHhcCCcEEEEccCCC
Q 004174 96 ICRGT----SI------------RKILVREAQSYSATKFIVGTAKN 125 (770)
Q Consensus 96 v~~~~----d~------------~~~L~~~a~~~~a~~LVlG~~~~ 125 (770)
-+... +. ...+.+.|+.++++.|++|.+..
T Consensus 85 ~~~~~~~~~~~~~~~e~~aR~~Ry~~l~~~a~~~g~~~IatgH~~d 130 (464)
T 3a2k_A 85 QIDVPAFQRSAGLGAQEAARICRYRFFAELMEKHQAGYVAVGHHGD 130 (464)
T ss_dssp ECCCHHHHTTTTCCSHHHHHHHHHHHHHHHHHTTTCCEEECCCCHH
T ss_pred EechhhhhhccCCCHHHHHHHHHHHHHHHHHHHcCcCEEEEeCChH
Confidence 44310 00 13455667778888888888743
|
| >1wy5_A TILS, hypothetical UPF0072 protein AQ_1887; N-type ATP-ppase, structural genomics, translation, NPPSFA; 2.42A {Aquifex aeolicus} SCOP: c.26.2.5 d.229.1.1 PDB: 2e21_A* 2e89_A* | Back alignment and structure |
|---|
Probab=86.59 E-value=3.3 Score=43.69 Aligned_cols=96 Identities=15% Similarity=0.014 Sum_probs=63.2
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCE-EEEEEeecCCCcccCCCCccchhhhHHHHHHHHHHHhHhhhcCCcEEE
Q 004174 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDT-VIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKL 94 (770)
Q Consensus 16 ~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~-vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~~ 94 (770)
+.+|+||+.+..+|.-+|.++....-..|-. |+++||-.... ...+.-....+.+|+.-+|.+..
T Consensus 24 ~~~vlva~SGG~DS~~Ll~ll~~~~~~~g~~~v~av~vd~g~r--------------~~s~~~~~~v~~~a~~lgi~~~v 89 (317)
T 1wy5_A 24 ERRVLIAFSGGVDSVVLTDVLLKLKNYFSLKEVALAHFNHMLR--------------ESAERDEEFCKEFAKERNMKIFV 89 (317)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHSTTTTTCSEEEEEEEECCSS--------------THHHHHHHHHHHHHHHHTCCEEE
T ss_pred CCEEEEEecchHHHHHHHHHHHHHHHHcCCCEEEEEEEECCCC--------------cccHHHHHHHHHHHHHcCCcEEE
Confidence 5689999999999998887766544344667 99999964321 01112234567788888887665
Q ss_pred EEEE--------CCC-------hh-HHHHHHHHhcCCcEEEEccCCC
Q 004174 95 KICR--------GTS-------IR-KILVREAQSYSATKFIVGTAKN 125 (770)
Q Consensus 95 ~v~~--------~~d-------~~-~~L~~~a~~~~a~~LVlG~~~~ 125 (770)
.-+. +.+ .+ ..+.+.|+.++++.|++|.+..
T Consensus 90 ~~~~~~~~~~~~~~~~e~~ar~~Ry~~l~~~a~~~g~~~i~~Gh~~d 136 (317)
T 1wy5_A 90 GKEDVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLN 136 (317)
T ss_dssp EECCHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHH
T ss_pred EEEechhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCEEEEeCchh
Confidence 4432 111 11 2566677888999999998853
|
| >1k92_A Argininosuccinate synthase, argininosuccinate SY; N-type ATP pyrophosphatase, ligase; 1.60A {Escherichia coli} SCOP: c.26.2.1 d.210.1.1 PDB: 1k97_A* 1kp2_A* 1kp3_A* | Back alignment and structure |
|---|
Probab=81.85 E-value=6.6 Score=43.58 Aligned_cols=37 Identities=16% Similarity=0.222 Sum_probs=32.3
Q ss_pred CCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecC
Q 004174 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLAN 55 (770)
Q Consensus 15 ~~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~ 55 (770)
.+.+|+||+.+..+|.-+|.|+.+. |..|+++|+...
T Consensus 9 ~~~KVvVA~SGGlDSSvll~~L~e~----G~eViavtvd~G 45 (455)
T 1k92_A 9 VGQRIGIAFSGGLDTSAALLWMRQK----GAVPYAYTANLG 45 (455)
T ss_dssp TTSEEEEECCSSHHHHHHHHHHHHT----TCEEEEEEEECC
T ss_pred CCCeEEEEEcChHHHHHHHHHHHHc----CCEEEEEEEEcC
Confidence 3568999999999999999999874 889999999754
|
| >2nz2_A Argininosuccinate synthase; amino-acid biosynthesis, aspartate, citrulline, ST genomics, structural genomics consortium, SGC, ligase; HET: CIR; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.60 E-value=4.8 Score=44.18 Aligned_cols=87 Identities=16% Similarity=0.072 Sum_probs=59.7
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCccchhhhHHHHHHHHHHHhHhhhcCCc-EEE
Q 004174 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVD-LKL 94 (770)
Q Consensus 16 ~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~-~~~ 94 (770)
+.+|+||+.+...|.-+|.|+.+. |..|+++|+-.... +. ++..+.+|..-++. +..
T Consensus 5 ~~kVvvalSGGlDSsvll~lL~e~----G~eV~av~vd~g~~--------------~e----~e~a~~~A~~lGi~~~~v 62 (413)
T 2nz2_A 5 KGSVVLAYSGGLDTSCILVWLKEQ----GYDVIAYLANIGQK--------------ED----FEEARKKALKLGAKKVFI 62 (413)
T ss_dssp CEEEEEECCSSHHHHHHHHHHHHT----TEEEEEEEEESSCC--------------CC----HHHHHHHHHHHTCSEEEE
T ss_pred CCeEEEEEcChHHHHHHHHHHHHc----CCEEEEEEEECCcH--------------HH----HHHHHHHHHHhCCCEEEE
Confidence 468999999999999999999875 78999999974421 00 12344455555554 332
Q ss_pred EEEE-----------------------CCC------hhHHHHHHHHhcCCcEEEEccCC
Q 004174 95 KICR-----------------------GTS------IRKILVREAQSYSATKFIVGTAK 124 (770)
Q Consensus 95 ~v~~-----------------------~~d------~~~~L~~~a~~~~a~~LVlG~~~ 124 (770)
.-+. -+. +.+.+.+.|++.+++.|+.|.++
T Consensus 63 vd~~~ef~~~~~~~~i~~~a~~e~~y~~g~~~aRp~i~~~l~~~A~~~Ga~~IatGh~~ 121 (413)
T 2nz2_A 63 EDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATG 121 (413)
T ss_dssp EECHHHHHHHTHHHHHHTTCCBTTTBCCTTTTHHHHHHHHHHHHHHHHTCSEEECCCCT
T ss_pred EeChHHHHHHHHHHHHHhCcccccccccccccchHHHHHHHHHHHHHcCCCEEEECCcC
Confidence 2110 011 14678899999999999999986
|
| >1ni5_A Putative cell cycle protein MESJ; structural genomics, ATPase, PP-type, putative cell cycle PR PSI, protein structure initiative; 2.65A {Escherichia coli} SCOP: b.153.1.2 c.26.2.5 d.229.1.1 | Back alignment and structure |
|---|
Probab=80.38 E-value=2 Score=47.46 Aligned_cols=68 Identities=24% Similarity=0.249 Sum_probs=46.6
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccC-CCCEEEEEEeecCCCcccCCCCccchhhhHHHHHHHHHHHhHhhhcCCcEEE
Q 004174 16 GRTVVVGVKLDTHSRELLTWALVKVAQ-PGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKL 94 (770)
Q Consensus 16 ~r~I~VaVd~s~~S~~AL~WAl~~~~~-~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~~ 94 (770)
+.+|+||+.+..+|.-+|.++....-+ .|-.|+++||-..... . . +.-....+.+|+..+|.+..
T Consensus 13 ~~~vlVa~SGG~DS~~Ll~ll~~~~~~~~g~~v~avhvdhglr~--------~---s---~~~~~~v~~~~~~lgi~~~v 78 (433)
T 1ni5_A 13 SRQILVAFSGGLDSTVLLHQLVQWRTENPGVALRAIHVHHGLSA--------N---A---DAWVTHCENVCQQWQVPLVV 78 (433)
T ss_dssp CSEEEEECCSBHHHHHHHHHHHHHHTTSTTCEEEEEEECCSCCS--------S---H---HHHHHHHHHHHHHTTCCEEE
T ss_pred CCEEEEEEcchHHHHHHHHHHHHHHHhcCCCeEEEEEEECCCCc--------c---c---HHHHHHHHHHHHHcCCcEEE
Confidence 468999999999999777776654444 6889999999643210 0 0 11234567789988887766
Q ss_pred EEE
Q 004174 95 KIC 97 (770)
Q Consensus 95 ~v~ 97 (770)
.-+
T Consensus 79 ~~~ 81 (433)
T 1ni5_A 79 ERV 81 (433)
T ss_dssp ECC
T ss_pred EEe
Confidence 544
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 770 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-64 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-54 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 1e-64
Identities = 74/281 (26%), Positives = 128/281 (45%), Gaps = 26/281 (9%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKN 478
IG G VYKG ++AVK+L P+ ++ F E+ ++ H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
I+ +G+ L +V + SL +LH + F + +A A+ ++YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLH 121
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
+ + +IHRD+KS+NI L +D ++ DFGLA S S ++G+ ++APE
Sbjct: 122 A---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 599 MY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655
+ + DVYAFG+VL EL+TG+ P SN + + Q ++ +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD-------L 231
Query: 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
+ +N M+R++ C+++ RP +L +
Sbjct: 232 SKVRSNCP-KAMKRLMAE---CLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-61
Identities = 56/274 (20%), Positives = 114/274 (41%), Gaps = 22/274 (8%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
+G G +V+ G ++AVK LK F+ E ++ L H+ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L + ++ +++ GSL + L ++ +A +AE + ++
Sbjct: 73 LYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEE-- 127
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
+ IHRD++++NIL+SD +++DFGLA+ + + APE YG
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYG 185
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661
K DV++FG++L E++T + + V+ + + +N
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQ--------NLERGYRMVRPDN 234
Query: 662 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695
+++ +++ LC + P RP + +L
Sbjct: 235 CP-EELYQLMR---LCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 7e-61
Identities = 66/279 (23%), Positives = 119/279 (42%), Gaps = 22/279 (7%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
S IG G V+ G + ++A+K ++ ++F+ E E++ L H ++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L G C E + LV++F+ G L + L F + + V E + YL
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
VIHRD+ + N L+ ++ ++SDFG+ ++ + + +PE F +
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFS 177
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661
+ + K DV++FGV++ E+ + K P S + I + + L P L +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKI-----PYENRSNSEVVEDISTGFR---LYKPRLAST 229
Query: 662 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 700
+ Y M C + P RP S +L+ L A+
Sbjct: 230 HVYQIMNH-------CWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 3e-60
Identities = 59/304 (19%), Positives = 119/304 (39%), Gaps = 40/304 (13%)
Query: 420 ATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHH 476
+F + +G G V+K P G +A K++ + + + E++++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
I+ G + D + + + + GSL++ L + KV++ V + L Y
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTY 119
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
L +++HRDVK SNIL++ E +L DFG++ S + GT Y++PE
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPE 173
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPI-SNDHPKGQESLVMWAKPILSSGKVTQLLD 655
+ + D+++ G+ L+E+ GR PI D + + + +
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 656 PALGNNYDYDQMERMVLASIL--------------------------CIRRDPRARPQMS 689
++Y D M + +L C+ ++P R +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 690 LVLK 693
++
Sbjct: 294 QLMV 297
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 6e-59
Identities = 72/292 (24%), Positives = 115/292 (39%), Gaps = 28/292 (9%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+ IGKG +V++G G+E+AVKI E+ EI L H+NI+ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 487 FEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS--- 539
+DN L LV D+ GSL + L+ K+A+ A L +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT-----VEGMIKLALSTASGLAHLHMEIV 121
Query: 540 --GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW--ASTSSSHITCTDVAGTFGYLAP 595
+ HRD+KS NIL+ + ++D GLA ++T + I GT Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 596 EYF------MYGKVNDKIDVYAFGVVLLELLTGRKPISND----HPKGQESLVMWAKPIL 645
E + + + D+YA G+V E+ P + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 646 SSGKVTQLLDPALGNNYDYDQMERMVLASIL-CIRRDPRARPQMSLVLKLLR 696
Q L P + N + + R++ + C + AR + K L
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 8e-58
Identities = 69/277 (24%), Positives = 114/277 (41%), Gaps = 33/277 (11%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHH 476
+F +GKG VY LA+K+L + V + E+EI + L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
NI+ L G+ + + L+ ++ G++ L K F +A AL Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSY 121
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
HS +RVIHRD+K N+LL E +++DFG + A +S C GT YL PE
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPE 174
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656
++K+D+++ GV+ E L G+ P + + + + +
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD-----FVTE 229
Query: 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
D + R ++ +P RP + VL+
Sbjct: 230 GA-----RDLISR-------LLKHNPSQRPMLREVLE 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-57
Identities = 60/276 (21%), Positives = 114/276 (41%), Gaps = 24/276 (8%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
+ +G G V G ++A+K++K EF+ E +++ L H+ ++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L G C + + ++ ++++ G L L + F + ++ V EA+EYL S
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLES-- 118
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
++ +HRD+ + N L++D ++SDFGL+++ + + PE MY
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYS 176
Query: 602 KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660
K + K D++AFGV++ E+ + G+ P + L P L +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR---------LYRPHLAS 227
Query: 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
Y M C RP ++L +
Sbjct: 228 EKVYTIMYS-------CWHEKADERPTFKILLSNIL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-57
Identities = 58/274 (21%), Positives = 117/274 (42%), Gaps = 22/274 (8%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
+ E +G+G +V+ G +A+K LKP + F+ E +++ L H+ ++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L + + +V +++S+GSL + L G + +A +A + Y+
Sbjct: 77 LYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVER-- 131
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
+HRD++++NIL+ ++ +++DFGLA+ + + APE +YG
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYG 189
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661
+ K DV++FG++L EL T + + + +V ++
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPG---------------MVNREVLDQVERGYRMP 234
Query: 662 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695
+ E + C R++P RP + L
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 3e-57
Identities = 62/283 (21%), Positives = 106/283 (37%), Gaps = 26/283 (9%)
Query: 419 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTL 474
S ++ IG G + K DGK L K L +E + V E+ ++ L
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 475 HHKNIISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
H NI+ + + L +V ++ G L + K+ +V +
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 533 ALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
AL+ H S V+HRD+K +N+ L +L DFGLA+ + +S GT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTP 178
Query: 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650
Y++PE N+K D+++ G +L EL P + K + K +
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238
Query: 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
+ L + + R + RP + +L+
Sbjct: 239 SDEL---------NEIITR-------MLNLKDYHRPSVEEILE 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (494), Expect = 6e-57
Identities = 69/304 (22%), Positives = 127/304 (41%), Gaps = 41/304 (13%)
Query: 412 FNYQDLLSATSNFLAE---------NLIGKGGSSQVYKGCLPDGKEL----AVKILKP-- 456
F ++D A F E +IG G +V G L + A+K LK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 457 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 516
+E ++F+ E I+ H N+I L G + ++++ +F+ GSL+ L N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-- 124
Query: 517 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576
F + + G+A ++YL +HRD+ + NIL++ + ++SDFGL+++
Sbjct: 125 -FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 577 SSSHITCTDVAG---TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPK 632
+S T T G + APE Y K DV+++G+V+ E+++ G +P + +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 633 GQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 692
V ++ D + + C ++D RP+ ++
Sbjct: 241 ----------------DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 693 KLLR 696
L
Sbjct: 285 NTLD 288
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-56
Identities = 66/290 (22%), Positives = 121/290 (41%), Gaps = 31/290 (10%)
Query: 415 QDLLSATSNFLAENL-IGKGGSSQVYKGCL---PDGKELAVKILKP--SEDVIKEFVLEI 468
+ L N L ++ +G G V +G ++A+K+LK + +E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 469 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 528
+I+ L + I+ L+G C + L+LV + G L + L G +++ S ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLH 116
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VA 587
V+ ++YL + +HRD+ + N+LL + ++SDFGL+K S+ T
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 588 GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILS 646
+ APE + K + + DV+++GV + E L+ G+KP + + K +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 233
Query: 647 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
+ L Y M C RP V + +R
Sbjct: 234 PPECPPEL---------YALMSD-------CWIYKWEDRPDFLTVEQRMR 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-56
Identities = 70/276 (25%), Positives = 120/276 (43%), Gaps = 28/276 (10%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
IGKG V G G ++AVK +K ++ + F+ E ++T L H N++
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQ 64
Query: 482 LLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
LLG E+ L +V +++++GSL + L + G K ++ V EA+EYL
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEG- 121
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
+HRD+ + N+L+S+D ++SDFGL K AS+ T + APE
Sbjct: 122 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALRE 174
Query: 601 GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660
K + K DV++FG++L E+ + + P + L +V + +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVP------RVEKGYKMDAPD 223
Query: 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
+ ++ C D RP + + L
Sbjct: 224 GCP-PAVYEVMK---NCWHLDAAMRPSFLQLREQLE 255
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (491), Expect = 3e-56
Identities = 66/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISL 482
IG G VY + + + +A+K + S + ++ + E+ + L H N I
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
G ++ LV ++ + + K E V G + L YLHS
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLHS--- 133
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM--- 599
+IHRDVK+ NILLS+ +L DFG A + ++S + GT ++APE +
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMD 187
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659
G+ + K+DV++ G+ +EL + P+ N + + + PAL
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES------------PALQ 235
Query: 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
+ + + V + C+++ P+ RP ++LK
Sbjct: 236 SGHWSEYFRNFVDS---CLQKIPQDRPTSEVLLK 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 4e-55
Identities = 60/275 (21%), Positives = 109/275 (39%), Gaps = 25/275 (9%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNI 479
++ +G+G +V + +AVKI+ + D + EI I L+H+N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
+ G E N L ++ S G L + + + + + + + YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHG 121
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+ HRD+K N+LL + ++SDFGLA ++ + GT Y+APE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 600 YGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658
+ + +DV++ G+VL +L G P QE K + + +D A
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN--PWKKIDSAP 236
Query: 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
+ + + +P AR + + K
Sbjct: 237 -----LALLHK-------ILVENPSARITIPDIKK 259
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 5e-55
Identities = 66/280 (23%), Positives = 112/280 (40%), Gaps = 32/280 (11%)
Query: 425 LAENLIGKGGSSQVYKGCLPD---GKELAVKILKP---SEDVIKEFVLEIEIITTLHHKN 478
L + +G G V KG K +AVKILK + E + E ++ L +
Sbjct: 10 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 69
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
I+ ++G C E + +LV + G L + L N+ ++ V+ ++YL
Sbjct: 70 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLE 124
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAPEY 597
+HRD+ + N+LL ++SDFGL+K ++ + APE
Sbjct: 125 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 598 FMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656
Y K + K DV++FGV++ E + G+KP +++ + + + +
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM-- 239
Query: 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
YD M C D RP + V LR
Sbjct: 240 -------YDLMNL-------CWTYDVENRPGFAAVELRLR 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 6e-55
Identities = 66/273 (24%), Positives = 125/273 (45%), Gaps = 29/273 (10%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+G G +VYK A K++ SE+ ++++++EI+I+ + H NI+ LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
+ +NNL ++ +F + G+++ + ++ S+ V +AL YLH ++
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHD---NKI 131
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 605
IHRD+K+ NIL + D + +L+DFG++ + + GT ++APE M D
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKD 189
Query: 606 -----KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660
K DV++ G+ L+E+ P +P + ++P P L
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP------------PTLAQ 237
Query: 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
+ + L C+ ++ AR S +L+
Sbjct: 238 PSRWSSNFKDFLKK--CLEKNVDARWTTSQLLQ 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (478), Expect = 8e-55
Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 22/285 (7%)
Query: 413 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEII 471
NY ++ ++ +G G +VY+G +AVK LK ++EF+ E ++
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 67
Query: 472 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA 531
+ H N++ LLG C + ++ +F++ G+L + L + +A ++
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQIS 125
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 591
A+EYL + IHRD+ + N L+ ++ +++DFGL++ + +
Sbjct: 126 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIK 181
Query: 592 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 651
+ APE Y K + K DV+AFGV+L E+ T Q V
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VY 226
Query: 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
+LL+ E++ C + +P RP + + +
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-54
Identities = 60/300 (20%), Positives = 114/300 (38%), Gaps = 40/300 (13%)
Query: 422 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSEDV--IKEFVLEIEIITT 473
+ +G G +V + +AVK+LKPS + + + E+++++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 474 L-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK--------------DPAAF 518
L +H NI++LLG C L++ ++ G L L + D A
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 519 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578
+ + VA+ + +L S + IHRD+ + NILL+ ++ DFGLA+ S
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638
+++ + ++APE + DV+++G+ L EL + P +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256
Query: 639 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698
+++ M C DP RP +++L+
Sbjct: 257 -----------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 3e-54
Identities = 66/276 (23%), Positives = 119/276 (43%), Gaps = 33/276 (11%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISL 482
+ IG+G VYKG E+A L+ ++ + F E E++ L H NI+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 483 LGFCFE----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
++LV + ++ G+L+ L K + + L++LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLH 129
Query: 539 SGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
+ + +IHRD+K NI ++ ++ D GLA S + V GT ++APE
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEM 184
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657
+ K ++ +DVYAFG+ +LE+ T P S Q ++ +VT + PA
Sbjct: 185 YE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IYR-------RVTSGVKPA 232
Query: 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
+ +++ ++ CIR++ R + +L
Sbjct: 233 SFDKVAIPEVKEIIEG---CIRQNKDERYSIKDLLN 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 6e-54
Identities = 72/282 (25%), Positives = 121/282 (42%), Gaps = 32/282 (11%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGK----ELAVKILKPSEDV--IKEFVLEIEIITTLHH 476
+F +IG+G VY G L D AVK L D+ + +F+ E I+ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 477 KNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
N++SLLG C + + L+V ++ G L + +P + + VA+ ++
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT---VKDLIGFGLQVAKGMK 144
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS--SHITCTDVAGTFGYL 593
+L S ++ +HRD+ + N +L + F +++DFGLA+ S T ++
Sbjct: 145 FLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653
A E K K DV++FGV+L EL+T P P + +L + L
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---L 253
Query: 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 695
L P Y D + ++L C RP S ++ +
Sbjct: 254 LQP----EYCPDPLYEVML---KCWHPKAEMRPSFSELVSRI 288
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-53
Identities = 60/302 (19%), Positives = 118/302 (39%), Gaps = 45/302 (14%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPSED--VIKEFVLEIEIITT 473
N ++G G +V ++AVK+LK D + + E++++T
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 474 L-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK------------------- 513
L H+NI++LLG C + L++++ G L L ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 514 DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
D + + A VA+ +E+L + +HRD+ + N+L++ ++ DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633
+ S+++ + ++APE G K DV+++G++L E+ + P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 634 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
+L+ + + E + + C D R RP +
Sbjct: 274 AN--------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 694 LL 695
L
Sbjct: 320 FL 321
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-53
Identities = 59/284 (20%), Positives = 119/284 (41%), Gaps = 29/284 (10%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKE-----LAVKILKP--SEDVIKEFVLEIEIITTL 474
S + +IG G +VYKG L +A+K LK +E +F+ E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 475 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 534
H NII L G + ++++ +++ G+ ++ F + + G+A +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGA---LDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI-TCTDVAGTFGYL 593
+YL + +HRD+ + NIL++ + ++SDFGL++ T + +
Sbjct: 124 KYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653
APE Y K DV++FG+V+ E++T + + + V +
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------VMKA 225
Query: 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697
++ D + + C +++ RP+ + ++ +L
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-53
Identities = 70/268 (26%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGF 485
IG+G S VY + G+E+A++ + + KE ++ EI ++ + NI++ L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
+ L +V ++L+ GSL + + D + V +ALE+LHS +V
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLHS---NQV 137
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 605
IHRD+KS NILL D +L+DFG + S + + GT ++APE
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGP 195
Query: 606 KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 665
K+D+++ G++ +E++ G P N++P L+ P L N
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT------------PELQNPEKLS 243
Query: 666 QMERMVLASILCIRRDPRARPQMSLVLK 693
+ R L C+ D R +L+
Sbjct: 244 AIFRDFLNR--CLDMDVEKRGSAKELLQ 269
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 183 bits (465), Expect = 8e-53
Identities = 62/303 (20%), Positives = 126/303 (41%), Gaps = 46/303 (15%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKP--SEDVIKEFVLEIEIITT 473
+N IG+G +V++ P +AVK+LK S D+ +F E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 474 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD------------------- 514
+ NI+ LLG C + L++++++ G L E L
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 515 -PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
P +E+ +A VA + YL ++ +HRD+ + N L+ ++ +++DFGL++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633
++ + + A ++ PE Y + + DV+A+GVVL E+ +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-- 247
Query: 634 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
E ++ + + G + + ++ ++ LC + P RP + +
Sbjct: 248 HEEVIYYVR----DGNILACPENCP------LELYNLMR---LCWSKLPADRPSFCSIHR 294
Query: 694 LLR 696
+L+
Sbjct: 295 ILQ 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 5e-52
Identities = 61/269 (22%), Positives = 103/269 (38%), Gaps = 29/269 (10%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHK 477
+F ++G+G S V L +E A+KIL+ E+ + E ++++ L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+ L +D L + G L + + F + + ALEYL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYL 124
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
H + +IHRD+K NILL++D Q++DFG AK S S GT Y++PE
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657
D++A G ++ +L+ G P + ++ + P
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK-----FFPK 236
Query: 658 LGNNYDYDQMERMVLASILCIRRDPRARP 686
D +E+ + D R
Sbjct: 237 A-----RDLVEK-------LLVLDATKRL 253
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-51
Identities = 64/293 (21%), Positives = 124/293 (42%), Gaps = 39/293 (13%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKEL---AVKILKP--SEDVIKEFVLEIEIITTL-H 475
++ +++IG+G QV K + A+K +K S+D ++F E+E++ L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGN------------KKDPAAFGWSER 523
H NII+LLG C L L ++ G+L + L + + +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 524 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
A VA ++YL ++ IHRD+ + NIL+ +++ +++DFGL++
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 584 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 643
++A E Y DV+++GV+L E+++ P + +
Sbjct: 187 R---LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEK 238
Query: 644 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
+ ++ + L+ D++ ++ C R P RP + +L L
Sbjct: 239 LPQGYRLEKPLNCD-------DEVYDLMR---QCWREKPYERPSFAQILVSLN 281
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 6e-51
Identities = 65/341 (19%), Positives = 140/341 (41%), Gaps = 46/341 (13%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
++G G VYKG +P+G+++ A+K L+ S KE + E ++ ++ + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
LLG C + + L+ + G L + + +K + G + +A+ + YL
Sbjct: 75 RLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED- 129
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
+R++HRD+ + N+L+ +++DFGLAK ++A E ++
Sbjct: 130 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 601 GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660
+ DV+++GV + EL+T + P + ++ +L+
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------------ISSILEKGERL 232
Query: 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLK-LLRGDADVTKWARLQVNASEESEMLD 719
+ + + C D +RP+ ++ + D ++ +Q +
Sbjct: 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPT 292
Query: 720 DESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLL 760
D + R+ L+D ED ++ V ++YL+
Sbjct: 293 DSNFYRA---------LMDEED-------MDDVVDADEYLI 317
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 177 bits (450), Expect = 3e-50
Identities = 56/275 (20%), Positives = 103/275 (37%), Gaps = 26/275 (9%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL-KPSEDVIKEFVLEIEIITTLHHKNII 480
++ +G G V++ G A K + P E + EI+ ++ L H ++
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
+L +DN ++++Y+F+S G L E + E + V + L ++H
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
+H D+K NI+ + + L DFGL S T GT + APE
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 197
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658
V D+++ GV+ LL+G P ++ V + + + +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG- 256
Query: 659 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
D + + + DP R + L+
Sbjct: 257 -----KDFIRK-------LLLADPNTRMTIHQALE 279
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 7e-49
Identities = 66/297 (22%), Positives = 119/297 (40%), Gaps = 39/297 (13%)
Query: 422 SNFLAENLIGKGGSSQVYKGC------LPDGKELAVKILKPS--EDVIKEFVLEIEIIT- 472
+G+G QV + + +AVK+LK + + E++I+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 473 TLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPA------------AFG 519
HH N+++LLG C + L+++ +F G+L L + +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 520 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579
+ VA+ +E+L S ++ IHRD+ + NILLS+ ++ DFGLA+
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639
++ D ++APE + DV++FGV+L E+ + P +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDE 244
Query: 640 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
L G + D Y +M + +L C +P RP S +++ L
Sbjct: 245 EFCRRLKEGTRMRAPD------YTTPEMYQTML---DCWHGEPSQRPTFSELVEHLG 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 170 bits (431), Expect = 2e-48
Identities = 65/271 (23%), Positives = 114/271 (42%), Gaps = 30/271 (11%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIIS 481
++G GG S+V+ L +++AVK+L+ F E + L+H I++
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 482 LLGFCFEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+ + +V +++ +L + +H +V +AL +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFS 127
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT-CTDVAGTFGYLAPE 596
H +IHRDVK +NI++S ++ DFG+A+ + S + +T V GT YL+PE
Sbjct: 128 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656
V+ + DVY+ G VL E+LTG P + D P + PI S + L
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244
Query: 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQ 687
+ + + ++P R Q
Sbjct: 245 L------DAVVLK-------ALAKNPENRYQ 262
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 4e-48
Identities = 63/276 (22%), Positives = 107/276 (38%), Gaps = 30/276 (10%)
Query: 430 IGKGGSSQVYKGCLP----DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIIS 481
+G G V +G +AVK LKP + + +F+ E+ + +L H+N+I
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L G + +V + GSL + L ++ F + A+ VAE + YL S
Sbjct: 76 LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLES-- 129
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAPEYFMY 600
+R IHRD+ + N+LL+ ++ DFGL + + H + F + APE
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 601 GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660
+ D + FGV L E+ T + P + I G+
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGE-----RLPRPE 238
Query: 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
+ + +++ C P RP + L
Sbjct: 239 DCP-QDIYNVMV---QCWAHKPEDRPTFVALRDFLL 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 7e-48
Identities = 53/293 (18%), Positives = 118/293 (40%), Gaps = 32/293 (10%)
Query: 422 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKP--SEDVIKEFVLEIEIITT 473
+G+G VY+G +A+K + S EF+ E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 474 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFG------WSERYKVA 527
+ +++ LLG + L++ + ++RG L+ L + A S+ ++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
+A+ + YL++ + +HRD+ + N ++++DF ++ DFG+ + + +
Sbjct: 140 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 588 GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 647
+++PE G DV++FGVVL E+ T + +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQVLRFVME 250
Query: 648 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 700
G + D D + ++ +C + +P+ RP ++ ++ + +
Sbjct: 251 GGLLDKPDNCP------DMLFELMR---MCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 171 bits (433), Expect = 7e-48
Identities = 56/269 (20%), Positives = 99/269 (36%), Gaps = 26/269 (9%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 486
+G G V++ G+ K + + K V EI I+ LHH +I+L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
+ ++L+ +FLS G L + + +E E L+++H ++
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHE---HSIV 149
Query: 547 HRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 604
H D+K NI+ + DFGLA + T T + APE V
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVG 206
Query: 605 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 664
D++A GV+ LL+G P + + V + + A
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA------K 260
Query: 665 DQMERMVLASILCIRRDPRARPQMSLVLK 693
D ++ ++++PR R + L+
Sbjct: 261 DFIKN-------LLQKEPRKRLTVHDALE 282
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 168 bits (427), Expect = 7e-48
Identities = 68/289 (23%), Positives = 115/289 (39%), Gaps = 41/289 (14%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----------EDVIKEFVLEIEII 471
N+ + ++G+G SS V + P KE AVKI+ + +++ + + E++I+
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 472 TTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 530
+ H NII L + LV+D + +G L + L E K+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRAL 119
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
E + LH ++HRD+K NILL DD +L+DFG + +V GT
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 591 GYLAPEYFM------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 644
YLAPE + ++D+++ GV++ LL G P + ++M
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 645 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
S + D D + R + P+ R L
Sbjct: 234 FGSPEWDDYSDTV------KDLVSR-------FLVVQPQKRYTAEEALA 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-47
Identities = 60/277 (21%), Positives = 113/277 (40%), Gaps = 31/277 (11%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKE----LAVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
IG+G V++G + +A+K K S+ V ++F+ E + H +I+
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L+G +N + ++ + + G L + + + A ++ AL YL S
Sbjct: 72 KLIGVI-TENPVWIIMELCTLGEL---RSFLQVRKYSLDLASLILYAYQLSTALAYLES- 126
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
+R +HRD+ + N+L+S + +L DFGL+++ S+ + + ++APE +
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINF 183
Query: 601 GKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659
+ DV+ FGV + E+L G KP + + + L
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL----- 238
Query: 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
Y M + C DP RP+ + + L
Sbjct: 239 ----YSLMTK-------CWAYDPSRRPRFTELKAQLS 264
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-47
Identities = 61/277 (22%), Positives = 113/277 (40%), Gaps = 32/277 (11%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIIT-TLHH 476
+F+ ++GKG +V+ + A+K LK +D ++ ++E +++ H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
+ + NL V ++L+ G L ++ K F S A + L++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQF 118
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
LHS + +++RD+K NILL D +++DFG+ K GT Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPE 173
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656
+ K N +D ++FGV+L E+L G+ P + + P L+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW-----LEK 228
Query: 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
D + + R+P R + ++
Sbjct: 229 EA-----KDLLVK-------LFVREPEKRLGVRGDIR 253
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 4e-47
Identities = 51/268 (19%), Positives = 103/268 (38%), Gaps = 25/268 (9%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 487
+G+G V++ K K +K EI I+ H+NI+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547
L+++++F+S + E ++ + + E V EAL++LHS + H
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 548 RDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 605
D++ NI+ + +FG A+ + Y APE + V+
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPEVHQHDVVST 182
Query: 606 KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 665
D+++ G ++ LL+G P + + +M A+ ++ A+ D
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM------D 236
Query: 666 QMERMVLASILCIRRDPRARPQMSLVLK 693
++R + ++ ++R S L+
Sbjct: 237 FVDR-------LLVKERKSRMTASEALQ 257
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (422), Expect = 8e-47
Identities = 67/315 (21%), Positives = 123/315 (39%), Gaps = 37/315 (11%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLL 483
+++G G S+V K +A+K + E EI ++ + H NI++L
Sbjct: 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+L L+ +S G L + + + + ++ V +A++YLH
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQVLDAVKYLHD---L 126
Query: 544 RVIHRDVKSSNILLS---DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
++HRD+K N+L +D + +SDFGL+K S + GT GY+APE
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQ 183
Query: 601 GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 660
+ +D ++ GV+ LL G P +++ ++ A+ S + D A
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA--- 240
Query: 661 NYDYDQMERMVLASILCIRRDPRARPQMSLVLK--LLRGDADVTKWARLQVNASEESEML 718
D + + +DP R L+ + GD + K V+ +
Sbjct: 241 ---KDFIRH-------LMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNF- 289
Query: 719 DDESCPRSNLQSHLN 733
+S + N
Sbjct: 290 -----AKSKWKQAFN 299
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 167 bits (423), Expect = 2e-46
Identities = 62/273 (22%), Positives = 109/273 (39%), Gaps = 34/273 (12%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTL 474
+F +IG+GG +VY GK A+K L E + + + +++T
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 475 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 534
I+ + + L + D ++ G L +L + ++ A + L
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMRFYAAEIILGL 120
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
E++H+ + V++RD+K +NILL + ++SD GLA S H + GT GY+A
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMA 173
Query: 595 PEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653
PE G D D ++ G +L +LL G P K + + + ++
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--ELPDS 231
Query: 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARP 686
P L +E ++RD R
Sbjct: 232 FSPEL-----RSLLEG-------LLQRDVNRRL 252
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 5e-46
Identities = 70/304 (23%), Positives = 125/304 (41%), Gaps = 41/304 (13%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKP--SEDVIKEFVLEIEII 471
+ +G+G QV ++AVK+LK +E + + + E+E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 472 TTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA------------F 518
+ HKNII+LLG C +D L ++ ++ S+G+L E L +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 519 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578
+ A VA +EYL S ++ IHRD+ + N+L+++D +++DFGLA+
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638
+ T+ ++APE + DV++FGV+L E+ T P V
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------V 243
Query: 639 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698
+L G +++ M+ C P RP +++ L
Sbjct: 244 EELFKLLKEGHRMDKPSNCT------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRI 294
Query: 699 ADVT 702
+T
Sbjct: 295 VALT 298
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 4e-45
Identities = 55/279 (19%), Positives = 99/279 (35%), Gaps = 25/279 (8%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
IG G +Y G + G+E+A+K+ + +E +I + I + +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
C + + ++ L SLE+ + + F +A + +EY+HS +
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS---KNF 124
Query: 546 IHRDVKSSNILLSD---DFEPQLSDFGLAKWASTSSSHITC-----TDVAGTFGYLAPEY 597
IHRDVK N L+ + DFGLAK + +H ++ GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657
+ + + + D+ + G VL+ G P + K
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-----KKMSTPIEV 239
Query: 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
L Y + + C +P S + +L R
Sbjct: 240 LCKGYP-SEFATYLNF---CRSLRFDDKPDYSYLRQLFR 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (409), Expect = 5e-45
Identities = 63/271 (23%), Positives = 112/271 (41%), Gaps = 34/271 (12%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHH 476
+F +G G +V+ +G+ A+K+LK ++ E +++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
II + G + + ++ D++ G L L +++ P A V ALEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP----NPVAKFYAAEVCLALEY 119
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
LHS + +I+RD+K NILL + +++DFG AK+ + GT Y+APE
Sbjct: 120 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPE 171
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656
N ID ++FG+++ E+L G P + + ++ A+ +
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF-----FNE 226
Query: 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQ 687
+ D + R I RD R
Sbjct: 227 DV-----KDLLSR-------LITRDLSQRLG 245
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 9e-45
Identities = 70/285 (24%), Positives = 118/285 (41%), Gaps = 28/285 (9%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNII 480
+ +G+G + VYK + +A+K +K + + + + EI+++ L H NII
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
LL +N+ LV+DF+ + S + + LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV----LTPSHIKAYMLMTLQGLEYLHQ- 118
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
++HRD+K +N+LL ++ +L+DFGLAK S S + T T Y APE
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 601 GKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM----------WAKPILSSGK 649
++ +D++A G +L ELL + D Q + + W
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 650 VTQLLDPALGNNYDYDQMERMVLASIL-CIRRDPRARPQMSLVLK 693
VT P + ++ + +L I +P AR + LK
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 6e-44
Identities = 58/296 (19%), Positives = 107/296 (36%), Gaps = 31/296 (10%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHK 477
+ + IG+G V + +A+K + P E + + EI+I+ H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 478 NIISLLGFC----FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
NII + E + + L L + L +
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-----LSNDHICYFLYQILRG 121
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGY 592
L+Y+HS V+HRD+K SN+LL+ + ++ DFGLA+ T+ T Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 593 LAPEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 651
APE + K ID+++ G +L E+L+ R H Q + ++ S +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 652 QLLD-PALGNNYDYDQMERMVLASIL-------------CIRRDPRARPQMSLVLK 693
+++ A ++ + + +P R ++ L
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 155 bits (393), Expect = 4e-43
Identities = 53/282 (18%), Positives = 102/282 (36%), Gaps = 25/282 (8%)
Query: 428 NLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLG 484
IG+G VYK G+ A+K ++ E + + EI I+ L H NI+ L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
L+LV++ L + + + + + Y H +R
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCHD---RR 120
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 604
V+HRD+K N+L++ + E +++DFGLA+ ++ + K +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YTHEIVTLWYRAPDVLMGSKKYS 179
Query: 605 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 664
ID+++ G + E++ G Q + +S + + + ++
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK-YDPNF 238
Query: 665 DQMERMVLASIL-------------CIRRDPRARPQMSLVLK 693
E + S L ++ DP R L+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (388), Expect = 2e-42
Identities = 43/285 (15%), Positives = 95/285 (33%), Gaps = 27/285 (9%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
++ IG+G +++G L + +++A+K D + E L I
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-PQLRDEYRTYKLLAGCTGIP 64
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
+ + ++ ++ L SLE+ L + F A + ++ +H
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK---FSVKTVAMAAKQMLARVQSIHE-- 119
Query: 542 AQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKWASTSSSH-----ITCTDVAGTFG 591
+ +++RD+K N L+ + DFG+ K+ + +++GT
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 592 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 651
Y++ + + + + D+ A G V + L G P + S +
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696
+L + + + A P + L
Sbjct: 239 ELCA-------GFPEEFYKYMHY--ARNLAFDATPDYDYLQGLFS 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 3e-42
Identities = 59/333 (17%), Positives = 134/333 (40%), Gaps = 28/333 (8%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
++G G + +V + ++ A+K+L+ +E L +I+ ++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA---SQCPHIVRIVDV 73
Query: 486 C----FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
LL+V + L G L + F E ++ + EA++YLHS
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAIQYLHS-- 129
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
+ HRDVK N+L + + +A ++SH + T T Y+APE
Sbjct: 130 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661
K + D+++ GV++ LL G P ++H + + + + ++ Q P +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRMGQYEFPNPEWS 242
Query: 662 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDE 721
++++ ++ ++ +P R ++ + + + ++ S +L ++
Sbjct: 243 EVSEEVKMLIRN---LLKTEPTQRMTITEFMN----HPWIMQSTKVPQTPLHTSRVLKED 295
Query: 722 SCPRSNLQSHLNLAL--LDVEDDSFSMSSIEQS 752
+++ + AL + V+ + + IE +
Sbjct: 296 KERWEDVKEEMTSALATMRVDYEQIKIKKIEDA 328
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-42
Identities = 58/277 (20%), Positives = 108/277 (38%), Gaps = 35/277 (12%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTLHHKNII 480
+G G + V K G + A K +K ++ E+ I+ + H N+I
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
+L +++L+ + ++ G L + L + E + + + YLHS
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS- 131
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
++ H D+K NI+L D P+ + DFGLA + ++ GT ++APE
Sbjct: 132 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 186
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656
Y + + D+++ GV+ LL+G P D + + V +
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
A D + R + +DP+ R + L+
Sbjct: 247 A------KDFIRR-------LLVKDPKKRMTIQDSLQ 270
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 6e-42
Identities = 66/293 (22%), Positives = 115/293 (39%), Gaps = 35/293 (11%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKN 478
NF IG+G VYK G+ +A+K ++ +E V + EI ++ L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
I+ LL +N L LV++FL + + + + L + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFCH 119
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE-Y 597
S RV+HRD+K N+L++ + +L+DFGLA+ T T Y APE
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEIL 174
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657
+ +D+++ G + E++T R D Q + + G +++ P
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-----LFRIFRTLGTPDEVVWPG 229
Query: 658 LGNNYDYD----QMERMVLASIL-------------CIRRDPRARPQMSLVLK 693
+ + DY + R + ++ + DP R L
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-41
Identities = 63/302 (20%), Positives = 123/302 (40%), Gaps = 37/302 (12%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHK 477
S + IG+G +V+K G+++A+K + E + EI+I+ L H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 478 NIISLLGFCFE--------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 529
N+++L+ C ++ LV+DF + K F SE +V
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQM 125
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS--SSHITCTDVA 587
+ L Y+H +++HRD+K++N+L++ D +L+DFGLA+ S + S T+
Sbjct: 126 LLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 588 GTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 646
T Y PE + + ID++ G ++ E+ T + + + Q +L+ ++
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 647 SGKVTQLLDPALGNNYDYDQMERMVLASIL---------------CIRRDPRARPQMSLV 691
+ + L + + ++ + L + DP R
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
Query: 692 LK 693
L
Sbjct: 303 LN 304
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 54/297 (18%), Positives = 107/297 (36%), Gaps = 32/297 (10%)
Query: 420 ATSNFLAENLIGKGGSSQVYKG--CLPDGKELAVKILKPS---EDVIKEFVLEIEIITTL 474
A + IG+G +V+K G+ +A+K ++ E + + E+ ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 475 ---HHKNIISLLGFCF-----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 526
H N++ L C + L LV++ + + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP---GVPTETIKDM 121
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586
+ L++LHS RV+HRD+K NIL++ + +L+DFGLA+ S + T V
Sbjct: 122 MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSV 175
Query: 587 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 646
T Y APE + +D+++ G + E+ + Q ++ +
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 647 SGKVTQLLDPALGNNYDYDQMERMVLASIL----------CIRRDPRARPQMSLVLK 693
+ + + + + C+ +P R L
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-41
Identities = 76/352 (21%), Positives = 129/352 (36%), Gaps = 32/352 (9%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
++ +IG G VY+ G+ +A+K + + E++I+ L H NI+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNIVR 77
Query: 482 LLGFCFE------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
L F + + L LV D++ H ++ + +L
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LPVIYVKLYMYQLFRSLA 136
Query: 536 YLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
Y+HS + HRD+K N+LL D +L DFG AK +++ + Y A
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRYYRA 190
Query: 595 PEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653
PE IDV++ G VL ELL G+ D Q LV K + + +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIR 248
Query: 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASE 713
+ + Q++ + R P A +L +LL ARL +
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAI---ALCSRLLEYTPT----ARLTPLEAC 301
Query: 714 ESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSR 765
D+ P L + + L +F+ + + L L+ +R
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPAL----FNFTTQELSSNPPLATILIPPHAR 349
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-40
Identities = 51/277 (18%), Positives = 99/277 (35%), Gaps = 45/277 (16%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSE-------DVIKEFVLEIEIITTLH--HKN 478
L+G GG VY G + D +A+K ++ +E+ ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+I LL + ++ +L+ + + + A V EA+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH 127
Query: 539 SGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
+ V+HRD+K NIL+ + E +L DFG + TD GT Y PE+
Sbjct: 128 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEW 180
Query: 598 FMYGKVNDK-IDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656
Y + + + V++ G++L +++ G P +D ++ + +
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR-----VSS 229
Query: 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693
+ C+ P RP +
Sbjct: 230 EC-----QHLIRW-------CLALRPSDRPTFEEIQN 254
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 5e-39
Identities = 59/283 (20%), Positives = 104/283 (36%), Gaps = 25/283 (8%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLG 484
+G G V G ++A+K L SE K E+ ++ + H+N+I LL
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
D L DF G G + + + L Y+H+
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AG 141
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 604
+IHRD+K N+ +++D E ++ DFGLA+ A + + V + + +
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT----GYVVTRWYRAPEVILNWMRYT 197
Query: 605 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL-LDPALGNNYD 663
+D+++ G ++ E++TG+ Q +M + V +L D A
Sbjct: 198 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257
Query: 664 YDQMERMVLASIL-------------CIRRDPRARPQMSLVLK 693
++E+ ASIL + D R L
Sbjct: 258 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 9e-39
Identities = 63/271 (23%), Positives = 109/271 (40%), Gaps = 31/271 (11%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHK 477
+F L+GKG +V G+ A+KIL+ ++D + V E ++ H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+ +L + L V ++ + G L +L + F + ALEYL
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYL 121
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
HS + V++RD+K N++L D +++DFGL K + + + GT YLAPE
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 176
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657
+D + GVV+ E++ GR P N + L++ + L P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT-----LSPE 231
Query: 658 LGNNYDYDQMERMVLASILCIRRDPRARPQM 688
+ +++DP+ R
Sbjct: 232 A-----KSLLAG-------LLKKDPKQRLGG 250
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-38
Identities = 57/287 (19%), Positives = 105/287 (36%), Gaps = 33/287 (11%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 483
IG+G V+K + +A+K ++ E V + EI ++ L HKNI+ L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
D L LV++F + + N + + L + HS +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD----PEIVKSFLFQLLKGLGFCHS---R 120
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
V+HRD+K N+L++ + E +L++FGLA+ + V + F
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE-VVTLWYRPPDVLFGAKLY 179
Query: 604 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 663
+ ID+++ G + EL +P+ G + + G T+ P++ D
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLF----PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 664 YDQMERMVLASIL-----------------CIRRDPRARPQMSLVLK 693
Y + L ++ +P R L+
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (360), Expect = 5e-38
Identities = 58/263 (22%), Positives = 99/263 (37%), Gaps = 34/263 (12%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLG 484
+G G +V G A+KIL I+ + E I+ ++ ++ L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
+++NL +V ++++ G + +L + F A + EYLHS
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 604
+I+RD+K N+L+ Q++DFG AK + GT LAPE + N
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 605 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 664
+D +A GV++ E+ G P D P ++ K S L
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH-----FSSDL-----K 266
Query: 665 DQMERMVLASILCIRRDPRARPQ 687
D + ++ D R
Sbjct: 267 DLLRN-------LLQVDLTKRFG 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 64/279 (22%), Positives = 115/279 (41%), Gaps = 33/279 (11%)
Query: 423 NFLAENLIGKGGSSQVYKG----CLPDGKELAVKILKPS-----EDVIKEFVLEIEIITT 473
NF ++G G +V+ GK A+K+LK + + E +++
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 474 L-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
+ +++L + L L+ D+++ G L +L ++ F E +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVL 140
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
ALE+LH +I+RD+K NILL + L+DFGL+K + GT Y
Sbjct: 141 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEY 196
Query: 593 LAPEYFMYGKVND--KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650
+AP+ G +D ++ GV++ ELLTG P + D K ++ + + + S
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS-RRILKSEPPY 255
Query: 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMS 689
Q + D ++R + +DP+ R
Sbjct: 256 PQEMSALA-----KDLIQR-------LLMKDPKKRLGCG 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (322), Expect = 4e-33
Identities = 55/287 (19%), Positives = 120/287 (41%), Gaps = 27/287 (9%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNII 480
++ +G+G S+V++ + + +++ VKILKP + K+ EI+I+ L NII
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNII 93
Query: 481 SLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+L + LV++ ++ ++ + + +AL+Y H
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCH 146
Query: 539 SGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
S ++HRDVK N+++ + + +L D+GLA++ + + PE
Sbjct: 147 S---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPEL 200
Query: 598 FM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656
+ Y + +D+++ G +L ++ ++P + H + LV AK + + +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYIDKY 259
Query: 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMS-----LVLKLLRGD 698
+ + ++ + + +S + KLLR D
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 9e-33
Identities = 58/284 (20%), Positives = 102/284 (35%), Gaps = 25/284 (8%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 483
+ +G G V G +AVK L S K E+ ++ + H+N+I LL
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+L D L N + + L+Y+HS
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 140
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
+IHRD+K SN+ +++D E ++ DFGLA+ + T + +
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT----RWYRAPEIMLNWMHY 196
Query: 604 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 663
N +D+++ G ++ ELLTGR Q L++ + + ++ + N
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 664 -YDQMERMVLASIL-------------CIRRDPRARPQMSLVLK 693
QM +M A++ + D R + L
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 123 bits (308), Expect = 5e-31
Identities = 54/312 (17%), Positives = 106/312 (33%), Gaps = 47/312 (15%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+G G S V+ + + +A+KI++ + + EI+++ ++ +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 486 C----------FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEA 533
F V+ + L ENL K G Y +++ +
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 534 LEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
L+Y+H +IH D+K N+L+ D L +A + T+ T Y
Sbjct: 138 LDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 593 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG-----------QESLVMWA 641
+PE + D+++ ++ EL+TG D E L
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255
Query: 642 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--------------------CIRRD 681
+L +GK T+ + G + +++ L +L ++ D
Sbjct: 256 SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315
Query: 682 PRARPQMSLVLK 693
PR R ++
Sbjct: 316 PRKRADAGGLVN 327
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-30
Identities = 57/288 (19%), Positives = 105/288 (36%), Gaps = 31/288 (10%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLG 484
IG G V + +A+K L ++ K E+ ++ ++HKNIISLL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 485 FCF------EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
E ++ LV + + + + + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHLH 136
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
S +IHRD+K SNI++ D ++ DFGLA+ A TS T T Y APE
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVI 190
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 658
+ + +D+++ G ++ E++ + Q + V+ + +L
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 659 GNNYDYDQMERMVLASILCIRRDPRARPQ--------MSLVLKLLRGD 698
+ + + + P L+ K+L D
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.5 bits (216), Expect = 2e-20
Identities = 23/156 (14%), Positives = 45/156 (28%), Gaps = 22/156 (14%)
Query: 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIK-----------EFVLEIEIITTLHH 476
L+G+G S V+ E VK K K F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
+ + L G Y + L E + + + + E +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEV--LDMILEEVAK 118
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ + ++H D+ N+L+ + + DF +
Sbjct: 119 FYH---RGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 770 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.83 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 99.75 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 99.72 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 99.67 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 99.65 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 99.36 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.31 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.84 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.47 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.09 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.6 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.23 | |
| d1wy5a1 | 216 | TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId | 90.92 | |
| d1ni5a1 | 227 | tRNA-Ile-lysidine synthetase, TilS, N-terminal dom | 87.68 | |
| d2c5sa1 | 218 | Thiamine biosynthesis protein ThiI, C-terminal dom | 84.26 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=420.49 Aligned_cols=254 Identities=24% Similarity=0.443 Sum_probs=199.8
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
.++|.+.+.||+|+||+||+|.+.+++.||||+++......++|.+|+.++++++|||||+++|+|..++.+++||||++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 35788999999999999999999888899999998766667889999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+|+|.+++.... ..++|..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 999999987543 368999999999999999999999 89999999999999999999999999999877554332
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhC-CCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG-RKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
. .....||+.|+|||++..+.|+.++|||||||+||||+|| ++||...........+.. +. ....|.
T Consensus 158 ~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~-------~~--~~~~p~-- 225 (263)
T d1sm2a_ 158 S-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-------GF--RLYKPR-- 225 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH-------TC--CCCCCT--
T ss_pred e-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh-------cC--CCCCcc--
Confidence 2 2235799999999999999999999999999999999995 555554332221111111 10 011111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.....+..++..||+.||.+||||++|+++|+.
T Consensus 226 -----~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 226 -----LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp -----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 112345667788999999999999999999874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=422.79 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=202.6
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.++|.+.+.||+|+||+||+|.. .+|+.||||+++... +..+.+.+|+++|++++||||+++++++.+++.+|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 35799999999999999999986 479999999987543 345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+++|+|.++|... ..+++.+++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 99999999999654 368999999999999999999999 89999999999999999999999999999977654
Q ss_pred CCCceecccccccCCCCceeeccCCC-CCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
.........+||+.|+|||++.+..+ +.++|||||||+||||+||+.||............ +...... ..+
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-~~~~~~~-------~~~ 228 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-WKEKKTY-------LNP 228 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-HHTTCTT-------STT
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-HhcCCCC-------CCc
Confidence 43333445789999999999988876 56899999999999999999999765433222111 1111000 000
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
.......+..++..||+.||.+|||+.++++
T Consensus 229 ------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 ------WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0001123345567899999999999999976
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-50 Score=422.14 Aligned_cols=257 Identities=29% Similarity=0.471 Sum_probs=200.3
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.++|.+.+.||+|+||+||+|.++. .||||+++. .....+.|.+|+.+|.+++|||||++++++.+ +.++||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 4678889999999999999998643 599999974 34567889999999999999999999999854 57899999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+++|+|.+++.... ..+++..++.|+.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999997543 358999999999999999999999 89999999999999999999999999999877654
Q ss_pred CCCceecccccccCCCCceeecc---CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
..........||+.|+|||++.. +.|+.++|||||||+||||+||+.||.+..+.......... +. .
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~------~~----~ 227 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR------GY----L 227 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH------TS----C
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc------CC----C
Confidence 44444455789999999999964 35899999999999999999999999876543322211111 10 0
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+.+. .........+..++..||+.||.+||||.+|++.|+.
T Consensus 228 ~p~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 228 SPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp CCCGG-GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcch-hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11110 0111112345566778999999999999999998863
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=418.42 Aligned_cols=253 Identities=23% Similarity=0.398 Sum_probs=205.3
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
.++|.+.+.||+|+||.||+|.+++++.||||+++......+.|.+|+.++.+++|||||+++++|.+ +.+++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 35688899999999999999999888899999998766667889999999999999999999998855 56799999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+|+|.+++..... ..++|..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+........
T Consensus 91 ~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 91 NGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999998765432 358999999999999999999999 89999999999999999999999999999977653322
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCC-CCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP-ISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~P-f~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
......||+.|+|||++..+.++.++|||||||+||||+||..| |...... .+..... .+. .+...
T Consensus 166 -~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~---~~~~~i~----~~~-----~~~~p 232 (272)
T d1qpca_ 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNLE----RGY-----RMVRP 232 (272)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHH----TTC-----CCCCC
T ss_pred -cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----hcC-----CCCCc
Confidence 22346799999999999999999999999999999999996555 4433221 1111111 110 11111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
... ...+..++..||+.+|.+||||.+|++.|+
T Consensus 233 ~~~----~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~ 265 (272)
T d1qpca_ 233 DNC----PEELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (272)
T ss_dssp TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccC----hHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 111 234556677899999999999999999886
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-49 Score=422.89 Aligned_cols=254 Identities=26% Similarity=0.435 Sum_probs=195.2
Q ss_pred cCcccceeecccCceEEEEEEeC-CC---CEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DG---KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g---~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
++|.+.++||+|+||+||+|.+. +| ..||||.+... ....+.|.+|+.+|++++|||||+++++|.+++.+++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45677899999999999999864 33 25899988653 45667899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++|+|.+++.... ..++|.+++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+...
T Consensus 106 ~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 99999999999887543 368999999999999999999999 899999999999999999999999999998776
Q ss_pred CCCCCce---ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 576 TSSSHIT---CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 576 ~~~~~~~---~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
....... .....||+.|+|||++..+.|+.++|||||||+||||+| |+.||...........+. .+..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-------~~~~- 251 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-------QDYR- 251 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-------TTCC-
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCC-
Confidence 5433222 122468999999999999999999999999999999998 899998765432222111 1100
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+ ..+.+....+..++..||+.||.+||||.+|++.|+.
T Consensus 252 ------~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 252 ------L--PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp ------C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ------C--CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 0 0111223445667788999999999999999998863
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=416.06 Aligned_cols=244 Identities=27% Similarity=0.431 Sum_probs=204.1
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||+||+|... +|+.||||++.+.. ...+.+.+|+.+++.++||||++++++|.+++.+|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46999999999999999999874 68999999986432 34567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+++|+|.+++.... .+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999997643 58999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
... ....||+.|+|||++.+..|+.++|||||||+||||++|+.||...+.......+... . .
T Consensus 159 ~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-------~------~ 221 (263)
T d2j4za1 159 SRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------E------F 221 (263)
T ss_dssp CCC----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------C------C
T ss_pred Ccc----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------C------C
Confidence 322 2368999999999999999999999999999999999999999875543322221111 1 0
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
.+....+ ..+..++..||+.||.+|||+.++++
T Consensus 222 ~~p~~~s----~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 TFPDFVT----EGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCccCC----HHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1111111 23445667899999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.3e-50 Score=425.73 Aligned_cols=256 Identities=23% Similarity=0.376 Sum_probs=210.3
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++.+....++|.+|+.+|++++|||||+++++|.+++.+++||||+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 457888999999999999999875 5889999999877666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++|+|.+++..... ..+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.......
T Consensus 96 ~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 96 TYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp TTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred cCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999976433 468999999999999999999999 8999999999999999999999999999987765433
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
. ......||+.|+|||++.++.|+.++|||||||+||||++|..||........ +.... ..+. .+..
T Consensus 171 ~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~~i----~~~~-----~~~~- 237 (287)
T d1opja_ 171 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELL----EKDY-----RMER- 237 (287)
T ss_dssp E-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHH----HTTC-----CCCC-
T ss_pred e-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHHHH----hcCC-----CCCC-
Confidence 2 33345689999999999999999999999999999999997776644332211 11111 1110 0111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+......+..++..||+.||.+|||+.+|++.|+.
T Consensus 238 ---~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~ 272 (287)
T d1opja_ 238 ---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272 (287)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11122345667778999999999999999998864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=417.52 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=194.2
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEee--cCceEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLV 495 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~LV 495 (770)
++|.+.+.||+|+||+||+|.. .+|+.||||+++.. +...+.+.+|+++|++++|||||+++++|.+ ++.+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6799999999999999999986 47899999998753 3456779999999999999999999999865 4568999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
|||+++|+|.+++.........+++..++.++.||+.||.|||+.+ ..+||||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998754333357999999999999999999999822 23599999999999999999999999999998
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
....... .....||+.|+|||++.+..|+.++|||||||+||||+||+.||...+.......+. .+....
T Consensus 164 ~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~-------~~~~~~- 233 (269)
T d2java1 164 LNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-------EGKFRR- 233 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-------HTCCCC-
T ss_pred cccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH-------cCCCCC-
Confidence 7653322 234689999999999999999999999999999999999999998754432211111 111111
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+...++ ..+..++..||+.||.+|||+.+++++
T Consensus 234 ----~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 234 ----IPYRYS----DELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ----CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----CCcccC----HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 111122 234556678999999999999999863
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=416.17 Aligned_cols=249 Identities=26% Similarity=0.403 Sum_probs=204.7
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
++|.+.+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+.+|+.++|||||+++++|.+.+.+||||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4699999999999999999986 579999999987543 34567999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
+||+|.+++... .+++.+++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.......
T Consensus 100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999988653 48999999999999999999999 8999999999999999999999999999987755433
Q ss_pred CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
. ....+||+.|+|||++.++.|+.++|||||||+||||+||+.||.+.+.......+. . .+. ..+..
T Consensus 172 ~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~--~----~~~-~~~~~---- 238 (293)
T d1yhwa1 172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--T----NGT-PELQN---- 238 (293)
T ss_dssp C--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--H----HCS-CCCSS----
T ss_pred c--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH--h----CCC-CCCCC----
Confidence 2 234689999999999999999999999999999999999999997655432221111 0 000 00000
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+......+..++..||+.||.+|||+.+++++
T Consensus 239 ---~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 239 ---PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp ---GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ---cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112334456678999999999999999863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=408.55 Aligned_cols=253 Identities=23% Similarity=0.437 Sum_probs=212.6
Q ss_pred hcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecC
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~ 500 (770)
.++|.+.+.||+|+||+||+|.+++++.||||+++......++|.+|+.++.+++||||++++|+|.+++.+++||||++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 36889999999999999999999888899999998766666789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+|+|.+++.... ..+++..+++++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 999999976543 358899999999999999999999 89999999999999999999999999999876554332
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
......||+.|+|||++..+.++.++|||||||++|||+| |+.||...........+. .+. .+..|
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-------~~~--~~~~p--- 223 (258)
T d1k2pa_ 157 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGL--RLYRP--- 223 (258)
T ss_dssp -CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-------TTC--CCCCC---
T ss_pred -eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-------hCC--CCCCc---
Confidence 2233579999999999999999999999999999999998 899998765433222211 111 11111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
......+..++..||+.||.+|||+.+|+++|.
T Consensus 224 ----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 224 ----HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp ----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ----ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 111234556777899999999999999999985
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=422.80 Aligned_cols=257 Identities=23% Similarity=0.410 Sum_probs=207.5
Q ss_pred cCcccceeecccCceEEEEEEeCC-C-----CEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCce
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPD-G-----KELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~-g-----~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 492 (770)
++|.+.+.||+|+||+||+|.... + ..||||++... ......+.+|+.+|.++ +|||||+++++|.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578899999999999999998632 2 36999998653 24456789999999998 899999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCC
Q 004174 493 LLVYDFLSRGSLEENLHGNKK-------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 553 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~ 553 (770)
+|||||+++|+|.++|+.... ....++|..++.|+.||+.||.|||+ ++||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence 999999999999999976532 12358999999999999999999999 89999999999
Q ss_pred CeeeCCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCcc
Q 004174 554 NILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPK 632 (770)
Q Consensus 554 NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~ 632 (770)
|||++.++.+||+|||+|+...............||+.|+|||++..+.|+.++|||||||+||||+| |+.||.+....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999998776665555556789999999999999999999999999999999998 89999876543
Q ss_pred chhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 633 GQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 633 ~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
.....+ +..+. .+. .+......+..++..||+.||.+|||+.+|+++|.
T Consensus 274 ~~~~~~------~~~~~-----~~~----~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANFYKL------IQNGF-----KMD----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHH------HHTTC-----CCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHH------HhcCC-----CCC----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 321111 11110 000 11111234556777899999999999999999984
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=413.38 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=205.2
Q ss_pred hcCccccee-ecccCceEEEEEEeC---CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 421 TSNFLAENL-IGKGGSSQVYKGCLP---DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 421 t~~f~~~~~-LG~G~fG~Vy~a~~~---~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
.++|.+.+. ||+|+||.||+|.+. ++..||||+++.. ....+.|.+|+++|.+++|||||+++++|.. +.+||
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 456777775 999999999999753 4557999999753 4566789999999999999999999999865 57899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||+++|+|.+++...+ ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 86 vmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcc
Confidence 999999999999986543 368999999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCc-eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 575 STSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 575 ~~~~~~~-~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
....... ......||+.|+|||++..+.++.++|||||||+||||+| |+.||...........+. .|....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-------~~~~~~ 232 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGKRME 232 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-------TTCCCC
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCCCC
Confidence 6543322 1223568999999999999999999999999999999998 999998765432222211 121111
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
+.... ...+..++..||+.+|++||||.+|++.|+
T Consensus 233 -----~p~~~----~~~l~~li~~cl~~~p~~RPs~~~i~~~L~ 267 (285)
T d1u59a_ 233 -----CPPEC----PPELYALMSDCWIYKWEDRPDFLTVEQRMR 267 (285)
T ss_dssp -----CCTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred -----CCCcC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 11111 234556677899999999999999999886
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=417.72 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=202.2
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+++|++++||||++++++|.+++.+||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999986 47999999999743 234567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||++||+|.+++...+ .+++..++.++.|++.||+|||+ ++||||||||+||||+.++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999987654 58999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
..........+||+.|+|||++.+..|+.++|||||||+||||++|+.||...+.......+. .+.+
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~-------~~~~------ 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-------KLEY------ 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------TTCC------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH-------cCCC------
Confidence 444434445789999999999999999999999999999999999999998764432221111 1110
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
.+...+. ..+..++..||+.||.+|||+.|++.
T Consensus 228 ~~p~~~s----~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 DFPEKFF----PKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCCTTCC----HHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCccCC----HHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1111122 23455667899999999999998754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=410.51 Aligned_cols=256 Identities=24% Similarity=0.394 Sum_probs=197.9
Q ss_pred hcCcccceeecccCceEEEEEEeCCC-----CEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPDG-----KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~g-----~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
.+.|...++||+|+||.||+|.++.. ..||||+++.. .....+|.+|+.++++++|||||+++|+|.+.+.++
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688899999999999999986532 36999999753 345667999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+||||+.+|+|.+.+.... ..++|.++..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999999886543 368999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCC-ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccc
Q 004174 574 ASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 652 (770)
Q Consensus 574 ~~~~~~~-~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 652 (770)
....... .......||+.|+|||++..+.++.++|||||||+||||++|..|+....... .+..... .+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~~~~~i~----~~~--- 230 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAIN----DGF--- 230 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHH----TTC---
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--HHHHHHh----ccC---
Confidence 6543322 12233568999999999999999999999999999999999666654432211 1111111 111
Q ss_pred ccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 653 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 653 lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+ ..+.+....+..++..||+.+|.+||+|.+|+++|+.
T Consensus 231 --~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 231 --RL----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp --CC----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --CC----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 01 1112223456667788999999999999999998864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-49 Score=422.96 Aligned_cols=202 Identities=25% Similarity=0.442 Sum_probs=179.7
Q ss_pred hhcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
..++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ......+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 357899999999999999999986 47899999998753 345678999999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||++||+|.+++.+.+ .+++..++.++.||+.||.|||+. ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999997653 589999999999999999999961 3799999999999999999999999999987654
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 631 (770)
... ...+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.
T Consensus 158 ~~~----~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 158 SMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp HTC-------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred Ccc----ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 322 236899999999999999999999999999999999999999987553
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=412.47 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=203.3
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC-hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
+.|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+++|++++|||||+++++|.+.+.++|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 3588999999999999999986 47899999999653 355678999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.......
T Consensus 92 ~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp TTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 9999999986543 358999999999999999999999 8999999999999999999999999999976543211
Q ss_pred CceecccccccCCCCceeec-----cCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 580 HITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
......||+.|+|||++. ...|+.++|||||||+||||+||+.||...++......+.- +....+.
T Consensus 166 --~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~-------~~~~~~~ 236 (288)
T d2jfla1 166 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-------SEPPTLA 236 (288)
T ss_dssp --HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHH-------SCCCCCS
T ss_pred --cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHc-------CCCCCCC
Confidence 123467999999999984 45689999999999999999999999987654332221111 1100110
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. +......+..++..||+.||.+|||+.+++++
T Consensus 237 ~-------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 237 Q-------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp S-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred c-------cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 11112344556678999999999999999873
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-48 Score=406.11 Aligned_cols=245 Identities=27% Similarity=0.400 Sum_probs=197.2
Q ss_pred eeecccCceEEEEEEeC---CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004174 428 NLIGKGGSSQVYKGCLP---DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 428 ~~LG~G~fG~Vy~a~~~---~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
+.||+|+||+||+|.+. .++.||||+++.. ....++|.+|+++|++++|||||+++++|.. +.++|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999853 3568999999753 2446789999999999999999999999964 568999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
|+|.+++.... .++|..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999997653 58999999999999999999999 899999999999999999999999999998765543332
Q ss_pred e-ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 582 T-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 582 ~-~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
. .....||+.|+|||++..+.++.++|||||||++|||+| |+.||.+.........+. .+.... +.
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-------~~~~~~-----~p 232 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KGERMG-----CP 232 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TTCCCC-----CC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-------cCCCCC-----CC
Confidence 2 233579999999999999999999999999999999998 999998765432222211 111111 11
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
... ...+..++..||+.||.+|||+.+|+++|+
T Consensus 233 ~~~----~~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 233 AGC----PREMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp TTC----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred ccc----CHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 111 234556677899999999999999998885
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-48 Score=412.83 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=189.3
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.+.|.+.+.||+|+||+||+|... +|+.||||++.... .....+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 456999999999999999999864 68999999997543 334568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC---CCCceEEccccccccc
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKWA 574 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~---~~~~vkL~DFGla~~~ 574 (770)
|++||+|.++|.... .+++.++..++.||+.||.|||+ ++|+||||||+|||+. +++.+||+|||+|+..
T Consensus 88 ~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999997543 58999999999999999999999 8999999999999994 5789999999999876
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
...... ...+||+.|+|||++.++.|+.++|||||||+||||++|+.||.+.........+...... +
T Consensus 161 ~~~~~~---~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~---------~ 228 (307)
T d1a06a_ 161 DPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE---------F 228 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC---------C
T ss_pred cCCCee---eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC---------C
Confidence 543322 2367999999999999999999999999999999999999999875443222211111100 0
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
........ ...+..++..||+.||.+|||+.+++++
T Consensus 229 ~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 229 DSPYWDDI----SDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CTTTTTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCccccCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00111111 2334556678999999999999999984
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=403.71 Aligned_cols=244 Identities=26% Similarity=0.380 Sum_probs=194.1
Q ss_pred ccceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcCCCceeEEeeEEee----cCceEEEE
Q 004174 425 LAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLLVY 496 (770)
Q Consensus 425 ~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~---~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~LV~ 496 (770)
.+.+.||+|+||+||+|.+. +++.||+|++.. .....+.|.+|+++|++++|||||+++++|.. +..++|||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56778999999999999864 688999999864 33456789999999999999999999999875 34589999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc--eEEecccCCCeeeC-CCCceEEcccccccc
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLS-DDFEPQLSDFGLAKW 573 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--IiHrDLKp~NILL~-~~~~vkL~DFGla~~ 573 (770)
||+++|+|.+++.... .+++..++.++.||+.||+|||+ ++ |+||||||+||||+ .++.+||+|||+|+.
T Consensus 92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999999999997653 58999999999999999999998 56 99999999999996 578999999999986
Q ss_pred ccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 574 ~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
...... ...+||+.|+|||++. ++|+.++|||||||+||||++|+.||....... .+.... ..+....
T Consensus 165 ~~~~~~----~~~~GT~~Y~aPE~~~-~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~~i----~~~~~~~- 232 (270)
T d1t4ha_ 165 KRASFA----KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRV----TSGVKPA- 232 (270)
T ss_dssp CCTTSB----EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHH----TTTCCCG-
T ss_pred ccCCcc----CCcccCccccCHHHhC-CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHHHHH----HcCCCCc-
Confidence 544322 2468999999999886 569999999999999999999999997543322 111111 1111111
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+..... + .+..++..||+.||++|||+.+++++
T Consensus 233 ---~~~~~~~-~---~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 233 ---SFDKVAI-P---EVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ---GGGGCCC-H---HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---ccCccCC-H---HHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1111111 2 34456678999999999999999873
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.3e-47 Score=414.21 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=206.0
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
++|.+.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.+|++++|||||+++++|.+++.+||||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999986 478999999997654 45677899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC--CCCceEEccccccccccCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~--~~~~vkL~DFGla~~~~~~ 577 (770)
+||+|.+++.... ..+++..++.|+.||+.||.|||+ ++||||||||+||||+ .++.+||+|||+|+.....
T Consensus 106 ~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 106 SGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999986443 359999999999999999999999 8999999999999995 4578999999999877654
Q ss_pred CCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
... ....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.......+..... .+. ..
T Consensus 180 ~~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-----~~~----~~ 247 (350)
T d1koaa2 180 QSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW-----NMD----DS 247 (350)
T ss_dssp SCE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-----CSC----CG
T ss_pred ccc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CCC----cc
Confidence 332 336899999999999999999999999999999999999999987654332222211110 000 00
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..... ...+..++..||+.||.+|||+.+++++
T Consensus 248 ~~~~~----s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 AFSGI----SEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGGC----CHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011 1234556678999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-48 Score=409.08 Aligned_cols=254 Identities=23% Similarity=0.407 Sum_probs=200.5
Q ss_pred cCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeecCC
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~~g 501 (770)
++|++.+.||+|+||.||+|.+++++.||||+++......+.|.+|+.++.+++|||||+++++|.+ +..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 4689999999999999999999888899999998776666889999999999999999999999954 568999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCCc
Q 004174 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (770)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~~ 581 (770)
|+|..++..... ..++|.+++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++........
T Consensus 96 g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~- 169 (285)
T d1fmka3 96 GSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 169 (285)
T ss_dssp CBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred Cchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence 999998875432 358999999999999999999999 89999999999999999999999999999876543322
Q ss_pred eecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcccCCC
Q 004174 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 661 (770)
Q Consensus 582 ~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 661 (770)
......||+.|+|||++..+.++.++|||||||+||||+||..||...... ..+..+... +. .+..
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~~----~~-----~~~~--- 235 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVER----GY-----RMPC--- 235 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHT----TC-----CCCC---
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHh----cC-----CCCC---
Confidence 223367999999999999999999999999999999999966655443221 111111111 10 0011
Q ss_pred CChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 662 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 662 ~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+....+.+..++..||+.||++||+|.+|+++|+.
T Consensus 236 -~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 270 (285)
T d1fmka3 236 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270 (285)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence 11122345667788999999999999999998875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.5e-47 Score=412.12 Aligned_cols=251 Identities=21% Similarity=0.251 Sum_probs=206.0
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
++|.+.+.||+|+||.||+|.. .+|+.||||+++... ...+.+.+|+.+|+.++|||||+++++|.+++.+||||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4699999999999999999986 479999999997654 44567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC--CCCceEEccccccccccCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~--~~~~vkL~DFGla~~~~~~ 577 (770)
+||+|.+.+.... ..+++.+++.|+.||+.||.|||+ ++||||||||+||||+ .++.+||+|||+|+.....
T Consensus 109 ~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999999876443 369999999999999999999999 8999999999999997 6789999999999887654
Q ss_pred CCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
... ....||+.|+|||++.+..|+.++|||||||+||||+||+.||.+.+.......+.-... . +...
T Consensus 183 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-----~----~~~~ 250 (352)
T d1koba_ 183 EIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW-----E----FDED 250 (352)
T ss_dssp SCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC-----C----CCSS
T ss_pred Cce---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----C----CCcc
Confidence 332 336799999999999999999999999999999999999999987554332221111100 0 0011
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..... ...+..++..||+.||.+|||+.+++++
T Consensus 251 ~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 251 AFSSV----SPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111 1234556678999999999999999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-47 Score=406.64 Aligned_cols=260 Identities=24% Similarity=0.416 Sum_probs=211.2
Q ss_pred hhcCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc
Q 004174 420 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (770)
Q Consensus 420 ~t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 491 (770)
..++|.+.+.||+|+||+||+|... +++.||||+++.. ....++|.+|+.+|+.++||||++++++|...+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4678999999999999999999853 4578999999753 3456789999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEeccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKK--------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 551 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLK 551 (770)
.++||||+++|+|.+++..... ....+++..++.|+.||+.||+|||+ ++|||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEc
Confidence 9999999999999999964321 12358999999999999999999999 899999999
Q ss_pred CCCeeeCCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCC-CCCCCCC
Q 004174 552 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR-KPISNDH 630 (770)
Q Consensus 552 p~NILL~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~-~Pf~~~~ 630 (770)
|+||||+.++.+||+|||+|+...........+...||+.|+|||++....|+.++|||||||+||||++|. +||...+
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998765544444444578999999999999999999999999999999999985 6787655
Q ss_pred ccchhhHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 631 PKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 631 ~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
.......+ ..+....+ +......+..++..||+.+|.+||||.+|+++|+..
T Consensus 248 ~~e~~~~v-------~~~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 248 HEEVIYYV-------RDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp HHHHHHHH-------HTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHHHHHH-------HcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 43322221 12221111 111223466677889999999999999999999754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-47 Score=406.78 Aligned_cols=243 Identities=26% Similarity=0.390 Sum_probs=198.7
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
.|...+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+.+|++++|||||+++++|.+++.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 488899999999999999986 47889999998653 2455679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+.+|+|..++... ..+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 99999998766543 258999999999999999999999 89999999999999999999999999999865432
Q ss_pred CCCceecccccccCCCCceeecc---CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcccccc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 654 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 654 (770)
....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||.+.........+. . +....+.
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~------~-~~~~~~~ 235 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------Q-NESPALQ 235 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------H-SCCCCCS
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH------h-CCCCCCC
Confidence 23579999999999863 468999999999999999999999997654332211111 0 1111111
Q ss_pred CcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 004174 655 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 693 (770)
Q Consensus 655 d~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~ 693 (770)
. ..+ ...+..++..||+.||.+|||+.++++
T Consensus 236 ~----~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 S----GHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C----CCC----CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 111 123455667899999999999999987
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-47 Score=401.52 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=204.6
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCce
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 492 (770)
.+.|.+.+.||+|+||+||+|.. .+|+.||||++++.. ...+.+.+|+.+|++++|||||+++++|.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35799999999999999999986 579999999986421 2467899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC----ceEEccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 568 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~----~vkL~DF 568 (770)
||||||+++|+|.+++...+ .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999997653 58999999999999999999999 8999999999999998776 4999999
Q ss_pred cccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC
Q 004174 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 648 (770)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 648 (770)
|+|+........ ....||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+.......+.....
T Consensus 162 G~a~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~----- 233 (293)
T d1jksa_ 162 GLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY----- 233 (293)
T ss_dssp TTCEECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-----
T ss_pred hhhhhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-----
Confidence 999877544322 235799999999999999999999999999999999999999987654322211111100
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.. .+...... ...+..++..||+.||.+|||+.+++++
T Consensus 234 ~~----~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 EF----EDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CC----CHHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC----CchhcCCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00010111 1234456678999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=404.31 Aligned_cols=253 Identities=22% Similarity=0.386 Sum_probs=201.9
Q ss_pred cCcccceeecccCceEEEEEEeC-CCC----EEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~----~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
++|.+.++||+|+||+||+|.+. +|+ .||||.++.. ....++|.+|+.++++++|||||+++++|.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence 46999999999999999999863 444 5899988753 3456789999999999999999999999976 46788
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
+|||+.+|+|.+.+.... ..+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 899999999999887654 368999999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
.............||+.|+|||++.++.|+.++|||||||+||||+| |.+||...........+......
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~--------- 232 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--------- 232 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC---------
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 66555444444679999999999999999999999999999999999 89999876544333332211100
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
..+......+..++..||+.||.+|||+.+|+++|..
T Consensus 233 -------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 233 -------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp -------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 0111122345667778999999999999999998764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=406.13 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=205.7
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
.++|.+.+.||+|+||.||+|.. .+|+.||||++++. ....+.+.+|+.+|+.++||||++++++|.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36799999999999999999986 57999999999753 23457789999999999999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||++||+|.+++.... .+++..++.++.||+.||+|||+ ++||||||||+||||+.+|.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999997654 58899999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
.... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+.......+.. +.
T Consensus 157 ~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~-------~~------ 221 (337)
T d1o6la_ 157 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-------EE------ 221 (337)
T ss_dssp CTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CC------
T ss_pred cCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc-------CC------
Confidence 4332 22346899999999999999999999999999999999999999987654332222111 11
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 694 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs-----~~eVL~~ 694 (770)
..+...+. ..+..++..||+.||.+||+ +.+++++
T Consensus 222 ~~~p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 IRFPRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCccCC----HHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 01111122 23445667899999999995 7888874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=402.11 Aligned_cols=259 Identities=24% Similarity=0.382 Sum_probs=198.0
Q ss_pred hcCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec-C
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED-N 490 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~-~ 490 (770)
.++|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+.+|..++.++ +|+||+.+++++.+. +
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 467999999999999999999853 3568999999753 34567788888888877 689999999998765 4
Q ss_pred ceEEEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~ 558 (770)
.+++||||+++|+|.++|+.... ....+++..+..++.||+.||.|||+ ++||||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeEC
Confidence 68999999999999999975432 12458999999999999999999999 8999999999999999
Q ss_pred CCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhC-CCCCCCCCccchhhH
Q 004174 559 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG-RKPISNDHPKGQESL 637 (770)
Q Consensus 559 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~~~~~~~~l 637 (770)
.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+|| .+||.........
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~-- 246 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-- 246 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH--
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH--
Confidence 9999999999999877665554444557899999999999999999999999999999999996 5678655432211
Q ss_pred HHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 638 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 638 v~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
... +..+.. +..... ....+..++..||+.||.+|||+.+|+++|+.
T Consensus 247 ~~~----~~~~~~-----~~~~~~----~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 247 CRR----LKEGTR-----MRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp HHH----HHHTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH----HhcCCC-----CCCCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 110 111111 111111 12345566778999999999999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.2e-46 Score=401.82 Aligned_cols=244 Identities=26% Similarity=0.361 Sum_probs=203.9
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5699999999999999999986 469999999997432 34577899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||++||+|..++.... .+++..++.++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccccc----cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999987654 47889999999999999999999 8999999999999999999999999999987754
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
.. ...+||+.|+|||++.+..|+.++|||||||+||||+||+.||...+.......+..... .
T Consensus 157 ~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-----~------- 219 (316)
T d1fota_ 157 VT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-----R------- 219 (316)
T ss_dssp CB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-----C-------
T ss_pred cc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-----C-------
Confidence 32 236899999999999999999999999999999999999999987654332222211100 0
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 694 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~ 694 (770)
+....+ ..+..++..||+.||.+|| ++.+++++
T Consensus 220 -~p~~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 -FPPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CCTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 111112 2344566789999999996 89999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=392.96 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=195.0
Q ss_pred hcCcccceeecccCceEEEEEEeCC----CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~~----g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~L 494 (770)
.++|.+.+.||+|+||.||+|.+.. +..||||+++.. ....+.|.+|+.+|++++|||||+++++|. .+.+++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578999999999999999998642 356899998753 355678999999999999999999999995 467899
Q ss_pred EEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccc
Q 004174 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (770)
Q Consensus 495 V~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~ 574 (770)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+..
T Consensus 85 v~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheec
Confidence 999999999999876543 368999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccc
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 653 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 653 (770)
....... .....||+.|+|||++..+.|+.++|||||||+||||+| |.+||...........+. .+....
T Consensus 159 ~~~~~~~-~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-------~~~~~~- 229 (273)
T d1mp8a_ 159 EDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------NGERLP- 229 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTCCCC-
T ss_pred cCCccee-ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCCCC-
Confidence 5433322 233578999999999999999999999999999999998 899998765543222221 111111
Q ss_pred cCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 654 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 654 ld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
+.... ...+..++..||..||.+|||+.+|++.|+.
T Consensus 230 ----~~~~~----~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 230 ----MPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCCC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11111 2345566778999999999999999998864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=394.09 Aligned_cols=248 Identities=29% Similarity=0.448 Sum_probs=195.6
Q ss_pred cCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEee-cCceEEEEeecC
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLS 500 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~LV~E~~~ 500 (770)
++|.+.+.||+|+||.||+|.+ .|+.||||+++.+ ...+.|.+|++++++++||||++++|+|.+ .+.++|||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 5688899999999999999998 5789999999764 345789999999999999999999999965 466899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCCC
Q 004174 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (770)
Q Consensus 501 ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~~ 580 (770)
+|+|.++|..... ..++|..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 85 KGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp TEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC--
Confidence 9999999975432 358999999999999999999999 899999999999999999999999999998654432
Q ss_pred ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccccccCcccC
Q 004174 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 659 (770)
Q Consensus 581 ~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 659 (770)
....+|+.|+|||++.++.++.++|||||||++|||+| |++||....... +..+.. .+.. +.+.
T Consensus 158 ---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~----~~~~-----~~~~ 222 (262)
T d1byga_ 158 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVE----KGYK-----MDAP 222 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHT----TTCC-----CCCC
T ss_pred ---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH----cCCC-----CCCC
Confidence 22468999999999999999999999999999999998 788887654332 222211 1111 1111
Q ss_pred CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 660 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 660 ~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
... ...+..++..||+.||.+||||.+|+++|+.
T Consensus 223 ~~~----~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 223 DGC----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccC----CHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 111 2345566778999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-46 Score=400.63 Aligned_cols=252 Identities=19% Similarity=0.241 Sum_probs=206.6
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
.++|.+.+.||+|+||+||+|... +|+.||||+++........+.+|+++|+.++|||||+++++|.+++.+||||||+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 367999999999999999999864 6889999999887766677889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCC--CceEEccccccccccCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--FEPQLSDFGLAKWASTS 577 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~--~~vkL~DFGla~~~~~~ 577 (770)
+||+|.+++.... ..+++.+++.|+.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 84 ~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 84 SGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999997543 358999999999999999999999 899999999999999854 57999999999876543
Q ss_pred CCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
.. .....||+.|+|||.+.+..|+.++|||||||+||+|++|+.||...+.......+.-.... ++..
T Consensus 158 ~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~---------~~~~ 225 (321)
T d1tkia_ 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT---------FDEE 225 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC---------CCHH
T ss_pred Cc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------CChh
Confidence 32 23357999999999999999999999999999999999999999876543322222111100 0000
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..... ...+..++..||+.||.+|||+.+++++
T Consensus 226 ~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 226 AFKEI----SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011 1234556678999999999999999984
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-45 Score=389.62 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=203.5
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh----------hHHHHHHHHHHHHHhcC-CCceeEEeeEEeec
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----------DVIKEFVLEIEIITTLH-HKNIISLLGFCFED 489 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~----------~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~ 489 (770)
++|.+.+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+.++++++ ||||++++++|.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5799999999999999999986 578999999986531 23456889999999997 99999999999999
Q ss_pred CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccc
Q 004174 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (770)
Q Consensus 490 ~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFG 569 (770)
+.+||||||+++|+|.++|.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999997543 58999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCceecccccccCCCCceeecc------CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcc
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 643 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~YlAPE~~~~------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~ 643 (770)
+++........ ....||+.|+|||++.. ..++.++|||||||+||||++|+.||.+.+.......+.-...
T Consensus 156 ~a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~ 232 (277)
T d1phka_ 156 FSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232 (277)
T ss_dssp TCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred heeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC
Confidence 99987654322 34689999999999863 3578899999999999999999999987654332222211110
Q ss_pred cccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 644 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 644 ~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+ ..+ ........+..++..||+.||.+|||+.+|+++
T Consensus 233 ~~--------~~~-----~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 233 QF--------GSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CC--------CTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CC--------CCc-----ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00 000 011112345566678999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=399.41 Aligned_cols=270 Identities=26% Similarity=0.324 Sum_probs=200.4
Q ss_pred cCcccceeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC----ceEEEEe
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----NLLLVYD 497 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----~~~LV~E 497 (770)
++|.+.+.||+|+||.||+|.+ +|+.||||+++........+..|+..+..++||||++++++|.+.+ .++||||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 4678889999999999999987 7889999999765443333334555556789999999999998764 5799999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG-----SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-----~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
|+++|+|.++|+.. .++|..++.++.+++.||.|||+. ..++||||||||+||||+.++.+||+|||+++
T Consensus 82 y~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999754 489999999999999999999973 12699999999999999999999999999998
Q ss_pred cccCCCCCc--eecccccccCCCCceeeccC------CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHh-hcc
Q 004174 573 WASTSSSHI--TCTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMW-AKP 643 (770)
Q Consensus 573 ~~~~~~~~~--~~~~~~GT~~YlAPE~~~~~------~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~-~~~ 643 (770)
......... ......||+.|+|||++... .++.++|||||||+||||+||..||.............. ..+
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 775543221 22346899999999998754 367799999999999999999988854332211100000 000
Q ss_pred ---cccCCccccccCcccCCCC-ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 644 ---ILSSGKVTQLLDPALGNNY-DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 644 ---~~~~g~l~~lld~~l~~~~-~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+........++|.+.... ..+....+..++..||+.||.+|||+.+|++.|+.
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 0000001111222222221 23455667788889999999999999999998863
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-45 Score=389.65 Aligned_cols=256 Identities=23% Similarity=0.355 Sum_probs=197.5
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCc----
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN---- 491 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~---- 491 (770)
.++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ......|.+|+.+++.++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999986 57999999999753 3456789999999999999999999999987653
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 571 (770)
+||||||++||+|.+++...+ .+++.+++.|+.||+.||.|||+ ++|+||||||+||||+.++..+|+|||++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhh
Confidence 899999999999999887653 58999999999999999999999 89999999999999999999999999998
Q ss_pred ccccCCCC-CceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcc
Q 004174 572 KWASTSSS-HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650 (770)
Q Consensus 572 ~~~~~~~~-~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 650 (770)
+....... .......+||+.|+|||++.+..|+.++|||||||+||||+||+.||...++......+....+ ..
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~-----~~ 233 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP-----IP 233 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-----CC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCC-----CC
Confidence 76544322 2223346899999999999999999999999999999999999999987654322111111110 00
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCC-CHHHHHHHhh
Q 004174 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP-QMSLVLKLLR 696 (770)
Q Consensus 651 ~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RP-s~~eVL~~L~ 696 (770)
..... ...+ ..+..++..||+.||.+|| +++++++.|.
T Consensus 234 ~~~~~----~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 234 PSARH----EGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp GGGTS----SSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred Cchhc----cCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 01111 1111 3344566789999999999 7898877654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=399.74 Aligned_cols=258 Identities=24% Similarity=0.368 Sum_probs=211.0
Q ss_pred hcCcccceeecccCceEEEEEEe------CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCc
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 491 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 491 (770)
.++|.+.+.||+|+||.||+|.+ .+++.||||+++.. ......|.+|+.++..+ +|||||+++++|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 35788899999999999999975 34678999999754 34566899999999999 69999999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee
Q 004174 492 LLLVYDFLSRGSLEENLHGNKK--------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 557 (770)
++|||||+++|+|.++++.... ....+++..+..++.||+.||.|||+ ++||||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccc
Confidence 9999999999999999976532 22358999999999999999999999 899999999999999
Q ss_pred CCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchh-
Q 004174 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQE- 635 (770)
Q Consensus 558 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~- 635 (770)
+.++.+||+|||+++...........+...||+.|+|||++..+.++.++|||||||+||||+| |.+||...+.....
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999998877666555566789999999999999999999999999999999999 55556554433221
Q ss_pred hHHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 636 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 636 ~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.++....+ + ..+......+..++..||+.||.+||||.+|+++|+.
T Consensus 259 ~~i~~~~~------------~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 259 KMIKEGFR------------M----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HHHHHTCC------------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcCCC------------C----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 12211110 0 1111122346667788999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.8e-45 Score=403.40 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=199.0
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHH---HHHHHHhcCCCceeEEeeEEeecCce
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVL---EIEIITTLHHKNIISLLGFCFEDNNL 492 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~----~~~~~~~~---Ei~iL~~l~HpnIv~l~~~~~~~~~~ 492 (770)
.++|.+.++||+|+||.||+|... +|+.||||++.... .....+.+ |+.+++.++|||||+++++|.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 368999999999999999999864 69999999986422 11223334 46677777899999999999999999
Q ss_pred EEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 493 ~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
||||||++||+|.++|.... .+++..++.++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceee
Confidence 99999999999999997653 57899999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 573 WASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 573 ~~~~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
....... ....||+.|+|||++..+ .|+.++|||||||+||||+||+.||..........+.......
T Consensus 156 ~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------- 224 (364)
T d1omwa3 156 DFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------- 224 (364)
T ss_dssp ECSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC-------
T ss_pred ecCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-------
Confidence 7765432 235799999999999754 6899999999999999999999999876554433332211100
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 694 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs-----~~eVL~~ 694 (770)
...+...++ ..+..++..||+.||.+||| +.+++++
T Consensus 225 ---~~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 225 ---AVELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ---CCCCCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ---CCCCCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 011111122 23445667899999999999 6888874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=392.99 Aligned_cols=258 Identities=27% Similarity=0.424 Sum_probs=205.8
Q ss_pred hcCcccceeecccCceEEEEEEeC--------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeec
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~--------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 489 (770)
.++|.+.+.||+|+||.||+|... ++..||||+++.. .....++.+|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 357888999999999999999852 2347999999754 35567899999999888 799999999999999
Q ss_pred CceEEEEeecCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeee
Q 004174 490 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (770)
Q Consensus 490 ~~~~LV~E~~~ggsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL 557 (770)
+..++||||+++|+|.++|..... ....+++..++.++.||+.||+|||+ ++||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence 999999999999999999975532 12458999999999999999999999 899999999999999
Q ss_pred CCCCceEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhh
Q 004174 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 636 (770)
Q Consensus 558 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~ 636 (770)
+.++.+||+|||+++...............||+.|+|||++..+.|+.++|||||||+||||++ |+.||..........
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 9999999999999998776555544455789999999999999999999999999999999998 788887655432211
Q ss_pred HHHhhcccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 637 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 637 lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+ ..+.. +..... ....+..++.+||+.||.+|||+.+|++.|+.
T Consensus 249 ~i-------~~~~~-----~~~p~~----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 249 LL-------KEGHR-----MDKPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp HH-------HTTCC-----CCCCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH-------HcCCC-----CCCCcc----chHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 11 11110 111111 12345667788999999999999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-46 Score=391.30 Aligned_cols=254 Identities=25% Similarity=0.406 Sum_probs=195.5
Q ss_pred cCcccceeecccCceEEEEEEeC--CC--CEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP--DG--KELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~--~g--~~vAVK~l~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
++|.+.+.||+|+||.||+|.+. ++ ..||||+++.. ....++|.+|+.+|++++||||++++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56899999999999999999853 23 36899998753 3556789999999999999999999999965 5779
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
+||||+++|+|.+.+.... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhh
Confidence 9999999999999887543 358999999999999999999999 8999999999999999999999999999997
Q ss_pred ccCCCCCce-ecccccccCCCCceeeccCCCCCcceEeechHHHHHHHh-CCCCCCCCCccchhhHHHhhcccccCCccc
Q 004174 574 ASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 651 (770)
Q Consensus 574 ~~~~~~~~~-~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 651 (770)
......... .....||+.|+|||++....++.++|||||||++|||+| |+.||...+..... .+. ...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~---~~i---~~~~~~~ 234 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---HKI---DKEGERL 234 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHH---HTSCCCC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH---HHH---HhCCCCC
Confidence 755443322 223568889999999999999999999999999999998 89999865443321 111 1111100
Q ss_pred cccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 652 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 652 ~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
......+ ..+..++..||+.||.+||||.+|++.|+.
T Consensus 235 -----~~~~~~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 235 -----PRPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -----CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCccccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 0111112 235566778999999999999999998863
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-45 Score=400.71 Aligned_cols=244 Identities=23% Similarity=0.301 Sum_probs=203.9
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~ 496 (770)
++|.+.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.+|+.++|||||+++++|.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999986 479999999986432 34567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccC
Q 004174 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 497 E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~ 576 (770)
||+.+|+|.+++...+ .+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999997654 58999999999999999999999 8999999999999999999999999999987754
Q ss_pred CCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCc
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 656 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 656 (770)
.. ....||+.|+|||++.+..|+.++|||||||+||||+||+.||.+.+.......+.....
T Consensus 194 ~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------------- 255 (350)
T d1rdqe_ 194 RT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV------------- 255 (350)
T ss_dssp CB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------------
T ss_pred cc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC-------------
Confidence 32 236799999999999999999999999999999999999999987654332222211110
Q ss_pred ccCCCCChHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 004174 657 ALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 694 (770)
Q Consensus 657 ~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RP-----s~~eVL~~ 694 (770)
......+ ..+..++..||+.||.+|+ ++.+++++
T Consensus 256 ~~p~~~s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 256 RFPSHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCCTTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCccCC----HHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 0111112 2344566789999999994 89999874
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=397.43 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=196.7
Q ss_pred hcCcccc-eeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEeeEEee----cCceE
Q 004174 421 TSNFLAE-NLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE----DNNLL 493 (770)
Q Consensus 421 t~~f~~~-~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~----~~~~~ 493 (770)
.++|.+. ++||+|+||+||+|.. .+|+.||||+++.. ..+.+|+.++.++ +|||||+++++|.+ +..+|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 4578776 5699999999999986 57999999999754 3466799887654 89999999999875 46789
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC---CCceEEccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGL 570 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~---~~~vkL~DFGl 570 (770)
||||||+||+|.++|..... ..+++.+++.|+.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccce
Confidence 99999999999999975432 469999999999999999999999 89999999999999975 45799999999
Q ss_pred cccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcc
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 650 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 650 (770)
|+........ ....||+.|+|||++.+..|+.++|||||||+||+|+||+.||.+.+.......+ ...+..+..
T Consensus 161 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~~i~~~~~ 234 (335)
T d2ozaa1 161 AKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQY 234 (335)
T ss_dssp CEECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS
T ss_pred eeeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HHHHhcCCC
Confidence 9877654332 2368999999999999999999999999999999999999999765433221110 001111110
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 651 ~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
. +...........+..++..||+.||.+|||+.+++++
T Consensus 235 -~-----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 -E-----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -S-----CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -C-----CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0 0000001112345666778999999999999999984
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=394.29 Aligned_cols=254 Identities=26% Similarity=0.423 Sum_probs=200.6
Q ss_pred cCcccceeecccCceEEEEEEeC-CCC--EEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEeeEEeecCceEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGK--ELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~--~vAVK~l~~~--~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~LV 495 (770)
++|.+.+.||+|+||.||+|.+. +|. .||||.++.. .+..+.|.+|+++|.++ +|||||+++++|.+.+.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57888999999999999999875 444 4778887542 34566899999999998 799999999999999999999
Q ss_pred EeecCCCChhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCce
Q 004174 496 YDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~v 563 (770)
|||+++|+|.++|+... .....++|..+..++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 99999999999997542 223579999999999999999999999 899999999999999999999
Q ss_pred EEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCC-CCCCCCCccchhhHHHhhc
Q 004174 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR-KPISNDHPKGQESLVMWAK 642 (770)
Q Consensus 564 kL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~-~Pf~~~~~~~~~~lv~~~~ 642 (770)
||+|||+++........ ....||+.|+|||.+..+.|+.++|||||||++|||++|. +||...+... +.....
T Consensus 167 kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~~~i~ 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKLP 240 (309)
T ss_dssp EECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHGG
T ss_pred EEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HHHHHH
Confidence 99999999865543322 2246899999999999999999999999999999999965 5676544322 222111
Q ss_pred ccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhC
Q 004174 643 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 697 (770)
Q Consensus 643 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~ 697 (770)
.+. .+.. +......+..++..||+.||++||||.+|++.|+.
T Consensus 241 ----~~~-----~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 282 (309)
T d1fvra_ 241 ----QGY-----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282 (309)
T ss_dssp ----GTC-----CCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----hcC-----CCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111 0111 11122345566778999999999999999998864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=393.70 Aligned_cols=260 Identities=20% Similarity=0.372 Sum_probs=210.4
Q ss_pred cCcccceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 493 (770)
++|.+.+.||+|+||.||+|.+. +++.||||+++.. ......|.+|+.++++++||||++++++|...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 56888999999999999999863 3578999999753 345567999999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcc
Q 004174 494 LVYDFLSRGSLEENLHGNK------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 567 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~D 567 (770)
+||||+++|+|.+++.... .....+++..+.+++.|++.||.|||+ ++|+||||||+||||+.++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence 9999999999999886432 122357899999999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhC-CCCCCCCCccchhhHHHhhccccc
Q 004174 568 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG-RKPISNDHPKGQESLVMWAKPILS 646 (770)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~~~~~~~~lv~~~~~~~~ 646 (770)
||+|+...............||+.|+|||.+.++.++.++|||||||+||||+|| ++||...+.......+.
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~------- 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM------- 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-------
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------
Confidence 9999877655444444445799999999999999999999999999999999998 57776544332222111
Q ss_pred CCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCCCC
Q 004174 647 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 700 (770)
Q Consensus 647 ~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~~~ 700 (770)
.+..... +......+..++..||+.+|.+||||.+|+++|+...+
T Consensus 250 ~~~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111111 11112346667778999999999999999999986543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=389.70 Aligned_cols=259 Identities=25% Similarity=0.287 Sum_probs=195.0
Q ss_pred ceeecccCceEEEEEEe-CCCCEEEEEEeCCCh------hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEeec
Q 004174 427 ENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~------~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~~ 499 (770)
+++||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+.+|+.++|||||+++++|..++.+||||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999996 469999999997532 12346889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
.++++..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 988777665433 358889999999999999999999 8999999999999999999999999999987655432
Q ss_pred CceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccc---cccC
Q 004174 580 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT---QLLD 655 (770)
Q Consensus 580 ~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~---~lld 655 (770)
. ....+||+.|+|||++..+ .|+.++|||||||++|||+||+.||.......+...+.-.........+. ....
T Consensus 156 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 156 A--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp C--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred c--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 2 2235799999999998755 57999999999999999999999998765443322221110000000000 0000
Q ss_pred cc-cC--CCCCh-----HHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 656 PA-LG--NNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 656 ~~-l~--~~~~~-----~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.. .. ...+. .....+..++..||+.||++|||+.++|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 00 00010 112345566778999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-45 Score=390.36 Aligned_cols=251 Identities=26% Similarity=0.439 Sum_probs=198.3
Q ss_pred ceeecccCceEEEEEEeCCC----CEEEEEEeCC--ChhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-CceEEEEeec
Q 004174 427 ENLIGKGGSSQVYKGCLPDG----KELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFED-NNLLLVYDFL 499 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~g----~~vAVK~l~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-~~~~LV~E~~ 499 (770)
.++||+|+||+||+|.+.++ ..||||+++. .....++|.+|+++|++++||||++++|+|.+. +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999986432 2589999974 445668899999999999999999999998764 5789999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCCC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~~ 579 (770)
++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999987654 357888999999999999999999 8999999999999999999999999999987654432
Q ss_pred C--ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccCcc
Q 004174 580 H--ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 657 (770)
Q Consensus 580 ~--~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 657 (770)
. .......||+.|+|||++..+.++.++||||||++||||+||..||....... .+..+. ..|. ....|
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i----~~g~--~~~~p- 256 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL----LQGR--RLLQP- 256 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTTC--CCCCC-
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHH----HcCC--CCCCc-
Confidence 2 12233578999999999999999999999999999999999888876543221 111111 1111 11111
Q ss_pred cCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhhCC
Q 004174 658 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 698 (770)
Q Consensus 658 l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~~~ 698 (770)
. ... ..+..++..||+.||++||+|.+|+++|+..
T Consensus 257 --~-~~~---~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 257 --E-YCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp --T-TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --c-cCc---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 112 3455667789999999999999999998643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=397.30 Aligned_cols=246 Identities=24% Similarity=0.398 Sum_probs=202.0
Q ss_pred cCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHH-hcCCCceeEEeeEEeecCceEEE
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIIT-TLHHKNIISLLGFCFEDNNLLLV 495 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~iL~-~l~HpnIv~l~~~~~~~~~~~LV 495 (770)
++|.+.+.||+|+||+||+|... +|+.||||++++. ....+.+..|..++. .++|||||+++++|.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999864 7899999999753 233456777877765 68999999999999999999999
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~ 575 (770)
|||+++|+|.+++.... .+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999997654 58899999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCccccccC
Q 004174 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 655 (770)
Q Consensus 576 ~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 655 (770)
..... .....||+.|+|||++.++.|+.++|||||||++|||++|+.||.+.++......+....+
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~------------ 220 (320)
T d1xjda_ 155 LGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP------------ 220 (320)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------
T ss_pred ccccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 43332 2346899999999999999999999999999999999999999987654333222221111
Q ss_pred cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHH-HHHH
Q 004174 656 PALGNNYDYDQMERMVLASILCIRRDPRARPQMS-LVLK 693 (770)
Q Consensus 656 ~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~-eVL~ 693 (770)
.+....+ ..+..++..||+.||.+||++. ++++
T Consensus 221 -~~p~~~s----~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 -FYPRWLE----KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -CCCTTSC----HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CCCccCC----HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1111112 2345566789999999999985 6765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=385.46 Aligned_cols=265 Identities=26% Similarity=0.357 Sum_probs=198.7
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
++|.+.+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+++|++++|||||+++++|.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999986 579999999997543 235678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
|+.++ +.+++..... ..+++..++.++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~-~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEE-HHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCc-hhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99764 4444433222 368999999999999999999999 89999999999999999999999999999877543
Q ss_pred CCCceecccccccCCCCceeeccCC-CCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC---ccccc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG---KVTQL 653 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~-~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g---~l~~l 653 (770)
.. ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+.......+.-........ .....
T Consensus 156 ~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 156 VR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp SB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 32 223357999999999887665 5789999999999999999999998765433221111000000000 00000
Q ss_pred cC--cccCC--CCC-----hHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 654 LD--PALGN--NYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 654 ld--~~l~~--~~~-----~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.+ +.+.. ..+ ......+..++..||+.||.+|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 00000 000 0111344556678999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.2e-44 Score=381.36 Aligned_cols=264 Identities=23% Similarity=0.328 Sum_probs=200.0
Q ss_pred cCcccceeecccCceEEEEEEeCCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEee
Q 004174 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E~ 498 (770)
++|.+.+.||+|+||+||+|.+++|+.||||+++... ...+.+.+|+.+|++++||||++++++|...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5799999999999999999999899999999997542 3357899999999999999999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCCC
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~~ 578 (770)
+.++.+..+.... ..+++..++.++.||+.||+|||+ ++||||||||+||||+.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9887666665433 368999999999999999999999 899999999999999999999999999998775543
Q ss_pred CCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC---cccccc
Q 004174 579 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG---KVTQLL 654 (770)
Q Consensus 579 ~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g---~l~~ll 654 (770)
.. .....||+.|+|||.+... .++.++|||||||++|||++|+.||.+.+.......+.......... ......
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 155 RK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cc--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence 22 2235789999999998754 57899999999999999999999998765433222111110000000 000000
Q ss_pred --CcccC-------CCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 655 --DPALG-------NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 655 --d~~l~-------~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+..+. ..........+..++..||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 00011112345566778999999999999999863
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=384.98 Aligned_cols=264 Identities=21% Similarity=0.309 Sum_probs=195.9
Q ss_pred hcCcccceeecccCceEEEEEEe-CC-CCEEEEEEeCCC---hhHHHHHHHHHHHHHhc---CCCceeEEeeEEee----
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PD-GKELAVKILKPS---EDVIKEFVLEIEIITTL---HHKNIISLLGFCFE---- 488 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~-g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~---- 488 (770)
.++|.+.+.||+|+||+||+|.+ .+ ++.||||+++.. ......+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999986 34 567999998642 22233566777777666 79999999999863
Q ss_pred -cCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcc
Q 004174 489 -DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 567 (770)
Q Consensus 489 -~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~D 567 (770)
...++++|||+.++.+........ ..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecc
Confidence 346899999999877765544332 368999999999999999999999 8999999999999999999999999
Q ss_pred ccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccC
Q 004174 568 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 647 (770)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 647 (770)
||+++...... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.++......+.........
T Consensus 160 fg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 99997654332 223468999999999999999999999999999999999999999876544333222211100000
Q ss_pred Ccc-----------ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 648 GKV-----------TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 648 g~l-----------~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+ .......+ ..+.......+..++..||+.||.+|||+.++|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccccccchhhhhccccccch-hhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00000000 00111112234456678999999999999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=381.52 Aligned_cols=239 Identities=22% Similarity=0.364 Sum_probs=193.9
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-------hHHHHHHHHHHHHHhcC--CCceeEEeeEEeecCc
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-------DVIKEFVLEIEIITTLH--HKNIISLLGFCFEDNN 491 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~-------~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~~~ 491 (770)
++|.+.+.||+|+||+||+|.. .+|+.||||+++... .....+.+|+.+|++++ |||||+++++|.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999986 478999999986421 12244678999999997 8999999999999999
Q ss_pred eEEEEeecCC-CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC-CCceEEcccc
Q 004174 492 LLLVYDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFG 569 (770)
Q Consensus 492 ~~LV~E~~~g-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-~~~vkL~DFG 569 (770)
.++||||+.+ +++.+++.... .+++.+++.++.||+.||.|||+ ++|+||||||+||||+. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 57778776543 58999999999999999999999 89999999999999985 5799999999
Q ss_pred ccccccCCCCCceecccccccCCCCceeeccCCC-CCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC
Q 004174 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 648 (770)
Q Consensus 570 la~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 648 (770)
+|+...... .+...||+.|+|||++.+..+ +.++|||||||+||||+||+.||.... .+. .....
T Consensus 157 ~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~-~~~~~---- 222 (273)
T d1xwsa_ 157 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII-RGQVF---- 222 (273)
T ss_dssp TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH-HCCCC----
T ss_pred cceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHh-hcccC----
Confidence 998765432 234689999999999987776 567899999999999999999996531 111 11100
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 649 ~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+...++ ..+..++..||+.||.+|||+.+++++
T Consensus 223 ---------~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 223 ---------FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ---------CSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---------CCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 111122 234556678999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-43 Score=374.28 Aligned_cols=267 Identities=23% Similarity=0.306 Sum_probs=196.8
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEee--------
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-------- 488 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-------- 488 (770)
.++|.+.+.||+|+||+||+|.. .+|+.||||++... ....+.+.+|+.+|+.++||||++++++|..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36899999999999999999996 57999999998643 2345678899999999999999999999855
Q ss_pred cCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccc
Q 004174 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (770)
Q Consensus 489 ~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DF 568 (770)
.+.+++||||+.++.+....... ..++...++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeec
Confidence 34689999999887666554332 358899999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCCCC--ceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccc
Q 004174 569 GLAKWASTSSSH--ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 645 (770)
Q Consensus 569 Gla~~~~~~~~~--~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~ 645 (770)
|+++........ ......+||+.|+|||++... .|+.++|||||||++|||++|+.||.+.+.......+.......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999866543211 112235799999999998765 68999999999999999999999998765443333322211111
Q ss_pred cCCccccccCccc--------CCCCCh-HH------HHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 646 SSGKVTQLLDPAL--------GNNYDY-DQ------MERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 646 ~~g~l~~lld~~l--------~~~~~~-~~------~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
............+ ...... +. ...+..++.+||+.||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 1111111100000 000011 11 1123446678999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-43 Score=380.20 Aligned_cols=262 Identities=24% Similarity=0.272 Sum_probs=191.7
Q ss_pred CcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEeeEEeec------CceEEE
Q 004174 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NNLLLV 495 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~~~~LV 495 (770)
+|...++||+|+||+||+|.+. +|+.||||+++.... .+.+|+++|++++||||++++++|... .+++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 4777899999999999999974 699999999976542 234799999999999999999998643 247899
Q ss_pred EeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC-ceEEccccccccc
Q 004174 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWA 574 (770)
Q Consensus 496 ~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-~vkL~DFGla~~~ 574 (770)
|||++++.+..+.. .......+++..++.|+.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||+++..
T Consensus 98 ~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 98 LDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99998754443332 11222468999999999999999999999 8999999999999999775 8999999999876
Q ss_pred cCCCCCceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhc-----------
Q 004174 575 STSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK----------- 642 (770)
Q Consensus 575 ~~~~~~~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~----------- 642 (770)
...... ....||+.|+|||.+.. ..|+.++|||||||++|||++|+.||...........+....
T Consensus 174 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 554332 23579999999998775 468999999999999999999999998765433222211100
Q ss_pred -ccccCCccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 643 -PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 643 -~~~~~g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+......+...................+..++.+||+.||++|||+.++|++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000001111100000000111112234556678999999999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=374.58 Aligned_cols=266 Identities=22% Similarity=0.300 Sum_probs=196.9
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC----ceE
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----NLL 493 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----~~~ 493 (770)
+++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+++|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 56799999999999999999985 58999999999754 355678999999999999999999999997653 234
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccccc
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
++++|+.+|+|.+++... .+++..++.++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+++.
T Consensus 87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 555667799999999643 48999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCC-ceecccccccCCCCceeecc-CCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCcc-
Q 004174 574 ASTSSSH-ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV- 650 (770)
Q Consensus 574 ~~~~~~~-~~~~~~~GT~~YlAPE~~~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l- 650 (770)
....... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||........................
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 6543222 11234679999999999864 46789999999999999999999999876543332222111100000000
Q ss_pred -------cc-ccCcccCCCCChH-----HHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 651 -------TQ-LLDPALGNNYDYD-----QMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 651 -------~~-lld~~l~~~~~~~-----~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.. ..........+.. ....+..++..||+.||.+|||+.++|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000000000110 01234566778999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-42 Score=373.57 Aligned_cols=259 Identities=22% Similarity=0.305 Sum_probs=192.6
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecC------
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 490 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------ 490 (770)
.++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46799999999999999999986 46999999999753 355678999999999999999999999997654
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 570 (770)
.+|+||||+ +++|..+++.. .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccc
Confidence 579999999 66787776532 48999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccC--
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS-- 647 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~-- 647 (770)
|+...... +...||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.................
T Consensus 168 a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 168 ARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 98765432 235799999999998764 5689999999999999999999999876543322111110000000
Q ss_pred -------------CccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 648 -------------GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 648 -------------g~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
..+.......+... .......+..++..||+.||.+|||+.++|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASI-LTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGT-CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhhhcchhhhhhhccCCcccccchHHh-ccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000000000 00111233456678999999999999999984
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=360.33 Aligned_cols=264 Identities=21% Similarity=0.247 Sum_probs=202.0
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeecCceEEEEe
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~LV~E 497 (770)
++|.+.+.||+|+||+||+|.+ .+|+.||||+++.. ......+.+|+.+|+.++||||++++++|......++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999996 57899999998643 3457889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccccccccCC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~~~~~~ 577 (770)
++.+++|..++...+ .+++..++.++.|++.||+|||+ ++|+||||||+||||+.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999988876543 57899999999999999999999 89999999999999999999999999999877654
Q ss_pred CCCceecccccccCCCCceeeccCC-CCCcceEeechHHHHHHHhCCCCCCCCCccch-hhHHHhhcccccCCc---ccc
Q 004174 578 SSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ-ESLVMWAKPILSSGK---VTQ 652 (770)
Q Consensus 578 ~~~~~~~~~~GT~~YlAPE~~~~~~-~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~-~~lv~~~~~~~~~g~---l~~ 652 (770)
.... ....+++.|+|||.+.... ++.++|||||||++|||++|+.||........ ...+........... ...
T Consensus 155 ~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 155 VRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CSCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred Cccc--eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 3322 2246788999999988665 68999999999999999999999755433221 111111000000000 000
Q ss_pred ccC---------cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 653 LLD---------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 653 lld---------~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
+.+ ..-...........+..++.+||+.||.+|||+.|+|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000000111112334456678999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-41 Score=362.52 Aligned_cols=257 Identities=22% Similarity=0.273 Sum_probs=193.7
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCcee-EEeeEEeecCceEEEEeec
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDFL 499 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnIv-~l~~~~~~~~~~~LV~E~~ 499 (770)
++|.+.+.||+|+||.||+|.+ .+|+.||||++..... ..++..|+++++.++|+|++ .+..++.+++..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 5699999999999999999986 5689999999875432 24578899999999877655 4555567778889999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeC---CCCceEEccccccccccC
Q 004174 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKWAST 576 (770)
Q Consensus 500 ~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~---~~~~vkL~DFGla~~~~~ 576 (770)
+++|.+.+.... ..+++..+..++.|++.||+|||+ ++||||||||+|||++ .+..+||+|||+|+....
T Consensus 86 -~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 86 -GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp -CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred -CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 557777665433 368999999999999999999999 8999999999999986 355799999999997765
Q ss_pred CCCC-----ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHH-HhhcccccCCcc
Q 004174 577 SSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV-MWAKPILSSGKV 650 (770)
Q Consensus 577 ~~~~-----~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv-~~~~~~~~~g~l 650 (770)
.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||...........+ .+......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~---- 234 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS---- 234 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH----
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC----
Confidence 4322 1223468999999999999989999999999999999999999999876543322221 11110000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 651 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 651 ~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
...+.+....+ ..+..++..||+.+|.+||++.++.++|+
T Consensus 235 --~~~~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 274 (299)
T d1ckia_ 235 --TPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274 (299)
T ss_dssp --SCHHHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred --CChhHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 00011111122 23455667899999999999999888775
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.9e-41 Score=360.45 Aligned_cols=259 Identities=18% Similarity=0.209 Sum_probs=203.1
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC-CceeEEeeEEeecCceEEEEee
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYDF 498 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~LV~E~ 498 (770)
.++|.+.+.||+|+||+||+|.+. +|+.||||++.... ....+.+|++++..+.| +|++.+++++..+...++||||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 468999999999999999999964 68999999986543 22456788999999975 8999999999999999999999
Q ss_pred cCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCC-----CCceEEcccccccc
Q 004174 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-----DFEPQLSDFGLAKW 573 (770)
Q Consensus 499 ~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~-----~~~vkL~DFGla~~ 573 (770)
+ +++|.+++.... ..+++..+..++.|++.||+|||+ ++||||||||+||||+. ++.+||+|||+|+.
T Consensus 83 ~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 83 L-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9 789999987654 358999999999999999999999 89999999999999974 57899999999987
Q ss_pred ccCCCCC-----ceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCC
Q 004174 574 ASTSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 648 (770)
Q Consensus 574 ~~~~~~~-----~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 648 (770)
....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 6543221 12234689999999999999999999999999999999999999998765544332221111100000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHHhh
Q 004174 649 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 696 (770)
Q Consensus 649 ~l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~L~ 696 (770)
... .+....+ ..+..++..|+..+|++||+++.+.+.|+
T Consensus 236 ~~~-----~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~ 274 (293)
T d1csna_ 236 PLR-----ELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFS 274 (293)
T ss_dssp CHH-----HHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred ChH-----HhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 111 1112222 23445556799999999999999888775
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2e-41 Score=365.49 Aligned_cols=258 Identities=19% Similarity=0.302 Sum_probs=195.6
Q ss_pred cCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CCceeEEeeEEeec--CceEEEEe
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFED--NNLLLVYD 497 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~--~~~~LV~E 497 (770)
++|.+.+.||+|+||+||+|.. .+|+.||||+++... .+.+.+|+.+|..++ ||||++++++|... ..+++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 5799999999999999999986 578999999997643 467889999999996 99999999999753 56999999
Q ss_pred ecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCC-ceEEccccccccccC
Q 004174 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWAST 576 (770)
Q Consensus 498 ~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~-~vkL~DFGla~~~~~ 576 (770)
|+.+++|..... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++ .+||+|||+|+....
T Consensus 113 ~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 113 HVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp CCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred ecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987642 48899999999999999999999 9999999999999998655 699999999987755
Q ss_pred CCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchh-hHH----------Hhhcc-
Q 004174 577 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE-SLV----------MWAKP- 643 (770)
Q Consensus 577 ~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~lv----------~~~~~- 643 (770)
.... ....||+.|+|||.+... .++.++|||||||++|||++|+.||......... ..+ .|...
T Consensus 183 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCcc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 4322 235799999999998765 4799999999999999999999999765432211 100 00000
Q ss_pred -cccCCccccccC--------cccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 644 -ILSSGKVTQLLD--------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 644 -~~~~g~l~~lld--------~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
............ ..............+..++..||+.||.+|||++++|++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000 000111111112234556678999999999999999873
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=367.33 Aligned_cols=252 Identities=25% Similarity=0.336 Sum_probs=199.7
Q ss_pred cCcccceeecccCceEEEEEEe----CCCCEEEEEEeCCC-----hhHHHHHHHHHHHHHhcCC-CceeEEeeEEeecCc
Q 004174 422 SNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPS-----EDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNN 491 (770)
Q Consensus 422 ~~f~~~~~LG~G~fG~Vy~a~~----~~g~~vAVK~l~~~-----~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~ 491 (770)
++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999974 25889999998742 2345678899999999976 899999999999999
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 571 (770)
+++||||+.+|+|.+++.... .++...++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999997664 46788899999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCceecccccccCCCCceeeccC--CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccCCc
Q 004174 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 649 (770)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~--~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 649 (770)
+......... .....||+.|+|||.+... .++.++|||||||+||||++|+.||...........+.-.... +
T Consensus 177 ~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~---~- 251 (322)
T d1vzoa_ 177 KEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK---S- 251 (322)
T ss_dssp EECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH---C-
T ss_pred hhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc---C-
Confidence 8765433322 2346799999999999754 4788999999999999999999999876554432222111000 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHhhcccCCCCCCC-----HHHHHHH
Q 004174 650 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 694 (770)
Q Consensus 650 l~~lld~~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs-----~~eVL~~ 694 (770)
.+.+ +......+..++..||+.||.+||+ +++++++
T Consensus 252 -----~~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 -----EPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -----CCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----CCCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0111 1112234455667899999999994 7888863
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-41 Score=364.48 Aligned_cols=261 Identities=23% Similarity=0.260 Sum_probs=190.6
Q ss_pred hcCcccceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEee------cC
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE------DN 490 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------~~ 490 (770)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++.. ......+.+|+.+|++++||||++++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 467999999999999999999864 6999999999753 3556678999999999999999999999964 36
Q ss_pred ceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEccccc
Q 004174 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (770)
Q Consensus 491 ~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGl 570 (770)
.+|+||||+.++ |.+.+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhh
Confidence 789999999765 444443 247899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHH----------h
Q 004174 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM----------W 640 (770)
Q Consensus 571 a~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~----------~ 640 (770)
++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+. |
T Consensus 166 ~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 166 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 886654332 234679999999999999999999999999999999999999998765332221111 0
Q ss_pred hc------------ccccCCccccccCcccCCCC---ChHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 641 AK------------PILSSGKVTQLLDPALGNNY---DYDQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 641 ~~------------~~~~~g~l~~lld~~l~~~~---~~~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
.. +..........+........ .......+..++..||+.||++|||++++|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00000011111111111111 11223456667788999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=366.01 Aligned_cols=261 Identities=22% Similarity=0.286 Sum_probs=193.8
Q ss_pred hcCcccceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEeeEEeec-----Cc
Q 004174 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 491 (770)
Q Consensus 421 t~~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~ 491 (770)
+++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+++|+.++|||||+++++|... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56799999999999999999985 57999999999753 34556789999999999999999999998643 34
Q ss_pred eEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEEcccccc
Q 004174 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (770)
Q Consensus 492 ~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla 571 (770)
.+++|+|+.+|+|.+++... .+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchh
Confidence 46677888899999998542 48999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCceecccccccCCCCceeeccC-CCCCcceEeechHHHHHHHhCCCCCCCCCccchhhHHHhhcccccC---
Q 004174 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS--- 647 (770)
Q Consensus 572 ~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~lv~~~~~~~~~--- 647 (770)
...... .....||+.|+|||.+... .++.++|||||||++|+|++|+.||.+.+.......+.........
T Consensus 169 ~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 169 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp -CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 765432 2235799999999987765 4688999999999999999999999876543322222111000000
Q ss_pred -----CccccccCcccC-CCCCh-----HHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 004174 648 -----GKVTQLLDPALG-NNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLKL 694 (770)
Q Consensus 648 -----g~l~~lld~~l~-~~~~~-----~~~~~l~~~a~~Cl~~dP~~RPs~~eVL~~ 694 (770)
............ ..... .....+..++..||+.||.+|||+.++|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000000000000 00000 011234456678999999999999999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-36 Score=330.34 Aligned_cols=264 Identities=18% Similarity=0.240 Sum_probs=191.9
Q ss_pred CcccceeecccCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-----------CCceeEEeeEEeec-
Q 004174 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-----------HKNIISLLGFCFED- 489 (770)
Q Consensus 423 ~f~~~~~LG~G~fG~Vy~a~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~-----------HpnIv~l~~~~~~~- 489 (770)
+|.+.+.||+|+||+||+|.. .+|+.||||+++......+.+.+|+.+++.++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 499999999999999999986 57999999999988777778889999998885 47899999988653
Q ss_pred -CceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCc------
Q 004174 490 -NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE------ 562 (770)
Q Consensus 490 -~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~------ 562 (770)
...+++|+++..+.......... ....+++..+..++.||+.||.|||+ ..+|+||||||+||||+.++.
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 45677777776655443332221 22468889999999999999999996 268999999999999976543
Q ss_pred eEEccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHHHHHhCCCCCCCCCccch----hhHH
Q 004174 563 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ----ESLV 638 (770)
Q Consensus 563 vkL~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~----~~lv 638 (770)
++|+|||.+....... ...+||+.|+|||++....++.++|||||||++++|++|+.||........ ..+.
T Consensus 171 ~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 171 IKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 8999999998654432 235799999999999999999999999999999999999999976543211 1111
Q ss_pred Hhhc-----------------ccccCCccccccCc----------ccCCCCChHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 004174 639 MWAK-----------------PILSSGKVTQLLDP----------ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLV 691 (770)
Q Consensus 639 ~~~~-----------------~~~~~g~l~~lld~----------~l~~~~~~~~~~~l~~~a~~Cl~~dP~~RPs~~eV 691 (770)
.... ...........+.. .............+..++..||+.||.+|||+.|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 1000 00000000000000 00112234455667778889999999999999999
Q ss_pred HHH
Q 004174 692 LKL 694 (770)
Q Consensus 692 L~~ 694 (770)
|++
T Consensus 326 L~H 328 (362)
T d1q8ya_ 326 VNH 328 (362)
T ss_dssp HTC
T ss_pred hcC
Confidence 864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.5e-23 Score=207.22 Aligned_cols=169 Identities=15% Similarity=0.148 Sum_probs=122.5
Q ss_pred ccceeecccCceEEEEEEeCCCCEEEEEEeCCCh-------------------hHHHHHHHHHHHHHhcCCCceeEEeeE
Q 004174 425 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-------------------DVIKEFVLEIEIITTLHHKNIISLLGF 485 (770)
Q Consensus 425 ~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~-------------------~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 485 (770)
.+.+.||+|+||+||+|...+|+.||||+++... .....+..|+..+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4678999999999999998899999999876321 112345568889999999999988765
Q ss_pred EeecCceEEEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEecccCCCeeeCCCCceEE
Q 004174 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565 (770)
Q Consensus 486 ~~~~~~~~LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDLKp~NILL~~~~~vkL 565 (770)
. ..+++|||++++.+.+ +.......++.|++.+|.|||+ ++|+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEE
Confidence 3 2389999998865543 2334456799999999999999 899999999999999865 5999
Q ss_pred ccccccccccCCCCCceecccccccCCCCceeeccCCCCCcceEeechHHHH
Q 004174 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 617 (770)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~GT~~YlAPE~~~~~~~s~ksDVwSlGvvL~ 617 (770)
+|||+|...............+.. -.+++ .+.|+.++|+||+.--++
T Consensus 144 iDFG~a~~~~~~~~~~~l~rd~~~----~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 144 IDFPQSVEVGEEGWREILERDVRN----IITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCCTTCEETTSTTHHHHHHHHHHH----HHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred EECCCcccCCCCCcHHHHHHHHHH----HHHHH-cCCCCCcccHHHHHHHHh
Confidence 999999765433211100000000 01222 357888999999764443
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.83 E-value=1.2e-20 Score=182.85 Aligned_cols=134 Identities=19% Similarity=0.298 Sum_probs=102.8
Q ss_pred cEEEEEEcCCc---------chHHHHHHHHhhccCCCC---EEEEEEeecCCCcccCCCCc---c-------chhhhHHH
Q 004174 17 RTVVVGVKLDT---------HSRELLTWALVKVAQPGD---TVIALHVLANNAIVDRDGKS---S-------LLSLVKAF 74 (770)
Q Consensus 17 r~I~VaVd~s~---------~S~~AL~WAl~~~~~~gd---~vvlvHV~~~~~~~~~~~~~---~-------~~~~~~~~ 74 (770)
++|+||||+|. +|++||+||++++++.|| .|+++||............. . .....+..
T Consensus 2 ~ki~vavd~s~~~~~~~~~~~S~~Al~wal~~~~~~~~~~~~L~~vhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (171)
T d2gm3a1 2 TKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKAKG 81 (171)
T ss_dssp EEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHHHHH
T ss_pred CEEEEEEcCCcccCCCCCCHHHHHHHHHHHHHHHHCCCCCcEEEEEEeccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 68999999986 799999999999999999 49999998654332111111 1 11112233
Q ss_pred HHHHHHHHhHhhhcCCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEE
Q 004174 75 DSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLA 151 (770)
Q Consensus 75 ~~~l~~~~~~C~~k~V~~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~v 151 (770)
.++|+.+...|..+++.++..+.+ |++.++|+++|++.++++||||++++ .+.++| ||++||++|++ |||++
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~v~~-G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~lG--Sv~~~vi~~~~--cpVlv 156 (171)
T d2gm3a1 82 LHLLEFFVNKCHEIGVGCEAWIKT-GDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVG--TVSAFCVKHAE--CPVMT 156 (171)
T ss_dssp HHHHHHHHHHHHHHTCEEEEEEEE-SCHHHHHHHHHHHHCCSEEEEEECCCC----------CHHHHHHHHCS--SCEEE
T ss_pred HHHHHHHHHHHHhcCCceEEEEEe-CChHHHHHHHHhhcCCcEEEeccCCccccccCccC--cHHHHHHhCCC--CCEEE
Confidence 478899999999999999999888 79999999999999999999999988 667788 99999999998 99999
Q ss_pred EeCC
Q 004174 152 VNNG 155 (770)
Q Consensus 152 V~~g 155 (770)
|+.+
T Consensus 157 V~~~ 160 (171)
T d2gm3a1 157 IKRN 160 (171)
T ss_dssp EECC
T ss_pred EeCC
Confidence 9875
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=99.75 E-value=5.4e-18 Score=161.59 Aligned_cols=134 Identities=17% Similarity=0.156 Sum_probs=108.5
Q ss_pred cEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCC----------Cccchh--------hhHHHHHHH
Q 004174 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDG----------KSSLLS--------LVKAFDSVL 78 (770)
Q Consensus 17 r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~----------~~~~~~--------~~~~~~~~l 78 (770)
|+|+||||+|+.|.+||+||++.+-+.|+.|++|||.++........ .....+ ..+...+.+
T Consensus 4 ~~ILvavD~s~~s~~al~~a~~la~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 83 (160)
T d1mjha_ 4 KKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKNKM 83 (160)
T ss_dssp CEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEECCCHHHHHHHHHHHHHHHhcCCEEEEEEecccccccccccccccccccccchhHHHHHHHHHHHHHHHHHHHH
Confidence 79999999999999999999999999999999999985543221100 000111 112223677
Q ss_pred HHHHhHhhhcCCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeCC
Q 004174 79 AVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (770)
Q Consensus 79 ~~~~~~C~~k~V~~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~~g 155 (770)
+.+...|...+|.++..+.. |++.+.|+++|+..++|++|||++++ .+.|+| |+++|++++++ |||++|++.
T Consensus 84 ~~~~~~~~~~gv~~~~~~~~-G~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~G--S~a~~vl~~s~--~pVlvV~~~ 158 (160)
T d1mjha_ 84 ENIKKELEDVGFKVKDIIVV-GIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLG--SVTENVIKKSN--KPVLVVKRK 158 (160)
T ss_dssp HHHHHHHHHTTCEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSC--HHHHHHHHHCC--SCEEEECCC
T ss_pred HHHHHHHHhcCCeEEEEEEe-ccHHHHHhhhhhccccceEEeccCCCCcccccccC--cHHHHHHhcCC--CCEEEEcCC
Confidence 77888888999999999998 79999999999999999999999988 677788 99999999998 999999864
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=99.72 E-value=7.4e-18 Score=155.97 Aligned_cols=131 Identities=16% Similarity=0.141 Sum_probs=103.7
Q ss_pred cEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCccchhhhHHHHHHHHHHHhHhhhcCCcEEEEE
Q 004174 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKI 96 (770)
Q Consensus 17 r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~~~v 96 (770)
++|+|++|+|+.|..||+||++.+.+.|+.|+++||.++....... ........+..+...+.++.+++..++.....+
T Consensus 2 k~Ilv~~D~s~~s~~a~~~a~~~a~~~~~~l~ll~V~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 80 (135)
T d2z3va1 2 KTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYLGE-PFFEEALRRRLERAEGVLEEARALTGVPKEDAL 80 (135)
T ss_dssp CEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECCCCTTCCT-THHHHHHHHHHHHHHHHHHHHHHHHCCCGGGEE
T ss_pred CEEEEEECCCHHHHHHHHHHHHHHHHcCCEEEEEEEecCCcccccc-chhHHHHHHHHHHHHHHHHHHHHhcCCCeEEEE
Confidence 6899999999999999999999999999999999999754332111 111112223334555666667777666666666
Q ss_pred EECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEE
Q 004174 97 CRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAV 152 (770)
Q Consensus 97 ~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV 152 (770)
+.+|++.++|+++|+..++|+||||++++ .|.++| |+++||+++++ |||++|
T Consensus 81 ~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~G--s~~~~ll~~~~--~pVlvV 135 (135)
T d2z3va1 81 LLEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFLG--SQSQRVVAEAP--CPVLLV 135 (135)
T ss_dssp EEESCHHHHHHHHHHHTTCSEEEEESSCSSSCBCSSCB--HHHHHHHHHCS--SCEEEE
T ss_pred EEcCChHHHHHHHhhhhheeeEEeccCCCCcccccccC--cHHHHHHHhCC--CCEEeC
Confidence 66699999999999999999999999988 566777 99999999998 999997
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=99.67 E-value=3.9e-17 Score=151.77 Aligned_cols=134 Identities=13% Similarity=0.142 Sum_probs=104.5
Q ss_pred cEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccCCCCccchh-hh-HHHHHHHHHHHhHhhhcCCcEEE
Q 004174 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLS-LV-KAFDSVLAVYEGFCNLKQVDLKL 94 (770)
Q Consensus 17 r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~-~~-~~~~~~l~~~~~~C~~k~V~~~~ 94 (770)
++|+||||+++.|..||+||...+.+.|+.|+++||.++.............. .. +........+..++...+.....
T Consensus 3 k~ILv~vD~s~~s~~al~~A~~~a~~~~~~v~~lhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (140)
T d1jmva_ 3 KHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGLIDVNMSSMQDRISTETQKALLDLAESVDYPISE 82 (140)
T ss_dssp SEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCCEEHHHHHHTTCCCCHHHHHHHHHHHHSSSCCCC
T ss_pred CeEEEEECCCHHHHHHHHHHHHHHHHcCCeEEEEEEeeecccccccccccchHHHHHHHHHHHHHHHHHHHHhcCCceEE
Confidence 78999999999999999999999999999999999987664322211111100 00 00114555666677777766666
Q ss_pred EEEECCChhHHHHHHHHhcCCcEEEEccCCCcccccCCCchHHHHhccCCCCcEEEEEeC
Q 004174 95 KICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (770)
Q Consensus 95 ~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~~r~~~~~~sVs~yc~~~ap~~C~V~vV~~ 154 (770)
.++++|++.++|+++|+++++|+||||++++....+| |+++|+++|++ |||++|+-
T Consensus 83 ~~~~~~~~~~~I~~~a~~~~~dliV~G~~~~~~~~lg--s~~~~li~~~~--~pVliVp~ 138 (140)
T d1jmva_ 83 KLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDFWSKLM--SSTRQVMNTIK--IDMLVVPL 138 (140)
T ss_dssp EEEEEECHHHHHHHHHHHTTCCEEEEEECCCCHHHHH--HHHHHHHTTCC--SEEEEEEC
T ss_pred EEEEecCHHHHHHHhhhhchhhEEEeccCCCCCCCcc--cHHHHHHhccC--CCEEEEec
Confidence 7777799999999999999999999999988655577 99999999998 99999974
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.65 E-value=3.2e-16 Score=146.69 Aligned_cols=137 Identities=15% Similarity=0.054 Sum_probs=98.5
Q ss_pred CCCCcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEee-cCCCcccCC----CCccchhhhHHHHHHHHHHHhHhhh
Q 004174 13 SGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVL-ANNAIVDRD----GKSSLLSLVKAFDSVLAVYEGFCNL 87 (770)
Q Consensus 13 ~~~~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~-~~~~~~~~~----~~~~~~~~~~~~~~~l~~~~~~C~~ 87 (770)
|..=++|+|+||+|+.|.+||+||+..+. .++.++++|+. ++....... .........+...+.++.++..|..
T Consensus 2 M~~yk~ILv~vD~s~~s~~al~~A~~la~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 80 (147)
T d1tq8a_ 2 LSAYKTVVVGTDGSDSSMRAVDRAAQIAG-ADAKLIIASAYLPQHEDARAADILKDESYKVTGTAPIYEILHDAKERAHN 80 (147)
T ss_dssp CCCCCEEEEECCSSHHHHHHHHHHHHHHT-TTSEEEEEEECCC--------------------CCTHHHHHHHHHHHHHT
T ss_pred CcCCCEEEEEECCCHHHHHHHHHHHHHHh-cCCCEEEEEEEecccccccccccchhhhHHHHHHHHHHHHHHHHHHHHHH
Confidence 33458999999999999999999998764 55555555544 322211111 0111112223344788889999998
Q ss_pred cCCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCC---cccccCCCchHHHHhccCCCCcEEEEEeC
Q 004174 88 KQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKN---HHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (770)
Q Consensus 88 k~V~~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~---~r~~~~~~sVs~yc~~~ap~~C~V~vV~~ 154 (770)
.++......+..|++.++|+++|+.+++++||||++++ .+.++| |++.||+++++ |||++|+.
T Consensus 81 ~~~~~~~~~~~~G~~~~~i~~~a~~~~~dlIv~g~~~~~~~~~~l~G--s~~~~ll~~~~--~pVlvV~~ 146 (147)
T d1tq8a_ 81 AGAKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLG--SVPANVSRRAK--VDVLIVHT 146 (147)
T ss_dssp TTCCEEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTB--BHHHHHHHHTT--CEEEEECC
T ss_pred cCCCcEEEEEEecChHHHHHHhhhccceeEEEecCCCCCcccccccc--cHHHHHHHhCC--CCEEEEec
Confidence 88874444555599999999999999999999999987 566788 99999999998 99999973
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=99.36 E-value=6.6e-13 Score=122.03 Aligned_cols=127 Identities=9% Similarity=-0.001 Sum_probs=89.0
Q ss_pred CcEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeecCCCcccC----CCCccchhhh-HHHHHHHHHHHhHh---hh
Q 004174 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDR----DGKSSLLSLV-KAFDSVLAVYEGFC---NL 87 (770)
Q Consensus 16 ~r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~----~~~~~~~~~~-~~~~~~l~~~~~~C---~~ 87 (770)
-|+|+|++|+|+.|..||+||++.+-+.|+.|+++||..+...... .+........ +..+.....++.+| ..
T Consensus 4 mk~ILv~~D~S~~s~~al~~A~~~a~~~~a~l~llhv~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~l~~~~~~~~~ 83 (138)
T d1q77a_ 4 MKVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPFPPEIKEESKKRIERRLREVWEKLTG 83 (138)
T ss_dssp CEEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCCCCTHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred CCEEEEEEeCCHHHHHHHHHHHHhhhhccceEEEEEEccCcccccccccccccchhhhhhhhhhhhccccchhhcccccc
Confidence 3899999999999999999999999999999999999843211000 1111111111 11223333344444 34
Q ss_pred cCCcEEEEEEECCChhHHHHHHHHhcCCcEEEEccCCCcccccCCCchHHHHhccCCCCcEEEEEe
Q 004174 88 KQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (770)
Q Consensus 88 k~V~~~~~v~~~~d~~~~L~~~a~~~~a~~LVlG~~~~~r~~~~~~sVs~yc~~~ap~~C~V~vV~ 153 (770)
..+.++..+.. |++.+.|++.|++.++|++|||++++ +....++.... ||+++|+
T Consensus 84 ~~~~~~~~v~~-G~~~~~I~~~a~~~~~DLIV~Gs~g~--------~~l~r~l~g~~--~~~livk 138 (138)
T d1q77a_ 84 STEIPGVEYRI-GPLSEEVKKFVEGKGYELVVWACYPS--------AYLCKVIDGLN--LASLIVK 138 (138)
T ss_dssp CCCCCCEEEEC-SCHHHHHHHHHTTSCCSEEEECSCCG--------GGTHHHHHHSS--SEEEECC
T ss_pred cceeEEEeeec-chhHHHHHHhhhhccCCEEEEecCCC--------cHHHHHhcCCC--CCEEEeC
Confidence 56777788777 89999999999999999999999985 22333444443 9999985
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.31 E-value=1.2e-06 Score=87.83 Aligned_cols=147 Identities=18% Similarity=0.142 Sum_probs=97.5
Q ss_pred HHHHhhcCcccceeecccCceEEEEEEeCCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcC-CCceeEEeeEEeecCceE
Q 004174 416 DLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLL 493 (770)
Q Consensus 416 ~l~~~t~~f~~~~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~-~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~ 493 (770)
++......|.+.+..+.+..+.||+... +++.+++|+..... .....+.+|...+..+. +--+.+++.++..++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3444445666665544455578998765 66678889876432 23345677888888774 333567778888888899
Q ss_pred EEEeecCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------
Q 004174 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS-------------------------------- 541 (770)
Q Consensus 494 LV~E~~~ggsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-------------------------------- 541 (770)
+||++++|.++.+..... .....++.+++..|..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEeccccccccccccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 999999998886554211 112234444555555555311
Q ss_pred ------------------------CCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 542 ------------------------AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 542 ------------------------~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999877666799998775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.84 E-value=1.2e-05 Score=80.03 Aligned_cols=76 Identities=16% Similarity=0.040 Sum_probs=54.9
Q ss_pred eecccC-ceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC--CceeEEeeEEeecCceEEEEeecCCCChh
Q 004174 429 LIGKGG-SSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLVYDFLSRGSLE 505 (770)
Q Consensus 429 ~LG~G~-fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~LV~E~~~ggsL~ 505 (770)
.+..|. .+.||+....++..+++|....... ..+..|...|..+.. -.+.+++.++.+++..++||+|++|.++.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT--SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH--hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 344454 3679998887888899998875432 346678887777753 23566788888888899999999987654
Q ss_pred h
Q 004174 506 E 506 (770)
Q Consensus 506 ~ 506 (770)
+
T Consensus 95 ~ 95 (255)
T d1nd4a_ 95 S 95 (255)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.47 E-value=0.00019 Score=76.57 Aligned_cols=76 Identities=17% Similarity=0.138 Sum_probs=49.6
Q ss_pred ceeecccCceEEEEEEeC-CCCEEEEEEeCCC--------hhHHHHHHHHHHHHHhcC-C--CceeEEeeEEeecCceEE
Q 004174 427 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--------EDVIKEFVLEIEIITTLH-H--KNIISLLGFCFEDNNLLL 494 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~-~g~~vAVK~l~~~--------~~~~~~~~~Ei~iL~~l~-H--pnIv~l~~~~~~~~~~~L 494 (770)
.+.||.|....||+.... +++.++||.-.+. .....+...|.+.|..+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 456899999999999865 4678999976431 112334556888887763 2 345555544 4456689
Q ss_pred EEeecCCCCh
Q 004174 495 VYDFLSRGSL 504 (770)
Q Consensus 495 V~E~~~ggsL 504 (770)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.09 E-value=0.00082 Score=69.39 Aligned_cols=137 Identities=16% Similarity=0.221 Sum_probs=81.1
Q ss_pred ceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCce--eEEe-----eEEeecCceEEEEeecCCCChhh-
Q 004174 435 SSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI--ISLL-----GFCFEDNNLLLVYDFLSRGSLEE- 506 (770)
Q Consensus 435 fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnI--v~l~-----~~~~~~~~~~LV~E~~~ggsL~~- 506 (770)
--.||+....+|..|++|+.++.....+++..|+..+..|....+ +..+ ..+..++..+.+++|++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 468999999899999999998765556778889888888752221 1111 12344567889999998754321
Q ss_pred -------------hhcc----CC-CCCCCCCHH-------------------HHHHHHHHHHHHHHHHH----cCCCCce
Q 004174 507 -------------NLHG----NK-KDPAAFGWS-------------------ERYKVAMGVAEALEYLH----SGSAQRV 545 (770)
Q Consensus 507 -------------~l~~----~~-~~~~~l~~~-------------------~~~~i~~qia~aL~yLH----~~~~~~I 545 (770)
.+|. .. .....+++. .+..+...+...+..+. .....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0110 00 000111111 11112222222333332 2234679
Q ss_pred EEecccCCCeeeCCCCceEEcccccccc
Q 004174 546 IHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (770)
Q Consensus 546 iHrDLKp~NILL~~~~~vkL~DFGla~~ 573 (770)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 56899987753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.60 E-value=0.0018 Score=68.60 Aligned_cols=74 Identities=18% Similarity=0.229 Sum_probs=51.2
Q ss_pred ceeecccCceEEEEEEeCC--------CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCce-eEEeeEEeecCceEEEEe
Q 004174 427 ENLIGKGGSSQVYKGCLPD--------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYD 497 (770)
Q Consensus 427 ~~~LG~G~fG~Vy~a~~~~--------g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~LV~E 497 (770)
.+.|+.|-.-.+|+...++ .+.|++++.-..... -...+|..+++.+.-.++ .+++++|.. .+|||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE-SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4678889999999988643 356788887643332 345678889888863344 467777642 78999
Q ss_pred ecCCCChh
Q 004174 498 FLSRGSLE 505 (770)
Q Consensus 498 ~~~ggsL~ 505 (770)
|++|..|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99876543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.23 E-value=0.005 Score=62.55 Aligned_cols=157 Identities=13% Similarity=0.036 Sum_probs=81.5
Q ss_pred HHHHHHhhcCcccc-----eeecccCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC-----CceeEEe
Q 004174 414 YQDLLSATSNFLAE-----NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-----KNIISLL 483 (770)
Q Consensus 414 ~~~l~~~t~~f~~~-----~~LG~G~fG~Vy~a~~~~g~~vAVK~l~~~~~~~~~~~~Ei~iL~~l~H-----pnIv~l~ 483 (770)
.+++.....+|.+. ..|..|---+.|+....+|+ +++|+..... ..+++..|++++..|.. |..+...
T Consensus 5 ~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi~~~ 82 (316)
T d2ppqa1 5 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRK 82 (316)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred HHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccceec
Confidence 34555555556543 33456666888998886665 8999986532 22344556666666642 2211110
Q ss_pred ---eEEeecCceEEEEeecCCCChhhh--------------hccC---CCCCCC--C------------------CHHHH
Q 004174 484 ---GFCFEDNNLLLVYDFLSRGSLEEN--------------LHGN---KKDPAA--F------------------GWSER 523 (770)
Q Consensus 484 ---~~~~~~~~~~LV~E~~~ggsL~~~--------------l~~~---~~~~~~--l------------------~~~~~ 523 (770)
.+.........++.++.+...... ++.. ...... . .....
T Consensus 83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (316)
T d2ppqa1 83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 162 (316)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhH
Confidence 012223456777777766533210 0000 000000 0 00111
Q ss_pred HHHHHHHHHHHHHHHc-CCCCceEEecccCCCeeeCCCCceEEccccccc
Q 004174 524 YKVAMGVAEALEYLHS-GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (770)
Q Consensus 524 ~~i~~qia~aL~yLH~-~~~~~IiHrDLKp~NILL~~~~~vkL~DFGla~ 572 (770)
...+..+...+.-.+. .-..++||+|+.+.||+++.+...-|+||+.+.
T Consensus 163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 2222333333333332 235789999999999999988767899999773
|
| >d1wy5a1 c.26.2.5 (A:1-216) TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: TilS-like protein Aq 1887 species: Aquifex aeolicus [TaxId: 63363]
Probab=90.92 E-value=0.4 Score=45.44 Aligned_cols=97 Identities=13% Similarity=-0.026 Sum_probs=63.1
Q ss_pred CCcEEEEEEcCCcchHHHHHHHHhhccCCC-CEEEEEEeecCCCcccCCCCccchhhhHHHHHHHHHHHhHhhhcCCcEE
Q 004174 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPG-DTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLK 93 (770)
Q Consensus 15 ~~r~I~VaVd~s~~S~~AL~WAl~~~~~~g-d~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~ 93 (770)
++.+|+|||.+..+|.-+|.++....-.-+ ..|.++||-..-.. . -+.-....+.+|...+|.+.
T Consensus 23 ~~~kv~Va~SGG~DS~~Ll~lL~~~~~~~~~~~i~~~~vdh~~r~------~--------s~~~~~~~~~~~~~l~i~~~ 88 (216)
T d1wy5a1 23 GERRVLIAFSGGVDSVVLTDVLLKLKNYFSLKEVALAHFNHMLRE------S--------AERDEEFCKEFAKERNMKIF 88 (216)
T ss_dssp SCCEEEEECCSSHHHHHHHHHHHHSTTTTTCSEEEEEEEECCSST------H--------HHHHHHHHHHHHHHHTCCEE
T ss_pred CCCeEEEEeCCcHHHHHHHHHHHHHHHhcCCCcEEEEEeeccccc------c--------hhhhhhHHHHHHHhhhhhhh
Confidence 467999999999999966665554322223 37889999642110 0 01112345788988888876
Q ss_pred EEEEEC--------C-------Ch-hHHHHHHHHhcCCcEEEEccCCC
Q 004174 94 LKICRG--------T-------SI-RKILVREAQSYSATKFIVGTAKN 125 (770)
Q Consensus 94 ~~v~~~--------~-------d~-~~~L~~~a~~~~a~~LVlG~~~~ 125 (770)
..-... . .. ...+.+.|++.+++.|++|.+.-
T Consensus 89 i~~~~~~~~~~~~~~~~~~~~R~~Ry~~l~~~a~~~~~~~ia~GH~~d 136 (216)
T d1wy5a1 89 VGKEDVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLN 136 (216)
T ss_dssp EEECCHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHH
T ss_pred hhccchhhhccCCccchHHHHHHHHHHHhhhhccccccceeEeeeecc
Confidence 543220 0 11 24678889999999999999965
|
| >d1ni5a1 c.26.2.5 (A:0-226) tRNA-Ile-lysidine synthetase, TilS, N-terminal domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: tRNA-Ile-lysidine synthetase, TilS, N-terminal domain species: Escherichia coli [TaxId: 562]
Probab=87.68 E-value=0.35 Score=46.09 Aligned_cols=96 Identities=17% Similarity=0.145 Sum_probs=60.4
Q ss_pred CCcEEEEEEcCCcchHHHHHHHHhhcc-CCCCEEEEEEeecCCCcccCCCCccchhhhHHHHHHHHHHHhHhhhcCCcEE
Q 004174 15 AGRTVVVGVKLDTHSRELLTWALVKVA-QPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLK 93 (770)
Q Consensus 15 ~~r~I~VaVd~s~~S~~AL~WAl~~~~-~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~V~~~ 93 (770)
..++|+|||.+..+|..+|..+.+... .+|-.|+++||-..-.. . . +......+.+|...+|.+.
T Consensus 12 ~~kkvlva~SGG~DS~~Ll~ll~~~~~~~~~~~l~~~~vdh~~r~--------~---s---~~~~~~~~~~~~~~~i~~~ 77 (227)
T d1ni5a1 12 TSRQILVAFSGGLDSTVLLHQLVQWRTENPGVALRAIHVHHGLSA--------N---A---DAWVTHCENVCQQWQVPLV 77 (227)
T ss_dssp TCSEEEEECCSBHHHHHHHHHHHHHHTTSTTCEEEEEEECCSCCS--------S---H---HHHHHHHHHHHHHTTCCEE
T ss_pred CCCcEEEEecCcHHHHHHHHHHHHHHHhCCCceEEEEEeCCCCCc--------c---h---hhhHHHHHHHHhhccCcce
Confidence 357999999999999977776655432 35789999999643210 0 1 1223456788999988877
Q ss_pred EEEEECCCh----------hHHHHHHHHhcCCcEEEEccCC
Q 004174 94 LKICRGTSI----------RKILVREAQSYSATKFIVGTAK 124 (770)
Q Consensus 94 ~~v~~~~d~----------~~~L~~~a~~~~a~~LVlG~~~ 124 (770)
..-...... ++.+...+...+++.+++|.+.
T Consensus 78 i~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~i~~gH~~ 118 (227)
T d1ni5a1 78 VERVQLAQEGLGIEAQARQARYQAFARTLLPGEVLVTAQHL 118 (227)
T ss_dssp EECCCCCCSSSTTTTHHHHHHHHHHHHTCCTTEEEECCCCH
T ss_pred eeeccccccccchhhHHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence 654432111 1222333455667777777664
|
| >d2c5sa1 c.26.2.6 (A:174-391) Thiamine biosynthesis protein ThiI, C-terminal domain {Bacillus anthracis [TaxId: 1392]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: ThiI-like domain: Thiamine biosynthesis protein ThiI, C-terminal domain species: Bacillus anthracis [TaxId: 1392]
Probab=84.26 E-value=2.8 Score=38.62 Aligned_cols=34 Identities=21% Similarity=0.146 Sum_probs=29.0
Q ss_pred cEEEEEEcCCcchHHHHHHHHhhccCCCCEEEEEEeec
Q 004174 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLA 54 (770)
Q Consensus 17 r~I~VaVd~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~ 54 (770)
-+|+||+.+..+|.-|+.|+... |..|++||+-.
T Consensus 5 gKvvv~~SGG~DS~vla~ll~k~----g~~v~av~~~~ 38 (218)
T d2c5sa1 5 GKVMVLLSGGIDSPVAAYLTMKR----GVSVEAVHFHS 38 (218)
T ss_dssp EEEEEECCSSSHHHHHHHHHHHB----TEEEEEEEEEC
T ss_pred CEEEEEecCcHHHHHHHHHHHHc----CCeEEEEEEeC
Confidence 37999999999999888888653 78999999964
|